data_1afi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1afi _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -126.88 165.95 18.4 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.254 -0.904 . . . . 0.0 111.666 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 14.6 t -130.42 134.3 47.01 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.58 -0.7 . . . . 0.0 110.324 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.528 HG23 ' CG2' ' A' ' 54' ' ' VAL . 10.8 t -122.6 171.42 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -0.765 . . . . 0.0 109.266 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.562 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -106.96 158.56 16.94 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.003 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.629 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -132.13 156.32 46.57 Favored 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 118.476 -1.289 . . . . 0.0 110.538 -178.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.19 101.67 10.68 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.412 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.463 HG23 ' SG ' ' A' ' 17' ' ' CYS . 1.5 p -113.89 87.85 13.29 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.609 -0.682 . . . . 0.0 109.614 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 11.5 Cg_endo -78.1 39.94 0.83 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.351 1.367 . . . . 0.0 111.764 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.582 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -81.4 -28.57 43.51 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.506 ' CG ' ' C ' ' A' ' 11' ' ' GLY . 7.7 ptt? 33.12 62.11 0.38 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.92 -0.753 . . . . 0.0 110.541 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.537 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -85.25 11.59 9.74 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.466 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.1 OUTLIER 70.31 90.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 110.088 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' A' ' 14' ' ' CYS . . . 59.4 26.98 15.98 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.573 -0.704 . . . . 0.0 110.103 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.537 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -131.44 -40.69 1.11 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.801 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.607 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -53.59 -48.93 91.41 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.0 110.992 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 7.5 Cg_endo -72.45 -10.36 25.33 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.434 1.229 . . . . 0.0 112.33 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.06 -45.75 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.682 -1.262 . . . . 0.0 109.875 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.561 ' CG2' ' CB ' ' A' ' 64' ' ' ALA 0.257 1.2 m -73.44 -36.75 65.97 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.679 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.587 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 13.5 t -70.26 -47.85 64.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.878 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 18' ' ' PRO . 6.3 tmtt? -49.9 -51.57 39.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.491 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.531 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -70.52 -21.9 62.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.922 -1.111 . . . . 0.0 111.252 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.496 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . -66.87 -54.36 23.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.243 -0.911 . . . . 0.0 110.471 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.614 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 3.6 mp -70.7 -31.09 67.83 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.084 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.529 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 3.6 p -68.8 -20.47 64.33 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -116.31 4.92 13.5 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.449 -0.901 . . . . 0.0 109.816 179.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.532 ' CG2' ' HB3' ' A' ' 56' ' ' LYS . 8.0 p -51.01 -50.03 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.0 110.867 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER 175.44 -77.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.883 -1.135 . . . . 0.0 110.888 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.94 2.36 56.82 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 26' ' ' SER . 14.9 p -44.77 144.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.042 -1.27 . . . . 0.0 110.592 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.419 ' OG ' ' OD2' ' A' ' 48' ' ' ASP . 19.4 m -113.28 -16.3 12.54 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' O ' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -170.19 167.82 8.49 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.698 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.6 p -157.88 167.36 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.124 -0.985 . . . . 0.0 110.55 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.495 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 1.6 m-20 -167.68 178.53 5.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.977 . . . . 0.0 110.086 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 3.8 m -150.13 165.4 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 111.127 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.3 106.85 0.32 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -70.05 -8.24 47.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -1.176 . . . . 0.0 110.53 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -60.34 -23.98 64.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.058 -1.026 . . . . 0.0 109.17 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -150.29 30.65 0.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.462 -0.774 . . . . 0.0 110.144 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 40' ' ' LYS . 2.0 mpp_? 40.56 58.94 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.522 -0.736 . . . . 0.0 110.408 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 2.4 pt-20 -136.88 149.53 47.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 0.0 110.211 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.551 ' CB ' ' CG1' ' A' ' 21' ' ' VAL . . . -117.86 132.18 56.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.972 -1.08 . . . . 0.0 109.449 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.495 ' CG1' ' HB2' ' A' ' 35' ' ' ASP . 8.1 p -106.83 130.61 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.738 -1.226 . . . . 0.0 109.531 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.591 ' CG1' ' CD1' ' A' ' 57' ' ' LEU . 4.2 p -133.33 147.47 31.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.178 -1.009 . . . . 0.0 113.049 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 47' ' ' PHE . 1.3 m -109.71 154.2 23.22 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.581 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 36.2 p90 -172.11 -177.2 1.82 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 117.883 -1.527 . . . . 0.0 111.811 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.419 ' OD2' ' OG ' ' A' ' 32' ' ' SER . 10.5 m-20 -107.22 114.44 28.49 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 11.0 t70 -62.96 -9.36 9.62 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.304 -0.872 . . . . 0.0 110.715 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.8 t -72.88 -22.49 60.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -128.15 -7.16 5.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.213 -0.929 . . . . 0.0 110.902 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.455 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -154.43 -167.61 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.482 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.581 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 170.76 171.87 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.48 -0.763 . . . . 0.0 109.606 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.528 ' CG2' HG23 ' A' ' 5' ' ' VAL . 2.7 t -40.65 -47.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 110.317 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.96 -48.35 43.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.007 -1.058 . . . . 0.0 110.198 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.532 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 28.1 mmtm -73.74 -26.55 60.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -0.864 . . . . 0.0 111.318 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.591 ' CD1' ' CG1' ' A' ' 45' ' ' VAL . 63.3 mt -68.37 -58.18 4.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.668 -1.27 . . . . 0.0 108.809 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.516 ' N ' HD22 ' A' ' 7' ' ' LEU . 16.4 m -57.79 -29.22 64.7 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.456 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 68.1 tttt -73.68 -29.37 62.26 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.379 -0.826 . . . . 0.0 109.54 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.74 -50.32 37.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.291 -0.881 . . . . 0.0 109.504 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.503 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 1.5 t -69.74 -26.63 64.41 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . -66.73 -36.62 82.89 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.57 -9.92 55.08 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.561 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -29.27 55.68 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.564 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 135.04 25.18 0.55 Allowed Glycine 0 N--CA 1.486 2.002 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.067 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.582 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 42.0 m-85 -146.03 120.86 5.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.62 -1.518 . . . . 0.0 111.856 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.72 95.54 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 N-CA-C 107.014 -1.956 . . . . 0.0 107.014 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -108.47 -173.73 2.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 0.0 112.543 -176.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.518 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.5 OUTLIER -148.8 -162.57 1.59 Allowed 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.629 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.0 p -141.0 158.95 23.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.07 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.499 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 6.1 mtmt -116.27 17.52 15.6 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.198 0.999 . . . . 0.0 110.307 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.461 ' C ' HG11 ' A' ' 5' ' ' VAL . 13.2 mt-30 . . . . . 0 C--N 1.282 -2.368 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.57 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -118.68 160.84 21.1 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.086 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.412 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 2.0 t -134.49 132.87 39.76 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.7 -0.625 . . . . 0.0 109.648 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.583 HG22 ' CG2' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -133.24 169.03 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.884 0.849 . . . . 0.0 109.508 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.19 157.03 18.2 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -132.07 157.07 45.13 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.465 -178.146 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.23 112.44 24.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.55 -0.719 . . . . 0.0 110.279 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.481 ' CG2' HG22 ' A' ' 21' ' ' VAL . 1.4 p -123.42 88.0 51.7 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.272 -0.892 . . . . 0.0 110.011 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -78.53 59.77 7.31 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.427 1.418 . . . . 0.0 111.806 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.58 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -104.03 -26.83 6.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.497 ' O ' ' HG3' ' A' ' 12' ' ' MET . 19.0 ptm 29.64 61.47 0.16 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.717 0.77 . . . . 0.0 111.356 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.54 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -85.97 13.72 7.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.465 -0.772 . . . . 0.0 109.36 179.024 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 13' ' ' THR . 2.7 t 69.76 91.82 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.556 -0.715 . . . . 0.0 110.24 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.53 16.83 5.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 110.31 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.54 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -118.64 -44.05 2.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.528 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.607 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -51.59 -48.37 87.05 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.421 -0.799 . . . . 0.0 111.231 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 5.6 Cg_endo -73.24 -11.87 25.16 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 121.274 1.316 . . . . 0.0 112.634 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.0 mm -92.28 -41.43 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.692 -1.255 . . . . 0.0 109.567 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.529 ' CG2' ' CB ' ' A' ' 64' ' ' ALA 0.25 1.2 m -73.83 -39.87 63.73 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.58 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 98.9 t -69.49 -49.86 55.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.108 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HG3' HG11 ' A' ' 34' ' ' VAL . 13.8 tttt -47.23 -51.76 17.81 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 110.471 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.567 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -72.88 -21.38 60.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.034 -1.041 . . . . 0.0 111.393 -179.258 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.498 ' N ' ' HG3' ' A' ' 23' ' ' LYS . . . -68.12 -53.95 21.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 110.719 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 3.9 mp -71.18 -29.08 64.74 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.08 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -74.79 -17.82 60.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.422 -0.799 . . . . 0.0 109.224 179.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.567 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -115.35 2.07 13.88 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.111 -0.993 . . . . 0.0 110.062 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 56' ' ' LYS . 9.3 p -53.56 -47.71 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.317 -0.864 . . . . 0.0 110.853 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.5 OUTLIER 179.25 -86.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.72 -1.237 . . . . 0.0 111.517 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -95.34 3.25 66.08 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.504 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 26' ' ' SER . 8.8 p -42.33 142.16 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.142 -1.211 . . . . 0.0 110.366 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 t -114.58 -17.34 11.71 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.688 0.756 . . . . 0.0 108.999 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 3.0 tttm -162.43 163.83 27.48 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.961 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.509 ' CG1' ' HB2' ' A' ' 26' ' ' SER . 9.9 p -162.59 159.22 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 110.489 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.505 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 2.7 t70 -166.26 171.84 11.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 109.853 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.497 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 4.3 m -140.69 163.17 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.033 -1.042 . . . . 0.0 110.865 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.77 113.23 0.57 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.588 ' CE2' ' HG3' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -70.19 -21.57 63.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -1.228 . . . . 0.0 110.281 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -45.82 -45.51 14.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.131 -0.981 . . . . 0.0 109.458 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.0 mttm -126.4 25.85 6.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.439 -0.788 . . . . 0.0 109.687 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.584 ' HD3' ' CE1' ' A' ' 38' ' ' PHE . 7.1 mmm180 38.75 60.19 1.43 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.837 -0.539 . . . . 0.0 110.175 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.514 ' CA ' ' O ' ' A' ' 7' ' ' LEU . 6.9 pt-20 -141.68 150.27 41.66 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.957 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.526 ' CB ' HG13 ' A' ' 21' ' ' VAL . . . -116.14 131.95 56.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.004 -1.06 . . . . 0.0 108.969 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 35' ' ' ASP . 13.4 p -105.22 130.89 55.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.786 -1.196 . . . . 0.0 109.676 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.575 ' CG1' ' CD1' ' A' ' 57' ' ' LEU . 4.2 p -131.92 143.06 41.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.946 0.879 . . . . 0.0 112.454 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -109.38 157.89 18.47 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.598 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 34.9 p90 -171.88 -176.33 1.7 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 117.399 -1.72 . . . . 0.0 112.122 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -106.85 113.51 27.05 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.61 -10.96 4.03 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 111.147 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.8 t -69.02 -24.75 64.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 110.929 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -128.84 -12.0 4.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.903 -1.123 . . . . 0.0 111.509 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -148.24 -169.41 3.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.017 -1.052 . . . . 0.0 110.712 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.598 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER 171.2 172.58 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.442 -0.786 . . . . 0.0 109.914 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.518 HG22 HG23 ' A' ' 70' ' ' VAL . 2.1 p -40.73 -35.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 110.406 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.406 ' N ' HG11 ' A' ' 54' ' ' VAL . 4.0 tp60 -56.59 -49.63 74.35 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.232 -0.917 . . . . 0.0 110.293 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.534 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 15.9 mmtt -78.82 -18.38 54.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.27 -0.894 . . . . 0.0 111.526 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.575 ' CD1' ' CG1' ' A' ' 45' ' ' VAL . 52.3 mt -75.01 -58.87 3.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.415 -1.428 . . . . 0.0 108.268 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.492 ' N ' HD23 ' A' ' 7' ' ' LEU . 19.5 m -58.76 -30.04 67.23 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.741 -0.783 . . . . 0.0 109.111 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -80.79 -23.43 39.29 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.308 -0.87 . . . . 0.0 109.536 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.445 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -72.81 -47.06 49.68 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.394 -0.816 . . . . 0.0 109.086 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.521 HG21 ' N ' ' A' ' 62' ' ' ALA . 9.2 t -71.39 -35.78 71.17 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.521 ' N ' HG21 ' A' ' 61' ' ' THR . . . -64.04 -29.68 70.81 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.626 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 63' ' ' ASP . 2.1 t70 -89.67 -11.35 42.71 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.529 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -28.26 55.28 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.72 23.44 0.51 Allowed Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.697 -1.239 . . . . 0.0 111.228 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.58 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 46.8 m-85 -146.13 110.94 4.37 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.649 -1.501 . . . . 0.0 111.103 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.49 99.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 N-CA-C 107.297 -1.847 . . . . 0.0 107.297 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -109.06 -172.02 1.96 Allowed 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.362 -176.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.512 ' N ' ' OG ' ' A' ' 68' ' ' SER . 19.9 m -147.32 -162.75 1.61 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.601 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.5 p -139.92 160.37 26.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 C-N-CA 118.647 -1.221 . . . . 0.0 111.763 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.498 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 1.7 mttt -123.24 19.1 9.87 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.963 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.511 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 1.8 tt0 . . . . . 0 C--N 1.283 -2.306 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.126 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.6 151.8 25.13 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.898 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.43 117.23 23.97 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.288 0.566 . . . . 0.0 109.616 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 72' ' ' GLN . 4.6 t -126.76 168.19 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 109.931 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.559 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -108.88 160.47 15.97 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.588 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.1 mp -133.66 155.36 49.85 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.623 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.6 110.75 21.91 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.879 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.469 HG23 ' SG ' ' A' ' 17' ' ' CYS . 1.6 p -124.38 85.99 55.25 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.505 -0.747 . . . . 0.0 109.67 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.428 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 11.2 Cg_endo -79.51 52.36 4.26 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.965 1.508 . . . . 0.0 111.294 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.605 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -97.6 -34.11 5.64 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.536 ' HG2' ' CZ ' ' A' ' 41' ' ' ARG . 1.8 mtp 69.04 -79.57 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.982 -0.716 . . . . 0.0 110.456 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.501 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 0.6 OUTLIER 50.86 14.39 0.18 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.92 -1.112 . . . . 0.0 109.638 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' THR . 0.7 OUTLIER 51.25 108.41 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.333 -0.855 . . . . 0.0 111.519 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 43.81 36.76 1.41 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -0.772 . . . . 0.0 111.034 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.501 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -139.01 -37.68 0.51 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 110.021 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -51.76 -50.34 78.16 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.772 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.583 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 9.4 Cg_endo -73.38 -11.26 24.61 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.189 1.26 . . . . 0.0 112.633 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.8 mm -92.1 -45.47 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.64 -1.288 . . . . 0.0 109.872 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.562 ' CG2' ' CB ' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -70.13 -37.23 75.25 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.572 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 13.0 t -64.75 -44.64 96.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.518 ' HA ' ' CG1' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -52.78 -41.42 64.08 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.476 -0.765 . . . . 0.0 109.805 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -79.57 -22.37 43.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 111.173 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 60' ' ' ALA . . . -67.99 -51.15 50.51 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.174 -0.954 . . . . 0.0 110.089 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.572 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 4.1 mp -78.93 -31.36 45.18 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.516 -0.74 . . . . 0.0 110.874 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.527 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 42.5 p -69.31 -21.36 63.86 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.04 -1.037 . . . . 0.0 108.844 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -116.12 0.55 12.99 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.843 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 25' ' ' LEU . 3.7 p -45.46 -52.64 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.032 -1.043 . . . . 0.0 110.681 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER 176.41 -77.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.84 -1.163 . . . . 0.0 111.08 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.46 0.43 61.55 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.538 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 6.8 p -42.57 143.21 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.24 . . . . 0.0 110.834 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 m -117.26 -16.21 10.36 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.105 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.495 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -166.62 164.26 16.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.617 -0.677 . . . . 0.0 109.509 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.524 HG21 ' CG1' ' A' ' 45' ' ' VAL . 37.9 t -156.14 163.22 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.061 -1.025 . . . . 0.0 110.687 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.544 ' CB ' HG11 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -162.95 161.78 25.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.292 -0.88 . . . . 0.0 109.758 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 18' ' ' PRO . 4.1 m -142.82 151.85 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.516 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.49 104.54 0.35 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.583 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -64.44 -29.55 70.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -1.161 . . . . 0.0 110.276 -179.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.9 mm-40 -44.68 -28.52 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 109.721 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -132.99 1.55 3.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 110.396 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.549 ' HG3' ' NH1' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 59.06 51.27 7.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.448 -0.783 . . . . 0.0 110.135 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 51.7 mt-10 -138.12 146.46 42.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.472 -0.767 . . . . 0.0 109.813 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.563 ' CB ' ' CG1' ' A' ' 21' ' ' VAL . . . -115.36 130.38 56.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.998 -1.064 . . . . 0.0 109.32 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.544 HG11 ' CB ' ' A' ' 35' ' ' ASP . 14.7 p -105.68 127.45 60.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.907 -1.12 . . . . 0.0 109.079 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.529 HG23 ' CB ' ' A' ' 25' ' ' LEU . 37.3 t -134.06 148.06 30.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 119.049 -1.06 . . . . 0.0 112.484 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -108.89 158.62 17.51 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 2' ' ' THR . 33.1 p90 -171.54 -174.84 1.47 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 117.637 -1.625 . . . . 0.0 111.933 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -105.65 110.6 22.98 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 5.0 t70 -61.47 -11.48 10.83 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.709 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 82.4 p -75.01 -27.7 60.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.26 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 mtpp -122.08 -1.63 9.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 110.345 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -158.77 -169.07 2.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 110.33 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.601 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.4 p 170.32 170.53 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.437 -0.79 . . . . 0.0 109.528 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.533 ' CG2' ' CG2' ' A' ' 70' ' ' VAL . 2.5 p -42.24 -44.44 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 110.03 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -51.44 -47.89 62.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -0.989 . . . . 0.0 109.694 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.432 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 18.2 mmtp -75.12 -20.67 59.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 0.0 110.966 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.529 ' HB3' HD22 ' A' ' 25' ' ' LEU . 82.0 mt -72.77 -60.27 2.31 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.688 -1.258 . . . . 0.0 108.19 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 62' ' ' ALA . 1.2 p -57.42 -29.66 64.33 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.483 -0.761 . . . . 0.0 109.012 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.456 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 55.2 tttt -74.57 -31.41 62.07 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.339 -0.85 . . . . 0.0 109.726 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . -69.87 -51.34 34.13 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.283 -0.886 . . . . 0.0 109.325 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.477 HG22 ' OG ' ' A' ' 68' ' ' SER . 1.6 t -68.64 -27.18 65.78 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . -65.4 -35.22 80.28 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.79 -15.71 50.66 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.634 -0.827 . . . . 0.0 108.953 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.562 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -71.4 -29.55 65.05 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.93 23.71 0.84 Allowed Glycine 0 N--CA 1.486 1.978 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.952 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.605 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 50.7 m-85 -139.36 111.84 7.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.686 -1.479 . . . . 0.0 111.72 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.85 96.65 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 107.046 -1.944 . . . . 0.0 107.046 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 10.0 p -108.1 -167.1 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 112.581 -176.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.481 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 19.2 m -157.81 -165.94 1.87 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.588 ' HA ' HD13 ' A' ' 7' ' ' LEU . 4.0 p -135.75 161.12 38.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 120.631 -1.293 . . . . 0.0 111.433 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.429 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 0.6 OUTLIER -123.97 25.7 7.85 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.303 1.049 . . . . 0.0 110.134 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.508 ' HA ' HG11 ' A' ' 5' ' ' VAL . 2.0 tm0? . . . . . 0 C--N 1.284 -2.261 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.113 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.33 162.03 14.71 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.713 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.482 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 1.2 t -125.0 147.33 48.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -153.49 159.29 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -106.69 155.74 19.35 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.601 ' CD2' ' CD2' ' A' ' 25' ' ' LEU . 1.1 mp -129.9 158.54 39.22 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.41 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -112.39 105.32 13.56 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.212 0.529 . . . . 0.0 110.302 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.462 HG23 ' SG ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -120.21 85.42 36.07 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.606 -0.684 . . . . 0.0 109.42 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' A' ' 41' ' ' ARG . 10.2 Cg_endo -78.56 58.31 6.7 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.807 1.424 . . . . 0.0 111.216 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -102.08 -25.05 8.12 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 14.2 mtm 59.15 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.739 -0.859 . . . . 0.0 110.064 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.491 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 0.8 OUTLIER 50.32 14.05 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.363 -0.836 . . . . 0.0 109.958 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 54.48 109.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 111.626 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 39.99 26.27 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.563 -0.711 . . . . 0.0 111.706 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 13' ' ' THR . . . -118.63 -42.53 2.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.939 -1.101 . . . . 0.0 109.139 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -52.5 -46.96 95.01 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.621 -0.675 . . . . 0.0 111.903 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 5.6 Cg_endo -70.29 -20.27 32.56 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.201 1.268 . . . . 0.0 113.49 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.6 mp -92.4 -36.64 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.447 -1.408 . . . . 0.0 110.038 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.484 ' CG2' ' HB3' ' A' ' 64' ' ' ALA 0.252 1.2 m -73.45 -42.48 61.9 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.587 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 96.9 t -62.75 -50.37 79.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.457 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HD2' ' CG2' ' A' ' 36' ' ' VAL . 15.9 tttm -51.39 -44.07 62.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 110.268 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 5.0 mttm -69.89 -23.21 63.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.111 -0.993 . . . . 0.0 111.102 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HB2' ' C ' ' A' ' 60' ' ' ALA . . . -76.26 -62.5 1.59 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.533 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.601 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 3.6 mp -56.85 -30.73 64.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 0.0 110.486 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.518 ' CB ' HG22 ' A' ' 34' ' ' VAL . 4.5 p -76.05 -30.34 58.35 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.416 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -88.36 -3.92 58.76 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.268 -0.895 . . . . 0.0 109.625 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 29' ' ' GLU . 3.8 t -41.76 -83.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.429 -0.794 . . . . 0.0 110.066 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.533 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 3.3 tt0 179.36 -52.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.46 -0.775 . . . . 0.0 109.062 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.74 -23.33 15.96 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.588 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 39.6 t -51.63 134.52 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -1.108 . . . . 0.0 110.103 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.7 t -127.84 -5.09 5.73 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.083 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 13.9 tttp -155.71 116.33 3.8 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.524 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.518 HG22 ' CB ' ' A' ' 26' ' ' SER . 3.9 t -109.25 -178.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.686 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.486 ' CB ' HG11 ' A' ' 44' ' ' VAL . 26.4 t0 -161.26 159.28 28.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.984 -1.073 . . . . 0.0 110.249 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.545 HG12 ' CB ' ' A' ' 18' ' ' PRO . 17.6 t -112.62 135.85 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.811 . . . . 0.0 110.699 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.09 60.02 0.53 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.647 ' CZ ' ' NH1' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -62.49 -16.49 55.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -1.175 . . . . 0.0 110.358 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -44.84 -26.52 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 109.148 179.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 41' ' ' ARG . 5.0 ttpt -152.43 47.21 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.611 -0.68 . . . . 0.0 109.833 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.647 ' NH1' ' CZ ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER 39.91 63.16 1.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.661 -0.649 . . . . 0.0 109.684 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 2.0 tm-20 -140.18 148.16 41.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.497 -0.752 . . . . 0.0 110.363 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -124.09 132.16 53.63 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 6' ' ' THR . 0.9 OUTLIER -105.95 145.01 14.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.358 -1.464 . . . . 0.0 109.561 -178.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.578 ' CG2' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -139.52 177.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 122.703 1.24 . . . . 0.0 112.362 -177.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -152.68 143.65 23.01 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 105.682 -1.969 . . . . 0.0 105.682 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 34.3 p90 -166.06 -176.0 3.58 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 117.242 -1.783 . . . . 0.0 112.934 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.8 115.83 30.87 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 17.5 t70 -62.12 -8.6 5.73 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 111.028 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.509 HG21 ' N ' ' A' ' 51' ' ' LYS . 15.1 t -76.26 -21.55 56.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 110.74 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.509 ' N ' HG21 ' A' ' 50' ' ' THR . 4.0 mtpt -128.59 -6.45 5.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.101 -0.999 . . . . 0.0 110.922 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -156.52 -169.7 3.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 110.216 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.592 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 14.8 t 175.81 168.62 0.39 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.535 HG22 ' CG2' ' A' ' 70' ' ' VAL . 2.8 p -42.91 -40.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 110.039 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -54.34 -47.65 72.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.114 -0.991 . . . . 0.0 109.826 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 17.8 mmtt -75.73 -18.09 59.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 111.249 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 53' ' ' SER . 68.4 mt -75.49 -58.68 3.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.501 -1.375 . . . . 0.0 107.949 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.518 ' N ' HD22 ' A' ' 7' ' ' LEU . 1.9 m -57.67 -32.21 67.1 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.46 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -73.57 -33.18 64.54 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.406 -0.809 . . . . 0.0 109.727 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.485 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -66.3 -46.34 77.31 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.272 -0.893 . . . . 0.0 109.371 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.534 HG21 ' N ' ' A' ' 62' ' ' ALA . 5.7 t -68.7 -32.92 73.06 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.534 ' N ' HG21 ' A' ' 61' ' ' THR . . . -62.53 -31.83 72.68 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -86.95 -13.87 43.42 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.484 ' HB3' ' CG2' ' A' ' 20' ' ' THR . . . -75.64 -24.79 56.46 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 131.58 19.09 1.21 Allowed Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.848 -1.167 . . . . 0.0 110.937 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.589 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 35.4 m-85 -144.03 111.72 5.2 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.695 -1.474 . . . . 0.0 111.594 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.0 96.37 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 N-CA-C 107.844 -1.637 . . . . 0.0 107.844 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -108.85 -168.42 1.34 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.211 -0.931 . . . . 0.0 111.748 -177.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.539 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.0 OUTLIER -156.5 -163.49 1.46 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.588 ' HA ' HD13 ' A' ' 7' ' ' LEU . 5.7 p -137.18 159.44 36.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 O-C-N 120.583 -1.323 . . . . 0.0 111.022 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.57 ' CG ' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -130.56 39.12 3.66 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.019 -1.073 . . . . 0.0 109.46 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.524 ' CB ' HG12 ' A' ' 5' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.687 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.274 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.214 -0.78 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -110.09 169.92 8.42 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.799 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.1 t -143.99 113.41 6.98 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.36 0.6 . . . . 0.0 109.792 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.517 HG22 ' CG2' ' A' ' 54' ' ' VAL . 2.7 m -120.17 168.69 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 109.747 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.81 159.49 16.2 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 178.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.596 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.4 153.89 50.36 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.737 -1.227 . . . . 0.0 110.344 -178.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -108.84 104.74 14.05 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.411 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.469 HG23 ' SG ' ' A' ' 17' ' ' CYS . 1.2 p -112.4 93.36 22.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.608 -0.683 . . . . 0.0 109.999 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -76.82 35.24 0.47 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 O-C-N 123.737 1.388 . . . . 0.0 111.647 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.583 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.14 -62.85 4.57 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 41' ' ' ARG . 21.5 mtp 56.03 49.08 16.4 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.414 -1.051 . . . . 0.0 109.412 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.61 ' CG2' ' CB ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -84.08 10.33 10.36 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.27 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.1 OUTLIER 77.32 97.06 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.651 0.739 . . . . 0.0 111.273 179.324 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 54.62 42.55 31.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.525 -0.735 . . . . 0.0 111.396 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.61 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -162.45 -29.61 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.976 -1.077 . . . . 0.0 111.315 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -50.33 -52.01 58.35 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.689 -1.257 . . . . 0.0 110.184 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.604 ' HG3' ' CG ' ' A' ' 38' ' ' PHE . 9.5 Cg_endo -74.66 -6.9 18.83 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.353 1.369 . . . . 0.0 112.306 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.4 mm -90.87 -42.25 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.69 -1.257 . . . . 0.0 109.759 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.547 ' CG2' ' CB ' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -69.79 -32.03 70.27 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.57 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 40.4 t -73.42 -40.91 56.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.476 ' O ' HG13 ' A' ' 34' ' ' VAL . 7.8 tmtt? -50.06 -50.15 48.89 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.456 -0.778 . . . . 0.0 109.768 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.6 mmmm -77.6 -25.37 49.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.879 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 20' ' ' THR . . . -62.5 -57.82 9.82 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.315 -0.865 . . . . 0.0 110.813 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.57 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 2.8 mp -75.91 -30.97 58.96 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.391 -0.818 . . . . 0.0 111.295 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.557 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 1.8 t -69.39 -19.28 63.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.896 -1.127 . . . . 0.0 108.655 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.573 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 1.3 mptp? -115.54 -1.12 12.85 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.904 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.543 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 11.5 p -44.24 -45.25 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 110.221 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.543 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 163.31 -85.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.458 -0.776 . . . . 0.0 111.193 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.79 -6.07 89.63 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.81 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.578 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 7.6 p -50.06 141.89 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.892 -1.358 . . . . 0.0 110.36 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -121.18 -12.55 8.66 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.576 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -176.02 107.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.788 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.557 ' CG1' ' HB2' ' A' ' 26' ' ' SER . 1.5 p -114.01 179.06 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.154 -0.966 . . . . 0.0 111.399 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.04 160.82 16.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.5 -0.75 . . . . 0.0 110.045 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 15.8 m -130.39 158.75 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 0.0 110.476 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.3 112.47 0.62 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CG ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -75.22 -28.44 59.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 110.604 -179.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -55.17 -23.35 21.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.146 -0.971 . . . . 0.0 110.346 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HB3' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -134.59 16.5 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 0.0 110.43 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 12' ' ' MET . 1.5 mpp_? 42.53 55.58 4.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 110.043 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 2.2 pp20? -148.49 149.77 32.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.397 -0.814 . . . . 0.0 109.898 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.559 ' CB ' HG13 ' A' ' 21' ' ' VAL . . . -123.03 136.73 54.96 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.956 -1.09 . . . . 0.0 108.932 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 8.2 p -105.44 132.19 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.493 -1.379 . . . . 0.0 109.325 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.541 HG23 ' CD2' ' A' ' 25' ' ' LEU . 3.2 t -123.11 152.3 27.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.442 1.115 . . . . 0.0 112.401 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 1.3 m -125.51 145.94 49.87 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 176.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 2' ' ' THR . 35.4 p90 -170.59 -178.43 2.64 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 117.235 -1.786 . . . . 0.0 112.523 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.0 120.22 41.47 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.6 -3.24 2.95 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.399 -0.813 . . . . 0.0 111.327 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.4 p -77.0 -23.25 52.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.027 . . . . 0.0 110.651 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -130.32 0.63 4.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.022 -1.049 . . . . 0.0 110.894 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -159.65 -166.58 1.79 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 109.917 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.583 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.0 t 176.21 160.62 0.32 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 110.001 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.593 ' CG2' ' CG2' ' A' ' 70' ' ' VAL . 5.7 p -42.49 -37.86 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.363 -0.836 . . . . 0.0 110.151 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.481 ' N ' HG11 ' A' ' 54' ' ' VAL . 2.4 tt0 -56.96 -49.1 76.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.883 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HG3' ' CG2' ' A' ' 28' ' ' VAL . 2.0 tptt -70.06 -23.71 63.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 0.0 110.76 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.592 HD13 ' CE2' ' A' ' 47' ' ' PHE . 66.8 mt -69.32 -56.62 6.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.795 -1.19 . . . . 0.0 108.812 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.447 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 12.3 m -60.2 -30.44 69.37 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 33.3 tttt -77.06 -23.17 52.02 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.542 -0.724 . . . . 0.0 109.61 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.438 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . . . -72.79 -46.06 55.27 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.334 -0.854 . . . . 0.0 109.255 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.534 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 7.6 t -72.71 -34.14 66.93 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.526 ' N ' HG21 ' A' ' 61' ' ' THR . . . -63.96 -32.6 74.19 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.824 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -91.0 -9.53 45.6 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.457 -0.777 . . . . 0.0 109.395 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.547 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -79.08 -24.73 43.3 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.44 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.04 15.57 0.91 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.249 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.626 ' CZ ' ' HA ' ' A' ' 17' ' ' CYS . 26.5 m-85 -139.72 110.21 7.34 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.562 -1.552 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.51 99.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 N-CA-C 107.509 -1.766 . . . . 0.0 107.509 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.529 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 9.2 p -108.43 -170.65 1.71 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.233 1.016 . . . . 0.0 112.767 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 t -150.64 -162.19 1.5 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.596 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.7 p -141.92 162.46 20.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.19 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.5 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -124.92 23.83 7.75 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.363 1.078 . . . . 0.0 108.944 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.472 ' HB2' HG22 ' A' ' 54' ' ' VAL . 1.7 tt0 . . . . . 0 C--N 1.286 -2.18 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.755 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -108.81 162.79 13.86 Favored 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 119.476 -0.889 . . . . 0.0 112.445 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.414 ' O ' HG21 ' A' ' 4' ' ' THR . 1.1 t -137.66 119.28 14.98 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.264 0.554 . . . . 0.0 109.599 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.537 HG12 ' CG2' ' A' ' 54' ' ' VAL . 3.0 m -126.55 170.36 16.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.279 -0.888 . . . . 0.0 109.803 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.535 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.95 161.32 14.82 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.636 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.94 156.45 48.98 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 118.541 -1.264 . . . . 0.0 110.036 -178.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.66 109.63 20.43 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.182 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.552 HG23 ' CG2' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -117.71 102.94 51.22 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.244 -0.91 . . . . 0.0 109.617 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.44 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 7.7 Cg_endo -75.71 32.48 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.428 1.418 . . . . 0.0 112.329 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.565 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -74.62 -69.72 1.35 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.524 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 48.63 30.68 2.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -1.078 . . . . 0.0 109.365 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.626 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -61.23 -10.4 6.69 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.626 ' CB ' ' O ' ' A' ' 13' ' ' THR . 2.8 t 89.93 98.4 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.615 0.722 . . . . 0.0 111.019 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 71.7 27.59 2.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.61 -0.681 . . . . 0.0 111.256 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.614 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -150.61 -44.67 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.796 -1.19 . . . . 0.0 110.531 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.57 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -45.73 -50.03 34.84 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.862 -1.149 . . . . 0.0 111.39 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 17' ' ' CYS . 6.8 Cg_endo -69.94 -20.89 33.39 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.234 1.289 . . . . 0.0 113.484 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.5 mt -91.35 -30.04 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.381 -1.45 . . . . 0.0 110.028 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.436 HG21 ' HB3' ' A' ' 64' ' ' ALA 0.254 1.5 m -78.21 -40.59 37.05 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.471 0.653 . . . . 0.0 109.524 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.561 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 55.8 t -70.54 -52.05 32.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.182 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.524 ' HA ' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -50.93 -43.26 60.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.82 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 12.8 mtpt -71.96 -26.69 62.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 110.795 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.24 -62.17 1.49 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.487 -0.758 . . . . 0.0 110.714 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.606 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 2.8 mp -59.55 -34.72 73.02 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.309 -0.869 . . . . 0.0 110.562 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.525 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 2.1 t -72.11 -22.89 61.27 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.406 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.22 -10.47 41.5 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.276 -0.89 . . . . 0.0 109.716 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 29' ' ' GLU . 2.4 t -42.61 -80.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.444 -0.785 . . . . 0.0 109.851 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.565 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 1.1 mt-10 177.11 -69.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 110.051 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.419 ' O ' ' OD2' ' A' ' 48' ' ' ASP . . . -77.52 -13.39 83.58 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.546 HG22 ' CG2' ' A' ' 34' ' ' VAL . 12.2 p -48.2 139.4 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -1.125 . . . . 0.0 110.539 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.412 ' OG ' ' OD2' ' A' ' 48' ' ' ASP . 5.9 m -128.26 -6.46 5.38 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -173.62 103.9 0.12 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.421 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.546 ' CG2' HG22 ' A' ' 31' ' ' VAL . 70.9 t -111.77 171.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 110.304 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.536 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -169.28 178.55 4.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.188 -0.945 . . . . 0.0 110.269 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 3.2 m -113.63 167.66 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.37 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.44 69.05 0.29 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -56.7 -15.84 5.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.302 -1.116 . . . . 0.0 110.472 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 38' ' ' PHE . 10.3 tp10 -44.41 -29.81 0.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 0.0 109.319 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -160.91 52.52 0.28 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.457 -0.777 . . . . 0.0 110.288 179.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.524 ' NH1' ' HB2' ' A' ' 12' ' ' MET . 2.4 mtt180 41.31 63.61 1.2 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.526 -0.734 . . . . 0.0 110.496 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 1.1 pt-20 -149.02 150.17 32.36 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.599 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.436 ' HB3' HG12 ' A' ' 21' ' ' VAL . . . -115.81 143.88 44.78 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 35' ' ' ASP . 8.5 p -105.15 129.18 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.509 -1.369 . . . . 0.0 108.895 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.548 ' CG2' HD21 ' A' ' 25' ' ' LEU . 21.5 t -124.97 156.35 33.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 122.524 1.154 . . . . 0.0 112.051 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.4 m -137.85 146.65 43.7 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 53' ' ' SER . 30.6 p90 -170.65 -174.57 1.64 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 117.154 -1.818 . . . . 0.0 112.569 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 30' ' ' GLY . 8.9 m-20 -106.27 116.56 32.15 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -63.21 -8.19 7.62 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.878 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.413 HG21 ' N ' ' A' ' 51' ' ' LYS . 9.2 t -77.31 -17.98 57.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.925 . . . . 0.0 110.484 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' N ' HG21 ' A' ' 50' ' ' THR . 1.7 mmtm -132.36 0.9 3.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.969 . . . . 0.0 110.894 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -166.28 -170.54 1.71 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.068 -1.02 . . . . 0.0 110.447 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER 171.52 173.04 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 110.008 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.537 ' CG2' HG12 ' A' ' 5' ' ' VAL . 17.8 t -41.59 -41.96 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.125 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -50.86 -48.53 60.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 110.228 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.474 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 52.3 mmtt -79.26 -21.88 45.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 111.861 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.517 ' CD2' HG12 ' A' ' 45' ' ' VAL . 63.1 mt -71.5 -59.15 2.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.27 -1.519 . . . . 0.0 108.649 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.537 HG22 ' CA ' ' A' ' 69' ' ' SER . 8.0 m -58.88 -28.4 66.1 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.512 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -79.18 -25.79 42.73 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.345 -0.847 . . . . 0.0 110.005 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.481 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . . . -73.6 -47.41 40.57 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.022 -1.049 . . . . 0.0 109.201 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.535 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 9.0 t -71.38 -32.82 68.92 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . -63.43 -34.53 77.94 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.964 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -89.43 -8.86 52.12 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.352 -0.842 . . . . 0.0 109.042 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB3' HG21 ' A' ' 20' ' ' THR . . . -79.61 -25.05 41.58 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.89 15.37 0.72 Allowed Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.426 -1.368 . . . . 0.0 111.66 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.565 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 53.7 m-85 -141.71 111.43 6.29 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.443 -1.622 . . . . 0.0 111.41 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.02 99.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 85.6 p -108.22 -165.35 1.03 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 122.147 0.975 . . . . 0.0 112.793 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.537 ' CA ' HG22 ' A' ' 58' ' ' THR . 0.1 OUTLIER -157.68 -165.93 1.88 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.636 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.6 p -139.55 158.1 27.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 120.816 -1.178 . . . . 0.0 111.524 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.499 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 4.1 mtmt -124.41 25.85 7.52 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.478 1.132 . . . . 0.0 108.91 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.515 ' CB ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.284 -2.274 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.992 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -117.26 165.39 13.51 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.71 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 4.2 t -132.5 124.29 28.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.794 -0.566 . . . . 0.0 110.031 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.58 ' CG2' ' N ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -124.79 172.41 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.58 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -107.6 162.01 14.34 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.227 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.59 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -133.35 153.54 51.5 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.859 -1.136 . . . . 0.0 109.651 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -108.9 98.55 8.02 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.137 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.501 ' CG2' HG23 ' A' ' 21' ' ' VAL . 2.2 p -113.17 90.69 16.91 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.7 Cg_endo -74.8 31.33 0.35 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.394 1.396 . . . . 0.0 112.323 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.488 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.3 -43.11 95.69 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 13.0 ptm 35.83 45.93 0.31 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.748 0.785 . . . . 0.0 109.894 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.649 ' CG2' ' CB ' ' A' ' 16' ' ' ALA . 1.2 t -72.1 0.54 9.34 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.69 -0.631 . . . . 0.0 110.142 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.59 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.5 OUTLIER 82.19 88.58 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.508 0.671 . . . . 0.0 111.127 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 71.17 31.51 2.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.527 -0.733 . . . . 0.0 112.078 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.649 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -155.72 -35.4 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.532 -1.355 . . . . 0.0 110.658 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.611 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -49.87 -48.57 77.57 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.727 -1.233 . . . . 0.0 110.825 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.597 ' HG3' ' CD1' ' A' ' 38' ' ' PHE . 18.7 Cg_endo -77.94 -9.87 16.77 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.312 1.341 . . . . 0.0 112.599 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 19' ' ' ILE . 18.7 mm -90.31 -42.38 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.719 -1.238 . . . . 0.0 109.735 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.497 ' CG2' ' CB ' ' A' ' 64' ' ' ALA 0.251 0.9 OUTLIER -71.92 -39.11 69.7 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.921 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.611 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 21.1 t -67.7 -48.44 76.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.4 -47.32 26.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.31 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.564 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 1.2 mmmm -74.46 -20.37 60.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 111.693 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . -73.24 -48.78 32.09 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 110.062 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.611 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 4.9 mp -68.86 -33.28 73.54 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 109.676 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.486 ' O ' HG12 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -78.58 -20.88 49.55 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.964 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.564 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -98.3 -7.26 29.36 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.894 -1.129 . . . . 0.0 109.588 179.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' A' ' 29' ' ' GLU . 2.9 t -40.36 -80.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.668 -0.645 . . . . 0.0 109.776 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.482 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 5.1 tt0 179.3 -57.85 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.183 -0.948 . . . . 0.0 109.825 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -92.15 -15.12 54.84 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.548 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 10.6 p -43.16 141.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.101 -1.235 . . . . 0.0 110.49 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 t -120.89 -12.95 8.71 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.555 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.494 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 4.1 ttmt -166.25 168.71 14.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.028 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.7 p -164.68 172.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.405 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.575 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -167.21 169.4 12.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.835 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.467 ' CG1' ' HB2' ' A' ' 18' ' ' PRO . 24.8 t -109.92 147.47 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 110.509 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 42' ' ' GLU . . . -139.41 60.47 0.58 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.597 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -58.79 -20.82 53.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -1.116 . . . . 0.0 110.236 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.4 mp0 -45.93 -26.37 0.69 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.06 -1.025 . . . . 0.0 109.294 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.38 37.95 0.94 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.747 . . . . 0.0 110.104 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? 43.43 56.25 4.43 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.348 -0.845 . . . . 0.0 110.482 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -143.46 150.11 38.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.835 . . . . 0.0 110.152 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HB1' HG13 ' A' ' 21' ' ' VAL . . . -117.69 138.83 51.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.018 . . . . 0.0 108.791 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.575 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 10.1 p -105.61 144.57 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.532 -1.355 . . . . 0.0 109.939 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.533 HG12 ' CD1' ' A' ' 57' ' ' LEU . 4.2 p -145.86 144.94 20.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 118.928 -1.109 . . . . 0.0 113.174 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -111.77 153.17 26.92 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.578 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 35.9 p90 -171.48 -177.09 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.58 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.426 ' CG ' HG23 ' A' ' 50' ' ' THR . 6.3 t0 -106.38 110.76 23.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 23.6 t0 -64.65 -8.19 13.47 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.978 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.426 HG23 ' CG ' ' A' ' 48' ' ' ASP . 10.0 t -68.64 -11.36 60.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.957 -1.089 . . . . 0.0 110.134 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.3 -35.57 0.46 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.18 -0.95 . . . . 0.0 111.243 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -122.61 -174.67 2.97 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.273 -0.892 . . . . 0.0 110.366 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.578 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 7.3 t 173.14 175.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.552 HG22 ' CG1' ' A' ' 70' ' ' VAL . 1.6 p -40.34 -32.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.87 . . . . 0.0 110.672 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -49.98 75.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.098 . . . . 0.0 109.813 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.486 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 37.0 mmtt -77.43 -18.92 56.79 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.386 -0.821 . . . . 0.0 110.961 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.533 ' CD1' HG12 ' A' ' 45' ' ' VAL . 79.0 mt -74.51 -61.08 1.99 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.656 -1.277 . . . . 0.0 108.364 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 62' ' ' ALA . 42.9 p -60.27 -25.38 65.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 63' ' ' ASP . 5.5 tttm -78.11 -29.8 49.11 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 121.469 -0.77 . . . . 0.0 109.822 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . -72.14 -46.63 55.72 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.101 -0.999 . . . . 0.0 109.224 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.532 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 7.3 t -70.5 -32.22 69.64 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . -67.68 -31.67 71.81 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.261 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -90.47 -9.36 47.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.43 -0.794 . . . . 0.0 109.262 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.497 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -80.98 -29.02 35.38 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 140.89 22.47 0.27 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.424 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 17' ' ' CYS . 42.5 m-85 -148.28 108.94 3.65 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.46 -1.612 . . . . 0.0 111.278 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.17 100.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 3.7 t -107.3 -177.43 3.35 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.562 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 58' ' ' THR . 0.1 OUTLIER -140.77 -164.75 1.8 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.59 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.5 p -142.73 155.25 17.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 O-C-N 120.813 -1.18 . . . . 0.0 111.384 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -124.81 25.72 7.32 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.583 1.182 . . . . 0.0 109.086 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.45 ' OXT' HG22 ' A' ' 5' ' ' VAL . 1.2 mm-40 . . . . . 0 C--N 1.286 -2.193 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.11 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.753 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.215 -0.74 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -111.79 160.65 17.13 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.861 0.839 . . . . 0.0 112.376 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 95.8 m -122.9 128.33 50.17 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.58 ' CG2' ' N ' ' A' ' 6' ' ' THR . 1.3 p -141.64 168.88 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 122.477 1.132 . . . . 0.0 111.101 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.58 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -108.84 159.36 16.85 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -131.39 154.24 48.84 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.768 -1.207 . . . . 0.0 110.072 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.29 99.21 8.51 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.956 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.476 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 2.2 p -117.13 86.3 20.32 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 0.0 109.6 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.5 Cg_endo -76.62 37.51 0.57 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.575 1.517 . . . . 0.0 112.095 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' CG ' ' A' ' 12' ' ' MET . . . -79.68 -26.25 56.85 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.512 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 17.4 ptm 36.45 65.26 0.47 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.781 -0.835 . . . . 0.0 110.386 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.534 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -88.83 15.54 8.23 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.521 -0.737 . . . . 0.0 109.465 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.1 OUTLIER 68.12 88.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.548 -0.72 . . . . 0.0 110.128 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' O ' HG13 ' A' ' 19' ' ' ILE . . . 58.01 31.95 21.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 0.0 110.174 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -134.4 -41.64 0.79 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.0 109.919 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.584 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -52.96 -50.0 84.14 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.748 179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.592 ' CG ' ' CE2' ' A' ' 38' ' ' PHE . 9.7 Cg_endo -75.0 -8.87 20.46 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.168 1.246 . . . . 0.0 112.302 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 15' ' ' ALA . 12.3 mm -90.59 -43.48 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.808 -1.182 . . . . 0.0 109.699 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.53 ' CG2' ' HB2' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -78.86 -43.93 23.98 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.556 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 21.3 t -59.85 -43.57 92.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.987 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.55 ' CG ' HG13 ' A' ' 34' ' ' VAL . 14.0 tttt -56.34 -58.67 7.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.073 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.7 pttt -73.58 3.41 6.28 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 110.547 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 21' ' ' VAL . . . -87.71 -72.14 0.54 Allowed 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.887 -1.133 . . . . 0.0 108.775 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -60.65 -16.23 36.73 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.154 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.576 ' N ' HD21 ' A' ' 25' ' ' LEU . 13.1 t -81.38 -35.03 31.28 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -75.9 -10.2 59.23 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.458 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 6.5 t -37.47 -80.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.68 -0.637 . . . . 0.0 110.888 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 28' ' ' VAL . 2.4 mt-10 -172.85 -51.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.837 -1.165 . . . . 0.0 111.741 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -108.33 14.3 36.33 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.857 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.543 ' CG1' ' O ' ' A' ' 26' ' ' SER . 8.5 p -41.3 143.88 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.275 . . . . 0.0 111.11 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.484 ' N ' ' HA ' ' A' ' 47' ' ' PHE . 2.8 t -120.89 -16.22 8.16 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.461 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.503 ' C ' ' CG2' ' A' ' 34' ' ' VAL . 0.9 OUTLIER -173.06 162.64 4.61 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.768 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.55 HG13 ' CG ' ' A' ' 22' ' ' LYS . 1.3 t -153.04 148.12 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.058 -1.026 . . . . 0.0 110.684 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.564 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -154.64 164.41 38.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.315 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.533 ' HB ' ' CB ' ' A' ' 18' ' ' PRO . 18.8 m -128.34 161.66 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.047 . . . . 0.0 110.74 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.18 90.7 0.13 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.592 ' CE2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -65.51 -21.07 66.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 110.23 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 0.7 OUTLIER -53.24 -23.01 7.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.973 . . . . 0.0 109.122 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 41' ' ' ARG . 2.3 mmpp? -138.73 19.43 2.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.636 -0.665 . . . . 0.0 109.839 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 40' ' ' LYS . 1.7 tpp180 42.69 55.51 4.23 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -145.2 151.54 38.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.49 -0.756 . . . . 0.0 110.071 -179.251 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.23 136.96 52.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.979 . . . . 0.0 109.77 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.564 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 7.5 p -107.07 110.51 32.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.68 -1.263 . . . . 0.0 108.911 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.539 HG23 ' CD2' ' A' ' 25' ' ' LEU . 65.4 t -123.4 143.97 34.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.932 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -110.07 163.01 14.0 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' A' ' 2' ' ' THR . 31.1 p90 -171.35 -178.15 2.29 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.328 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 11.1 m-20 -106.99 116.67 32.32 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -61.18 -11.33 8.75 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.735 -177.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.2 t -68.94 -13.76 62.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 110.551 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -143.62 10.2 1.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 110.512 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -169.83 -167.01 0.62 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.104 -0.997 . . . . 0.0 110.298 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.631 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 t 172.3 164.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.538 ' CG2' HG13 ' A' ' 5' ' ' VAL . 0.9 OUTLIER -42.18 -50.95 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 109.613 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.468 ' O ' HG21 ' A' ' 58' ' ' THR . 40.0 tp60 -47.9 -46.08 31.29 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.326 -0.858 . . . . 0.0 109.657 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -72.45 -27.33 62.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 111.246 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.569 HD13 ' CE2' ' A' ' 47' ' ' PHE . 55.3 mt -68.78 -59.83 2.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.63 -1.294 . . . . 0.0 108.682 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.468 HG21 ' O ' ' A' ' 55' ' ' GLN . 1.7 t -56.27 -28.84 60.01 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 29.9 tttp -72.1 -33.74 68.08 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.348 -0.845 . . . . 0.0 109.441 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 25' ' ' LEU . . . -67.85 -40.43 83.69 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.169 -0.957 . . . . 0.0 110.022 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.528 HG21 ' N ' ' A' ' 62' ' ' ALA . 3.7 t -72.21 -32.0 66.37 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.528 ' N ' HG21 ' A' ' 61' ' ' THR . . . -64.19 -36.54 84.4 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.47 -7.49 52.9 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.463 -0.773 . . . . 0.0 109.572 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -82.2 -24.4 34.94 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 133.3 20.11 0.93 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.789 -1.196 . . . . 0.0 110.946 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 44.4 m-85 -147.94 112.59 3.89 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.585 -1.538 . . . . 0.0 111.404 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.07 93.57 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 N-CA-C 107.671 -1.704 . . . . 0.0 107.671 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -108.71 -171.21 1.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 111.827 -177.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.521 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -142.62 -164.02 1.74 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.574 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.4 p -141.39 154.1 20.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.886 -1.133 . . . . 0.0 111.448 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.46 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -118.8 23.69 11.3 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.394 1.093 . . . . 0.0 109.617 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.484 ' OXT' ' CB ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.283 -2.311 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.248 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -109.09 148.28 31.08 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.893 0.854 . . . . 0.0 111.947 -177.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 m -123.48 108.14 12.34 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.575 ' CG1' ' CB ' ' A' ' 72' ' ' GLN . 5.6 m -125.36 165.0 23.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.184 -0.947 . . . . 0.0 110.688 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.536 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -107.01 159.95 15.91 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.564 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -131.48 159.31 38.47 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.511 -178.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 68' ' ' SER . . . -114.03 119.13 36.13 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.923 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.541 ' CG1' ' CB ' ' A' ' 66' ' ' TYR . 2.9 t -108.87 103.3 51.49 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.289 -0.882 . . . . 0.0 109.315 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 7.3 Cg_endo -74.79 29.41 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.314 1.165 . . . . 0.0 111.867 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.506 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -91.93 -58.82 1.37 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.557 ' CG ' ' HD2' ' A' ' 41' ' ' ARG . 4.0 tmm? 52.25 51.17 16.83 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.406 -1.055 . . . . 0.0 109.195 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.596 ' CG2' ' CB ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -76.72 2.74 13.4 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.755 -0.59 . . . . 0.0 109.54 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.558 ' CB ' ' O ' ' A' ' 13' ' ' THR . 4.1 t 80.48 94.51 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.604 0.716 . . . . 0.0 111.13 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.52 ' O ' ' CD1' ' A' ' 19' ' ' ILE . . . 68.08 37.4 2.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.606 -0.684 . . . . 0.0 111.825 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.596 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -163.19 -37.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.782 -1.199 . . . . 0.0 110.602 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -44.2 -51.54 18.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.861 -1.15 . . . . 0.0 110.132 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.649 ' CG ' ' CD2' ' A' ' 38' ' ' PHE . 17.9 Cg_endo -83.4 -14.15 8.25 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.423 1.416 . . . . 0.0 112.572 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 84.6 mt -80.77 -54.19 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.864 -1.148 . . . . 0.0 110.306 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -37.54 85.92 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.585 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 15.1 t -63.65 -41.61 93.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.532 ' HE2' ' CG1' ' A' ' 34' ' ' VAL . 16.0 tttm -52.82 -39.31 62.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 109.743 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 11.6 mtmt -73.08 -26.2 61.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 110.845 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . . . -69.07 -55.64 10.15 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 110.646 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.585 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 3.7 mp -65.45 -37.44 86.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 111.478 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.478 ' HA ' HG13 ' A' ' 31' ' ' VAL . 36.1 p -70.98 -26.1 63.0 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.099 -1.0 . . . . 0.0 110.21 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -99.64 -3.82 32.28 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.222 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.552 ' CG2' ' CB ' ' A' ' 60' ' ' ALA . 2.2 t -42.9 -73.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 109.855 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 175.08 -71.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.354 -0.841 . . . . 0.0 109.75 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.94 -20.51 70.31 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.615 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 46.1 t -52.0 134.29 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -1.13 . . . . 0.0 110.449 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.1 m -122.63 -12.2 8.14 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.836 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.544 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -146.56 154.57 41.67 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.873 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.532 ' CG1' ' HE2' ' A' ' 22' ' ' LYS . 7.1 p -155.23 165.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 110.026 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.552 ' CB ' HG11 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -162.96 155.04 18.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.062 -1.024 . . . . 0.0 110.835 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.45 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 8.7 m -109.68 113.76 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.766 . . . . 0.0 110.18 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.4 73.76 0.21 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.649 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -65.56 -14.94 62.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -1.193 . . . . 0.0 110.056 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -57.29 -17.31 11.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.89 . . . . 0.0 109.265 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.3 mttm -147.35 32.51 0.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.517 -0.74 . . . . 0.0 110.134 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.557 ' HD2' ' CG ' ' A' ' 12' ' ' MET . 0.6 OUTLIER 42.89 57.47 3.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 4.6 pt-20 -149.77 148.68 29.51 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.216 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -115.63 130.26 56.8 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.552 HG11 ' CB ' ' A' ' 35' ' ' ASP . 8.4 p -105.66 143.49 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.478 -1.389 . . . . 0.0 110.003 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.548 HG23 ' CB ' ' A' ' 25' ' ' LEU . 57.4 t -152.48 148.12 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.447 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.54 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.1 m -109.42 159.03 17.36 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' A' ' 2' ' ' THR . 34.4 p90 -170.33 179.74 3.32 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 117.962 -1.495 . . . . 0.0 111.726 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -106.49 112.9 26.11 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -53.33 -17.3 1.74 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.9 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -65.88 -40.84 91.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.948 . . . . 0.0 110.702 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.6 -0.65 13.59 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.096 -1.002 . . . . 0.0 110.747 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.473 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -150.55 -165.09 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.06 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.593 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 170.84 154.44 0.06 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.582 -0.699 . . . . 0.0 109.464 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.61 ' CG2' ' CG2' ' A' ' 70' ' ' VAL . 9.5 p -42.39 -39.84 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.902 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.508 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 5.7 tp-100 -59.69 -47.5 85.39 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.169 -0.957 . . . . 0.0 109.313 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.407 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 63.2 mmtt -66.29 -24.16 66.51 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.469 -0.769 . . . . 0.0 110.698 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.61 HD13 ' CE2' ' A' ' 47' ' ' PHE . 43.0 mt -72.65 -54.59 8.62 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.706 -1.246 . . . . 0.0 108.12 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.512 ' N ' HD22 ' A' ' 7' ' ' LEU . 52.5 m -56.29 -32.84 64.96 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.538 -0.726 . . . . 0.0 109.223 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -77.55 -28.78 51.94 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.291 -0.88 . . . . 0.0 110.053 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.552 ' CB ' ' CG2' ' A' ' 28' ' ' VAL . . . -68.54 -49.39 59.88 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.214 -0.929 . . . . 0.0 109.12 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.534 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 7.4 t -67.02 -32.26 73.35 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.503 ' N ' HG21 ' A' ' 61' ' ' THR . . . -68.29 -26.86 65.86 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.053 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -88.65 -13.31 40.12 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.3 -32.64 43.59 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 143.35 31.11 0.1 Allowed Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.593 -1.289 . . . . 0.0 111.168 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 17' ' ' CYS . 63.8 m-85 -155.9 105.89 2.12 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.664 -1.492 . . . . 0.0 111.621 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.529 ' O ' ' CG ' ' A' ' 10' ' ' PRO . 5.0 Cg_exo -56.31 98.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 N-CA-C 106.768 -2.051 . . . . 0.0 106.768 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 8' ' ' ALA . 1.1 t -107.27 -177.91 3.49 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.077 -1.014 . . . . 0.0 111.939 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.481 ' N ' ' OG ' ' A' ' 68' ' ' SER . 12.9 p -136.99 -162.01 1.23 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.61 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 4.6 p -144.27 157.43 15.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 118.522 -1.271 . . . . 0.0 112.058 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -128.62 33.3 4.68 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.317 1.056 . . . . 0.0 108.195 179.149 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.575 ' CB ' ' CG1' ' A' ' 5' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.338 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.724 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.86 173.5 6.33 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.164 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.39 128.48 18.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.776 -0.578 . . . . 0.0 110.064 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.542 ' CG1' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -132.79 161.4 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.391 -0.818 . . . . 0.0 109.371 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.555 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.61 157.31 17.78 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.605 ' CD2' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -130.38 157.65 42.0 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.753 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.04 106.48 16.0 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.906 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.454 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.4 p -115.62 94.33 39.99 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.3 Cg_endo -78.64 43.33 1.42 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.56 1.507 . . . . 0.0 111.56 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.575 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -90.44 -49.71 3.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.575 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 4.2 ptm 36.4 61.94 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.77 -0.841 . . . . 0.0 110.981 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.578 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 6.6 t -70.94 -2.38 15.02 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 109.269 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.5 OUTLIER 78.12 3.03 2.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.708 -0.62 . . . . 0.0 111.458 178.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.45 ' H ' HG21 ' A' ' 13' ' ' THR . . . -174.74 33.59 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.229 -0.92 . . . . 0.0 109.924 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.565 ' CB ' HG23 ' A' ' 13' ' ' THR . . . 179.74 -21.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.108 -0.995 . . . . 0.0 112.155 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -46.27 -48.97 44.3 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.201 -1.562 . . . . 0.0 110.969 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 19.5 Cg_endo -81.66 -11.75 11.42 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.437 1.425 . . . . 0.0 113.558 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 16' ' ' ALA . 8.1 mt -92.57 -37.99 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.495 -1.378 . . . . 0.0 110.862 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.525 ' CG2' ' CB ' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -73.26 -36.57 66.4 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 42.1 t -67.67 -44.04 86.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.227 -0.989 . . . . 0.0 108.56 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.52 ' HA ' ' CG1' ' A' ' 34' ' ' VAL . 4.5 tptm -52.74 -47.59 67.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.542 -0.724 . . . . 0.0 110.311 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 5.0 mmtm -77.08 -16.19 59.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.974 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.423 ' HB2' ' C ' ' A' ' 60' ' ' ALA . . . -73.93 -58.73 3.11 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.966 -1.084 . . . . 0.0 110.315 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.605 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 3.7 mp -71.7 -29.15 64.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.597 -0.689 . . . . 0.0 110.487 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.522 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 54.7 p -73.36 -26.11 60.88 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.432 -0.792 . . . . 0.0 109.426 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -110.48 3.54 19.68 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.001 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.536 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 3.3 p -49.24 -55.33 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.024 -1.048 . . . . 0.0 110.448 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 176.31 -69.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.781 -1.2 . . . . 0.0 111.541 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -98.57 -9.52 52.7 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.776 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.551 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 11.0 p -42.56 143.4 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.307 . . . . 0.0 110.928 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.39 -15.56 10.32 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.73 0.776 . . . . 0.0 109.14 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -161.33 161.44 30.51 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.537 HG21 ' CG1' ' A' ' 45' ' ' VAL . 25.6 t -157.61 161.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.097 -1.002 . . . . 0.0 110.43 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.525 ' CB ' HG11 ' A' ' 44' ' ' VAL . 1.1 m-20 -163.63 166.57 22.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.915 . . . . 0.0 110.29 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 15.7 m -140.92 157.22 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.419 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -147.61 105.31 0.31 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.565 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -64.0 -23.69 67.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.288 -1.124 . . . . 0.0 110.269 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -47.18 -37.3 9.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.925 . . . . 0.0 109.987 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -135.32 29.65 3.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.414 -0.804 . . . . 0.0 110.481 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.575 ' CD ' ' HB3' ' A' ' 12' ' ' MET . 0.0 OUTLIER 38.55 60.52 1.33 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.571 -0.706 . . . . 0.0 110.319 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 20.7 pt-20 -143.18 145.97 33.27 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.663 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.526 ' CB ' HG13 ' A' ' 21' ' ' VAL . . . -114.82 130.14 56.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 108.982 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.525 HG11 ' CB ' ' A' ' 35' ' ' ASP . 10.0 p -105.54 126.91 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.904 -1.122 . . . . 0.0 109.1 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.537 ' CG1' HG21 ' A' ' 34' ' ' VAL . 40.7 t -131.88 144.55 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.691 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -108.86 157.62 18.43 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.626 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 46.7 p90 -171.6 -173.77 1.26 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.098 -1.441 . . . . 0.0 111.326 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 5.7 m-20 -107.04 129.42 54.81 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 25.4 t70 -80.36 35.77 0.35 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.958 -1.089 . . . . 0.0 111.391 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.5 p -118.23 -16.97 9.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.37 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -133.05 1.93 3.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.457 -0.777 . . . . 0.0 110.092 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . -179.65 -178.57 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 110.368 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.626 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 8.1 p 174.24 -176.01 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 0.0 109.659 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.512 HG22 HG23 ' A' ' 70' ' ' VAL . 2.1 p -38.34 -40.07 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.304 -0.873 . . . . 0.0 110.632 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 6.0 tt0 -56.52 -50.56 71.46 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.028 -1.045 . . . . 0.0 109.812 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.449 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 31.7 mmtt -79.69 -13.68 59.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 111.52 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.527 HD12 ' CD2' ' A' ' 47' ' ' PHE . 89.3 mt -78.35 -56.51 4.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.515 -1.366 . . . . 0.0 108.062 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.554 HG22 ' CA ' ' A' ' 69' ' ' SER . 26.8 m -58.27 -29.68 65.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.466 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -78.05 -26.27 48.23 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.359 -0.838 . . . . 0.0 109.714 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . . . -71.81 -46.33 58.54 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.264 -0.897 . . . . 0.0 109.237 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.466 ' OG1' HG23 ' A' ' 21' ' ' VAL . 10.0 t -71.57 -33.81 69.39 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -62.09 -34.64 76.68 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.849 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -91.13 -8.33 49.06 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.467 -0.771 . . . . 0.0 109.21 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.525 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -79.65 -25.18 41.41 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.55 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 137.11 17.29 0.71 Allowed Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.391 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.575 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 33.7 m-85 -143.94 114.78 5.49 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.444 -1.621 . . . . 0.0 111.601 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.99 95.32 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 N-CA-C 107.6 -1.731 . . . . 0.0 107.6 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.02 -170.56 1.68 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 112.332 -176.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.554 ' CA ' HG22 ' A' ' 58' ' ' THR . 10.4 m -148.93 -161.86 1.44 Allowed 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.578 ' HA ' HD13 ' A' ' 7' ' ' LEU . 5.1 p -140.09 163.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 120.657 -1.277 . . . . 0.0 111.937 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -125.88 26.12 6.68 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.381 1.086 . . . . 0.0 109.504 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.542 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 1.5 mt-30 . . . . . 0 C--N 1.285 -2.205 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.22 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -112.43 162.42 15.6 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.361 -177.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.418 HG22 ' OG1' ' A' ' 46' ' ' THR . 27.5 m -135.31 132.87 38.22 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.528 HG23 ' CG2' ' A' ' 54' ' ' VAL . 3.9 t -139.18 169.34 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.015 . . . . 0.0 109.966 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.594 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.48 156.53 18.87 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.121 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.599 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -130.59 157.46 42.65 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 117.855 -1.538 . . . . 0.0 110.861 -178.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 68' ' ' SER . . . -109.84 111.35 22.72 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.808 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -117.94 98.13 51.31 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.186 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 10.7 Cg_endo -80.17 49.91 3.36 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.514 1.476 . . . . 0.0 110.965 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.625 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -90.97 -39.59 5.74 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 8.2 ptm 38.43 42.83 0.58 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.661 -0.905 . . . . 0.0 110.6 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -71.61 2.9 4.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.675 -0.64 . . . . 0.0 110.044 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 13' ' ' THR . 3.9 t 78.99 95.86 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.453 0.644 . . . . 0.0 110.152 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 54.44 23.61 4.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.45 -0.781 . . . . 0.0 110.028 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 13' ' ' THR . . . -123.61 -48.6 1.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -0.866 . . . . 0.0 109.71 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.583 ' SG ' ' CE1' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -39.7 -61.53 1.04 Allowed Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 121.474 -0.766 . . . . 0.0 111.445 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.604 ' HG3' ' CG ' ' A' ' 38' ' ' PHE . 5.6 Cg_endo -61.16 -20.65 68.81 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.96 1.773 . . . . 0.0 114.62 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.4 mt -90.42 -36.57 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.332 -1.48 . . . . 0.0 110.755 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.507 ' CG2' ' HB2' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -77.2 -40.71 44.21 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.578 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 41.8 t -66.21 -48.08 82.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 26' ' ' SER . 23.3 tttm -52.42 -43.99 65.15 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.795 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 13.9 mmtt -72.82 -20.93 61.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 111.277 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.436 ' C ' ' HB3' ' A' ' 60' ' ' ALA . . . -75.86 -60.95 2.1 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.165 -0.959 . . . . 0.0 110.269 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.578 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 3.7 mp -56.89 -36.32 69.98 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.431 -0.793 . . . . 0.0 109.96 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.527 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -71.07 -27.18 63.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.567 -0.708 . . . . 0.0 109.224 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -92.51 -4.54 53.41 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 121.225 -0.922 . . . . 0.0 109.753 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.535 ' CG1' ' N ' ' A' ' 29' ' ' GLU . 2.7 t -44.01 -81.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.737 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.535 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 174.07 -73.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.466 ' HA3' ' HB1' ' A' ' 52' ' ' ALA . . . -69.45 -19.18 74.27 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.595 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 4.2 p -49.97 137.56 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.559 -0.965 . . . . 0.0 110.454 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -121.5 -13.17 8.44 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.395 0.617 . . . . 0.0 109.606 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -162.01 160.49 27.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.175 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.521 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 8.1 p -142.33 177.44 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.414 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.539 ' CB ' HG13 ' A' ' 44' ' ' VAL . 12.0 t70 -156.6 155.64 32.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 110.186 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.517 ' CG1' ' HB2' ' A' ' 18' ' ' PRO . 3.3 t -108.87 111.27 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 110.443 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -117.47 52.48 0.68 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CG ' ' HG3' ' A' ' 18' ' ' PRO . 2.2 t80 -62.49 -19.39 63.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -1.115 . . . . 0.0 110.128 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -48.81 -27.17 2.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -139.96 43.09 1.95 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.504 -0.748 . . . . 0.0 109.923 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.475 ' HD2' ' HA ' ' A' ' 10' ' ' PRO . 1.6 mtt180 41.35 60.04 2.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.445 -0.784 . . . . 0.0 110.182 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -149.32 150.83 33.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.848 . . . . 0.0 110.777 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -122.23 134.03 54.7 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.594 ' CG2' ' CG2' ' A' ' 6' ' ' THR . 1.0 OUTLIER -106.38 142.55 19.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.327 -1.483 . . . . 0.0 109.396 -178.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.585 ' CG1' ' CD1' ' A' ' 57' ' ' LEU . 2.4 p -147.51 145.06 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.238 -1.385 . . . . 0.0 113.558 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -109.96 153.74 24.11 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.595 ' CB ' ' HA ' ' A' ' 31' ' ' VAL . 31.5 p90 -168.93 -178.43 3.31 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.675 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.96 113.86 27.59 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 9.3 t70 -57.67 -13.15 3.56 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 110.767 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.4 p -61.96 -31.24 71.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.664 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -133.15 -3.46 3.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.947 -1.095 . . . . 0.0 111.33 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB1' ' HA3' ' A' ' 30' ' ' GLY . . . -143.37 -175.93 4.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.973 -1.079 . . . . 0.0 110.642 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 172.3 169.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 0.0 109.681 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.528 ' CG2' HG23 ' A' ' 5' ' ' VAL . 19.1 t -39.1 -55.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.436 -0.79 . . . . 0.0 110.773 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 3.7 tp60 -44.51 -46.72 9.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 0.0 110.377 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.454 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -73.51 -28.5 61.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.185 -0.947 . . . . 0.0 111.333 -179.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.585 ' CD1' ' CG1' ' A' ' 45' ' ' VAL . 65.4 mt -68.95 -61.27 1.87 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.774 -1.204 . . . . 0.0 108.575 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.524 ' N ' HD23 ' A' ' 7' ' ' LEU . 10.1 t -60.34 -22.9 63.77 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.395 -0.816 . . . . 0.0 108.803 178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.509 ' N ' HG21 ' A' ' 58' ' ' THR . 2.7 tttt -78.34 -28.92 47.35 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.374 -0.829 . . . . 0.0 109.35 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.534 ' HB1' ' CG2' ' A' ' 28' ' ' VAL . . . -72.09 -45.55 60.22 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 108.995 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.527 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 9.9 t -70.8 -32.44 69.53 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.489 ' N ' HG21 ' A' ' 61' ' ' THR . . . -65.24 -31.71 73.02 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.579 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -88.72 -12.16 43.09 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.507 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -77.54 -26.48 51.05 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.06 19.84 0.69 Allowed Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.781 -1.2 . . . . 0.0 111.362 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.625 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 32.5 m-85 -142.51 113.7 6.09 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.511 -1.581 . . . . 0.0 111.758 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.17 97.16 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 N-CA-C 107.418 -1.801 . . . . 0.0 107.418 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -108.3 -172.57 2.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.09 -1.006 . . . . 0.0 112.347 -176.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.503 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -148.52 -159.05 0.98 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.599 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.9 p -139.63 158.52 27.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 121.012 -1.055 . . . . 0.0 111.435 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.468 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 4.8 mtmt -121.41 23.09 10.54 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.223 1.011 . . . . 0.0 109.843 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.493 ' HA ' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.283 -2.319 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.2 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.6 mt-30 -109.05 149.48 29.21 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.842 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.493 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 24.5 m -120.04 130.05 54.52 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.542 HG12 ' CB ' ' A' ' 72' ' ' GLN . 1.7 t -151.77 165.56 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.062 -1.024 . . . . 0.0 109.528 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.582 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -106.83 171.12 7.54 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.607 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.24 154.18 51.42 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.605 -178.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -108.57 94.24 4.95 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.463 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.519 HG22 ' CB ' ' A' ' 66' ' ' TYR . 2.5 p -110.27 101.7 48.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.686 -0.634 . . . . 0.0 109.615 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.5 Cg_endo -78.28 44.37 1.59 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.728 1.383 . . . . 0.0 111.114 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.645 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -86.49 -41.35 6.93 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 12.2 mtp 59.18 -87.19 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.61 -0.935 . . . . 0.0 109.813 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.53 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 1.1 p 48.27 15.69 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' THR . 0.3 OUTLIER 45.43 104.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.823 . . . . 0.0 112.058 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 19' ' ' ILE . . . 56.01 32.19 19.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.263 -0.898 . . . . 0.0 111.044 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -137.61 -47.39 0.56 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 109.359 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -53.81 -45.94 98.63 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.538 -0.727 . . . . 0.0 111.183 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 10.3 Cg_endo -74.0 -11.37 23.45 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.005 1.136 . . . . 0.0 112.599 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 1.7 mt -92.39 -40.02 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.669 -1.269 . . . . 0.0 109.349 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.539 HG23 ' CB ' ' A' ' 64' ' ' ALA . 1.3 m -74.68 -40.5 61.36 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.593 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 37.5 t -66.45 -48.89 79.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.544 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.461 ' HA ' HG13 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -47.93 -45.97 31.53 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 14.3 mttt -74.63 -23.43 58.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.251 -0.906 . . . . 0.0 111.6 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.492 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . -68.92 -50.09 52.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.283 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.593 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 4.6 mp -70.53 -34.52 72.37 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 110.272 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.535 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -68.22 -21.33 64.86 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.329 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -113.39 5.04 16.61 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.04 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.542 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 12.7 p -53.43 -49.19 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.128 -0.982 . . . . 0.0 110.421 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 170.17 -80.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.075 -1.016 . . . . 0.0 110.853 179.462 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.14 5.63 78.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 26' ' ' SER . 12.2 p -50.26 142.52 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.865 -1.373 . . . . 0.0 110.457 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.8 m -124.74 -9.79 7.29 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.758 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.507 ' O ' HG21 ' A' ' 45' ' ' VAL . 1.3 tttt -168.31 138.55 2.56 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.578 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 26' ' ' SER . 5.0 t -130.22 166.43 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.137 -0.977 . . . . 0.0 110.689 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.545 ' CB ' HG11 ' A' ' 44' ' ' VAL . 8.8 t0 -156.58 162.76 39.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.162 -0.961 . . . . 0.0 110.213 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 18' ' ' PRO . 4.5 t -113.83 125.97 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.486 ' O ' ' CG ' ' A' ' 42' ' ' GLU . . . -124.89 69.37 0.49 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.59 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -63.51 -11.75 26.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -1.116 . . . . 0.0 110.527 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -43.97 -31.36 0.88 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 108.979 179.239 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 41' ' ' ARG . 1.4 tttp -148.07 47.05 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.44 0.638 . . . . 0.0 109.308 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.476 ' HD2' ' CG ' ' A' ' 12' ' ' MET . 2.0 tpp180 42.03 58.96 2.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.436 -0.79 . . . . 0.0 110.363 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 13.9 pt-20 -138.38 169.42 17.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.294 -0.879 . . . . 0.0 110.286 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.488 ' HB1' HG12 ' A' ' 21' ' ' VAL . . . -134.74 134.96 41.55 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.545 HG11 ' CB ' ' A' ' 35' ' ' ASP . 1.1 t -106.65 122.56 60.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.674 -1.266 . . . . 0.0 109.646 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -123.09 -178.28 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.669 1.223 . . . . 0.0 111.902 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -152.18 149.06 28.34 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 2' ' ' THR . 28.7 p90 -166.36 -175.3 3.19 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 117.601 -1.64 . . . . 0.0 112.011 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.497 ' OD1' ' CG2' ' A' ' 50' ' ' THR . 0.5 OUTLIER -106.23 110.52 22.79 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 5.9 t70 -57.81 -14.28 5.69 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.763 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.497 ' CG2' ' OD1' ' A' ' 48' ' ' ASP . 8.9 t -65.41 -34.97 79.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 110.294 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 mmpp? -125.39 3.82 7.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.146 -0.971 . . . . 0.0 110.431 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -150.77 -169.75 3.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.919 . . . . 0.0 110.339 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.603 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.4 p 170.05 165.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 0.0 109.618 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.53 HG11 ' CG2' ' A' ' 70' ' ' VAL . 2.9 t -43.44 -37.74 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.005 -1.059 . . . . 0.0 109.714 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -58.73 -46.72 86.74 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.019 -1.051 . . . . 0.0 109.544 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 10.5 mmmt -71.02 -25.61 62.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 110.861 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.537 ' HB3' HD22 ' A' ' 25' ' ' LEU . 55.2 mt -70.8 -58.7 3.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.786 -1.196 . . . . 0.0 108.21 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.472 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 99.7 m -56.47 -30.3 62.75 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.486 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -75.63 -28.73 58.93 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.403 -0.811 . . . . 0.0 109.555 179.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -70.01 -51.47 32.08 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.468 -0.77 . . . . 0.0 109.221 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.535 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 13.1 t -67.77 -30.06 69.41 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.486 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -67.54 -31.14 71.02 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.948 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -86.38 -12.88 48.03 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.539 ' CB ' HG23 ' A' ' 20' ' ' THR . . . -76.89 -32.4 57.42 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 137.94 31.9 0.22 Allowed Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.781 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.645 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 47.1 m-85 -151.88 113.81 2.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.786 -1.42 . . . . 0.0 111.596 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.38 94.71 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 N-CA-C 107.663 -1.706 . . . . 0.0 107.663 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -108.91 -165.0 0.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.032 . . . . 0.0 112.531 -177.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.499 ' N ' ' OG ' ' A' ' 68' ' ' SER . 49.1 m -152.49 -159.2 0.98 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.607 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.7 p -139.07 152.94 24.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.887 -1.133 . . . . 0.0 110.683 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.534 ' HB3' ' CG2' ' A' ' 6' ' ' THR . 1.3 tttp -125.51 49.51 1.91 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.923 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.542 ' CB ' HG12 ' A' ' 5' ' ' VAL . 3.5 pp0? . . . . . 0 C--N 1.28 -2.446 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.021 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -124.31 171.67 9.71 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.956 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.491 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 37.0 m -110.73 155.72 22.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.574 -0.704 . . . . 0.0 110.42 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 4' ' ' THR . 1.8 t -152.79 161.8 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 108.687 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.529 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -108.02 161.08 15.27 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.542 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -132.58 155.13 49.23 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.82 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.84 101.74 10.32 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.412 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.474 HG23 ' SG ' ' A' ' 17' ' ' CYS . 2.0 p -118.09 101.84 51.28 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.495 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.25 36.67 0.55 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.379 1.386 . . . . 0.0 111.579 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.61 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -76.58 -46.69 11.26 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 10.6 ptp 38.47 54.91 1.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.737 -0.861 . . . . 0.0 110.181 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.518 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -86.69 17.05 4.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.579 -0.7 . . . . 0.0 109.764 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 13' ' ' THR . 7.8 t 66.45 89.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 110.604 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 65.32 18.04 11.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 110.48 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.518 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -123.14 -48.12 2.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 109.522 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.626 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -55.7 -44.15 99.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.47 -0.769 . . . . 0.0 111.303 179.426 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 12.7 Cg_endo -76.55 -16.77 16.7 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 120.925 1.083 . . . . 0.0 112.681 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 19' ' ' ILE . 5.4 mt -91.67 -31.52 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.587 -1.321 . . . . 0.0 109.561 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.536 ' CG2' ' HB2' ' A' ' 64' ' ' ALA . 1.1 m -83.64 -47.98 10.67 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.6 ' O ' HD12 ' A' ' 25' ' ' LEU . 74.9 t -57.52 -48.8 82.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.889 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.476 ' O ' HG13 ' A' ' 34' ' ' VAL . 14.4 tttt -57.46 -45.84 84.3 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.27 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -76.21 -2.76 32.83 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.199 -0.938 . . . . 0.0 110.616 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 27' ' ' LYS . . . -85.18 -54.03 4.87 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.128 -0.983 . . . . 0.0 109.438 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.614 ' N ' HD11 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -80.55 -13.22 59.26 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.244 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.56 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 20.1 t -78.72 -35.93 44.15 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.499 -0.751 . . . . 0.0 108.981 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -104.15 2.95 32.45 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.825 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.546 ' CG2' ' CG ' ' A' ' 56' ' ' LYS . 4.6 p -54.11 -53.35 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.79 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.545 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER 169.28 -86.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.881 -1.137 . . . . 0.0 111.557 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.452 ' O ' ' OD2' ' A' ' 48' ' ' ASP . . . -67.69 -21.72 73.09 Favored Glycine 0 N--CA 1.494 2.514 0 O-C-N 121.221 -0.924 . . . . 0.0 111.331 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.588 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 10.8 p -40.15 144.74 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.933 -1.334 . . . . 0.0 111.702 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 m -127.99 -8.63 5.44 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.258 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.54 ' CG ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -162.36 165.05 26.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.157 -0.965 . . . . 0.0 109.842 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.543 ' CG1' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -160.28 155.6 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.989 -1.069 . . . . 0.0 111.165 -178.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.61 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -155.75 161.15 40.75 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 3.2 m -109.59 131.86 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.734 -1.229 . . . . 0.0 111.29 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.4 58.67 0.56 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.592 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -58.78 -17.52 24.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -1.05 . . . . 0.0 110.769 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.14 -22.54 1.72 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.031 . . . . 0.0 109.634 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -148.7 43.11 0.99 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.427 -0.795 . . . . 0.0 109.828 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 40' ' ' LYS . 5.4 mmt180 41.75 58.59 2.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.401 -0.812 . . . . 0.0 109.921 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 4.5 pt-20 -149.17 151.92 35.18 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.992 -1.067 . . . . 0.0 110.669 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.58 142.43 47.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.802 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.61 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 5.4 p -108.72 110.5 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.649 -1.282 . . . . 0.0 108.604 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.495 HG22 HD22 ' A' ' 25' ' ' LEU . 2.9 p -116.52 144.0 25.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.965 0.888 . . . . 0.0 112.36 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.54 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.2 m -109.79 150.78 27.86 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.621 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 23.4 p90 -171.25 173.03 5.06 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 117.736 -1.586 . . . . 0.0 112.303 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.454 ' HB3' HG21 ' A' ' 2' ' ' THR . 0.7 OUTLIER -107.26 118.86 37.83 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.176 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 6.1 p-10 -59.27 -10.99 3.41 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.279 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 48' ' ' ASP . 7.7 t -68.77 -27.02 65.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.958 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HB2' ' OD1' ' A' ' 48' ' ' ASP . 5.6 mttt -120.94 0.55 10.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.92 -1.112 . . . . 0.0 110.579 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.485 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -171.76 -160.79 0.17 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 110.206 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.621 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 169.18 167.74 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.502 -0.749 . . . . 0.0 110.098 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.528 ' CG1' ' CG2' ' A' ' 70' ' ' VAL . 3.0 t -41.08 -42.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.875 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -52.02 -49.79 62.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.022 . . . . 0.0 109.504 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.546 ' CG ' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -74.17 -22.7 59.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.458 -0.776 . . . . 0.0 111.645 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 57.0 mt -72.66 -61.42 1.81 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.39 -1.444 . . . . 0.0 108.237 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 69' ' ' SER . 79.1 m -57.11 -26.08 59.87 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 3.1 ttmt -72.47 -36.05 68.37 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.558 -0.713 . . . . 0.0 109.104 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . . . -66.13 -41.08 90.97 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.439 -0.788 . . . . 0.0 109.938 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.514 HG21 ' N ' ' A' ' 62' ' ' ALA . 8.9 t -73.65 -29.92 62.62 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.514 ' N ' HG21 ' A' ' 61' ' ' THR . . . -66.15 -32.66 74.24 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 63' ' ' ASP . 8.8 t0 -90.64 -12.45 36.83 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.672 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.536 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -78.22 -27.47 47.76 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 132.76 26.61 0.63 Allowed Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.672 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.61 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 37.7 m-85 -147.82 109.11 3.78 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.689 -1.477 . . . . 0.0 111.659 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -59.85 95.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 N-CA-C 107.312 -1.842 . . . . 0.0 107.312 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.03 -168.74 1.38 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 112.415 -176.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.543 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -151.63 -160.81 1.21 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.542 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.2 p -140.24 159.24 25.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.991 -1.068 . . . . 0.0 110.968 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 2.6 mttt -124.96 25.13 7.41 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.448 1.118 . . . . 0.0 109.155 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.466 ' HA ' HG12 ' A' ' 5' ' ' VAL . 13.4 mm100 . . . . . 0 C--N 1.285 -2.211 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.136 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -108.72 163.49 13.21 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.501 -0.88 . . . . 0.0 112.493 -177.048 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.455 ' O ' HG21 ' A' ' 4' ' ' THR . 1.3 t -135.14 111.4 9.68 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.281 0.562 . . . . 0.0 109.775 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.483 HG22 HD11 ' A' ' 57' ' ' LEU 0.256 14.5 m -122.75 166.39 17.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.216 -0.928 . . . . 0.0 109.925 -179.155 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.56 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.45 166.47 10.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.597 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.641 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.15 161.42 33.38 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.1 -178.448 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.56 105.88 15.37 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.434 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.474 HG11 ' NH1' ' A' ' 41' ' ' ARG . 2.3 p -116.43 85.9 17.05 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -76.39 36.06 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.67 1.353 . . . . 0.0 112.318 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.496 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -78.72 -31.07 45.94 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.76 -2.136 . . . . 0.0 107.76 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 36.84 42.0 0.2 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.923 -0.751 . . . . 0.0 110.386 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.625 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 4.0 t -45.78 -27.88 0.93 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 13' ' ' THR . 7.6 t 144.33 -41.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 121.91 0.862 . . . . 0.0 109.241 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.593 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . . . -176.23 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.577 0.703 . . . . 0.0 109.366 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.537 ' CB ' HG23 ' A' ' 13' ' ' THR . . . -129.07 -26.27 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.607 -0.683 . . . . 0.0 109.981 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -44.62 -47.27 27.51 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.917 -1.114 . . . . 0.0 111.689 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 6.9 Cg_endo -76.23 -18.21 16.35 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.334 1.356 . . . . 0.0 113.325 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 mm -87.59 -42.67 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.415 -1.428 . . . . 0.0 109.557 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 64' ' ' ALA 0.251 0.9 OUTLIER -69.55 -37.21 76.94 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.889 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.565 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 25.6 t -64.6 -45.61 94.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.553 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 68.7 tttt -50.67 -45.99 58.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.574 -0.704 . . . . 0.0 110.307 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 8.7 mtmt -75.67 -20.82 58.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 111.101 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.499 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . -69.97 -52.65 22.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.439 -0.788 . . . . 0.0 110.557 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.589 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 4.0 mp -71.91 -31.09 66.05 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.144 -0.973 . . . . 0.0 110.028 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.538 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 12.7 t -68.22 -22.99 64.76 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -111.6 2.8 17.52 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.274 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.552 ' CG2' ' HB3' ' A' ' 56' ' ' LYS . 7.7 p -49.94 -52.13 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.073 -1.017 . . . . 0.0 110.339 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER 172.34 -77.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 110.897 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.34 -1.88 66.26 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.538 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 6.9 p -44.0 141.05 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.238 . . . . 0.0 110.711 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.6 t -118.02 -13.86 9.99 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.606 0.717 . . . . 0.0 109.071 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 7.5 tttt -159.46 166.28 31.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.546 -0.721 . . . . 0.0 109.649 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.553 ' CG2' ' O ' ' A' ' 22' ' ' LYS . 7.2 p -162.51 154.47 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.99 . . . . 0.0 111.366 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.547 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 1.3 m-20 -164.86 171.19 14.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 109.238 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 3.1 m -152.06 164.6 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.935 -1.103 . . . . 0.0 111.173 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.26 112.31 0.52 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.593 ' CE2' ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -66.27 -19.35 65.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -1.142 . . . . 0.0 109.934 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -53.8 -64.67 0.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.354 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -95.6 22.63 6.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.33 -0.856 . . . . 0.0 109.33 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.602 ' HA ' ' NH1' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 36.89 59.64 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.33 0.586 . . . . 0.0 110.772 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 18.3 pt-20 -146.11 166.96 24.59 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.536 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.505 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . . . -125.56 132.57 52.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.161 -0.962 . . . . 0.0 109.163 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.547 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 7.8 p -106.51 116.18 49.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 120.791 -1.193 . . . . 0.0 109.119 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.543 HG23 ' CG2' ' A' ' 34' ' ' VAL . 39.3 t -129.84 144.78 37.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.122 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -108.6 161.29 15.21 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 31.4 p90 -170.22 -177.69 2.57 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 117.898 -1.521 . . . . 0.0 112.091 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -105.98 113.94 27.79 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 10.7 t70 -59.62 -10.2 3.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.784 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.0 p -70.55 -29.22 65.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 0.0 110.61 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -134.6 18.32 3.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.028 -1.045 . . . . 0.0 110.846 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -170.66 178.72 3.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.0 110.053 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.585 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.9 OUTLIER 176.2 171.01 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.387 -0.821 . . . . 0.0 109.511 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.525 HG11 ' CG2' ' A' ' 70' ' ' VAL . 2.7 t -41.8 -34.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -58.88 -50.27 74.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.896 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.552 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 16.3 mmtm -76.5 -20.52 56.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 111.246 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.567 HD13 ' CE2' ' A' ' 47' ' ' PHE . 76.1 mt -70.77 -59.71 2.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.572 -1.33 . . . . 0.0 108.482 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.526 ' N ' HD22 ' A' ' 7' ' ' LEU . 94.5 m -58.63 -26.88 64.19 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.518 -0.739 . . . . 0.0 109.049 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 60.4 tttt -76.35 -29.59 57.29 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.51 -0.744 . . . . 0.0 109.307 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -69.94 -51.12 35.48 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.521 ' OG1' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.64 -32.8 74.35 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . -64.87 -31.27 72.42 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.903 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -88.54 -11.11 46.63 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.498 -0.751 . . . . 0.0 109.028 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HB3' ' CG2' ' A' ' 20' ' ' THR . . . -78.35 -27.3 47.0 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 135.86 23.8 0.55 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.093 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 43.7 m-85 -148.15 109.12 3.69 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.493 -1.592 . . . . 0.0 111.64 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.19 98.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 107.014 -1.956 . . . . 0.0 107.014 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 71.6 p -108.41 -166.31 1.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.083 0.944 . . . . 0.0 112.68 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.475 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.8 m -151.8 -160.74 1.19 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.641 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.2 p -141.1 160.07 22.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.779 -1.2 . . . . 0.0 111.844 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 6' ' ' THR . 9.2 mttt -127.85 25.35 5.97 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.367 1.079 . . . . 0.0 108.93 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.122 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.401 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -113.68 -174.93 2.56 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.312 -0.955 . . . . 0.0 112.462 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.487 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 92.3 m -142.5 146.81 35.11 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.468 0.652 . . . . 0.0 110.34 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.559 ' CG1' ' HA ' ' A' ' 72' ' ' GLN . 15.9 t -156.03 167.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.461 -0.774 . . . . 0.0 109.764 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.571 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -109.66 169.47 8.69 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.477 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.571 ' CD1' ' O ' ' A' ' 6' ' ' THR . 0.9 OUTLIER -133.29 157.99 44.08 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.934 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.24 103.33 12.0 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.735 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.9 p -114.56 92.65 29.53 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.397 -0.814 . . . . 0.0 109.995 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 10.7 Cg_endo -79.54 51.42 3.87 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.669 1.579 . . . . 0.0 111.581 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.584 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -95.44 -21.09 25.42 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.524 ' CG ' ' C ' ' A' ' 11' ' ' GLY . 1.2 ptt? 35.77 59.4 0.86 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.768 -0.842 . . . . 0.0 110.559 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.526 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -90.51 19.68 5.12 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.521 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 13' ' ' THR . 2.4 t 68.5 92.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.471 -0.768 . . . . 0.0 110.309 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.567 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . . . 50.25 30.96 4.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 110.085 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.526 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -127.17 -45.45 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.586 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -40.05 -69.37 0.21 Allowed Pre-proline 0 N--CA 1.505 2.281 0 O-C-N 121.109 -0.994 . . . . 0.0 111.673 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 17' ' ' CYS . 10.0 Cg_endo -65.8 -12.75 36.63 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.173 1.249 . . . . 0.0 112.752 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.522 HD11 ' N ' ' A' ' 19' ' ' ILE . 1.5 mp -78.88 -56.0 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.864 -1.147 . . . . 0.0 109.583 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -69.37 -42.01 75.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.56 ' O ' HD12 ' A' ' 25' ' ' LEU . 5.6 t -57.71 -43.53 83.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.569 ' O ' ' CB ' ' A' ' 26' ' ' SER . 12.8 tttt -53.08 -50.11 65.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.511 -0.743 . . . . 0.0 109.861 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 7.9 mtpm? -72.47 -11.59 60.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 111.501 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.8 -67.22 0.75 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.124 -0.985 . . . . 0.0 109.466 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.583 HD11 ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -68.28 -12.3 60.81 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.579 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 6.8 t -79.32 -30.24 42.73 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.99 9.41 18.72 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.238 -0.914 . . . . 0.0 109.813 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.498 ' CG2' ' HB3' ' A' ' 56' ' ' LYS . 4.0 p -51.89 -53.73 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.349 -0.844 . . . . 0.0 111.08 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.547 ' CG ' ' N ' ' A' ' 30' ' ' GLY . 1.6 tt0 -179.9 -86.28 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.598 -1.314 . . . . 0.0 110.85 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.547 ' N ' ' CG ' ' A' ' 29' ' ' GLU . . . -74.67 -15.14 80.78 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.583 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 3.5 p -40.54 142.08 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -1.069 . . . . 0.0 110.961 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.434 ' N ' HG21 ' A' ' 31' ' ' VAL . 3.5 m -127.02 -11.92 5.88 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.396 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.512 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -158.07 165.2 35.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.18 -0.95 . . . . 0.0 110.044 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.552 ' CG2' ' HB2' ' A' ' 26' ' ' SER . 6.4 p -169.01 154.48 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.023 -1.048 . . . . 0.0 111.59 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.536 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -157.09 172.14 19.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.491 -0.756 . . . . 0.0 109.634 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 22' ' ' LYS . 2.9 m -109.91 151.09 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.057 -1.027 . . . . 0.0 110.926 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -142.85 64.35 0.49 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.583 ' CZ ' ' SG ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -57.33 -15.86 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 110.245 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -45.31 -33.62 2.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.124 -0.985 . . . . 0.0 109.21 179.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -141.57 40.04 1.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.509 -0.744 . . . . 0.0 109.459 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.6 OUTLIER 42.47 57.55 3.38 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.451 -0.781 . . . . 0.0 110.081 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 13.7 pt-20 -142.93 168.76 18.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 110.422 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -129.27 137.79 51.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.419 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 35' ' ' ASP . 8.6 p -107.85 109.02 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.706 -1.246 . . . . 0.0 110.288 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.582 HG23 ' CD2' ' A' ' 25' ' ' LEU . 11.6 t -122.71 150.89 26.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 122.138 0.971 . . . . 0.0 112.068 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -114.12 159.53 19.94 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.606 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 38.5 p90 -170.91 -175.04 1.67 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.606 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.18 124.75 50.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -80.94 37.87 0.44 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.45 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.6 p -115.53 -24.53 8.29 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.171 -0.956 . . . . 0.0 109.23 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.451 ' O ' ' HB1' ' A' ' 52' ' ' ALA . 5.7 mttt -127.7 -2.11 6.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.419 -0.8 . . . . 0.0 110.073 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . 179.17 176.21 0.61 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.93 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.606 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 6.8 p 172.83 -166.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.671 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.546 HG12 ' CG1' ' A' ' 70' ' ' VAL . 6.5 t -36.68 -40.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.559 -0.713 . . . . 0.0 111.149 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -57.53 -49.49 76.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.106 -0.997 . . . . 0.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.498 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 58.1 mmtt -82.01 -16.95 48.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.263 -0.898 . . . . 0.0 111.736 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.543 ' CD2' ' HB2' ' A' ' 25' ' ' LEU . 48.0 mt -75.27 -58.47 3.26 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.514 -1.366 . . . . 0.0 108.065 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.512 ' O ' ' CG2' ' A' ' 61' ' ' THR . 12.9 m -54.46 -30.61 53.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.29 -34.6 65.85 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.513 -0.742 . . . . 0.0 109.858 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.402 ' O ' ' HB1' ' A' ' 64' ' ' ALA . . . -67.93 -36.96 81.05 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.173 -0.955 . . . . 0.0 109.704 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.54 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 5.3 t -74.3 -35.57 63.7 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.535 ' N ' HG21 ' A' ' 61' ' ' THR . . . -64.65 -32.14 73.68 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -90.68 -8.08 50.91 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.484 ' HB3' HG22 ' A' ' 20' ' ' THR . . . -85.16 -21.11 29.33 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.452 -0.78 . . . . 0.0 108.942 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 133.08 17.01 1.18 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.004 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.584 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 35.2 m-85 -151.51 111.46 2.98 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.706 -1.467 . . . . 0.0 111.307 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.14 96.83 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 N-CA-C 107.87 -1.627 . . . . 0.0 107.87 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.9 -171.24 1.81 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.01 . . . . 0.0 112.187 -177.27 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.542 ' N ' ' OG ' ' A' ' 68' ' ' SER . 6.0 p -145.18 -157.45 0.79 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.546 ' CG1' HG12 ' A' ' 54' ' ' VAL . 3.1 p -142.47 158.81 19.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.209 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.534 ' HB2' ' CG2' ' A' ' 6' ' ' THR . 3.9 mttm -124.69 27.12 6.96 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.304 1.05 . . . . 0.0 109.659 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.559 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 17.2 pt20 . . . . . 0 C--N 1.287 -2.148 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.543 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.215 -0.711 0 CA-C-O 121.975 0.893 . . . . 0.0 109.181 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.06 176.1 9.75 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.071 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 21.6 m -113.4 131.86 55.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 110.138 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.566 ' CG2' ' N ' ' A' ' 6' ' ' THR . 0.6 OUTLIER -128.98 169.36 20.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.038 0.923 . . . . 0.0 109.296 179.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.566 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -108.51 159.88 16.34 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.565 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -133.04 152.97 51.91 Favored 'General case' 0 C--N 1.292 -1.921 0 O-C-N 120.868 -1.145 . . . . 0.0 109.688 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -108.95 111.48 23.18 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.616 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.536 ' CG2' HG23 ' A' ' 21' ' ' VAL . 2.1 p -133.23 93.55 22.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 109.167 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 5.5 Cg_endo -73.26 19.13 0.37 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.388 1.392 . . . . 0.0 112.291 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.605 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -52.19 -36.18 43.99 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.516 ' C ' ' O ' ' A' ' 11' ' ' GLY . 2.1 ptt? 26.61 50.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.67 0.748 . . . . 0.0 110.765 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.637 ' CG2' ' CB ' ' A' ' 16' ' ' ALA . 1.9 t -81.38 9.86 6.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.676 -0.64 . . . . 0.0 110.035 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.3 OUTLIER 78.74 94.18 0.06 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.601 0.715 . . . . 0.0 111.104 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 58.44 42.67 20.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.612 -0.68 . . . . 0.0 112.052 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.637 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -160.81 -44.0 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.709 -1.244 . . . . 0.0 111.005 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -46.62 -53.17 26.49 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.627 -1.295 . . . . 0.0 110.167 179.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.641 ' CG ' ' CD2' ' A' ' 38' ' ' PHE . 10.6 Cg_endo -74.04 -16.59 22.75 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.29 1.327 . . . . 0.0 112.219 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.6 mt -79.01 -38.49 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.828 -1.17 . . . . 0.0 109.632 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.515 ' CG2' ' HB2' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -77.06 -45.81 25.81 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.593 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 16.9 t -56.37 -40.69 68.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 26' ' ' SER . 7.2 tttt -55.67 -56.96 14.23 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 108.823 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -71.39 0.69 7.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.41 -0.806 . . . . 0.0 110.868 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.449 ' C ' ' CB ' ' A' ' 60' ' ' ALA . . . -88.79 -72.14 0.56 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.669 -1.269 . . . . 0.0 108.929 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -64.78 -9.93 24.05 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.49 178.587 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.576 ' N ' HD21 ' A' ' 25' ' ' LEU . 34.8 t -90.65 -45.5 8.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.5 -0.75 . . . . 0.0 110.397 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -79.28 -4.15 49.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.864 -1.147 . . . . 0.0 110.309 -179.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.529 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 5.4 t -29.85 -79.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.852 -0.53 . . . . 0.0 110.927 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.521 ' N ' HG13 ' A' ' 28' ' ' VAL . 1.2 pt-20 178.0 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.948 -1.095 . . . . 0.0 110.935 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 48' ' ' ASP . . . -117.66 2.27 17.87 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.565 ' CG2' ' O ' ' A' ' 25' ' ' LEU . 71.6 t -49.69 147.87 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 122.459 1.123 . . . . 0.0 111.399 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.466 ' N ' HG11 ' A' ' 31' ' ' VAL . 3.5 m -122.2 -10.18 8.56 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.459 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.497 ' CG ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -175.72 170.37 2.88 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.001 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 26' ' ' SER . 9.7 p -170.09 156.49 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.862 . . . . 0.0 110.517 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.54 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -156.2 164.88 37.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.427 -0.795 . . . . 0.0 109.633 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.452 HG11 ' HB2' ' A' ' 22' ' ' LYS . 7.2 m -112.18 140.49 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 110.704 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.17 69.82 0.53 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.641 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -61.92 -14.72 37.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -1.154 . . . . 0.0 110.435 -179.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -54.89 -27.15 40.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 109.8 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.446 ' HG3' ' HB3' ' A' ' 42' ' ' GLU . 2.8 ptmt -142.7 35.51 1.43 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 110.03 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 40' ' ' LYS . 1.9 mpp_? 42.9 55.75 4.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.214 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HG2' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -145.61 149.42 34.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.233 -0.917 . . . . 0.0 110.11 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.51 ' N ' ' HG2' ' A' ' 42' ' ' GLU . . . -115.87 139.25 50.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 110.031 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.54 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 9.1 p -106.47 111.78 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.763 -1.211 . . . . 0.0 109.47 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.608 ' CG1' ' CD1' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -117.51 137.83 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.776 0.798 . . . . 0.0 112.289 -178.056 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.497 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.6 m -109.0 155.77 20.51 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.721 ' O ' ' HA ' ' A' ' 2' ' ' THR . 35.5 p90 -171.92 -176.81 1.79 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.449 -1.407 . . . . 0.0 110.798 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 2' ' ' THR . 2.1 p30 -109.59 110.52 21.62 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 29.0 t70 -54.64 -14.69 1.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.959 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.418 ' OG1' ' HB2' ' A' ' 48' ' ' ASP . 2.2 p -61.63 -35.73 78.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 110.807 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.08 -5.23 9.52 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.043 -1.035 . . . . 0.0 111.361 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -153.02 -164.47 1.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.969 -1.082 . . . . 0.0 110.874 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.612 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 6.4 t 167.72 172.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 5' ' ' VAL . 6.6 m -51.54 -32.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.753 -1.217 . . . . 0.0 109.451 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -47.66 -44.86 27.54 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.014 -1.054 . . . . 0.0 108.404 179.003 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.464 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -89.06 -20.58 24.18 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.763 -0.586 . . . . 0.0 111.244 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.608 ' CD1' ' CG1' ' A' ' 45' ' ' VAL . 42.3 mt -73.77 -64.04 1.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.229 -1.544 . . . . 0.0 107.98 178.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 61' ' ' THR . 1.4 m -56.59 -27.61 58.42 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -74.81 -32.0 61.85 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.168 -0.957 . . . . 0.0 109.327 179.362 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.49 ' HB2' ' N ' ' A' ' 25' ' ' LEU . . . -70.48 -35.94 73.56 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.316 -0.865 . . . . 0.0 109.459 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.544 HG21 ' N ' ' A' ' 62' ' ' ALA . 4.8 t -74.68 -34.7 62.73 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.544 ' N ' HG21 ' A' ' 61' ' ' THR . . . -66.36 -32.29 73.59 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.39 -10.09 45.19 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.576 -0.703 . . . . 0.0 109.378 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.515 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -79.48 -29.66 41.75 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.56 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.98 27.93 0.34 Allowed Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.699 -1.238 . . . . 0.0 110.996 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.605 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 53.0 m-85 -150.9 116.72 3.28 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.622 -1.517 . . . . 0.0 111.449 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.54 95.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 N-CA-C 106.875 -2.01 . . . . 0.0 106.875 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 2.9 m -108.79 -165.1 0.99 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 112.51 -176.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 58' ' ' THR . 4.9 t -159.42 -167.11 1.95 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.565 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.1 p -139.06 155.92 27.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 120.804 -1.185 . . . . 0.0 111.379 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 1.1 mttt -124.49 26.72 7.19 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.432 1.111 . . . . 0.0 108.864 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.436 ' O ' HG22 ' A' ' 5' ' ' VAL . 1.8 mp0 . . . . . 0 C--N 1.29 -2.013 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.289 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -112.48 151.08 30.34 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.655 -177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.3 m -124.9 122.42 37.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.576 ' CG2' ' N ' ' A' ' 6' ' ' THR . 0.8 OUTLIER -130.32 171.68 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.03 . . . . 0.0 110.419 -178.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.576 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -107.28 158.91 16.76 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -130.07 155.89 45.41 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.662 -1.273 . . . . 0.0 109.847 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.98 100.76 9.4 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.946 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.517 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 1.8 p -114.45 89.97 19.67 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.476 -0.765 . . . . 0.0 109.337 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 11.0 Cg_endo -78.06 46.53 2.1 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.361 1.374 . . . . 0.0 112.008 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.592 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -92.42 -34.31 7.12 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.486 ' C ' ' O ' ' A' ' 11' ' ' GLY . 0.9 OUTLIER 35.59 44.33 0.2 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.758 0.789 . . . . 0.0 110.087 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.604 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 1.4 t -61.22 -11.03 7.84 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.679 -0.638 . . . . 0.0 109.639 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.604 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.5 OUTLIER 86.66 93.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.614 0.721 . . . . 0.0 111.029 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 73.55 24.4 2.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 111.831 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.601 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -150.84 -38.69 0.13 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.457 -1.402 . . . . 0.0 110.718 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.613 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -45.15 -47.74 32.36 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.606 -1.309 . . . . 0.0 110.459 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.6 Cg_endo -70.75 -28.17 20.83 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 O-C-N 123.229 1.12 . . . . 0.0 111.655 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.5 mm -73.39 -32.18 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.955 . . . . 0.0 110.839 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.544 HG21 ' CB ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -81.64 -53.27 6.37 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 108.965 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.54 ' O ' HD12 ' A' ' 25' ' ' LEU . 66.5 t -54.39 -43.46 62.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.678 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.9 tttm -55.55 -61.75 2.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.937 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -75.42 5.74 5.43 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.186 -0.946 . . . . 0.0 110.678 179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -85.36 -67.89 0.77 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.373 -1.454 . . . . 0.0 108.482 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.57 HD11 ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -74.26 -11.62 60.33 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 22' ' ' LYS . 46.5 t -85.51 -33.25 21.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.45 -10.1 42.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.6 -1.312 . . . . 0.0 110.433 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.589 ' CG1' ' CE ' ' A' ' 56' ' ' LYS . 3.2 t -40.39 -82.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.276 -0.89 . . . . 0.0 110.015 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 174.97 -57.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.418 -0.801 . . . . 0.0 109.906 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.444 ' O ' ' OD2' ' A' ' 48' ' ' ASP . . . -70.3 -26.76 73.73 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.615 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 14.8 p -56.56 142.3 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -1.145 . . . . 0.0 110.699 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.84 -10.9 8.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.757 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.4 tttt -162.47 168.96 21.17 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.068 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.7 p -169.07 159.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.093 -1.004 . . . . 0.0 111.384 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.452 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -158.85 162.95 37.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.505 ' CG1' ' HB2' ' A' ' 22' ' ' LYS . 22.4 m -116.23 152.33 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 110.603 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -144.41 79.13 0.25 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.547 ' CE2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -58.03 -18.92 27.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -1.121 . . . . 0.0 110.119 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -50.3 -47.99 55.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 0.0 109.092 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 41' ' ' ARG . 10.1 mttm -116.18 25.49 10.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.493 -0.754 . . . . 0.0 109.381 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.551 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 40.97 57.48 2.74 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.422 0.63 . . . . 0.0 110.191 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.537 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -148.06 155.86 41.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.412 -0.805 . . . . 0.0 109.742 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' CB ' HG13 ' A' ' 21' ' ' VAL . . . -112.13 138.66 48.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.944 -1.097 . . . . 0.0 110.276 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 44' ' ' VAL . 8.6 p -106.09 105.65 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.821 -1.174 . . . . 0.0 109.064 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 4.8 p -109.72 148.84 13.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 122.089 0.947 . . . . 0.0 112.292 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -115.94 154.13 30.35 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.615 ' CB ' ' HA ' ' A' ' 31' ' ' VAL . 34.6 p90 -170.83 -177.24 2.22 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 117.669 -1.612 . . . . 0.0 112.051 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 1.2 p30 -107.01 115.05 29.51 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 7.8 t70 -68.24 -3.79 11.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.777 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.468 HG23 ' HB2' ' A' ' 48' ' ' ASP . 4.1 t -66.63 -6.98 17.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 110.018 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -137.35 -51.09 0.64 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.136 -0.978 . . . . 0.0 110.937 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.573 ' HB2' ' CE ' ' A' ' 56' ' ' LYS . . . -130.49 -160.99 1.08 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.452 -0.78 . . . . 0.0 110.466 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.602 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.3 p 168.4 -169.02 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.379 -0.825 . . . . 0.0 109.338 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.543 HG12 ' CG1' ' A' ' 70' ' ' VAL . 3.1 t -35.5 -59.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.747 -0.595 . . . . 0.0 111.134 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 34.4 tt0 -43.13 -47.54 6.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 0.0 110.791 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.589 ' CE ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -79.14 -24.06 43.58 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.964 . . . . 0.0 111.849 -178.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.542 HD22 ' NZ ' ' A' ' 56' ' ' LYS . 79.9 mt -72.08 -56.73 5.1 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.503 -1.373 . . . . 0.0 108.384 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.472 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 7.4 m -56.48 -31.46 64.05 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.528 -0.732 . . . . 0.0 109.385 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -75.47 -31.57 60.29 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.287 -0.883 . . . . 0.0 110.005 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.07 -42.31 76.39 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.533 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 12.9 t -73.64 -32.89 64.26 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 66' ' ' TYR . . . -64.67 -31.25 72.4 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.59 -9.51 46.78 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.544 ' CB ' HG21 ' A' ' 20' ' ' THR . . . -81.93 -23.7 36.03 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.35 14.4 0.62 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.463 -1.351 . . . . 0.0 111.743 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.592 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 68.7 m-85 -145.69 114.11 4.71 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.313 -1.698 . . . . 0.0 111.79 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.77 97.58 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 N-CA-C 107.255 -1.863 . . . . 0.0 107.255 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 1.5 p -108.31 -166.14 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.0 112.751 -176.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.428 ' OG ' ' CB ' ' A' ' 8' ' ' ALA . 24.6 p -150.73 -164.92 2.13 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.4 p -141.07 158.32 22.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.906 -1.118 . . . . 0.0 111.516 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.482 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -125.95 24.72 6.95 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.294 1.045 . . . . 0.0 109.088 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.48 ' OXT' HG21 ' A' ' 5' ' ' VAL . 39.4 mt-30 . . . . . 0 C--N 1.289 -2.026 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.345 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.536 ' CA ' ' O ' ' A' ' 47' ' ' PHE 0.258 14.6 t . . . . . 0 C--O 1.214 -0.805 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.668 ' CB ' ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -173.37 153.88 2.5 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.455 179.048 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.6 m -143.16 107.73 4.83 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.535 HG11 ' CA ' ' A' ' 72' ' ' GLN . 2.5 t -140.17 165.15 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -0.854 . . . . 0.0 109.9 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.561 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 2.4 p -108.9 164.0 12.79 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.95 157.74 46.12 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.704 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.46 107.25 16.85 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.568 -0.707 . . . . 0.0 110.068 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.475 HG23 ' SG ' ' A' ' 17' ' ' CYS . 2.0 p -117.15 100.44 53.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.751 . . . . 0.0 109.524 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -76.27 34.96 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.381 1.388 . . . . 0.0 112.156 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.606 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.56 -46.11 86.34 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.549 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 16.9 ptt? 36.78 47.54 0.57 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.88 -0.776 . . . . 0.0 110.36 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.644 ' CG2' ' CB ' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -85.19 14.9 4.63 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.508 -0.745 . . . . 0.0 109.795 179.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 13' ' ' THR . 4.0 t 77.68 87.97 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.489 0.661 . . . . 0.0 111.363 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 56.12 38.83 30.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.489 -0.757 . . . . 0.0 111.788 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.644 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -154.43 -31.27 0.11 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.883 -1.136 . . . . 0.0 111.122 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -50.82 -55.23 28.87 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.647 -1.283 . . . . 0.0 110.676 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.626 ' CG ' ' CD2' ' A' ' 38' ' ' PHE . 9.5 Cg_endo -69.05 -3.79 12.25 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.249 1.299 . . . . 0.0 112.543 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.475 HG22 HD11 ' A' ' 19' ' ' ILE . 15.5 mt -90.54 -48.49 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.857 -1.152 . . . . 0.0 109.229 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.521 ' CG2' ' HB3' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -62.56 -36.81 83.84 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.568 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 60.4 t -65.54 -48.13 83.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.494 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 44.6 tttm -42.71 -54.19 4.16 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.634 -0.666 . . . . 0.0 110.669 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -71.44 -26.02 62.56 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.163 -0.961 . . . . 0.0 111.473 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . -65.11 -55.37 19.13 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.302 -0.874 . . . . 0.0 110.818 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.578 ' CD2' HD21 ' A' ' 7' ' ' LEU . 3.2 mp -69.71 -31.65 69.78 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.099 -1.001 . . . . 0.0 110.534 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.529 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -68.23 -22.08 64.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.239 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.46 1.09 15.78 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.025 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.547 HG13 ' CG2' ' A' ' 31' ' ' VAL . 7.6 p -45.7 -46.94 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.883 -1.136 . . . . 0.0 110.627 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.524 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.4 OUTLIER 173.17 -80.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.897 -1.127 . . . . 0.0 110.891 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -92.41 -14.77 55.19 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.006 -1.093 . . . . 0.0 110.528 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.585 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 9.6 t -42.43 139.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.027 -1.278 . . . . 0.0 110.428 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.1 t -118.32 -10.66 10.17 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.474 0.654 . . . . 0.0 109.245 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -154.0 164.59 38.19 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.264 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.494 ' CG1' ' HG3' ' A' ' 22' ' ' LYS . 6.4 p -152.94 174.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 109.242 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.47 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . 1.2 t0 -162.3 160.01 26.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.832 -1.168 . . . . 0.0 111.378 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 18' ' ' PRO . 25.1 t -110.07 136.08 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.487 -0.758 . . . . 0.0 109.963 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -138.63 61.75 0.57 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -58.87 -23.48 60.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -1.135 . . . . 0.0 110.326 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -42.99 -40.77 3.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.864 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.525 ' CG ' ' HG2' ' A' ' 42' ' ' GLU . 12.9 ptpt -139.21 49.2 1.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.421 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.549 ' CD ' ' HB3' ' A' ' 12' ' ' MET . 0.0 OUTLIER 39.47 62.31 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.505 -0.747 . . . . 0.0 110.299 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.525 ' HG2' ' CG ' ' A' ' 40' ' ' LYS . 2.0 pp20? -146.42 141.55 27.27 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.435 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -115.1 136.29 53.27 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.561 ' CG2' ' CG2' ' A' ' 6' ' ' THR . 1.6 t -106.24 143.68 16.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 120.233 -1.542 . . . . 0.0 109.355 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.548 ' CG2' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -142.51 153.49 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.797 -178.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -123.75 151.3 43.4 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.668 ' CZ ' ' CB ' ' A' ' 3' ' ' GLN . 31.9 p90 -167.52 -173.42 2.2 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 117.747 -1.581 . . . . 0.0 112.639 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 39.4 m-20 -105.59 118.49 36.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -66.15 -1.66 3.45 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.214 -177.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.0 t -86.27 -20.49 28.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.043 -1.036 . . . . 0.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -128.47 -14.94 4.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.887 -1.133 . . . . 0.0 111.707 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -143.25 -170.39 3.26 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.023 -1.048 . . . . 0.0 110.137 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.593 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 174.15 167.92 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.873 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.52 ' CG2' ' CG2' ' A' ' 70' ' ' VAL . 2.5 p -42.73 -49.81 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 110.215 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 7.3 tt0 -45.09 -47.04 12.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.041 . . . . 0.0 109.867 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 11.2 mmtm -75.6 -27.09 58.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.43 -0.794 . . . . 0.0 111.437 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 47' ' ' PHE . 68.5 mt -68.63 -57.69 5.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.602 -1.311 . . . . 0.0 108.761 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.423 ' O ' ' CB ' ' A' ' 62' ' ' ALA . 4.0 m -56.22 -29.61 61.2 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.381 -0.824 . . . . 0.0 109.45 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 3.9 tttm -76.98 -29.52 55.55 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.297 -0.877 . . . . 0.0 109.699 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . . . -69.97 -47.2 63.22 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.412 -0.805 . . . . 0.0 109.253 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.532 ' OG1' ' CG1' ' A' ' 21' ' ' VAL . 10.2 t -70.15 -32.95 71.18 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.488 ' N ' HG21 ' A' ' 61' ' ' THR . . . -68.14 -26.05 65.59 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.658 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 20.1 t0 -89.83 -13.34 36.77 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.521 ' HB3' ' CG2' ' A' ' 20' ' ' THR . . . -80.27 -28.25 38.43 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.589 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 138.88 26.2 0.29 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.11 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.626 ' CZ ' ' HA ' ' A' ' 17' ' ' CYS . 36.0 m-85 -151.38 105.2 2.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.655 -1.497 . . . . 0.0 110.993 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.38 101.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 N-CA-C 107.184 -1.891 . . . . 0.0 107.184 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -107.94 -169.68 1.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.19 -1.004 . . . . 0.0 112.642 -176.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.517 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -152.38 -165.23 2.15 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.591 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.8 p -137.95 157.81 32.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.513 -1.367 . . . . 0.0 111.733 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.496 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -122.87 27.26 7.8 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.058 0.932 . . . . 0.0 109.639 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.535 ' CA ' HG11 ' A' ' 5' ' ' VAL . 34.3 mt-30 . . . . . 0 C--N 1.29 -2.019 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.531 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -109.13 153.26 23.97 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.874 0.845 . . . . 0.0 112.103 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.447 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 5.4 t -123.45 143.27 50.25 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.539 ' CG1' ' HA ' ' A' ' 72' ' ' GLN . 1.5 t -149.49 160.95 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -0.93 . . . . 0.0 109.152 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.545 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 1.8 t -106.97 158.71 16.82 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.611 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -128.85 161.47 29.73 Favored 'General case' 0 C--N 1.276 -2.619 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.525 -177.601 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.43 101.15 10.14 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.816 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.525 HG22 ' CB ' ' A' ' 66' ' ' TYR . 3.5 p -115.21 90.3 23.66 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -77.41 45.35 1.71 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.545 1.496 . . . . 0.0 112.822 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.592 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -95.11 -34.04 6.33 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.554 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 1.2 mmt 54.3 -88.86 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.52 -0.988 . . . . 0.0 108.923 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.633 ' CG2' ' CB ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER 58.31 9.76 1.11 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.592 179.768 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER 68.2 110.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.441 -0.787 . . . . 0.0 112.319 178.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . 33.19 48.81 0.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.841 -0.537 . . . . 0.0 112.375 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.633 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -151.26 -40.91 0.12 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.038 -1.039 . . . . 0.0 109.513 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.668 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 13.7 t -56.08 -41.35 90.55 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 110.834 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 7.6 Cg_endo -78.35 -5.52 15.02 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.068 1.179 . . . . 0.0 111.661 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.9 mt -91.21 -35.52 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.831 -1.168 . . . . 0.0 108.672 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.487 ' CG2' ' CB ' ' A' ' 64' ' ' ALA . 1.2 m -75.94 -35.75 59.61 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.569 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 81.9 t -66.08 -46.06 88.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 26' ' ' SER . 7.8 tttm -51.39 -54.61 24.8 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.101 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -72.87 -12.88 61.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 111.299 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.418 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . . . -76.15 -63.61 1.28 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.956 -1.09 . . . . 0.0 109.649 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.602 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 3.5 mp -58.54 -33.8 70.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.495 -0.753 . . . . 0.0 110.081 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.523 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -70.46 -27.81 64.52 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.151 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -87.76 -9.57 53.58 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.322 -0.862 . . . . 0.0 109.942 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.525 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 3.0 t -43.3 -80.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.133 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 172.35 -57.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.0 109.242 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.447 ' HA3' ' HB1' ' A' ' 52' ' ' ALA . . . -84.89 -26.21 38.53 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.601 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 51.4 t -50.83 133.87 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -1.091 . . . . 0.0 110.324 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 m -115.0 -14.75 11.83 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.646 0.736 . . . . 0.0 109.218 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' O ' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -153.63 159.64 42.16 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.27 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 22' ' ' LYS . 7.1 p -156.84 157.13 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 110.203 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.533 ' CB ' HG11 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -158.1 171.52 20.07 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.227 -0.921 . . . . 0.0 110.113 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 19.2 m -144.55 156.32 14.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 110.333 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.28 106.98 0.41 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.599 ' CE2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -67.91 -25.54 65.54 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -1.091 . . . . 0.0 109.238 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -56.83 -23.55 44.69 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.354 -0.841 . . . . 0.0 108.984 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.524 ' O ' ' C ' ' A' ' 41' ' ' ARG . 6.7 tptm -138.93 33.18 2.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.546 -0.721 . . . . 0.0 109.807 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.551 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 8.7 tpm_? 22.35 60.2 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.225 0.535 . . . . 0.0 112.391 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 24.6 pt-20 -148.91 170.36 18.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.298 -0.876 . . . . 0.0 110.335 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -128.22 130.18 47.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.667 -1.27 . . . . 0.0 109.702 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.533 HG11 ' CB ' ' A' ' 35' ' ' ASP . 15.0 p -105.27 117.87 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.796 -1.19 . . . . 0.0 109.415 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 33' ' ' LYS . 7.2 p -126.3 150.77 32.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 122.257 1.027 . . . . 0.0 112.926 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -110.3 153.93 24.19 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 2' ' ' THR . 37.7 p90 -168.81 178.58 4.54 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 117.872 -1.531 . . . . 0.0 111.987 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -105.55 124.88 50.28 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 8.4 t0 -79.46 26.94 0.28 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.494 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.47 -29.07 11.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.941 -1.1 . . . . 0.0 109.145 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -123.77 -7.8 7.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.517 -0.739 . . . . 0.0 110.097 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.447 ' HB1' ' HA3' ' A' ' 30' ' ' GLY . . . -146.98 -164.77 2.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.454 -0.779 . . . . 0.0 109.498 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.567 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 174.06 164.28 0.2 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.08 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.6 ' CG2' ' CG2' ' A' ' 70' ' ' VAL . 7.9 p -44.86 -42.96 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.535 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 23.0 tt0 -55.88 -43.84 77.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.973 . . . . 0.0 109.358 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -73.75 -22.33 59.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.501 -0.749 . . . . 0.0 110.572 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.587 HD13 ' CE2' ' A' ' 47' ' ' PHE . 90.8 mt -69.93 -55.76 8.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.776 -1.203 . . . . 0.0 108.391 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.54 HG22 ' CA ' ' A' ' 69' ' ' SER . 59.5 m -56.87 -35.62 69.12 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -73.24 -26.86 61.29 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.333 -0.854 . . . . 0.0 109.585 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.513 ' HB1' ' CG2' ' A' ' 28' ' ' VAL . . . -68.31 -50.68 51.81 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.414 -0.804 . . . . 0.0 109.379 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.517 HG21 ' N ' ' A' ' 62' ' ' ALA . 6.6 t -67.12 -32.14 73.08 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.517 ' N ' HG21 ' A' ' 61' ' ' THR . . . -63.1 -32.27 73.61 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.058 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.482 ' OD2' ' HA ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -88.54 -11.09 46.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.461 -0.774 . . . . 0.0 109.129 178.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.487 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -76.85 -31.8 57.1 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 142.9 32.18 0.11 Allowed Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.902 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.592 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 72.8 m-85 -159.17 107.84 1.54 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.698 -1.472 . . . . 0.0 111.291 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -56.27 99.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 N-CA-C 106.687 -2.082 . . . . 0.0 106.687 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 60.3 p -108.42 -165.43 1.03 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.166 -0.959 . . . . 0.0 112.514 -176.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.54 ' CA ' HG22 ' A' ' 58' ' ' THR . 0.2 OUTLIER -150.86 -161.36 1.32 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.611 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.3 p -141.62 157.93 21.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 O-C-N 120.832 -1.167 . . . . 0.0 111.33 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.544 ' HB2' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -129.42 27.53 5.29 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.427 1.108 . . . . 0.0 109.002 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.539 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 10.9 pt20 . . . . . 0 C--N 1.289 -2.065 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.292 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -107.86 164.14 12.51 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.821 0.82 . . . . 0.0 112.236 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 t -131.59 128.12 38.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.445 0.64 . . . . 0.0 110.144 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 72' ' ' GLN . 5.4 t -139.35 168.08 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 109.148 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.568 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -108.77 171.57 7.35 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.604 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -134.33 159.36 41.25 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.917 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -113.02 99.25 7.71 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.175 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.486 ' HA ' ' OG ' ' A' ' 68' ' ' SER . 2.1 p -112.68 101.74 53.31 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 109.277 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.7 Cg_endo -77.63 39.83 0.79 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.494 1.463 . . . . 0.0 111.748 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.615 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -82.76 -51.24 4.34 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.46 ' HB2' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 42.97 57.23 3.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.538 -0.977 . . . . 0.0 109.916 -179.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.534 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -87.94 15.07 7.68 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.273 179.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 4.0 t 65.51 87.36 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.542 -0.724 . . . . 0.0 110.265 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' O ' ' CD1' ' A' ' 19' ' ' ILE . . . 68.26 29.72 5.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 0.0 110.089 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -138.56 -48.16 0.52 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -55.31 -47.4 98.67 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.411 -0.806 . . . . 0.0 111.206 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 9.2 Cg_endo -71.89 -9.44 24.73 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 120.895 1.063 . . . . 0.0 112.219 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.517 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 20.6 mt -93.13 -37.86 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.787 -1.195 . . . . 0.0 109.842 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.535 ' CG2' ' CB ' ' A' ' 64' ' ' ALA . 1.2 m -77.02 -40.8 45.16 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.616 ' O ' HD12 ' A' ' 25' ' ' LEU . 97.6 t -62.88 -45.45 98.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.827 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.524 ' CG ' HG13 ' A' ' 34' ' ' VAL . 39.7 tttt -54.04 -55.58 26.08 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.174 -0.954 . . . . 0.0 109.853 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -75.9 -0.94 23.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 111.223 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' C ' ' HB2' ' A' ' 60' ' ' ALA . . . -80.95 -64.41 1.19 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.722 -1.236 . . . . 0.0 108.843 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.637 ' H ' ' CD1' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.06 -24.63 65.99 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.546 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 3.3 t -72.66 -26.66 61.72 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -97.43 -5.23 36.64 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.329 -0.857 . . . . 0.0 110.378 179.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.568 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 2.7 t -46.09 -59.99 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.52 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.568 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER 158.1 -72.22 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.433 0.635 . . . . 0.0 110.225 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -69.24 -27.23 73.91 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.58 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 8.0 p -39.68 139.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.427 -1.043 . . . . 0.0 110.484 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.34 -14.67 9.19 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.536 0.684 . . . . 0.0 109.63 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.55 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 9.7 ttmm -162.96 164.7 25.65 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.114 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 33' ' ' LYS . 52.7 t -159.51 150.64 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.076 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.6 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -142.36 169.25 17.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 0.0 109.503 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 18' ' ' PRO . 62.9 t -108.99 151.5 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.118 -0.989 . . . . 0.0 110.981 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.67 60.04 0.49 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.598 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -60.93 -23.74 65.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.515 -0.991 . . . . 0.0 110.544 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -21.9 2.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.999 -1.063 . . . . 0.0 109.35 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 41' ' ' ARG . 21.5 mttt -143.05 39.45 1.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -0.758 . . . . 0.0 110.077 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.46 ' C ' ' O ' ' A' ' 40' ' ' LYS . 1.5 ttp180 36.22 60.21 0.88 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.633 -0.667 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -152.22 168.43 25.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.476 -0.889 . . . . 0.0 111.338 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -131.17 139.09 49.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 109.327 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.6 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 9.0 p -107.78 109.41 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.841 -1.162 . . . . 0.0 110.145 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.578 HG23 HD21 ' A' ' 25' ' ' LEU . 53.8 t -111.21 159.1 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 122.414 1.102 . . . . 0.0 112.915 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -123.59 150.72 43.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 177.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 2' ' ' THR . 32.7 p90 -171.62 -176.29 1.76 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.004 -1.878 . . . . 0.0 112.979 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.46 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 0.4 OUTLIER -105.38 114.14 28.15 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 14.6 t70 -62.67 -6.76 3.85 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.143 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 48' ' ' ASP . 73.5 p -83.73 -25.51 30.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.052 -1.03 . . . . 0.0 110.945 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -116.55 -7.15 11.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.924 -1.11 . . . . 0.0 110.726 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . 179.43 -179.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.614 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.0 p 172.17 -172.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 110.323 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.538 HG12 ' CG1' ' A' ' 70' ' ' VAL . 9.3 t -36.53 -38.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.539 -0.725 . . . . 0.0 111.003 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -55.97 -51.88 66.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.151 -0.968 . . . . 0.0 110.497 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.447 ' HB3' HG11 ' A' ' 28' ' ' VAL . 11.3 mmtp -82.93 -17.64 42.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 112.085 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.533 ' CD2' ' HB3' ' A' ' 25' ' ' LEU . 37.2 mt -74.41 -53.82 8.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.353 -1.467 . . . . 0.0 108.455 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.475 ' CG2' ' HA ' ' A' ' 69' ' ' SER . 3.2 m -59.89 -35.62 75.23 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.032 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -73.21 -29.02 62.5 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.311 -0.868 . . . . 0.0 110.206 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.467 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -70.48 -43.68 69.25 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.067 -1.021 . . . . 0.0 109.704 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.517 HG21 ' N ' ' A' ' 62' ' ' ALA . 2.8 t -73.06 -29.1 62.71 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.517 ' N ' HG21 ' A' ' 61' ' ' THR . . . -69.55 -30.74 68.61 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -10.8 42.15 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.516 -0.74 . . . . 0.0 109.22 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.535 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -81.61 -29.46 33.29 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.455 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 141.21 23.67 0.24 Allowed Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.618 -1.277 . . . . 0.0 111.471 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.615 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 56.1 m-85 -146.62 113.68 4.35 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.34 -1.682 . . . . 0.0 111.366 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.76 91.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 106.874 -2.01 . . . . 0.0 106.874 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 55.0 m -108.79 -170.22 1.63 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.178 -0.951 . . . . 0.0 112.995 -176.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.475 ' HA ' ' CG2' ' A' ' 58' ' ' THR . 2.3 m -160.13 -159.95 0.75 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.573 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.2 p -139.37 161.53 27.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.921 -1.112 . . . . 0.0 111.172 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.553 ' HB2' ' CG2' ' A' ' 6' ' ' THR . 4.3 mttt -122.31 24.0 9.54 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 122.264 1.031 . . . . 0.0 110.133 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.545 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 10.2 tt0 . . . . . 0 C--N 1.284 -2.252 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.369 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.068 0.461 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -152.62 88.76 1.36 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -126.88 165.95 18.4 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.254 -0.904 . . . . 0.0 111.666 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 14.6 t -130.42 134.3 47.01 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.58 -0.7 . . . . 0.0 110.324 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.528 HG23 ' CG2' ' A' ' 54' ' ' VAL . 10.8 t -122.6 171.42 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -0.765 . . . . 0.0 109.266 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.562 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -106.96 158.56 16.94 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.003 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.629 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -132.13 156.32 46.57 Favored 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 118.476 -1.289 . . . . 0.0 110.538 -178.471 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.19 101.67 10.68 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.412 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.463 HG23 ' SG ' ' A' ' 17' ' ' CYS . 1.5 p -113.89 87.85 13.29 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.609 -0.682 . . . . 0.0 109.614 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 11.5 Cg_endo -78.1 39.94 0.83 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.351 1.367 . . . . 0.0 111.764 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.582 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -81.4 -28.57 43.51 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.506 ' CG ' ' C ' ' A' ' 11' ' ' GLY . 7.7 ptt? 33.12 62.11 0.38 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.92 -0.753 . . . . 0.0 110.541 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.537 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -85.25 11.59 9.74 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.466 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.1 OUTLIER 70.31 90.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 110.088 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' A' ' 14' ' ' CYS . . . 59.4 26.98 15.98 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.573 -0.704 . . . . 0.0 110.103 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.537 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -131.44 -40.69 1.11 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.801 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.607 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -53.59 -48.93 91.41 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.0 110.992 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 7.5 Cg_endo -72.45 -10.36 25.33 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.434 1.229 . . . . 0.0 112.33 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.06 -45.75 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.682 -1.262 . . . . 0.0 109.875 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.561 ' CG2' ' CB ' ' A' ' 64' ' ' ALA 0.257 1.2 m -73.44 -36.75 65.97 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.679 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.587 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 13.5 t -70.26 -47.85 64.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.878 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 18' ' ' PRO . 6.3 tmtt? -49.9 -51.57 39.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.491 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.531 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -70.52 -21.9 62.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.922 -1.111 . . . . 0.0 111.252 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.496 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . -66.87 -54.36 23.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.243 -0.911 . . . . 0.0 110.471 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.614 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 3.6 mp -70.7 -31.09 67.83 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.084 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.529 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 3.6 p -68.8 -20.47 64.33 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.531 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -116.31 4.92 13.5 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.449 -0.901 . . . . 0.0 109.816 179.103 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.532 ' CG2' ' HB3' ' A' ' 56' ' ' LYS . 8.0 p -51.01 -50.03 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.0 110.867 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER 175.44 -77.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.883 -1.135 . . . . 0.0 110.888 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.94 2.36 56.82 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 26' ' ' SER . 14.9 p -44.77 144.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.042 -1.27 . . . . 0.0 110.592 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.419 ' OG ' ' OD2' ' A' ' 48' ' ' ASP . 19.4 m -113.28 -16.3 12.54 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' O ' HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -170.19 167.82 8.49 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.698 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.6 p -157.88 167.36 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.124 -0.985 . . . . 0.0 110.55 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.495 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 1.6 m-20 -167.68 178.53 5.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.977 . . . . 0.0 110.086 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 3.8 m -150.13 165.4 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 111.127 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.3 106.85 0.32 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -70.05 -8.24 47.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -1.176 . . . . 0.0 110.53 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -60.34 -23.98 64.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.058 -1.026 . . . . 0.0 109.17 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -150.29 30.65 0.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.462 -0.774 . . . . 0.0 110.144 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 40' ' ' LYS . 2.0 mpp_? 40.56 58.94 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.522 -0.736 . . . . 0.0 110.408 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 2.4 pt-20 -136.88 149.53 47.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 0.0 110.211 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.551 ' CB ' ' CG1' ' A' ' 21' ' ' VAL . . . -117.86 132.18 56.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.972 -1.08 . . . . 0.0 109.449 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.495 ' CG1' ' HB2' ' A' ' 35' ' ' ASP . 8.1 p -106.83 130.61 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.738 -1.226 . . . . 0.0 109.531 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.591 ' CG1' ' CD1' ' A' ' 57' ' ' LEU . 4.2 p -133.33 147.47 31.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.178 -1.009 . . . . 0.0 113.049 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 47' ' ' PHE . 1.3 m -109.71 154.2 23.22 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.581 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 36.2 p90 -172.11 -177.2 1.82 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 117.883 -1.527 . . . . 0.0 111.811 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 10.5 m-20 -107.22 114.44 28.49 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.518 ' HB3' ' CB ' ' A' ' 1' ' ' ALA . 11.0 t70 -62.96 -9.36 9.62 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.304 -0.872 . . . . 0.0 110.715 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.8 t -72.88 -22.49 60.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -128.15 -7.16 5.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.213 -0.929 . . . . 0.0 110.902 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.455 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -154.43 -167.61 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.482 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.581 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 170.76 171.87 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.48 -0.763 . . . . 0.0 109.606 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.528 ' CG2' HG23 ' A' ' 5' ' ' VAL . 2.7 t -40.65 -47.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 110.317 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.96 -48.35 43.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.007 -1.058 . . . . 0.0 110.198 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.532 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 28.1 mmtm -73.74 -26.55 60.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -0.864 . . . . 0.0 111.318 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.591 ' CD1' ' CG1' ' A' ' 45' ' ' VAL . 63.3 mt -68.37 -58.18 4.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.668 -1.27 . . . . 0.0 108.809 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.516 ' N ' HD22 ' A' ' 7' ' ' LEU . 16.4 m -57.79 -29.22 64.7 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.456 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 68.1 tttt -73.68 -29.37 62.26 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.379 -0.826 . . . . 0.0 109.54 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.74 -50.32 37.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.291 -0.881 . . . . 0.0 109.504 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.503 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 1.5 t -69.74 -26.63 64.41 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . -66.73 -36.62 82.89 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.57 -9.92 55.08 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.561 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -29.27 55.68 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.564 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 135.04 25.18 0.55 Allowed Glycine 0 N--CA 1.486 2.002 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.067 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.582 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 42.0 m-85 -146.03 120.86 5.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.62 -1.518 . . . . 0.0 111.856 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.72 95.54 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 N-CA-C 107.014 -1.956 . . . . 0.0 107.014 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -108.47 -173.73 2.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 0.0 112.543 -176.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.518 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.5 OUTLIER -148.8 -162.57 1.59 Allowed 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.629 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.0 p -141.0 158.95 23.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.07 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.499 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 6.1 mtmt -116.27 17.52 15.6 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.198 0.999 . . . . 0.0 110.307 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.461 ' C ' HG11 ' A' ' 5' ' ' VAL . 13.2 mt-30 . . . . . 0 C--N 1.282 -2.368 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.57 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.299 0.571 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -151.8 88.28 1.4 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -118.68 160.84 21.1 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.086 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.412 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 2.0 t -134.49 132.87 39.76 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.7 -0.625 . . . . 0.0 109.648 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.583 HG22 ' CG2' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -133.24 169.03 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.884 0.849 . . . . 0.0 109.508 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.19 157.03 18.2 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -132.07 157.07 45.13 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.465 -178.146 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.23 112.44 24.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.55 -0.719 . . . . 0.0 110.279 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' CG2' HG22 ' A' ' 21' ' ' VAL . 1.4 p -123.42 88.0 51.7 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.272 -0.892 . . . . 0.0 110.011 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -78.53 59.77 7.31 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.427 1.418 . . . . 0.0 111.806 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.58 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -104.03 -26.83 6.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.497 ' O ' ' HG3' ' A' ' 12' ' ' MET . 19.0 ptm 29.64 61.47 0.16 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.717 0.77 . . . . 0.0 111.356 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.54 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -85.97 13.72 7.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.465 -0.772 . . . . 0.0 109.36 179.024 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 13' ' ' THR . 2.7 t 69.76 91.82 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.556 -0.715 . . . . 0.0 110.24 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 59.53 16.83 5.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 110.31 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -118.64 -44.05 2.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.528 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.607 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -51.59 -48.37 87.05 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.421 -0.799 . . . . 0.0 111.231 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 5.6 Cg_endo -73.24 -11.87 25.16 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 121.274 1.316 . . . . 0.0 112.634 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.0 mm -92.28 -41.43 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.692 -1.255 . . . . 0.0 109.567 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.529 ' CG2' ' CB ' ' A' ' 64' ' ' ALA 0.25 1.2 m -73.83 -39.87 63.73 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.58 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 98.9 t -69.49 -49.86 55.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.108 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HG3' HG11 ' A' ' 34' ' ' VAL . 13.8 tttt -47.23 -51.76 17.81 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 110.471 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.567 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -72.88 -21.38 60.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.034 -1.041 . . . . 0.0 111.393 -179.258 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.498 ' N ' ' HG3' ' A' ' 23' ' ' LYS . . . -68.12 -53.95 21.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 110.719 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 3.9 mp -71.18 -29.08 64.74 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.08 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.527 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -74.79 -17.82 60.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.422 -0.799 . . . . 0.0 109.224 179.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.567 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -115.35 2.07 13.88 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.111 -0.993 . . . . 0.0 110.062 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 56' ' ' LYS . 9.3 p -53.56 -47.71 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.317 -0.864 . . . . 0.0 110.853 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.5 OUTLIER 179.25 -86.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.72 -1.237 . . . . 0.0 111.517 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -95.34 3.25 66.08 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.504 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 26' ' ' SER . 8.8 p -42.33 142.16 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.142 -1.211 . . . . 0.0 110.366 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 t -114.58 -17.34 11.71 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.688 0.756 . . . . 0.0 108.999 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 3.0 tttm -162.43 163.83 27.48 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.961 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.509 ' CG1' ' HB2' ' A' ' 26' ' ' SER . 9.9 p -162.59 159.22 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 110.489 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.505 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 2.7 t70 -166.26 171.84 11.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 109.853 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.497 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 4.3 m -140.69 163.17 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.033 -1.042 . . . . 0.0 110.865 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.77 113.23 0.57 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.588 ' CE2' ' HG3' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -70.19 -21.57 63.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -1.228 . . . . 0.0 110.281 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -45.82 -45.51 14.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.131 -0.981 . . . . 0.0 109.458 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.0 mttm -126.4 25.85 6.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.439 -0.788 . . . . 0.0 109.687 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.584 ' HD3' ' CE1' ' A' ' 38' ' ' PHE . 7.1 mmm180 38.75 60.19 1.43 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.837 -0.539 . . . . 0.0 110.175 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.514 ' CA ' ' O ' ' A' ' 7' ' ' LEU . 6.9 pt-20 -141.68 150.27 41.66 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.957 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.526 ' CB ' HG13 ' A' ' 21' ' ' VAL . . . -116.14 131.95 56.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.004 -1.06 . . . . 0.0 108.969 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 35' ' ' ASP . 13.4 p -105.22 130.89 55.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.786 -1.196 . . . . 0.0 109.676 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.575 ' CG1' ' CD1' ' A' ' 57' ' ' LEU . 4.2 p -131.92 143.06 41.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.946 0.879 . . . . 0.0 112.454 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -109.38 157.89 18.47 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.598 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 34.9 p90 -171.88 -176.33 1.7 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 117.399 -1.72 . . . . 0.0 112.122 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.542 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 65.2 m-20 -106.85 113.51 27.05 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.61 -10.96 4.03 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 111.147 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.8 t -69.02 -24.75 64.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 110.929 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -128.84 -12.0 4.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.903 -1.123 . . . . 0.0 111.509 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -148.24 -169.41 3.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.017 -1.052 . . . . 0.0 110.712 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.598 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.6 OUTLIER 171.2 172.58 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.442 -0.786 . . . . 0.0 109.914 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.518 HG22 HG23 ' A' ' 70' ' ' VAL . 2.1 p -40.73 -35.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 110.406 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.406 ' N ' HG11 ' A' ' 54' ' ' VAL . 4.0 tp60 -56.59 -49.63 74.35 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.232 -0.917 . . . . 0.0 110.293 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.534 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 15.9 mmtt -78.82 -18.38 54.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.27 -0.894 . . . . 0.0 111.526 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.575 ' CD1' ' CG1' ' A' ' 45' ' ' VAL . 52.3 mt -75.01 -58.87 3.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.415 -1.428 . . . . 0.0 108.268 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.492 ' N ' HD23 ' A' ' 7' ' ' LEU . 19.5 m -58.76 -30.04 67.23 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.741 -0.783 . . . . 0.0 109.111 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -80.79 -23.43 39.29 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.308 -0.87 . . . . 0.0 109.536 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.445 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -72.81 -47.06 49.68 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.394 -0.816 . . . . 0.0 109.086 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.521 HG21 ' N ' ' A' ' 62' ' ' ALA . 9.2 t -71.39 -35.78 71.17 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.521 ' N ' HG21 ' A' ' 61' ' ' THR . . . -64.04 -29.68 70.81 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.626 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 63' ' ' ASP . 2.1 t70 -89.67 -11.35 42.71 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.529 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -28.26 55.28 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.72 23.44 0.51 Allowed Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.697 -1.239 . . . . 0.0 111.228 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.58 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 46.8 m-85 -146.13 110.94 4.37 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.649 -1.501 . . . . 0.0 111.103 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -55.49 99.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 N-CA-C 107.297 -1.847 . . . . 0.0 107.297 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -109.06 -172.02 1.96 Allowed 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.362 -176.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.512 ' N ' ' OG ' ' A' ' 68' ' ' SER . 19.9 m -147.32 -162.75 1.61 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.601 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.5 p -139.92 160.37 26.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 C-N-CA 118.647 -1.221 . . . . 0.0 111.763 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.498 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 1.7 mttt -123.24 19.1 9.87 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.963 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.511 ' O ' ' CG ' ' A' ' 72' ' ' GLN . 1.8 tt0 . . . . . 0 C--N 1.283 -2.306 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.126 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.605 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.116 0.484 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -144.99 92.17 2.24 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.6 151.8 25.13 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.898 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.43 117.23 23.97 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.288 0.566 . . . . 0.0 109.616 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 72' ' ' GLN . 4.6 t -126.76 168.19 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 109.931 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.559 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -108.88 160.47 15.97 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.588 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.1 mp -133.66 155.36 49.85 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.623 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.6 110.75 21.91 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.879 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.469 HG23 ' SG ' ' A' ' 17' ' ' CYS . 1.6 p -124.38 85.99 55.25 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.505 -0.747 . . . . 0.0 109.67 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.428 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 11.2 Cg_endo -79.51 52.36 4.26 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.965 1.508 . . . . 0.0 111.294 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.605 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -97.6 -34.11 5.64 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.536 ' HG2' ' CZ ' ' A' ' 41' ' ' ARG . 1.8 mtp 69.04 -79.57 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.982 -0.716 . . . . 0.0 110.456 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.501 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 0.6 OUTLIER 50.86 14.39 0.18 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.92 -1.112 . . . . 0.0 109.638 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' THR . 0.7 OUTLIER 51.25 108.41 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.333 -0.855 . . . . 0.0 111.519 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 43.81 36.76 1.41 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -0.772 . . . . 0.0 111.034 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.501 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -139.01 -37.68 0.51 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 110.021 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -51.76 -50.34 78.16 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.772 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.583 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 9.4 Cg_endo -73.38 -11.26 24.61 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.189 1.26 . . . . 0.0 112.633 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.8 mm -92.1 -45.47 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.64 -1.288 . . . . 0.0 109.872 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.562 ' CG2' ' CB ' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -70.13 -37.23 75.25 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.572 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 13.0 t -64.75 -44.64 96.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.518 ' HA ' ' CG1' ' A' ' 34' ' ' VAL . 0.6 OUTLIER -52.78 -41.42 64.08 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.476 -0.765 . . . . 0.0 109.805 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -79.57 -22.37 43.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 111.173 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 60' ' ' ALA . . . -67.99 -51.15 50.51 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.174 -0.954 . . . . 0.0 110.089 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.572 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 4.1 mp -78.93 -31.36 45.18 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.516 -0.74 . . . . 0.0 110.874 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.527 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 42.5 p -69.31 -21.36 63.86 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.04 -1.037 . . . . 0.0 108.844 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -116.12 0.55 12.99 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.843 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 25' ' ' LEU . 3.7 p -45.46 -52.64 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.032 -1.043 . . . . 0.0 110.681 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER 176.41 -77.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.84 -1.163 . . . . 0.0 111.08 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.46 0.43 61.55 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.538 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 6.8 p -42.57 143.21 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.24 . . . . 0.0 110.834 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 m -117.26 -16.21 10.36 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.105 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.495 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.2 OUTLIER -166.62 164.26 16.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.617 -0.677 . . . . 0.0 109.509 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.524 HG21 ' CG1' ' A' ' 45' ' ' VAL . 37.9 t -156.14 163.22 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.061 -1.025 . . . . 0.0 110.687 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.544 ' CB ' HG11 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -162.95 161.78 25.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.292 -0.88 . . . . 0.0 109.758 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 18' ' ' PRO . 4.1 m -142.82 151.85 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.516 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.49 104.54 0.35 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.583 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -64.44 -29.55 70.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -1.161 . . . . 0.0 110.276 -179.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.9 mm-40 -44.68 -28.52 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 109.721 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -132.99 1.55 3.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 110.396 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' HG3' ' NH1' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 59.06 51.27 7.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.448 -0.783 . . . . 0.0 110.135 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 51.7 mt-10 -138.12 146.46 42.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.472 -0.767 . . . . 0.0 109.813 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.563 ' CB ' ' CG1' ' A' ' 21' ' ' VAL . . . -115.36 130.38 56.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.998 -1.064 . . . . 0.0 109.32 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.544 HG11 ' CB ' ' A' ' 35' ' ' ASP . 14.7 p -105.68 127.45 60.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.907 -1.12 . . . . 0.0 109.079 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.529 HG23 ' CB ' ' A' ' 25' ' ' LEU . 37.3 t -134.06 148.06 30.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 119.049 -1.06 . . . . 0.0 112.484 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -108.89 158.62 17.51 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.602 ' O ' ' HA ' ' A' ' 2' ' ' THR . 33.1 p90 -171.54 -174.84 1.47 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 117.637 -1.625 . . . . 0.0 111.933 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.605 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 13.5 t0 -105.65 110.6 22.98 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.548 ' HB3' ' CB ' ' A' ' 1' ' ' ALA . 5.0 t70 -61.47 -11.48 10.83 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.709 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 82.4 p -75.01 -27.7 60.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.26 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 mtpp -122.08 -1.63 9.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 110.345 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -158.77 -169.07 2.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 110.33 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.601 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.4 p 170.32 170.53 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.437 -0.79 . . . . 0.0 109.528 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.533 ' CG2' ' CG2' ' A' ' 70' ' ' VAL . 2.5 p -42.24 -44.44 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 110.03 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -51.44 -47.89 62.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -0.989 . . . . 0.0 109.694 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.432 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 18.2 mmtp -75.12 -20.67 59.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 0.0 110.966 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.529 ' HB3' HD22 ' A' ' 25' ' ' LEU . 82.0 mt -72.77 -60.27 2.31 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.688 -1.258 . . . . 0.0 108.19 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 62' ' ' ALA . 1.2 p -57.42 -29.66 64.33 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.483 -0.761 . . . . 0.0 109.012 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.456 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 55.2 tttt -74.57 -31.41 62.07 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.339 -0.85 . . . . 0.0 109.726 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . -69.87 -51.34 34.13 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.283 -0.886 . . . . 0.0 109.325 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.477 HG22 ' OG ' ' A' ' 68' ' ' SER . 1.6 t -68.64 -27.18 65.78 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . -65.4 -35.22 80.28 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.79 -15.71 50.66 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.634 -0.827 . . . . 0.0 108.953 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.562 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -71.4 -29.55 65.05 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.93 23.71 0.84 Allowed Glycine 0 N--CA 1.486 1.978 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.952 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.605 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 50.7 m-85 -139.36 111.84 7.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.686 -1.479 . . . . 0.0 111.72 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.85 96.65 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 107.046 -1.944 . . . . 0.0 107.046 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 10.0 p -108.1 -167.1 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 112.581 -176.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.481 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 19.2 m -157.81 -165.94 1.87 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.588 ' HA ' HD13 ' A' ' 7' ' ' LEU . 4.0 p -135.75 161.12 38.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 120.631 -1.293 . . . . 0.0 111.433 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.429 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 0.6 OUTLIER -123.97 25.7 7.85 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.303 1.049 . . . . 0.0 110.134 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.508 ' HA ' HG11 ' A' ' 5' ' ' VAL . 2.0 tm0? . . . . . 0 C--N 1.284 -2.261 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.113 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.181 0.515 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -146.36 89.92 1.9 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 179.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.33 162.03 14.71 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.713 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.482 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 1.2 t -125.0 147.33 48.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -153.49 159.29 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.588 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -106.69 155.74 19.35 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.601 ' CD2' ' CD2' ' A' ' 25' ' ' LEU . 1.1 mp -129.9 158.54 39.22 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.41 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -112.39 105.32 13.56 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.212 0.529 . . . . 0.0 110.302 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.462 HG23 ' SG ' ' A' ' 17' ' ' CYS . 0.9 OUTLIER -120.21 85.42 36.07 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.606 -0.684 . . . . 0.0 109.42 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.474 ' HA ' ' HB3' ' A' ' 41' ' ' ARG . 10.2 Cg_endo -78.56 58.31 6.7 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.807 1.424 . . . . 0.0 111.216 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.589 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -102.08 -25.05 8.12 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 14.2 mtm 59.15 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.739 -0.859 . . . . 0.0 110.064 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.491 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 0.8 OUTLIER 50.32 14.05 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.363 -0.836 . . . . 0.0 109.958 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 54.48 109.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 111.626 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 39.99 26.27 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.563 -0.711 . . . . 0.0 111.706 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 13' ' ' THR . . . -118.63 -42.53 2.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.939 -1.101 . . . . 0.0 109.139 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -52.5 -46.96 95.01 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.621 -0.675 . . . . 0.0 111.903 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 5.6 Cg_endo -70.29 -20.27 32.56 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.201 1.268 . . . . 0.0 113.49 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.6 mp -92.4 -36.64 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.447 -1.408 . . . . 0.0 110.038 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.484 ' CG2' ' HB3' ' A' ' 64' ' ' ALA 0.252 1.2 m -73.45 -42.48 61.9 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.587 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 96.9 t -62.75 -50.37 79.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.457 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HD2' ' CG2' ' A' ' 36' ' ' VAL . 15.9 tttm -51.39 -44.07 62.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 110.268 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 5.0 mttm -69.89 -23.21 63.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.111 -0.993 . . . . 0.0 111.102 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HB2' ' C ' ' A' ' 60' ' ' ALA . . . -76.26 -62.5 1.59 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.533 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.601 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 3.6 mp -56.85 -30.73 64.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 0.0 110.486 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.518 ' CB ' HG22 ' A' ' 34' ' ' VAL . 4.5 p -76.05 -30.34 58.35 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.416 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -88.36 -3.92 58.76 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.268 -0.895 . . . . 0.0 109.625 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.533 ' CG1' ' N ' ' A' ' 29' ' ' GLU . 3.8 t -41.76 -83.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.429 -0.794 . . . . 0.0 110.066 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.533 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 3.3 tt0 179.36 -52.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.46 -0.775 . . . . 0.0 109.062 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.74 -23.33 15.96 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.588 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 39.6 t -51.63 134.52 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -1.108 . . . . 0.0 110.103 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.7 t -127.84 -5.09 5.73 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.083 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 13.9 tttp -155.71 116.33 3.8 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.524 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.518 HG22 ' CB ' ' A' ' 26' ' ' SER . 3.9 t -109.25 -178.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.686 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.486 ' CB ' HG11 ' A' ' 44' ' ' VAL . 26.4 t0 -161.26 159.28 28.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.984 -1.073 . . . . 0.0 110.249 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.545 HG12 ' CB ' ' A' ' 18' ' ' PRO . 17.6 t -112.62 135.85 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.811 . . . . 0.0 110.699 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.09 60.02 0.53 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.647 ' CZ ' ' NH1' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -62.49 -16.49 55.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -1.175 . . . . 0.0 110.358 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -44.84 -26.52 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 109.148 179.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 41' ' ' ARG . 5.0 ttpt -152.43 47.21 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.611 -0.68 . . . . 0.0 109.833 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.647 ' NH1' ' CZ ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER 39.91 63.16 1.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.661 -0.649 . . . . 0.0 109.684 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 2.0 tm-20 -140.18 148.16 41.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.497 -0.752 . . . . 0.0 110.363 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -124.09 132.16 53.63 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 6' ' ' THR . 0.9 OUTLIER -105.95 145.01 14.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.358 -1.464 . . . . 0.0 109.561 -178.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.578 ' CG2' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -139.52 177.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 122.703 1.24 . . . . 0.0 112.362 -177.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -152.68 143.65 23.01 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 105.682 -1.969 . . . . 0.0 105.682 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 34.3 p90 -166.06 -176.0 3.58 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 117.242 -1.783 . . . . 0.0 112.934 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.587 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER -106.8 115.83 30.87 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 17.5 t70 -62.12 -8.6 5.73 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 111.028 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.509 HG21 ' N ' ' A' ' 51' ' ' LYS . 15.1 t -76.26 -21.55 56.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 110.74 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.509 ' N ' HG21 ' A' ' 50' ' ' THR . 4.0 mtpt -128.59 -6.45 5.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.101 -0.999 . . . . 0.0 110.922 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -156.52 -169.7 3.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 110.216 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.592 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 14.8 t 175.81 168.62 0.39 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.535 HG22 ' CG2' ' A' ' 70' ' ' VAL . 2.8 p -42.91 -40.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 110.039 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -54.34 -47.65 72.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.114 -0.991 . . . . 0.0 109.826 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 17.8 mmtt -75.73 -18.09 59.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 111.249 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 53' ' ' SER . 68.4 mt -75.49 -58.68 3.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.501 -1.375 . . . . 0.0 107.949 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.518 ' N ' HD22 ' A' ' 7' ' ' LEU . 1.9 m -57.67 -32.21 67.1 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.46 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -73.57 -33.18 64.54 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.406 -0.809 . . . . 0.0 109.727 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.485 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -66.3 -46.34 77.31 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.272 -0.893 . . . . 0.0 109.371 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.534 HG21 ' N ' ' A' ' 62' ' ' ALA . 5.7 t -68.7 -32.92 73.06 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.534 ' N ' HG21 ' A' ' 61' ' ' THR . . . -62.53 -31.83 72.68 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -86.95 -13.87 43.42 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.484 ' HB3' ' CG2' ' A' ' 20' ' ' THR . . . -75.64 -24.79 56.46 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 131.58 19.09 1.21 Allowed Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.848 -1.167 . . . . 0.0 110.937 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.589 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 35.4 m-85 -144.03 111.72 5.2 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.695 -1.474 . . . . 0.0 111.594 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.0 96.37 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 N-CA-C 107.844 -1.637 . . . . 0.0 107.844 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -108.85 -168.42 1.34 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.211 -0.931 . . . . 0.0 111.748 -177.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.539 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.0 OUTLIER -156.5 -163.49 1.46 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.588 ' HA ' HD13 ' A' ' 7' ' ' LEU . 5.7 p -137.18 159.44 36.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 O-C-N 120.583 -1.323 . . . . 0.0 111.022 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.57 ' CG ' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -130.56 39.12 3.66 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.019 -1.073 . . . . 0.0 109.46 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.524 ' CB ' HG12 ' A' ' 5' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.687 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.274 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.21 0.528 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -152.63 89.89 1.44 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -110.09 169.92 8.42 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.799 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 3.1 t -143.99 113.41 6.98 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.36 0.6 . . . . 0.0 109.792 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG22 ' CG2' ' A' ' 54' ' ' VAL . 2.7 m -120.17 168.69 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 109.747 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.81 159.49 16.2 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 178.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.596 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.4 153.89 50.36 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.737 -1.227 . . . . 0.0 110.344 -178.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -108.84 104.74 14.05 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.411 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.469 HG23 ' SG ' ' A' ' 17' ' ' CYS . 1.2 p -112.4 93.36 22.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.608 -0.683 . . . . 0.0 109.999 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -76.82 35.24 0.47 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 O-C-N 123.737 1.388 . . . . 0.0 111.647 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.583 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.14 -62.85 4.57 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.48 ' HG2' ' CZ ' ' A' ' 41' ' ' ARG . 21.5 mtp 56.03 49.08 16.4 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.414 -1.051 . . . . 0.0 109.412 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.61 ' CG2' ' CB ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -84.08 10.33 10.36 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.27 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.1 OUTLIER 77.32 97.06 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.651 0.739 . . . . 0.0 111.273 179.324 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 54.62 42.55 31.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.525 -0.735 . . . . 0.0 111.396 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.61 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -162.45 -29.61 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.976 -1.077 . . . . 0.0 111.315 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -50.33 -52.01 58.35 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.689 -1.257 . . . . 0.0 110.184 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.604 ' HG3' ' CG ' ' A' ' 38' ' ' PHE . 9.5 Cg_endo -74.66 -6.9 18.83 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.353 1.369 . . . . 0.0 112.306 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 13.4 mm -90.87 -42.25 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.69 -1.257 . . . . 0.0 109.759 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.547 ' CG2' ' CB ' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -69.79 -32.03 70.27 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.57 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 40.4 t -73.42 -40.91 56.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.476 ' O ' HG13 ' A' ' 34' ' ' VAL . 7.8 tmtt? -50.06 -50.15 48.89 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.456 -0.778 . . . . 0.0 109.768 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.6 mmmm -77.6 -25.37 49.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.879 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 20' ' ' THR . . . -62.5 -57.82 9.82 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.315 -0.865 . . . . 0.0 110.813 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.57 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 2.8 mp -75.91 -30.97 58.96 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.391 -0.818 . . . . 0.0 111.295 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.557 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 1.8 t -69.39 -19.28 63.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.896 -1.127 . . . . 0.0 108.655 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.573 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 1.3 mptp? -115.54 -1.12 12.85 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.904 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.543 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 11.5 p -44.24 -45.25 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 110.221 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 163.31 -85.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.458 -0.776 . . . . 0.0 111.193 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.79 -6.07 89.63 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.81 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.578 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 7.6 p -50.06 141.89 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.892 -1.358 . . . . 0.0 110.36 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -121.18 -12.55 8.66 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.576 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -176.02 107.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.788 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.557 ' CG1' ' HB2' ' A' ' 26' ' ' SER . 1.5 p -114.01 179.06 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.154 -0.966 . . . . 0.0 111.399 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.04 160.82 16.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.5 -0.75 . . . . 0.0 110.045 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 15.8 m -130.39 158.75 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 0.0 110.476 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.3 112.47 0.62 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CG ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -75.22 -28.44 59.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 110.604 -179.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -55.17 -23.35 21.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.146 -0.971 . . . . 0.0 110.346 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.449 ' HB3' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -134.59 16.5 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 0.0 110.43 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 12' ' ' MET . 1.5 mpp_? 42.53 55.58 4.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 110.043 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 2.2 pp20? -148.49 149.77 32.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.397 -0.814 . . . . 0.0 109.898 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.559 ' CB ' HG13 ' A' ' 21' ' ' VAL . . . -123.03 136.73 54.96 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.956 -1.09 . . . . 0.0 108.932 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 6' ' ' THR . 8.2 p -105.44 132.19 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.493 -1.379 . . . . 0.0 109.325 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.541 HG23 ' CD2' ' A' ' 25' ' ' LEU . 3.2 t -123.11 152.3 27.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.442 1.115 . . . . 0.0 112.401 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 1.3 m -125.51 145.94 49.87 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 176.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.595 ' O ' ' HA ' ' A' ' 2' ' ' THR . 35.4 p90 -170.59 -178.43 2.64 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 117.235 -1.786 . . . . 0.0 112.523 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -107.0 120.22 41.47 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.492 ' HB3' ' CB ' ' A' ' 1' ' ' ALA . 1.6 t70 -64.6 -3.24 2.95 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.399 -0.813 . . . . 0.0 111.327 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.4 p -77.0 -23.25 52.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.027 . . . . 0.0 110.651 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -130.32 0.63 4.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.022 -1.049 . . . . 0.0 110.894 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -159.65 -166.58 1.79 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 109.917 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.583 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.0 t 176.21 160.62 0.32 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 110.001 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.593 ' CG2' ' CG2' ' A' ' 70' ' ' VAL . 5.7 p -42.49 -37.86 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.363 -0.836 . . . . 0.0 110.151 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.481 ' N ' HG11 ' A' ' 54' ' ' VAL . 2.4 tt0 -56.96 -49.1 76.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.883 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HG3' ' CG2' ' A' ' 28' ' ' VAL . 2.0 tptt -70.06 -23.71 63.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 0.0 110.76 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.592 HD13 ' CE2' ' A' ' 47' ' ' PHE . 66.8 mt -69.32 -56.62 6.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.795 -1.19 . . . . 0.0 108.812 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.447 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 12.3 m -60.2 -30.44 69.37 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 33.3 tttt -77.06 -23.17 52.02 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.542 -0.724 . . . . 0.0 109.61 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.438 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . . . -72.79 -46.06 55.27 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.334 -0.854 . . . . 0.0 109.255 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.534 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 7.6 t -72.71 -34.14 66.93 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.526 ' N ' HG21 ' A' ' 61' ' ' THR . . . -63.96 -32.6 74.19 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.824 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -91.0 -9.53 45.6 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.457 -0.777 . . . . 0.0 109.395 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.547 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -79.08 -24.73 43.3 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.44 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.04 15.57 0.91 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.249 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.626 ' CZ ' ' HA ' ' A' ' 17' ' ' CYS . 26.5 m-85 -139.72 110.21 7.34 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.562 -1.552 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.51 99.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 N-CA-C 107.509 -1.766 . . . . 0.0 107.509 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.529 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 9.2 p -108.43 -170.65 1.71 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.233 1.016 . . . . 0.0 112.767 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 t -150.64 -162.19 1.5 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.596 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.7 p -141.92 162.46 20.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.19 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.5 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -124.92 23.83 7.75 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.363 1.078 . . . . 0.0 108.944 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.472 ' HB2' HG22 ' A' ' 54' ' ' VAL . 1.7 tt0 . . . . . 0 C--N 1.286 -2.18 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.095 0.474 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -148.38 90.49 1.81 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -108.81 162.79 13.86 Favored 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 119.476 -0.889 . . . . 0.0 112.445 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.414 ' O ' HG21 ' A' ' 4' ' ' THR . 1.1 t -137.66 119.28 14.98 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.264 0.554 . . . . 0.0 109.599 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.537 HG12 ' CG2' ' A' ' 54' ' ' VAL . 3.0 m -126.55 170.36 16.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.279 -0.888 . . . . 0.0 109.803 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.535 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.95 161.32 14.82 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.636 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.94 156.45 48.98 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 118.541 -1.264 . . . . 0.0 110.036 -178.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.66 109.63 20.43 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.182 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.552 HG23 ' CG2' ' A' ' 21' ' ' VAL . 0.7 OUTLIER -117.71 102.94 51.22 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.244 -0.91 . . . . 0.0 109.617 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.44 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 7.7 Cg_endo -75.71 32.48 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.428 1.418 . . . . 0.0 112.329 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.565 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -74.62 -69.72 1.35 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.524 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 48.63 30.68 2.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -1.078 . . . . 0.0 109.365 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.626 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -61.23 -10.4 6.69 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.626 ' CB ' ' O ' ' A' ' 13' ' ' THR . 2.8 t 89.93 98.4 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.615 0.722 . . . . 0.0 111.019 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.503 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 71.7 27.59 2.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.61 -0.681 . . . . 0.0 111.256 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.614 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -150.61 -44.67 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.796 -1.19 . . . . 0.0 110.531 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.57 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -45.73 -50.03 34.84 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.862 -1.149 . . . . 0.0 111.39 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 17' ' ' CYS . 6.8 Cg_endo -69.94 -20.89 33.39 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.234 1.289 . . . . 0.0 113.484 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.5 mt -91.35 -30.04 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.381 -1.45 . . . . 0.0 110.028 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.436 HG21 ' HB3' ' A' ' 64' ' ' ALA 0.254 1.5 m -78.21 -40.59 37.05 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.471 0.653 . . . . 0.0 109.524 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.561 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 55.8 t -70.54 -52.05 32.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.182 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.524 ' HA ' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -50.93 -43.26 60.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.82 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 12.8 mtpt -71.96 -26.69 62.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 110.795 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.24 -62.17 1.49 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.487 -0.758 . . . . 0.0 110.714 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.606 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 2.8 mp -59.55 -34.72 73.02 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.309 -0.869 . . . . 0.0 110.562 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.525 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 2.1 t -72.11 -22.89 61.27 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.406 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.22 -10.47 41.5 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.276 -0.89 . . . . 0.0 109.716 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 29' ' ' GLU . 2.4 t -42.61 -80.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.444 -0.785 . . . . 0.0 109.851 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.565 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 1.1 mt-10 177.11 -69.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 110.051 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.419 ' O ' ' OD2' ' A' ' 48' ' ' ASP . . . -77.52 -13.39 83.58 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.546 HG22 ' CG2' ' A' ' 34' ' ' VAL . 12.2 p -48.2 139.4 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -1.125 . . . . 0.0 110.539 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.412 ' OG ' ' OD2' ' A' ' 48' ' ' ASP . 5.9 m -128.26 -6.46 5.38 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -173.62 103.9 0.12 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.421 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.546 ' CG2' HG22 ' A' ' 31' ' ' VAL . 70.9 t -111.77 171.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 110.304 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.536 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -169.28 178.55 4.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.188 -0.945 . . . . 0.0 110.269 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 3.2 m -113.63 167.66 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.37 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.44 69.05 0.29 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -56.7 -15.84 5.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.302 -1.116 . . . . 0.0 110.472 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 38' ' ' PHE . 10.3 tp10 -44.41 -29.81 0.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 0.0 109.319 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -160.91 52.52 0.28 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.457 -0.777 . . . . 0.0 110.288 179.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.524 ' NH1' ' HB2' ' A' ' 12' ' ' MET . 2.4 mtt180 41.31 63.61 1.2 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.526 -0.734 . . . . 0.0 110.496 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.522 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 1.1 pt-20 -149.02 150.17 32.36 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.599 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' HB3' HG12 ' A' ' 21' ' ' VAL . . . -115.81 143.88 44.78 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 35' ' ' ASP . 8.5 p -105.15 129.18 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.509 -1.369 . . . . 0.0 108.895 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.548 ' CG2' HD21 ' A' ' 25' ' ' LEU . 21.5 t -124.97 156.35 33.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 122.524 1.154 . . . . 0.0 112.051 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.4 m -137.85 146.65 43.7 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 53' ' ' SER . 30.6 p90 -170.65 -174.57 1.64 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 117.154 -1.818 . . . . 0.0 112.569 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.564 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 8.9 m-20 -106.27 116.56 32.15 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 1' ' ' ALA . 35.7 t0 -63.21 -8.19 7.62 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.878 -177.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.413 HG21 ' N ' ' A' ' 51' ' ' LYS . 9.2 t -77.31 -17.98 57.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.925 . . . . 0.0 110.484 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' N ' HG21 ' A' ' 50' ' ' THR . 1.7 mmtm -132.36 0.9 3.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.969 . . . . 0.0 110.894 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -166.28 -170.54 1.71 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.068 -1.02 . . . . 0.0 110.447 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER 171.52 173.04 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 110.008 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.537 ' CG2' HG12 ' A' ' 5' ' ' VAL . 17.8 t -41.59 -41.96 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.125 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -50.86 -48.53 60.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 110.228 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.474 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 52.3 mmtt -79.26 -21.88 45.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 111.861 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.517 ' CD2' HG12 ' A' ' 45' ' ' VAL . 63.1 mt -71.5 -59.15 2.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.27 -1.519 . . . . 0.0 108.649 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.537 HG22 ' CA ' ' A' ' 69' ' ' SER . 8.0 m -58.88 -28.4 66.1 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.512 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -79.18 -25.79 42.73 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.345 -0.847 . . . . 0.0 110.005 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.481 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . . . -73.6 -47.41 40.57 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.022 -1.049 . . . . 0.0 109.201 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.535 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 9.0 t -71.38 -32.82 68.92 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . -63.43 -34.53 77.94 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.964 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -89.43 -8.86 52.12 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.352 -0.842 . . . . 0.0 109.042 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB3' HG21 ' A' ' 20' ' ' THR . . . -79.61 -25.05 41.58 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.89 15.37 0.72 Allowed Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.426 -1.368 . . . . 0.0 111.66 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.565 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 53.7 m-85 -141.71 111.43 6.29 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.443 -1.622 . . . . 0.0 111.41 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.02 99.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 85.6 p -108.22 -165.35 1.03 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 122.147 0.975 . . . . 0.0 112.793 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.537 ' CA ' HG22 ' A' ' 58' ' ' THR . 0.1 OUTLIER -157.68 -165.93 1.88 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.636 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.6 p -139.55 158.1 27.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 120.816 -1.178 . . . . 0.0 111.524 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.499 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 4.1 mtmt -124.41 25.85 7.52 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.478 1.132 . . . . 0.0 108.91 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.515 ' CB ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.284 -2.274 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.992 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.094 0.473 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -146.18 87.47 1.74 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -117.26 165.39 13.51 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.71 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 4.2 t -132.5 124.29 28.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.794 -0.566 . . . . 0.0 110.031 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.58 ' CG2' ' N ' ' A' ' 6' ' ' THR . 0.4 OUTLIER -124.79 172.41 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.58 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -107.6 162.01 14.34 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.227 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.59 HD13 ' HA ' ' A' ' 70' ' ' VAL . 1.0 OUTLIER -133.35 153.54 51.5 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.859 -1.136 . . . . 0.0 109.651 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -108.9 98.55 8.02 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.137 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.501 ' CG2' HG23 ' A' ' 21' ' ' VAL . 2.2 p -113.17 90.69 16.91 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.7 Cg_endo -74.8 31.33 0.35 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.394 1.396 . . . . 0.0 112.323 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.488 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.3 -43.11 95.69 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 13.0 ptm 35.83 45.93 0.31 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.748 0.785 . . . . 0.0 109.894 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.649 ' CG2' ' CB ' ' A' ' 16' ' ' ALA . 1.2 t -72.1 0.54 9.34 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.69 -0.631 . . . . 0.0 110.142 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.59 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.5 OUTLIER 82.19 88.58 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.508 0.671 . . . . 0.0 111.127 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 71.17 31.51 2.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.527 -0.733 . . . . 0.0 112.078 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.649 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -155.72 -35.4 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.532 -1.355 . . . . 0.0 110.658 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.611 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -49.87 -48.57 77.57 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.727 -1.233 . . . . 0.0 110.825 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.597 ' HG3' ' CD1' ' A' ' 38' ' ' PHE . 18.7 Cg_endo -77.94 -9.87 16.77 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.312 1.341 . . . . 0.0 112.599 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 19' ' ' ILE . 18.7 mm -90.31 -42.38 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.719 -1.238 . . . . 0.0 109.735 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.497 ' CG2' ' CB ' ' A' ' 64' ' ' ALA 0.251 0.9 OUTLIER -71.92 -39.11 69.7 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.921 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.611 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 21.1 t -67.7 -48.44 76.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.4 -47.32 26.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.31 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.564 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 1.2 mmmm -74.46 -20.37 60.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 111.693 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . -73.24 -48.78 32.09 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 110.062 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.611 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 4.9 mp -68.86 -33.28 73.54 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 109.676 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.486 ' O ' HG12 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -78.58 -20.88 49.55 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.964 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.564 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -98.3 -7.26 29.36 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.894 -1.129 . . . . 0.0 109.588 179.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' A' ' 29' ' ' GLU . 2.9 t -40.36 -80.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.668 -0.645 . . . . 0.0 109.776 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.482 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 5.1 tt0 179.3 -57.85 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.183 -0.948 . . . . 0.0 109.825 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -92.15 -15.12 54.84 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.548 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 10.6 p -43.16 141.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.101 -1.235 . . . . 0.0 110.49 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 t -120.89 -12.95 8.71 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.555 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.494 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 4.1 ttmt -166.25 168.71 14.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.028 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 4.7 p -164.68 172.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.405 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.575 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -167.21 169.4 12.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.835 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.467 ' CG1' ' HB2' ' A' ' 18' ' ' PRO . 24.8 t -109.92 147.47 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 110.509 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 42' ' ' GLU . . . -139.41 60.47 0.58 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.597 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -58.79 -20.82 53.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -1.116 . . . . 0.0 110.236 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.4 mp0 -45.93 -26.37 0.69 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.06 -1.025 . . . . 0.0 109.294 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.38 37.95 0.94 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.747 . . . . 0.0 110.104 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? 43.43 56.25 4.43 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.348 -0.845 . . . . 0.0 110.482 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -143.46 150.11 38.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.835 . . . . 0.0 110.152 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HB1' HG13 ' A' ' 21' ' ' VAL . . . -117.69 138.83 51.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.018 . . . . 0.0 108.791 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.575 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 10.1 p -105.61 144.57 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.532 -1.355 . . . . 0.0 109.939 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.533 HG12 ' CD1' ' A' ' 57' ' ' LEU . 4.2 p -145.86 144.94 20.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 118.928 -1.109 . . . . 0.0 113.174 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -111.77 153.17 26.92 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.578 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 35.9 p90 -171.48 -177.09 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.58 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.575 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 6.3 t0 -106.38 110.76 23.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 23.6 t0 -64.65 -8.19 13.47 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.978 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.426 HG23 ' CG ' ' A' ' 48' ' ' ASP . 10.0 t -68.64 -11.36 60.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.957 -1.089 . . . . 0.0 110.134 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.3 -35.57 0.46 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.18 -0.95 . . . . 0.0 111.243 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -122.61 -174.67 2.97 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.273 -0.892 . . . . 0.0 110.366 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.578 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 7.3 t 173.14 175.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.552 HG22 ' CG1' ' A' ' 70' ' ' VAL . 1.6 p -40.34 -32.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.87 . . . . 0.0 110.672 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -49.98 75.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.098 . . . . 0.0 109.813 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.486 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 37.0 mmtt -77.43 -18.92 56.79 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.386 -0.821 . . . . 0.0 110.961 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.533 ' CD1' HG12 ' A' ' 45' ' ' VAL . 79.0 mt -74.51 -61.08 1.99 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.656 -1.277 . . . . 0.0 108.364 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 62' ' ' ALA . 42.9 p -60.27 -25.38 65.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 63' ' ' ASP . 5.5 tttm -78.11 -29.8 49.11 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 121.469 -0.77 . . . . 0.0 109.822 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . -72.14 -46.63 55.72 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.101 -0.999 . . . . 0.0 109.224 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.532 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 7.3 t -70.5 -32.22 69.64 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . -67.68 -31.67 71.81 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.261 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -90.47 -9.36 47.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.43 -0.794 . . . . 0.0 109.262 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.497 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -80.98 -29.02 35.38 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 140.89 22.47 0.27 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.424 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 17' ' ' CYS . 42.5 m-85 -148.28 108.94 3.65 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.46 -1.612 . . . . 0.0 111.278 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.17 100.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 3.7 t -107.3 -177.43 3.35 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.562 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 58' ' ' THR . 0.1 OUTLIER -140.77 -164.75 1.8 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.59 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.5 p -142.73 155.25 17.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 O-C-N 120.813 -1.18 . . . . 0.0 111.384 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -124.81 25.72 7.32 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.583 1.182 . . . . 0.0 109.086 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.45 ' OXT' HG22 ' A' ' 5' ' ' VAL . 1.2 mm-40 . . . . . 0 C--N 1.286 -2.193 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.11 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.327 0.584 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.753 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -167.29 99.69 0.51 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -111.79 160.65 17.13 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.861 0.839 . . . . 0.0 112.376 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 95.8 m -122.9 128.33 50.17 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.58 ' CG2' ' N ' ' A' ' 6' ' ' THR . 1.3 p -141.64 168.88 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 122.477 1.132 . . . . 0.0 111.101 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.58 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -108.84 159.36 16.85 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -131.39 154.24 48.84 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.768 -1.207 . . . . 0.0 110.072 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.29 99.21 8.51 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.956 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.476 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 2.2 p -117.13 86.3 20.32 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 0.0 109.6 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.5 Cg_endo -76.62 37.51 0.57 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.575 1.517 . . . . 0.0 112.095 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' CG ' ' A' ' 12' ' ' MET . . . -79.68 -26.25 56.85 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.512 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 17.4 ptm 36.45 65.26 0.47 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.781 -0.835 . . . . 0.0 110.386 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.534 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -88.83 15.54 8.23 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.521 -0.737 . . . . 0.0 109.465 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.1 OUTLIER 68.12 88.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.548 -0.72 . . . . 0.0 110.128 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' O ' HG13 ' A' ' 19' ' ' ILE . . . 58.01 31.95 21.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 0.0 110.174 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -134.4 -41.64 0.79 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.0 109.919 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.584 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -52.96 -50.0 84.14 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.748 179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.592 ' CG ' ' CE2' ' A' ' 38' ' ' PHE . 9.7 Cg_endo -75.0 -8.87 20.46 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.168 1.246 . . . . 0.0 112.302 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 15' ' ' ALA . 12.3 mm -90.59 -43.48 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.808 -1.182 . . . . 0.0 109.699 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.53 ' CG2' ' HB2' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -78.86 -43.93 23.98 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.556 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 21.3 t -59.85 -43.57 92.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.987 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.55 ' CG ' HG13 ' A' ' 34' ' ' VAL . 14.0 tttt -56.34 -58.67 7.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.073 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.7 pttt -73.58 3.41 6.28 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 110.547 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' A' ' 21' ' ' VAL . . . -87.71 -72.14 0.54 Allowed 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.887 -1.133 . . . . 0.0 108.775 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -60.65 -16.23 36.73 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.154 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.576 ' N ' HD21 ' A' ' 25' ' ' LEU . 13.1 t -81.38 -35.03 31.28 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -75.9 -10.2 59.23 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.458 ' O ' ' HG3' ' A' ' 29' ' ' GLU . 6.5 t -37.47 -80.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.68 -0.637 . . . . 0.0 110.888 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 28' ' ' VAL . 2.4 mt-10 -172.85 -51.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.837 -1.165 . . . . 0.0 111.741 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -108.33 14.3 36.33 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.857 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.543 ' CG1' ' O ' ' A' ' 26' ' ' SER . 8.5 p -41.3 143.88 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.275 . . . . 0.0 111.11 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.484 ' N ' ' HA ' ' A' ' 47' ' ' PHE . 2.8 t -120.89 -16.22 8.16 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.461 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.503 ' C ' ' CG2' ' A' ' 34' ' ' VAL . 0.9 OUTLIER -173.06 162.64 4.61 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.768 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.55 HG13 ' CG ' ' A' ' 22' ' ' LYS . 1.3 t -153.04 148.12 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.058 -1.026 . . . . 0.0 110.684 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.564 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -154.64 164.41 38.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.315 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.533 ' HB ' ' CB ' ' A' ' 18' ' ' PRO . 18.8 m -128.34 161.66 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.047 . . . . 0.0 110.74 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.18 90.7 0.13 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.592 ' CE2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -65.51 -21.07 66.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 110.23 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 0.7 OUTLIER -53.24 -23.01 7.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.973 . . . . 0.0 109.122 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 41' ' ' ARG . 2.3 mmpp? -138.73 19.43 2.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.636 -0.665 . . . . 0.0 109.839 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 40' ' ' LYS . 1.7 tpp180 42.69 55.51 4.23 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -145.2 151.54 38.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.49 -0.756 . . . . 0.0 110.071 -179.251 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.23 136.96 52.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.979 . . . . 0.0 109.77 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.564 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 7.5 p -107.07 110.51 32.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.68 -1.263 . . . . 0.0 108.911 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.539 HG23 ' CD2' ' A' ' 25' ' ' LEU . 65.4 t -123.4 143.97 34.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.932 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -110.07 163.01 14.0 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' A' ' 2' ' ' THR . 31.1 p90 -171.35 -178.15 2.29 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.328 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 11.1 m-20 -106.99 116.67 32.32 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -61.18 -11.33 8.75 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.735 -177.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.2 t -68.94 -13.76 62.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 110.551 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -143.62 10.2 1.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 110.512 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -169.83 -167.01 0.62 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.104 -0.997 . . . . 0.0 110.298 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.631 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 t 172.3 164.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.538 ' CG2' HG13 ' A' ' 5' ' ' VAL . 0.9 OUTLIER -42.18 -50.95 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 109.613 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.468 ' O ' HG21 ' A' ' 58' ' ' THR . 40.0 tp60 -47.9 -46.08 31.29 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.326 -0.858 . . . . 0.0 109.657 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -72.45 -27.33 62.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 111.246 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.569 HD13 ' CE2' ' A' ' 47' ' ' PHE . 55.3 mt -68.78 -59.83 2.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.63 -1.294 . . . . 0.0 108.682 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.468 HG21 ' O ' ' A' ' 55' ' ' GLN . 1.7 t -56.27 -28.84 60.01 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 29.9 tttp -72.1 -33.74 68.08 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.348 -0.845 . . . . 0.0 109.441 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 25' ' ' LEU . . . -67.85 -40.43 83.69 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.169 -0.957 . . . . 0.0 110.022 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.528 HG21 ' N ' ' A' ' 62' ' ' ALA . 3.7 t -72.21 -32.0 66.37 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.528 ' N ' HG21 ' A' ' 61' ' ' THR . . . -64.19 -36.54 84.4 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.47 -7.49 52.9 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.463 -0.773 . . . . 0.0 109.572 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.53 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -82.2 -24.4 34.94 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 133.3 20.11 0.93 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.789 -1.196 . . . . 0.0 110.946 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 44.4 m-85 -147.94 112.59 3.89 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.585 -1.538 . . . . 0.0 111.404 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.07 93.57 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 N-CA-C 107.671 -1.704 . . . . 0.0 107.671 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -108.71 -171.21 1.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 111.827 -177.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.521 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -142.62 -164.02 1.74 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.574 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.4 p -141.39 154.1 20.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.886 -1.133 . . . . 0.0 111.448 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.46 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -118.8 23.69 11.3 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.394 1.093 . . . . 0.0 109.617 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.484 ' OXT' ' CB ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.283 -2.311 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.248 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.142 0.496 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.672 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -156.98 94.38 1.42 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -109.09 148.28 31.08 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.893 0.854 . . . . 0.0 111.947 -177.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 m -123.48 108.14 12.34 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.575 ' CG1' ' CB ' ' A' ' 72' ' ' GLN . 5.6 m -125.36 165.0 23.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.184 -0.947 . . . . 0.0 110.688 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.536 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -107.01 159.95 15.91 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.564 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -131.48 159.31 38.47 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.511 -178.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 68' ' ' SER . . . -114.03 119.13 36.13 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.923 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.541 ' CG1' ' CB ' ' A' ' 66' ' ' TYR . 2.9 t -108.87 103.3 51.49 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.289 -0.882 . . . . 0.0 109.315 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 7.3 Cg_endo -74.79 29.41 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.314 1.165 . . . . 0.0 111.867 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.506 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -91.93 -58.82 1.37 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.557 ' CG ' ' HD2' ' A' ' 41' ' ' ARG . 4.0 tmm? 52.25 51.17 16.83 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.406 -1.055 . . . . 0.0 109.195 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.596 ' CG2' ' CB ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -76.72 2.74 13.4 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.755 -0.59 . . . . 0.0 109.54 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.558 ' CB ' ' O ' ' A' ' 13' ' ' THR . 4.1 t 80.48 94.51 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.604 0.716 . . . . 0.0 111.13 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.52 ' O ' ' CD1' ' A' ' 19' ' ' ILE . . . 68.08 37.4 2.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.606 -0.684 . . . . 0.0 111.825 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.596 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -163.19 -37.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.782 -1.199 . . . . 0.0 110.602 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -44.2 -51.54 18.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.861 -1.15 . . . . 0.0 110.132 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.649 ' CG ' ' CD2' ' A' ' 38' ' ' PHE . 17.9 Cg_endo -83.4 -14.15 8.25 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.423 1.416 . . . . 0.0 112.572 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 84.6 mt -80.77 -54.19 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.864 -1.148 . . . . 0.0 110.306 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -37.54 85.92 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.585 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 15.1 t -63.65 -41.61 93.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.532 ' HE2' ' CG1' ' A' ' 34' ' ' VAL . 16.0 tttm -52.82 -39.31 62.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 109.743 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 11.6 mtmt -73.08 -26.2 61.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 110.845 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.491 ' HA ' ' CE ' ' A' ' 27' ' ' LYS . . . -69.07 -55.64 10.15 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 110.646 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.585 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 3.7 mp -65.45 -37.44 86.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 111.478 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.478 ' HA ' HG13 ' A' ' 31' ' ' VAL . 36.1 p -70.98 -26.1 63.0 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.099 -1.0 . . . . 0.0 110.21 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -99.64 -3.82 32.28 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.222 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.552 ' CG2' ' CB ' ' A' ' 60' ' ' ALA . 2.2 t -42.9 -73.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 109.855 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 175.08 -71.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.354 -0.841 . . . . 0.0 109.75 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.94 -20.51 70.31 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.615 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 46.1 t -52.0 134.29 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -1.13 . . . . 0.0 110.449 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.1 m -122.63 -12.2 8.14 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.836 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.544 ' O ' ' CG1' ' A' ' 45' ' ' VAL . 0.2 OUTLIER -146.56 154.57 41.67 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.873 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.532 ' CG1' ' HE2' ' A' ' 22' ' ' LYS . 7.1 p -155.23 165.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 110.026 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.552 ' CB ' HG11 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -162.96 155.04 18.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.062 -1.024 . . . . 0.0 110.835 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.45 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 8.7 m -109.68 113.76 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.766 . . . . 0.0 110.18 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.4 73.76 0.21 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.649 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -65.56 -14.94 62.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -1.193 . . . . 0.0 110.056 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -57.29 -17.31 11.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.89 . . . . 0.0 109.265 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.3 mttm -147.35 32.51 0.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.517 -0.74 . . . . 0.0 110.134 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.557 ' HD2' ' CG ' ' A' ' 12' ' ' MET . 0.6 OUTLIER 42.89 57.47 3.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 4.6 pt-20 -149.77 148.68 29.51 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.216 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -115.63 130.26 56.8 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.552 HG11 ' CB ' ' A' ' 35' ' ' ASP . 8.4 p -105.66 143.49 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.478 -1.389 . . . . 0.0 110.003 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.548 HG23 ' CB ' ' A' ' 25' ' ' LEU . 57.4 t -152.48 148.12 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.447 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.54 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.1 m -109.42 159.03 17.36 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.672 ' O ' ' HA ' ' A' ' 2' ' ' THR . 34.4 p90 -170.33 179.74 3.32 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 117.962 -1.495 . . . . 0.0 111.726 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.569 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 41.0 m-20 -106.49 112.9 26.11 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.481 ' HB3' ' CB ' ' A' ' 1' ' ' ALA . 4.7 t70 -53.33 -17.3 1.74 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.9 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -65.88 -40.84 91.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.948 . . . . 0.0 110.702 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.6 -0.65 13.59 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.096 -1.002 . . . . 0.0 110.747 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.473 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -150.55 -165.09 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.06 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.593 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 170.84 154.44 0.06 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.582 -0.699 . . . . 0.0 109.464 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.61 ' CG2' ' CG2' ' A' ' 70' ' ' VAL . 9.5 p -42.39 -39.84 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.902 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.508 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 5.7 tp-100 -59.69 -47.5 85.39 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.169 -0.957 . . . . 0.0 109.313 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.407 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 63.2 mmtt -66.29 -24.16 66.51 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.469 -0.769 . . . . 0.0 110.698 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.61 HD13 ' CE2' ' A' ' 47' ' ' PHE . 43.0 mt -72.65 -54.59 8.62 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.706 -1.246 . . . . 0.0 108.12 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.512 ' N ' HD22 ' A' ' 7' ' ' LEU . 52.5 m -56.29 -32.84 64.96 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.538 -0.726 . . . . 0.0 109.223 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -77.55 -28.78 51.94 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.291 -0.88 . . . . 0.0 110.053 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.552 ' CB ' ' CG2' ' A' ' 28' ' ' VAL . . . -68.54 -49.39 59.88 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.214 -0.929 . . . . 0.0 109.12 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.534 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 7.4 t -67.02 -32.26 73.35 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.503 ' N ' HG21 ' A' ' 61' ' ' THR . . . -68.29 -26.86 65.86 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.053 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -88.65 -13.31 40.12 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.3 -32.64 43.59 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 143.35 31.11 0.1 Allowed Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.593 -1.289 . . . . 0.0 111.168 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 17' ' ' CYS . 63.8 m-85 -155.9 105.89 2.12 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.664 -1.492 . . . . 0.0 111.621 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.529 ' O ' ' CG ' ' A' ' 10' ' ' PRO . 5.0 Cg_exo -56.31 98.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 N-CA-C 106.768 -2.051 . . . . 0.0 106.768 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 8' ' ' ALA . 1.1 t -107.27 -177.91 3.49 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.077 -1.014 . . . . 0.0 111.939 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.481 ' N ' ' OG ' ' A' ' 68' ' ' SER . 12.9 p -136.99 -162.01 1.23 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.61 ' CG2' ' CG2' ' A' ' 54' ' ' VAL . 4.6 p -144.27 157.43 15.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 118.522 -1.271 . . . . 0.0 112.058 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -128.62 33.3 4.68 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.317 1.056 . . . . 0.0 108.195 179.149 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.575 ' CB ' ' CG1' ' A' ' 5' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.338 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.556 ' CB ' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.367 0.604 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.15 91.27 1.51 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.86 173.5 6.33 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.164 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.39 128.48 18.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.776 -0.578 . . . . 0.0 110.064 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.542 ' CG1' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -132.79 161.4 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.391 -0.818 . . . . 0.0 109.371 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.555 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.61 157.31 17.78 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.605 ' CD2' ' CD2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -130.38 157.65 42.0 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.753 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.04 106.48 16.0 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.906 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.454 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.4 p -115.62 94.33 39.99 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.3 Cg_endo -78.64 43.33 1.42 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.56 1.507 . . . . 0.0 111.56 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.575 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -90.44 -49.71 3.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.575 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 4.2 ptm 36.4 61.94 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.77 -0.841 . . . . 0.0 110.981 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.578 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 6.6 t -70.94 -2.38 15.02 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 109.269 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.5 OUTLIER 78.12 3.03 2.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.708 -0.62 . . . . 0.0 111.458 178.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' H ' HG21 ' A' ' 13' ' ' THR . . . -174.74 33.59 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.229 -0.92 . . . . 0.0 109.924 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.565 ' CB ' HG23 ' A' ' 13' ' ' THR . . . 179.74 -21.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.108 -0.995 . . . . 0.0 112.155 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -46.27 -48.97 44.3 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.201 -1.562 . . . . 0.0 110.969 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 19.5 Cg_endo -81.66 -11.75 11.42 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.437 1.425 . . . . 0.0 113.558 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 16' ' ' ALA . 8.1 mt -92.57 -37.99 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.495 -1.378 . . . . 0.0 110.862 -178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.525 ' CG2' ' CB ' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -73.26 -36.57 66.4 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 42.1 t -67.67 -44.04 86.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.227 -0.989 . . . . 0.0 108.56 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.52 ' HA ' ' CG1' ' A' ' 34' ' ' VAL . 4.5 tptm -52.74 -47.59 67.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.542 -0.724 . . . . 0.0 110.311 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 5.0 mmtm -77.08 -16.19 59.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.974 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.423 ' HB2' ' C ' ' A' ' 60' ' ' ALA . . . -73.93 -58.73 3.11 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.966 -1.084 . . . . 0.0 110.315 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.605 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 3.7 mp -71.7 -29.15 64.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.597 -0.689 . . . . 0.0 110.487 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.522 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 54.7 p -73.36 -26.11 60.88 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.432 -0.792 . . . . 0.0 109.426 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -110.48 3.54 19.68 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.001 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.536 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 3.3 p -49.24 -55.33 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.024 -1.048 . . . . 0.0 110.448 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 176.31 -69.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.781 -1.2 . . . . 0.0 111.541 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -98.57 -9.52 52.7 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.776 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.551 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 11.0 p -42.56 143.4 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.307 . . . . 0.0 110.928 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.39 -15.56 10.32 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.73 0.776 . . . . 0.0 109.14 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -161.33 161.44 30.51 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.537 HG21 ' CG1' ' A' ' 45' ' ' VAL . 25.6 t -157.61 161.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.097 -1.002 . . . . 0.0 110.43 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.525 ' CB ' HG11 ' A' ' 44' ' ' VAL . 1.1 m-20 -163.63 166.57 22.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.915 . . . . 0.0 110.29 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 15.7 m -140.92 157.22 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.419 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -147.61 105.31 0.31 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.565 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -64.0 -23.69 67.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.288 -1.124 . . . . 0.0 110.269 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -47.18 -37.3 9.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.925 . . . . 0.0 109.987 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -135.32 29.65 3.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.414 -0.804 . . . . 0.0 110.481 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.575 ' CD ' ' HB3' ' A' ' 12' ' ' MET . 0.0 OUTLIER 38.55 60.52 1.33 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.571 -0.706 . . . . 0.0 110.319 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 20.7 pt-20 -143.18 145.97 33.27 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.663 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.526 ' CB ' HG13 ' A' ' 21' ' ' VAL . . . -114.82 130.14 56.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 108.982 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.525 HG11 ' CB ' ' A' ' 35' ' ' ASP . 10.0 p -105.54 126.91 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.904 -1.122 . . . . 0.0 109.1 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.537 ' CG1' HG21 ' A' ' 34' ' ' VAL . 40.7 t -131.88 144.55 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.691 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -108.86 157.62 18.43 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.626 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 46.7 p90 -171.6 -173.77 1.26 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.098 -1.441 . . . . 0.0 111.326 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 5.7 m-20 -107.04 129.42 54.81 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.556 ' HB3' ' CB ' ' A' ' 1' ' ' ALA . 25.4 t70 -80.36 35.77 0.35 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.958 -1.089 . . . . 0.0 111.391 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.5 p -118.23 -16.97 9.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.37 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -133.05 1.93 3.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.457 -0.777 . . . . 0.0 110.092 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . -179.65 -178.57 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 110.368 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.626 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 8.1 p 174.24 -176.01 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 0.0 109.659 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.512 HG22 HG23 ' A' ' 70' ' ' VAL . 2.1 p -38.34 -40.07 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.304 -0.873 . . . . 0.0 110.632 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 6.0 tt0 -56.52 -50.56 71.46 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.028 -1.045 . . . . 0.0 109.812 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.449 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 31.7 mmtt -79.69 -13.68 59.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 111.52 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.527 HD12 ' CD2' ' A' ' 47' ' ' PHE . 89.3 mt -78.35 -56.51 4.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.515 -1.366 . . . . 0.0 108.062 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.554 HG22 ' CA ' ' A' ' 69' ' ' SER . 26.8 m -58.27 -29.68 65.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.466 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -78.05 -26.27 48.23 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.359 -0.838 . . . . 0.0 109.714 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.465 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . . . -71.81 -46.33 58.54 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.264 -0.897 . . . . 0.0 109.237 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.466 ' OG1' HG23 ' A' ' 21' ' ' VAL . 10.0 t -71.57 -33.81 69.39 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -62.09 -34.64 76.68 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.849 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -91.13 -8.33 49.06 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.467 -0.771 . . . . 0.0 109.21 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.525 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -79.65 -25.18 41.41 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.55 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 137.11 17.29 0.71 Allowed Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.391 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.575 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 33.7 m-85 -143.94 114.78 5.49 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.444 -1.621 . . . . 0.0 111.601 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.99 95.32 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 N-CA-C 107.6 -1.731 . . . . 0.0 107.6 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.02 -170.56 1.68 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 112.332 -176.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.554 ' CA ' HG22 ' A' ' 58' ' ' THR . 10.4 m -148.93 -161.86 1.44 Allowed 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.578 ' HA ' HD13 ' A' ' 7' ' ' LEU . 5.1 p -140.09 163.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 120.657 -1.277 . . . . 0.0 111.937 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -125.88 26.12 6.68 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.381 1.086 . . . . 0.0 109.504 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.542 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 1.5 mt-30 . . . . . 0 C--N 1.285 -2.205 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.22 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.318 0.58 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -152.41 89.85 1.45 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -112.43 162.42 15.6 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.361 -177.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.418 HG22 ' OG1' ' A' ' 46' ' ' THR . 27.5 m -135.31 132.87 38.22 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.528 HG23 ' CG2' ' A' ' 54' ' ' VAL . 3.9 t -139.18 169.34 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.015 . . . . 0.0 109.966 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.594 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.48 156.53 18.87 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.121 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.599 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -130.59 157.46 42.65 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 117.855 -1.538 . . . . 0.0 110.861 -178.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 68' ' ' SER . . . -109.84 111.35 22.72 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.808 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -117.94 98.13 51.31 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.186 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 10.7 Cg_endo -80.17 49.91 3.36 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.514 1.476 . . . . 0.0 110.965 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.625 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -90.97 -39.59 5.74 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 8.2 ptm 38.43 42.83 0.58 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.661 -0.905 . . . . 0.0 110.6 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -71.61 2.9 4.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.675 -0.64 . . . . 0.0 110.044 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 13' ' ' THR . 3.9 t 78.99 95.86 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.453 0.644 . . . . 0.0 110.152 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 54.44 23.61 4.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.45 -0.781 . . . . 0.0 110.028 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 13' ' ' THR . . . -123.61 -48.6 1.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -0.866 . . . . 0.0 109.71 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.583 ' SG ' ' CE1' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -39.7 -61.53 1.04 Allowed Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 121.474 -0.766 . . . . 0.0 111.445 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.604 ' HG3' ' CG ' ' A' ' 38' ' ' PHE . 5.6 Cg_endo -61.16 -20.65 68.81 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.96 1.773 . . . . 0.0 114.62 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.4 mt -90.42 -36.57 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.332 -1.48 . . . . 0.0 110.755 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.507 ' CG2' ' HB2' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -77.2 -40.71 44.21 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.578 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 41.8 t -66.21 -48.08 82.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 26' ' ' SER . 23.3 tttm -52.42 -43.99 65.15 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.795 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 13.9 mmtt -72.82 -20.93 61.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 111.277 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' C ' ' HB3' ' A' ' 60' ' ' ALA . . . -75.86 -60.95 2.1 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.165 -0.959 . . . . 0.0 110.269 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.578 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 3.7 mp -56.89 -36.32 69.98 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.431 -0.793 . . . . 0.0 109.96 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.527 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -71.07 -27.18 63.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.567 -0.708 . . . . 0.0 109.224 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -92.51 -4.54 53.41 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 121.225 -0.922 . . . . 0.0 109.753 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.535 ' CG1' ' N ' ' A' ' 29' ' ' GLU . 2.7 t -44.01 -81.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.737 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.535 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 174.07 -73.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.466 ' HA3' ' HB1' ' A' ' 52' ' ' ALA . . . -69.45 -19.18 74.27 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.595 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 4.2 p -49.97 137.56 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.559 -0.965 . . . . 0.0 110.454 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -121.5 -13.17 8.44 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.395 0.617 . . . . 0.0 109.606 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -162.01 160.49 27.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.175 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.521 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 8.1 p -142.33 177.44 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.414 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.539 ' CB ' HG13 ' A' ' 44' ' ' VAL . 12.0 t70 -156.6 155.64 32.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 110.186 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.517 ' CG1' ' HB2' ' A' ' 18' ' ' PRO . 3.3 t -108.87 111.27 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 110.443 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -117.47 52.48 0.68 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' CG ' ' HG3' ' A' ' 18' ' ' PRO . 2.2 t80 -62.49 -19.39 63.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -1.115 . . . . 0.0 110.128 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -48.81 -27.17 2.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -139.96 43.09 1.95 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.504 -0.748 . . . . 0.0 109.923 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.475 ' HD2' ' HA ' ' A' ' 10' ' ' PRO . 1.6 mtt180 41.35 60.04 2.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.445 -0.784 . . . . 0.0 110.182 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -149.32 150.83 33.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.848 . . . . 0.0 110.777 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -122.23 134.03 54.7 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.594 ' CG2' ' CG2' ' A' ' 6' ' ' THR . 1.0 OUTLIER -106.38 142.55 19.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.327 -1.483 . . . . 0.0 109.396 -178.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.585 ' CG1' ' CD1' ' A' ' 57' ' ' LEU . 2.4 p -147.51 145.06 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.238 -1.385 . . . . 0.0 113.558 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -109.96 153.74 24.11 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.595 ' CB ' ' HA ' ' A' ' 31' ' ' VAL . 31.5 p90 -168.93 -178.43 3.31 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.675 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.563 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -106.96 113.86 27.59 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.629 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 9.3 t70 -57.67 -13.15 3.56 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 110.767 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.4 p -61.96 -31.24 71.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.664 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -133.15 -3.46 3.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.947 -1.095 . . . . 0.0 111.33 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.466 ' HB1' ' HA3' ' A' ' 30' ' ' GLY . . . -143.37 -175.93 4.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.973 -1.079 . . . . 0.0 110.642 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.57 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 172.3 169.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 0.0 109.681 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.528 ' CG2' HG23 ' A' ' 5' ' ' VAL . 19.1 t -39.1 -55.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.436 -0.79 . . . . 0.0 110.773 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 3.7 tp60 -44.51 -46.72 9.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 0.0 110.377 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.454 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -73.51 -28.5 61.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.185 -0.947 . . . . 0.0 111.333 -179.379 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.585 ' CD1' ' CG1' ' A' ' 45' ' ' VAL . 65.4 mt -68.95 -61.27 1.87 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.774 -1.204 . . . . 0.0 108.575 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.524 ' N ' HD23 ' A' ' 7' ' ' LEU . 10.1 t -60.34 -22.9 63.77 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.395 -0.816 . . . . 0.0 108.803 178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.509 ' N ' HG21 ' A' ' 58' ' ' THR . 2.7 tttt -78.34 -28.92 47.35 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.374 -0.829 . . . . 0.0 109.35 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.534 ' HB1' ' CG2' ' A' ' 28' ' ' VAL . . . -72.09 -45.55 60.22 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 108.995 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.527 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 9.9 t -70.8 -32.44 69.53 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.489 ' N ' HG21 ' A' ' 61' ' ' THR . . . -65.24 -31.71 73.02 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.579 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -88.72 -12.16 43.09 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.507 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -77.54 -26.48 51.05 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.06 19.84 0.69 Allowed Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.781 -1.2 . . . . 0.0 111.362 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.625 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 32.5 m-85 -142.51 113.7 6.09 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.511 -1.581 . . . . 0.0 111.758 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.17 97.16 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 N-CA-C 107.418 -1.801 . . . . 0.0 107.418 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -108.3 -172.57 2.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.09 -1.006 . . . . 0.0 112.347 -176.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.503 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -148.52 -159.05 0.98 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.599 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.9 p -139.63 158.52 27.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 121.012 -1.055 . . . . 0.0 111.435 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.468 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 4.8 mtmt -121.41 23.09 10.54 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.223 1.011 . . . . 0.0 109.843 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.493 ' HA ' HG11 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.283 -2.319 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.2 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.237 0.541 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -154.23 91.44 1.43 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.6 mt-30 -109.05 149.48 29.21 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.842 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.493 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 24.5 m -120.04 130.05 54.52 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.542 HG12 ' CB ' ' A' ' 72' ' ' GLN . 1.7 t -151.77 165.56 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.062 -1.024 . . . . 0.0 109.528 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.582 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -106.83 171.12 7.54 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.607 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.24 154.18 51.42 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.605 -178.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -108.57 94.24 4.95 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.463 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.519 HG22 ' CB ' ' A' ' 66' ' ' TYR . 2.5 p -110.27 101.7 48.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.686 -0.634 . . . . 0.0 109.615 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.5 Cg_endo -78.28 44.37 1.59 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.728 1.383 . . . . 0.0 111.114 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.645 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -86.49 -41.35 6.93 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.494 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 12.2 mtp 59.18 -87.19 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.61 -0.935 . . . . 0.0 109.813 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.53 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 1.1 p 48.27 15.69 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' THR . 0.3 OUTLIER 45.43 104.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.823 . . . . 0.0 112.058 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 19' ' ' ILE . . . 56.01 32.19 19.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.263 -0.898 . . . . 0.0 111.044 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -137.61 -47.39 0.56 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 109.359 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -53.81 -45.94 98.63 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.538 -0.727 . . . . 0.0 111.183 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 10.3 Cg_endo -74.0 -11.37 23.45 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.005 1.136 . . . . 0.0 112.599 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 1.7 mt -92.39 -40.02 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.669 -1.269 . . . . 0.0 109.349 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.539 HG23 ' CB ' ' A' ' 64' ' ' ALA . 1.3 m -74.68 -40.5 61.36 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.593 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 37.5 t -66.45 -48.89 79.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.544 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.461 ' HA ' HG13 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -47.93 -45.97 31.53 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 14.3 mttt -74.63 -23.43 58.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.251 -0.906 . . . . 0.0 111.6 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.492 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . -68.92 -50.09 52.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.283 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.593 ' CD1' ' O ' ' A' ' 21' ' ' VAL . 4.6 mp -70.53 -34.52 72.37 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 110.272 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.535 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -68.22 -21.33 64.86 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.329 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -113.39 5.04 16.61 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.04 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.542 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 12.7 p -53.43 -49.19 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.128 -0.982 . . . . 0.0 110.421 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER 170.17 -80.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.075 -1.016 . . . . 0.0 110.853 179.462 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.14 5.63 78.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 26' ' ' SER . 12.2 p -50.26 142.52 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.865 -1.373 . . . . 0.0 110.457 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.8 m -124.74 -9.79 7.29 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.758 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.507 ' O ' HG21 ' A' ' 45' ' ' VAL . 1.3 tttt -168.31 138.55 2.56 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.578 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 26' ' ' SER . 5.0 t -130.22 166.43 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.137 -0.977 . . . . 0.0 110.689 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.545 ' CB ' HG11 ' A' ' 44' ' ' VAL . 8.8 t0 -156.58 162.76 39.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.162 -0.961 . . . . 0.0 110.213 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 18' ' ' PRO . 4.5 t -113.83 125.97 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.486 ' O ' ' CG ' ' A' ' 42' ' ' GLU . . . -124.89 69.37 0.49 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.59 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -63.51 -11.75 26.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -1.116 . . . . 0.0 110.527 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -43.97 -31.36 0.88 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 108.979 179.239 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 41' ' ' ARG . 1.4 tttp -148.07 47.05 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.44 0.638 . . . . 0.0 109.308 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.476 ' HD2' ' CG ' ' A' ' 12' ' ' MET . 2.0 tpp180 42.03 58.96 2.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.436 -0.79 . . . . 0.0 110.363 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 13.9 pt-20 -138.38 169.42 17.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.294 -0.879 . . . . 0.0 110.286 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.488 ' HB1' HG12 ' A' ' 21' ' ' VAL . . . -134.74 134.96 41.55 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.545 HG11 ' CB ' ' A' ' 35' ' ' ASP . 1.1 t -106.65 122.56 60.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.674 -1.266 . . . . 0.0 109.646 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -123.09 -178.28 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.669 1.223 . . . . 0.0 111.902 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -152.18 149.06 28.34 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 2' ' ' THR . 28.7 p90 -166.36 -175.3 3.19 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 117.601 -1.64 . . . . 0.0 112.011 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.554 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -106.23 110.52 22.79 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.445 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 5.9 t70 -57.81 -14.28 5.69 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.763 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.497 ' CG2' ' OD1' ' A' ' 48' ' ' ASP . 8.9 t -65.41 -34.97 79.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 110.294 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 mmpp? -125.39 3.82 7.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.146 -0.971 . . . . 0.0 110.431 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -150.77 -169.75 3.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.919 . . . . 0.0 110.339 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.603 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.4 p 170.05 165.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 0.0 109.618 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.53 HG11 ' CG2' ' A' ' 70' ' ' VAL . 2.9 t -43.44 -37.74 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.005 -1.059 . . . . 0.0 109.714 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -58.73 -46.72 86.74 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.019 -1.051 . . . . 0.0 109.544 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 10.5 mmmt -71.02 -25.61 62.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 110.861 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.537 ' HB3' HD22 ' A' ' 25' ' ' LEU . 55.2 mt -70.8 -58.7 3.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.786 -1.196 . . . . 0.0 108.21 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.472 ' O ' ' HB1' ' A' ' 62' ' ' ALA . 99.7 m -56.47 -30.3 62.75 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.486 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -75.63 -28.73 58.93 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.403 -0.811 . . . . 0.0 109.555 179.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -70.01 -51.47 32.08 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.468 -0.77 . . . . 0.0 109.221 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.535 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 13.1 t -67.77 -30.06 69.41 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.486 ' HB1' ' HA ' ' A' ' 59' ' ' LYS . . . -67.54 -31.14 71.02 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.948 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -86.38 -12.88 48.03 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.539 ' CB ' HG23 ' A' ' 20' ' ' THR . . . -76.89 -32.4 57.42 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 137.94 31.9 0.22 Allowed Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.781 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.645 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 47.1 m-85 -151.88 113.81 2.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.786 -1.42 . . . . 0.0 111.596 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.38 94.71 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 N-CA-C 107.663 -1.706 . . . . 0.0 107.663 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -108.91 -165.0 0.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.032 . . . . 0.0 112.531 -177.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.499 ' N ' ' OG ' ' A' ' 68' ' ' SER . 49.1 m -152.49 -159.2 0.98 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.607 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.7 p -139.07 152.94 24.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.887 -1.133 . . . . 0.0 110.683 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.534 ' HB3' ' CG2' ' A' ' 6' ' ' THR . 1.3 tttp -125.51 49.51 1.91 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.923 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.542 ' CB ' HG12 ' A' ' 5' ' ' VAL . 3.5 pp0? . . . . . 0 C--N 1.28 -2.446 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.021 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.562 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.53 90.39 1.56 Allowed 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -124.31 171.67 9.71 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.956 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.491 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 37.0 m -110.73 155.72 22.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.574 -0.704 . . . . 0.0 110.42 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 4' ' ' THR . 1.8 t -152.79 161.8 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 108.687 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.529 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -108.02 161.08 15.27 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.542 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -132.58 155.13 49.23 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.82 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.84 101.74 10.32 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.412 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.474 HG23 ' SG ' ' A' ' 17' ' ' CYS . 2.0 p -118.09 101.84 51.28 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.495 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.25 36.67 0.55 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.379 1.386 . . . . 0.0 111.579 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.61 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -76.58 -46.69 11.26 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 10.6 ptp 38.47 54.91 1.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.737 -0.861 . . . . 0.0 110.181 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.518 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -86.69 17.05 4.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.579 -0.7 . . . . 0.0 109.764 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 13' ' ' THR . 7.8 t 66.45 89.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 110.604 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 65.32 18.04 11.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 110.48 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.518 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -123.14 -48.12 2.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 109.522 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.626 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -55.7 -44.15 99.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.47 -0.769 . . . . 0.0 111.303 179.426 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 12.7 Cg_endo -76.55 -16.77 16.7 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 120.925 1.083 . . . . 0.0 112.681 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 19' ' ' ILE . 5.4 mt -91.67 -31.52 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.587 -1.321 . . . . 0.0 109.561 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.536 ' CG2' ' HB2' ' A' ' 64' ' ' ALA . 1.1 m -83.64 -47.98 10.67 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.6 ' O ' HD12 ' A' ' 25' ' ' LEU . 74.9 t -57.52 -48.8 82.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.889 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.476 ' O ' HG13 ' A' ' 34' ' ' VAL . 14.4 tttt -57.46 -45.84 84.3 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.27 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -76.21 -2.76 32.83 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.199 -0.938 . . . . 0.0 110.616 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 27' ' ' LYS . . . -85.18 -54.03 4.87 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.128 -0.983 . . . . 0.0 109.438 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.614 ' N ' HD11 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -80.55 -13.22 59.26 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.244 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.56 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 20.1 t -78.72 -35.93 44.15 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.499 -0.751 . . . . 0.0 108.981 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -104.15 2.95 32.45 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.825 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.546 ' CG2' ' CG ' ' A' ' 56' ' ' LYS . 4.6 p -54.11 -53.35 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.79 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.545 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER 169.28 -86.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.881 -1.137 . . . . 0.0 111.557 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.452 ' O ' ' OD2' ' A' ' 48' ' ' ASP . . . -67.69 -21.72 73.09 Favored Glycine 0 N--CA 1.494 2.514 0 O-C-N 121.221 -0.924 . . . . 0.0 111.331 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.588 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 10.8 p -40.15 144.74 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.933 -1.334 . . . . 0.0 111.702 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 m -127.99 -8.63 5.44 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.258 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.54 ' CG ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -162.36 165.05 26.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.157 -0.965 . . . . 0.0 109.842 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.543 ' CG1' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -160.28 155.6 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.989 -1.069 . . . . 0.0 111.165 -178.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.61 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -155.75 161.15 40.75 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 3.2 m -109.59 131.86 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.734 -1.229 . . . . 0.0 111.29 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.4 58.67 0.56 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.592 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -58.78 -17.52 24.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -1.05 . . . . 0.0 110.769 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.14 -22.54 1.72 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.031 . . . . 0.0 109.634 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -148.7 43.11 0.99 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.427 -0.795 . . . . 0.0 109.828 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 40' ' ' LYS . 5.4 mmt180 41.75 58.59 2.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.401 -0.812 . . . . 0.0 109.921 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.521 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 4.5 pt-20 -149.17 151.92 35.18 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.992 -1.067 . . . . 0.0 110.669 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -117.58 142.43 47.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.802 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.61 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 5.4 p -108.72 110.5 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.649 -1.282 . . . . 0.0 108.604 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.495 HG22 HD22 ' A' ' 25' ' ' LEU . 2.9 p -116.52 144.0 25.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.965 0.888 . . . . 0.0 112.36 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.54 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.2 m -109.79 150.78 27.86 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.621 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 23.4 p90 -171.25 173.03 5.06 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 117.736 -1.586 . . . . 0.0 112.303 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.6 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.7 OUTLIER -107.26 118.86 37.83 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.176 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 6.1 p-10 -59.27 -10.99 3.41 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.279 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 48' ' ' ASP . 7.7 t -68.77 -27.02 65.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.958 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HB2' ' OD1' ' A' ' 48' ' ' ASP . 5.6 mttt -120.94 0.55 10.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.92 -1.112 . . . . 0.0 110.579 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.485 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -171.76 -160.79 0.17 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 110.206 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.621 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 169.18 167.74 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.502 -0.749 . . . . 0.0 110.098 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.528 ' CG1' ' CG2' ' A' ' 70' ' ' VAL . 3.0 t -41.08 -42.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.875 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -52.02 -49.79 62.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.022 . . . . 0.0 109.504 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.546 ' CG ' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -74.17 -22.7 59.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.458 -0.776 . . . . 0.0 111.645 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 57.0 mt -72.66 -61.42 1.81 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.39 -1.444 . . . . 0.0 108.237 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 69' ' ' SER . 79.1 m -57.11 -26.08 59.87 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 3.1 ttmt -72.47 -36.05 68.37 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.558 -0.713 . . . . 0.0 109.104 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 24' ' ' ALA . . . -66.13 -41.08 90.97 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.439 -0.788 . . . . 0.0 109.938 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.514 HG21 ' N ' ' A' ' 62' ' ' ALA . 8.9 t -73.65 -29.92 62.62 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.514 ' N ' HG21 ' A' ' 61' ' ' THR . . . -66.15 -32.66 74.24 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 63' ' ' ASP . 8.8 t0 -90.64 -12.45 36.83 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.672 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.536 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -78.22 -27.47 47.76 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 132.76 26.61 0.63 Allowed Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.672 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.61 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 37.7 m-85 -147.82 109.11 3.78 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.689 -1.477 . . . . 0.0 111.659 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -59.85 95.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 N-CA-C 107.312 -1.842 . . . . 0.0 107.312 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.03 -168.74 1.38 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 112.415 -176.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.543 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -151.63 -160.81 1.21 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.542 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.2 p -140.24 159.24 25.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.991 -1.068 . . . . 0.0 110.968 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 2.6 mttt -124.96 25.13 7.41 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.448 1.118 . . . . 0.0 109.155 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.466 ' HA ' HG12 ' A' ' 5' ' ' VAL . 13.4 mm100 . . . . . 0 C--N 1.285 -2.211 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.136 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.191 0.519 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -146.17 88.75 1.82 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -108.72 163.49 13.21 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.501 -0.88 . . . . 0.0 112.493 -177.048 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.455 ' O ' HG21 ' A' ' 4' ' ' THR . 1.3 t -135.14 111.4 9.68 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.281 0.562 . . . . 0.0 109.775 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.483 HG22 HD11 ' A' ' 57' ' ' LEU 0.256 14.5 m -122.75 166.39 17.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.216 -0.928 . . . . 0.0 109.925 -179.155 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.56 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.45 166.47 10.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.597 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.641 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.15 161.42 33.38 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.1 -178.448 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.56 105.88 15.37 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.434 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.474 HG11 ' NH1' ' A' ' 41' ' ' ARG . 2.3 p -116.43 85.9 17.05 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -76.39 36.06 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.67 1.353 . . . . 0.0 112.318 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.496 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -78.72 -31.07 45.94 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.76 -2.136 . . . . 0.0 107.76 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 36.84 42.0 0.2 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.923 -0.751 . . . . 0.0 110.386 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.625 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 4.0 t -45.78 -27.88 0.93 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 13' ' ' THR . 7.6 t 144.33 -41.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 121.91 0.862 . . . . 0.0 109.241 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.593 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . . . -176.23 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.577 0.703 . . . . 0.0 109.366 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.537 ' CB ' HG23 ' A' ' 13' ' ' THR . . . -129.07 -26.27 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.607 -0.683 . . . . 0.0 109.981 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -44.62 -47.27 27.51 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.917 -1.114 . . . . 0.0 111.689 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 6.9 Cg_endo -76.23 -18.21 16.35 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.334 1.356 . . . . 0.0 113.325 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 mm -87.59 -42.67 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.415 -1.428 . . . . 0.0 109.557 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 64' ' ' ALA 0.251 0.9 OUTLIER -69.55 -37.21 76.94 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.889 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.565 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 25.6 t -64.6 -45.61 94.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.553 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 68.7 tttt -50.67 -45.99 58.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.574 -0.704 . . . . 0.0 110.307 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 8.7 mtmt -75.67 -20.82 58.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 111.101 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.499 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . -69.97 -52.65 22.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.439 -0.788 . . . . 0.0 110.557 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.589 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 4.0 mp -71.91 -31.09 66.05 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.144 -0.973 . . . . 0.0 110.028 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.538 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 12.7 t -68.22 -22.99 64.76 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -111.6 2.8 17.52 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.274 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.552 ' CG2' ' HB3' ' A' ' 56' ' ' LYS . 7.7 p -49.94 -52.13 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.073 -1.017 . . . . 0.0 110.339 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER 172.34 -77.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 110.897 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.34 -1.88 66.26 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.538 ' CG2' ' HA ' ' A' ' 26' ' ' SER . 6.9 p -44.0 141.05 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.238 . . . . 0.0 110.711 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.6 t -118.02 -13.86 9.99 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.606 0.717 . . . . 0.0 109.071 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 7.5 tttt -159.46 166.28 31.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.546 -0.721 . . . . 0.0 109.649 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.553 ' CG2' ' O ' ' A' ' 22' ' ' LYS . 7.2 p -162.51 154.47 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.99 . . . . 0.0 111.366 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.547 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 1.3 m-20 -164.86 171.19 14.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 109.238 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 3.1 m -152.06 164.6 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.935 -1.103 . . . . 0.0 111.173 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.26 112.31 0.52 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.593 ' CE2' ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -66.27 -19.35 65.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -1.142 . . . . 0.0 109.934 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -53.8 -64.67 0.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.354 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -95.6 22.63 6.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.33 -0.856 . . . . 0.0 109.33 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.602 ' HA ' ' NH1' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 36.89 59.64 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.33 0.586 . . . . 0.0 110.772 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 18.3 pt-20 -146.11 166.96 24.59 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.536 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.505 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . . . -125.56 132.57 52.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.161 -0.962 . . . . 0.0 109.163 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.547 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 7.8 p -106.51 116.18 49.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 120.791 -1.193 . . . . 0.0 109.119 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.543 HG23 ' CG2' ' A' ' 34' ' ' VAL . 39.3 t -129.84 144.78 37.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.122 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -108.6 161.29 15.21 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 31.4 p90 -170.22 -177.69 2.57 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 117.898 -1.521 . . . . 0.0 112.091 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.571 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.7 m-20 -105.98 113.94 27.79 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 10.7 t70 -59.62 -10.2 3.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.784 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.0 p -70.55 -29.22 65.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 0.0 110.61 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -134.6 18.32 3.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.028 -1.045 . . . . 0.0 110.846 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -170.66 178.72 3.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.0 110.053 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.585 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.9 OUTLIER 176.2 171.01 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.387 -0.821 . . . . 0.0 109.511 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.525 HG11 ' CG2' ' A' ' 70' ' ' VAL . 2.7 t -41.8 -34.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -58.88 -50.27 74.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.896 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.552 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 16.3 mmtm -76.5 -20.52 56.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 111.246 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.567 HD13 ' CE2' ' A' ' 47' ' ' PHE . 76.1 mt -70.77 -59.71 2.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.572 -1.33 . . . . 0.0 108.482 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.526 ' N ' HD22 ' A' ' 7' ' ' LEU . 94.5 m -58.63 -26.88 64.19 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.518 -0.739 . . . . 0.0 109.049 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 60.4 tttt -76.35 -29.59 57.29 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.51 -0.744 . . . . 0.0 109.307 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -69.94 -51.12 35.48 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.521 ' OG1' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.64 -32.8 74.35 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . -64.87 -31.27 72.42 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.903 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -88.54 -11.11 46.63 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.498 -0.751 . . . . 0.0 109.028 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HB3' ' CG2' ' A' ' 20' ' ' THR . . . -78.35 -27.3 47.0 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 135.86 23.8 0.55 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.093 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 65' ' ' GLY . 43.7 m-85 -148.15 109.12 3.69 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.493 -1.592 . . . . 0.0 111.64 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.19 98.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 107.014 -1.956 . . . . 0.0 107.014 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 71.6 p -108.41 -166.31 1.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.083 0.944 . . . . 0.0 112.68 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.475 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.8 m -151.8 -160.74 1.19 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.641 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.2 p -141.1 160.07 22.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.779 -1.2 . . . . 0.0 111.844 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.54 ' HB2' ' CG2' ' A' ' 6' ' ' THR . 9.2 mttt -127.85 25.35 5.97 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.367 1.079 . . . . 0.0 108.93 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.122 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.401 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.105 0.478 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.58 91.58 1.5 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -113.68 -174.93 2.56 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.312 -0.955 . . . . 0.0 112.462 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.487 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 92.3 m -142.5 146.81 35.11 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.468 0.652 . . . . 0.0 110.34 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.559 ' CG1' ' HA ' ' A' ' 72' ' ' GLN . 15.9 t -156.03 167.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.461 -0.774 . . . . 0.0 109.764 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.571 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -109.66 169.47 8.69 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.477 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.571 ' CD1' ' O ' ' A' ' 6' ' ' THR . 0.9 OUTLIER -133.29 157.99 44.08 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.934 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.24 103.33 12.0 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.735 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 1.9 p -114.56 92.65 29.53 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.397 -0.814 . . . . 0.0 109.995 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 10.7 Cg_endo -79.54 51.42 3.87 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.669 1.579 . . . . 0.0 111.581 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.584 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -95.44 -21.09 25.42 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.524 ' CG ' ' C ' ' A' ' 11' ' ' GLY . 1.2 ptt? 35.77 59.4 0.86 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.768 -0.842 . . . . 0.0 110.559 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.526 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -90.51 19.68 5.12 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.521 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 13' ' ' THR . 2.4 t 68.5 92.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.471 -0.768 . . . . 0.0 110.309 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.567 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . . . 50.25 30.96 4.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 110.085 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.526 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -127.17 -45.45 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.586 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -40.05 -69.37 0.21 Allowed Pre-proline 0 N--CA 1.505 2.281 0 O-C-N 121.109 -0.994 . . . . 0.0 111.673 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 17' ' ' CYS . 10.0 Cg_endo -65.8 -12.75 36.63 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.173 1.249 . . . . 0.0 112.752 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.522 HD11 ' N ' ' A' ' 19' ' ' ILE . 1.5 mp -78.88 -56.0 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.864 -1.147 . . . . 0.0 109.583 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -69.37 -42.01 75.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.56 ' O ' HD12 ' A' ' 25' ' ' LEU . 5.6 t -57.71 -43.53 83.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.569 ' O ' ' CB ' ' A' ' 26' ' ' SER . 12.8 tttt -53.08 -50.11 65.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.511 -0.743 . . . . 0.0 109.861 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 7.9 mtpm? -72.47 -11.59 60.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 111.501 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.8 -67.22 0.75 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.124 -0.985 . . . . 0.0 109.466 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.583 HD11 ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -68.28 -12.3 60.81 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.579 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 6.8 t -79.32 -30.24 42.73 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.99 9.41 18.72 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.238 -0.914 . . . . 0.0 109.813 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.498 ' CG2' ' HB3' ' A' ' 56' ' ' LYS . 4.0 p -51.89 -53.73 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.349 -0.844 . . . . 0.0 111.08 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.547 ' CG ' ' N ' ' A' ' 30' ' ' GLY . 1.6 tt0 -179.9 -86.28 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.598 -1.314 . . . . 0.0 110.85 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.547 ' N ' ' CG ' ' A' ' 29' ' ' GLU . . . -74.67 -15.14 80.78 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.583 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 3.5 p -40.54 142.08 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -1.069 . . . . 0.0 110.961 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.434 ' N ' HG21 ' A' ' 31' ' ' VAL . 3.5 m -127.02 -11.92 5.88 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.396 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.512 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -158.07 165.2 35.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.18 -0.95 . . . . 0.0 110.044 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.552 ' CG2' ' HB2' ' A' ' 26' ' ' SER . 6.4 p -169.01 154.48 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.023 -1.048 . . . . 0.0 111.59 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.536 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -157.09 172.14 19.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.491 -0.756 . . . . 0.0 109.634 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 22' ' ' LYS . 2.9 m -109.91 151.09 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.057 -1.027 . . . . 0.0 110.926 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -142.85 64.35 0.49 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.583 ' CZ ' ' SG ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -57.33 -15.86 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 110.245 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -45.31 -33.62 2.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.124 -0.985 . . . . 0.0 109.21 179.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -141.57 40.04 1.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.509 -0.744 . . . . 0.0 109.459 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.6 OUTLIER 42.47 57.55 3.38 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.451 -0.781 . . . . 0.0 110.081 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 13.7 pt-20 -142.93 168.76 18.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 110.422 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -129.27 137.79 51.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.419 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 35' ' ' ASP . 8.6 p -107.85 109.02 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.706 -1.246 . . . . 0.0 110.288 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.582 HG23 ' CD2' ' A' ' 25' ' ' LEU . 11.6 t -122.71 150.89 26.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 122.138 0.971 . . . . 0.0 112.068 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -114.12 159.53 19.94 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.606 ' CE1' ' HA ' ' A' ' 53' ' ' SER . 38.5 p90 -170.91 -175.04 1.67 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.606 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.551 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.1 m-20 -106.18 124.75 50.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.528 ' HB3' ' CB ' ' A' ' 1' ' ' ALA . 10.2 t70 -80.94 37.87 0.44 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.45 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.6 p -115.53 -24.53 8.29 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.171 -0.956 . . . . 0.0 109.23 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.451 ' O ' ' HB1' ' A' ' 52' ' ' ALA . 5.7 mttt -127.7 -2.11 6.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.419 -0.8 . . . . 0.0 110.073 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . 179.17 176.21 0.61 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.93 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.606 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 6.8 p 172.83 -166.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.671 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.546 HG12 ' CG1' ' A' ' 70' ' ' VAL . 6.5 t -36.68 -40.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.559 -0.713 . . . . 0.0 111.149 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -57.53 -49.49 76.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.106 -0.997 . . . . 0.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.498 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 58.1 mmtt -82.01 -16.95 48.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.263 -0.898 . . . . 0.0 111.736 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.543 ' CD2' ' HB2' ' A' ' 25' ' ' LEU . 48.0 mt -75.27 -58.47 3.26 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.514 -1.366 . . . . 0.0 108.065 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.512 ' O ' ' CG2' ' A' ' 61' ' ' THR . 12.9 m -54.46 -30.61 53.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.29 -34.6 65.85 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.513 -0.742 . . . . 0.0 109.858 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.402 ' O ' ' HB1' ' A' ' 64' ' ' ALA . . . -67.93 -36.96 81.05 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.173 -0.955 . . . . 0.0 109.704 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.54 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 5.3 t -74.3 -35.57 63.7 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.535 ' N ' HG21 ' A' ' 61' ' ' THR . . . -64.65 -32.14 73.68 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -90.68 -8.08 50.91 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.484 ' HB3' HG22 ' A' ' 20' ' ' THR . . . -85.16 -21.11 29.33 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.452 -0.78 . . . . 0.0 108.942 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 133.08 17.01 1.18 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.004 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.584 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 35.2 m-85 -151.51 111.46 2.98 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.706 -1.467 . . . . 0.0 111.307 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.14 96.83 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 N-CA-C 107.87 -1.627 . . . . 0.0 107.87 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.9 -171.24 1.81 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.01 . . . . 0.0 112.187 -177.27 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.542 ' N ' ' OG ' ' A' ' 68' ' ' SER . 6.0 p -145.18 -157.45 0.79 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.546 ' CG1' HG12 ' A' ' 54' ' ' VAL . 3.1 p -142.47 158.81 19.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.209 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.534 ' HB2' ' CG2' ' A' ' 6' ' ' THR . 3.9 mttm -124.69 27.12 6.96 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.304 1.05 . . . . 0.0 109.659 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.559 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 17.2 pt20 . . . . . 0 C--N 1.287 -2.148 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.543 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.512 ' CB ' HG21 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.256 0.55 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER 171.16 108.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.975 0.893 . . . . 0.0 109.181 179.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.06 176.1 9.75 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.071 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 46' ' ' THR . 21.6 m -113.4 131.86 55.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 110.138 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.566 ' CG2' ' N ' ' A' ' 6' ' ' THR . 0.6 OUTLIER -128.98 169.36 20.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.038 0.923 . . . . 0.0 109.296 179.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.566 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -108.51 159.88 16.34 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.565 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -133.04 152.97 51.91 Favored 'General case' 0 C--N 1.292 -1.921 0 O-C-N 120.868 -1.145 . . . . 0.0 109.688 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -108.95 111.48 23.18 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.616 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.536 ' CG2' HG23 ' A' ' 21' ' ' VAL . 2.1 p -133.23 93.55 22.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 109.167 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 5.5 Cg_endo -73.26 19.13 0.37 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.388 1.392 . . . . 0.0 112.291 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.605 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -52.19 -36.18 43.99 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.516 ' C ' ' O ' ' A' ' 11' ' ' GLY . 2.1 ptt? 26.61 50.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.67 0.748 . . . . 0.0 110.765 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.637 ' CG2' ' CB ' ' A' ' 16' ' ' ALA . 1.9 t -81.38 9.86 6.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.676 -0.64 . . . . 0.0 110.035 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.3 OUTLIER 78.74 94.18 0.06 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.601 0.715 . . . . 0.0 111.104 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 58.44 42.67 20.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.612 -0.68 . . . . 0.0 112.052 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.637 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -160.81 -44.0 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.709 -1.244 . . . . 0.0 111.005 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -46.62 -53.17 26.49 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.627 -1.295 . . . . 0.0 110.167 179.519 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.641 ' CG ' ' CD2' ' A' ' 38' ' ' PHE . 10.6 Cg_endo -74.04 -16.59 22.75 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.29 1.327 . . . . 0.0 112.219 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.6 mt -79.01 -38.49 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.828 -1.17 . . . . 0.0 109.632 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.515 ' CG2' ' HB2' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -77.06 -45.81 25.81 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.593 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 16.9 t -56.37 -40.69 68.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 26' ' ' SER . 7.2 tttt -55.67 -56.96 14.23 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 108.823 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -71.39 0.69 7.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.41 -0.806 . . . . 0.0 110.868 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.449 ' C ' ' CB ' ' A' ' 60' ' ' ALA . . . -88.79 -72.14 0.56 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.669 -1.269 . . . . 0.0 108.929 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -64.78 -9.93 24.05 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.49 178.587 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.576 ' N ' HD21 ' A' ' 25' ' ' LEU . 34.8 t -90.65 -45.5 8.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.5 -0.75 . . . . 0.0 110.397 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.557 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -79.28 -4.15 49.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.864 -1.147 . . . . 0.0 110.309 -179.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.529 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 5.4 t -29.85 -79.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.852 -0.53 . . . . 0.0 110.927 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.521 ' N ' HG13 ' A' ' 28' ' ' VAL . 1.2 pt-20 178.0 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.948 -1.095 . . . . 0.0 110.935 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 48' ' ' ASP . . . -117.66 2.27 17.87 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.565 ' CG2' ' O ' ' A' ' 25' ' ' LEU . 71.6 t -49.69 147.87 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 122.459 1.123 . . . . 0.0 111.399 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.466 ' N ' HG11 ' A' ' 31' ' ' VAL . 3.5 m -122.2 -10.18 8.56 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.459 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.497 ' CG ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -175.72 170.37 2.88 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.001 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 26' ' ' SER . 9.7 p -170.09 156.49 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.862 . . . . 0.0 110.517 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.54 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -156.2 164.88 37.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.427 -0.795 . . . . 0.0 109.633 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.452 HG11 ' HB2' ' A' ' 22' ' ' LYS . 7.2 m -112.18 140.49 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 110.704 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.17 69.82 0.53 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.641 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -61.92 -14.72 37.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -1.154 . . . . 0.0 110.435 -179.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -54.89 -27.15 40.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 109.8 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.446 ' HG3' ' HB3' ' A' ' 42' ' ' GLU . 2.8 ptmt -142.7 35.51 1.43 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 110.03 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 40' ' ' LYS . 1.9 mpp_? 42.9 55.75 4.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.214 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HG2' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -145.61 149.42 34.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.233 -0.917 . . . . 0.0 110.11 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.51 ' N ' ' HG2' ' A' ' 42' ' ' GLU . . . -115.87 139.25 50.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 110.031 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.54 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 9.1 p -106.47 111.78 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.763 -1.211 . . . . 0.0 109.47 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.608 ' CG1' ' CD1' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -117.51 137.83 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.776 0.798 . . . . 0.0 112.289 -178.056 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.497 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.6 m -109.0 155.77 20.51 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.721 ' O ' ' HA ' ' A' ' 2' ' ' THR . 35.5 p90 -171.92 -176.81 1.79 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.449 -1.407 . . . . 0.0 110.798 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 2' ' ' THR . 2.1 p30 -109.59 110.52 21.62 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 29.0 t70 -54.64 -14.69 1.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.959 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.512 HG21 ' CB ' ' A' ' 1' ' ' ALA . 2.2 p -61.63 -35.73 78.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 110.807 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.08 -5.23 9.52 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.043 -1.035 . . . . 0.0 111.361 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -153.02 -164.47 1.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.969 -1.082 . . . . 0.0 110.874 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.612 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 6.4 t 167.72 172.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 5' ' ' VAL . 6.6 m -51.54 -32.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.753 -1.217 . . . . 0.0 109.451 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -47.66 -44.86 27.54 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.014 -1.054 . . . . 0.0 108.404 179.003 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.464 ' O ' ' HB1' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -89.06 -20.58 24.18 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.763 -0.586 . . . . 0.0 111.244 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.608 ' CD1' ' CG1' ' A' ' 45' ' ' VAL . 42.3 mt -73.77 -64.04 1.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.229 -1.544 . . . . 0.0 107.98 178.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 61' ' ' THR . 1.4 m -56.59 -27.61 58.42 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -74.81 -32.0 61.85 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.168 -0.957 . . . . 0.0 109.327 179.362 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.49 ' HB2' ' N ' ' A' ' 25' ' ' LEU . . . -70.48 -35.94 73.56 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.316 -0.865 . . . . 0.0 109.459 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.544 HG21 ' N ' ' A' ' 62' ' ' ALA . 4.8 t -74.68 -34.7 62.73 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.544 ' N ' HG21 ' A' ' 61' ' ' THR . . . -66.36 -32.29 73.59 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.39 -10.09 45.19 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.576 -0.703 . . . . 0.0 109.378 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.515 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -79.48 -29.66 41.75 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.56 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.98 27.93 0.34 Allowed Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.699 -1.238 . . . . 0.0 110.996 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.605 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 53.0 m-85 -150.9 116.72 3.28 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.622 -1.517 . . . . 0.0 111.449 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.54 95.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 N-CA-C 106.875 -2.01 . . . . 0.0 106.875 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 2.9 m -108.79 -165.1 0.99 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 112.51 -176.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.449 ' O ' ' OG1' ' A' ' 58' ' ' THR . 4.9 t -159.42 -167.11 1.95 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.565 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.1 p -139.06 155.92 27.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 120.804 -1.185 . . . . 0.0 111.379 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 1.1 mttt -124.49 26.72 7.19 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.432 1.111 . . . . 0.0 108.864 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.436 ' O ' HG22 ' A' ' 5' ' ' VAL . 1.8 mp0 . . . . . 0 C--N 1.29 -2.013 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.289 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.156 0.503 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.61 88.42 1.42 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -112.48 151.08 30.34 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.655 -177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.3 m -124.9 122.42 37.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.576 ' CG2' ' N ' ' A' ' 6' ' ' THR . 0.8 OUTLIER -130.32 171.68 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.03 . . . . 0.0 110.419 -178.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.576 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -107.28 158.91 16.76 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -130.07 155.89 45.41 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.662 -1.273 . . . . 0.0 109.847 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.98 100.76 9.4 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.946 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.517 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 1.8 p -114.45 89.97 19.67 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.476 -0.765 . . . . 0.0 109.337 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 11.0 Cg_endo -78.06 46.53 2.1 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.361 1.374 . . . . 0.0 112.008 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.592 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -92.42 -34.31 7.12 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.486 ' C ' ' O ' ' A' ' 11' ' ' GLY . 0.9 OUTLIER 35.59 44.33 0.2 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.758 0.789 . . . . 0.0 110.087 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.604 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 1.4 t -61.22 -11.03 7.84 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.679 -0.638 . . . . 0.0 109.639 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.604 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.5 OUTLIER 86.66 93.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.614 0.721 . . . . 0.0 111.029 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 14' ' ' CYS . . . 73.55 24.4 2.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 111.831 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.601 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -150.84 -38.69 0.13 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.457 -1.402 . . . . 0.0 110.718 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.613 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -45.15 -47.74 32.36 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.606 -1.309 . . . . 0.0 110.459 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.6 Cg_endo -70.75 -28.17 20.83 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 O-C-N 123.229 1.12 . . . . 0.0 111.655 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.5 mm -73.39 -32.18 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.955 . . . . 0.0 110.839 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.544 HG21 ' CB ' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -81.64 -53.27 6.37 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 108.965 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.54 ' O ' HD12 ' A' ' 25' ' ' LEU . 66.5 t -54.39 -43.46 62.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.678 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.9 tttm -55.55 -61.75 2.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.937 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -75.42 5.74 5.43 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.186 -0.946 . . . . 0.0 110.678 179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 20' ' ' THR . . . -85.36 -67.89 0.77 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.373 -1.454 . . . . 0.0 108.482 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.57 HD11 ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -74.26 -11.62 60.33 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.565 ' CB ' ' O ' ' A' ' 22' ' ' LYS . 46.5 t -85.51 -33.25 21.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.45 -10.1 42.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.6 -1.312 . . . . 0.0 110.433 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.589 ' CG1' ' CE ' ' A' ' 56' ' ' LYS . 3.2 t -40.39 -82.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.276 -0.89 . . . . 0.0 110.015 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 174.97 -57.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.418 -0.801 . . . . 0.0 109.906 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.444 ' O ' ' OD2' ' A' ' 48' ' ' ASP . . . -70.3 -26.76 73.73 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.615 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 14.8 p -56.56 142.3 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -1.145 . . . . 0.0 110.699 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.84 -10.9 8.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.757 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.509 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.4 tttt -162.47 168.96 21.17 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.068 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 45' ' ' VAL . 13.7 p -169.07 159.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.093 -1.004 . . . . 0.0 111.384 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.452 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -158.85 162.95 37.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.505 ' CG1' ' HB2' ' A' ' 22' ' ' LYS . 22.4 m -116.23 152.33 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 110.603 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -144.41 79.13 0.25 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.547 ' CE2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -58.03 -18.92 27.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -1.121 . . . . 0.0 110.119 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -50.3 -47.99 55.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 0.0 109.092 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 41' ' ' ARG . 10.1 mttm -116.18 25.49 10.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.493 -0.754 . . . . 0.0 109.381 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.551 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 40.97 57.48 2.74 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.422 0.63 . . . . 0.0 110.191 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.537 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -148.06 155.86 41.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.412 -0.805 . . . . 0.0 109.742 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' CB ' HG13 ' A' ' 21' ' ' VAL . . . -112.13 138.66 48.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.944 -1.097 . . . . 0.0 110.276 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 44' ' ' VAL . 8.6 p -106.09 105.65 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.821 -1.174 . . . . 0.0 109.064 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 4.8 p -109.72 148.84 13.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 122.089 0.947 . . . . 0.0 112.292 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -115.94 154.13 30.35 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.615 ' CB ' ' HA ' ' A' ' 31' ' ' VAL . 34.6 p90 -170.83 -177.24 2.22 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 117.669 -1.612 . . . . 0.0 112.051 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.2 p30 -107.01 115.05 29.51 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 7.8 t70 -68.24 -3.79 11.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.777 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.468 HG23 ' HB2' ' A' ' 48' ' ' ASP . 4.1 t -66.63 -6.98 17.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 110.018 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -137.35 -51.09 0.64 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.136 -0.978 . . . . 0.0 110.937 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.573 ' HB2' ' CE ' ' A' ' 56' ' ' LYS . . . -130.49 -160.99 1.08 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.452 -0.78 . . . . 0.0 110.466 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.602 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.3 p 168.4 -169.02 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.379 -0.825 . . . . 0.0 109.338 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.543 HG12 ' CG1' ' A' ' 70' ' ' VAL . 3.1 t -35.5 -59.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.747 -0.595 . . . . 0.0 111.134 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 34.4 tt0 -43.13 -47.54 6.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 0.0 110.791 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.589 ' CE ' ' CG1' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -79.14 -24.06 43.58 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.964 . . . . 0.0 111.849 -178.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.542 HD22 ' NZ ' ' A' ' 56' ' ' LYS . 79.9 mt -72.08 -56.73 5.1 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.503 -1.373 . . . . 0.0 108.384 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.472 ' OG1' ' HB ' ' A' ' 70' ' ' VAL . 7.4 m -56.48 -31.46 64.05 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.528 -0.732 . . . . 0.0 109.385 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -75.47 -31.57 60.29 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.287 -0.883 . . . . 0.0 110.005 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -69.07 -42.31 76.39 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.533 ' OG1' ' CG2' ' A' ' 21' ' ' VAL . 12.9 t -73.64 -32.89 64.26 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 66' ' ' TYR . . . -64.67 -31.25 72.4 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.59 -9.51 46.78 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.544 ' CB ' HG21 ' A' ' 20' ' ' THR . . . -81.93 -23.7 36.03 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.35 14.4 0.62 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.463 -1.351 . . . . 0.0 111.743 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.592 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 68.7 m-85 -145.69 114.11 4.71 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.313 -1.698 . . . . 0.0 111.79 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.77 97.58 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 N-CA-C 107.255 -1.863 . . . . 0.0 107.255 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 1.5 p -108.31 -166.14 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.0 112.751 -176.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.428 ' OG ' ' CB ' ' A' ' 8' ' ' ALA . 24.6 p -150.73 -164.92 2.13 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.561 ' HA ' HD13 ' A' ' 7' ' ' LEU . 2.4 p -141.07 158.32 22.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.906 -1.118 . . . . 0.0 111.516 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.482 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -125.95 24.72 6.95 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.294 1.045 . . . . 0.0 109.088 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.48 ' OXT' HG21 ' A' ' 5' ' ' VAL . 39.4 mt-30 . . . . . 0 C--N 1.289 -2.026 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.345 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.539 0.685 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.536 ' CA ' ' O ' ' A' ' 47' ' ' PHE 0.258 14.6 t -100.2 -135.3 0.29 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.668 ' CB ' ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -173.37 153.88 2.5 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.455 179.048 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.6 m -143.16 107.73 4.83 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.535 HG11 ' CA ' ' A' ' 72' ' ' GLN . 2.5 t -140.17 165.15 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -0.854 . . . . 0.0 109.9 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.561 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 2.4 p -108.9 164.0 12.79 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.591 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.95 157.74 46.12 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.704 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.534 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.46 107.25 16.85 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.568 -0.707 . . . . 0.0 110.068 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.475 HG23 ' SG ' ' A' ' 17' ' ' CYS . 2.0 p -117.15 100.44 53.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.751 . . . . 0.0 109.524 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -76.27 34.96 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.381 1.388 . . . . 0.0 112.156 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.606 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.56 -46.11 86.34 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.549 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 16.9 ptt? 36.78 47.54 0.57 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.88 -0.776 . . . . 0.0 110.36 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.644 ' CG2' ' CB ' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -85.19 14.9 4.63 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.508 -0.745 . . . . 0.0 109.795 179.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 13' ' ' THR . 4.0 t 77.68 87.97 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.489 0.661 . . . . 0.0 111.363 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 56.12 38.83 30.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.489 -0.757 . . . . 0.0 111.788 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.644 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -154.43 -31.27 0.11 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.883 -1.136 . . . . 0.0 111.122 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -50.82 -55.23 28.87 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.647 -1.283 . . . . 0.0 110.676 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.626 ' CG ' ' CD2' ' A' ' 38' ' ' PHE . 9.5 Cg_endo -69.05 -3.79 12.25 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.249 1.299 . . . . 0.0 112.543 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.475 HG22 HD11 ' A' ' 19' ' ' ILE . 15.5 mt -90.54 -48.49 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.857 -1.152 . . . . 0.0 109.229 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.521 ' CG2' ' HB3' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -62.56 -36.81 83.84 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.568 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 60.4 t -65.54 -48.13 83.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.494 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 44.6 tttm -42.71 -54.19 4.16 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.634 -0.666 . . . . 0.0 110.669 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -71.44 -26.02 62.56 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.163 -0.961 . . . . 0.0 111.473 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 27' ' ' LYS . . . -65.11 -55.37 19.13 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.302 -0.874 . . . . 0.0 110.818 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.578 ' CD2' HD21 ' A' ' 7' ' ' LEU . 3.2 mp -69.71 -31.65 69.78 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.099 -1.001 . . . . 0.0 110.534 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.529 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -68.23 -22.08 64.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.239 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.46 1.09 15.78 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.025 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.547 HG13 ' CG2' ' A' ' 31' ' ' VAL . 7.6 p -45.7 -46.94 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.883 -1.136 . . . . 0.0 110.627 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.524 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.4 OUTLIER 173.17 -80.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.897 -1.127 . . . . 0.0 110.891 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -92.41 -14.77 55.19 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.006 -1.093 . . . . 0.0 110.528 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.585 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 9.6 t -42.43 139.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.027 -1.278 . . . . 0.0 110.428 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.1 t -118.32 -10.66 10.17 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.474 0.654 . . . . 0.0 109.245 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -154.0 164.59 38.19 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.264 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.494 ' CG1' ' HG3' ' A' ' 22' ' ' LYS . 6.4 p -152.94 174.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 109.242 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.47 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . 1.2 t0 -162.3 160.01 26.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.832 -1.168 . . . . 0.0 111.378 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 18' ' ' PRO . 25.1 t -110.07 136.08 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.487 -0.758 . . . . 0.0 109.963 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -138.63 61.75 0.57 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -58.87 -23.48 60.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -1.135 . . . . 0.0 110.326 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -42.99 -40.77 3.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.864 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.525 ' CG ' ' HG2' ' A' ' 42' ' ' GLU . 12.9 ptpt -139.21 49.2 1.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.421 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.549 ' CD ' ' HB3' ' A' ' 12' ' ' MET . 0.0 OUTLIER 39.47 62.31 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.505 -0.747 . . . . 0.0 110.299 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' HG2' ' CG ' ' A' ' 40' ' ' LYS . 2.0 pp20? -146.42 141.55 27.27 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.435 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.566 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -115.1 136.29 53.27 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.561 ' CG2' ' CG2' ' A' ' 6' ' ' THR . 1.6 t -106.24 143.68 16.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 120.233 -1.542 . . . . 0.0 109.355 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.548 ' CG2' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -142.51 153.49 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.797 -178.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -123.75 151.3 43.4 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.668 ' CZ ' ' CB ' ' A' ' 3' ' ' GLN . 31.9 p90 -167.52 -173.42 2.2 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 117.747 -1.581 . . . . 0.0 112.639 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 39.4 m-20 -105.59 118.49 36.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -66.15 -1.66 3.45 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.214 -177.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.0 t -86.27 -20.49 28.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.043 -1.036 . . . . 0.0 110.525 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -128.47 -14.94 4.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.887 -1.133 . . . . 0.0 111.707 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -143.25 -170.39 3.26 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.023 -1.048 . . . . 0.0 110.137 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.593 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 174.15 167.92 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.873 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.52 ' CG2' ' CG2' ' A' ' 70' ' ' VAL . 2.5 p -42.73 -49.81 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 110.215 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 7.3 tt0 -45.09 -47.04 12.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.041 . . . . 0.0 109.867 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.451 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 11.2 mmtm -75.6 -27.09 58.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.43 -0.794 . . . . 0.0 111.437 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 47' ' ' PHE . 68.5 mt -68.63 -57.69 5.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.602 -1.311 . . . . 0.0 108.761 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.423 ' O ' ' CB ' ' A' ' 62' ' ' ALA . 4.0 m -56.22 -29.61 61.2 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.381 -0.824 . . . . 0.0 109.45 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 3.9 tttm -76.98 -29.52 55.55 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.297 -0.877 . . . . 0.0 109.699 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' A' ' 25' ' ' LEU . . . -69.97 -47.2 63.22 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.412 -0.805 . . . . 0.0 109.253 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.532 ' OG1' ' CG1' ' A' ' 21' ' ' VAL . 10.2 t -70.15 -32.95 71.18 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.488 ' N ' HG21 ' A' ' 61' ' ' THR . . . -68.14 -26.05 65.59 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.658 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 20.1 t0 -89.83 -13.34 36.77 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.521 ' HB3' ' CG2' ' A' ' 20' ' ' THR . . . -80.27 -28.25 38.43 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.589 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 138.88 26.2 0.29 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.11 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.626 ' CZ ' ' HA ' ' A' ' 17' ' ' CYS . 36.0 m-85 -151.38 105.2 2.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.655 -1.497 . . . . 0.0 110.993 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.38 101.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 N-CA-C 107.184 -1.891 . . . . 0.0 107.184 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -107.94 -169.68 1.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.19 -1.004 . . . . 0.0 112.642 -176.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.517 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -152.38 -165.23 2.15 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.591 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.8 p -137.95 157.81 32.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.513 -1.367 . . . . 0.0 111.733 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.496 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -122.87 27.26 7.8 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.058 0.932 . . . . 0.0 109.639 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.535 ' CA ' HG11 ' A' ' 5' ' ' VAL . 34.3 mt-30 . . . . . 0 C--N 1.29 -2.019 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.531 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.167 0.508 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -146.88 89.88 1.86 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.358 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -109.13 153.26 23.97 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.874 0.845 . . . . 0.0 112.103 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.447 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 5.4 t -123.45 143.27 50.25 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.539 ' CG1' ' HA ' ' A' ' 72' ' ' GLN . 1.5 t -149.49 160.95 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -0.93 . . . . 0.0 109.152 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.545 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 1.8 t -106.97 158.71 16.82 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.611 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.6 OUTLIER -128.85 161.47 29.73 Favored 'General case' 0 C--N 1.276 -2.619 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.525 -177.601 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.43 101.15 10.14 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.816 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.525 HG22 ' CB ' ' A' ' 66' ' ' TYR . 3.5 p -115.21 90.3 23.66 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -77.41 45.35 1.71 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.545 1.496 . . . . 0.0 112.822 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.592 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -95.11 -34.04 6.33 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.554 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 1.2 mmt 54.3 -88.86 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.52 -0.988 . . . . 0.0 108.923 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.633 ' CG2' ' CB ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER 58.31 9.76 1.11 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.592 179.768 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER 68.2 110.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.441 -0.787 . . . . 0.0 112.319 178.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . 33.19 48.81 0.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.841 -0.537 . . . . 0.0 112.375 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.633 ' CB ' ' CG2' ' A' ' 13' ' ' THR . . . -151.26 -40.91 0.12 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.038 -1.039 . . . . 0.0 109.513 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.668 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 13.7 t -56.08 -41.35 90.55 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 110.834 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.668 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 7.6 Cg_endo -78.35 -5.52 15.02 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.068 1.179 . . . . 0.0 111.661 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.9 mt -91.21 -35.52 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.831 -1.168 . . . . 0.0 108.672 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.487 ' CG2' ' CB ' ' A' ' 64' ' ' ALA . 1.2 m -75.94 -35.75 59.61 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.569 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 81.9 t -66.08 -46.06 88.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' A' ' 26' ' ' SER . 7.8 tttm -51.39 -54.61 24.8 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.101 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -72.87 -12.88 61.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 111.299 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.418 ' HB3' ' CB ' ' A' ' 64' ' ' ALA . . . -76.15 -63.61 1.28 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.956 -1.09 . . . . 0.0 109.649 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.602 ' CD2' ' CD2' ' A' ' 7' ' ' LEU . 3.5 mp -58.54 -33.8 70.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.495 -0.753 . . . . 0.0 110.081 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.523 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -70.46 -27.81 64.52 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.151 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -87.76 -9.57 53.58 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.322 -0.862 . . . . 0.0 109.942 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.525 ' O ' ' CG ' ' A' ' 29' ' ' GLU . 3.0 t -43.3 -80.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.133 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 172.35 -57.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.0 109.242 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.447 ' HA3' ' HB1' ' A' ' 52' ' ' ALA . . . -84.89 -26.21 38.53 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.601 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 51.4 t -50.83 133.87 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -1.091 . . . . 0.0 110.324 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 m -115.0 -14.75 11.83 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.646 0.736 . . . . 0.0 109.218 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' O ' ' CG2' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -153.63 159.64 42.16 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.27 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 22' ' ' LYS . 7.1 p -156.84 157.13 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 110.203 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.533 ' CB ' HG11 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -158.1 171.52 20.07 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.227 -0.921 . . . . 0.0 110.113 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 19.2 m -144.55 156.32 14.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 110.333 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.28 106.98 0.41 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.599 ' CE2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -67.91 -25.54 65.54 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -1.091 . . . . 0.0 109.238 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -56.83 -23.55 44.69 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.354 -0.841 . . . . 0.0 108.984 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.524 ' O ' ' C ' ' A' ' 41' ' ' ARG . 6.7 tptm -138.93 33.18 2.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.546 -0.721 . . . . 0.0 109.807 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.551 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 8.7 tpm_? 22.35 60.2 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.225 0.535 . . . . 0.0 112.391 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 24.6 pt-20 -148.91 170.36 18.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.298 -0.876 . . . . 0.0 110.335 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -128.22 130.18 47.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.667 -1.27 . . . . 0.0 109.702 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.533 HG11 ' CB ' ' A' ' 35' ' ' ASP . 15.0 p -105.27 117.87 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.796 -1.19 . . . . 0.0 109.415 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 33' ' ' LYS . 7.2 p -126.3 150.77 32.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 122.257 1.027 . . . . 0.0 112.926 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -110.3 153.93 24.19 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.615 ' O ' ' HA ' ' A' ' 2' ' ' THR . 37.7 p90 -168.81 178.58 4.54 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 117.872 -1.531 . . . . 0.0 111.987 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.569 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 9.3 m-20 -105.55 124.88 50.28 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 8.4 t0 -79.46 26.94 0.28 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.494 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.47 -29.07 11.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.941 -1.1 . . . . 0.0 109.145 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -123.77 -7.8 7.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.517 -0.739 . . . . 0.0 110.097 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.447 ' HB1' ' HA3' ' A' ' 30' ' ' GLY . . . -146.98 -164.77 2.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.454 -0.779 . . . . 0.0 109.498 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.567 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 174.06 164.28 0.2 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.08 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.6 ' CG2' ' CG2' ' A' ' 70' ' ' VAL . 7.9 p -44.86 -42.96 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.535 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 23.0 tt0 -55.88 -43.84 77.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.973 . . . . 0.0 109.358 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -73.75 -22.33 59.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.501 -0.749 . . . . 0.0 110.572 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.587 HD13 ' CE2' ' A' ' 47' ' ' PHE . 90.8 mt -69.93 -55.76 8.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.776 -1.203 . . . . 0.0 108.391 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.54 HG22 ' CA ' ' A' ' 69' ' ' SER . 59.5 m -56.87 -35.62 69.12 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -73.24 -26.86 61.29 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.333 -0.854 . . . . 0.0 109.585 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.513 ' HB1' ' CG2' ' A' ' 28' ' ' VAL . . . -68.31 -50.68 51.81 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.414 -0.804 . . . . 0.0 109.379 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.517 HG21 ' N ' ' A' ' 62' ' ' ALA . 6.6 t -67.12 -32.14 73.08 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.517 ' N ' HG21 ' A' ' 61' ' ' THR . . . -63.1 -32.27 73.61 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.058 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.482 ' OD2' ' HA ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -88.54 -11.09 46.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.461 -0.774 . . . . 0.0 109.129 178.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.487 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -76.85 -31.8 57.1 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 142.9 32.18 0.11 Allowed Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.902 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.592 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 72.8 m-85 -159.17 107.84 1.54 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.698 -1.472 . . . . 0.0 111.291 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -56.27 99.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 N-CA-C 106.687 -2.082 . . . . 0.0 106.687 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 60.3 p -108.42 -165.43 1.03 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.166 -0.959 . . . . 0.0 112.514 -176.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.54 ' CA ' HG22 ' A' ' 58' ' ' THR . 0.2 OUTLIER -150.86 -161.36 1.32 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.611 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.3 p -141.62 157.93 21.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 O-C-N 120.832 -1.167 . . . . 0.0 111.33 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.544 ' HB2' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -129.42 27.53 5.29 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.427 1.108 . . . . 0.0 109.002 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.539 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 10.9 pt20 . . . . . 0 C--N 1.289 -2.065 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.292 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.113 0.483 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -142.41 91.94 2.37 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.12 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -107.86 164.14 12.51 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.821 0.82 . . . . 0.0 112.236 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 t -131.59 128.12 38.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.445 0.64 . . . . 0.0 110.144 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 72' ' ' GLN . 5.4 t -139.35 168.08 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 109.148 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.568 ' O ' ' CD1' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -108.77 171.57 7.35 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.604 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.573 HD13 ' HA ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -134.33 159.36 41.25 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.917 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -113.02 99.25 7.71 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.175 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.486 ' HA ' ' OG ' ' A' ' 68' ' ' SER . 2.1 p -112.68 101.74 53.31 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 109.277 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.7 Cg_endo -77.63 39.83 0.79 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.494 1.463 . . . . 0.0 111.748 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.615 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -82.76 -51.24 4.34 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.46 ' HB2' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 42.97 57.23 3.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.538 -0.977 . . . . 0.0 109.916 -179.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.534 ' HB ' ' CB ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -87.94 15.07 7.68 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.273 179.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 4.0 t 65.51 87.36 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.542 -0.724 . . . . 0.0 110.265 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' O ' ' CD1' ' A' ' 19' ' ' ILE . . . 68.26 29.72 5.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 0.0 110.089 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' CB ' ' HB ' ' A' ' 13' ' ' THR . . . -138.56 -48.16 0.52 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -55.31 -47.4 98.67 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.411 -0.806 . . . . 0.0 111.206 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 9.2 Cg_endo -71.89 -9.44 24.73 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 120.895 1.063 . . . . 0.0 112.219 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.517 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 20.6 mt -93.13 -37.86 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.787 -1.195 . . . . 0.0 109.842 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.535 ' CG2' ' CB ' ' A' ' 64' ' ' ALA . 1.2 m -77.02 -40.8 45.16 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.616 ' O ' HD12 ' A' ' 25' ' ' LEU . 97.6 t -62.88 -45.45 98.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.827 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.524 ' CG ' HG13 ' A' ' 34' ' ' VAL . 39.7 tttt -54.04 -55.58 26.08 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.174 -0.954 . . . . 0.0 109.853 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -75.9 -0.94 23.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 111.223 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' C ' ' HB2' ' A' ' 60' ' ' ALA . . . -80.95 -64.41 1.19 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.722 -1.236 . . . . 0.0 108.843 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.637 ' H ' ' CD1' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.06 -24.63 65.99 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.546 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 3.3 t -72.66 -26.66 61.72 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -97.43 -5.23 36.64 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.329 -0.857 . . . . 0.0 110.378 179.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.568 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 2.7 t -46.09 -59.99 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.52 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.568 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER 158.1 -72.22 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.433 0.635 . . . . 0.0 110.225 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -69.24 -27.23 73.91 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.58 ' HA ' ' CB ' ' A' ' 47' ' ' PHE . 8.0 p -39.68 139.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.427 -1.043 . . . . 0.0 110.484 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.34 -14.67 9.19 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.536 0.684 . . . . 0.0 109.63 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.55 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 9.7 ttmm -162.96 164.7 25.65 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.114 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 33' ' ' LYS . 52.7 t -159.51 150.64 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.076 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.6 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -142.36 169.25 17.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 0.0 109.503 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 18' ' ' PRO . 62.9 t -108.99 151.5 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.118 -0.989 . . . . 0.0 110.981 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.67 60.04 0.49 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.598 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -60.93 -23.74 65.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.515 -0.991 . . . . 0.0 110.544 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -21.9 2.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.999 -1.063 . . . . 0.0 109.35 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 41' ' ' ARG . 21.5 mttt -143.05 39.45 1.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -0.758 . . . . 0.0 110.077 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.46 ' C ' ' O ' ' A' ' 40' ' ' LYS . 1.5 ttp180 36.22 60.21 0.88 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.633 -0.667 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -152.22 168.43 25.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.476 -0.889 . . . . 0.0 111.338 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -131.17 139.09 49.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 109.327 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.6 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 9.0 p -107.78 109.41 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.841 -1.162 . . . . 0.0 110.145 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.578 HG23 HD21 ' A' ' 25' ' ' LEU . 53.8 t -111.21 159.1 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 122.414 1.102 . . . . 0.0 112.915 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -123.59 150.72 43.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 177.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 2' ' ' THR . 32.7 p90 -171.62 -176.29 1.76 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.004 -1.878 . . . . 0.0 112.979 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.62 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -105.38 114.14 28.15 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 14.6 t70 -62.67 -6.76 3.85 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.143 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.46 ' OG1' ' OD2' ' A' ' 48' ' ' ASP . 73.5 p -83.73 -25.51 30.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.052 -1.03 . . . . 0.0 110.945 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -116.55 -7.15 11.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.924 -1.11 . . . . 0.0 110.726 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . 179.43 -179.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.614 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.0 p 172.17 -172.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 110.323 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.538 HG12 ' CG1' ' A' ' 70' ' ' VAL . 9.3 t -36.53 -38.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.539 -0.725 . . . . 0.0 111.003 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -55.97 -51.88 66.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.151 -0.968 . . . . 0.0 110.497 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.447 ' HB3' HG11 ' A' ' 28' ' ' VAL . 11.3 mmtp -82.93 -17.64 42.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 112.085 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.533 ' CD2' ' HB3' ' A' ' 25' ' ' LEU . 37.2 mt -74.41 -53.82 8.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.353 -1.467 . . . . 0.0 108.455 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.475 ' CG2' ' HA ' ' A' ' 69' ' ' SER . 3.2 m -59.89 -35.62 75.23 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.032 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -73.21 -29.02 62.5 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.311 -0.868 . . . . 0.0 110.206 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.467 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -70.48 -43.68 69.25 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.067 -1.021 . . . . 0.0 109.704 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.517 HG21 ' N ' ' A' ' 62' ' ' ALA . 2.8 t -73.06 -29.1 62.71 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.517 ' N ' HG21 ' A' ' 61' ' ' THR . . . -69.55 -30.74 68.61 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -10.8 42.15 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.516 -0.74 . . . . 0.0 109.22 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.535 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -81.61 -29.46 33.29 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.455 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 141.21 23.67 0.24 Allowed Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.618 -1.277 . . . . 0.0 111.471 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.615 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 56.1 m-85 -146.62 113.68 4.35 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.34 -1.682 . . . . 0.0 111.366 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.76 91.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 106.874 -2.01 . . . . 0.0 106.874 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 55.0 m -108.79 -170.22 1.63 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.178 -0.951 . . . . 0.0 112.995 -176.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.475 ' HA ' ' CG2' ' A' ' 58' ' ' THR . 2.3 m -160.13 -159.95 0.75 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.573 ' HA ' HD13 ' A' ' 7' ' ' LEU . 3.2 p -139.37 161.53 27.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.921 -1.112 . . . . 0.0 111.172 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.553 ' HB2' ' CG2' ' A' ' 6' ' ' THR . 4.3 mttt -122.31 24.0 9.54 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 122.264 1.031 . . . . 0.0 110.133 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.545 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 10.2 tt0 . . . . . 0 C--N 1.284 -2.252 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.369 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -126.88 165.95 18.4 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.254 -0.904 . . . . 0.0 111.666 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 14.6 t -130.42 134.3 47.01 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.58 -0.7 . . . . 0.0 110.324 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.967 HG21 HG23 ' A' ' 54' ' ' VAL . 10.8 t -122.6 171.42 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -0.765 . . . . 0.0 109.266 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.787 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -106.96 158.56 16.94 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.003 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.03 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -132.13 156.32 46.57 Favored 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 118.476 -1.289 . . . . 0.0 110.538 -178.471 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.542 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -109.19 101.67 10.68 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.412 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.968 HG21 HG21 ' A' ' 21' ' ' VAL . 1.5 p -113.89 87.85 13.29 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.609 -0.682 . . . . 0.0 109.614 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 11.5 Cg_endo -78.1 39.94 0.83 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.351 1.367 . . . . 0.0 111.764 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.601 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -81.4 -28.57 43.51 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.506 ' CG ' ' C ' ' A' ' 11' ' ' GLY . 7.7 ptt? 33.12 62.11 0.38 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.92 -0.753 . . . . 0.0 110.541 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.868 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -85.25 11.59 9.74 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.466 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER 70.31 90.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 110.088 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 59.4 26.98 15.98 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.573 -0.704 . . . . 0.0 110.103 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.868 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -131.44 -40.69 1.11 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.801 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.636 ' SG ' HG22 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -53.59 -48.93 91.41 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.0 110.992 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.614 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 7.5 Cg_endo -72.45 -10.36 25.33 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.434 1.229 . . . . 0.0 112.33 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.06 -45.75 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.682 -1.262 . . . . 0.0 109.875 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 1.061 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.257 1.2 m -73.44 -36.75 65.97 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.679 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.968 HG21 HG21 ' A' ' 9' ' ' VAL . 13.5 t -70.26 -47.85 64.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.878 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.619 ' O ' HG21 ' A' ' 34' ' ' VAL . 6.3 tmtt? -49.9 -51.57 39.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.491 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.556 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -70.52 -21.9 62.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.922 -1.111 . . . . 0.0 111.252 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.72 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -66.87 -54.36 23.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.243 -0.911 . . . . 0.0 110.471 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.907 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.6 mp -70.7 -31.09 67.83 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.084 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.854 ' C ' HG11 ' A' ' 31' ' ' VAL . 3.6 p -68.8 -20.47 64.33 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -116.31 4.92 13.5 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.449 -0.901 . . . . 0.0 109.816 179.103 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.819 HG12 ' O ' ' A' ' 25' ' ' LEU . 8.0 p -51.01 -50.03 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.0 110.867 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.611 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER 175.44 -77.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.883 -1.135 . . . . 0.0 110.888 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.94 2.36 56.82 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.854 HG11 ' C ' ' A' ' 26' ' ' SER . 14.9 p -44.77 144.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.042 -1.27 . . . . 0.0 110.592 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.513 ' HB2' HG22 ' A' ' 46' ' ' THR . 19.4 m -113.28 -16.3 12.54 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.4 OUTLIER -170.19 167.82 8.49 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.698 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.848 HG11 ' HB3' ' A' ' 26' ' ' SER . 13.6 p -157.88 167.36 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.124 -0.985 . . . . 0.0 110.55 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.519 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 1.6 m-20 -167.68 178.53 5.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.977 . . . . 0.0 110.086 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 3.8 m -150.13 165.4 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 111.127 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.3 106.85 0.32 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.614 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -70.05 -8.24 47.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -1.176 . . . . 0.0 110.53 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -60.34 -23.98 64.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.058 -1.026 . . . . 0.0 109.17 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -150.29 30.65 0.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.462 -0.774 . . . . 0.0 110.144 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 40' ' ' LYS . 2.0 mpp_? 40.56 58.94 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.522 -0.736 . . . . 0.0 110.408 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 2.4 pt-20 -136.88 149.53 47.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 0.0 110.211 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.776 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -117.86 132.18 56.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.972 -1.08 . . . . 0.0 109.449 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 35' ' ' ASP . 8.1 p -106.83 130.61 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.738 -1.226 . . . . 0.0 109.531 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.037 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.2 p -133.33 147.47 31.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.178 -1.009 . . . . 0.0 113.049 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 32' ' ' SER . 1.3 m -109.71 154.2 23.22 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.763 ' CE2' HD11 ' A' ' 57' ' ' LEU . 36.2 p90 -172.11 -177.2 1.82 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 117.883 -1.527 . . . . 0.0 111.811 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HB3' HG22 ' A' ' 50' ' ' THR . 10.5 m-20 -107.22 114.44 28.49 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 11.0 t70 -62.96 -9.36 9.62 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.304 -0.872 . . . . 0.0 110.715 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.628 HG22 ' HB3' ' A' ' 48' ' ' ASP . 4.8 t -72.88 -22.49 60.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -128.15 -7.16 5.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.213 -0.929 . . . . 0.0 110.902 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -154.43 -167.61 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.482 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.585 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 170.76 171.87 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.48 -0.763 . . . . 0.0 109.606 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.056 HG13 HG21 ' A' ' 70' ' ' VAL . 2.7 t -40.65 -47.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 110.317 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.96 -48.35 43.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.007 -1.058 . . . . 0.0 110.198 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 28.1 mmtm -73.74 -26.55 60.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -0.864 . . . . 0.0 111.318 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.037 HD13 ' CG1' ' A' ' 45' ' ' VAL . 63.3 mt -68.37 -58.18 4.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.668 -1.27 . . . . 0.0 108.809 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.682 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 16.4 m -57.79 -29.22 64.7 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 68.1 tttt -73.68 -29.37 62.26 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.379 -0.826 . . . . 0.0 109.54 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.72 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -70.74 -50.32 37.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.291 -0.881 . . . . 0.0 109.504 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.94 ' OG1' HG22 ' A' ' 21' ' ' VAL . 1.5 t -69.74 -26.63 64.41 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -66.73 -36.62 82.89 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.57 -9.92 55.08 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.061 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -29.27 55.68 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.564 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 135.04 25.18 0.55 Allowed Glycine 0 N--CA 1.486 2.002 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.067 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.601 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 42.0 m-85 -146.03 120.86 5.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.62 -1.518 . . . . 0.0 111.856 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.72 95.54 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 N-CA-C 107.014 -1.956 . . . . 0.0 107.014 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -108.47 -173.73 2.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 0.0 112.543 -176.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.518 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.5 OUTLIER -148.8 -162.57 1.59 Allowed 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.056 HG21 HG13 ' A' ' 54' ' ' VAL . 3.0 p -141.0 158.95 23.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.07 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.504 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 6.1 mtmt -116.27 17.52 15.6 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.198 0.999 . . . . 0.0 110.307 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.685 ' C ' HG13 ' A' ' 5' ' ' VAL . 13.2 mt-30 . . . . . 0 C--N 1.282 -2.368 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.57 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -118.68 160.84 21.1 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.086 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.418 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 2.0 t -134.49 132.87 39.76 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.7 -0.625 . . . . 0.0 109.648 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.643 HG21 ' CG2' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -133.24 169.03 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.884 0.849 . . . . 0.0 109.508 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.715 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.19 157.03 18.2 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.971 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.07 157.07 45.13 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.465 -178.146 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.23 112.44 24.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.55 -0.719 . . . . 0.0 110.279 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.036 HG21 HG21 ' A' ' 21' ' ' VAL . 1.4 p -123.42 88.0 51.7 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.272 -0.892 . . . . 0.0 110.011 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -78.53 59.77 7.31 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.427 1.418 . . . . 0.0 111.806 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.601 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -104.03 -26.83 6.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.509 ' O ' ' HG3' ' A' ' 12' ' ' MET . 19.0 ptm 29.64 61.47 0.16 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.717 0.77 . . . . 0.0 111.356 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.847 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -85.97 13.72 7.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.465 -0.772 . . . . 0.0 109.36 179.024 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.7 t 69.76 91.82 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.556 -0.715 . . . . 0.0 110.24 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 59.53 16.83 5.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 110.31 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.847 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -118.64 -44.05 2.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.528 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.607 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -51.59 -48.37 87.05 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.421 -0.799 . . . . 0.0 111.231 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 5.6 Cg_endo -73.24 -11.87 25.16 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 121.274 1.316 . . . . 0.0 112.634 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 19' ' ' ILE . 10.0 mm -92.28 -41.43 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.692 -1.255 . . . . 0.0 109.567 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.993 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.25 1.2 m -73.83 -39.87 63.73 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.036 HG21 HG21 ' A' ' 9' ' ' VAL . 98.9 t -69.49 -49.86 55.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.108 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.555 ' HG3' HG13 ' A' ' 34' ' ' VAL . 13.8 tttt -47.23 -51.76 17.81 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 110.471 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.567 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -72.88 -21.38 60.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.034 -1.041 . . . . 0.0 111.393 -179.258 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 60' ' ' ALA . . . -68.12 -53.95 21.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 110.719 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.908 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.9 mp -71.18 -29.08 64.74 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.08 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.872 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -74.79 -17.82 60.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.422 -0.799 . . . . 0.0 109.224 179.537 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.567 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -115.35 2.07 13.88 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.111 -0.993 . . . . 0.0 110.062 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 56' ' ' LYS . 9.3 p -53.56 -47.71 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.317 -0.864 . . . . 0.0 110.853 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.577 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.5 OUTLIER 179.25 -86.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.72 -1.237 . . . . 0.0 111.517 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -95.34 3.25 66.08 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.504 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.872 HG11 ' C ' ' A' ' 26' ' ' SER . 8.8 p -42.33 142.16 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.142 -1.211 . . . . 0.0 110.366 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 t -114.58 -17.34 11.71 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.688 0.756 . . . . 0.0 108.999 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 3.0 tttm -162.43 163.83 27.48 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.961 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 26' ' ' SER . 9.9 p -162.59 159.22 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 110.489 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.507 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 2.7 t70 -166.26 171.84 11.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 109.853 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.497 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 4.3 m -140.69 163.17 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.033 -1.042 . . . . 0.0 110.865 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.77 113.23 0.57 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.615 ' CE1' ' HD3' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -70.19 -21.57 63.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -1.228 . . . . 0.0 110.281 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -45.82 -45.51 14.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.131 -0.981 . . . . 0.0 109.458 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.0 mttm -126.4 25.85 6.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.439 -0.788 . . . . 0.0 109.687 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.687 HH21 HG13 ' A' ' 9' ' ' VAL . 7.1 mmm180 38.75 60.19 1.43 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.837 -0.539 . . . . 0.0 110.175 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 6.9 pt-20 -141.68 150.27 41.66 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.957 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -116.14 131.95 56.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.004 -1.06 . . . . 0.0 108.969 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 35' ' ' ASP . 13.4 p -105.22 130.89 55.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.786 -1.196 . . . . 0.0 109.676 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.014 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.2 p -131.92 143.06 41.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.946 0.879 . . . . 0.0 112.454 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -109.38 157.89 18.47 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.773 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.9 p90 -171.88 -176.33 1.7 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 117.399 -1.72 . . . . 0.0 112.122 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -106.85 113.51 27.05 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 15.8 t70 -59.61 -10.96 4.03 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 111.147 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.8 t -69.02 -24.75 64.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 110.929 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -128.84 -12.0 4.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.903 -1.123 . . . . 0.0 111.509 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -148.24 -169.41 3.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.017 -1.052 . . . . 0.0 110.712 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.593 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER 171.2 172.58 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.442 -0.786 . . . . 0.0 109.914 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.03 HG23 HG21 ' A' ' 70' ' ' VAL . 2.1 p -40.73 -35.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 110.406 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -56.59 -49.63 74.35 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.232 -0.917 . . . . 0.0 110.293 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.641 ' O ' HG21 ' A' ' 28' ' ' VAL . 15.9 mmtt -78.82 -18.38 54.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.27 -0.894 . . . . 0.0 111.526 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.014 HD13 ' CG1' ' A' ' 45' ' ' VAL . 52.3 mt -75.01 -58.87 3.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.415 -1.428 . . . . 0.0 108.268 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.554 ' N ' HD21 ' A' ' 7' ' ' LEU . 19.5 m -58.76 -30.04 67.23 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.741 -0.783 . . . . 0.0 109.111 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.503 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -80.79 -23.43 39.29 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.308 -0.87 . . . . 0.0 109.536 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.597 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -72.81 -47.06 49.68 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.394 -0.816 . . . . 0.0 109.086 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.594 ' CB ' HG13 ' A' ' 21' ' ' VAL . 9.2 t -71.39 -35.78 71.17 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -64.04 -29.68 70.81 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.626 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 2.1 t70 -89.67 -11.35 42.71 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.993 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -28.26 55.28 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.72 23.44 0.51 Allowed Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.697 -1.239 . . . . 0.0 111.228 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.699 ' CB ' HG23 ' A' ' 9' ' ' VAL . 46.8 m-85 -146.13 110.94 4.37 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.649 -1.501 . . . . 0.0 111.103 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 4.3 Cg_exo -55.49 99.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 N-CA-C 107.297 -1.847 . . . . 0.0 107.297 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -109.06 -172.02 1.96 Allowed 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.362 -176.773 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.512 ' N ' ' OG ' ' A' ' 68' ' ' SER . 19.9 m -147.32 -162.75 1.61 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.03 HG21 HG23 ' A' ' 54' ' ' VAL . 3.5 p -139.92 160.37 26.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 C-N-CA 118.647 -1.221 . . . . 0.0 111.763 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.506 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 1.7 mttt -123.24 19.1 9.87 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.963 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.511 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.8 tt0 . . . . . 0 C--N 1.283 -2.306 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.126 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.6 151.8 25.13 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.898 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.43 117.23 23.97 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.288 0.566 . . . . 0.0 109.616 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.527 HG11 ' CG2' ' A' ' 70' ' ' VAL . 4.6 t -126.76 168.19 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 109.931 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.811 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -108.88 160.47 15.97 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.695 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.937 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -133.66 155.36 49.85 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.623 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 68' ' ' SER . . . -109.6 110.75 21.91 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.879 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.845 HG21 HG21 ' A' ' 21' ' ' VAL . 1.6 p -124.38 85.99 55.25 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.505 -0.747 . . . . 0.0 109.67 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 11.2 Cg_endo -79.51 52.36 4.26 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.965 1.508 . . . . 0.0 111.294 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.624 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -97.6 -34.11 5.64 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.562 ' HG2' ' CZ ' ' A' ' 41' ' ' ARG . 1.8 mtp 69.04 -79.57 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.982 -0.716 . . . . 0.0 110.456 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.87 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.6 OUTLIER 50.86 14.39 0.18 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.92 -1.112 . . . . 0.0 109.638 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' THR . 0.7 OUTLIER 51.25 108.41 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.333 -0.855 . . . . 0.0 111.519 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 43.81 36.76 1.41 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -0.772 . . . . 0.0 111.034 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.87 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -139.01 -37.68 0.51 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 110.021 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -51.76 -50.34 78.16 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.772 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.77 ' O ' HG11 ' A' ' 36' ' ' VAL . 9.4 Cg_endo -73.38 -11.26 24.61 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.189 1.26 . . . . 0.0 112.633 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.8 mm -92.1 -45.47 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.64 -1.288 . . . . 0.0 109.872 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 1.117 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -70.13 -37.23 75.25 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.845 HG21 HG21 ' A' ' 9' ' ' VAL . 13.0 t -64.75 -44.64 96.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.581 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -52.78 -41.42 64.08 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.476 -0.765 . . . . 0.0 109.805 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -79.57 -22.37 43.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 111.173 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.821 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -67.99 -51.15 50.51 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.174 -0.954 . . . . 0.0 110.089 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.944 ' O ' HG12 ' A' ' 28' ' ' VAL . 4.1 mp -78.93 -31.36 45.18 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.516 -0.74 . . . . 0.0 110.874 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.817 ' HA ' HG21 ' A' ' 31' ' ' VAL . 42.5 p -69.31 -21.36 63.86 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.04 -1.037 . . . . 0.0 108.844 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -116.12 0.55 12.99 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.843 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.944 HG12 ' O ' ' A' ' 25' ' ' LEU . 3.7 p -45.46 -52.64 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.032 -1.043 . . . . 0.0 110.681 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.592 ' H ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER 176.41 -77.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.84 -1.163 . . . . 0.0 111.08 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.5 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -96.46 0.43 61.55 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' A' ' 26' ' ' SER . 6.8 p -42.57 143.21 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.24 . . . . 0.0 110.834 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 m -117.26 -16.21 10.36 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.105 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.648 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -166.62 164.26 16.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.617 -0.677 . . . . 0.0 109.509 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 45' ' ' VAL . 37.9 t -156.14 163.22 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.061 -1.025 . . . . 0.0 110.687 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.559 ' HB3' HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -162.95 161.78 25.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.292 -0.88 . . . . 0.0 109.758 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.77 HG11 ' O ' ' A' ' 18' ' ' PRO . 4.1 m -142.82 151.85 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.516 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.49 104.54 0.35 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.607 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -64.44 -29.55 70.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -1.161 . . . . 0.0 110.276 -179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.9 mm-40 -44.68 -28.52 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 109.721 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -132.99 1.55 3.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 110.396 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.569 ' NH1' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 59.06 51.27 7.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.448 -0.783 . . . . 0.0 110.135 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 51.7 mt-10 -138.12 146.46 42.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.472 -0.767 . . . . 0.0 109.813 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.828 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -115.36 130.38 56.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.998 -1.064 . . . . 0.0 109.32 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 35' ' ' ASP . 14.7 p -105.68 127.45 60.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.907 -1.12 . . . . 0.0 109.079 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 34' ' ' VAL . 37.3 t -134.06 148.06 30.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 119.049 -1.06 . . . . 0.0 112.484 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -108.89 158.62 17.51 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.799 ' CE2' HD11 ' A' ' 57' ' ' LEU . 33.1 p90 -171.54 -174.84 1.47 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 117.637 -1.625 . . . . 0.0 111.933 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -105.65 110.6 22.98 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 5.0 t70 -61.47 -11.48 10.83 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.709 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 82.4 p -75.01 -27.7 60.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.26 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 mtpp -122.08 -1.63 9.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 110.345 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -158.77 -169.07 2.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 110.33 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.598 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.4 p 170.32 170.53 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.437 -0.79 . . . . 0.0 109.528 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.998 HG23 HG21 ' A' ' 70' ' ' VAL . 2.5 p -42.24 -44.44 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 110.03 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.514 ' N ' HG13 ' A' ' 54' ' ' VAL . 6.7 tp-100 -51.44 -47.89 62.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -0.989 . . . . 0.0 109.694 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 18.2 mmtp -75.12 -20.67 59.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 0.0 110.966 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.799 HD11 ' CE2' ' A' ' 47' ' ' PHE . 82.0 mt -72.77 -60.27 2.31 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.688 -1.258 . . . . 0.0 108.19 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.741 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 1.2 p -57.42 -29.66 64.33 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.483 -0.761 . . . . 0.0 109.012 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 55.2 tttt -74.57 -31.41 62.07 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.339 -0.85 . . . . 0.0 109.726 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.821 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -69.87 -51.34 34.13 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.283 -0.886 . . . . 0.0 109.325 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.75 ' OG1' HG22 ' A' ' 21' ' ' VAL . 1.6 t -68.64 -27.18 65.78 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -65.4 -35.22 80.28 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.79 -15.71 50.66 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.634 -0.827 . . . . 0.0 108.953 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.117 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -71.4 -29.55 65.05 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.93 23.71 0.84 Allowed Glycine 0 N--CA 1.486 1.978 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.952 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.716 ' HB3' HG23 ' A' ' 9' ' ' VAL . 50.7 m-85 -139.36 111.84 7.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.686 -1.479 . . . . 0.0 111.72 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.85 96.65 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 107.046 -1.944 . . . . 0.0 107.046 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 10.0 p -108.1 -167.1 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 112.581 -176.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.493 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 19.2 m -157.81 -165.94 1.87 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.998 HG21 HG23 ' A' ' 54' ' ' VAL . 4.0 p -135.75 161.12 38.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 120.631 -1.293 . . . . 0.0 111.433 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.49 ' HE2' ' HB2' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -123.97 25.7 7.85 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.303 1.049 . . . . 0.0 110.134 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.468 ' HA ' HG13 ' A' ' 5' ' ' VAL . 2.0 tm0? . . . . . 0 C--N 1.284 -2.261 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.113 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.33 162.03 14.71 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.713 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.482 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 1.2 t -125.0 147.33 48.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.568 HG13 ' CB ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -153.49 159.29 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.965 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -106.69 155.74 19.35 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.539 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.974 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -129.9 158.54 39.22 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.41 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -112.39 105.32 13.56 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.212 0.529 . . . . 0.0 110.302 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.924 HG21 HG21 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -120.21 85.42 36.07 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.606 -0.684 . . . . 0.0 109.42 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 41' ' ' ARG . 10.2 Cg_endo -78.56 58.31 6.7 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.807 1.424 . . . . 0.0 111.216 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.608 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -102.08 -25.05 8.12 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 14.2 mtm 59.15 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.739 -0.859 . . . . 0.0 110.064 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.804 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER 50.32 14.05 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.363 -0.836 . . . . 0.0 109.958 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 54.48 109.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 111.626 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.687 ' O ' HD13 ' A' ' 19' ' ' ILE . . . 39.99 26.27 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.563 -0.711 . . . . 0.0 111.706 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.804 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -118.63 -42.53 2.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.939 -1.101 . . . . 0.0 109.139 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.741 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -52.5 -46.96 95.01 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.621 -0.675 . . . . 0.0 111.903 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 5.6 Cg_endo -70.29 -20.27 32.56 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.201 1.268 . . . . 0.0 113.49 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 15' ' ' ALA . 2.6 mp -92.4 -36.64 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.447 -1.408 . . . . 0.0 110.038 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.974 HG22 ' HB1' ' A' ' 64' ' ' ALA 0.252 1.2 m -73.45 -42.48 61.9 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.955 ' O ' HD12 ' A' ' 25' ' ' LEU . 96.9 t -62.75 -50.37 79.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.457 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.739 ' HA ' HG11 ' A' ' 34' ' ' VAL . 15.9 tttm -51.39 -44.07 62.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 110.268 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 5.0 mttm -69.89 -23.21 63.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.111 -0.993 . . . . 0.0 111.102 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -76.26 -62.5 1.59 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.533 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.955 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.6 mp -56.85 -30.73 64.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 0.0 110.486 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 1.024 ' HB3' HG21 ' A' ' 34' ' ' VAL . 4.5 p -76.05 -30.34 58.35 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.416 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -88.36 -3.92 58.76 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.268 -0.895 . . . . 0.0 109.625 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.792 HG12 ' N ' ' A' ' 29' ' ' GLU . 3.8 t -41.76 -83.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.429 -0.794 . . . . 0.0 110.066 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.792 ' N ' HG12 ' A' ' 28' ' ' VAL . 3.3 tt0 179.36 -52.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.46 -0.775 . . . . 0.0 109.062 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.492 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -96.74 -23.33 15.96 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 25' ' ' LEU . 39.6 t -51.63 134.52 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -1.108 . . . . 0.0 110.103 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.7 t -127.84 -5.09 5.73 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.083 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 13.9 tttp -155.71 116.33 3.8 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.524 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.024 HG21 ' HB3' ' A' ' 26' ' ' SER . 3.9 t -109.25 -178.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.686 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.647 ' H ' HG12 ' A' ' 34' ' ' VAL . 26.4 t0 -161.26 159.28 28.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.984 -1.073 . . . . 0.0 110.249 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.542 HG13 ' CB ' ' A' ' 18' ' ' PRO . 17.6 t -112.62 135.85 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.811 . . . . 0.0 110.699 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.09 60.02 0.53 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.647 ' CZ ' ' NH1' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -62.49 -16.49 55.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -1.175 . . . . 0.0 110.358 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -44.84 -26.52 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 109.148 179.289 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 41' ' ' ARG . 5.0 ttpt -152.43 47.21 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.611 -0.68 . . . . 0.0 109.833 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.647 ' NH1' ' CZ ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER 39.91 63.16 1.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.661 -0.649 . . . . 0.0 109.684 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 2.0 tm-20 -140.18 148.16 41.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.497 -0.752 . . . . 0.0 110.363 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.716 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -124.09 132.16 53.63 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.965 ' CG2' HG22 ' A' ' 6' ' ' THR . 0.9 OUTLIER -105.95 145.01 14.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.358 -1.464 . . . . 0.0 109.561 -178.701 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.791 HG11 ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -139.52 177.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 122.703 1.24 . . . . 0.0 112.362 -177.543 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -152.68 143.65 23.01 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 105.682 -1.969 . . . . 0.0 105.682 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.84 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.3 p90 -166.06 -176.0 3.58 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 117.242 -1.783 . . . . 0.0 112.934 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.733 ' HB3' HG22 ' A' ' 50' ' ' THR . 0.8 OUTLIER -106.8 115.83 30.87 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.427 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 17.5 t70 -62.12 -8.6 5.73 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 111.028 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.733 HG22 ' HB3' ' A' ' 48' ' ' ASP . 15.1 t -76.26 -21.55 56.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 110.74 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -128.59 -6.45 5.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.101 -0.999 . . . . 0.0 110.922 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.492 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -156.52 -169.7 3.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 110.216 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.591 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 14.8 t 175.81 168.62 0.39 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.11 HG23 HG21 ' A' ' 70' ' ' VAL . 2.8 p -42.91 -40.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 110.039 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.496 ' N ' HG13 ' A' ' 54' ' ' VAL . 1.1 tt0 -54.34 -47.65 72.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.114 -0.991 . . . . 0.0 109.826 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 17.8 mmtt -75.73 -18.09 59.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 111.249 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.84 HD11 ' CE2' ' A' ' 47' ' ' PHE . 68.4 mt -75.49 -58.68 3.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.501 -1.375 . . . . 0.0 107.949 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.46 ' N ' HD21 ' A' ' 7' ' ' LEU . 1.9 m -57.67 -32.21 67.1 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -73.57 -33.18 64.54 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.406 -0.809 . . . . 0.0 109.727 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.751 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -66.3 -46.34 77.31 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.272 -0.893 . . . . 0.0 109.371 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.638 ' HB ' HD11 ' A' ' 25' ' ' LEU . 5.7 t -68.7 -32.92 73.06 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.409 ' N ' HG23 ' A' ' 61' ' ' THR . . . -62.53 -31.83 72.68 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -86.95 -13.87 43.42 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.974 ' HB1' HG22 ' A' ' 20' ' ' THR . . . -75.64 -24.79 56.46 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 131.58 19.09 1.21 Allowed Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.848 -1.167 . . . . 0.0 110.937 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.707 ' CB ' HG23 ' A' ' 9' ' ' VAL . 35.4 m-85 -144.03 111.72 5.2 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.695 -1.474 . . . . 0.0 111.594 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.0 96.37 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 N-CA-C 107.844 -1.637 . . . . 0.0 107.844 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -108.85 -168.42 1.34 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.211 -0.931 . . . . 0.0 111.748 -177.411 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.539 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.0 OUTLIER -156.5 -163.49 1.46 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.11 HG21 HG23 ' A' ' 54' ' ' VAL . 5.7 p -137.18 159.44 36.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 O-C-N 120.583 -1.323 . . . . 0.0 111.022 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.57 ' CG ' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -130.56 39.12 3.66 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.019 -1.073 . . . . 0.0 109.46 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.568 ' CB ' HG13 ' A' ' 5' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.687 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.274 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.214 -0.78 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -110.09 169.92 8.42 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.799 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 4' ' ' THR . 3.1 t -143.99 113.41 6.98 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.36 0.6 . . . . 0.0 109.792 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.899 HG21 HG23 ' A' ' 54' ' ' VAL . 2.7 m -120.17 168.69 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 109.747 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.74 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.81 159.49 16.2 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 178.405 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.02 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.4 153.89 50.36 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.737 -1.227 . . . . 0.0 110.344 -178.469 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.536 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -108.84 104.74 14.05 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.411 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.881 HG21 HG21 ' A' ' 21' ' ' VAL . 1.2 p -112.4 93.36 22.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.608 -0.683 . . . . 0.0 109.999 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -76.82 35.24 0.47 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 O-C-N 123.737 1.388 . . . . 0.0 111.647 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.613 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.14 -62.85 4.57 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.497 ' HG2' ' CZ ' ' A' ' 41' ' ' ARG . 21.5 mtp 56.03 49.08 16.4 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.414 -1.051 . . . . 0.0 109.412 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 1.116 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -84.08 10.33 10.36 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.27 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.1 OUTLIER 77.32 97.06 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.651 0.739 . . . . 0.0 111.273 179.324 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 54.62 42.55 31.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.525 -0.735 . . . . 0.0 111.396 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.116 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -162.45 -29.61 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.976 -1.077 . . . . 0.0 111.315 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.645 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -50.33 -52.01 58.35 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.689 -1.257 . . . . 0.0 110.184 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.899 ' O ' HG11 ' A' ' 36' ' ' VAL . 9.5 Cg_endo -74.66 -6.9 18.83 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.353 1.369 . . . . 0.0 112.306 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 19' ' ' ILE . 13.4 mm -90.87 -42.25 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.69 -1.257 . . . . 0.0 109.759 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 1.032 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -69.79 -32.03 70.27 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.969 ' O ' HD12 ' A' ' 25' ' ' LEU . 40.4 t -73.42 -40.91 56.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.548 ' O ' HG11 ' A' ' 34' ' ' VAL . 7.8 tmtt? -50.06 -50.15 48.89 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.456 -0.778 . . . . 0.0 109.768 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.6 mmmm -77.6 -25.37 49.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.879 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 60' ' ' ALA . . . -62.5 -57.82 9.82 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.315 -0.865 . . . . 0.0 110.813 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.118 ' HB2' HG21 ' A' ' 34' ' ' VAL . 2.8 mp -75.91 -30.97 58.96 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.391 -0.818 . . . . 0.0 111.295 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.803 ' C ' HG11 ' A' ' 31' ' ' VAL . 1.8 t -69.39 -19.28 63.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.896 -1.127 . . . . 0.0 108.655 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.573 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 1.3 mptp? -115.54 -1.12 12.85 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.904 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.578 HG13 ' N ' ' A' ' 29' ' ' GLU . 11.5 p -44.24 -45.25 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 110.221 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.578 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 163.31 -85.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.458 -0.776 . . . . 0.0 111.193 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.743 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -80.79 -6.07 89.63 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.81 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.803 HG11 ' C ' ' A' ' 26' ' ' SER . 7.6 p -50.06 141.89 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.892 -1.358 . . . . 0.0 110.36 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -121.18 -12.55 8.66 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.576 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.479 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -176.02 107.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.788 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.118 HG21 ' HB2' ' A' ' 25' ' ' LEU . 1.5 p -114.01 179.06 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.154 -0.966 . . . . 0.0 111.399 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.556 ' H ' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -166.04 160.82 16.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.5 -0.75 . . . . 0.0 110.045 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.899 HG11 ' O ' ' A' ' 18' ' ' PRO . 15.8 m -130.39 158.75 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 0.0 110.476 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.3 112.47 0.62 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.625 ' CG ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -75.22 -28.44 59.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 110.604 -179.468 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -55.17 -23.35 21.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.146 -0.971 . . . . 0.0 110.346 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.474 ' HB3' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -134.59 16.5 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 0.0 110.43 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.497 ' CZ ' ' HG2' ' A' ' 12' ' ' MET . 1.5 mpp_? 42.53 55.58 4.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 110.043 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 2.2 pp20? -148.49 149.77 32.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.397 -0.814 . . . . 0.0 109.898 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.515 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -123.03 136.73 54.96 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.956 -1.09 . . . . 0.0 108.932 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.2 p -105.44 132.19 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.493 -1.379 . . . . 0.0 109.325 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.009 HG11 HD22 ' A' ' 57' ' ' LEU . 3.2 t -123.11 152.3 27.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.442 1.115 . . . . 0.0 112.401 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 1.3 m -125.51 145.94 49.87 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 176.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.853 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.4 p90 -170.59 -178.43 2.64 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 117.235 -1.786 . . . . 0.0 112.523 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.0 120.22 41.47 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.6 -3.24 2.95 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.399 -0.813 . . . . 0.0 111.327 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.4 p -77.0 -23.25 52.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.027 . . . . 0.0 110.651 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -130.32 0.63 4.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.022 -1.049 . . . . 0.0 110.894 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.743 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -159.65 -166.58 1.79 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 109.917 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.599 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.0 t 176.21 160.62 0.32 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 110.001 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.019 ' CG2' HG21 ' A' ' 70' ' ' VAL . 5.7 p -42.49 -37.86 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.363 -0.836 . . . . 0.0 110.151 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.478 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 2.4 tt0 -56.96 -49.1 76.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.883 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' HG3' ' CG2' ' A' ' 28' ' ' VAL . 2.0 tptt -70.06 -23.71 63.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 0.0 110.76 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.009 HD22 HG11 ' A' ' 45' ' ' VAL . 66.8 mt -69.32 -56.62 6.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.795 -1.19 . . . . 0.0 108.812 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.664 ' N ' HD21 ' A' ' 7' ' ' LEU . 12.3 m -60.2 -30.44 69.37 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 33.3 tttt -77.06 -23.17 52.02 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.542 -0.724 . . . . 0.0 109.61 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.719 ' HB3' ' HG ' ' A' ' 25' ' ' LEU . . . -72.79 -46.06 55.27 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.334 -0.854 . . . . 0.0 109.255 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.827 ' OG1' HG22 ' A' ' 21' ' ' VAL . 7.6 t -72.71 -34.14 66.93 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -63.96 -32.6 74.19 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.824 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -91.0 -9.53 45.6 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.457 -0.777 . . . . 0.0 109.395 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.032 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.08 -24.73 43.3 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.44 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.04 15.57 0.91 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.249 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.645 ' CB ' HG23 ' A' ' 9' ' ' VAL . 26.5 m-85 -139.72 110.21 7.34 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.562 -1.552 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.51 99.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 N-CA-C 107.509 -1.766 . . . . 0.0 107.509 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.529 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 9.2 p -108.43 -170.65 1.71 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.233 1.016 . . . . 0.0 112.767 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 t -150.64 -162.19 1.5 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.02 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.7 p -141.92 162.46 20.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.19 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.501 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -124.92 23.83 7.75 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.363 1.078 . . . . 0.0 108.944 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.592 ' HB2' HG21 ' A' ' 54' ' ' VAL . 1.7 tt0 . . . . . 0 C--N 1.286 -2.18 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.755 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -108.81 162.79 13.86 Favored 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 119.476 -0.889 . . . . 0.0 112.445 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 t -137.66 119.28 14.98 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.264 0.554 . . . . 0.0 109.599 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.617 HG21 HG22 ' A' ' 54' ' ' VAL . 3.0 m -126.55 170.36 16.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.279 -0.888 . . . . 0.0 109.803 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.95 161.32 14.82 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.001 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.94 156.45 48.98 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 118.541 -1.264 . . . . 0.0 110.036 -178.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.66 109.63 20.43 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.182 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -117.71 102.94 51.22 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.244 -0.91 . . . . 0.0 109.617 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.529 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 7.7 Cg_endo -75.71 32.48 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.428 1.418 . . . . 0.0 112.329 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.593 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -74.62 -69.72 1.35 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.546 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 48.63 30.68 2.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -1.078 . . . . 0.0 109.365 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 1.106 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -61.23 -10.4 6.69 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.078 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.735 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.8 t 89.93 98.4 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.615 0.722 . . . . 0.0 111.019 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 71.7 27.59 2.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.61 -0.681 . . . . 0.0 111.256 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.106 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -150.61 -44.67 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.796 -1.19 . . . . 0.0 110.531 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -45.73 -50.03 34.84 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.862 -1.149 . . . . 0.0 111.39 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 17' ' ' CYS . 6.8 Cg_endo -69.94 -20.89 33.39 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.234 1.289 . . . . 0.0 113.484 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.5 mt -91.35 -30.04 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.381 -1.45 . . . . 0.0 110.028 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.665 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.254 1.5 m -78.21 -40.59 37.05 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.471 0.653 . . . . 0.0 109.524 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.995 ' O ' HD12 ' A' ' 25' ' ' LEU . 55.8 t -70.54 -52.05 32.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.182 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.556 ' HA ' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -50.93 -43.26 60.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.82 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 12.8 mtpt -71.96 -26.69 62.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 110.795 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.587 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -70.24 -62.17 1.49 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.487 -0.758 . . . . 0.0 110.714 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.027 HD22 ' CG2' ' A' ' 45' ' ' VAL . 2.8 mp -59.55 -34.72 73.02 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.309 -0.869 . . . . 0.0 110.562 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.71 ' HA ' HG21 ' A' ' 31' ' ' VAL . 2.1 t -72.11 -22.89 61.27 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.406 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.22 -10.47 41.5 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.276 -0.89 . . . . 0.0 109.716 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.814 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.4 t -42.61 -80.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.444 -0.785 . . . . 0.0 109.851 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.814 ' N ' HG12 ' A' ' 28' ' ' VAL . 1.1 mt-10 177.11 -69.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 110.051 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.419 ' O ' ' OD2' ' A' ' 48' ' ' ASP . . . -77.52 -13.39 83.58 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 26' ' ' SER . 12.2 p -48.2 139.4 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -1.125 . . . . 0.0 110.539 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.412 ' OG ' ' OD2' ' A' ' 48' ' ' ASP . 5.9 m -128.26 -6.46 5.38 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -173.62 103.9 0.12 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.421 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.061 HG22 HG13 ' A' ' 45' ' ' VAL . 70.9 t -111.77 171.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 110.304 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.724 ' HB3' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -169.28 178.55 4.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.188 -0.945 . . . . 0.0 110.269 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 3.2 m -113.63 167.66 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.37 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.44 69.05 0.29 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -56.7 -15.84 5.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.302 -1.116 . . . . 0.0 110.472 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 38' ' ' PHE . 10.3 tp10 -44.41 -29.81 0.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 0.0 109.319 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -160.91 52.52 0.28 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.457 -0.777 . . . . 0.0 110.288 179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.546 ' NH1' ' HB2' ' A' ' 12' ' ' MET . 2.4 mtt180 41.31 63.61 1.2 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.526 -0.734 . . . . 0.0 110.496 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 1.1 pt-20 -149.02 150.17 32.36 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.599 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.698 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -115.81 143.88 44.78 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.724 HG12 ' HB3' ' A' ' 35' ' ' ASP . 8.5 p -105.15 129.18 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.509 -1.369 . . . . 0.0 108.895 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.061 HG13 HG22 ' A' ' 34' ' ' VAL . 21.5 t -124.97 156.35 33.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 122.524 1.154 . . . . 0.0 112.051 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 1.4 m -137.85 146.65 43.7 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.817 ' CE2' HD11 ' A' ' 57' ' ' LEU . 30.6 p90 -170.65 -174.57 1.64 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 117.154 -1.818 . . . . 0.0 112.569 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 30' ' ' GLY . 8.9 m-20 -106.27 116.56 32.15 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 35.7 t0 -63.21 -8.19 7.62 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.878 -177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.2 t -77.31 -17.98 57.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.925 . . . . 0.0 110.484 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -132.36 0.9 3.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.969 . . . . 0.0 110.894 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -166.28 -170.54 1.71 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.068 -1.02 . . . . 0.0 110.447 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.627 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER 171.52 173.04 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 110.008 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.068 HG13 HG21 ' A' ' 70' ' ' VAL . 17.8 t -41.59 -41.96 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.125 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -50.86 -48.53 60.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 110.228 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -79.26 -21.88 45.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 111.861 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.972 HD22 HG11 ' A' ' 45' ' ' VAL . 63.1 mt -71.5 -59.15 2.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.27 -1.519 . . . . 0.0 108.649 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.694 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 8.0 m -58.88 -28.4 66.1 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -79.18 -25.79 42.73 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.345 -0.847 . . . . 0.0 110.005 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.594 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -73.6 -47.41 40.57 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.022 -1.049 . . . . 0.0 109.201 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.969 ' OG1' HG22 ' A' ' 21' ' ' VAL . 9.0 t -71.38 -32.82 68.92 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -63.43 -34.53 77.94 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.964 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -89.43 -8.86 52.12 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.352 -0.842 . . . . 0.0 109.042 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.665 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.61 -25.05 41.58 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.89 15.37 0.72 Allowed Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.426 -1.368 . . . . 0.0 111.66 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.593 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 53.7 m-85 -141.71 111.43 6.29 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.443 -1.622 . . . . 0.0 111.41 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.02 99.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 85.6 p -108.22 -165.35 1.03 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 122.147 0.975 . . . . 0.0 112.793 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.62 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -157.68 -165.93 1.88 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.068 HG21 HG13 ' A' ' 54' ' ' VAL . 3.6 p -139.55 158.1 27.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 120.816 -1.178 . . . . 0.0 111.524 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 4.1 mtmt -124.41 25.85 7.52 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.478 1.132 . . . . 0.0 108.91 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.493 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.284 -2.274 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.992 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -117.26 165.39 13.51 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.71 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 4.2 t -132.5 124.29 28.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.794 -0.566 . . . . 0.0 110.031 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.7 HG21 HG22 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -124.79 172.41 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.797 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.6 162.01 14.34 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.227 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.029 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -133.35 153.54 51.5 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.859 -1.136 . . . . 0.0 109.651 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.537 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -108.9 98.55 8.02 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.137 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.126 HG21 HG21 ' A' ' 21' ' ' VAL . 2.2 p -113.17 90.69 16.91 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.7 Cg_endo -74.8 31.33 0.35 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.394 1.396 . . . . 0.0 112.323 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.3 -43.11 95.69 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 13.0 ptm 35.83 45.93 0.31 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.748 0.785 . . . . 0.0 109.894 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 1.165 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.2 t -72.1 0.54 9.34 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.69 -0.631 . . . . 0.0 110.142 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.719 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 82.19 88.58 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.508 0.671 . . . . 0.0 111.127 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 71.17 31.51 2.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.527 -0.733 . . . . 0.0 112.078 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.165 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -155.72 -35.4 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.532 -1.355 . . . . 0.0 110.658 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.749 ' H ' HG22 ' A' ' 13' ' ' THR . 0.0 OUTLIER -49.87 -48.57 77.57 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.727 -1.233 . . . . 0.0 110.825 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.595 ' HG3' ' CD1' ' A' ' 38' ' ' PHE . 18.7 Cg_endo -77.94 -9.87 16.77 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.312 1.341 . . . . 0.0 112.599 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 19' ' ' ILE . 18.7 mm -90.31 -42.38 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.719 -1.238 . . . . 0.0 109.735 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.965 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.251 0.9 OUTLIER -71.92 -39.11 69.7 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.921 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.126 HG21 HG21 ' A' ' 9' ' ' VAL . 21.1 t -67.7 -48.44 76.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.4 -47.32 26.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.31 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.564 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 1.2 mmmm -74.46 -20.37 60.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 111.693 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.7 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -73.24 -48.78 32.09 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 110.062 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 21' ' ' VAL . 4.9 mp -68.86 -33.28 73.54 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 109.676 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.726 ' HA ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -78.58 -20.88 49.55 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.964 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.564 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -98.3 -7.26 29.36 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.894 -1.129 . . . . 0.0 109.588 179.285 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.733 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.9 t -40.36 -80.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.668 -0.645 . . . . 0.0 109.776 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.733 ' N ' HG12 ' A' ' 28' ' ' VAL . 5.1 tt0 179.3 -57.85 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.183 -0.948 . . . . 0.0 109.825 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -92.15 -15.12 54.84 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' A' ' 26' ' ' SER . 10.6 p -43.16 141.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.101 -1.235 . . . . 0.0 110.49 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 t -120.89 -12.95 8.71 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.555 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.498 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 4.1 ttmt -166.25 168.71 14.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.028 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.461 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 4.7 p -164.68 172.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.405 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.575 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -167.21 169.4 12.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.835 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.584 HG13 ' HB3' ' A' ' 18' ' ' PRO . 24.8 t -109.92 147.47 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 110.509 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 42' ' ' GLU . . . -139.41 60.47 0.58 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.595 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -58.79 -20.82 53.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -1.116 . . . . 0.0 110.236 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.4 mp0 -45.93 -26.37 0.69 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.06 -1.025 . . . . 0.0 109.294 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.38 37.95 0.94 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.747 . . . . 0.0 110.104 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.451 ' CG ' ' HA ' ' A' ' 10' ' ' PRO . 1.7 mpp_? 43.43 56.25 4.43 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.348 -0.845 . . . . 0.0 110.482 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -143.46 150.11 38.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.835 . . . . 0.0 110.152 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -117.69 138.83 51.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.018 . . . . 0.0 108.791 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.575 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 10.1 p -105.61 144.57 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.532 -1.355 . . . . 0.0 109.939 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.893 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.2 p -145.86 144.94 20.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 118.928 -1.109 . . . . 0.0 113.174 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -111.77 153.17 26.92 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.676 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.9 p90 -171.48 -177.09 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.58 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.409 ' CG ' HG22 ' A' ' 50' ' ' THR . 6.3 t0 -106.38 110.76 23.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 23.6 t0 -64.65 -8.19 13.47 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.978 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.409 HG22 ' CG ' ' A' ' 48' ' ' ASP . 10.0 t -68.64 -11.36 60.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.957 -1.089 . . . . 0.0 110.134 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.3 -35.57 0.46 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.18 -0.95 . . . . 0.0 111.243 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -122.61 -174.67 2.97 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.273 -0.892 . . . . 0.0 110.366 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.568 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 7.3 t 173.14 175.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.024 HG23 HG21 ' A' ' 70' ' ' VAL . 1.6 p -40.34 -32.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.87 . . . . 0.0 110.672 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -49.98 75.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.098 . . . . 0.0 109.813 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 37.0 mmtt -77.43 -18.92 56.79 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.386 -0.821 . . . . 0.0 110.961 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.893 HD13 ' CG1' ' A' ' 45' ' ' VAL . 79.0 mt -74.51 -61.08 1.99 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.656 -1.277 . . . . 0.0 108.364 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.692 HG21 ' HB ' ' A' ' 70' ' ' VAL . 42.9 p -60.27 -25.38 65.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.469 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 5.5 tttm -78.11 -29.8 49.11 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 121.469 -0.77 . . . . 0.0 109.822 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.7 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -72.14 -46.63 55.72 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.101 -0.999 . . . . 0.0 109.224 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.882 ' OG1' HG22 ' A' ' 21' ' ' VAL . 7.3 t -70.5 -32.22 69.64 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -67.68 -31.67 71.81 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.261 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -90.47 -9.36 47.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.43 -0.794 . . . . 0.0 109.262 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.965 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -80.98 -29.02 35.38 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 140.89 22.47 0.27 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.424 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.8 ' CB ' HG23 ' A' ' 9' ' ' VAL . 42.5 m-85 -148.28 108.94 3.65 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.46 -1.612 . . . . 0.0 111.278 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.0 Cg_exo -57.17 100.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 3.7 t -107.3 -177.43 3.35 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.562 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.41 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -140.77 -164.75 1.8 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.029 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.5 p -142.73 155.25 17.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 O-C-N 120.813 -1.18 . . . . 0.0 111.384 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -124.81 25.72 7.32 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.583 1.182 . . . . 0.0 109.086 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.459 ' OXT' HG23 ' A' ' 5' ' ' VAL . 1.2 mm-40 . . . . . 0 C--N 1.286 -2.193 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.11 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.215 -0.74 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -111.79 160.65 17.13 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.861 0.839 . . . . 0.0 112.376 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.8 m -122.9 128.33 50.17 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.697 HG21 HG22 ' A' ' 70' ' ' VAL . 1.3 p -141.64 168.88 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 122.477 1.132 . . . . 0.0 111.101 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.697 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -108.84 159.36 16.85 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.403 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.015 HD11 HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -131.39 154.24 48.84 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.768 -1.207 . . . . 0.0 110.072 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.29 99.21 8.51 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.956 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.083 HG21 HG21 ' A' ' 21' ' ' VAL . 2.2 p -117.13 86.3 20.32 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 0.0 109.6 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.5 Cg_endo -76.62 37.51 0.57 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.575 1.517 . . . . 0.0 112.095 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' CG ' ' A' ' 12' ' ' MET . . . -79.68 -26.25 56.85 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.512 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 17.4 ptm 36.45 65.26 0.47 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.781 -0.835 . . . . 0.0 110.386 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.857 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -88.83 15.54 8.23 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.521 -0.737 . . . . 0.0 109.465 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER 68.12 88.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.548 -0.72 . . . . 0.0 110.128 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 58.01 31.95 21.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 0.0 110.174 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.857 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -134.4 -41.64 0.79 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.0 109.919 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.702 ' SG ' HG22 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -52.96 -50.0 84.14 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.748 179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.678 ' O ' HG11 ' A' ' 36' ' ' VAL . 9.7 Cg_endo -75.0 -8.87 20.46 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.168 1.246 . . . . 0.0 112.302 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 15' ' ' ALA . 12.3 mm -90.59 -43.48 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.808 -1.182 . . . . 0.0 109.699 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.956 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -78.86 -43.93 23.98 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.083 HG21 HG21 ' A' ' 9' ' ' VAL . 21.3 t -59.85 -43.57 92.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.987 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.756 ' O ' HG11 ' A' ' 34' ' ' VAL . 14.0 tttt -56.34 -58.67 7.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.073 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.7 pttt -73.58 3.41 6.28 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 110.547 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.672 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -87.71 -72.14 0.54 Allowed 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.887 -1.133 . . . . 0.0 108.775 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.839 ' CD2' HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -60.65 -16.23 36.73 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.154 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.739 ' O ' HG11 ' A' ' 31' ' ' VAL . 13.1 t -81.38 -35.03 31.28 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -75.9 -10.2 59.23 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.674 HG12 ' N ' ' A' ' 29' ' ' GLU . 6.5 t -37.47 -80.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.68 -0.637 . . . . 0.0 110.888 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.674 ' N ' HG12 ' A' ' 28' ' ' VAL . 2.4 mt-10 -172.85 -51.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.837 -1.165 . . . . 0.0 111.741 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -108.33 14.3 36.33 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.857 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.739 HG11 ' O ' ' A' ' 26' ' ' SER . 8.5 p -41.3 143.88 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.275 . . . . 0.0 111.11 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.614 ' HB3' HG22 ' A' ' 46' ' ' THR . 2.8 t -120.89 -16.22 8.16 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.461 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -173.06 162.64 4.61 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.768 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.777 HG13 HG22 ' A' ' 45' ' ' VAL . 1.3 t -153.04 148.12 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.058 -1.026 . . . . 0.0 110.684 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.595 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -154.64 164.41 38.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.315 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 18' ' ' PRO . 18.8 m -128.34 161.66 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.047 . . . . 0.0 110.74 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.18 90.7 0.13 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.611 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -65.51 -21.07 66.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 110.23 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 0.7 OUTLIER -53.24 -23.01 7.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.973 . . . . 0.0 109.122 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 41' ' ' ARG . 2.3 mmpp? -138.73 19.43 2.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.636 -0.665 . . . . 0.0 109.839 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 40' ' ' LYS . 1.7 tpp180 42.69 55.51 4.23 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -145.2 151.54 38.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.49 -0.756 . . . . 0.0 110.071 -179.251 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.23 136.96 52.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.979 . . . . 0.0 109.77 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.698 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.5 p -107.07 110.51 32.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.68 -1.263 . . . . 0.0 108.911 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.839 HG21 ' CD2' ' A' ' 25' ' ' LEU . 65.4 t -123.4 143.97 34.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.932 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.614 HG22 ' HB3' ' A' ' 32' ' ' SER . 1.3 m -110.07 163.01 14.0 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.873 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.1 p90 -171.35 -178.15 2.29 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.328 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -106.99 116.67 32.32 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -61.18 -11.33 8.75 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.735 -177.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.573 HG23 ' HG3' ' A' ' 51' ' ' LYS . 15.2 t -68.94 -13.76 62.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 110.551 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HG3' HG23 ' A' ' 50' ' ' THR . 21.7 mttt -143.62 10.2 1.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 110.512 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.572 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -169.83 -167.01 0.62 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.104 -0.997 . . . . 0.0 110.298 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.635 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 t 172.3 164.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.033 HG13 HG21 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -42.18 -50.95 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 109.613 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.504 ' N ' HG12 ' A' ' 54' ' ' VAL . 40.0 tp60 -47.9 -46.08 31.29 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.326 -0.858 . . . . 0.0 109.657 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -72.45 -27.33 62.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 111.246 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.873 HD11 ' CE2' ' A' ' 47' ' ' PHE . 55.3 mt -68.78 -59.83 2.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.63 -1.294 . . . . 0.0 108.682 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.668 HG22 ' O ' ' A' ' 54' ' ' VAL . 1.7 t -56.27 -28.84 60.01 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 29.9 tttp -72.1 -33.74 68.08 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.348 -0.845 . . . . 0.0 109.441 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.672 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -67.85 -40.43 83.69 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.169 -0.957 . . . . 0.0 110.022 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.801 ' OG1' HG22 ' A' ' 21' ' ' VAL . 3.7 t -72.21 -32.0 66.37 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.54 84.4 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.47 -7.49 52.9 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.463 -0.773 . . . . 0.0 109.572 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.956 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -82.2 -24.4 34.94 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 133.3 20.11 0.93 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.789 -1.196 . . . . 0.0 110.946 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.767 ' CB ' HG23 ' A' ' 9' ' ' VAL . 44.4 m-85 -147.94 112.59 3.89 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.585 -1.538 . . . . 0.0 111.404 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.07 93.57 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 N-CA-C 107.671 -1.704 . . . . 0.0 107.671 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.71 -171.21 1.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 111.827 -177.361 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.521 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -142.62 -164.02 1.74 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.033 HG21 HG13 ' A' ' 54' ' ' VAL . 2.4 p -141.39 154.1 20.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.886 -1.133 . . . . 0.0 111.448 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.464 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -118.8 23.69 11.3 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.394 1.093 . . . . 0.0 109.617 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.484 ' OXT' ' CB ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.283 -2.311 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.248 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.709 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -109.09 148.28 31.08 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.893 0.854 . . . . 0.0 111.947 -177.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 m -123.48 108.14 12.34 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.597 HG12 ' CB ' ' A' ' 72' ' ' GLN . 5.6 m -125.36 165.0 23.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.184 -0.947 . . . . 0.0 110.688 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.727 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -107.01 159.95 15.91 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.035 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -131.48 159.31 38.47 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.511 -178.475 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.803 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -114.03 119.13 36.13 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.923 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.568 HG13 ' CB ' ' A' ' 66' ' ' TYR . 2.9 t -108.87 103.3 51.49 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.289 -0.882 . . . . 0.0 109.315 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 7.3 Cg_endo -74.79 29.41 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.314 1.165 . . . . 0.0 111.867 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.523 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -91.93 -58.82 1.37 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.561 ' CG ' ' HD2' ' A' ' 41' ' ' ARG . 4.0 tmm? 52.25 51.17 16.83 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.406 -1.055 . . . . 0.0 109.195 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 1.134 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -76.72 2.74 13.4 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.755 -0.59 . . . . 0.0 109.54 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.67 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 4.1 t 80.48 94.51 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.604 0.716 . . . . 0.0 111.13 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.843 ' O ' HD12 ' A' ' 19' ' ' ILE . . . 68.08 37.4 2.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.606 -0.684 . . . . 0.0 111.825 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.134 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -163.19 -37.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.782 -1.199 . . . . 0.0 110.602 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.61 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -44.2 -51.54 18.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.861 -1.15 . . . . 0.0 110.132 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.83 ' O ' HG12 ' A' ' 36' ' ' VAL . 17.9 Cg_endo -83.4 -14.15 8.25 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.423 1.416 . . . . 0.0 112.572 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 15' ' ' ALA . 84.6 mt -80.77 -54.19 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.864 -1.148 . . . . 0.0 110.306 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.795 HG23 ' HB1' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -62.29 -37.54 85.92 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.744 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.925 ' O ' HD12 ' A' ' 25' ' ' LEU . 15.1 t -63.65 -41.61 93.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.914 ' HE2' HG13 ' A' ' 34' ' ' VAL . 16.0 tttm -52.82 -39.31 62.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 109.743 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 11.6 mtmt -73.08 -26.2 61.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 110.845 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.758 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -69.07 -55.64 10.15 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 110.646 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.925 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.7 mp -65.45 -37.44 86.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 111.478 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.526 ' HB3' HG11 ' A' ' 34' ' ' VAL . 36.1 p -70.98 -26.1 63.0 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.099 -1.0 . . . . 0.0 110.21 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' CE ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -99.64 -3.82 32.28 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.222 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.81 ' CG2' ' HB2' ' A' ' 60' ' ' ALA . 2.2 t -42.9 -73.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 109.855 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.712 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 175.08 -71.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.354 -0.841 . . . . 0.0 109.75 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -78.94 -20.51 70.31 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 25' ' ' LEU . 46.1 t -52.0 134.29 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -1.13 . . . . 0.0 110.449 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.1 m -122.63 -12.2 8.14 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.836 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.916 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -146.56 154.57 41.67 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.873 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.914 HG13 ' HE2' ' A' ' 22' ' ' LYS . 7.1 p -155.23 165.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 110.026 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.631 ' HB3' HG12 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -162.96 155.04 18.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.062 -1.024 . . . . 0.0 110.835 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 18' ' ' PRO . 8.7 m -109.68 113.76 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.766 . . . . 0.0 110.18 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.4 73.76 0.21 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.649 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -65.56 -14.94 62.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -1.193 . . . . 0.0 110.056 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -57.29 -17.31 11.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.89 . . . . 0.0 109.265 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.3 mttm -147.35 32.51 0.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.517 -0.74 . . . . 0.0 110.134 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.573 ' HD3' ' CD1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER 42.89 57.47 3.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 4.6 pt-20 -149.77 148.68 29.51 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.216 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -115.63 130.26 56.8 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' A' ' 35' ' ' ASP . 8.4 p -105.66 143.49 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.478 -1.389 . . . . 0.0 110.003 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.916 HG13 ' O ' ' A' ' 33' ' ' LYS . 57.4 t -152.48 148.12 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.447 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.548 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.1 m -109.42 159.03 17.36 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.854 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.4 p90 -170.33 179.74 3.32 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 117.962 -1.495 . . . . 0.0 111.726 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -106.49 112.9 26.11 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -53.33 -17.3 1.74 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.9 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -65.88 -40.84 91.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.948 . . . . 0.0 110.702 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.6 -0.65 13.59 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.096 -1.002 . . . . 0.0 110.747 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.473 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -150.55 -165.09 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.06 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.607 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 170.84 154.44 0.06 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.582 -0.699 . . . . 0.0 109.464 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.122 ' CG2' HG21 ' A' ' 70' ' ' VAL . 9.5 p -42.39 -39.84 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.902 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.538 ' N ' HG13 ' A' ' 54' ' ' VAL . 5.7 tp-100 -59.69 -47.5 85.39 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.169 -0.957 . . . . 0.0 109.313 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -66.29 -24.16 66.51 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.469 -0.769 . . . . 0.0 110.698 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.888 HD12 ' HA ' ' A' ' 54' ' ' VAL . 43.0 mt -72.65 -54.59 8.62 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.706 -1.246 . . . . 0.0 108.12 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 52.5 m -56.29 -32.84 64.96 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.538 -0.726 . . . . 0.0 109.223 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -77.55 -28.78 51.94 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.291 -0.88 . . . . 0.0 110.053 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.81 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -68.54 -49.39 59.88 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.214 -0.929 . . . . 0.0 109.12 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.734 ' CB ' HG13 ' A' ' 21' ' ' VAL . 7.4 t -67.02 -32.26 73.35 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -68.29 -26.86 65.86 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.053 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 4.1 t0 -88.65 -13.31 40.12 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.795 ' HB1' HG23 ' A' ' 20' ' ' THR . . . -79.3 -32.64 43.59 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 143.35 31.11 0.1 Allowed Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.593 -1.289 . . . . 0.0 111.168 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.61 ' CZ ' ' HA ' ' A' ' 17' ' ' CYS . 63.8 m-85 -155.9 105.89 2.12 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.664 -1.492 . . . . 0.0 111.621 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.529 ' O ' ' CG ' ' A' ' 10' ' ' PRO . 5.0 Cg_exo -56.31 98.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 N-CA-C 106.768 -2.051 . . . . 0.0 106.768 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 8' ' ' ALA . 1.1 t -107.27 -177.91 3.49 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.077 -1.014 . . . . 0.0 111.939 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.803 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 12.9 p -136.99 -162.01 1.23 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.122 HG21 ' CG2' ' A' ' 54' ' ' VAL . 4.6 p -144.27 157.43 15.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 118.522 -1.271 . . . . 0.0 112.058 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.431 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -128.62 33.3 4.68 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.317 1.056 . . . . 0.0 108.195 179.149 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.597 ' CB ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.338 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.724 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.86 173.5 6.33 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.164 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.699 HG23 ' OG1' ' A' ' 46' ' ' THR . 0.7 OUTLIER -143.39 128.48 18.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.776 -0.578 . . . . 0.0 110.064 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.584 ' CG1' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -132.79 161.4 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.391 -0.818 . . . . 0.0 109.371 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.712 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.61 157.31 17.78 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.023 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -130.38 157.65 42.0 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.753 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.04 106.48 16.0 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.906 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.699 HG23 ' CB ' ' A' ' 66' ' ' TYR . 1.4 p -115.62 94.33 39.99 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.3 Cg_endo -78.64 43.33 1.42 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.56 1.507 . . . . 0.0 111.56 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.597 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -90.44 -49.71 3.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.592 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 4.2 ptm 36.4 61.94 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.77 -0.841 . . . . 0.0 110.981 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.968 HG21 ' HB3' ' A' ' 16' ' ' ALA . 6.6 t -70.94 -2.38 15.02 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 109.269 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.5 OUTLIER 78.12 3.03 2.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.708 -0.62 . . . . 0.0 111.458 178.743 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.598 ' H ' HG23 ' A' ' 13' ' ' THR . . . -174.74 33.59 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.229 -0.92 . . . . 0.0 109.924 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.968 ' HB3' HG21 ' A' ' 13' ' ' THR . . . 179.74 -21.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.108 -0.995 . . . . 0.0 112.155 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.889 ' H ' HG22 ' A' ' 13' ' ' THR . 0.0 OUTLIER -46.27 -48.97 44.3 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.201 -1.562 . . . . 0.0 110.969 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.596 ' O ' HG11 ' A' ' 36' ' ' VAL . 19.5 Cg_endo -81.66 -11.75 11.42 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.437 1.425 . . . . 0.0 113.558 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.1 mt -92.57 -37.99 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.495 -1.378 . . . . 0.0 110.862 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.953 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -73.26 -36.57 66.4 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.342 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.882 ' O ' HD12 ' A' ' 25' ' ' LEU . 42.1 t -67.67 -44.04 86.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.227 -0.989 . . . . 0.0 108.56 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.558 ' HA ' ' CG1' ' A' ' 34' ' ' VAL . 4.5 tptm -52.74 -47.59 67.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.542 -0.724 . . . . 0.0 110.311 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 5.0 mmtm -77.08 -16.19 59.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.974 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.681 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -73.93 -58.73 3.11 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.966 -1.084 . . . . 0.0 110.315 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.902 ' O ' HG12 ' A' ' 28' ' ' VAL . 3.7 mp -71.7 -29.15 64.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.597 -0.689 . . . . 0.0 110.487 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.761 ' C ' HG11 ' A' ' 31' ' ' VAL . 54.7 p -73.36 -26.11 60.88 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.432 -0.792 . . . . 0.0 109.426 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -110.48 3.54 19.68 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.001 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.902 HG12 ' O ' ' A' ' 25' ' ' LEU . 3.3 p -49.24 -55.33 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.024 -1.048 . . . . 0.0 110.448 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.655 ' H ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 176.31 -69.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.781 -1.2 . . . . 0.0 111.541 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -98.57 -9.52 52.7 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.776 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.761 HG11 ' C ' ' A' ' 26' ' ' SER . 11.0 p -42.56 143.4 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.307 . . . . 0.0 110.928 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.39 -15.56 10.32 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.73 0.776 . . . . 0.0 109.14 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.653 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -161.33 161.44 30.51 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 45' ' ' VAL . 25.6 t -157.61 161.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.097 -1.002 . . . . 0.0 110.43 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.532 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 1.1 m-20 -163.63 166.57 22.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.915 . . . . 0.0 110.29 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.596 HG11 ' O ' ' A' ' 18' ' ' PRO . 15.7 m -140.92 157.22 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.419 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -147.61 105.31 0.31 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.58 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -64.0 -23.69 67.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.288 -1.124 . . . . 0.0 110.269 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -47.18 -37.3 9.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.925 . . . . 0.0 109.987 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -135.32 29.65 3.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.414 -0.804 . . . . 0.0 110.481 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.592 ' CD ' ' HB3' ' A' ' 12' ' ' MET . 0.0 OUTLIER 38.55 60.52 1.33 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.571 -0.706 . . . . 0.0 110.319 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 20.7 pt-20 -143.18 145.97 33.27 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.663 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.628 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -114.82 130.14 56.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 108.982 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 44' ' ' VAL . 10.0 p -105.54 126.91 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.904 -1.122 . . . . 0.0 109.1 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 34' ' ' VAL . 40.7 t -131.88 144.55 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.691 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.699 ' OG1' HG23 ' A' ' 4' ' ' THR . 1.3 m -108.86 157.62 18.43 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.615 ' CE2' HD11 ' A' ' 57' ' ' LEU . 46.7 p90 -171.6 -173.77 1.26 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.098 -1.441 . . . . 0.0 111.326 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 5.7 m-20 -107.04 129.42 54.81 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 25.4 t70 -80.36 35.77 0.35 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.958 -1.089 . . . . 0.0 111.391 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.5 p -118.23 -16.97 9.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.37 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 7.5 mtpt -133.05 1.93 3.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.457 -0.777 . . . . 0.0 110.092 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . -179.65 -178.57 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 110.368 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.609 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 8.1 p 174.24 -176.01 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 0.0 109.659 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.023 HG23 HG21 ' A' ' 70' ' ' VAL . 2.1 p -38.34 -40.07 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.304 -0.873 . . . . 0.0 110.632 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 6.0 tt0 -56.52 -50.56 71.46 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.028 -1.045 . . . . 0.0 109.812 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 31.7 mmtt -79.69 -13.68 59.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 111.52 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.777 ' HB3' HD23 ' A' ' 25' ' ' LEU . 89.3 mt -78.35 -56.51 4.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.515 -1.366 . . . . 0.0 108.062 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 26.8 m -58.27 -29.68 65.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -78.05 -26.27 48.23 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.359 -0.838 . . . . 0.0 109.714 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.619 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -71.81 -46.33 58.54 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.264 -0.897 . . . . 0.0 109.237 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.56 ' HB ' HD11 ' A' ' 25' ' ' LEU . 10.0 t -71.57 -33.81 69.39 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -62.09 -34.64 76.68 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.849 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -91.13 -8.33 49.06 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.467 -0.771 . . . . 0.0 109.21 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.953 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.65 -25.18 41.41 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.55 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 137.11 17.29 0.71 Allowed Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.391 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.699 ' CB ' HG23 ' A' ' 9' ' ' VAL . 33.7 m-85 -143.94 114.78 5.49 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.444 -1.621 . . . . 0.0 111.601 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.99 95.32 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 N-CA-C 107.6 -1.731 . . . . 0.0 107.6 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.02 -170.56 1.68 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 112.332 -176.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 68' ' ' SER . 10.4 m -148.93 -161.86 1.44 Allowed 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 54' ' ' VAL . 5.1 p -140.09 163.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 120.657 -1.277 . . . . 0.0 111.937 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -125.88 26.12 6.68 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.381 1.086 . . . . 0.0 109.504 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.584 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 5.4 mt-30 . . . . . 0 C--N 1.285 -2.205 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.22 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -112.43 162.42 15.6 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.361 -177.208 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.5 m -135.31 132.87 38.22 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.705 HG21 ' CG2' ' A' ' 54' ' ' VAL . 3.9 t -139.18 169.34 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.015 . . . . 0.0 109.966 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.975 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.48 156.53 18.87 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.121 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.89 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -130.59 157.46 42.65 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 117.855 -1.538 . . . . 0.0 110.861 -178.671 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 68' ' ' SER . . . -109.84 111.35 22.72 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.808 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.751 HG21 HG21 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -117.94 98.13 51.31 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.186 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.518 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 10.7 Cg_endo -80.17 49.91 3.36 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.514 1.476 . . . . 0.0 110.965 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.655 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -90.97 -39.59 5.74 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 8.2 ptm 38.43 42.83 0.58 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.661 -0.905 . . . . 0.0 110.6 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.759 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -71.61 2.9 4.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.675 -0.64 . . . . 0.0 110.044 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 13' ' ' THR . 3.9 t 78.99 95.86 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.453 0.644 . . . . 0.0 110.152 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 54.44 23.61 4.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.45 -0.781 . . . . 0.0 110.028 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -123.61 -48.6 1.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -0.866 . . . . 0.0 109.71 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.577 ' SG ' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -39.7 -61.53 1.04 Allowed Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 121.474 -0.766 . . . . 0.0 111.445 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.617 ' HG3' ' CG ' ' A' ' 38' ' ' PHE . 5.6 Cg_endo -61.16 -20.65 68.81 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.96 1.773 . . . . 0.0 114.62 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.4 mt -90.42 -36.57 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.332 -1.48 . . . . 0.0 110.755 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.976 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -77.2 -40.71 44.21 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.937 ' O ' HD12 ' A' ' 25' ' ' LEU . 41.8 t -66.21 -48.08 82.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.616 ' HA ' HG21 ' A' ' 34' ' ' VAL . 23.3 tttm -52.42 -43.99 65.15 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.795 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 13.9 mmtt -72.82 -20.93 61.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 111.277 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -75.86 -60.95 2.1 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.165 -0.959 . . . . 0.0 110.269 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.937 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.7 mp -56.89 -36.32 69.98 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.431 -0.793 . . . . 0.0 109.96 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.562 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -71.07 -27.18 63.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.567 -0.708 . . . . 0.0 109.224 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -92.51 -4.54 53.41 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 121.225 -0.922 . . . . 0.0 109.753 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.777 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.7 t -44.01 -81.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.737 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.777 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 174.07 -73.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.45 -19.18 74.27 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.821 HG21 ' O ' ' A' ' 25' ' ' LEU . 4.2 p -49.97 137.56 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.559 -0.965 . . . . 0.0 110.454 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -121.5 -13.17 8.44 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.395 0.617 . . . . 0.0 109.606 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HG3' ' N ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -162.01 160.49 27.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.175 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.616 HG21 ' HA ' ' A' ' 22' ' ' LYS . 8.1 p -142.33 177.44 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.414 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.559 ' H ' HG22 ' A' ' 34' ' ' VAL . 12.0 t70 -156.6 155.64 32.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 110.186 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.549 ' CG1' ' HB2' ' A' ' 18' ' ' PRO . 3.3 t -108.87 111.27 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 110.443 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -117.47 52.48 0.68 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.617 ' CG ' ' HG3' ' A' ' 18' ' ' PRO . 2.2 t80 -62.49 -19.39 63.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -1.115 . . . . 0.0 110.128 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -48.81 -27.17 2.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -139.96 43.09 1.95 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.504 -0.748 . . . . 0.0 109.923 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HD2' ' HA ' ' A' ' 10' ' ' PRO . 1.6 mtt180 41.35 60.04 2.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.445 -0.784 . . . . 0.0 110.182 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -149.32 150.83 33.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.848 . . . . 0.0 110.777 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.645 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -122.23 134.03 54.7 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.975 ' CG2' HG22 ' A' ' 6' ' ' THR . 1.0 OUTLIER -106.38 142.55 19.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.327 -1.483 . . . . 0.0 109.396 -178.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.011 ' CG1' HD13 ' A' ' 57' ' ' LEU . 2.4 p -147.51 145.06 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.238 -1.385 . . . . 0.0 113.558 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -109.96 153.74 24.11 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.869 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.5 p90 -168.93 -178.43 3.31 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.675 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.96 113.86 27.59 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 9.3 t70 -57.67 -13.15 3.56 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 110.767 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.4 p -61.96 -31.24 71.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.664 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -133.15 -3.46 3.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.947 -1.095 . . . . 0.0 111.33 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -143.37 -175.93 4.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.973 -1.079 . . . . 0.0 110.642 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 172.3 169.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 0.0 109.681 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.06 HG13 HG21 ' A' ' 70' ' ' VAL . 19.1 t -39.1 -55.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.436 -0.79 . . . . 0.0 110.773 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 3.7 tp60 -44.51 -46.72 9.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 0.0 110.377 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -73.51 -28.5 61.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.185 -0.947 . . . . 0.0 111.333 -179.379 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.011 HD13 ' CG1' ' A' ' 45' ' ' VAL . 65.4 mt -68.95 -61.27 1.87 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.774 -1.204 . . . . 0.0 108.575 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.633 ' N ' HD21 ' A' ' 7' ' ' LEU . 10.1 t -60.34 -22.9 63.77 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.395 -0.816 . . . . 0.0 108.803 178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 2.7 tttt -78.34 -28.92 47.35 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.374 -0.829 . . . . 0.0 109.35 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.573 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -72.09 -45.55 60.22 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 108.995 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.854 ' OG1' HG22 ' A' ' 21' ' ' VAL . 9.9 t -70.8 -32.44 69.53 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -65.24 -31.71 73.02 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.579 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -88.72 -12.16 43.09 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.976 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -77.54 -26.48 51.05 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.06 19.84 0.69 Allowed Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.781 -1.2 . . . . 0.0 111.362 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.655 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 32.5 m-85 -142.51 113.7 6.09 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.511 -1.581 . . . . 0.0 111.758 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 2.7 Cg_endo -60.17 97.16 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 N-CA-C 107.418 -1.801 . . . . 0.0 107.418 177.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -108.3 -172.57 2.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.09 -1.006 . . . . 0.0 112.347 -176.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.503 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -148.52 -159.05 0.98 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.06 HG21 HG13 ' A' ' 54' ' ' VAL . 2.9 p -139.63 158.52 27.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 121.012 -1.055 . . . . 0.0 111.435 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 4.8 mtmt -121.41 23.09 10.54 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.223 1.011 . . . . 0.0 109.843 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.465 ' HA ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.283 -2.319 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.2 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.6 mt-30 -109.05 149.48 29.21 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.842 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.493 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 24.5 m -120.04 130.05 54.52 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.818 HG13 ' HA ' ' A' ' 72' ' ' GLN . 1.7 t -151.77 165.56 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.062 -1.024 . . . . 0.0 109.528 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.794 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -106.83 171.12 7.54 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.404 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.97 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.24 154.18 51.42 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.605 -178.515 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 68' ' ' SER . . . -108.57 94.24 4.95 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.463 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 21' ' ' VAL . 2.5 p -110.27 101.7 48.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.686 -0.634 . . . . 0.0 109.615 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.5 Cg_endo -78.28 44.37 1.59 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.728 1.383 . . . . 0.0 111.114 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.678 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -86.49 -41.35 6.93 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.513 ' HG3' ' HG2' ' A' ' 41' ' ' ARG . 12.2 mtp 59.18 -87.19 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.61 -0.935 . . . . 0.0 109.813 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.838 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 1.1 p 48.27 15.69 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' THR . 0.3 OUTLIER 45.43 104.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.823 . . . . 0.0 112.058 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 19' ' ' ILE . . . 56.01 32.19 19.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.263 -0.898 . . . . 0.0 111.044 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.838 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -137.61 -47.39 0.56 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 109.359 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -53.81 -45.94 98.63 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.538 -0.727 . . . . 0.0 111.183 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 10.3 Cg_endo -74.0 -11.37 23.45 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.005 1.136 . . . . 0.0 112.599 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 1.7 mt -92.39 -40.02 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.669 -1.269 . . . . 0.0 109.349 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 1.026 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.3 m -74.68 -40.5 61.36 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 9' ' ' VAL . 37.5 t -66.45 -48.89 79.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.544 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.612 ' O ' HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -47.93 -45.97 31.53 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 14.3 mttt -74.63 -23.43 58.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.251 -0.906 . . . . 0.0 111.6 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.699 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -68.92 -50.09 52.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.283 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.006 ' HB3' HG21 ' A' ' 45' ' ' VAL . 4.6 mp -70.53 -34.52 72.37 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 110.272 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.87 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -68.22 -21.33 64.86 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.329 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -113.39 5.04 16.61 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.04 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 25' ' ' LEU . 12.7 p -53.43 -49.19 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.128 -0.982 . . . . 0.0 110.421 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.608 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 170.17 -80.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.075 -1.016 . . . . 0.0 110.853 179.462 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.496 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -92.14 5.63 78.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.87 HG11 ' C ' ' A' ' 26' ' ' SER . 12.2 p -50.26 142.52 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.865 -1.373 . . . . 0.0 110.457 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.8 m -124.74 -9.79 7.29 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.758 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 1.3 tttt -168.31 138.55 2.56 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.578 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.793 HG21 ' CB ' ' A' ' 26' ' ' SER . 5.0 t -130.22 166.43 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.137 -0.977 . . . . 0.0 110.689 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.637 ' CB ' HG12 ' A' ' 44' ' ' VAL . 8.8 t0 -156.58 162.76 39.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.162 -0.961 . . . . 0.0 110.213 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.565 HG13 ' HB3' ' A' ' 18' ' ' PRO . 4.5 t -113.83 125.97 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -124.89 69.37 0.49 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -63.51 -11.75 26.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -1.116 . . . . 0.0 110.527 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -43.97 -31.36 0.88 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 108.979 179.239 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 41' ' ' ARG . 1.4 tttp -148.07 47.05 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.44 0.638 . . . . 0.0 109.308 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.513 ' HG2' ' HG3' ' A' ' 12' ' ' MET . 2.0 tpp180 42.03 58.96 2.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.436 -0.79 . . . . 0.0 110.363 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 13.9 pt-20 -138.38 169.42 17.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.294 -0.879 . . . . 0.0 110.286 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -134.74 134.96 41.55 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.648 HG23 ' HB ' ' A' ' 6' ' ' THR . 1.1 t -106.65 122.56 60.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.674 -1.266 . . . . 0.0 109.646 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.006 HG21 ' HB3' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -123.09 -178.28 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.669 1.223 . . . . 0.0 111.902 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -152.18 149.06 28.34 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.99 ' CE2' HD11 ' A' ' 57' ' ' LEU . 28.7 p90 -166.36 -175.3 3.19 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 117.601 -1.64 . . . . 0.0 112.011 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.542 ' OD1' HG22 ' A' ' 50' ' ' THR . 0.5 OUTLIER -106.23 110.52 22.79 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 5.9 t70 -57.81 -14.28 5.69 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.763 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.542 HG22 ' OD1' ' A' ' 48' ' ' ASP . 8.9 t -65.41 -34.97 79.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 110.294 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' N ' HG23 ' A' ' 50' ' ' THR . 1.6 mmpp? -125.39 3.82 7.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.146 -0.971 . . . . 0.0 110.431 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -150.77 -169.75 3.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.919 . . . . 0.0 110.339 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.4 p 170.05 165.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 0.0 109.618 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.925 HG13 HG21 ' A' ' 70' ' ' VAL . 2.9 t -43.44 -37.74 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.005 -1.059 . . . . 0.0 109.714 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -58.73 -46.72 86.74 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.019 -1.051 . . . . 0.0 109.544 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.509 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 10.5 mmmt -71.02 -25.61 62.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 110.861 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.99 HD11 ' CE2' ' A' ' 47' ' ' PHE . 55.2 mt -70.8 -58.7 3.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.786 -1.196 . . . . 0.0 108.21 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.649 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 99.7 m -56.47 -30.3 62.75 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -75.63 -28.73 58.93 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.403 -0.811 . . . . 0.0 109.555 179.593 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.699 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -70.01 -51.47 32.08 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.468 -0.77 . . . . 0.0 109.221 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.92 ' OG1' HG22 ' A' ' 21' ' ' VAL . 13.1 t -67.77 -30.06 69.41 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -67.54 -31.14 71.02 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.948 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -86.38 -12.88 48.03 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 1.026 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -32.4 57.42 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 137.94 31.9 0.22 Allowed Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.781 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.818 ' CB ' HG23 ' A' ' 9' ' ' VAL . 47.1 m-85 -151.88 113.81 2.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.786 -1.42 . . . . 0.0 111.596 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.38 94.71 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 N-CA-C 107.663 -1.706 . . . . 0.0 107.663 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -108.91 -165.0 0.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.032 . . . . 0.0 112.531 -177.137 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.499 ' N ' ' OG ' ' A' ' 68' ' ' SER . 49.1 m -152.49 -159.2 0.98 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.97 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.7 p -139.07 152.94 24.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.887 -1.133 . . . . 0.0 110.683 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.79 ' HB3' HG23 ' A' ' 6' ' ' THR . 1.3 tttp -125.51 49.51 1.91 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.923 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.818 ' HA ' HG13 ' A' ' 5' ' ' VAL . 3.5 pp0? . . . . . 0 C--N 1.28 -2.446 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.021 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -124.31 171.67 9.71 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.956 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.491 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 37.0 m -110.73 155.72 22.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.574 -0.704 . . . . 0.0 110.42 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.787 HG13 ' C ' ' A' ' 72' ' ' GLN . 1.8 t -152.79 161.8 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 108.687 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.763 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -108.02 161.08 15.27 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.999 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -132.58 155.13 49.23 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.82 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.84 101.74 10.32 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.412 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 21' ' ' VAL . 2.0 p -118.09 101.84 51.28 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.495 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.25 36.67 0.55 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.379 1.386 . . . . 0.0 111.579 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.643 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -76.58 -46.69 11.26 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 10.6 ptp 38.47 54.91 1.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.737 -0.861 . . . . 0.0 110.181 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.841 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -86.69 17.05 4.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.579 -0.7 . . . . 0.0 109.764 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.648 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 7.8 t 66.45 89.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 110.604 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 65.32 18.04 11.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 110.48 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.841 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -123.14 -48.12 2.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 109.522 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.626 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -55.7 -44.15 99.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.47 -0.769 . . . . 0.0 111.303 179.426 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 12.7 Cg_endo -76.55 -16.77 16.7 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 120.925 1.083 . . . . 0.0 112.681 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.67 -31.52 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.587 -1.321 . . . . 0.0 109.561 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.965 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.1 m -83.64 -47.98 10.67 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 9' ' ' VAL . 74.9 t -57.52 -48.8 82.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.889 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.677 ' O ' HG11 ' A' ' 34' ' ' VAL . 14.4 tttt -57.46 -45.84 84.3 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.27 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -76.21 -2.76 32.83 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.199 -0.938 . . . . 0.0 110.616 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.579 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -85.18 -54.03 4.87 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.128 -0.983 . . . . 0.0 109.438 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.944 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -80.55 -13.22 59.26 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.244 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.915 ' HA ' HG21 ' A' ' 31' ' ' VAL . 20.1 t -78.72 -35.93 44.15 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.499 -0.751 . . . . 0.0 108.981 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HD2' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -104.15 2.95 32.45 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.825 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 25' ' ' LEU . 4.6 p -54.11 -53.35 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.79 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.608 ' H ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 169.28 -86.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.881 -1.137 . . . . 0.0 111.557 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.662 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -67.69 -21.72 73.09 Favored Glycine 0 N--CA 1.494 2.514 0 O-C-N 121.221 -0.924 . . . . 0.0 111.331 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.915 HG21 ' HA ' ' A' ' 26' ' ' SER . 10.8 p -40.15 144.74 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.933 -1.334 . . . . 0.0 111.702 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 m -127.99 -8.63 5.44 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.258 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.555 ' C ' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -162.36 165.05 26.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.157 -0.965 . . . . 0.0 109.842 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -160.28 155.6 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.989 -1.069 . . . . 0.0 111.165 -178.36 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.61 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -155.75 161.15 40.75 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 18' ' ' PRO . 3.2 m -109.59 131.86 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.734 -1.229 . . . . 0.0 111.29 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.4 58.67 0.56 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -58.78 -17.52 24.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -1.05 . . . . 0.0 110.769 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.14 -22.54 1.72 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.031 . . . . 0.0 109.634 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -148.7 43.11 0.99 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.427 -0.795 . . . . 0.0 109.828 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 40' ' ' LYS . 5.4 mmt180 41.75 58.59 2.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.401 -0.812 . . . . 0.0 109.921 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 4.5 pt-20 -149.17 151.92 35.18 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.992 -1.067 . . . . 0.0 110.669 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.423 ' CB ' HG12 ' A' ' 21' ' ' VAL . . . -117.58 142.43 47.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.802 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 44' ' ' VAL . 5.4 p -108.72 110.5 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.649 -1.282 . . . . 0.0 108.604 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 34' ' ' VAL . 2.9 p -116.52 144.0 25.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.965 0.888 . . . . 0.0 112.36 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.549 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.2 m -109.79 150.78 27.86 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.656 ' CE2' HD11 ' A' ' 57' ' ' LEU . 23.4 p90 -171.25 173.03 5.06 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 117.736 -1.586 . . . . 0.0 112.303 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.752 ' HB2' HG22 ' A' ' 50' ' ' THR . 0.7 OUTLIER -107.26 118.86 37.83 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.176 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 6.1 p-10 -59.27 -10.99 3.41 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.279 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.752 HG22 ' HB2' ' A' ' 48' ' ' ASP . 7.7 t -68.77 -27.02 65.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.958 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HB2' ' OD1' ' A' ' 48' ' ' ASP . 5.6 mttt -120.94 0.55 10.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.92 -1.112 . . . . 0.0 110.579 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.662 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -171.76 -160.79 0.17 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 110.206 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.626 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 169.18 167.74 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.502 -0.749 . . . . 0.0 110.098 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.029 HG13 HG21 ' A' ' 70' ' ' VAL . 3.0 t -41.08 -42.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.875 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 6.9 tp-100 -52.02 -49.79 62.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.022 . . . . 0.0 109.504 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.546 ' CG ' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -74.17 -22.7 59.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.458 -0.776 . . . . 0.0 111.645 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.864 HD13 ' CG1' ' A' ' 45' ' ' VAL . 57.0 mt -72.66 -61.42 1.81 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.39 -1.444 . . . . 0.0 108.237 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.493 ' O ' HG22 ' A' ' 61' ' ' THR . 79.1 m -57.11 -26.08 59.87 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.503 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 3.1 ttmt -72.47 -36.05 68.37 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.558 -0.713 . . . . 0.0 109.104 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.579 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -66.13 -41.08 90.97 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.439 -0.788 . . . . 0.0 109.938 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.557 ' OG1' HG22 ' A' ' 21' ' ' VAL . 8.9 t -73.65 -29.92 62.62 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.15 -32.66 74.24 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 8.8 t0 -90.64 -12.45 36.83 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.672 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.965 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -78.22 -27.47 47.76 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 132.76 26.61 0.63 Allowed Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.672 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.762 ' CB ' HG23 ' A' ' 9' ' ' VAL . 37.7 m-85 -147.82 109.11 3.78 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.689 -1.477 . . . . 0.0 111.659 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -59.85 95.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 N-CA-C 107.312 -1.842 . . . . 0.0 107.312 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.03 -168.74 1.38 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 112.415 -176.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.543 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -151.63 -160.81 1.21 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.029 HG21 HG13 ' A' ' 54' ' ' VAL . 2.2 p -140.24 159.24 25.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.991 -1.068 . . . . 0.0 110.968 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.486 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 2.6 mttt -124.96 25.13 7.41 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.448 1.118 . . . . 0.0 109.155 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.787 ' C ' HG13 ' A' ' 5' ' ' VAL . 13.4 mm100 . . . . . 0 C--N 1.285 -2.211 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.136 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -108.72 163.49 13.21 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.501 -0.88 . . . . 0.0 112.493 -177.048 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.448 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 1.3 t -135.14 111.4 9.68 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.281 0.562 . . . . 0.0 109.775 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.447 HG21 HD12 ' A' ' 57' ' ' LEU 0.256 14.5 m -122.75 166.39 17.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.216 -0.928 . . . . 0.0 109.925 -179.155 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.731 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.45 166.47 10.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.597 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.008 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.15 161.42 33.38 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.1 -178.448 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.512 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -109.56 105.88 15.37 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.434 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.747 HG23 ' CB ' ' A' ' 66' ' ' TYR . 2.3 p -116.43 85.9 17.05 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -76.39 36.06 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.67 1.353 . . . . 0.0 112.318 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -78.72 -31.07 45.94 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.76 -2.136 . . . . 0.0 107.76 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 36.84 42.0 0.2 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.923 -0.751 . . . . 0.0 110.386 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.991 HG21 ' HB3' ' A' ' 16' ' ' ALA . 4.0 t -45.78 -27.88 0.93 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 13' ' ' THR . 7.6 t 144.33 -41.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 121.91 0.862 . . . . 0.0 109.241 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.601 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . . . -176.23 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.577 0.703 . . . . 0.0 109.366 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.991 ' HB3' HG21 ' A' ' 13' ' ' THR . . . -129.07 -26.27 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.607 -0.683 . . . . 0.0 109.981 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.642 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -44.62 -47.27 27.51 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.917 -1.114 . . . . 0.0 111.689 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.856 ' O ' HG21 ' A' ' 36' ' ' VAL . 6.9 Cg_endo -76.23 -18.21 16.35 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.334 1.356 . . . . 0.0 113.325 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 mm -87.59 -42.67 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.415 -1.428 . . . . 0.0 109.557 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.871 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.251 0.9 OUTLIER -69.55 -37.21 76.94 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.889 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.908 ' O ' HD12 ' A' ' 25' ' ' LEU . 25.6 t -64.6 -45.61 94.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 1.078 ' O ' HG21 ' A' ' 34' ' ' VAL . 68.7 tttt -50.67 -45.99 58.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.574 -0.704 . . . . 0.0 110.307 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 8.7 mtmt -75.67 -20.82 58.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 111.101 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.594 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -69.97 -52.65 22.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.439 -0.788 . . . . 0.0 110.557 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.932 HD21 ' CD2' ' A' ' 7' ' ' LEU . 4.0 mp -71.91 -31.09 66.05 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.144 -0.973 . . . . 0.0 110.028 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.803 ' C ' HG11 ' A' ' 31' ' ' VAL . 12.7 t -68.22 -22.99 64.76 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -111.6 2.8 17.52 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.274 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.922 HG12 ' O ' ' A' ' 25' ' ' LEU . 7.7 p -49.94 -52.13 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.073 -1.017 . . . . 0.0 110.339 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.602 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 172.34 -77.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 110.897 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.499 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -93.34 -1.88 66.26 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.803 HG11 ' C ' ' A' ' 26' ' ' SER . 6.9 p -44.0 141.05 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.238 . . . . 0.0 110.711 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.6 t -118.02 -13.86 9.99 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.606 0.717 . . . . 0.0 109.071 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.702 ' O ' HG13 ' A' ' 45' ' ' VAL . 7.5 tttt -159.46 166.28 31.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.546 -0.721 . . . . 0.0 109.649 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.078 HG21 ' O ' ' A' ' 22' ' ' LYS . 7.2 p -162.51 154.47 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.99 . . . . 0.0 111.366 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.565 ' HB2' HG13 ' A' ' 44' ' ' VAL . 1.3 m-20 -164.86 171.19 14.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 109.238 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.856 HG21 ' O ' ' A' ' 18' ' ' PRO . 3.1 m -152.06 164.6 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.935 -1.103 . . . . 0.0 111.173 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.26 112.31 0.52 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.602 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -66.27 -19.35 65.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -1.142 . . . . 0.0 109.934 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -53.8 -64.67 0.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.354 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -95.6 22.63 6.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.33 -0.856 . . . . 0.0 109.33 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.656 ' NH1' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 36.89 59.64 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.33 0.586 . . . . 0.0 110.772 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 18.3 pt-20 -146.11 166.96 24.59 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.536 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.786 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -125.56 132.57 52.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.161 -0.962 . . . . 0.0 109.163 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.668 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.8 p -106.51 116.18 49.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 120.791 -1.193 . . . . 0.0 109.119 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.876 HG22 HG23 ' A' ' 34' ' ' VAL . 39.3 t -129.84 144.78 37.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.122 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 1.2 m -108.6 161.29 15.21 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.4 p90 -170.22 -177.69 2.57 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 117.898 -1.521 . . . . 0.0 112.091 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -105.98 113.94 27.79 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 10.7 t70 -59.62 -10.2 3.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.784 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.0 p -70.55 -29.22 65.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 0.0 110.61 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -134.6 18.32 3.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.028 -1.045 . . . . 0.0 110.846 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -170.66 178.72 3.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.0 110.053 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.585 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.9 OUTLIER 176.2 171.01 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.387 -0.821 . . . . 0.0 109.511 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.963 HG13 HG21 ' A' ' 70' ' ' VAL . 2.7 t -41.8 -34.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -58.88 -50.27 74.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.896 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.575 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 16.3 mmtm -76.5 -20.52 56.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 111.246 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.859 HD11 ' CE2' ' A' ' 47' ' ' PHE . 76.1 mt -70.77 -59.71 2.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.572 -1.33 . . . . 0.0 108.482 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 94.5 m -58.63 -26.88 64.19 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.518 -0.739 . . . . 0.0 109.049 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 60.4 tttt -76.35 -29.59 57.29 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.51 -0.744 . . . . 0.0 109.307 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.594 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -69.94 -51.12 35.48 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.626 ' HB ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.64 -32.8 74.35 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.38 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -64.87 -31.27 72.42 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.903 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -88.54 -11.11 46.63 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.498 -0.751 . . . . 0.0 109.028 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.871 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -78.35 -27.3 47.0 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 135.86 23.8 0.55 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.093 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.747 ' CB ' HG23 ' A' ' 9' ' ' VAL . 43.7 m-85 -148.15 109.12 3.69 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.493 -1.592 . . . . 0.0 111.64 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.1 Cg_exo -57.19 98.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 107.014 -1.956 . . . . 0.0 107.014 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 71.6 p -108.41 -166.31 1.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.083 0.944 . . . . 0.0 112.68 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.497 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.8 m -151.8 -160.74 1.19 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.008 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.2 p -141.1 160.07 22.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.779 -1.2 . . . . 0.0 111.844 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.728 ' HG3' HG23 ' A' ' 6' ' ' THR . 9.2 mttt -127.85 25.35 5.97 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.367 1.079 . . . . 0.0 108.93 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.122 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.401 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -113.68 -174.93 2.56 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.312 -0.955 . . . . 0.0 112.462 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.552 ' C ' HG23 ' A' ' 5' ' ' VAL . 92.3 m -142.5 146.81 35.11 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.468 0.652 . . . . 0.0 110.34 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.918 HG13 ' HA ' ' A' ' 72' ' ' GLN . 15.9 t -156.03 167.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.461 -0.774 . . . . 0.0 109.764 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -109.66 169.47 8.69 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.477 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.997 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -133.29 157.99 44.08 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.934 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 68' ' ' SER . . . -110.24 103.33 12.0 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.735 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.828 HG21 HG21 ' A' ' 21' ' ' VAL . 1.9 p -114.56 92.65 29.53 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.397 -0.814 . . . . 0.0 109.995 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 10.7 Cg_endo -79.54 51.42 3.87 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.669 1.579 . . . . 0.0 111.581 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.606 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -95.44 -21.09 25.42 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.524 ' CG ' ' C ' ' A' ' 11' ' ' GLY . 1.2 ptt? 35.77 59.4 0.86 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.768 -0.842 . . . . 0.0 110.559 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.821 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -90.51 19.68 5.12 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.521 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 13' ' ' THR . 2.4 t 68.5 92.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.471 -0.768 . . . . 0.0 110.309 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.585 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . . . 50.25 30.96 4.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 110.085 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.821 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -127.17 -45.45 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.586 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -40.05 -69.37 0.21 Allowed Pre-proline 0 N--CA 1.505 2.281 0 O-C-N 121.109 -0.994 . . . . 0.0 111.673 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.857 ' O ' HG12 ' A' ' 36' ' ' VAL . 10.0 Cg_endo -65.8 -12.75 36.63 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.173 1.249 . . . . 0.0 112.752 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 20' ' ' THR . 1.5 mp -78.88 -56.0 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.864 -1.147 . . . . 0.0 109.583 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.533 HG23 ' HB1' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -69.37 -42.01 75.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.888 HG22 ' OG1' ' A' ' 61' ' ' THR . 5.6 t -57.71 -43.53 83.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.847 ' O ' HG21 ' A' ' 34' ' ' VAL . 12.8 tttt -53.08 -50.11 65.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.511 -0.743 . . . . 0.0 109.861 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 7.9 mtpm? -72.47 -11.59 60.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 111.501 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.476 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -77.8 -67.22 0.75 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.124 -0.985 . . . . 0.0 109.466 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.767 HD22 ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -68.28 -12.3 60.81 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 1.052 ' HA ' HG21 ' A' ' 31' ' ' VAL . 6.8 t -79.32 -30.24 42.73 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.99 9.41 18.72 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.238 -0.914 . . . . 0.0 109.813 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.613 HG13 ' H ' ' A' ' 29' ' ' GLU . 4.0 p -51.89 -53.73 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.349 -0.844 . . . . 0.0 111.08 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.613 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.6 tt0 -179.9 -86.28 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.598 -1.314 . . . . 0.0 110.85 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.547 ' N ' ' CG ' ' A' ' 29' ' ' GLU . . . -74.67 -15.14 80.78 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.052 HG21 ' HA ' ' A' ' 26' ' ' SER . 3.5 p -40.54 142.08 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -1.069 . . . . 0.0 110.961 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 m -127.02 -11.92 5.88 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.396 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.641 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -158.07 165.2 35.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.18 -0.95 . . . . 0.0 110.044 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 1.081 HG23 HG22 ' A' ' 45' ' ' VAL . 6.4 p -169.01 154.48 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.023 -1.048 . . . . 0.0 111.59 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.563 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -157.09 172.14 19.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.491 -0.756 . . . . 0.0 109.634 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.857 HG12 ' O ' ' A' ' 18' ' ' PRO . 2.9 m -109.91 151.09 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.057 -1.027 . . . . 0.0 110.926 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -142.85 64.35 0.49 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -57.33 -15.86 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 110.245 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -45.31 -33.62 2.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.124 -0.985 . . . . 0.0 109.21 179.522 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -141.57 40.04 1.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.509 -0.744 . . . . 0.0 109.459 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.6 OUTLIER 42.47 57.55 3.38 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.451 -0.781 . . . . 0.0 110.081 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 13.7 pt-20 -142.93 168.76 18.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 110.422 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -129.27 137.79 51.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.419 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.6 p -107.85 109.02 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.706 -1.246 . . . . 0.0 110.288 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.081 HG22 HG23 ' A' ' 34' ' ' VAL . 11.6 t -122.71 150.89 26.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 122.138 0.971 . . . . 0.0 112.068 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -114.12 159.53 19.94 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.637 ' CD2' HD11 ' A' ' 57' ' ' LEU . 38.5 p90 -170.91 -175.04 1.67 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.606 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.18 124.75 50.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -80.94 37.87 0.44 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.45 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.6 p -115.53 -24.53 8.29 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.171 -0.956 . . . . 0.0 109.23 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.7 mttt -127.7 -2.11 6.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.419 -0.8 . . . . 0.0 110.073 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 179.17 176.21 0.61 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.93 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.594 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 6.8 p 172.83 -166.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.671 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.046 HG13 HG21 ' A' ' 70' ' ' VAL . 6.5 t -36.68 -40.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.559 -0.713 . . . . 0.0 111.149 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -57.53 -49.49 76.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.106 -0.997 . . . . 0.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.585 ' HB3' HG21 ' A' ' 28' ' ' VAL . 58.1 mmtt -82.01 -16.95 48.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.263 -0.898 . . . . 0.0 111.736 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.751 HD22 ' HB2' ' A' ' 25' ' ' LEU . 48.0 mt -75.27 -58.47 3.26 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.514 -1.366 . . . . 0.0 108.065 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.534 ' O ' HG22 ' A' ' 61' ' ' THR . 12.9 m -54.46 -30.61 53.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.29 -34.6 65.85 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.513 -0.742 . . . . 0.0 109.858 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.446 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -67.93 -36.96 81.05 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.173 -0.955 . . . . 0.0 109.704 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.888 ' OG1' HG22 ' A' ' 21' ' ' VAL . 5.3 t -74.3 -35.57 63.7 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.418 ' N ' HG23 ' A' ' 61' ' ' THR . . . -64.65 -32.14 73.68 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -90.68 -8.08 50.91 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.533 ' HB1' HG23 ' A' ' 20' ' ' THR . . . -85.16 -21.11 29.33 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.452 -0.78 . . . . 0.0 108.942 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 133.08 17.01 1.18 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.004 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.812 ' CB ' HG23 ' A' ' 9' ' ' VAL . 35.2 m-85 -151.51 111.46 2.98 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.706 -1.467 . . . . 0.0 111.307 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.14 96.83 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 N-CA-C 107.87 -1.627 . . . . 0.0 107.87 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.9 -171.24 1.81 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.01 . . . . 0.0 112.187 -177.27 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.542 ' N ' ' OG ' ' A' ' 68' ' ' SER . 6.0 p -145.18 -157.45 0.79 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.046 HG21 HG13 ' A' ' 54' ' ' VAL . 3.1 p -142.47 158.81 19.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.209 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.536 ' CG ' HG23 ' A' ' 6' ' ' THR . 3.9 mttm -124.69 27.12 6.96 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.304 1.05 . . . . 0.0 109.659 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.918 ' HA ' HG13 ' A' ' 5' ' ' VAL . 17.2 pt20 . . . . . 0 C--N 1.287 -2.148 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.543 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.777 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.215 -0.711 0 CA-C-O 121.975 0.893 . . . . 0.0 109.181 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.06 176.1 9.75 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.071 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.4 HG23 ' OG1' ' A' ' 46' ' ' THR . 21.6 m -113.4 131.86 55.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 110.138 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.599 HG21 HG22 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -128.98 169.36 20.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.038 0.923 . . . . 0.0 109.296 179.582 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.683 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -108.51 159.88 16.34 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.83 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.963 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -133.04 152.97 51.91 Favored 'General case' 0 C--N 1.292 -1.921 0 O-C-N 120.868 -1.145 . . . . 0.0 109.688 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -108.95 111.48 23.18 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.616 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 21' ' ' VAL . 2.1 p -133.23 93.55 22.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 109.167 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 5.5 Cg_endo -73.26 19.13 0.37 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.388 1.392 . . . . 0.0 112.291 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.637 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -52.19 -36.18 43.99 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.516 ' C ' ' O ' ' A' ' 11' ' ' GLY . 2.1 ptt? 26.61 50.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.67 0.748 . . . . 0.0 110.765 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 1.155 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.9 t -81.38 9.86 6.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.676 -0.64 . . . . 0.0 110.035 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.3 OUTLIER 78.74 94.18 0.06 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.601 0.715 . . . . 0.0 111.104 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.518 ' O ' HD12 ' A' ' 19' ' ' ILE . . . 58.44 42.67 20.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.612 -0.68 . . . . 0.0 112.052 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.155 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -160.81 -44.0 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.709 -1.244 . . . . 0.0 111.005 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.858 ' H ' HG22 ' A' ' 13' ' ' THR . 0.0 OUTLIER -46.62 -53.17 26.49 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.627 -1.295 . . . . 0.0 110.167 179.519 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.641 ' CG ' ' CD2' ' A' ' 38' ' ' PHE . 10.6 Cg_endo -74.04 -16.59 22.75 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.29 1.327 . . . . 0.0 112.219 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 15' ' ' ALA . 29.6 mt -79.01 -38.49 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.828 -1.17 . . . . 0.0 109.632 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.923 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -77.06 -45.81 25.81 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 9' ' ' VAL . 16.9 t -56.37 -40.69 68.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.538 ' O ' HG21 ' A' ' 34' ' ' VAL . 7.2 tttt -55.67 -56.96 14.23 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 108.823 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -71.39 0.69 7.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.41 -0.806 . . . . 0.0 110.868 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.642 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -88.79 -72.14 0.56 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.669 -1.269 . . . . 0.0 108.929 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.808 HD12 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -64.78 -9.93 24.05 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.49 178.587 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.886 ' HA ' HG11 ' A' ' 31' ' ' VAL . 34.8 t -90.65 -45.5 8.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.5 -0.75 . . . . 0.0 110.397 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -79.28 -4.15 49.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.864 -1.147 . . . . 0.0 110.309 -179.51 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.682 HG12 ' CG ' ' A' ' 29' ' ' GLU . 5.4 t -29.85 -79.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.852 -0.53 . . . . 0.0 110.927 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.682 ' CG ' HG12 ' A' ' 28' ' ' VAL . 1.2 pt-20 178.0 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.948 -1.095 . . . . 0.0 110.935 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 48' ' ' ASP . . . -117.66 2.27 17.87 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.886 HG11 ' HA ' ' A' ' 26' ' ' SER . 71.6 t -49.69 147.87 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 122.459 1.123 . . . . 0.0 111.399 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 m -122.2 -10.18 8.56 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.459 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.508 ' CG ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -175.72 170.37 2.88 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.001 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.806 HG21 ' HB2' ' A' ' 26' ' ' SER . 9.7 p -170.09 156.49 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.862 . . . . 0.0 110.517 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.56 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -156.2 164.88 37.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.427 -0.795 . . . . 0.0 109.633 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 18' ' ' PRO . 7.2 m -112.18 140.49 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 110.704 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.17 69.82 0.53 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.641 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -61.92 -14.72 37.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -1.154 . . . . 0.0 110.435 -179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -54.89 -27.15 40.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 109.8 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 42' ' ' GLU . 2.8 ptmt -142.7 35.51 1.43 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 110.03 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 10' ' ' PRO . 1.9 mpp_? 42.9 55.75 4.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.214 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -145.61 149.42 34.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.233 -0.917 . . . . 0.0 110.11 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.501 ' N ' ' HG2' ' A' ' 42' ' ' GLU . . . -115.87 139.25 50.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 110.031 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.705 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.1 p -106.47 111.78 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.763 -1.211 . . . . 0.0 109.47 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.102 ' CG1' HD13 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -117.51 137.83 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.776 0.798 . . . . 0.0 112.289 -178.056 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.508 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.6 m -109.0 155.77 20.51 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.777 ' O ' ' HA ' ' A' ' 2' ' ' THR . 35.5 p90 -171.92 -176.81 1.79 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.449 -1.407 . . . . 0.0 110.798 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.498 ' HA ' ' HB ' ' A' ' 2' ' ' THR . 2.1 p30 -109.59 110.52 21.62 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 29.0 t70 -54.64 -14.69 1.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.959 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.418 ' OG1' ' HB2' ' A' ' 48' ' ' ASP . 2.2 p -61.63 -35.73 78.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 110.807 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.08 -5.23 9.52 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.043 -1.035 . . . . 0.0 111.361 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -153.02 -164.47 1.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.969 -1.082 . . . . 0.0 110.874 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.605 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 6.4 t 167.72 172.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.96 ' HB ' HG21 ' A' ' 70' ' ' VAL . 6.6 m -51.54 -32.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.753 -1.217 . . . . 0.0 109.451 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -47.66 -44.86 27.54 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.014 -1.054 . . . . 0.0 108.404 179.003 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -89.06 -20.58 24.18 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.763 -0.586 . . . . 0.0 111.244 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.102 HD13 ' CG1' ' A' ' 45' ' ' VAL . 42.3 mt -73.77 -64.04 1.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.229 -1.544 . . . . 0.0 107.98 178.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.532 ' O ' HG22 ' A' ' 61' ' ' THR . 1.4 m -56.59 -27.61 58.42 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -74.81 -32.0 61.85 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.168 -0.957 . . . . 0.0 109.327 179.362 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.642 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -70.48 -35.94 73.56 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.316 -0.865 . . . . 0.0 109.459 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.833 ' OG1' HG22 ' A' ' 21' ' ' VAL . 4.8 t -74.68 -34.7 62.73 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.415 ' N ' HG23 ' A' ' 61' ' ' THR . . . -66.36 -32.29 73.59 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.39 -10.09 45.19 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.576 -0.703 . . . . 0.0 109.378 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.923 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.48 -29.66 41.75 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.56 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.98 27.93 0.34 Allowed Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.699 -1.238 . . . . 0.0 110.996 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.701 ' CB ' HG23 ' A' ' 9' ' ' VAL . 53.0 m-85 -150.9 116.72 3.28 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.622 -1.517 . . . . 0.0 111.449 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.54 95.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 N-CA-C 106.875 -2.01 . . . . 0.0 106.875 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.605 ' HB2' HG23 ' A' ' 61' ' ' THR . 2.9 m -108.79 -165.1 0.99 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 112.51 -176.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.428 ' O ' ' OG1' ' A' ' 58' ' ' THR . 4.9 t -159.42 -167.11 1.95 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.963 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.1 p -139.06 155.92 27.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 120.804 -1.185 . . . . 0.0 111.379 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.502 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 1.1 mttt -124.49 26.72 7.19 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.432 1.111 . . . . 0.0 108.864 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 5' ' ' VAL . 1.8 mp0 . . . . . 0 C--N 1.29 -2.013 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.289 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 11.5 mt-30 -112.48 151.08 30.34 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.655 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 52.3 m -124.9 122.42 37.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.708 HG21 HG22 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -130.32 171.68 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.03 . . . . 0.0 110.419 -178.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.724 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.28 158.91 16.76 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.818 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.925 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -130.07 155.89 45.41 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.662 -1.273 . . . . 0.0 109.847 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.748 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -110.98 100.76 9.4 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.946 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.725 HG21 HG21 ' A' ' 21' ' ' VAL . 1.8 p -114.45 89.97 19.67 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.476 -0.765 . . . . 0.0 109.337 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 11.0 Cg_endo -78.06 46.53 2.1 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.361 1.374 . . . . 0.0 112.008 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.616 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -92.42 -34.31 7.12 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.486 ' C ' ' O ' ' A' ' 11' ' ' GLY . 0.9 OUTLIER 35.59 44.33 0.2 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.758 0.789 . . . . 0.0 110.087 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 1.14 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.4 t -61.22 -11.03 7.84 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.679 -0.638 . . . . 0.0 109.639 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.733 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 86.66 93.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.614 0.721 . . . . 0.0 111.029 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 73.55 24.4 2.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 111.831 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.14 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -150.84 -38.69 0.13 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.457 -1.402 . . . . 0.0 110.718 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.819 ' H ' HG22 ' A' ' 13' ' ' THR . 0.5 OUTLIER -45.15 -47.74 32.36 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.606 -1.309 . . . . 0.0 110.459 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.6 Cg_endo -70.75 -28.17 20.83 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 O-C-N 123.229 1.12 . . . . 0.0 111.655 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.5 mm -73.39 -32.18 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.955 . . . . 0.0 110.839 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.851 HG23 ' HB1' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -81.64 -53.27 6.37 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 108.965 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.037 HG22 ' OG1' ' A' ' 61' ' ' THR . 66.5 t -54.39 -43.46 62.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.678 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.9 tttm -55.55 -61.75 2.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.937 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.59 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -75.42 5.74 5.43 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.186 -0.946 . . . . 0.0 110.678 179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.547 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -85.36 -67.89 0.77 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.373 -1.454 . . . . 0.0 108.482 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.76 ' HB2' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -74.26 -11.62 60.33 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.22 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.859 ' HA ' HG21 ' A' ' 31' ' ' VAL . 46.5 t -85.51 -33.25 21.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.59 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.45 -10.1 42.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.6 -1.312 . . . . 0.0 110.433 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.061 HG11 ' CE ' ' A' ' 56' ' ' LYS . 3.2 t -40.39 -82.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.276 -0.89 . . . . 0.0 110.015 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.799 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 174.97 -57.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.418 -0.801 . . . . 0.0 109.906 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.444 ' O ' ' OD2' ' A' ' 48' ' ' ASP . . . -70.3 -26.76 73.73 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.859 HG21 ' HA ' ' A' ' 26' ' ' SER . 14.8 p -56.56 142.3 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -1.145 . . . . 0.0 110.699 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.84 -10.9 8.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.757 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.4 tttt -162.47 168.96 21.17 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.068 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.552 HG21 ' O ' ' A' ' 22' ' ' LYS . 13.7 p -169.07 159.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.093 -1.004 . . . . 0.0 111.384 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.476 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -158.85 162.95 37.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.513 ' CG1' ' HB2' ' A' ' 22' ' ' LYS . 22.4 m -116.23 152.33 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 110.603 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -144.41 79.13 0.25 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.565 ' CE2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -58.03 -18.92 27.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -1.121 . . . . 0.0 110.119 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -50.3 -47.99 55.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 0.0 109.092 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 41' ' ' ARG . 10.1 mttm -116.18 25.49 10.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.493 -0.754 . . . . 0.0 109.381 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.614 ' NH1' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 40.97 57.48 2.74 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.422 0.63 . . . . 0.0 110.191 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -148.06 155.86 41.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.412 -0.805 . . . . 0.0 109.742 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -112.13 138.66 48.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.944 -1.097 . . . . 0.0 110.276 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.744 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.6 p -106.09 105.65 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.821 -1.174 . . . . 0.0 109.064 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.004 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.8 p -109.72 148.84 13.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 122.089 0.947 . . . . 0.0 112.292 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -115.94 154.13 30.35 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.6 p90 -170.83 -177.24 2.22 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 117.669 -1.612 . . . . 0.0 112.051 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.765 ' HB2' HG22 ' A' ' 50' ' ' THR . 1.2 p30 -107.01 115.05 29.51 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 7.8 t70 -68.24 -3.79 11.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.777 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.765 HG22 ' HB2' ' A' ' 48' ' ' ASP . 4.1 t -66.63 -6.98 17.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 110.018 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -137.35 -51.09 0.64 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.136 -0.978 . . . . 0.0 110.937 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB1' ' CG ' ' A' ' 56' ' ' LYS . . . -130.49 -160.99 1.08 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.452 -0.78 . . . . 0.0 110.466 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.591 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.3 p 168.4 -169.02 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.379 -0.825 . . . . 0.0 109.338 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.036 HG13 HG21 ' A' ' 70' ' ' VAL . 3.1 t -35.5 -59.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.747 -0.595 . . . . 0.0 111.134 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 34.4 tt0 -43.13 -47.54 6.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 0.0 110.791 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 1.061 ' CE ' HG11 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -79.14 -24.06 43.58 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.964 . . . . 0.0 111.849 -178.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.004 HD13 ' CG1' ' A' ' 45' ' ' VAL . 79.9 mt -72.08 -56.73 5.1 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.503 -1.373 . . . . 0.0 108.384 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.491 ' O ' HG22 ' A' ' 61' ' ' THR . 7.4 m -56.48 -31.46 64.05 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.528 -0.732 . . . . 0.0 109.385 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -75.47 -31.57 60.29 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.287 -0.883 . . . . 0.0 110.005 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -69.07 -42.31 76.39 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.037 ' OG1' HG22 ' A' ' 21' ' ' VAL . 12.9 t -73.64 -32.89 64.26 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 66' ' ' TYR . . . -64.67 -31.25 72.4 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.59 -9.51 46.78 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.851 ' HB1' HG23 ' A' ' 20' ' ' THR . . . -81.93 -23.7 36.03 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.35 14.4 0.62 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.463 -1.351 . . . . 0.0 111.743 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.682 ' CB ' HG23 ' A' ' 9' ' ' VAL . 68.7 m-85 -145.69 114.11 4.71 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.313 -1.698 . . . . 0.0 111.79 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.77 97.58 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 N-CA-C 107.255 -1.863 . . . . 0.0 107.255 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 1.5 p -108.31 -166.14 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.0 112.751 -176.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.748 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 24.6 p -150.73 -164.92 2.13 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.036 HG21 HG13 ' A' ' 54' ' ' VAL . 2.4 p -141.07 158.32 22.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.906 -1.118 . . . . 0.0 111.516 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.482 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -125.95 24.72 6.95 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.294 1.045 . . . . 0.0 109.088 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.489 ' OXT' HG23 ' A' ' 5' ' ' VAL . 39.4 mt-30 . . . . . 0 C--N 1.289 -2.026 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.345 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.698 HG23 ' N ' ' A' ' 3' ' ' GLN 0.258 14.6 t . . . . . 0 C--O 1.214 -0.805 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.698 ' N ' HG23 ' A' ' 2' ' ' THR . 0.6 OUTLIER -173.37 153.88 2.5 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.455 179.048 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.6 m -143.16 107.73 4.83 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.594 HG13 ' HA ' ' A' ' 72' ' ' GLN . 2.5 t -140.17 165.15 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -0.854 . . . . 0.0 109.9 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 1.047 HG22 ' CG2' ' A' ' 44' ' ' VAL . 2.4 p -108.9 164.0 12.79 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.989 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.95 157.74 46.12 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.704 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.46 107.25 16.85 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.568 -0.707 . . . . 0.0 110.068 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.021 HG21 HG21 ' A' ' 21' ' ' VAL . 2.0 p -117.15 100.44 53.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.751 . . . . 0.0 109.524 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -76.27 34.96 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.381 1.388 . . . . 0.0 112.156 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.642 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.56 -46.11 86.34 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.562 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 16.9 ptt? 36.78 47.54 0.57 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.88 -0.776 . . . . 0.0 110.36 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 1.123 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -85.19 14.9 4.63 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.508 -0.745 . . . . 0.0 109.795 179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 13' ' ' THR . 4.0 t 77.68 87.97 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.489 0.661 . . . . 0.0 111.363 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 56.12 38.83 30.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.489 -0.757 . . . . 0.0 111.788 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.123 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -154.43 -31.27 0.11 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.883 -1.136 . . . . 0.0 111.122 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.761 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -50.82 -55.23 28.87 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.647 -1.283 . . . . 0.0 110.676 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 1.008 ' HB2' HG13 ' A' ' 36' ' ' VAL . 9.5 Cg_endo -69.05 -3.79 12.25 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.249 1.299 . . . . 0.0 112.543 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 15.5 mt -90.54 -48.49 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.857 -1.152 . . . . 0.0 109.229 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.941 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -62.56 -36.81 83.84 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.366 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.021 HG21 HG21 ' A' ' 9' ' ' VAL . 60.4 t -65.54 -48.13 83.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.653 ' O ' HG21 ' A' ' 34' ' ' VAL . 44.6 tttm -42.71 -54.19 4.16 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.634 -0.666 . . . . 0.0 110.669 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -71.44 -26.02 62.56 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.163 -0.961 . . . . 0.0 111.473 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -65.11 -55.37 19.13 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.302 -0.874 . . . . 0.0 110.818 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.99 ' HB3' HG11 ' A' ' 45' ' ' VAL . 3.2 mp -69.71 -31.65 69.78 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.099 -1.001 . . . . 0.0 110.534 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.569 ' HA ' HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -68.23 -22.08 64.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.239 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.46 1.09 15.78 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.025 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.579 HG13 ' N ' ' A' ' 29' ' ' GLU . 7.6 p -45.7 -46.94 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.883 -1.136 . . . . 0.0 110.627 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.579 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.4 OUTLIER 173.17 -80.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.897 -1.127 . . . . 0.0 110.891 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.534 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -92.41 -14.77 55.19 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.006 -1.093 . . . . 0.0 110.528 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.589 HG11 ' O ' ' A' ' 25' ' ' LEU . 9.6 t -42.43 139.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.027 -1.278 . . . . 0.0 110.428 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.1 t -118.32 -10.66 10.17 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.474 0.654 . . . . 0.0 109.245 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -154.0 164.59 38.19 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.264 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.888 HG23 HG13 ' A' ' 45' ' ' VAL . 6.4 p -152.94 174.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 109.242 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . 1.2 t0 -162.3 160.01 26.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.832 -1.168 . . . . 0.0 111.378 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.008 HG13 ' HB2' ' A' ' 18' ' ' PRO . 25.1 t -110.07 136.08 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.487 -0.758 . . . . 0.0 109.963 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -138.63 61.75 0.57 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -58.87 -23.48 60.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -1.135 . . . . 0.0 110.326 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -42.99 -40.77 3.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.864 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.539 ' CG ' ' HG2' ' A' ' 42' ' ' GLU . 12.9 ptpt -139.21 49.2 1.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.421 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.562 ' CD ' ' HB3' ' A' ' 12' ' ' MET . 0.0 OUTLIER 39.47 62.31 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.505 -0.747 . . . . 0.0 110.299 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HG2' ' CG ' ' A' ' 40' ' ' LYS . 2.0 pp20? -146.42 141.55 27.27 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.435 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -115.1 136.29 53.27 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.047 ' CG2' HG22 ' A' ' 6' ' ' THR . 1.6 t -106.24 143.68 16.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 120.233 -1.542 . . . . 0.0 109.355 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.99 HG11 ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -142.51 153.49 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.797 -178.059 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -123.75 151.3 43.4 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.932 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.9 p90 -167.52 -173.42 2.2 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 117.747 -1.581 . . . . 0.0 112.639 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 39.4 m-20 -105.59 118.49 36.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -66.15 -1.66 3.45 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.214 -177.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 48' ' ' ASP . 13.0 t -86.27 -20.49 28.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.043 -1.036 . . . . 0.0 110.525 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -128.47 -14.94 4.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.887 -1.133 . . . . 0.0 111.707 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -143.25 -170.39 3.26 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.023 -1.048 . . . . 0.0 110.137 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.632 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 174.15 167.92 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.873 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.931 HG23 HG21 ' A' ' 70' ' ' VAL . 2.5 p -42.73 -49.81 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 110.215 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.562 ' H ' HG13 ' A' ' 54' ' ' VAL . 7.3 tt0 -45.09 -47.04 12.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.041 . . . . 0.0 109.867 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.515 ' O ' HG21 ' A' ' 28' ' ' VAL . 11.2 mmtm -75.6 -27.09 58.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.43 -0.794 . . . . 0.0 111.437 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.932 HD11 ' CE2' ' A' ' 47' ' ' PHE . 68.5 mt -68.63 -57.69 5.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.602 -1.311 . . . . 0.0 108.761 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 4.0 m -56.22 -29.61 61.2 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.381 -0.824 . . . . 0.0 109.45 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 3.9 tttm -76.98 -29.52 55.55 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.297 -0.877 . . . . 0.0 109.699 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.765 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -69.97 -47.2 63.22 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.412 -0.805 . . . . 0.0 109.253 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.835 ' OG1' HG13 ' A' ' 21' ' ' VAL . 10.2 t -70.15 -32.95 71.18 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -68.14 -26.05 65.59 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.658 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 20.1 t0 -89.83 -13.34 36.77 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.941 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -80.27 -28.25 38.43 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.589 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 138.88 26.2 0.29 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.11 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.824 ' CB ' HG23 ' A' ' 9' ' ' VAL . 36.0 m-85 -151.38 105.2 2.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.655 -1.497 . . . . 0.0 110.993 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 3.0 Cg_exo -55.38 101.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 N-CA-C 107.184 -1.891 . . . . 0.0 107.184 177.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.53 ' HB3' HG23 ' A' ' 61' ' ' THR . 0.1 OUTLIER -107.94 -169.68 1.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.19 -1.004 . . . . 0.0 112.642 -176.637 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.529 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -152.38 -165.23 2.15 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.989 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.8 p -137.95 157.81 32.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.513 -1.367 . . . . 0.0 111.733 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.52 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -122.87 27.26 7.8 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.058 0.932 . . . . 0.0 109.639 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.594 ' HA ' HG13 ' A' ' 5' ' ' VAL . 34.3 mt-30 . . . . . 0 C--N 1.29 -2.019 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.531 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -109.13 153.26 23.97 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.874 0.845 . . . . 0.0 112.103 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 5.4 t -123.45 143.27 50.25 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.769 HG13 ' HA ' ' A' ' 72' ' ' GLN . 1.5 t -149.49 160.95 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -0.93 . . . . 0.0 109.152 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.687 ' O ' HD12 ' A' ' 7' ' ' LEU . 1.8 t -106.97 158.71 16.82 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.968 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -128.85 161.47 29.73 Favored 'General case' 0 C--N 1.276 -2.619 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.525 -177.601 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.43 101.15 10.14 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.816 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.84 HG22 ' SG ' ' A' ' 17' ' ' CYS . 3.5 p -115.21 90.3 23.66 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -77.41 45.35 1.71 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.545 1.496 . . . . 0.0 112.822 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.609 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -95.11 -34.04 6.33 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 1.2 mmt 54.3 -88.86 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.52 -0.988 . . . . 0.0 108.923 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 1.142 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.4 OUTLIER 58.31 9.76 1.11 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.592 179.768 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER 68.2 110.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.441 -0.787 . . . . 0.0 112.319 178.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . 33.19 48.81 0.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.841 -0.537 . . . . 0.0 112.375 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.142 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -151.26 -40.91 0.12 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.038 -1.039 . . . . 0.0 109.513 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.84 ' SG ' HG22 ' A' ' 9' ' ' VAL . 13.7 t -56.08 -41.35 90.55 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 110.834 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 1.021 ' O ' HG11 ' A' ' 36' ' ' VAL . 7.6 Cg_endo -78.35 -5.52 15.02 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.068 1.179 . . . . 0.0 111.661 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.9 mt -91.21 -35.52 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.831 -1.168 . . . . 0.0 108.672 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.933 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.2 m -75.94 -35.75 59.61 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.927 ' O ' HD12 ' A' ' 25' ' ' LEU . 81.9 t -66.08 -46.06 88.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.815 ' HG3' HG13 ' A' ' 34' ' ' VAL . 7.8 tttm -51.39 -54.61 24.8 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.101 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -72.87 -12.88 61.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 111.299 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.652 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -76.15 -63.61 1.28 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.956 -1.09 . . . . 0.0 109.649 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.928 HD21 ' CD2' ' A' ' 7' ' ' LEU . 3.5 mp -58.54 -33.8 70.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.495 -0.753 . . . . 0.0 110.081 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.517 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -70.46 -27.81 64.52 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.151 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -87.76 -9.57 53.58 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.322 -0.862 . . . . 0.0 109.942 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.762 HG12 ' N ' ' A' ' 29' ' ' GLU . 3.0 t -43.3 -80.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.133 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.762 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 172.35 -57.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.0 109.242 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.89 -26.21 38.53 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 25' ' ' LEU . 51.4 t -50.83 133.87 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -1.091 . . . . 0.0 110.324 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 m -115.0 -14.75 11.83 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.646 0.736 . . . . 0.0 109.218 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.754 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -153.63 159.64 42.16 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.27 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.815 HG13 ' HG3' ' A' ' 22' ' ' LYS . 7.1 p -156.84 157.13 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 110.203 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.584 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -158.1 171.52 20.07 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.227 -0.921 . . . . 0.0 110.113 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.021 HG11 ' O ' ' A' ' 18' ' ' PRO . 19.2 m -144.55 156.32 14.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 110.333 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.28 106.98 0.41 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.606 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -67.91 -25.54 65.54 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -1.091 . . . . 0.0 109.238 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -56.83 -23.55 44.69 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.354 -0.841 . . . . 0.0 108.984 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.524 ' O ' ' C ' ' A' ' 41' ' ' ARG . 6.7 tptm -138.93 33.18 2.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.546 -0.721 . . . . 0.0 109.807 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.575 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 8.7 tpm_? 22.35 60.2 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.225 0.535 . . . . 0.0 112.391 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 24.6 pt-20 -148.91 170.36 18.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.298 -0.876 . . . . 0.0 110.335 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.765 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -128.22 130.18 47.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.667 -1.27 . . . . 0.0 109.702 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 44' ' ' VAL . 15.0 p -105.27 117.87 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.796 -1.19 . . . . 0.0 109.415 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.798 ' CG1' HD13 ' A' ' 57' ' ' LEU . 7.2 p -126.3 150.77 32.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 122.257 1.027 . . . . 0.0 112.926 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -110.3 153.93 24.19 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.822 ' CD2' HD11 ' A' ' 57' ' ' LEU . 37.7 p90 -168.81 178.58 4.54 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 117.872 -1.531 . . . . 0.0 111.987 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -105.55 124.88 50.28 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 8.4 t0 -79.46 26.94 0.28 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.494 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.47 -29.07 11.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.941 -1.1 . . . . 0.0 109.145 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -123.77 -7.8 7.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.517 -0.739 . . . . 0.0 110.097 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -146.98 -164.77 2.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.454 -0.779 . . . . 0.0 109.498 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.597 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 174.06 164.28 0.2 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.08 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.08 HG22 HG21 ' A' ' 70' ' ' VAL . 7.9 p -44.86 -42.96 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.571 ' N ' HG13 ' A' ' 54' ' ' VAL . 23.0 tt0 -55.88 -43.84 77.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.973 . . . . 0.0 109.358 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -73.75 -22.33 59.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.501 -0.749 . . . . 0.0 110.572 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.87 HD12 ' HA ' ' A' ' 54' ' ' VAL . 90.8 mt -69.93 -55.76 8.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.776 -1.203 . . . . 0.0 108.391 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.52 ' N ' HD21 ' A' ' 7' ' ' LEU . 59.5 m -56.87 -35.62 69.12 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 16.9 tttt -73.24 -26.86 61.29 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.333 -0.854 . . . . 0.0 109.585 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.708 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -68.31 -50.68 51.81 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.414 -0.804 . . . . 0.0 109.379 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.792 ' OG1' HG22 ' A' ' 21' ' ' VAL . 6.6 t -67.12 -32.14 73.08 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -63.1 -32.27 73.61 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.058 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -88.54 -11.09 46.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.461 -0.774 . . . . 0.0 109.129 178.966 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.933 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.85 -31.8 57.1 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 142.9 32.18 0.11 Allowed Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.902 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.821 ' CB ' HG23 ' A' ' 9' ' ' VAL . 72.8 m-85 -159.17 107.84 1.54 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.698 -1.472 . . . . 0.0 111.291 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -56.27 99.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 N-CA-C 106.687 -2.082 . . . . 0.0 106.687 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.525 ' OG ' HG23 ' A' ' 61' ' ' THR . 60.3 p -108.42 -165.43 1.03 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.166 -0.959 . . . . 0.0 112.514 -176.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.86 -161.36 1.32 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.08 HG21 HG22 ' A' ' 54' ' ' VAL . 3.3 p -141.62 157.93 21.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 O-C-N 120.832 -1.167 . . . . 0.0 111.33 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.547 ' CG ' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -129.42 27.53 5.29 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.427 1.108 . . . . 0.0 109.002 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.769 ' HA ' HG13 ' A' ' 5' ' ' VAL . 10.9 pt20 . . . . . 0 C--N 1.289 -2.065 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.292 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -107.86 164.14 12.51 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.821 0.82 . . . . 0.0 112.236 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 t -131.59 128.12 38.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.445 0.64 . . . . 0.0 110.144 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.904 HG13 ' HA ' ' A' ' 72' ' ' GLN . 5.4 t -139.35 168.08 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 109.148 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.756 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -108.77 171.57 7.35 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.604 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.985 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -134.33 159.36 41.25 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.917 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -113.02 99.25 7.71 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.175 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.898 HG21 ' CG2' ' A' ' 21' ' ' VAL . 2.1 p -112.68 101.74 53.31 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 109.277 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.7 Cg_endo -77.63 39.83 0.79 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.494 1.463 . . . . 0.0 111.748 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.648 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -82.76 -51.24 4.34 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.482 ' HB2' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 42.97 57.23 3.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.538 -0.977 . . . . 0.0 109.916 -179.69 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.834 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -87.94 15.07 7.68 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.273 179.287 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 4.0 t 65.51 87.36 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.542 -0.724 . . . . 0.0 110.265 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.747 ' O ' HD12 ' A' ' 19' ' ' ILE . . . 68.26 29.72 5.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 0.0 110.089 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.834 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -138.56 -48.16 0.52 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.609 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -55.31 -47.4 98.67 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.411 -0.806 . . . . 0.0 111.206 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 9.2 Cg_endo -71.89 -9.44 24.73 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 120.895 1.063 . . . . 0.0 112.219 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.747 HD12 ' O ' ' A' ' 15' ' ' ALA . 20.6 mt -93.13 -37.86 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.787 -1.195 . . . . 0.0 109.842 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.905 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.2 m -77.02 -40.8 45.16 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.898 ' CG2' HG21 ' A' ' 9' ' ' VAL . 97.6 t -62.88 -45.45 98.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.827 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.871 ' HG3' HG12 ' A' ' 34' ' ' VAL . 39.7 tttt -54.04 -55.58 26.08 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.174 -0.954 . . . . 0.0 109.853 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -75.9 -0.94 23.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 111.223 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -80.95 -64.41 1.19 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.722 -1.236 . . . . 0.0 108.843 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.898 HD13 ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.06 -24.63 65.99 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.774 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.795 ' C ' HG11 ' A' ' 31' ' ' VAL . 3.3 t -72.66 -26.66 61.72 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -97.43 -5.23 36.64 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.329 -0.857 . . . . 0.0 110.378 179.727 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 25' ' ' LEU . 2.7 t -46.09 -59.99 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.52 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.568 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER 158.1 -72.22 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.433 0.635 . . . . 0.0 110.225 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -69.24 -27.23 73.91 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.795 HG11 ' C ' ' A' ' 26' ' ' SER . 8.0 p -39.68 139.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.427 -1.043 . . . . 0.0 110.484 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.34 -14.67 9.19 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.536 0.684 . . . . 0.0 109.63 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.686 ' O ' HG23 ' A' ' 34' ' ' VAL . 9.7 ttmm -162.96 164.7 25.65 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.114 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.894 HG22 HG22 ' A' ' 45' ' ' VAL . 52.7 t -159.51 150.64 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.076 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.682 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -142.36 169.25 17.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 0.0 109.503 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 18' ' ' PRO . 62.9 t -108.99 151.5 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.118 -0.989 . . . . 0.0 110.981 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.67 60.04 0.49 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.594 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -60.93 -23.74 65.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.515 -0.991 . . . . 0.0 110.544 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -21.9 2.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.999 -1.063 . . . . 0.0 109.35 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 41' ' ' ARG . 21.5 mttt -143.05 39.45 1.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -0.758 . . . . 0.0 110.077 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.482 ' HD2' ' HB2' ' A' ' 12' ' ' MET . 1.5 ttp180 36.22 60.21 0.88 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.633 -0.667 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -152.22 168.43 25.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.476 -0.889 . . . . 0.0 111.338 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -131.17 139.09 49.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 109.327 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.733 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.0 p -107.78 109.41 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.841 -1.162 . . . . 0.0 110.145 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.894 HG22 HG22 ' A' ' 34' ' ' VAL . 53.8 t -111.21 159.1 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 122.414 1.102 . . . . 0.0 112.915 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -123.59 150.72 43.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 177.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 2' ' ' THR . 32.7 p90 -171.62 -176.29 1.76 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.004 -1.878 . . . . 0.0 112.979 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.38 114.14 28.15 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 14.6 t70 -62.67 -6.76 3.85 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.143 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.5 p -83.73 -25.51 30.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.052 -1.03 . . . . 0.0 110.945 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.1 mmmt -116.55 -7.15 11.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.924 -1.11 . . . . 0.0 110.726 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . 179.43 -179.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.59 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.0 p 172.17 -172.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 110.323 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.942 HG22 HG21 ' A' ' 70' ' ' VAL . 9.3 t -36.53 -38.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.539 -0.725 . . . . 0.0 111.003 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -55.97 -51.88 66.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.151 -0.968 . . . . 0.0 110.497 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.49 ' HB3' HG13 ' A' ' 28' ' ' VAL . 11.3 mmtp -82.93 -17.64 42.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 112.085 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 ' HB2' ' A' ' 25' ' ' LEU . 37.2 mt -74.41 -53.82 8.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.353 -1.467 . . . . 0.0 108.455 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.488 ' CG2' ' HA ' ' A' ' 69' ' ' SER . 3.2 m -59.89 -35.62 75.23 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.032 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -73.21 -29.02 62.5 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.311 -0.868 . . . . 0.0 110.206 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.526 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -70.48 -43.68 69.25 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.067 -1.021 . . . . 0.0 109.704 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.592 HG23 ' HB2' ' A' ' 68' ' ' SER . 2.8 t -73.06 -29.1 62.71 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.74 68.61 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -10.8 42.15 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.516 -0.74 . . . . 0.0 109.22 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.905 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -81.61 -29.46 33.29 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.455 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 141.21 23.67 0.24 Allowed Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.618 -1.277 . . . . 0.0 111.471 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.703 ' CB ' HG23 ' A' ' 9' ' ' VAL . 56.1 m-85 -146.62 113.68 4.35 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.34 -1.682 . . . . 0.0 111.366 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.76 91.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 106.874 -2.01 . . . . 0.0 106.874 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.592 ' HB2' HG23 ' A' ' 61' ' ' THR . 55.0 m -108.79 -170.22 1.63 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.178 -0.951 . . . . 0.0 112.995 -176.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.488 ' HA ' ' CG2' ' A' ' 58' ' ' THR . 2.3 m -160.13 -159.95 0.75 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.985 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.2 p -139.37 161.53 27.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.921 -1.112 . . . . 0.0 111.172 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.721 ' HG3' HG23 ' A' ' 6' ' ' THR . 4.3 mttt -122.31 24.0 9.54 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 122.264 1.031 . . . . 0.0 110.133 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.904 ' HA ' HG13 ' A' ' 5' ' ' VAL . 10.2 tt0 . . . . . 0 C--N 1.284 -2.252 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.369 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 1.015 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.068 0.461 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -152.62 88.76 1.36 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -126.88 165.95 18.4 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.254 -0.904 . . . . 0.0 111.666 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 14.6 t -130.42 134.3 47.01 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.58 -0.7 . . . . 0.0 110.324 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.967 HG21 HG23 ' A' ' 54' ' ' VAL . 10.8 t -122.6 171.42 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -0.765 . . . . 0.0 109.266 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.787 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -106.96 158.56 16.94 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.003 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.03 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -132.13 156.32 46.57 Favored 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 118.476 -1.289 . . . . 0.0 110.538 -178.471 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.542 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -109.19 101.67 10.68 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.412 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.968 HG21 HG21 ' A' ' 21' ' ' VAL . 1.5 p -113.89 87.85 13.29 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.609 -0.682 . . . . 0.0 109.614 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 11.5 Cg_endo -78.1 39.94 0.83 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.351 1.367 . . . . 0.0 111.764 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.601 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -81.4 -28.57 43.51 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.506 ' CG ' ' C ' ' A' ' 11' ' ' GLY . 7.7 ptt? 33.12 62.11 0.38 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.92 -0.753 . . . . 0.0 110.541 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.868 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -85.25 11.59 9.74 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.466 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER 70.31 90.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 110.088 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 59.4 26.98 15.98 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.573 -0.704 . . . . 0.0 110.103 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.868 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -131.44 -40.69 1.11 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.801 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.636 ' SG ' HG22 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -53.59 -48.93 91.41 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.0 110.992 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.614 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 7.5 Cg_endo -72.45 -10.36 25.33 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.434 1.229 . . . . 0.0 112.33 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.06 -45.75 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.682 -1.262 . . . . 0.0 109.875 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 1.061 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.257 1.2 m -73.44 -36.75 65.97 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.679 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.968 HG21 HG21 ' A' ' 9' ' ' VAL . 13.5 t -70.26 -47.85 64.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.878 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.619 ' O ' HG21 ' A' ' 34' ' ' VAL . 6.3 tmtt? -49.9 -51.57 39.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.491 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.556 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -70.52 -21.9 62.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.922 -1.111 . . . . 0.0 111.252 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.72 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -66.87 -54.36 23.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.243 -0.911 . . . . 0.0 110.471 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.907 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.6 mp -70.7 -31.09 67.83 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.084 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.854 ' C ' HG11 ' A' ' 31' ' ' VAL . 3.6 p -68.8 -20.47 64.33 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -116.31 4.92 13.5 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.449 -0.901 . . . . 0.0 109.816 179.103 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.819 HG12 ' O ' ' A' ' 25' ' ' LEU . 8.0 p -51.01 -50.03 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.0 110.867 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.611 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER 175.44 -77.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.883 -1.135 . . . . 0.0 110.888 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.94 2.36 56.82 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.854 HG11 ' C ' ' A' ' 26' ' ' SER . 14.9 p -44.77 144.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.042 -1.27 . . . . 0.0 110.592 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.513 ' HB2' HG22 ' A' ' 46' ' ' THR . 19.4 m -113.28 -16.3 12.54 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.4 OUTLIER -170.19 167.82 8.49 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.698 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.848 HG11 ' HB3' ' A' ' 26' ' ' SER . 13.6 p -157.88 167.36 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.124 -0.985 . . . . 0.0 110.55 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.519 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 1.6 m-20 -167.68 178.53 5.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.977 . . . . 0.0 110.086 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 3.8 m -150.13 165.4 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 111.127 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.3 106.85 0.32 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.614 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -70.05 -8.24 47.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -1.176 . . . . 0.0 110.53 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -60.34 -23.98 64.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.058 -1.026 . . . . 0.0 109.17 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -150.29 30.65 0.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.462 -0.774 . . . . 0.0 110.144 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 40' ' ' LYS . 2.0 mpp_? 40.56 58.94 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.522 -0.736 . . . . 0.0 110.408 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 2.4 pt-20 -136.88 149.53 47.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 0.0 110.211 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.776 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -117.86 132.18 56.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.972 -1.08 . . . . 0.0 109.449 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 35' ' ' ASP . 8.1 p -106.83 130.61 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.738 -1.226 . . . . 0.0 109.531 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.037 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.2 p -133.33 147.47 31.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.178 -1.009 . . . . 0.0 113.049 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 32' ' ' SER . 1.3 m -109.71 154.2 23.22 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.763 ' CE2' HD11 ' A' ' 57' ' ' LEU . 36.2 p90 -172.11 -177.2 1.82 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 117.883 -1.527 . . . . 0.0 111.811 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HB3' HG22 ' A' ' 50' ' ' THR . 10.5 m-20 -107.22 114.44 28.49 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 1.015 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 11.0 t70 -62.96 -9.36 9.62 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.304 -0.872 . . . . 0.0 110.715 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.628 HG22 ' HB3' ' A' ' 48' ' ' ASP . 4.8 t -72.88 -22.49 60.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -128.15 -7.16 5.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.213 -0.929 . . . . 0.0 110.902 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -154.43 -167.61 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.482 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.585 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 170.76 171.87 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.48 -0.763 . . . . 0.0 109.606 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.056 HG13 HG21 ' A' ' 70' ' ' VAL . 2.7 t -40.65 -47.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 110.317 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.96 -48.35 43.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.007 -1.058 . . . . 0.0 110.198 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 28.1 mmtm -73.74 -26.55 60.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -0.864 . . . . 0.0 111.318 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.037 HD13 ' CG1' ' A' ' 45' ' ' VAL . 63.3 mt -68.37 -58.18 4.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.668 -1.27 . . . . 0.0 108.809 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.682 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 16.4 m -57.79 -29.22 64.7 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 68.1 tttt -73.68 -29.37 62.26 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.379 -0.826 . . . . 0.0 109.54 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.72 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -70.74 -50.32 37.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.291 -0.881 . . . . 0.0 109.504 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.94 ' OG1' HG22 ' A' ' 21' ' ' VAL . 1.5 t -69.74 -26.63 64.41 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -66.73 -36.62 82.89 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.57 -9.92 55.08 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.061 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -29.27 55.68 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.564 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 135.04 25.18 0.55 Allowed Glycine 0 N--CA 1.486 2.002 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.067 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.601 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 42.0 m-85 -146.03 120.86 5.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.62 -1.518 . . . . 0.0 111.856 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.72 95.54 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 N-CA-C 107.014 -1.956 . . . . 0.0 107.014 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -108.47 -173.73 2.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 0.0 112.543 -176.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.518 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.5 OUTLIER -148.8 -162.57 1.59 Allowed 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.056 HG21 HG13 ' A' ' 54' ' ' VAL . 3.0 p -141.0 158.95 23.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.07 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.504 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 6.1 mtmt -116.27 17.52 15.6 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.198 0.999 . . . . 0.0 110.307 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.685 ' C ' HG13 ' A' ' 5' ' ' VAL . 13.2 mt-30 . . . . . 0 C--N 1.282 -2.368 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.57 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.299 0.571 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -151.8 88.28 1.4 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -118.68 160.84 21.1 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.086 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.418 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 2.0 t -134.49 132.87 39.76 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.7 -0.625 . . . . 0.0 109.648 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.643 HG21 ' CG2' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -133.24 169.03 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.884 0.849 . . . . 0.0 109.508 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.715 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.19 157.03 18.2 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.971 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.07 157.07 45.13 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.465 -178.146 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.23 112.44 24.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.55 -0.719 . . . . 0.0 110.279 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.036 HG21 HG21 ' A' ' 21' ' ' VAL . 1.4 p -123.42 88.0 51.7 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.272 -0.892 . . . . 0.0 110.011 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -78.53 59.77 7.31 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.427 1.418 . . . . 0.0 111.806 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.601 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -104.03 -26.83 6.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.509 ' O ' ' HG3' ' A' ' 12' ' ' MET . 19.0 ptm 29.64 61.47 0.16 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.717 0.77 . . . . 0.0 111.356 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.847 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -85.97 13.72 7.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.465 -0.772 . . . . 0.0 109.36 179.024 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.7 t 69.76 91.82 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.556 -0.715 . . . . 0.0 110.24 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 59.53 16.83 5.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 110.31 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.847 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -118.64 -44.05 2.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.528 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.607 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -51.59 -48.37 87.05 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.421 -0.799 . . . . 0.0 111.231 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 5.6 Cg_endo -73.24 -11.87 25.16 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 121.274 1.316 . . . . 0.0 112.634 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 19' ' ' ILE . 10.0 mm -92.28 -41.43 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.692 -1.255 . . . . 0.0 109.567 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.993 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.25 1.2 m -73.83 -39.87 63.73 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.036 HG21 HG21 ' A' ' 9' ' ' VAL . 98.9 t -69.49 -49.86 55.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.108 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.555 ' HG3' HG13 ' A' ' 34' ' ' VAL . 13.8 tttt -47.23 -51.76 17.81 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 110.471 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.567 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -72.88 -21.38 60.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.034 -1.041 . . . . 0.0 111.393 -179.258 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 60' ' ' ALA . . . -68.12 -53.95 21.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 110.719 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.908 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.9 mp -71.18 -29.08 64.74 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.08 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.872 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -74.79 -17.82 60.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.422 -0.799 . . . . 0.0 109.224 179.537 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.567 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -115.35 2.07 13.88 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.111 -0.993 . . . . 0.0 110.062 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 56' ' ' LYS . 9.3 p -53.56 -47.71 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.317 -0.864 . . . . 0.0 110.853 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.577 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.5 OUTLIER 179.25 -86.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.72 -1.237 . . . . 0.0 111.517 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -95.34 3.25 66.08 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.504 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.872 HG11 ' C ' ' A' ' 26' ' ' SER . 8.8 p -42.33 142.16 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.142 -1.211 . . . . 0.0 110.366 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 t -114.58 -17.34 11.71 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.688 0.756 . . . . 0.0 108.999 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 3.0 tttm -162.43 163.83 27.48 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.961 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 26' ' ' SER . 9.9 p -162.59 159.22 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 110.489 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.507 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 2.7 t70 -166.26 171.84 11.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 109.853 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.497 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 4.3 m -140.69 163.17 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.033 -1.042 . . . . 0.0 110.865 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.77 113.23 0.57 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.615 ' CE1' ' HD3' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -70.19 -21.57 63.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -1.228 . . . . 0.0 110.281 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -45.82 -45.51 14.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.131 -0.981 . . . . 0.0 109.458 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.0 mttm -126.4 25.85 6.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.439 -0.788 . . . . 0.0 109.687 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.687 HH21 HG13 ' A' ' 9' ' ' VAL . 7.1 mmm180 38.75 60.19 1.43 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.837 -0.539 . . . . 0.0 110.175 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 6.9 pt-20 -141.68 150.27 41.66 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.957 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -116.14 131.95 56.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.004 -1.06 . . . . 0.0 108.969 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 35' ' ' ASP . 13.4 p -105.22 130.89 55.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.786 -1.196 . . . . 0.0 109.676 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.014 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.2 p -131.92 143.06 41.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.946 0.879 . . . . 0.0 112.454 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -109.38 157.89 18.47 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.773 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.9 p90 -171.88 -176.33 1.7 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 117.399 -1.72 . . . . 0.0 112.122 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.585 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 65.2 m-20 -106.85 113.51 27.05 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 15.8 t70 -59.61 -10.96 4.03 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 111.147 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.8 t -69.02 -24.75 64.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 110.929 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -128.84 -12.0 4.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.903 -1.123 . . . . 0.0 111.509 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -148.24 -169.41 3.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.017 -1.052 . . . . 0.0 110.712 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.593 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER 171.2 172.58 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.442 -0.786 . . . . 0.0 109.914 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.03 HG23 HG21 ' A' ' 70' ' ' VAL . 2.1 p -40.73 -35.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 110.406 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -56.59 -49.63 74.35 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.232 -0.917 . . . . 0.0 110.293 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.641 ' O ' HG21 ' A' ' 28' ' ' VAL . 15.9 mmtt -78.82 -18.38 54.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.27 -0.894 . . . . 0.0 111.526 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.014 HD13 ' CG1' ' A' ' 45' ' ' VAL . 52.3 mt -75.01 -58.87 3.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.415 -1.428 . . . . 0.0 108.268 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.554 ' N ' HD21 ' A' ' 7' ' ' LEU . 19.5 m -58.76 -30.04 67.23 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.741 -0.783 . . . . 0.0 109.111 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.503 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -80.79 -23.43 39.29 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.308 -0.87 . . . . 0.0 109.536 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.597 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -72.81 -47.06 49.68 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.394 -0.816 . . . . 0.0 109.086 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.594 ' CB ' HG13 ' A' ' 21' ' ' VAL . 9.2 t -71.39 -35.78 71.17 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -64.04 -29.68 70.81 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.626 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 2.1 t70 -89.67 -11.35 42.71 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.993 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -28.26 55.28 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.72 23.44 0.51 Allowed Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.697 -1.239 . . . . 0.0 111.228 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.699 ' CB ' HG23 ' A' ' 9' ' ' VAL . 46.8 m-85 -146.13 110.94 4.37 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.649 -1.501 . . . . 0.0 111.103 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 4.3 Cg_exo -55.49 99.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 N-CA-C 107.297 -1.847 . . . . 0.0 107.297 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -109.06 -172.02 1.96 Allowed 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.362 -176.773 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.512 ' N ' ' OG ' ' A' ' 68' ' ' SER . 19.9 m -147.32 -162.75 1.61 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.03 HG21 HG23 ' A' ' 54' ' ' VAL . 3.5 p -139.92 160.37 26.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 C-N-CA 118.647 -1.221 . . . . 0.0 111.763 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.506 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 1.7 mttt -123.24 19.1 9.87 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.963 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.511 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.8 tt0 . . . . . 0 C--N 1.283 -2.306 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.126 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.647 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.116 0.484 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -144.99 92.17 2.24 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.6 151.8 25.13 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.898 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.43 117.23 23.97 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.288 0.566 . . . . 0.0 109.616 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.527 HG11 ' CG2' ' A' ' 70' ' ' VAL . 4.6 t -126.76 168.19 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 109.931 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.811 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -108.88 160.47 15.97 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.937 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -133.66 155.36 49.85 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.623 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 68' ' ' SER . . . -109.6 110.75 21.91 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.879 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.845 HG21 HG21 ' A' ' 21' ' ' VAL . 1.6 p -124.38 85.99 55.25 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.505 -0.747 . . . . 0.0 109.67 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 11.2 Cg_endo -79.51 52.36 4.26 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.965 1.508 . . . . 0.0 111.294 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.624 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -97.6 -34.11 5.64 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.562 ' HG2' ' CZ ' ' A' ' 41' ' ' ARG . 1.8 mtp 69.04 -79.57 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.982 -0.716 . . . . 0.0 110.456 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.87 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.6 OUTLIER 50.86 14.39 0.18 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.92 -1.112 . . . . 0.0 109.638 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' THR . 0.7 OUTLIER 51.25 108.41 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.333 -0.855 . . . . 0.0 111.519 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 43.81 36.76 1.41 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -0.772 . . . . 0.0 111.034 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.87 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -139.01 -37.68 0.51 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 110.021 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -51.76 -50.34 78.16 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.772 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.77 ' O ' HG11 ' A' ' 36' ' ' VAL . 9.4 Cg_endo -73.38 -11.26 24.61 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.189 1.26 . . . . 0.0 112.633 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.8 mm -92.1 -45.47 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.64 -1.288 . . . . 0.0 109.872 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 1.117 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -70.13 -37.23 75.25 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.845 HG21 HG21 ' A' ' 9' ' ' VAL . 13.0 t -64.75 -44.64 96.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.581 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -52.78 -41.42 64.08 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.476 -0.765 . . . . 0.0 109.805 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -79.57 -22.37 43.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 111.173 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.821 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -67.99 -51.15 50.51 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.174 -0.954 . . . . 0.0 110.089 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.944 ' O ' HG12 ' A' ' 28' ' ' VAL . 4.1 mp -78.93 -31.36 45.18 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.516 -0.74 . . . . 0.0 110.874 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.817 ' HA ' HG21 ' A' ' 31' ' ' VAL . 42.5 p -69.31 -21.36 63.86 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.04 -1.037 . . . . 0.0 108.844 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -116.12 0.55 12.99 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.843 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.944 HG12 ' O ' ' A' ' 25' ' ' LEU . 3.7 p -45.46 -52.64 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.032 -1.043 . . . . 0.0 110.681 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.592 ' H ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER 176.41 -77.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.84 -1.163 . . . . 0.0 111.08 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.5 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -96.46 0.43 61.55 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' A' ' 26' ' ' SER . 6.8 p -42.57 143.21 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.24 . . . . 0.0 110.834 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 m -117.26 -16.21 10.36 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.105 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.648 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -166.62 164.26 16.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.617 -0.677 . . . . 0.0 109.509 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 45' ' ' VAL . 37.9 t -156.14 163.22 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.061 -1.025 . . . . 0.0 110.687 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' HB3' HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -162.95 161.78 25.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.292 -0.88 . . . . 0.0 109.758 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.77 HG11 ' O ' ' A' ' 18' ' ' PRO . 4.1 m -142.82 151.85 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.516 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.49 104.54 0.35 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.607 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -64.44 -29.55 70.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -1.161 . . . . 0.0 110.276 -179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.9 mm-40 -44.68 -28.52 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 109.721 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -132.99 1.55 3.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 110.396 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.569 ' NH1' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 59.06 51.27 7.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.448 -0.783 . . . . 0.0 110.135 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 51.7 mt-10 -138.12 146.46 42.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.472 -0.767 . . . . 0.0 109.813 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.828 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -115.36 130.38 56.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.998 -1.064 . . . . 0.0 109.32 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 35' ' ' ASP . 14.7 p -105.68 127.45 60.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.907 -1.12 . . . . 0.0 109.079 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 34' ' ' VAL . 37.3 t -134.06 148.06 30.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 119.049 -1.06 . . . . 0.0 112.484 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -108.89 158.62 17.51 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.799 ' CE2' HD11 ' A' ' 57' ' ' LEU . 33.1 p90 -171.54 -174.84 1.47 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 117.637 -1.625 . . . . 0.0 111.933 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.647 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 13.5 t0 -105.65 110.6 22.98 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.574 ' HB3' ' CB ' ' A' ' 1' ' ' ALA . 5.0 t70 -61.47 -11.48 10.83 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.709 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 82.4 p -75.01 -27.7 60.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.26 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 mtpp -122.08 -1.63 9.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 110.345 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -158.77 -169.07 2.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 110.33 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.598 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.4 p 170.32 170.53 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.437 -0.79 . . . . 0.0 109.528 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.998 HG23 HG21 ' A' ' 70' ' ' VAL . 2.5 p -42.24 -44.44 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 110.03 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.514 ' N ' HG13 ' A' ' 54' ' ' VAL . 6.7 tp-100 -51.44 -47.89 62.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -0.989 . . . . 0.0 109.694 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 18.2 mmtp -75.12 -20.67 59.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 0.0 110.966 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.799 HD11 ' CE2' ' A' ' 47' ' ' PHE . 82.0 mt -72.77 -60.27 2.31 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.688 -1.258 . . . . 0.0 108.19 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.741 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 1.2 p -57.42 -29.66 64.33 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.483 -0.761 . . . . 0.0 109.012 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 55.2 tttt -74.57 -31.41 62.07 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.339 -0.85 . . . . 0.0 109.726 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.821 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -69.87 -51.34 34.13 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.283 -0.886 . . . . 0.0 109.325 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.75 ' OG1' HG22 ' A' ' 21' ' ' VAL . 1.6 t -68.64 -27.18 65.78 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -65.4 -35.22 80.28 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.79 -15.71 50.66 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.634 -0.827 . . . . 0.0 108.953 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.117 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -71.4 -29.55 65.05 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.93 23.71 0.84 Allowed Glycine 0 N--CA 1.486 1.978 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.952 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.716 ' HB3' HG23 ' A' ' 9' ' ' VAL . 50.7 m-85 -139.36 111.84 7.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.686 -1.479 . . . . 0.0 111.72 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.85 96.65 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 107.046 -1.944 . . . . 0.0 107.046 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 10.0 p -108.1 -167.1 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 112.581 -176.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.493 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 19.2 m -157.81 -165.94 1.87 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.998 HG21 HG23 ' A' ' 54' ' ' VAL . 4.0 p -135.75 161.12 38.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 120.631 -1.293 . . . . 0.0 111.433 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.49 ' HE2' ' HB2' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -123.97 25.7 7.85 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.303 1.049 . . . . 0.0 110.134 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.468 ' HA ' HG13 ' A' ' 5' ' ' VAL . 2.0 tm0? . . . . . 0 C--N 1.284 -2.261 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.113 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.181 0.515 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -146.36 89.92 1.9 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 179.267 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.33 162.03 14.71 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.713 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.482 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 1.2 t -125.0 147.33 48.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.568 HG13 ' CB ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -153.49 159.29 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.965 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -106.69 155.74 19.35 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.539 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.974 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -129.9 158.54 39.22 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.41 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -112.39 105.32 13.56 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.212 0.529 . . . . 0.0 110.302 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.924 HG21 HG21 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -120.21 85.42 36.07 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.606 -0.684 . . . . 0.0 109.42 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 41' ' ' ARG . 10.2 Cg_endo -78.56 58.31 6.7 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.807 1.424 . . . . 0.0 111.216 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.608 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -102.08 -25.05 8.12 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 14.2 mtm 59.15 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.739 -0.859 . . . . 0.0 110.064 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.804 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER 50.32 14.05 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.363 -0.836 . . . . 0.0 109.958 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 54.48 109.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 111.626 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.687 ' O ' HD13 ' A' ' 19' ' ' ILE . . . 39.99 26.27 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.563 -0.711 . . . . 0.0 111.706 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.804 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -118.63 -42.53 2.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.939 -1.101 . . . . 0.0 109.139 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.741 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -52.5 -46.96 95.01 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.621 -0.675 . . . . 0.0 111.903 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 5.6 Cg_endo -70.29 -20.27 32.56 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.201 1.268 . . . . 0.0 113.49 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 15' ' ' ALA . 2.6 mp -92.4 -36.64 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.447 -1.408 . . . . 0.0 110.038 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.974 HG22 ' HB1' ' A' ' 64' ' ' ALA 0.252 1.2 m -73.45 -42.48 61.9 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.955 ' O ' HD12 ' A' ' 25' ' ' LEU . 96.9 t -62.75 -50.37 79.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.457 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.739 ' HA ' HG11 ' A' ' 34' ' ' VAL . 15.9 tttm -51.39 -44.07 62.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 110.268 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 5.0 mttm -69.89 -23.21 63.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.111 -0.993 . . . . 0.0 111.102 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -76.26 -62.5 1.59 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.533 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.955 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.6 mp -56.85 -30.73 64.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 0.0 110.486 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 1.024 ' HB3' HG21 ' A' ' 34' ' ' VAL . 4.5 p -76.05 -30.34 58.35 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.416 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -88.36 -3.92 58.76 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.268 -0.895 . . . . 0.0 109.625 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.792 HG12 ' N ' ' A' ' 29' ' ' GLU . 3.8 t -41.76 -83.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.429 -0.794 . . . . 0.0 110.066 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.792 ' N ' HG12 ' A' ' 28' ' ' VAL . 3.3 tt0 179.36 -52.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.46 -0.775 . . . . 0.0 109.062 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.492 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -96.74 -23.33 15.96 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 25' ' ' LEU . 39.6 t -51.63 134.52 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -1.108 . . . . 0.0 110.103 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.7 t -127.84 -5.09 5.73 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.083 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 13.9 tttp -155.71 116.33 3.8 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.524 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.024 HG21 ' HB3' ' A' ' 26' ' ' SER . 3.9 t -109.25 -178.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.686 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.647 ' H ' HG12 ' A' ' 34' ' ' VAL . 26.4 t0 -161.26 159.28 28.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.984 -1.073 . . . . 0.0 110.249 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.542 HG13 ' CB ' ' A' ' 18' ' ' PRO . 17.6 t -112.62 135.85 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.811 . . . . 0.0 110.699 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.09 60.02 0.53 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.647 ' CZ ' ' NH1' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -62.49 -16.49 55.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -1.175 . . . . 0.0 110.358 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -44.84 -26.52 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 109.148 179.289 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 41' ' ' ARG . 5.0 ttpt -152.43 47.21 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.611 -0.68 . . . . 0.0 109.833 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.647 ' NH1' ' CZ ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER 39.91 63.16 1.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.661 -0.649 . . . . 0.0 109.684 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 2.0 tm-20 -140.18 148.16 41.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.497 -0.752 . . . . 0.0 110.363 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.716 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -124.09 132.16 53.63 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.965 ' CG2' HG22 ' A' ' 6' ' ' THR . 0.9 OUTLIER -105.95 145.01 14.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.358 -1.464 . . . . 0.0 109.561 -178.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.791 HG11 ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -139.52 177.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 122.703 1.24 . . . . 0.0 112.362 -177.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -152.68 143.65 23.01 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 105.682 -1.969 . . . . 0.0 105.682 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.84 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.3 p90 -166.06 -176.0 3.58 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 117.242 -1.783 . . . . 0.0 112.934 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.733 ' HB3' HG22 ' A' ' 50' ' ' THR . 0.8 OUTLIER -106.8 115.83 30.87 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 17.5 t70 -62.12 -8.6 5.73 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 111.028 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.733 HG22 ' HB3' ' A' ' 48' ' ' ASP . 15.1 t -76.26 -21.55 56.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 110.74 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -128.59 -6.45 5.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.101 -0.999 . . . . 0.0 110.922 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.492 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -156.52 -169.7 3.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 110.216 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.591 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 14.8 t 175.81 168.62 0.39 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.11 HG23 HG21 ' A' ' 70' ' ' VAL . 2.8 p -42.91 -40.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 110.039 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.496 ' N ' HG13 ' A' ' 54' ' ' VAL . 1.1 tt0 -54.34 -47.65 72.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.114 -0.991 . . . . 0.0 109.826 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 17.8 mmtt -75.73 -18.09 59.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 111.249 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.84 HD11 ' CE2' ' A' ' 47' ' ' PHE . 68.4 mt -75.49 -58.68 3.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.501 -1.375 . . . . 0.0 107.949 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.46 ' N ' HD21 ' A' ' 7' ' ' LEU . 1.9 m -57.67 -32.21 67.1 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -73.57 -33.18 64.54 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.406 -0.809 . . . . 0.0 109.727 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.751 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -66.3 -46.34 77.31 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.272 -0.893 . . . . 0.0 109.371 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.638 ' HB ' HD11 ' A' ' 25' ' ' LEU . 5.7 t -68.7 -32.92 73.06 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.409 ' N ' HG23 ' A' ' 61' ' ' THR . . . -62.53 -31.83 72.68 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -86.95 -13.87 43.42 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.974 ' HB1' HG22 ' A' ' 20' ' ' THR . . . -75.64 -24.79 56.46 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 131.58 19.09 1.21 Allowed Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.848 -1.167 . . . . 0.0 110.937 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.707 ' CB ' HG23 ' A' ' 9' ' ' VAL . 35.4 m-85 -144.03 111.72 5.2 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.695 -1.474 . . . . 0.0 111.594 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.0 96.37 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 N-CA-C 107.844 -1.637 . . . . 0.0 107.844 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -108.85 -168.42 1.34 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.211 -0.931 . . . . 0.0 111.748 -177.411 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.539 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.0 OUTLIER -156.5 -163.49 1.46 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.11 HG21 HG23 ' A' ' 54' ' ' VAL . 5.7 p -137.18 159.44 36.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 O-C-N 120.583 -1.323 . . . . 0.0 111.022 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.57 ' CG ' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -130.56 39.12 3.66 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.019 -1.073 . . . . 0.0 109.46 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.568 ' CB ' HG13 ' A' ' 5' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.687 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.274 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.982 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.21 0.528 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -152.63 89.89 1.44 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -110.09 169.92 8.42 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.799 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 4' ' ' THR . 3.1 t -143.99 113.41 6.98 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.36 0.6 . . . . 0.0 109.792 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.899 HG21 HG23 ' A' ' 54' ' ' VAL . 2.7 m -120.17 168.69 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 109.747 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.74 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.81 159.49 16.2 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 178.405 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.02 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.4 153.89 50.36 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.737 -1.227 . . . . 0.0 110.344 -178.469 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.536 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -108.84 104.74 14.05 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.411 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.881 HG21 HG21 ' A' ' 21' ' ' VAL . 1.2 p -112.4 93.36 22.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.608 -0.683 . . . . 0.0 109.999 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -76.82 35.24 0.47 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 O-C-N 123.737 1.388 . . . . 0.0 111.647 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.613 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.14 -62.85 4.57 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.497 ' HG2' ' CZ ' ' A' ' 41' ' ' ARG . 21.5 mtp 56.03 49.08 16.4 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.414 -1.051 . . . . 0.0 109.412 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 1.116 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -84.08 10.33 10.36 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.27 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.1 OUTLIER 77.32 97.06 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.651 0.739 . . . . 0.0 111.273 179.324 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 54.62 42.55 31.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.525 -0.735 . . . . 0.0 111.396 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.116 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -162.45 -29.61 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.976 -1.077 . . . . 0.0 111.315 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.645 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -50.33 -52.01 58.35 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.689 -1.257 . . . . 0.0 110.184 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.899 ' O ' HG11 ' A' ' 36' ' ' VAL . 9.5 Cg_endo -74.66 -6.9 18.83 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.353 1.369 . . . . 0.0 112.306 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 19' ' ' ILE . 13.4 mm -90.87 -42.25 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.69 -1.257 . . . . 0.0 109.759 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 1.032 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -69.79 -32.03 70.27 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.969 ' O ' HD12 ' A' ' 25' ' ' LEU . 40.4 t -73.42 -40.91 56.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.548 ' O ' HG11 ' A' ' 34' ' ' VAL . 7.8 tmtt? -50.06 -50.15 48.89 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.456 -0.778 . . . . 0.0 109.768 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.6 mmmm -77.6 -25.37 49.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.879 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 60' ' ' ALA . . . -62.5 -57.82 9.82 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.315 -0.865 . . . . 0.0 110.813 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.118 ' HB2' HG21 ' A' ' 34' ' ' VAL . 2.8 mp -75.91 -30.97 58.96 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.391 -0.818 . . . . 0.0 111.295 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.803 ' C ' HG11 ' A' ' 31' ' ' VAL . 1.8 t -69.39 -19.28 63.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.896 -1.127 . . . . 0.0 108.655 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.573 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 1.3 mptp? -115.54 -1.12 12.85 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.904 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.578 HG13 ' N ' ' A' ' 29' ' ' GLU . 11.5 p -44.24 -45.25 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 110.221 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.578 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 163.31 -85.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.458 -0.776 . . . . 0.0 111.193 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.743 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -80.79 -6.07 89.63 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.81 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.803 HG11 ' C ' ' A' ' 26' ' ' SER . 7.6 p -50.06 141.89 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.892 -1.358 . . . . 0.0 110.36 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -121.18 -12.55 8.66 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.576 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.479 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -176.02 107.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.788 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.118 HG21 ' HB2' ' A' ' 25' ' ' LEU . 1.5 p -114.01 179.06 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.154 -0.966 . . . . 0.0 111.399 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.556 ' H ' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -166.04 160.82 16.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.5 -0.75 . . . . 0.0 110.045 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.899 HG11 ' O ' ' A' ' 18' ' ' PRO . 15.8 m -130.39 158.75 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 0.0 110.476 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.3 112.47 0.62 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.625 ' CG ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -75.22 -28.44 59.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 110.604 -179.468 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -55.17 -23.35 21.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.146 -0.971 . . . . 0.0 110.346 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.474 ' HB3' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -134.59 16.5 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 0.0 110.43 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.497 ' CZ ' ' HG2' ' A' ' 12' ' ' MET . 1.5 mpp_? 42.53 55.58 4.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 110.043 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 2.2 pp20? -148.49 149.77 32.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.397 -0.814 . . . . 0.0 109.898 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.515 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -123.03 136.73 54.96 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.956 -1.09 . . . . 0.0 108.932 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.2 p -105.44 132.19 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.493 -1.379 . . . . 0.0 109.325 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.009 HG11 HD22 ' A' ' 57' ' ' LEU . 3.2 t -123.11 152.3 27.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.442 1.115 . . . . 0.0 112.401 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 1.3 m -125.51 145.94 49.87 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 176.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.853 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.4 p90 -170.59 -178.43 2.64 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 117.235 -1.786 . . . . 0.0 112.523 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.577 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -107.0 120.22 41.47 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.318 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.982 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 1.6 t70 -64.6 -3.24 2.95 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.399 -0.813 . . . . 0.0 111.327 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.4 p -77.0 -23.25 52.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.027 . . . . 0.0 110.651 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -130.32 0.63 4.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.022 -1.049 . . . . 0.0 110.894 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.743 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -159.65 -166.58 1.79 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 109.917 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.599 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.0 t 176.21 160.62 0.32 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 110.001 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.019 ' CG2' HG21 ' A' ' 70' ' ' VAL . 5.7 p -42.49 -37.86 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.363 -0.836 . . . . 0.0 110.151 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.478 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 2.4 tt0 -56.96 -49.1 76.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.883 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' HG3' ' CG2' ' A' ' 28' ' ' VAL . 2.0 tptt -70.06 -23.71 63.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 0.0 110.76 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.009 HD22 HG11 ' A' ' 45' ' ' VAL . 66.8 mt -69.32 -56.62 6.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.795 -1.19 . . . . 0.0 108.812 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.664 ' N ' HD21 ' A' ' 7' ' ' LEU . 12.3 m -60.2 -30.44 69.37 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 33.3 tttt -77.06 -23.17 52.02 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.542 -0.724 . . . . 0.0 109.61 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.719 ' HB3' ' HG ' ' A' ' 25' ' ' LEU . . . -72.79 -46.06 55.27 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.334 -0.854 . . . . 0.0 109.255 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.827 ' OG1' HG22 ' A' ' 21' ' ' VAL . 7.6 t -72.71 -34.14 66.93 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -63.96 -32.6 74.19 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.824 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -91.0 -9.53 45.6 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.457 -0.777 . . . . 0.0 109.395 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.032 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.08 -24.73 43.3 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.44 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.04 15.57 0.91 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.249 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.645 ' CB ' HG23 ' A' ' 9' ' ' VAL . 26.5 m-85 -139.72 110.21 7.34 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.562 -1.552 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.51 99.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 N-CA-C 107.509 -1.766 . . . . 0.0 107.509 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.529 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 9.2 p -108.43 -170.65 1.71 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.233 1.016 . . . . 0.0 112.767 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 t -150.64 -162.19 1.5 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.02 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.7 p -141.92 162.46 20.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.19 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.501 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -124.92 23.83 7.75 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.363 1.078 . . . . 0.0 108.944 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.592 ' HB2' HG21 ' A' ' 54' ' ' VAL . 1.7 tt0 . . . . . 0 C--N 1.286 -2.18 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.933 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.095 0.474 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -148.38 90.49 1.81 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -108.81 162.79 13.86 Favored 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 119.476 -0.889 . . . . 0.0 112.445 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 t -137.66 119.28 14.98 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.264 0.554 . . . . 0.0 109.599 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.617 HG21 HG22 ' A' ' 54' ' ' VAL . 3.0 m -126.55 170.36 16.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.279 -0.888 . . . . 0.0 109.803 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.95 161.32 14.82 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.001 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.94 156.45 48.98 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 118.541 -1.264 . . . . 0.0 110.036 -178.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.66 109.63 20.43 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.182 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -117.71 102.94 51.22 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.244 -0.91 . . . . 0.0 109.617 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.529 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 7.7 Cg_endo -75.71 32.48 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.428 1.418 . . . . 0.0 112.329 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.593 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -74.62 -69.72 1.35 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.546 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 48.63 30.68 2.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -1.078 . . . . 0.0 109.365 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 1.106 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -61.23 -10.4 6.69 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.078 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.735 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.8 t 89.93 98.4 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.615 0.722 . . . . 0.0 111.019 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 71.7 27.59 2.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.61 -0.681 . . . . 0.0 111.256 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.106 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -150.61 -44.67 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.796 -1.19 . . . . 0.0 110.531 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -45.73 -50.03 34.84 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.862 -1.149 . . . . 0.0 111.39 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 17' ' ' CYS . 6.8 Cg_endo -69.94 -20.89 33.39 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.234 1.289 . . . . 0.0 113.484 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.5 mt -91.35 -30.04 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.381 -1.45 . . . . 0.0 110.028 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.665 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.254 1.5 m -78.21 -40.59 37.05 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.471 0.653 . . . . 0.0 109.524 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.995 ' O ' HD12 ' A' ' 25' ' ' LEU . 55.8 t -70.54 -52.05 32.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.182 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.556 ' HA ' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -50.93 -43.26 60.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.82 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 12.8 mtpt -71.96 -26.69 62.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 110.795 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.587 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -70.24 -62.17 1.49 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.487 -0.758 . . . . 0.0 110.714 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.027 HD22 ' CG2' ' A' ' 45' ' ' VAL . 2.8 mp -59.55 -34.72 73.02 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.309 -0.869 . . . . 0.0 110.562 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.71 ' HA ' HG21 ' A' ' 31' ' ' VAL . 2.1 t -72.11 -22.89 61.27 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.406 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.22 -10.47 41.5 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.276 -0.89 . . . . 0.0 109.716 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.814 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.4 t -42.61 -80.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.444 -0.785 . . . . 0.0 109.851 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.814 ' N ' HG12 ' A' ' 28' ' ' VAL . 1.1 mt-10 177.11 -69.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 110.051 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.419 ' O ' ' OD2' ' A' ' 48' ' ' ASP . . . -77.52 -13.39 83.58 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 26' ' ' SER . 12.2 p -48.2 139.4 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -1.125 . . . . 0.0 110.539 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.412 ' OG ' ' OD2' ' A' ' 48' ' ' ASP . 5.9 m -128.26 -6.46 5.38 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -173.62 103.9 0.12 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.421 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.061 HG22 HG13 ' A' ' 45' ' ' VAL . 70.9 t -111.77 171.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 110.304 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.724 ' HB3' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -169.28 178.55 4.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.188 -0.945 . . . . 0.0 110.269 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 3.2 m -113.63 167.66 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.37 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.44 69.05 0.29 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -56.7 -15.84 5.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.302 -1.116 . . . . 0.0 110.472 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 38' ' ' PHE . 10.3 tp10 -44.41 -29.81 0.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 0.0 109.319 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -160.91 52.52 0.28 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.457 -0.777 . . . . 0.0 110.288 179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.546 ' NH1' ' HB2' ' A' ' 12' ' ' MET . 2.4 mtt180 41.31 63.61 1.2 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.526 -0.734 . . . . 0.0 110.496 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 1.1 pt-20 -149.02 150.17 32.36 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.599 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.698 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -115.81 143.88 44.78 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.724 HG12 ' HB3' ' A' ' 35' ' ' ASP . 8.5 p -105.15 129.18 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.509 -1.369 . . . . 0.0 108.895 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.061 HG13 HG22 ' A' ' 34' ' ' VAL . 21.5 t -124.97 156.35 33.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 122.524 1.154 . . . . 0.0 112.051 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 1.4 m -137.85 146.65 43.7 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.817 ' CE2' HD11 ' A' ' 57' ' ' LEU . 30.6 p90 -170.65 -174.57 1.64 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 117.154 -1.818 . . . . 0.0 112.569 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.607 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 8.9 m-20 -106.27 116.56 32.15 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.933 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 35.7 t0 -63.21 -8.19 7.62 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.878 -177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.2 t -77.31 -17.98 57.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.925 . . . . 0.0 110.484 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -132.36 0.9 3.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.969 . . . . 0.0 110.894 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -166.28 -170.54 1.71 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.068 -1.02 . . . . 0.0 110.447 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.627 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER 171.52 173.04 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 110.008 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.068 HG13 HG21 ' A' ' 70' ' ' VAL . 17.8 t -41.59 -41.96 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.125 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -50.86 -48.53 60.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 110.228 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -79.26 -21.88 45.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 111.861 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.972 HD22 HG11 ' A' ' 45' ' ' VAL . 63.1 mt -71.5 -59.15 2.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.27 -1.519 . . . . 0.0 108.649 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.694 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 8.0 m -58.88 -28.4 66.1 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -79.18 -25.79 42.73 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.345 -0.847 . . . . 0.0 110.005 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.594 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -73.6 -47.41 40.57 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.022 -1.049 . . . . 0.0 109.201 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.969 ' OG1' HG22 ' A' ' 21' ' ' VAL . 9.0 t -71.38 -32.82 68.92 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -63.43 -34.53 77.94 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.964 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -89.43 -8.86 52.12 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.352 -0.842 . . . . 0.0 109.042 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.665 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.61 -25.05 41.58 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.89 15.37 0.72 Allowed Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.426 -1.368 . . . . 0.0 111.66 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.593 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 53.7 m-85 -141.71 111.43 6.29 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.443 -1.622 . . . . 0.0 111.41 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.02 99.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 85.6 p -108.22 -165.35 1.03 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 122.147 0.975 . . . . 0.0 112.793 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.62 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -157.68 -165.93 1.88 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.068 HG21 HG13 ' A' ' 54' ' ' VAL . 3.6 p -139.55 158.1 27.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 120.816 -1.178 . . . . 0.0 111.524 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 4.1 mtmt -124.41 25.85 7.52 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.478 1.132 . . . . 0.0 108.91 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.493 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.284 -2.274 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.992 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.617 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.094 0.473 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -146.18 87.47 1.74 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -117.26 165.39 13.51 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.71 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 4.2 t -132.5 124.29 28.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.794 -0.566 . . . . 0.0 110.031 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.7 HG21 HG22 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -124.79 172.41 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.797 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.6 162.01 14.34 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.227 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.029 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -133.35 153.54 51.5 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.859 -1.136 . . . . 0.0 109.651 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.537 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -108.9 98.55 8.02 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.137 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.126 HG21 HG21 ' A' ' 21' ' ' VAL . 2.2 p -113.17 90.69 16.91 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.7 Cg_endo -74.8 31.33 0.35 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.394 1.396 . . . . 0.0 112.323 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.3 -43.11 95.69 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 13.0 ptm 35.83 45.93 0.31 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.748 0.785 . . . . 0.0 109.894 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 1.165 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.2 t -72.1 0.54 9.34 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.69 -0.631 . . . . 0.0 110.142 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.719 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 82.19 88.58 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.508 0.671 . . . . 0.0 111.127 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 71.17 31.51 2.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.527 -0.733 . . . . 0.0 112.078 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.165 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -155.72 -35.4 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.532 -1.355 . . . . 0.0 110.658 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.749 ' H ' HG22 ' A' ' 13' ' ' THR . 0.0 OUTLIER -49.87 -48.57 77.57 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.727 -1.233 . . . . 0.0 110.825 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.595 ' HG3' ' CD1' ' A' ' 38' ' ' PHE . 18.7 Cg_endo -77.94 -9.87 16.77 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.312 1.341 . . . . 0.0 112.599 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 19' ' ' ILE . 18.7 mm -90.31 -42.38 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.719 -1.238 . . . . 0.0 109.735 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.965 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.251 0.9 OUTLIER -71.92 -39.11 69.7 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.921 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.126 HG21 HG21 ' A' ' 9' ' ' VAL . 21.1 t -67.7 -48.44 76.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.4 -47.32 26.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.31 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.564 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 1.2 mmmm -74.46 -20.37 60.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 111.693 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.7 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -73.24 -48.78 32.09 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 110.062 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 21' ' ' VAL . 4.9 mp -68.86 -33.28 73.54 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 109.676 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.726 ' HA ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -78.58 -20.88 49.55 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.964 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.564 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -98.3 -7.26 29.36 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.894 -1.129 . . . . 0.0 109.588 179.285 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.733 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.9 t -40.36 -80.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.668 -0.645 . . . . 0.0 109.776 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.733 ' N ' HG12 ' A' ' 28' ' ' VAL . 5.1 tt0 179.3 -57.85 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.183 -0.948 . . . . 0.0 109.825 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -92.15 -15.12 54.84 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' A' ' 26' ' ' SER . 10.6 p -43.16 141.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.101 -1.235 . . . . 0.0 110.49 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 t -120.89 -12.95 8.71 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.555 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.498 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 4.1 ttmt -166.25 168.71 14.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.028 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.461 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 4.7 p -164.68 172.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.405 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.575 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -167.21 169.4 12.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.835 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.584 HG13 ' HB3' ' A' ' 18' ' ' PRO . 24.8 t -109.92 147.47 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 110.509 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 42' ' ' GLU . . . -139.41 60.47 0.58 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.595 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -58.79 -20.82 53.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -1.116 . . . . 0.0 110.236 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.4 mp0 -45.93 -26.37 0.69 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.06 -1.025 . . . . 0.0 109.294 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.38 37.95 0.94 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.747 . . . . 0.0 110.104 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.451 ' CG ' ' HA ' ' A' ' 10' ' ' PRO . 1.7 mpp_? 43.43 56.25 4.43 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.348 -0.845 . . . . 0.0 110.482 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -143.46 150.11 38.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.835 . . . . 0.0 110.152 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -117.69 138.83 51.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.018 . . . . 0.0 108.791 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.575 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 10.1 p -105.61 144.57 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.532 -1.355 . . . . 0.0 109.939 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.893 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.2 p -145.86 144.94 20.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 118.928 -1.109 . . . . 0.0 113.174 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -111.77 153.17 26.92 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.676 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.9 p90 -171.48 -177.09 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.58 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.617 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 6.3 t0 -106.38 110.76 23.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 23.6 t0 -64.65 -8.19 13.47 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.978 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.409 HG22 ' CG ' ' A' ' 48' ' ' ASP . 10.0 t -68.64 -11.36 60.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.957 -1.089 . . . . 0.0 110.134 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.3 -35.57 0.46 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.18 -0.95 . . . . 0.0 111.243 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -122.61 -174.67 2.97 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.273 -0.892 . . . . 0.0 110.366 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.568 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 7.3 t 173.14 175.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.024 HG23 HG21 ' A' ' 70' ' ' VAL . 1.6 p -40.34 -32.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.87 . . . . 0.0 110.672 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -49.98 75.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.098 . . . . 0.0 109.813 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 37.0 mmtt -77.43 -18.92 56.79 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.386 -0.821 . . . . 0.0 110.961 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.893 HD13 ' CG1' ' A' ' 45' ' ' VAL . 79.0 mt -74.51 -61.08 1.99 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.656 -1.277 . . . . 0.0 108.364 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.692 HG21 ' HB ' ' A' ' 70' ' ' VAL . 42.9 p -60.27 -25.38 65.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.469 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 5.5 tttm -78.11 -29.8 49.11 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 121.469 -0.77 . . . . 0.0 109.822 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.7 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -72.14 -46.63 55.72 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.101 -0.999 . . . . 0.0 109.224 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.882 ' OG1' HG22 ' A' ' 21' ' ' VAL . 7.3 t -70.5 -32.22 69.64 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -67.68 -31.67 71.81 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.261 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -90.47 -9.36 47.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.43 -0.794 . . . . 0.0 109.262 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.965 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -80.98 -29.02 35.38 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 140.89 22.47 0.27 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.424 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.8 ' CB ' HG23 ' A' ' 9' ' ' VAL . 42.5 m-85 -148.28 108.94 3.65 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.46 -1.612 . . . . 0.0 111.278 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.0 Cg_exo -57.17 100.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 3.7 t -107.3 -177.43 3.35 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.562 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.41 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -140.77 -164.75 1.8 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.029 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.5 p -142.73 155.25 17.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 O-C-N 120.813 -1.18 . . . . 0.0 111.384 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -124.81 25.72 7.32 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.583 1.182 . . . . 0.0 109.086 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.459 ' OXT' HG23 ' A' ' 5' ' ' VAL . 1.2 mm-40 . . . . . 0 C--N 1.286 -2.193 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.11 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.327 0.584 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -167.29 99.69 0.51 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.426 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -111.79 160.65 17.13 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.861 0.839 . . . . 0.0 112.376 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.8 m -122.9 128.33 50.17 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.697 HG21 HG22 ' A' ' 70' ' ' VAL . 1.3 p -141.64 168.88 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 122.477 1.132 . . . . 0.0 111.101 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.697 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -108.84 159.36 16.85 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.015 HD11 HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -131.39 154.24 48.84 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.768 -1.207 . . . . 0.0 110.072 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.29 99.21 8.51 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.956 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.083 HG21 HG21 ' A' ' 21' ' ' VAL . 2.2 p -117.13 86.3 20.32 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 0.0 109.6 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.5 Cg_endo -76.62 37.51 0.57 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.575 1.517 . . . . 0.0 112.095 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' CG ' ' A' ' 12' ' ' MET . . . -79.68 -26.25 56.85 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.512 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 17.4 ptm 36.45 65.26 0.47 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.781 -0.835 . . . . 0.0 110.386 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.857 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -88.83 15.54 8.23 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.521 -0.737 . . . . 0.0 109.465 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER 68.12 88.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.548 -0.72 . . . . 0.0 110.128 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 58.01 31.95 21.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 0.0 110.174 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.857 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -134.4 -41.64 0.79 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.0 109.919 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.702 ' SG ' HG22 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -52.96 -50.0 84.14 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.748 179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.678 ' O ' HG11 ' A' ' 36' ' ' VAL . 9.7 Cg_endo -75.0 -8.87 20.46 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.168 1.246 . . . . 0.0 112.302 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 15' ' ' ALA . 12.3 mm -90.59 -43.48 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.808 -1.182 . . . . 0.0 109.699 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.956 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -78.86 -43.93 23.98 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.083 HG21 HG21 ' A' ' 9' ' ' VAL . 21.3 t -59.85 -43.57 92.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.987 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.756 ' O ' HG11 ' A' ' 34' ' ' VAL . 14.0 tttt -56.34 -58.67 7.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.073 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.7 pttt -73.58 3.41 6.28 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 110.547 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.672 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -87.71 -72.14 0.54 Allowed 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.887 -1.133 . . . . 0.0 108.775 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.839 ' CD2' HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -60.65 -16.23 36.73 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.154 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.739 ' O ' HG11 ' A' ' 31' ' ' VAL . 13.1 t -81.38 -35.03 31.28 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -75.9 -10.2 59.23 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.674 HG12 ' N ' ' A' ' 29' ' ' GLU . 6.5 t -37.47 -80.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.68 -0.637 . . . . 0.0 110.888 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.674 ' N ' HG12 ' A' ' 28' ' ' VAL . 2.4 mt-10 -172.85 -51.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.837 -1.165 . . . . 0.0 111.741 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -108.33 14.3 36.33 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.857 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.739 HG11 ' O ' ' A' ' 26' ' ' SER . 8.5 p -41.3 143.88 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.275 . . . . 0.0 111.11 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.614 ' HB3' HG22 ' A' ' 46' ' ' THR . 2.8 t -120.89 -16.22 8.16 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.461 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -173.06 162.64 4.61 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.768 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.777 HG13 HG22 ' A' ' 45' ' ' VAL . 1.3 t -153.04 148.12 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.058 -1.026 . . . . 0.0 110.684 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.595 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -154.64 164.41 38.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.315 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 18' ' ' PRO . 18.8 m -128.34 161.66 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.047 . . . . 0.0 110.74 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.18 90.7 0.13 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.611 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -65.51 -21.07 66.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 110.23 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 0.7 OUTLIER -53.24 -23.01 7.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.973 . . . . 0.0 109.122 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 41' ' ' ARG . 2.3 mmpp? -138.73 19.43 2.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.636 -0.665 . . . . 0.0 109.839 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 40' ' ' LYS . 1.7 tpp180 42.69 55.51 4.23 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -145.2 151.54 38.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.49 -0.756 . . . . 0.0 110.071 -179.251 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.23 136.96 52.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.979 . . . . 0.0 109.77 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.698 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.5 p -107.07 110.51 32.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.68 -1.263 . . . . 0.0 108.911 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.839 HG21 ' CD2' ' A' ' 25' ' ' LEU . 65.4 t -123.4 143.97 34.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.932 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.614 HG22 ' HB3' ' A' ' 32' ' ' SER . 1.3 m -110.07 163.01 14.0 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.873 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.1 p90 -171.35 -178.15 2.29 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.328 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.559 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 11.1 m-20 -106.99 116.67 32.32 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -61.18 -11.33 8.75 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.735 -177.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.573 HG23 ' HG3' ' A' ' 51' ' ' LYS . 15.2 t -68.94 -13.76 62.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 110.551 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HG3' HG23 ' A' ' 50' ' ' THR . 21.7 mttt -143.62 10.2 1.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 110.512 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.572 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -169.83 -167.01 0.62 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.104 -0.997 . . . . 0.0 110.298 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.635 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 t 172.3 164.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.033 HG13 HG21 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -42.18 -50.95 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 109.613 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.504 ' N ' HG12 ' A' ' 54' ' ' VAL . 40.0 tp60 -47.9 -46.08 31.29 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.326 -0.858 . . . . 0.0 109.657 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -72.45 -27.33 62.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 111.246 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.873 HD11 ' CE2' ' A' ' 47' ' ' PHE . 55.3 mt -68.78 -59.83 2.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.63 -1.294 . . . . 0.0 108.682 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.668 HG22 ' O ' ' A' ' 54' ' ' VAL . 1.7 t -56.27 -28.84 60.01 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 29.9 tttp -72.1 -33.74 68.08 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.348 -0.845 . . . . 0.0 109.441 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.672 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -67.85 -40.43 83.69 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.169 -0.957 . . . . 0.0 110.022 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.801 ' OG1' HG22 ' A' ' 21' ' ' VAL . 3.7 t -72.21 -32.0 66.37 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.54 84.4 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.47 -7.49 52.9 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.463 -0.773 . . . . 0.0 109.572 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.956 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -82.2 -24.4 34.94 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 133.3 20.11 0.93 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.789 -1.196 . . . . 0.0 110.946 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.767 ' CB ' HG23 ' A' ' 9' ' ' VAL . 44.4 m-85 -147.94 112.59 3.89 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.585 -1.538 . . . . 0.0 111.404 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.07 93.57 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 N-CA-C 107.671 -1.704 . . . . 0.0 107.671 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.71 -171.21 1.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 111.827 -177.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.521 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -142.62 -164.02 1.74 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.033 HG21 HG13 ' A' ' 54' ' ' VAL . 2.4 p -141.39 154.1 20.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.886 -1.133 . . . . 0.0 111.448 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.464 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -118.8 23.69 11.3 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.394 1.093 . . . . 0.0 109.617 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.484 ' OXT' ' CB ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.283 -2.311 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.248 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.721 ' HB1' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.142 0.496 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.709 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -156.98 94.38 1.42 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -109.09 148.28 31.08 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.893 0.854 . . . . 0.0 111.947 -177.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 m -123.48 108.14 12.34 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG12 ' CB ' ' A' ' 72' ' ' GLN . 5.6 m -125.36 165.0 23.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.184 -0.947 . . . . 0.0 110.688 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.727 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -107.01 159.95 15.91 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.035 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -131.48 159.31 38.47 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.511 -178.475 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.803 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -114.03 119.13 36.13 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.923 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.568 HG13 ' CB ' ' A' ' 66' ' ' TYR . 2.9 t -108.87 103.3 51.49 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.289 -0.882 . . . . 0.0 109.315 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 7.3 Cg_endo -74.79 29.41 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.314 1.165 . . . . 0.0 111.867 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.523 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -91.93 -58.82 1.37 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.561 ' CG ' ' HD2' ' A' ' 41' ' ' ARG . 4.0 tmm? 52.25 51.17 16.83 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.406 -1.055 . . . . 0.0 109.195 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 1.134 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -76.72 2.74 13.4 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.755 -0.59 . . . . 0.0 109.54 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.67 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 4.1 t 80.48 94.51 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.604 0.716 . . . . 0.0 111.13 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.843 ' O ' HD12 ' A' ' 19' ' ' ILE . . . 68.08 37.4 2.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.606 -0.684 . . . . 0.0 111.825 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.134 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -163.19 -37.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.782 -1.199 . . . . 0.0 110.602 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.61 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -44.2 -51.54 18.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.861 -1.15 . . . . 0.0 110.132 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.83 ' O ' HG12 ' A' ' 36' ' ' VAL . 17.9 Cg_endo -83.4 -14.15 8.25 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.423 1.416 . . . . 0.0 112.572 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 15' ' ' ALA . 84.6 mt -80.77 -54.19 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.864 -1.148 . . . . 0.0 110.306 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.795 HG23 ' HB1' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -62.29 -37.54 85.92 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.925 ' O ' HD12 ' A' ' 25' ' ' LEU . 15.1 t -63.65 -41.61 93.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.914 ' HE2' HG13 ' A' ' 34' ' ' VAL . 16.0 tttm -52.82 -39.31 62.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 109.743 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 11.6 mtmt -73.08 -26.2 61.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 110.845 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.758 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -69.07 -55.64 10.15 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 110.646 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.925 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.7 mp -65.45 -37.44 86.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 111.478 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.526 ' HB3' HG11 ' A' ' 34' ' ' VAL . 36.1 p -70.98 -26.1 63.0 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.099 -1.0 . . . . 0.0 110.21 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' CE ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -99.64 -3.82 32.28 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.222 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.81 ' CG2' ' HB2' ' A' ' 60' ' ' ALA . 2.2 t -42.9 -73.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 109.855 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.712 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 175.08 -71.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.354 -0.841 . . . . 0.0 109.75 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -78.94 -20.51 70.31 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 25' ' ' LEU . 46.1 t -52.0 134.29 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -1.13 . . . . 0.0 110.449 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.1 m -122.63 -12.2 8.14 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.836 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.916 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -146.56 154.57 41.67 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.873 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.914 HG13 ' HE2' ' A' ' 22' ' ' LYS . 7.1 p -155.23 165.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 110.026 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.631 ' HB3' HG12 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -162.96 155.04 18.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.062 -1.024 . . . . 0.0 110.835 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 18' ' ' PRO . 8.7 m -109.68 113.76 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.766 . . . . 0.0 110.18 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.4 73.76 0.21 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.649 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -65.56 -14.94 62.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -1.193 . . . . 0.0 110.056 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -57.29 -17.31 11.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.89 . . . . 0.0 109.265 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.3 mttm -147.35 32.51 0.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.517 -0.74 . . . . 0.0 110.134 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.573 ' HD3' ' CD1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER 42.89 57.47 3.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 4.6 pt-20 -149.77 148.68 29.51 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.216 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -115.63 130.26 56.8 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' A' ' 35' ' ' ASP . 8.4 p -105.66 143.49 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.478 -1.389 . . . . 0.0 110.003 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.916 HG13 ' O ' ' A' ' 33' ' ' LYS . 57.4 t -152.48 148.12 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.447 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.548 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.1 m -109.42 159.03 17.36 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.854 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.4 p90 -170.33 179.74 3.32 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 117.962 -1.495 . . . . 0.0 111.726 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 41.0 m-20 -106.49 112.9 26.11 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.721 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . 4.7 t70 -53.33 -17.3 1.74 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.9 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -65.88 -40.84 91.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.948 . . . . 0.0 110.702 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.6 -0.65 13.59 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.096 -1.002 . . . . 0.0 110.747 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.473 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -150.55 -165.09 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.06 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.607 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 170.84 154.44 0.06 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.582 -0.699 . . . . 0.0 109.464 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.122 ' CG2' HG21 ' A' ' 70' ' ' VAL . 9.5 p -42.39 -39.84 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.902 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.538 ' N ' HG13 ' A' ' 54' ' ' VAL . 5.7 tp-100 -59.69 -47.5 85.39 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.169 -0.957 . . . . 0.0 109.313 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -66.29 -24.16 66.51 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.469 -0.769 . . . . 0.0 110.698 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.888 HD12 ' HA ' ' A' ' 54' ' ' VAL . 43.0 mt -72.65 -54.59 8.62 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.706 -1.246 . . . . 0.0 108.12 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 52.5 m -56.29 -32.84 64.96 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.538 -0.726 . . . . 0.0 109.223 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -77.55 -28.78 51.94 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.291 -0.88 . . . . 0.0 110.053 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.81 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -68.54 -49.39 59.88 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.214 -0.929 . . . . 0.0 109.12 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.734 ' CB ' HG13 ' A' ' 21' ' ' VAL . 7.4 t -67.02 -32.26 73.35 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -68.29 -26.86 65.86 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.053 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 4.1 t0 -88.65 -13.31 40.12 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.795 ' HB1' HG23 ' A' ' 20' ' ' THR . . . -79.3 -32.64 43.59 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 143.35 31.11 0.1 Allowed Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.593 -1.289 . . . . 0.0 111.168 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.61 ' CZ ' ' HA ' ' A' ' 17' ' ' CYS . 63.8 m-85 -155.9 105.89 2.12 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.664 -1.492 . . . . 0.0 111.621 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.529 ' O ' ' CG ' ' A' ' 10' ' ' PRO . 5.0 Cg_exo -56.31 98.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 N-CA-C 106.768 -2.051 . . . . 0.0 106.768 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 8' ' ' ALA . 1.1 t -107.27 -177.91 3.49 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.077 -1.014 . . . . 0.0 111.939 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.803 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 12.9 p -136.99 -162.01 1.23 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.122 HG21 ' CG2' ' A' ' 54' ' ' VAL . 4.6 p -144.27 157.43 15.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 118.522 -1.271 . . . . 0.0 112.058 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.431 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -128.62 33.3 4.68 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.317 1.056 . . . . 0.0 108.195 179.149 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.597 ' CB ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.338 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 1.017 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.367 0.604 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.15 91.27 1.51 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.86 173.5 6.33 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.164 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.699 HG23 ' OG1' ' A' ' 46' ' ' THR . 0.7 OUTLIER -143.39 128.48 18.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.776 -0.578 . . . . 0.0 110.064 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.584 ' CG1' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -132.79 161.4 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.391 -0.818 . . . . 0.0 109.371 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.712 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.61 157.31 17.78 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.023 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -130.38 157.65 42.0 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.753 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.04 106.48 16.0 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.906 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.699 HG23 ' CB ' ' A' ' 66' ' ' TYR . 1.4 p -115.62 94.33 39.99 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.3 Cg_endo -78.64 43.33 1.42 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.56 1.507 . . . . 0.0 111.56 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.597 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -90.44 -49.71 3.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.592 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 4.2 ptm 36.4 61.94 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.77 -0.841 . . . . 0.0 110.981 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.968 HG21 ' HB3' ' A' ' 16' ' ' ALA . 6.6 t -70.94 -2.38 15.02 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 109.269 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.5 OUTLIER 78.12 3.03 2.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.708 -0.62 . . . . 0.0 111.458 178.743 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.598 ' H ' HG23 ' A' ' 13' ' ' THR . . . -174.74 33.59 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.229 -0.92 . . . . 0.0 109.924 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.968 ' HB3' HG21 ' A' ' 13' ' ' THR . . . 179.74 -21.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.108 -0.995 . . . . 0.0 112.155 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.889 ' H ' HG22 ' A' ' 13' ' ' THR . 0.0 OUTLIER -46.27 -48.97 44.3 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.201 -1.562 . . . . 0.0 110.969 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.596 ' O ' HG11 ' A' ' 36' ' ' VAL . 19.5 Cg_endo -81.66 -11.75 11.42 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.437 1.425 . . . . 0.0 113.558 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.1 mt -92.57 -37.99 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.495 -1.378 . . . . 0.0 110.862 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.953 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -73.26 -36.57 66.4 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.342 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.882 ' O ' HD12 ' A' ' 25' ' ' LEU . 42.1 t -67.67 -44.04 86.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.227 -0.989 . . . . 0.0 108.56 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.558 ' HA ' ' CG1' ' A' ' 34' ' ' VAL . 4.5 tptm -52.74 -47.59 67.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.542 -0.724 . . . . 0.0 110.311 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 5.0 mmtm -77.08 -16.19 59.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.974 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.681 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -73.93 -58.73 3.11 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.966 -1.084 . . . . 0.0 110.315 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.902 ' O ' HG12 ' A' ' 28' ' ' VAL . 3.7 mp -71.7 -29.15 64.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.597 -0.689 . . . . 0.0 110.487 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.761 ' C ' HG11 ' A' ' 31' ' ' VAL . 54.7 p -73.36 -26.11 60.88 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.432 -0.792 . . . . 0.0 109.426 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -110.48 3.54 19.68 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.001 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.902 HG12 ' O ' ' A' ' 25' ' ' LEU . 3.3 p -49.24 -55.33 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.024 -1.048 . . . . 0.0 110.448 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.655 ' H ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 176.31 -69.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.781 -1.2 . . . . 0.0 111.541 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -98.57 -9.52 52.7 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.776 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.761 HG11 ' C ' ' A' ' 26' ' ' SER . 11.0 p -42.56 143.4 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.307 . . . . 0.0 110.928 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.39 -15.56 10.32 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.73 0.776 . . . . 0.0 109.14 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.653 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -161.33 161.44 30.51 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 45' ' ' VAL . 25.6 t -157.61 161.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.097 -1.002 . . . . 0.0 110.43 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.532 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 1.1 m-20 -163.63 166.57 22.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.915 . . . . 0.0 110.29 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.596 HG11 ' O ' ' A' ' 18' ' ' PRO . 15.7 m -140.92 157.22 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.419 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -147.61 105.31 0.31 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.58 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -64.0 -23.69 67.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.288 -1.124 . . . . 0.0 110.269 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -47.18 -37.3 9.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.925 . . . . 0.0 109.987 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -135.32 29.65 3.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.414 -0.804 . . . . 0.0 110.481 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.592 ' CD ' ' HB3' ' A' ' 12' ' ' MET . 0.0 OUTLIER 38.55 60.52 1.33 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.571 -0.706 . . . . 0.0 110.319 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 20.7 pt-20 -143.18 145.97 33.27 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.663 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.628 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -114.82 130.14 56.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 108.982 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 44' ' ' VAL . 10.0 p -105.54 126.91 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.904 -1.122 . . . . 0.0 109.1 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 34' ' ' VAL . 40.7 t -131.88 144.55 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.691 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.699 ' OG1' HG23 ' A' ' 4' ' ' THR . 1.3 m -108.86 157.62 18.43 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.615 ' CE2' HD11 ' A' ' 57' ' ' LEU . 46.7 p90 -171.6 -173.77 1.26 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.098 -1.441 . . . . 0.0 111.326 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 5.7 m-20 -107.04 129.42 54.81 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 1.017 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 25.4 t70 -80.36 35.77 0.35 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.958 -1.089 . . . . 0.0 111.391 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.5 p -118.23 -16.97 9.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.37 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 7.5 mtpt -133.05 1.93 3.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.457 -0.777 . . . . 0.0 110.092 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . -179.65 -178.57 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 110.368 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.609 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 8.1 p 174.24 -176.01 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 0.0 109.659 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.023 HG23 HG21 ' A' ' 70' ' ' VAL . 2.1 p -38.34 -40.07 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.304 -0.873 . . . . 0.0 110.632 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 6.0 tt0 -56.52 -50.56 71.46 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.028 -1.045 . . . . 0.0 109.812 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 31.7 mmtt -79.69 -13.68 59.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 111.52 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.777 ' HB3' HD23 ' A' ' 25' ' ' LEU . 89.3 mt -78.35 -56.51 4.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.515 -1.366 . . . . 0.0 108.062 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 26.8 m -58.27 -29.68 65.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -78.05 -26.27 48.23 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.359 -0.838 . . . . 0.0 109.714 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.619 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -71.81 -46.33 58.54 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.264 -0.897 . . . . 0.0 109.237 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.56 ' HB ' HD11 ' A' ' 25' ' ' LEU . 10.0 t -71.57 -33.81 69.39 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -62.09 -34.64 76.68 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.849 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -91.13 -8.33 49.06 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.467 -0.771 . . . . 0.0 109.21 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.953 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.65 -25.18 41.41 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.55 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 137.11 17.29 0.71 Allowed Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.391 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.699 ' CB ' HG23 ' A' ' 9' ' ' VAL . 33.7 m-85 -143.94 114.78 5.49 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.444 -1.621 . . . . 0.0 111.601 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.99 95.32 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 N-CA-C 107.6 -1.731 . . . . 0.0 107.6 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.02 -170.56 1.68 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 112.332 -176.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 68' ' ' SER . 10.4 m -148.93 -161.86 1.44 Allowed 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 54' ' ' VAL . 5.1 p -140.09 163.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 120.657 -1.277 . . . . 0.0 111.937 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -125.88 26.12 6.68 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.381 1.086 . . . . 0.0 109.504 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.584 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 5.4 mt-30 . . . . . 0 C--N 1.285 -2.205 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.22 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.902 ' HB1' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.318 0.58 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -152.41 89.85 1.45 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -112.43 162.42 15.6 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.361 -177.208 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.5 m -135.31 132.87 38.22 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.705 HG21 ' CG2' ' A' ' 54' ' ' VAL . 3.9 t -139.18 169.34 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.015 . . . . 0.0 109.966 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.975 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.48 156.53 18.87 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.121 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.89 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -130.59 157.46 42.65 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 117.855 -1.538 . . . . 0.0 110.861 -178.671 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 68' ' ' SER . . . -109.84 111.35 22.72 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.808 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.751 HG21 HG21 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -117.94 98.13 51.31 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.186 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.518 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 10.7 Cg_endo -80.17 49.91 3.36 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.514 1.476 . . . . 0.0 110.965 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.655 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -90.97 -39.59 5.74 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 8.2 ptm 38.43 42.83 0.58 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.661 -0.905 . . . . 0.0 110.6 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.759 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -71.61 2.9 4.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.675 -0.64 . . . . 0.0 110.044 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 13' ' ' THR . 3.9 t 78.99 95.86 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.453 0.644 . . . . 0.0 110.152 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 54.44 23.61 4.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.45 -0.781 . . . . 0.0 110.028 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -123.61 -48.6 1.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -0.866 . . . . 0.0 109.71 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.577 ' SG ' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -39.7 -61.53 1.04 Allowed Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 121.474 -0.766 . . . . 0.0 111.445 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.617 ' HG3' ' CG ' ' A' ' 38' ' ' PHE . 5.6 Cg_endo -61.16 -20.65 68.81 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.96 1.773 . . . . 0.0 114.62 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.4 mt -90.42 -36.57 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.332 -1.48 . . . . 0.0 110.755 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.976 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -77.2 -40.71 44.21 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.937 ' O ' HD12 ' A' ' 25' ' ' LEU . 41.8 t -66.21 -48.08 82.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.616 ' HA ' HG21 ' A' ' 34' ' ' VAL . 23.3 tttm -52.42 -43.99 65.15 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.795 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 13.9 mmtt -72.82 -20.93 61.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 111.277 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -75.86 -60.95 2.1 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.165 -0.959 . . . . 0.0 110.269 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.937 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.7 mp -56.89 -36.32 69.98 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.431 -0.793 . . . . 0.0 109.96 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.562 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -71.07 -27.18 63.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.567 -0.708 . . . . 0.0 109.224 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -92.51 -4.54 53.41 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 121.225 -0.922 . . . . 0.0 109.753 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.777 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.7 t -44.01 -81.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.737 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.777 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 174.07 -73.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.45 -19.18 74.27 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.821 HG21 ' O ' ' A' ' 25' ' ' LEU . 4.2 p -49.97 137.56 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.559 -0.965 . . . . 0.0 110.454 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -121.5 -13.17 8.44 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.395 0.617 . . . . 0.0 109.606 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HG3' ' N ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -162.01 160.49 27.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.175 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.616 HG21 ' HA ' ' A' ' 22' ' ' LYS . 8.1 p -142.33 177.44 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.414 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' H ' HG22 ' A' ' 34' ' ' VAL . 12.0 t70 -156.6 155.64 32.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 110.186 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.549 ' CG1' ' HB2' ' A' ' 18' ' ' PRO . 3.3 t -108.87 111.27 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 110.443 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -117.47 52.48 0.68 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.617 ' CG ' ' HG3' ' A' ' 18' ' ' PRO . 2.2 t80 -62.49 -19.39 63.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -1.115 . . . . 0.0 110.128 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -48.81 -27.17 2.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -139.96 43.09 1.95 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.504 -0.748 . . . . 0.0 109.923 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HD2' ' HA ' ' A' ' 10' ' ' PRO . 1.6 mtt180 41.35 60.04 2.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.445 -0.784 . . . . 0.0 110.182 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -149.32 150.83 33.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.848 . . . . 0.0 110.777 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.645 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -122.23 134.03 54.7 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.975 ' CG2' HG22 ' A' ' 6' ' ' THR . 1.0 OUTLIER -106.38 142.55 19.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.327 -1.483 . . . . 0.0 109.396 -178.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.011 ' CG1' HD13 ' A' ' 57' ' ' LEU . 2.4 p -147.51 145.06 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.238 -1.385 . . . . 0.0 113.558 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -109.96 153.74 24.11 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.869 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.5 p90 -168.93 -178.43 3.31 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.675 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.617 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -106.96 113.86 27.59 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.629 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.512 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 9.3 t70 -57.67 -13.15 3.56 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 110.767 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.902 HG23 ' HB1' ' A' ' 1' ' ' ALA . 8.4 p -61.96 -31.24 71.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.664 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -133.15 -3.46 3.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.947 -1.095 . . . . 0.0 111.33 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -143.37 -175.93 4.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.973 -1.079 . . . . 0.0 110.642 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 172.3 169.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 0.0 109.681 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.06 HG13 HG21 ' A' ' 70' ' ' VAL . 19.1 t -39.1 -55.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.436 -0.79 . . . . 0.0 110.773 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 3.7 tp60 -44.51 -46.72 9.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 0.0 110.377 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -73.51 -28.5 61.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.185 -0.947 . . . . 0.0 111.333 -179.379 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.011 HD13 ' CG1' ' A' ' 45' ' ' VAL . 65.4 mt -68.95 -61.27 1.87 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.774 -1.204 . . . . 0.0 108.575 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.633 ' N ' HD21 ' A' ' 7' ' ' LEU . 10.1 t -60.34 -22.9 63.77 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.395 -0.816 . . . . 0.0 108.803 178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 2.7 tttt -78.34 -28.92 47.35 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.374 -0.829 . . . . 0.0 109.35 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.573 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -72.09 -45.55 60.22 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 108.995 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.854 ' OG1' HG22 ' A' ' 21' ' ' VAL . 9.9 t -70.8 -32.44 69.53 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -65.24 -31.71 73.02 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.579 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -88.72 -12.16 43.09 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.976 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -77.54 -26.48 51.05 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.06 19.84 0.69 Allowed Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.781 -1.2 . . . . 0.0 111.362 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.655 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 32.5 m-85 -142.51 113.7 6.09 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.511 -1.581 . . . . 0.0 111.758 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 2.7 Cg_endo -60.17 97.16 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 N-CA-C 107.418 -1.801 . . . . 0.0 107.418 177.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -108.3 -172.57 2.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.09 -1.006 . . . . 0.0 112.347 -176.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.503 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -148.52 -159.05 0.98 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.06 HG21 HG13 ' A' ' 54' ' ' VAL . 2.9 p -139.63 158.52 27.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 121.012 -1.055 . . . . 0.0 111.435 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 4.8 mtmt -121.41 23.09 10.54 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.223 1.011 . . . . 0.0 109.843 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.465 ' HA ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.283 -2.319 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.2 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.237 0.541 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -154.23 91.44 1.43 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.6 mt-30 -109.05 149.48 29.21 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.842 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.493 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 24.5 m -120.04 130.05 54.52 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.818 HG13 ' HA ' ' A' ' 72' ' ' GLN . 1.7 t -151.77 165.56 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.062 -1.024 . . . . 0.0 109.528 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.794 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -106.83 171.12 7.54 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.404 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.97 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.24 154.18 51.42 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.605 -178.515 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 68' ' ' SER . . . -108.57 94.24 4.95 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.463 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 21' ' ' VAL . 2.5 p -110.27 101.7 48.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.686 -0.634 . . . . 0.0 109.615 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.5 Cg_endo -78.28 44.37 1.59 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.728 1.383 . . . . 0.0 111.114 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.678 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -86.49 -41.35 6.93 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.513 ' HG3' ' HG2' ' A' ' 41' ' ' ARG . 12.2 mtp 59.18 -87.19 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.61 -0.935 . . . . 0.0 109.813 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.838 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 1.1 p 48.27 15.69 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' THR . 0.3 OUTLIER 45.43 104.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.823 . . . . 0.0 112.058 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 19' ' ' ILE . . . 56.01 32.19 19.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.263 -0.898 . . . . 0.0 111.044 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.838 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -137.61 -47.39 0.56 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 109.359 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -53.81 -45.94 98.63 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.538 -0.727 . . . . 0.0 111.183 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 10.3 Cg_endo -74.0 -11.37 23.45 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.005 1.136 . . . . 0.0 112.599 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 1.7 mt -92.39 -40.02 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.669 -1.269 . . . . 0.0 109.349 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 1.026 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.3 m -74.68 -40.5 61.36 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 9' ' ' VAL . 37.5 t -66.45 -48.89 79.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.544 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.612 ' O ' HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -47.93 -45.97 31.53 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 14.3 mttt -74.63 -23.43 58.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.251 -0.906 . . . . 0.0 111.6 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.699 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -68.92 -50.09 52.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.283 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.006 ' HB3' HG21 ' A' ' 45' ' ' VAL . 4.6 mp -70.53 -34.52 72.37 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 110.272 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.87 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -68.22 -21.33 64.86 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.329 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -113.39 5.04 16.61 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.04 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 25' ' ' LEU . 12.7 p -53.43 -49.19 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.128 -0.982 . . . . 0.0 110.421 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.608 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 170.17 -80.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.075 -1.016 . . . . 0.0 110.853 179.462 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.496 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -92.14 5.63 78.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.87 HG11 ' C ' ' A' ' 26' ' ' SER . 12.2 p -50.26 142.52 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.865 -1.373 . . . . 0.0 110.457 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.8 m -124.74 -9.79 7.29 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.758 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 1.3 tttt -168.31 138.55 2.56 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.578 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.793 HG21 ' CB ' ' A' ' 26' ' ' SER . 5.0 t -130.22 166.43 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.137 -0.977 . . . . 0.0 110.689 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.637 ' CB ' HG12 ' A' ' 44' ' ' VAL . 8.8 t0 -156.58 162.76 39.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.162 -0.961 . . . . 0.0 110.213 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.565 HG13 ' HB3' ' A' ' 18' ' ' PRO . 4.5 t -113.83 125.97 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -124.89 69.37 0.49 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -63.51 -11.75 26.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -1.116 . . . . 0.0 110.527 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -43.97 -31.36 0.88 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 108.979 179.239 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 41' ' ' ARG . 1.4 tttp -148.07 47.05 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.44 0.638 . . . . 0.0 109.308 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.513 ' HG2' ' HG3' ' A' ' 12' ' ' MET . 2.0 tpp180 42.03 58.96 2.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.436 -0.79 . . . . 0.0 110.363 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 13.9 pt-20 -138.38 169.42 17.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.294 -0.879 . . . . 0.0 110.286 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -134.74 134.96 41.55 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.648 HG23 ' HB ' ' A' ' 6' ' ' THR . 1.1 t -106.65 122.56 60.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.674 -1.266 . . . . 0.0 109.646 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.006 HG21 ' HB3' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -123.09 -178.28 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.669 1.223 . . . . 0.0 111.902 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -152.18 149.06 28.34 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.99 ' CE2' HD11 ' A' ' 57' ' ' LEU . 28.7 p90 -166.36 -175.3 3.19 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 117.601 -1.64 . . . . 0.0 112.011 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.601 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -106.23 110.52 22.79 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.488 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 5.9 t70 -57.81 -14.28 5.69 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.763 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.542 HG22 ' OD1' ' A' ' 48' ' ' ASP . 8.9 t -65.41 -34.97 79.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 110.294 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' N ' HG23 ' A' ' 50' ' ' THR . 1.6 mmpp? -125.39 3.82 7.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.146 -0.971 . . . . 0.0 110.431 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -150.77 -169.75 3.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.919 . . . . 0.0 110.339 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.4 p 170.05 165.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 0.0 109.618 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.925 HG13 HG21 ' A' ' 70' ' ' VAL . 2.9 t -43.44 -37.74 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.005 -1.059 . . . . 0.0 109.714 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -58.73 -46.72 86.74 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.019 -1.051 . . . . 0.0 109.544 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.509 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 10.5 mmmt -71.02 -25.61 62.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 110.861 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.99 HD11 ' CE2' ' A' ' 47' ' ' PHE . 55.2 mt -70.8 -58.7 3.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.786 -1.196 . . . . 0.0 108.21 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.649 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 99.7 m -56.47 -30.3 62.75 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -75.63 -28.73 58.93 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.403 -0.811 . . . . 0.0 109.555 179.593 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.699 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -70.01 -51.47 32.08 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.468 -0.77 . . . . 0.0 109.221 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.92 ' OG1' HG22 ' A' ' 21' ' ' VAL . 13.1 t -67.77 -30.06 69.41 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -67.54 -31.14 71.02 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.948 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -86.38 -12.88 48.03 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 1.026 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -32.4 57.42 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 137.94 31.9 0.22 Allowed Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.781 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.818 ' CB ' HG23 ' A' ' 9' ' ' VAL . 47.1 m-85 -151.88 113.81 2.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.786 -1.42 . . . . 0.0 111.596 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.38 94.71 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 N-CA-C 107.663 -1.706 . . . . 0.0 107.663 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -108.91 -165.0 0.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.032 . . . . 0.0 112.531 -177.137 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.499 ' N ' ' OG ' ' A' ' 68' ' ' SER . 49.1 m -152.49 -159.2 0.98 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.97 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.7 p -139.07 152.94 24.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.887 -1.133 . . . . 0.0 110.683 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.79 ' HB3' HG23 ' A' ' 6' ' ' THR . 1.3 tttp -125.51 49.51 1.91 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.923 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.818 ' HA ' HG13 ' A' ' 5' ' ' VAL . 3.5 pp0? . . . . . 0 C--N 1.28 -2.446 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.021 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.657 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.53 90.39 1.56 Allowed 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -124.31 171.67 9.71 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.956 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.491 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 37.0 m -110.73 155.72 22.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.574 -0.704 . . . . 0.0 110.42 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.787 HG13 ' C ' ' A' ' 72' ' ' GLN . 1.8 t -152.79 161.8 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 108.687 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.763 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -108.02 161.08 15.27 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.999 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -132.58 155.13 49.23 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.82 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.84 101.74 10.32 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.412 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 21' ' ' VAL . 2.0 p -118.09 101.84 51.28 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.495 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.25 36.67 0.55 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.379 1.386 . . . . 0.0 111.579 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.643 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -76.58 -46.69 11.26 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 10.6 ptp 38.47 54.91 1.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.737 -0.861 . . . . 0.0 110.181 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.841 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -86.69 17.05 4.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.579 -0.7 . . . . 0.0 109.764 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.648 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 7.8 t 66.45 89.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 110.604 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 65.32 18.04 11.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 110.48 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.841 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -123.14 -48.12 2.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 109.522 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.626 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -55.7 -44.15 99.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.47 -0.769 . . . . 0.0 111.303 179.426 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 12.7 Cg_endo -76.55 -16.77 16.7 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 120.925 1.083 . . . . 0.0 112.681 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.67 -31.52 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.587 -1.321 . . . . 0.0 109.561 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.965 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.1 m -83.64 -47.98 10.67 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 9' ' ' VAL . 74.9 t -57.52 -48.8 82.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.889 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.677 ' O ' HG11 ' A' ' 34' ' ' VAL . 14.4 tttt -57.46 -45.84 84.3 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.27 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -76.21 -2.76 32.83 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.199 -0.938 . . . . 0.0 110.616 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.579 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -85.18 -54.03 4.87 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.128 -0.983 . . . . 0.0 109.438 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.944 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -80.55 -13.22 59.26 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.244 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.915 ' HA ' HG21 ' A' ' 31' ' ' VAL . 20.1 t -78.72 -35.93 44.15 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.499 -0.751 . . . . 0.0 108.981 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HD2' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -104.15 2.95 32.45 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.825 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 25' ' ' LEU . 4.6 p -54.11 -53.35 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.79 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.608 ' H ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 169.28 -86.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.881 -1.137 . . . . 0.0 111.557 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.662 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -67.69 -21.72 73.09 Favored Glycine 0 N--CA 1.494 2.514 0 O-C-N 121.221 -0.924 . . . . 0.0 111.331 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.915 HG21 ' HA ' ' A' ' 26' ' ' SER . 10.8 p -40.15 144.74 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.933 -1.334 . . . . 0.0 111.702 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 m -127.99 -8.63 5.44 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.258 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.555 ' C ' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -162.36 165.05 26.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.157 -0.965 . . . . 0.0 109.842 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -160.28 155.6 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.989 -1.069 . . . . 0.0 111.165 -178.36 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.61 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -155.75 161.15 40.75 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 18' ' ' PRO . 3.2 m -109.59 131.86 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.734 -1.229 . . . . 0.0 111.29 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.4 58.67 0.56 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -58.78 -17.52 24.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -1.05 . . . . 0.0 110.769 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.14 -22.54 1.72 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.031 . . . . 0.0 109.634 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -148.7 43.11 0.99 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.427 -0.795 . . . . 0.0 109.828 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 40' ' ' LYS . 5.4 mmt180 41.75 58.59 2.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.401 -0.812 . . . . 0.0 109.921 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 4.5 pt-20 -149.17 151.92 35.18 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.992 -1.067 . . . . 0.0 110.669 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.423 ' CB ' HG12 ' A' ' 21' ' ' VAL . . . -117.58 142.43 47.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.802 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 44' ' ' VAL . 5.4 p -108.72 110.5 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.649 -1.282 . . . . 0.0 108.604 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 34' ' ' VAL . 2.9 p -116.52 144.0 25.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.965 0.888 . . . . 0.0 112.36 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.549 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.2 m -109.79 150.78 27.86 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.656 ' CE2' HD11 ' A' ' 57' ' ' LEU . 23.4 p90 -171.25 173.03 5.06 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 117.736 -1.586 . . . . 0.0 112.303 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.752 ' HB2' HG22 ' A' ' 50' ' ' THR . 0.7 OUTLIER -107.26 118.86 37.83 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.176 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.653 ' CG ' ' HB3' ' A' ' 1' ' ' ALA . 6.1 p-10 -59.27 -10.99 3.41 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.279 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.752 HG22 ' HB2' ' A' ' 48' ' ' ASP . 7.7 t -68.77 -27.02 65.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.958 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HB2' ' OD1' ' A' ' 48' ' ' ASP . 5.6 mttt -120.94 0.55 10.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.92 -1.112 . . . . 0.0 110.579 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.662 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -171.76 -160.79 0.17 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 110.206 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.626 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 169.18 167.74 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.502 -0.749 . . . . 0.0 110.098 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.029 HG13 HG21 ' A' ' 70' ' ' VAL . 3.0 t -41.08 -42.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.875 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 6.9 tp-100 -52.02 -49.79 62.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.022 . . . . 0.0 109.504 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.546 ' CG ' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -74.17 -22.7 59.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.458 -0.776 . . . . 0.0 111.645 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.864 HD13 ' CG1' ' A' ' 45' ' ' VAL . 57.0 mt -72.66 -61.42 1.81 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.39 -1.444 . . . . 0.0 108.237 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.493 ' O ' HG22 ' A' ' 61' ' ' THR . 79.1 m -57.11 -26.08 59.87 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.503 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 3.1 ttmt -72.47 -36.05 68.37 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.558 -0.713 . . . . 0.0 109.104 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.579 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -66.13 -41.08 90.97 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.439 -0.788 . . . . 0.0 109.938 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.557 ' OG1' HG22 ' A' ' 21' ' ' VAL . 8.9 t -73.65 -29.92 62.62 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.15 -32.66 74.24 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 8.8 t0 -90.64 -12.45 36.83 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.672 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.965 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -78.22 -27.47 47.76 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 132.76 26.61 0.63 Allowed Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.672 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.762 ' CB ' HG23 ' A' ' 9' ' ' VAL . 37.7 m-85 -147.82 109.11 3.78 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.689 -1.477 . . . . 0.0 111.659 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -59.85 95.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 N-CA-C 107.312 -1.842 . . . . 0.0 107.312 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.03 -168.74 1.38 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 112.415 -176.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.543 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -151.63 -160.81 1.21 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.029 HG21 HG13 ' A' ' 54' ' ' VAL . 2.2 p -140.24 159.24 25.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.991 -1.068 . . . . 0.0 110.968 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.486 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 2.6 mttt -124.96 25.13 7.41 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.448 1.118 . . . . 0.0 109.155 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.787 ' C ' HG13 ' A' ' 5' ' ' VAL . 13.4 mm100 . . . . . 0 C--N 1.285 -2.211 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.136 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.191 0.519 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -146.17 88.75 1.82 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -108.72 163.49 13.21 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.501 -0.88 . . . . 0.0 112.493 -177.048 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.448 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 1.3 t -135.14 111.4 9.68 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.281 0.562 . . . . 0.0 109.775 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.447 HG21 HD12 ' A' ' 57' ' ' LEU 0.256 14.5 m -122.75 166.39 17.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.216 -0.928 . . . . 0.0 109.925 -179.155 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.731 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.45 166.47 10.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.597 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.008 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.15 161.42 33.38 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.1 -178.448 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.512 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -109.56 105.88 15.37 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.434 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.747 HG23 ' CB ' ' A' ' 66' ' ' TYR . 2.3 p -116.43 85.9 17.05 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -76.39 36.06 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.67 1.353 . . . . 0.0 112.318 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -78.72 -31.07 45.94 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.76 -2.136 . . . . 0.0 107.76 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 36.84 42.0 0.2 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.923 -0.751 . . . . 0.0 110.386 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.991 HG21 ' HB3' ' A' ' 16' ' ' ALA . 4.0 t -45.78 -27.88 0.93 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 13' ' ' THR . 7.6 t 144.33 -41.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 121.91 0.862 . . . . 0.0 109.241 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.601 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . . . -176.23 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.577 0.703 . . . . 0.0 109.366 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.991 ' HB3' HG21 ' A' ' 13' ' ' THR . . . -129.07 -26.27 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.607 -0.683 . . . . 0.0 109.981 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.642 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -44.62 -47.27 27.51 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.917 -1.114 . . . . 0.0 111.689 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.856 ' O ' HG21 ' A' ' 36' ' ' VAL . 6.9 Cg_endo -76.23 -18.21 16.35 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.334 1.356 . . . . 0.0 113.325 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 mm -87.59 -42.67 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.415 -1.428 . . . . 0.0 109.557 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.871 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.251 0.9 OUTLIER -69.55 -37.21 76.94 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.889 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.908 ' O ' HD12 ' A' ' 25' ' ' LEU . 25.6 t -64.6 -45.61 94.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 1.078 ' O ' HG21 ' A' ' 34' ' ' VAL . 68.7 tttt -50.67 -45.99 58.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.574 -0.704 . . . . 0.0 110.307 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 8.7 mtmt -75.67 -20.82 58.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 111.101 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.594 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -69.97 -52.65 22.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.439 -0.788 . . . . 0.0 110.557 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.932 HD21 ' CD2' ' A' ' 7' ' ' LEU . 4.0 mp -71.91 -31.09 66.05 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.144 -0.973 . . . . 0.0 110.028 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.803 ' C ' HG11 ' A' ' 31' ' ' VAL . 12.7 t -68.22 -22.99 64.76 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -111.6 2.8 17.52 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.274 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.922 HG12 ' O ' ' A' ' 25' ' ' LEU . 7.7 p -49.94 -52.13 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.073 -1.017 . . . . 0.0 110.339 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.602 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 172.34 -77.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 110.897 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.499 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -93.34 -1.88 66.26 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.803 HG11 ' C ' ' A' ' 26' ' ' SER . 6.9 p -44.0 141.05 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.238 . . . . 0.0 110.711 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.6 t -118.02 -13.86 9.99 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.606 0.717 . . . . 0.0 109.071 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.702 ' O ' HG13 ' A' ' 45' ' ' VAL . 7.5 tttt -159.46 166.28 31.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.546 -0.721 . . . . 0.0 109.649 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.078 HG21 ' O ' ' A' ' 22' ' ' LYS . 7.2 p -162.51 154.47 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.99 . . . . 0.0 111.366 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.565 ' HB2' HG13 ' A' ' 44' ' ' VAL . 1.3 m-20 -164.86 171.19 14.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 109.238 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.856 HG21 ' O ' ' A' ' 18' ' ' PRO . 3.1 m -152.06 164.6 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.935 -1.103 . . . . 0.0 111.173 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.26 112.31 0.52 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.602 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -66.27 -19.35 65.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -1.142 . . . . 0.0 109.934 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -53.8 -64.67 0.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.354 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -95.6 22.63 6.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.33 -0.856 . . . . 0.0 109.33 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.656 ' NH1' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 36.89 59.64 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.33 0.586 . . . . 0.0 110.772 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 18.3 pt-20 -146.11 166.96 24.59 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.536 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.786 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -125.56 132.57 52.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.161 -0.962 . . . . 0.0 109.163 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.668 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.8 p -106.51 116.18 49.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 120.791 -1.193 . . . . 0.0 109.119 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.876 HG22 HG23 ' A' ' 34' ' ' VAL . 39.3 t -129.84 144.78 37.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.122 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 1.2 m -108.6 161.29 15.21 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.4 p90 -170.22 -177.69 2.57 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 117.898 -1.521 . . . . 0.0 112.091 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.613 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.7 m-20 -105.98 113.94 27.79 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 10.7 t70 -59.62 -10.2 3.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.784 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.0 p -70.55 -29.22 65.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 0.0 110.61 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -134.6 18.32 3.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.028 -1.045 . . . . 0.0 110.846 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -170.66 178.72 3.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.0 110.053 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.585 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.9 OUTLIER 176.2 171.01 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.387 -0.821 . . . . 0.0 109.511 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.963 HG13 HG21 ' A' ' 70' ' ' VAL . 2.7 t -41.8 -34.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -58.88 -50.27 74.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.896 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.575 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 16.3 mmtm -76.5 -20.52 56.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 111.246 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.859 HD11 ' CE2' ' A' ' 47' ' ' PHE . 76.1 mt -70.77 -59.71 2.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.572 -1.33 . . . . 0.0 108.482 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 94.5 m -58.63 -26.88 64.19 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.518 -0.739 . . . . 0.0 109.049 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 60.4 tttt -76.35 -29.59 57.29 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.51 -0.744 . . . . 0.0 109.307 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.594 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -69.94 -51.12 35.48 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.626 ' HB ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.64 -32.8 74.35 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.38 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -64.87 -31.27 72.42 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.903 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -88.54 -11.11 46.63 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.498 -0.751 . . . . 0.0 109.028 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.871 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -78.35 -27.3 47.0 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 135.86 23.8 0.55 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.093 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.747 ' CB ' HG23 ' A' ' 9' ' ' VAL . 43.7 m-85 -148.15 109.12 3.69 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.493 -1.592 . . . . 0.0 111.64 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.1 Cg_exo -57.19 98.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 107.014 -1.956 . . . . 0.0 107.014 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 71.6 p -108.41 -166.31 1.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.083 0.944 . . . . 0.0 112.68 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.497 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.8 m -151.8 -160.74 1.19 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.008 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.2 p -141.1 160.07 22.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.779 -1.2 . . . . 0.0 111.844 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.728 ' HG3' HG23 ' A' ' 6' ' ' THR . 9.2 mttt -127.85 25.35 5.97 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.367 1.079 . . . . 0.0 108.93 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.122 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.401 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.105 0.478 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.58 91.58 1.5 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -113.68 -174.93 2.56 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.312 -0.955 . . . . 0.0 112.462 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.552 ' C ' HG23 ' A' ' 5' ' ' VAL . 92.3 m -142.5 146.81 35.11 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.468 0.652 . . . . 0.0 110.34 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.918 HG13 ' HA ' ' A' ' 72' ' ' GLN . 15.9 t -156.03 167.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.461 -0.774 . . . . 0.0 109.764 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -109.66 169.47 8.69 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.477 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.997 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -133.29 157.99 44.08 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.934 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 68' ' ' SER . . . -110.24 103.33 12.0 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.735 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.828 HG21 HG21 ' A' ' 21' ' ' VAL . 1.9 p -114.56 92.65 29.53 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.397 -0.814 . . . . 0.0 109.995 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 10.7 Cg_endo -79.54 51.42 3.87 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.669 1.579 . . . . 0.0 111.581 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.606 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -95.44 -21.09 25.42 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.524 ' CG ' ' C ' ' A' ' 11' ' ' GLY . 1.2 ptt? 35.77 59.4 0.86 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.768 -0.842 . . . . 0.0 110.559 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.821 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -90.51 19.68 5.12 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.521 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 13' ' ' THR . 2.4 t 68.5 92.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.471 -0.768 . . . . 0.0 110.309 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.585 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . . . 50.25 30.96 4.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 110.085 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.821 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -127.17 -45.45 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.586 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -40.05 -69.37 0.21 Allowed Pre-proline 0 N--CA 1.505 2.281 0 O-C-N 121.109 -0.994 . . . . 0.0 111.673 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.857 ' O ' HG12 ' A' ' 36' ' ' VAL . 10.0 Cg_endo -65.8 -12.75 36.63 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.173 1.249 . . . . 0.0 112.752 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 20' ' ' THR . 1.5 mp -78.88 -56.0 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.864 -1.147 . . . . 0.0 109.583 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.533 HG23 ' HB1' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -69.37 -42.01 75.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.888 HG22 ' OG1' ' A' ' 61' ' ' THR . 5.6 t -57.71 -43.53 83.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.847 ' O ' HG21 ' A' ' 34' ' ' VAL . 12.8 tttt -53.08 -50.11 65.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.511 -0.743 . . . . 0.0 109.861 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 7.9 mtpm? -72.47 -11.59 60.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 111.501 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.476 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -77.8 -67.22 0.75 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.124 -0.985 . . . . 0.0 109.466 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.767 HD22 ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -68.28 -12.3 60.81 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 1.052 ' HA ' HG21 ' A' ' 31' ' ' VAL . 6.8 t -79.32 -30.24 42.73 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.99 9.41 18.72 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.238 -0.914 . . . . 0.0 109.813 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.613 HG13 ' H ' ' A' ' 29' ' ' GLU . 4.0 p -51.89 -53.73 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.349 -0.844 . . . . 0.0 111.08 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.613 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.6 tt0 -179.9 -86.28 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.598 -1.314 . . . . 0.0 110.85 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.547 ' N ' ' CG ' ' A' ' 29' ' ' GLU . . . -74.67 -15.14 80.78 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.052 HG21 ' HA ' ' A' ' 26' ' ' SER . 3.5 p -40.54 142.08 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -1.069 . . . . 0.0 110.961 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 m -127.02 -11.92 5.88 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.396 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.641 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -158.07 165.2 35.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.18 -0.95 . . . . 0.0 110.044 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 1.081 HG23 HG22 ' A' ' 45' ' ' VAL . 6.4 p -169.01 154.48 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.023 -1.048 . . . . 0.0 111.59 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.563 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -157.09 172.14 19.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.491 -0.756 . . . . 0.0 109.634 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.857 HG12 ' O ' ' A' ' 18' ' ' PRO . 2.9 m -109.91 151.09 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.057 -1.027 . . . . 0.0 110.926 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -142.85 64.35 0.49 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -57.33 -15.86 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 110.245 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -45.31 -33.62 2.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.124 -0.985 . . . . 0.0 109.21 179.522 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -141.57 40.04 1.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.509 -0.744 . . . . 0.0 109.459 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.6 OUTLIER 42.47 57.55 3.38 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.451 -0.781 . . . . 0.0 110.081 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 13.7 pt-20 -142.93 168.76 18.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 110.422 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -129.27 137.79 51.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.419 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.6 p -107.85 109.02 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.706 -1.246 . . . . 0.0 110.288 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.081 HG22 HG23 ' A' ' 34' ' ' VAL . 11.6 t -122.71 150.89 26.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 122.138 0.971 . . . . 0.0 112.068 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -114.12 159.53 19.94 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.637 ' CD2' HD11 ' A' ' 57' ' ' LEU . 38.5 p90 -170.91 -175.04 1.67 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.606 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.606 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.1 m-20 -106.18 124.75 50.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HB3' ' CB ' ' A' ' 1' ' ' ALA . 10.2 t70 -80.94 37.87 0.44 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.45 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.6 p -115.53 -24.53 8.29 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.171 -0.956 . . . . 0.0 109.23 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.7 mttt -127.7 -2.11 6.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.419 -0.8 . . . . 0.0 110.073 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 179.17 176.21 0.61 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.93 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.594 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 6.8 p 172.83 -166.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.671 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.046 HG13 HG21 ' A' ' 70' ' ' VAL . 6.5 t -36.68 -40.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.559 -0.713 . . . . 0.0 111.149 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -57.53 -49.49 76.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.106 -0.997 . . . . 0.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.585 ' HB3' HG21 ' A' ' 28' ' ' VAL . 58.1 mmtt -82.01 -16.95 48.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.263 -0.898 . . . . 0.0 111.736 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.751 HD22 ' HB2' ' A' ' 25' ' ' LEU . 48.0 mt -75.27 -58.47 3.26 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.514 -1.366 . . . . 0.0 108.065 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.534 ' O ' HG22 ' A' ' 61' ' ' THR . 12.9 m -54.46 -30.61 53.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.29 -34.6 65.85 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.513 -0.742 . . . . 0.0 109.858 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.446 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -67.93 -36.96 81.05 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.173 -0.955 . . . . 0.0 109.704 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.888 ' OG1' HG22 ' A' ' 21' ' ' VAL . 5.3 t -74.3 -35.57 63.7 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' N ' HG23 ' A' ' 61' ' ' THR . . . -64.65 -32.14 73.68 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -90.68 -8.08 50.91 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.533 ' HB1' HG23 ' A' ' 20' ' ' THR . . . -85.16 -21.11 29.33 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.452 -0.78 . . . . 0.0 108.942 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 133.08 17.01 1.18 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.004 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.812 ' CB ' HG23 ' A' ' 9' ' ' VAL . 35.2 m-85 -151.51 111.46 2.98 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.706 -1.467 . . . . 0.0 111.307 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.14 96.83 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 N-CA-C 107.87 -1.627 . . . . 0.0 107.87 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.9 -171.24 1.81 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.01 . . . . 0.0 112.187 -177.27 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.542 ' N ' ' OG ' ' A' ' 68' ' ' SER . 6.0 p -145.18 -157.45 0.79 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.046 HG21 HG13 ' A' ' 54' ' ' VAL . 3.1 p -142.47 158.81 19.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.209 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.536 ' CG ' HG23 ' A' ' 6' ' ' THR . 3.9 mttm -124.69 27.12 6.96 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.304 1.05 . . . . 0.0 109.659 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.918 ' HA ' HG13 ' A' ' 5' ' ' VAL . 17.2 pt20 . . . . . 0 C--N 1.287 -2.148 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.543 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.903 ' CB ' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.256 0.55 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.777 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER 171.16 108.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.975 0.893 . . . . 0.0 109.181 179.403 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.06 176.1 9.75 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.071 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.4 HG23 ' OG1' ' A' ' 46' ' ' THR . 21.6 m -113.4 131.86 55.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 110.138 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.599 HG21 HG22 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -128.98 169.36 20.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.038 0.923 . . . . 0.0 109.296 179.582 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.683 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -108.51 159.88 16.34 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.963 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -133.04 152.97 51.91 Favored 'General case' 0 C--N 1.292 -1.921 0 O-C-N 120.868 -1.145 . . . . 0.0 109.688 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -108.95 111.48 23.18 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.616 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 21' ' ' VAL . 2.1 p -133.23 93.55 22.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 109.167 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 5.5 Cg_endo -73.26 19.13 0.37 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.388 1.392 . . . . 0.0 112.291 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.637 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -52.19 -36.18 43.99 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.516 ' C ' ' O ' ' A' ' 11' ' ' GLY . 2.1 ptt? 26.61 50.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.67 0.748 . . . . 0.0 110.765 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 1.155 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.9 t -81.38 9.86 6.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.676 -0.64 . . . . 0.0 110.035 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.3 OUTLIER 78.74 94.18 0.06 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.601 0.715 . . . . 0.0 111.104 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.518 ' O ' HD12 ' A' ' 19' ' ' ILE . . . 58.44 42.67 20.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.612 -0.68 . . . . 0.0 112.052 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.155 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -160.81 -44.0 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.709 -1.244 . . . . 0.0 111.005 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.858 ' H ' HG22 ' A' ' 13' ' ' THR . 0.0 OUTLIER -46.62 -53.17 26.49 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.627 -1.295 . . . . 0.0 110.167 179.519 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.641 ' CG ' ' CD2' ' A' ' 38' ' ' PHE . 10.6 Cg_endo -74.04 -16.59 22.75 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.29 1.327 . . . . 0.0 112.219 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 15' ' ' ALA . 29.6 mt -79.01 -38.49 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.828 -1.17 . . . . 0.0 109.632 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.923 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -77.06 -45.81 25.81 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 9' ' ' VAL . 16.9 t -56.37 -40.69 68.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.538 ' O ' HG21 ' A' ' 34' ' ' VAL . 7.2 tttt -55.67 -56.96 14.23 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 108.823 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -71.39 0.69 7.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.41 -0.806 . . . . 0.0 110.868 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.642 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -88.79 -72.14 0.56 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.669 -1.269 . . . . 0.0 108.929 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.808 HD12 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -64.78 -9.93 24.05 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.49 178.587 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.886 ' HA ' HG11 ' A' ' 31' ' ' VAL . 34.8 t -90.65 -45.5 8.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.5 -0.75 . . . . 0.0 110.397 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -79.28 -4.15 49.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.864 -1.147 . . . . 0.0 110.309 -179.51 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.682 HG12 ' CG ' ' A' ' 29' ' ' GLU . 5.4 t -29.85 -79.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.852 -0.53 . . . . 0.0 110.927 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.682 ' CG ' HG12 ' A' ' 28' ' ' VAL . 1.2 pt-20 178.0 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.948 -1.095 . . . . 0.0 110.935 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 48' ' ' ASP . . . -117.66 2.27 17.87 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.886 HG11 ' HA ' ' A' ' 26' ' ' SER . 71.6 t -49.69 147.87 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 122.459 1.123 . . . . 0.0 111.399 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 m -122.2 -10.18 8.56 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.459 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.508 ' CG ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -175.72 170.37 2.88 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.001 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.806 HG21 ' HB2' ' A' ' 26' ' ' SER . 9.7 p -170.09 156.49 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.862 . . . . 0.0 110.517 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.56 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -156.2 164.88 37.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.427 -0.795 . . . . 0.0 109.633 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 18' ' ' PRO . 7.2 m -112.18 140.49 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 110.704 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.17 69.82 0.53 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.641 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -61.92 -14.72 37.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -1.154 . . . . 0.0 110.435 -179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -54.89 -27.15 40.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 109.8 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 42' ' ' GLU . 2.8 ptmt -142.7 35.51 1.43 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 110.03 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 10' ' ' PRO . 1.9 mpp_? 42.9 55.75 4.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.214 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -145.61 149.42 34.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.233 -0.917 . . . . 0.0 110.11 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.501 ' N ' ' HG2' ' A' ' 42' ' ' GLU . . . -115.87 139.25 50.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 110.031 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.705 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.1 p -106.47 111.78 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.763 -1.211 . . . . 0.0 109.47 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.102 ' CG1' HD13 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -117.51 137.83 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.776 0.798 . . . . 0.0 112.289 -178.056 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.508 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.6 m -109.0 155.77 20.51 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.777 ' O ' ' HA ' ' A' ' 2' ' ' THR . 35.5 p90 -171.92 -176.81 1.79 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.449 -1.407 . . . . 0.0 110.798 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.498 ' HA ' ' HB ' ' A' ' 2' ' ' THR . 2.1 p30 -109.59 110.52 21.62 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 29.0 t70 -54.64 -14.69 1.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.959 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.903 HG23 ' CB ' ' A' ' 1' ' ' ALA . 2.2 p -61.63 -35.73 78.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 110.807 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.08 -5.23 9.52 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.043 -1.035 . . . . 0.0 111.361 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -153.02 -164.47 1.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.969 -1.082 . . . . 0.0 110.874 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.605 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 6.4 t 167.72 172.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.96 ' HB ' HG21 ' A' ' 70' ' ' VAL . 6.6 m -51.54 -32.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.753 -1.217 . . . . 0.0 109.451 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -47.66 -44.86 27.54 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.014 -1.054 . . . . 0.0 108.404 179.003 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -89.06 -20.58 24.18 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.763 -0.586 . . . . 0.0 111.244 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.102 HD13 ' CG1' ' A' ' 45' ' ' VAL . 42.3 mt -73.77 -64.04 1.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.229 -1.544 . . . . 0.0 107.98 178.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.532 ' O ' HG22 ' A' ' 61' ' ' THR . 1.4 m -56.59 -27.61 58.42 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -74.81 -32.0 61.85 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.168 -0.957 . . . . 0.0 109.327 179.362 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.642 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -70.48 -35.94 73.56 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.316 -0.865 . . . . 0.0 109.459 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.833 ' OG1' HG22 ' A' ' 21' ' ' VAL . 4.8 t -74.68 -34.7 62.73 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.415 ' N ' HG23 ' A' ' 61' ' ' THR . . . -66.36 -32.29 73.59 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.39 -10.09 45.19 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.576 -0.703 . . . . 0.0 109.378 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.923 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.48 -29.66 41.75 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.56 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.98 27.93 0.34 Allowed Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.699 -1.238 . . . . 0.0 110.996 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.701 ' CB ' HG23 ' A' ' 9' ' ' VAL . 53.0 m-85 -150.9 116.72 3.28 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.622 -1.517 . . . . 0.0 111.449 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.54 95.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 N-CA-C 106.875 -2.01 . . . . 0.0 106.875 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.605 ' HB2' HG23 ' A' ' 61' ' ' THR . 2.9 m -108.79 -165.1 0.99 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 112.51 -176.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.428 ' O ' ' OG1' ' A' ' 58' ' ' THR . 4.9 t -159.42 -167.11 1.95 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.963 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.1 p -139.06 155.92 27.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 120.804 -1.185 . . . . 0.0 111.379 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.502 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 1.1 mttt -124.49 26.72 7.19 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.432 1.111 . . . . 0.0 108.864 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 5' ' ' VAL . 1.8 mp0 . . . . . 0 C--N 1.29 -2.013 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.289 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.156 0.503 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.61 88.42 1.42 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 11.5 mt-30 -112.48 151.08 30.34 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.655 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 52.3 m -124.9 122.42 37.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.708 HG21 HG22 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -130.32 171.68 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.03 . . . . 0.0 110.419 -178.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.724 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.28 158.91 16.76 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.818 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.925 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -130.07 155.89 45.41 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.662 -1.273 . . . . 0.0 109.847 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.748 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -110.98 100.76 9.4 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.946 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.725 HG21 HG21 ' A' ' 21' ' ' VAL . 1.8 p -114.45 89.97 19.67 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.476 -0.765 . . . . 0.0 109.337 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 11.0 Cg_endo -78.06 46.53 2.1 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.361 1.374 . . . . 0.0 112.008 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.616 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -92.42 -34.31 7.12 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.486 ' C ' ' O ' ' A' ' 11' ' ' GLY . 0.9 OUTLIER 35.59 44.33 0.2 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.758 0.789 . . . . 0.0 110.087 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 1.14 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.4 t -61.22 -11.03 7.84 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.679 -0.638 . . . . 0.0 109.639 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.733 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 86.66 93.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.614 0.721 . . . . 0.0 111.029 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 73.55 24.4 2.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 111.831 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.14 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -150.84 -38.69 0.13 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.457 -1.402 . . . . 0.0 110.718 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.819 ' H ' HG22 ' A' ' 13' ' ' THR . 0.5 OUTLIER -45.15 -47.74 32.36 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.606 -1.309 . . . . 0.0 110.459 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.6 Cg_endo -70.75 -28.17 20.83 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 O-C-N 123.229 1.12 . . . . 0.0 111.655 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.5 mm -73.39 -32.18 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.955 . . . . 0.0 110.839 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.851 HG23 ' HB1' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -81.64 -53.27 6.37 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 108.965 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.037 HG22 ' OG1' ' A' ' 61' ' ' THR . 66.5 t -54.39 -43.46 62.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.678 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.9 tttm -55.55 -61.75 2.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.937 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.59 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -75.42 5.74 5.43 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.186 -0.946 . . . . 0.0 110.678 179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.547 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -85.36 -67.89 0.77 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.373 -1.454 . . . . 0.0 108.482 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.76 ' HB2' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -74.26 -11.62 60.33 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.22 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.859 ' HA ' HG21 ' A' ' 31' ' ' VAL . 46.5 t -85.51 -33.25 21.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.59 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.45 -10.1 42.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.6 -1.312 . . . . 0.0 110.433 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.061 HG11 ' CE ' ' A' ' 56' ' ' LYS . 3.2 t -40.39 -82.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.276 -0.89 . . . . 0.0 110.015 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.799 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 174.97 -57.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.418 -0.801 . . . . 0.0 109.906 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.444 ' O ' ' OD2' ' A' ' 48' ' ' ASP . . . -70.3 -26.76 73.73 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.859 HG21 ' HA ' ' A' ' 26' ' ' SER . 14.8 p -56.56 142.3 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -1.145 . . . . 0.0 110.699 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.84 -10.9 8.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.757 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.4 tttt -162.47 168.96 21.17 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.068 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.552 HG21 ' O ' ' A' ' 22' ' ' LYS . 13.7 p -169.07 159.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.093 -1.004 . . . . 0.0 111.384 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.476 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -158.85 162.95 37.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.513 ' CG1' ' HB2' ' A' ' 22' ' ' LYS . 22.4 m -116.23 152.33 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 110.603 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -144.41 79.13 0.25 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.565 ' CE2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -58.03 -18.92 27.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -1.121 . . . . 0.0 110.119 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -50.3 -47.99 55.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 0.0 109.092 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 41' ' ' ARG . 10.1 mttm -116.18 25.49 10.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.493 -0.754 . . . . 0.0 109.381 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.614 ' NH1' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 40.97 57.48 2.74 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.422 0.63 . . . . 0.0 110.191 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -148.06 155.86 41.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.412 -0.805 . . . . 0.0 109.742 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -112.13 138.66 48.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.944 -1.097 . . . . 0.0 110.276 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.744 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.6 p -106.09 105.65 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.821 -1.174 . . . . 0.0 109.064 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.004 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.8 p -109.72 148.84 13.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 122.089 0.947 . . . . 0.0 112.292 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -115.94 154.13 30.35 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.6 p90 -170.83 -177.24 2.22 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 117.669 -1.612 . . . . 0.0 112.051 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.765 ' HB2' HG22 ' A' ' 50' ' ' THR . 1.2 p30 -107.01 115.05 29.51 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 7.8 t70 -68.24 -3.79 11.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.777 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.765 HG22 ' HB2' ' A' ' 48' ' ' ASP . 4.1 t -66.63 -6.98 17.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 110.018 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -137.35 -51.09 0.64 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.136 -0.978 . . . . 0.0 110.937 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB1' ' CG ' ' A' ' 56' ' ' LYS . . . -130.49 -160.99 1.08 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.452 -0.78 . . . . 0.0 110.466 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.591 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.3 p 168.4 -169.02 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.379 -0.825 . . . . 0.0 109.338 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.036 HG13 HG21 ' A' ' 70' ' ' VAL . 3.1 t -35.5 -59.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.747 -0.595 . . . . 0.0 111.134 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 34.4 tt0 -43.13 -47.54 6.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 0.0 110.791 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 1.061 ' CE ' HG11 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -79.14 -24.06 43.58 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.964 . . . . 0.0 111.849 -178.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.004 HD13 ' CG1' ' A' ' 45' ' ' VAL . 79.9 mt -72.08 -56.73 5.1 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.503 -1.373 . . . . 0.0 108.384 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.491 ' O ' HG22 ' A' ' 61' ' ' THR . 7.4 m -56.48 -31.46 64.05 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.528 -0.732 . . . . 0.0 109.385 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -75.47 -31.57 60.29 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.287 -0.883 . . . . 0.0 110.005 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -69.07 -42.31 76.39 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.037 ' OG1' HG22 ' A' ' 21' ' ' VAL . 12.9 t -73.64 -32.89 64.26 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 66' ' ' TYR . . . -64.67 -31.25 72.4 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.59 -9.51 46.78 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.851 ' HB1' HG23 ' A' ' 20' ' ' THR . . . -81.93 -23.7 36.03 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.35 14.4 0.62 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.463 -1.351 . . . . 0.0 111.743 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.682 ' CB ' HG23 ' A' ' 9' ' ' VAL . 68.7 m-85 -145.69 114.11 4.71 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.313 -1.698 . . . . 0.0 111.79 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.77 97.58 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 N-CA-C 107.255 -1.863 . . . . 0.0 107.255 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 1.5 p -108.31 -166.14 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.0 112.751 -176.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.748 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 24.6 p -150.73 -164.92 2.13 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.036 HG21 HG13 ' A' ' 54' ' ' VAL . 2.4 p -141.07 158.32 22.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.906 -1.118 . . . . 0.0 111.516 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.482 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -125.95 24.72 6.95 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.294 1.045 . . . . 0.0 109.088 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.489 ' OXT' HG23 ' A' ' 5' ' ' VAL . 39.4 mt-30 . . . . . 0 C--N 1.289 -2.026 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.345 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.539 0.685 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.698 HG23 ' N ' ' A' ' 3' ' ' GLN 0.258 14.6 t -100.2 -135.3 0.29 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.698 ' N ' HG23 ' A' ' 2' ' ' THR . 0.6 OUTLIER -173.37 153.88 2.5 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.455 179.048 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.6 m -143.16 107.73 4.83 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.594 HG13 ' HA ' ' A' ' 72' ' ' GLN . 2.5 t -140.17 165.15 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -0.854 . . . . 0.0 109.9 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 1.047 HG22 ' CG2' ' A' ' 44' ' ' VAL . 2.4 p -108.9 164.0 12.79 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.989 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.95 157.74 46.12 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.704 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.46 107.25 16.85 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.568 -0.707 . . . . 0.0 110.068 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.021 HG21 HG21 ' A' ' 21' ' ' VAL . 2.0 p -117.15 100.44 53.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.751 . . . . 0.0 109.524 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -76.27 34.96 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.381 1.388 . . . . 0.0 112.156 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.642 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.56 -46.11 86.34 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.562 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 16.9 ptt? 36.78 47.54 0.57 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.88 -0.776 . . . . 0.0 110.36 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 1.123 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -85.19 14.9 4.63 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.508 -0.745 . . . . 0.0 109.795 179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 13' ' ' THR . 4.0 t 77.68 87.97 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.489 0.661 . . . . 0.0 111.363 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 56.12 38.83 30.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.489 -0.757 . . . . 0.0 111.788 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.123 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -154.43 -31.27 0.11 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.883 -1.136 . . . . 0.0 111.122 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.761 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -50.82 -55.23 28.87 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.647 -1.283 . . . . 0.0 110.676 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 1.008 ' HB2' HG13 ' A' ' 36' ' ' VAL . 9.5 Cg_endo -69.05 -3.79 12.25 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.249 1.299 . . . . 0.0 112.543 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 15.5 mt -90.54 -48.49 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.857 -1.152 . . . . 0.0 109.229 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.941 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -62.56 -36.81 83.84 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.366 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.021 HG21 HG21 ' A' ' 9' ' ' VAL . 60.4 t -65.54 -48.13 83.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.653 ' O ' HG21 ' A' ' 34' ' ' VAL . 44.6 tttm -42.71 -54.19 4.16 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.634 -0.666 . . . . 0.0 110.669 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -71.44 -26.02 62.56 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.163 -0.961 . . . . 0.0 111.473 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -65.11 -55.37 19.13 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.302 -0.874 . . . . 0.0 110.818 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.99 ' HB3' HG11 ' A' ' 45' ' ' VAL . 3.2 mp -69.71 -31.65 69.78 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.099 -1.001 . . . . 0.0 110.534 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.569 ' HA ' HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -68.23 -22.08 64.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.239 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.46 1.09 15.78 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.025 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.579 HG13 ' N ' ' A' ' 29' ' ' GLU . 7.6 p -45.7 -46.94 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.883 -1.136 . . . . 0.0 110.627 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.579 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.4 OUTLIER 173.17 -80.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.897 -1.127 . . . . 0.0 110.891 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.534 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -92.41 -14.77 55.19 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.006 -1.093 . . . . 0.0 110.528 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.589 HG11 ' O ' ' A' ' 25' ' ' LEU . 9.6 t -42.43 139.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.027 -1.278 . . . . 0.0 110.428 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.1 t -118.32 -10.66 10.17 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.474 0.654 . . . . 0.0 109.245 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -154.0 164.59 38.19 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.264 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.888 HG23 HG13 ' A' ' 45' ' ' VAL . 6.4 p -152.94 174.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 109.242 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . 1.2 t0 -162.3 160.01 26.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.832 -1.168 . . . . 0.0 111.378 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.008 HG13 ' HB2' ' A' ' 18' ' ' PRO . 25.1 t -110.07 136.08 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.487 -0.758 . . . . 0.0 109.963 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -138.63 61.75 0.57 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -58.87 -23.48 60.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -1.135 . . . . 0.0 110.326 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -42.99 -40.77 3.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.864 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.539 ' CG ' ' HG2' ' A' ' 42' ' ' GLU . 12.9 ptpt -139.21 49.2 1.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.421 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.562 ' CD ' ' HB3' ' A' ' 12' ' ' MET . 0.0 OUTLIER 39.47 62.31 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.505 -0.747 . . . . 0.0 110.299 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HG2' ' CG ' ' A' ' 40' ' ' LYS . 2.0 pp20? -146.42 141.55 27.27 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.435 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -115.1 136.29 53.27 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.047 ' CG2' HG22 ' A' ' 6' ' ' THR . 1.6 t -106.24 143.68 16.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 120.233 -1.542 . . . . 0.0 109.355 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.99 HG11 ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -142.51 153.49 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.797 -178.059 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -123.75 151.3 43.4 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.932 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.9 p90 -167.52 -173.42 2.2 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 117.747 -1.581 . . . . 0.0 112.639 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 39.4 m-20 -105.59 118.49 36.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -66.15 -1.66 3.45 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.214 -177.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 48' ' ' ASP . 13.0 t -86.27 -20.49 28.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.043 -1.036 . . . . 0.0 110.525 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -128.47 -14.94 4.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.887 -1.133 . . . . 0.0 111.707 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -143.25 -170.39 3.26 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.023 -1.048 . . . . 0.0 110.137 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.632 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 174.15 167.92 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.873 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.931 HG23 HG21 ' A' ' 70' ' ' VAL . 2.5 p -42.73 -49.81 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 110.215 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.562 ' H ' HG13 ' A' ' 54' ' ' VAL . 7.3 tt0 -45.09 -47.04 12.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.041 . . . . 0.0 109.867 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.515 ' O ' HG21 ' A' ' 28' ' ' VAL . 11.2 mmtm -75.6 -27.09 58.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.43 -0.794 . . . . 0.0 111.437 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.932 HD11 ' CE2' ' A' ' 47' ' ' PHE . 68.5 mt -68.63 -57.69 5.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.602 -1.311 . . . . 0.0 108.761 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 4.0 m -56.22 -29.61 61.2 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.381 -0.824 . . . . 0.0 109.45 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 3.9 tttm -76.98 -29.52 55.55 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.297 -0.877 . . . . 0.0 109.699 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.765 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -69.97 -47.2 63.22 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.412 -0.805 . . . . 0.0 109.253 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.835 ' OG1' HG13 ' A' ' 21' ' ' VAL . 10.2 t -70.15 -32.95 71.18 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -68.14 -26.05 65.59 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.658 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 20.1 t0 -89.83 -13.34 36.77 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.941 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -80.27 -28.25 38.43 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.589 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 138.88 26.2 0.29 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.11 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.824 ' CB ' HG23 ' A' ' 9' ' ' VAL . 36.0 m-85 -151.38 105.2 2.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.655 -1.497 . . . . 0.0 110.993 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 3.0 Cg_exo -55.38 101.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 N-CA-C 107.184 -1.891 . . . . 0.0 107.184 177.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.53 ' HB3' HG23 ' A' ' 61' ' ' THR . 0.1 OUTLIER -107.94 -169.68 1.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.19 -1.004 . . . . 0.0 112.642 -176.637 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.529 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -152.38 -165.23 2.15 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.989 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.8 p -137.95 157.81 32.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.513 -1.367 . . . . 0.0 111.733 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.52 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -122.87 27.26 7.8 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.058 0.932 . . . . 0.0 109.639 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.594 ' HA ' HG13 ' A' ' 5' ' ' VAL . 34.3 mt-30 . . . . . 0 C--N 1.29 -2.019 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.531 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.618 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.167 0.508 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -146.88 89.88 1.86 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.358 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -109.13 153.26 23.97 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.874 0.845 . . . . 0.0 112.103 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 5.4 t -123.45 143.27 50.25 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.769 HG13 ' HA ' ' A' ' 72' ' ' GLN . 1.5 t -149.49 160.95 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -0.93 . . . . 0.0 109.152 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.687 ' O ' HD12 ' A' ' 7' ' ' LEU . 1.8 t -106.97 158.71 16.82 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.968 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -128.85 161.47 29.73 Favored 'General case' 0 C--N 1.276 -2.619 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.525 -177.601 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.43 101.15 10.14 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.816 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.84 HG22 ' SG ' ' A' ' 17' ' ' CYS . 3.5 p -115.21 90.3 23.66 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -77.41 45.35 1.71 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.545 1.496 . . . . 0.0 112.822 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.609 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -95.11 -34.04 6.33 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 1.2 mmt 54.3 -88.86 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.52 -0.988 . . . . 0.0 108.923 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 1.142 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.4 OUTLIER 58.31 9.76 1.11 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.592 179.768 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER 68.2 110.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.441 -0.787 . . . . 0.0 112.319 178.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . 33.19 48.81 0.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.841 -0.537 . . . . 0.0 112.375 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.142 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -151.26 -40.91 0.12 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.038 -1.039 . . . . 0.0 109.513 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.84 ' SG ' HG22 ' A' ' 9' ' ' VAL . 13.7 t -56.08 -41.35 90.55 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 110.834 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 1.021 ' O ' HG11 ' A' ' 36' ' ' VAL . 7.6 Cg_endo -78.35 -5.52 15.02 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.068 1.179 . . . . 0.0 111.661 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.9 mt -91.21 -35.52 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.831 -1.168 . . . . 0.0 108.672 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.933 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.2 m -75.94 -35.75 59.61 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.927 ' O ' HD12 ' A' ' 25' ' ' LEU . 81.9 t -66.08 -46.06 88.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.815 ' HG3' HG13 ' A' ' 34' ' ' VAL . 7.8 tttm -51.39 -54.61 24.8 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.101 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -72.87 -12.88 61.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 111.299 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.652 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -76.15 -63.61 1.28 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.956 -1.09 . . . . 0.0 109.649 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.928 HD21 ' CD2' ' A' ' 7' ' ' LEU . 3.5 mp -58.54 -33.8 70.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.495 -0.753 . . . . 0.0 110.081 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.517 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -70.46 -27.81 64.52 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.151 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -87.76 -9.57 53.58 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.322 -0.862 . . . . 0.0 109.942 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.762 HG12 ' N ' ' A' ' 29' ' ' GLU . 3.0 t -43.3 -80.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.133 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.762 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 172.35 -57.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.0 109.242 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.89 -26.21 38.53 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 25' ' ' LEU . 51.4 t -50.83 133.87 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -1.091 . . . . 0.0 110.324 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 m -115.0 -14.75 11.83 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.646 0.736 . . . . 0.0 109.218 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.754 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -153.63 159.64 42.16 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.27 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.815 HG13 ' HG3' ' A' ' 22' ' ' LYS . 7.1 p -156.84 157.13 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 110.203 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.584 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -158.1 171.52 20.07 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.227 -0.921 . . . . 0.0 110.113 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.021 HG11 ' O ' ' A' ' 18' ' ' PRO . 19.2 m -144.55 156.32 14.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 110.333 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.28 106.98 0.41 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.606 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -67.91 -25.54 65.54 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -1.091 . . . . 0.0 109.238 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -56.83 -23.55 44.69 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.354 -0.841 . . . . 0.0 108.984 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.524 ' O ' ' C ' ' A' ' 41' ' ' ARG . 6.7 tptm -138.93 33.18 2.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.546 -0.721 . . . . 0.0 109.807 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.575 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 8.7 tpm_? 22.35 60.2 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.225 0.535 . . . . 0.0 112.391 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 24.6 pt-20 -148.91 170.36 18.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.298 -0.876 . . . . 0.0 110.335 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.765 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -128.22 130.18 47.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.667 -1.27 . . . . 0.0 109.702 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 44' ' ' VAL . 15.0 p -105.27 117.87 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.796 -1.19 . . . . 0.0 109.415 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.798 ' CG1' HD13 ' A' ' 57' ' ' LEU . 7.2 p -126.3 150.77 32.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 122.257 1.027 . . . . 0.0 112.926 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -110.3 153.93 24.19 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.822 ' CD2' HD11 ' A' ' 57' ' ' LEU . 37.7 p90 -168.81 178.58 4.54 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 117.872 -1.531 . . . . 0.0 111.987 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 9.3 m-20 -105.55 124.88 50.28 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 8.4 t0 -79.46 26.94 0.28 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.494 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.47 -29.07 11.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.941 -1.1 . . . . 0.0 109.145 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -123.77 -7.8 7.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.517 -0.739 . . . . 0.0 110.097 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -146.98 -164.77 2.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.454 -0.779 . . . . 0.0 109.498 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.597 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 174.06 164.28 0.2 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.08 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.08 HG22 HG21 ' A' ' 70' ' ' VAL . 7.9 p -44.86 -42.96 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.571 ' N ' HG13 ' A' ' 54' ' ' VAL . 23.0 tt0 -55.88 -43.84 77.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.973 . . . . 0.0 109.358 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -73.75 -22.33 59.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.501 -0.749 . . . . 0.0 110.572 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.87 HD12 ' HA ' ' A' ' 54' ' ' VAL . 90.8 mt -69.93 -55.76 8.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.776 -1.203 . . . . 0.0 108.391 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.52 ' N ' HD21 ' A' ' 7' ' ' LEU . 59.5 m -56.87 -35.62 69.12 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 16.9 tttt -73.24 -26.86 61.29 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.333 -0.854 . . . . 0.0 109.585 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.708 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -68.31 -50.68 51.81 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.414 -0.804 . . . . 0.0 109.379 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.792 ' OG1' HG22 ' A' ' 21' ' ' VAL . 6.6 t -67.12 -32.14 73.08 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -63.1 -32.27 73.61 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.058 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -88.54 -11.09 46.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.461 -0.774 . . . . 0.0 109.129 178.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.933 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.85 -31.8 57.1 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 142.9 32.18 0.11 Allowed Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.902 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.821 ' CB ' HG23 ' A' ' 9' ' ' VAL . 72.8 m-85 -159.17 107.84 1.54 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.698 -1.472 . . . . 0.0 111.291 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -56.27 99.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 N-CA-C 106.687 -2.082 . . . . 0.0 106.687 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.525 ' OG ' HG23 ' A' ' 61' ' ' THR . 60.3 p -108.42 -165.43 1.03 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.166 -0.959 . . . . 0.0 112.514 -176.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.86 -161.36 1.32 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.08 HG21 HG22 ' A' ' 54' ' ' VAL . 3.3 p -141.62 157.93 21.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 O-C-N 120.832 -1.167 . . . . 0.0 111.33 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.547 ' CG ' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -129.42 27.53 5.29 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.427 1.108 . . . . 0.0 109.002 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.769 ' HA ' HG13 ' A' ' 5' ' ' VAL . 10.9 pt20 . . . . . 0 C--N 1.289 -2.065 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.292 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.658 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.113 0.483 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -142.41 91.94 2.37 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.12 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -107.86 164.14 12.51 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.821 0.82 . . . . 0.0 112.236 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 t -131.59 128.12 38.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.445 0.64 . . . . 0.0 110.144 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.904 HG13 ' HA ' ' A' ' 72' ' ' GLN . 5.4 t -139.35 168.08 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 109.148 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.756 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -108.77 171.57 7.35 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.604 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.985 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -134.33 159.36 41.25 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.917 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -113.02 99.25 7.71 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.175 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.898 HG21 ' CG2' ' A' ' 21' ' ' VAL . 2.1 p -112.68 101.74 53.31 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 109.277 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.7 Cg_endo -77.63 39.83 0.79 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.494 1.463 . . . . 0.0 111.748 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.648 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -82.76 -51.24 4.34 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.482 ' HB2' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 42.97 57.23 3.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.538 -0.977 . . . . 0.0 109.916 -179.69 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.834 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -87.94 15.07 7.68 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.273 179.287 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 4.0 t 65.51 87.36 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.542 -0.724 . . . . 0.0 110.265 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.747 ' O ' HD12 ' A' ' 19' ' ' ILE . . . 68.26 29.72 5.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 0.0 110.089 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.834 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -138.56 -48.16 0.52 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.609 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -55.31 -47.4 98.67 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.411 -0.806 . . . . 0.0 111.206 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 9.2 Cg_endo -71.89 -9.44 24.73 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 120.895 1.063 . . . . 0.0 112.219 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.747 HD12 ' O ' ' A' ' 15' ' ' ALA . 20.6 mt -93.13 -37.86 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.787 -1.195 . . . . 0.0 109.842 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.905 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.2 m -77.02 -40.8 45.16 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.898 ' CG2' HG21 ' A' ' 9' ' ' VAL . 97.6 t -62.88 -45.45 98.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.827 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.871 ' HG3' HG12 ' A' ' 34' ' ' VAL . 39.7 tttt -54.04 -55.58 26.08 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.174 -0.954 . . . . 0.0 109.853 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -75.9 -0.94 23.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 111.223 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -80.95 -64.41 1.19 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.722 -1.236 . . . . 0.0 108.843 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.898 HD13 ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.06 -24.63 65.99 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.795 ' C ' HG11 ' A' ' 31' ' ' VAL . 3.3 t -72.66 -26.66 61.72 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -97.43 -5.23 36.64 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.329 -0.857 . . . . 0.0 110.378 179.727 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 25' ' ' LEU . 2.7 t -46.09 -59.99 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.52 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.568 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER 158.1 -72.22 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.433 0.635 . . . . 0.0 110.225 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -69.24 -27.23 73.91 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.795 HG11 ' C ' ' A' ' 26' ' ' SER . 8.0 p -39.68 139.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.427 -1.043 . . . . 0.0 110.484 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.34 -14.67 9.19 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.536 0.684 . . . . 0.0 109.63 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.686 ' O ' HG23 ' A' ' 34' ' ' VAL . 9.7 ttmm -162.96 164.7 25.65 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.114 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.894 HG22 HG22 ' A' ' 45' ' ' VAL . 52.7 t -159.51 150.64 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.076 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.682 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -142.36 169.25 17.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 0.0 109.503 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 18' ' ' PRO . 62.9 t -108.99 151.5 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.118 -0.989 . . . . 0.0 110.981 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.67 60.04 0.49 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.594 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -60.93 -23.74 65.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.515 -0.991 . . . . 0.0 110.544 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -21.9 2.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.999 -1.063 . . . . 0.0 109.35 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 41' ' ' ARG . 21.5 mttt -143.05 39.45 1.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -0.758 . . . . 0.0 110.077 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.482 ' HD2' ' HB2' ' A' ' 12' ' ' MET . 1.5 ttp180 36.22 60.21 0.88 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.633 -0.667 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -152.22 168.43 25.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.476 -0.889 . . . . 0.0 111.338 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -131.17 139.09 49.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 109.327 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.733 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.0 p -107.78 109.41 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.841 -1.162 . . . . 0.0 110.145 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.894 HG22 HG22 ' A' ' 34' ' ' VAL . 53.8 t -111.21 159.1 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 122.414 1.102 . . . . 0.0 112.915 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -123.59 150.72 43.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 177.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 2' ' ' THR . 32.7 p90 -171.62 -176.29 1.76 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.004 -1.878 . . . . 0.0 112.979 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.658 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -105.38 114.14 28.15 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.787 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 14.6 t70 -62.67 -6.76 3.85 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.143 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.5 p -83.73 -25.51 30.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.052 -1.03 . . . . 0.0 110.945 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.1 mmmt -116.55 -7.15 11.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.924 -1.11 . . . . 0.0 110.726 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . 179.43 -179.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.59 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.0 p 172.17 -172.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 110.323 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.942 HG22 HG21 ' A' ' 70' ' ' VAL . 9.3 t -36.53 -38.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.539 -0.725 . . . . 0.0 111.003 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -55.97 -51.88 66.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.151 -0.968 . . . . 0.0 110.497 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.49 ' HB3' HG13 ' A' ' 28' ' ' VAL . 11.3 mmtp -82.93 -17.64 42.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 112.085 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 ' HB2' ' A' ' 25' ' ' LEU . 37.2 mt -74.41 -53.82 8.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.353 -1.467 . . . . 0.0 108.455 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.488 ' CG2' ' HA ' ' A' ' 69' ' ' SER . 3.2 m -59.89 -35.62 75.23 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.032 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -73.21 -29.02 62.5 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.311 -0.868 . . . . 0.0 110.206 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.526 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -70.48 -43.68 69.25 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.067 -1.021 . . . . 0.0 109.704 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.592 HG23 ' HB2' ' A' ' 68' ' ' SER . 2.8 t -73.06 -29.1 62.71 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.74 68.61 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -10.8 42.15 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.516 -0.74 . . . . 0.0 109.22 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.905 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -81.61 -29.46 33.29 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.455 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 141.21 23.67 0.24 Allowed Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.618 -1.277 . . . . 0.0 111.471 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.703 ' CB ' HG23 ' A' ' 9' ' ' VAL . 56.1 m-85 -146.62 113.68 4.35 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.34 -1.682 . . . . 0.0 111.366 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.76 91.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 106.874 -2.01 . . . . 0.0 106.874 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.592 ' HB2' HG23 ' A' ' 61' ' ' THR . 55.0 m -108.79 -170.22 1.63 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.178 -0.951 . . . . 0.0 112.995 -176.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.488 ' HA ' ' CG2' ' A' ' 58' ' ' THR . 2.3 m -160.13 -159.95 0.75 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.985 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.2 p -139.37 161.53 27.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.921 -1.112 . . . . 0.0 111.172 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.721 ' HG3' HG23 ' A' ' 6' ' ' THR . 4.3 mttt -122.31 24.0 9.54 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 122.264 1.031 . . . . 0.0 110.133 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.904 ' HA ' HG13 ' A' ' 5' ' ' VAL . 10.2 tt0 . . . . . 0 C--N 1.284 -2.252 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.369 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -126.88 165.95 18.4 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.254 -0.904 . . . . 0.0 111.666 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 14.6 t -130.42 134.3 47.01 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.58 -0.7 . . . . 0.0 110.324 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.967 HG21 HG23 ' A' ' 54' ' ' VAL . 10.8 t -122.6 171.42 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -0.765 . . . . 0.0 109.266 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.787 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -106.96 158.56 16.94 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.003 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.03 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -132.13 156.32 46.57 Favored 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 118.476 -1.289 . . . . 0.0 110.538 -178.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.542 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -109.19 101.67 10.68 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.412 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.968 HG21 HG21 ' A' ' 21' ' ' VAL . 1.5 p -113.89 87.85 13.29 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.609 -0.682 . . . . 0.0 109.614 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 11.5 Cg_endo -78.1 39.94 0.83 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.351 1.367 . . . . 0.0 111.764 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.601 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -81.4 -28.57 43.51 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.506 ' CG ' ' C ' ' A' ' 11' ' ' GLY . 7.7 ptt? 33.12 62.11 0.38 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.92 -0.753 . . . . 0.0 110.541 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.868 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -85.25 11.59 9.74 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.466 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER 70.31 90.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 110.088 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 59.4 26.98 15.98 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.573 -0.704 . . . . 0.0 110.103 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.868 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -131.44 -40.69 1.11 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.801 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.636 ' SG ' HG22 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -53.59 -48.93 91.41 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.0 110.992 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.614 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 7.5 Cg_endo -72.45 -10.36 25.33 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.434 1.229 . . . . 0.0 112.33 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.06 -45.75 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.682 -1.262 . . . . 0.0 109.875 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 1.061 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.257 1.2 m -73.44 -36.75 65.97 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.679 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.968 HG21 HG21 ' A' ' 9' ' ' VAL . 13.5 t -70.26 -47.85 64.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.878 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.619 ' O ' HG21 ' A' ' 34' ' ' VAL . 6.3 tmtt? -49.9 -51.57 39.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.491 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.556 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -70.52 -21.9 62.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.922 -1.111 . . . . 0.0 111.252 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.72 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -66.87 -54.36 23.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.243 -0.911 . . . . 0.0 110.471 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.907 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.6 mp -70.7 -31.09 67.83 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.084 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.854 ' C ' HG11 ' A' ' 31' ' ' VAL . 3.6 p -68.8 -20.47 64.33 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -116.31 4.92 13.5 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.449 -0.901 . . . . 0.0 109.816 179.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.819 HG12 ' O ' ' A' ' 25' ' ' LEU . 8.0 p -51.01 -50.03 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.0 110.867 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.611 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER 175.44 -77.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.883 -1.135 . . . . 0.0 110.888 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.94 2.36 56.82 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.854 HG11 ' C ' ' A' ' 26' ' ' SER . 14.9 p -44.77 144.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.042 -1.27 . . . . 0.0 110.592 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.513 ' HB2' HG22 ' A' ' 46' ' ' THR . 19.4 m -113.28 -16.3 12.54 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.4 OUTLIER -170.19 167.82 8.49 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.698 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.848 HG11 ' HB3' ' A' ' 26' ' ' SER . 13.6 p -157.88 167.36 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.124 -0.985 . . . . 0.0 110.55 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.519 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 1.6 m-20 -167.68 178.53 5.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.977 . . . . 0.0 110.086 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 3.8 m -150.13 165.4 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 111.127 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.3 106.85 0.32 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.614 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -70.05 -8.24 47.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -1.176 . . . . 0.0 110.53 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -60.34 -23.98 64.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.058 -1.026 . . . . 0.0 109.17 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -150.29 30.65 0.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.462 -0.774 . . . . 0.0 110.144 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 40' ' ' LYS . 2.0 mpp_? 40.56 58.94 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.522 -0.736 . . . . 0.0 110.408 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 2.4 pt-20 -136.88 149.53 47.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 0.0 110.211 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.776 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -117.86 132.18 56.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.972 -1.08 . . . . 0.0 109.449 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 35' ' ' ASP . 8.1 p -106.83 130.61 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.738 -1.226 . . . . 0.0 109.531 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.037 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.2 p -133.33 147.47 31.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.178 -1.009 . . . . 0.0 113.049 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 32' ' ' SER . 1.3 m -109.71 154.2 23.22 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.763 ' CE2' HD11 ' A' ' 57' ' ' LEU . 36.2 p90 -172.11 -177.2 1.82 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 117.883 -1.527 . . . . 0.0 111.811 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HB3' HG22 ' A' ' 50' ' ' THR . 10.5 m-20 -107.22 114.44 28.49 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 11.0 t70 -62.96 -9.36 9.62 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.304 -0.872 . . . . 0.0 110.715 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.628 HG22 ' HB3' ' A' ' 48' ' ' ASP . 4.8 t -72.88 -22.49 60.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -128.15 -7.16 5.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.213 -0.929 . . . . 0.0 110.902 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -154.43 -167.61 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.482 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.585 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 170.76 171.87 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.48 -0.763 . . . . 0.0 109.606 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.056 HG13 HG21 ' A' ' 70' ' ' VAL . 2.7 t -40.65 -47.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 110.317 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.96 -48.35 43.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.007 -1.058 . . . . 0.0 110.198 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 28.1 mmtm -73.74 -26.55 60.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -0.864 . . . . 0.0 111.318 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.037 HD13 ' CG1' ' A' ' 45' ' ' VAL . 63.3 mt -68.37 -58.18 4.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.668 -1.27 . . . . 0.0 108.809 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.682 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 16.4 m -57.79 -29.22 64.7 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 68.1 tttt -73.68 -29.37 62.26 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.379 -0.826 . . . . 0.0 109.54 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.72 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -70.74 -50.32 37.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.291 -0.881 . . . . 0.0 109.504 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.94 ' OG1' HG22 ' A' ' 21' ' ' VAL . 1.5 t -69.74 -26.63 64.41 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -66.73 -36.62 82.89 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.57 -9.92 55.08 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.061 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -29.27 55.68 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.564 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 135.04 25.18 0.55 Allowed Glycine 0 N--CA 1.486 2.002 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.067 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.601 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 42.0 m-85 -146.03 120.86 5.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.62 -1.518 . . . . 0.0 111.856 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.72 95.54 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 N-CA-C 107.014 -1.956 . . . . 0.0 107.014 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -108.47 -173.73 2.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 0.0 112.543 -176.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.518 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.5 OUTLIER -148.8 -162.57 1.59 Allowed 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.056 HG21 HG13 ' A' ' 54' ' ' VAL . 3.0 p -141.0 158.95 23.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.07 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.504 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 6.1 mtmt -116.27 17.52 15.6 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.198 0.999 . . . . 0.0 110.307 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.685 ' C ' HG13 ' A' ' 5' ' ' VAL . 13.2 mt-30 . . . . . 0 C--N 1.282 -2.368 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.57 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -118.68 160.84 21.1 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.086 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.418 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 2.0 t -134.49 132.87 39.76 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.7 -0.625 . . . . 0.0 109.648 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.643 HG21 ' CG2' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -133.24 169.03 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.884 0.849 . . . . 0.0 109.508 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.715 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.19 157.03 18.2 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.971 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.07 157.07 45.13 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.465 -178.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.23 112.44 24.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.55 -0.719 . . . . 0.0 110.279 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.036 HG21 HG21 ' A' ' 21' ' ' VAL . 1.4 p -123.42 88.0 51.7 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.272 -0.892 . . . . 0.0 110.011 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -78.53 59.77 7.31 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.427 1.418 . . . . 0.0 111.806 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.601 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -104.03 -26.83 6.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.509 ' O ' ' HG3' ' A' ' 12' ' ' MET . 19.0 ptm 29.64 61.47 0.16 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.717 0.77 . . . . 0.0 111.356 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.847 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -85.97 13.72 7.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.465 -0.772 . . . . 0.0 109.36 179.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.7 t 69.76 91.82 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.556 -0.715 . . . . 0.0 110.24 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 59.53 16.83 5.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 110.31 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.847 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -118.64 -44.05 2.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.528 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.607 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -51.59 -48.37 87.05 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.421 -0.799 . . . . 0.0 111.231 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 5.6 Cg_endo -73.24 -11.87 25.16 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 121.274 1.316 . . . . 0.0 112.634 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 19' ' ' ILE . 10.0 mm -92.28 -41.43 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.692 -1.255 . . . . 0.0 109.567 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.993 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.25 1.2 m -73.83 -39.87 63.73 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.036 HG21 HG21 ' A' ' 9' ' ' VAL . 98.9 t -69.49 -49.86 55.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.108 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.555 ' HG3' HG13 ' A' ' 34' ' ' VAL . 13.8 tttt -47.23 -51.76 17.81 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 110.471 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.567 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -72.88 -21.38 60.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.034 -1.041 . . . . 0.0 111.393 -179.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 60' ' ' ALA . . . -68.12 -53.95 21.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 110.719 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.908 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.9 mp -71.18 -29.08 64.74 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.08 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.872 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -74.79 -17.82 60.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.422 -0.799 . . . . 0.0 109.224 179.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.567 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -115.35 2.07 13.88 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.111 -0.993 . . . . 0.0 110.062 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 56' ' ' LYS . 9.3 p -53.56 -47.71 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.317 -0.864 . . . . 0.0 110.853 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.577 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.5 OUTLIER 179.25 -86.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.72 -1.237 . . . . 0.0 111.517 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -95.34 3.25 66.08 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.504 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.872 HG11 ' C ' ' A' ' 26' ' ' SER . 8.8 p -42.33 142.16 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.142 -1.211 . . . . 0.0 110.366 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 t -114.58 -17.34 11.71 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.688 0.756 . . . . 0.0 108.999 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 3.0 tttm -162.43 163.83 27.48 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.961 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 26' ' ' SER . 9.9 p -162.59 159.22 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 110.489 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.507 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 2.7 t70 -166.26 171.84 11.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 109.853 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.497 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 4.3 m -140.69 163.17 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.033 -1.042 . . . . 0.0 110.865 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.77 113.23 0.57 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.615 ' CE1' ' HD3' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -70.19 -21.57 63.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -1.228 . . . . 0.0 110.281 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -45.82 -45.51 14.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.131 -0.981 . . . . 0.0 109.458 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.0 mttm -126.4 25.85 6.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.439 -0.788 . . . . 0.0 109.687 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.687 HH21 HG13 ' A' ' 9' ' ' VAL . 7.1 mmm180 38.75 60.19 1.43 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.837 -0.539 . . . . 0.0 110.175 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 6.9 pt-20 -141.68 150.27 41.66 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.957 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -116.14 131.95 56.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.004 -1.06 . . . . 0.0 108.969 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 35' ' ' ASP . 13.4 p -105.22 130.89 55.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.786 -1.196 . . . . 0.0 109.676 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.014 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.2 p -131.92 143.06 41.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.946 0.879 . . . . 0.0 112.454 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -109.38 157.89 18.47 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.773 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.9 p90 -171.88 -176.33 1.7 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 117.399 -1.72 . . . . 0.0 112.122 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -106.85 113.51 27.05 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 15.8 t70 -59.61 -10.96 4.03 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 111.147 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.8 t -69.02 -24.75 64.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 110.929 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -128.84 -12.0 4.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.903 -1.123 . . . . 0.0 111.509 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -148.24 -169.41 3.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.017 -1.052 . . . . 0.0 110.712 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.593 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER 171.2 172.58 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.442 -0.786 . . . . 0.0 109.914 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.03 HG23 HG21 ' A' ' 70' ' ' VAL . 2.1 p -40.73 -35.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 110.406 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -56.59 -49.63 74.35 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.232 -0.917 . . . . 0.0 110.293 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.641 ' O ' HG21 ' A' ' 28' ' ' VAL . 15.9 mmtt -78.82 -18.38 54.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.27 -0.894 . . . . 0.0 111.526 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.014 HD13 ' CG1' ' A' ' 45' ' ' VAL . 52.3 mt -75.01 -58.87 3.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.415 -1.428 . . . . 0.0 108.268 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.554 ' N ' HD21 ' A' ' 7' ' ' LEU . 19.5 m -58.76 -30.04 67.23 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.741 -0.783 . . . . 0.0 109.111 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.503 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -80.79 -23.43 39.29 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.308 -0.87 . . . . 0.0 109.536 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.597 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -72.81 -47.06 49.68 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.394 -0.816 . . . . 0.0 109.086 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.594 ' CB ' HG13 ' A' ' 21' ' ' VAL . 9.2 t -71.39 -35.78 71.17 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -64.04 -29.68 70.81 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.626 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 2.1 t70 -89.67 -11.35 42.71 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.993 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -28.26 55.28 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.72 23.44 0.51 Allowed Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.697 -1.239 . . . . 0.0 111.228 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.699 ' CB ' HG23 ' A' ' 9' ' ' VAL . 46.8 m-85 -146.13 110.94 4.37 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.649 -1.501 . . . . 0.0 111.103 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 4.3 Cg_exo -55.49 99.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 N-CA-C 107.297 -1.847 . . . . 0.0 107.297 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -109.06 -172.02 1.96 Allowed 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.362 -176.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.512 ' N ' ' OG ' ' A' ' 68' ' ' SER . 19.9 m -147.32 -162.75 1.61 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.03 HG21 HG23 ' A' ' 54' ' ' VAL . 3.5 p -139.92 160.37 26.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 C-N-CA 118.647 -1.221 . . . . 0.0 111.763 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.506 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 1.7 mttt -123.24 19.1 9.87 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.963 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.511 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.8 tt0 . . . . . 0 C--N 1.283 -2.306 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.126 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.6 151.8 25.13 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.898 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.43 117.23 23.97 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.288 0.566 . . . . 0.0 109.616 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.527 HG11 ' CG2' ' A' ' 70' ' ' VAL . 4.6 t -126.76 168.19 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 109.931 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.811 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -108.88 160.47 15.97 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.937 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -133.66 155.36 49.85 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.623 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 68' ' ' SER . . . -109.6 110.75 21.91 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.879 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.845 HG21 HG21 ' A' ' 21' ' ' VAL . 1.6 p -124.38 85.99 55.25 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.505 -0.747 . . . . 0.0 109.67 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 11.2 Cg_endo -79.51 52.36 4.26 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.965 1.508 . . . . 0.0 111.294 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.624 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -97.6 -34.11 5.64 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.562 ' HG2' ' CZ ' ' A' ' 41' ' ' ARG . 1.8 mtp 69.04 -79.57 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.982 -0.716 . . . . 0.0 110.456 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.87 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.6 OUTLIER 50.86 14.39 0.18 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.92 -1.112 . . . . 0.0 109.638 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' THR . 0.7 OUTLIER 51.25 108.41 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.333 -0.855 . . . . 0.0 111.519 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 43.81 36.76 1.41 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -0.772 . . . . 0.0 111.034 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.87 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -139.01 -37.68 0.51 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 110.021 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -51.76 -50.34 78.16 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.772 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.77 ' O ' HG11 ' A' ' 36' ' ' VAL . 9.4 Cg_endo -73.38 -11.26 24.61 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.189 1.26 . . . . 0.0 112.633 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.8 mm -92.1 -45.47 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.64 -1.288 . . . . 0.0 109.872 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 1.117 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -70.13 -37.23 75.25 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.845 HG21 HG21 ' A' ' 9' ' ' VAL . 13.0 t -64.75 -44.64 96.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.581 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -52.78 -41.42 64.08 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.476 -0.765 . . . . 0.0 109.805 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -79.57 -22.37 43.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 111.173 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.821 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -67.99 -51.15 50.51 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.174 -0.954 . . . . 0.0 110.089 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.944 ' O ' HG12 ' A' ' 28' ' ' VAL . 4.1 mp -78.93 -31.36 45.18 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.516 -0.74 . . . . 0.0 110.874 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.817 ' HA ' HG21 ' A' ' 31' ' ' VAL . 42.5 p -69.31 -21.36 63.86 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.04 -1.037 . . . . 0.0 108.844 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -116.12 0.55 12.99 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.843 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.944 HG12 ' O ' ' A' ' 25' ' ' LEU . 3.7 p -45.46 -52.64 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.032 -1.043 . . . . 0.0 110.681 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.592 ' H ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER 176.41 -77.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.84 -1.163 . . . . 0.0 111.08 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.5 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -96.46 0.43 61.55 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' A' ' 26' ' ' SER . 6.8 p -42.57 143.21 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.24 . . . . 0.0 110.834 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 m -117.26 -16.21 10.36 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.105 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.648 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -166.62 164.26 16.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.617 -0.677 . . . . 0.0 109.509 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 45' ' ' VAL . 37.9 t -156.14 163.22 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.061 -1.025 . . . . 0.0 110.687 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.559 ' HB3' HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -162.95 161.78 25.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.292 -0.88 . . . . 0.0 109.758 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.77 HG11 ' O ' ' A' ' 18' ' ' PRO . 4.1 m -142.82 151.85 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.516 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.49 104.54 0.35 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.607 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -64.44 -29.55 70.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -1.161 . . . . 0.0 110.276 -179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.9 mm-40 -44.68 -28.52 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 109.721 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -132.99 1.55 3.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 110.396 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.569 ' NH1' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 59.06 51.27 7.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.448 -0.783 . . . . 0.0 110.135 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 51.7 mt-10 -138.12 146.46 42.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.472 -0.767 . . . . 0.0 109.813 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.828 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -115.36 130.38 56.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.998 -1.064 . . . . 0.0 109.32 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 35' ' ' ASP . 14.7 p -105.68 127.45 60.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.907 -1.12 . . . . 0.0 109.079 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 34' ' ' VAL . 37.3 t -134.06 148.06 30.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 119.049 -1.06 . . . . 0.0 112.484 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -108.89 158.62 17.51 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.799 ' CE2' HD11 ' A' ' 57' ' ' LEU . 33.1 p90 -171.54 -174.84 1.47 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 117.637 -1.625 . . . . 0.0 111.933 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -105.65 110.6 22.98 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 5.0 t70 -61.47 -11.48 10.83 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.709 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 82.4 p -75.01 -27.7 60.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.26 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 mtpp -122.08 -1.63 9.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 110.345 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -158.77 -169.07 2.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 110.33 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.598 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.4 p 170.32 170.53 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.437 -0.79 . . . . 0.0 109.528 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.998 HG23 HG21 ' A' ' 70' ' ' VAL . 2.5 p -42.24 -44.44 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 110.03 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.514 ' N ' HG13 ' A' ' 54' ' ' VAL . 6.7 tp-100 -51.44 -47.89 62.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -0.989 . . . . 0.0 109.694 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 18.2 mmtp -75.12 -20.67 59.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 0.0 110.966 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.799 HD11 ' CE2' ' A' ' 47' ' ' PHE . 82.0 mt -72.77 -60.27 2.31 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.688 -1.258 . . . . 0.0 108.19 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.741 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 1.2 p -57.42 -29.66 64.33 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.483 -0.761 . . . . 0.0 109.012 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 55.2 tttt -74.57 -31.41 62.07 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.339 -0.85 . . . . 0.0 109.726 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.821 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -69.87 -51.34 34.13 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.283 -0.886 . . . . 0.0 109.325 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.75 ' OG1' HG22 ' A' ' 21' ' ' VAL . 1.6 t -68.64 -27.18 65.78 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -65.4 -35.22 80.28 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.79 -15.71 50.66 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.634 -0.827 . . . . 0.0 108.953 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.117 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -71.4 -29.55 65.05 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.93 23.71 0.84 Allowed Glycine 0 N--CA 1.486 1.978 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.952 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.716 ' HB3' HG23 ' A' ' 9' ' ' VAL . 50.7 m-85 -139.36 111.84 7.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.686 -1.479 . . . . 0.0 111.72 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.85 96.65 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 107.046 -1.944 . . . . 0.0 107.046 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 10.0 p -108.1 -167.1 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 112.581 -176.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.493 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 19.2 m -157.81 -165.94 1.87 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.998 HG21 HG23 ' A' ' 54' ' ' VAL . 4.0 p -135.75 161.12 38.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 120.631 -1.293 . . . . 0.0 111.433 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.49 ' HE2' ' HB2' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -123.97 25.7 7.85 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.303 1.049 . . . . 0.0 110.134 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.468 ' HA ' HG13 ' A' ' 5' ' ' VAL . 2.0 tm0? . . . . . 0 C--N 1.284 -2.261 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.113 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.33 162.03 14.71 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.713 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.482 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 1.2 t -125.0 147.33 48.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.568 HG13 ' CB ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -153.49 159.29 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.965 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -106.69 155.74 19.35 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.974 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -129.9 158.54 39.22 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.41 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -112.39 105.32 13.56 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.212 0.529 . . . . 0.0 110.302 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.924 HG21 HG21 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -120.21 85.42 36.07 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.606 -0.684 . . . . 0.0 109.42 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 41' ' ' ARG . 10.2 Cg_endo -78.56 58.31 6.7 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.807 1.424 . . . . 0.0 111.216 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.608 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -102.08 -25.05 8.12 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 14.2 mtm 59.15 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.739 -0.859 . . . . 0.0 110.064 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.804 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER 50.32 14.05 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.363 -0.836 . . . . 0.0 109.958 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 54.48 109.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 111.626 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.687 ' O ' HD13 ' A' ' 19' ' ' ILE . . . 39.99 26.27 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.563 -0.711 . . . . 0.0 111.706 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.804 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -118.63 -42.53 2.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.939 -1.101 . . . . 0.0 109.139 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.741 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -52.5 -46.96 95.01 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.621 -0.675 . . . . 0.0 111.903 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 5.6 Cg_endo -70.29 -20.27 32.56 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.201 1.268 . . . . 0.0 113.49 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 15' ' ' ALA . 2.6 mp -92.4 -36.64 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.447 -1.408 . . . . 0.0 110.038 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.974 HG22 ' HB1' ' A' ' 64' ' ' ALA 0.252 1.2 m -73.45 -42.48 61.9 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.955 ' O ' HD12 ' A' ' 25' ' ' LEU . 96.9 t -62.75 -50.37 79.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.457 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.739 ' HA ' HG11 ' A' ' 34' ' ' VAL . 15.9 tttm -51.39 -44.07 62.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 110.268 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 5.0 mttm -69.89 -23.21 63.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.111 -0.993 . . . . 0.0 111.102 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -76.26 -62.5 1.59 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.533 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.955 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.6 mp -56.85 -30.73 64.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 0.0 110.486 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 1.024 ' HB3' HG21 ' A' ' 34' ' ' VAL . 4.5 p -76.05 -30.34 58.35 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.416 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -88.36 -3.92 58.76 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.268 -0.895 . . . . 0.0 109.625 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.792 HG12 ' N ' ' A' ' 29' ' ' GLU . 3.8 t -41.76 -83.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.429 -0.794 . . . . 0.0 110.066 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.792 ' N ' HG12 ' A' ' 28' ' ' VAL . 3.3 tt0 179.36 -52.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.46 -0.775 . . . . 0.0 109.062 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.492 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -96.74 -23.33 15.96 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 25' ' ' LEU . 39.6 t -51.63 134.52 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -1.108 . . . . 0.0 110.103 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.7 t -127.84 -5.09 5.73 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.083 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 13.9 tttp -155.71 116.33 3.8 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.524 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.024 HG21 ' HB3' ' A' ' 26' ' ' SER . 3.9 t -109.25 -178.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.686 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.647 ' H ' HG12 ' A' ' 34' ' ' VAL . 26.4 t0 -161.26 159.28 28.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.984 -1.073 . . . . 0.0 110.249 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.542 HG13 ' CB ' ' A' ' 18' ' ' PRO . 17.6 t -112.62 135.85 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.811 . . . . 0.0 110.699 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.09 60.02 0.53 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.647 ' CZ ' ' NH1' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -62.49 -16.49 55.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -1.175 . . . . 0.0 110.358 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -44.84 -26.52 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 109.148 179.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 41' ' ' ARG . 5.0 ttpt -152.43 47.21 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.611 -0.68 . . . . 0.0 109.833 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.647 ' NH1' ' CZ ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER 39.91 63.16 1.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.661 -0.649 . . . . 0.0 109.684 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 2.0 tm-20 -140.18 148.16 41.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.497 -0.752 . . . . 0.0 110.363 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.716 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -124.09 132.16 53.63 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.965 ' CG2' HG22 ' A' ' 6' ' ' THR . 0.9 OUTLIER -105.95 145.01 14.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.358 -1.464 . . . . 0.0 109.561 -178.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.791 HG11 ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -139.52 177.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 122.703 1.24 . . . . 0.0 112.362 -177.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -152.68 143.65 23.01 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 105.682 -1.969 . . . . 0.0 105.682 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.84 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.3 p90 -166.06 -176.0 3.58 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 117.242 -1.783 . . . . 0.0 112.934 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.733 ' HB3' HG22 ' A' ' 50' ' ' THR . 0.8 OUTLIER -106.8 115.83 30.87 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 17.5 t70 -62.12 -8.6 5.73 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 111.028 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.733 HG22 ' HB3' ' A' ' 48' ' ' ASP . 15.1 t -76.26 -21.55 56.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 110.74 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -128.59 -6.45 5.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.101 -0.999 . . . . 0.0 110.922 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.492 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -156.52 -169.7 3.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 110.216 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.591 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 14.8 t 175.81 168.62 0.39 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.11 HG23 HG21 ' A' ' 70' ' ' VAL . 2.8 p -42.91 -40.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 110.039 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.496 ' N ' HG13 ' A' ' 54' ' ' VAL . 1.1 tt0 -54.34 -47.65 72.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.114 -0.991 . . . . 0.0 109.826 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 17.8 mmtt -75.73 -18.09 59.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 111.249 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.84 HD11 ' CE2' ' A' ' 47' ' ' PHE . 68.4 mt -75.49 -58.68 3.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.501 -1.375 . . . . 0.0 107.949 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.46 ' N ' HD21 ' A' ' 7' ' ' LEU . 1.9 m -57.67 -32.21 67.1 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -73.57 -33.18 64.54 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.406 -0.809 . . . . 0.0 109.727 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.751 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -66.3 -46.34 77.31 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.272 -0.893 . . . . 0.0 109.371 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.638 ' HB ' HD11 ' A' ' 25' ' ' LEU . 5.7 t -68.7 -32.92 73.06 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.409 ' N ' HG23 ' A' ' 61' ' ' THR . . . -62.53 -31.83 72.68 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -86.95 -13.87 43.42 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.974 ' HB1' HG22 ' A' ' 20' ' ' THR . . . -75.64 -24.79 56.46 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 131.58 19.09 1.21 Allowed Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.848 -1.167 . . . . 0.0 110.937 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.707 ' CB ' HG23 ' A' ' 9' ' ' VAL . 35.4 m-85 -144.03 111.72 5.2 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.695 -1.474 . . . . 0.0 111.594 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.0 96.37 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 N-CA-C 107.844 -1.637 . . . . 0.0 107.844 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -108.85 -168.42 1.34 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.211 -0.931 . . . . 0.0 111.748 -177.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.539 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.0 OUTLIER -156.5 -163.49 1.46 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.11 HG21 HG23 ' A' ' 54' ' ' VAL . 5.7 p -137.18 159.44 36.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 O-C-N 120.583 -1.323 . . . . 0.0 111.022 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.57 ' CG ' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -130.56 39.12 3.66 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.019 -1.073 . . . . 0.0 109.46 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.568 ' CB ' HG13 ' A' ' 5' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.687 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.274 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.214 -0.78 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -110.09 169.92 8.42 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.799 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 4' ' ' THR . 3.1 t -143.99 113.41 6.98 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.36 0.6 . . . . 0.0 109.792 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.899 HG21 HG23 ' A' ' 54' ' ' VAL . 2.7 m -120.17 168.69 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 109.747 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.74 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.81 159.49 16.2 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 178.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.02 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.4 153.89 50.36 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.737 -1.227 . . . . 0.0 110.344 -178.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.536 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -108.84 104.74 14.05 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.411 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.881 HG21 HG21 ' A' ' 21' ' ' VAL . 1.2 p -112.4 93.36 22.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.608 -0.683 . . . . 0.0 109.999 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -76.82 35.24 0.47 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 O-C-N 123.737 1.388 . . . . 0.0 111.647 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.613 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.14 -62.85 4.57 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.497 ' HG2' ' CZ ' ' A' ' 41' ' ' ARG . 21.5 mtp 56.03 49.08 16.4 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.414 -1.051 . . . . 0.0 109.412 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 1.116 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -84.08 10.33 10.36 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.27 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.1 OUTLIER 77.32 97.06 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.651 0.739 . . . . 0.0 111.273 179.324 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 54.62 42.55 31.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.525 -0.735 . . . . 0.0 111.396 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.116 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -162.45 -29.61 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.976 -1.077 . . . . 0.0 111.315 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.645 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -50.33 -52.01 58.35 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.689 -1.257 . . . . 0.0 110.184 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.899 ' O ' HG11 ' A' ' 36' ' ' VAL . 9.5 Cg_endo -74.66 -6.9 18.83 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.353 1.369 . . . . 0.0 112.306 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 19' ' ' ILE . 13.4 mm -90.87 -42.25 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.69 -1.257 . . . . 0.0 109.759 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 1.032 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -69.79 -32.03 70.27 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.969 ' O ' HD12 ' A' ' 25' ' ' LEU . 40.4 t -73.42 -40.91 56.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.548 ' O ' HG11 ' A' ' 34' ' ' VAL . 7.8 tmtt? -50.06 -50.15 48.89 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.456 -0.778 . . . . 0.0 109.768 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.6 mmmm -77.6 -25.37 49.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.879 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 60' ' ' ALA . . . -62.5 -57.82 9.82 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.315 -0.865 . . . . 0.0 110.813 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.118 ' HB2' HG21 ' A' ' 34' ' ' VAL . 2.8 mp -75.91 -30.97 58.96 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.391 -0.818 . . . . 0.0 111.295 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.803 ' C ' HG11 ' A' ' 31' ' ' VAL . 1.8 t -69.39 -19.28 63.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.896 -1.127 . . . . 0.0 108.655 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.573 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 1.3 mptp? -115.54 -1.12 12.85 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.904 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.578 HG13 ' N ' ' A' ' 29' ' ' GLU . 11.5 p -44.24 -45.25 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 110.221 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.578 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 163.31 -85.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.458 -0.776 . . . . 0.0 111.193 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.743 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -80.79 -6.07 89.63 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.81 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.803 HG11 ' C ' ' A' ' 26' ' ' SER . 7.6 p -50.06 141.89 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.892 -1.358 . . . . 0.0 110.36 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -121.18 -12.55 8.66 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.576 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.479 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -176.02 107.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.788 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.118 HG21 ' HB2' ' A' ' 25' ' ' LEU . 1.5 p -114.01 179.06 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.154 -0.966 . . . . 0.0 111.399 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.556 ' H ' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -166.04 160.82 16.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.5 -0.75 . . . . 0.0 110.045 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.899 HG11 ' O ' ' A' ' 18' ' ' PRO . 15.8 m -130.39 158.75 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 0.0 110.476 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.3 112.47 0.62 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.625 ' CG ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -75.22 -28.44 59.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 110.604 -179.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -55.17 -23.35 21.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.146 -0.971 . . . . 0.0 110.346 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.474 ' HB3' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -134.59 16.5 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 0.0 110.43 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.497 ' CZ ' ' HG2' ' A' ' 12' ' ' MET . 1.5 mpp_? 42.53 55.58 4.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 110.043 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 2.2 pp20? -148.49 149.77 32.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.397 -0.814 . . . . 0.0 109.898 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.515 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -123.03 136.73 54.96 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.956 -1.09 . . . . 0.0 108.932 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.2 p -105.44 132.19 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.493 -1.379 . . . . 0.0 109.325 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.009 HG11 HD22 ' A' ' 57' ' ' LEU . 3.2 t -123.11 152.3 27.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.442 1.115 . . . . 0.0 112.401 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 1.3 m -125.51 145.94 49.87 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 176.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.853 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.4 p90 -170.59 -178.43 2.64 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 117.235 -1.786 . . . . 0.0 112.523 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.0 120.22 41.47 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.6 -3.24 2.95 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.399 -0.813 . . . . 0.0 111.327 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.4 p -77.0 -23.25 52.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.027 . . . . 0.0 110.651 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -130.32 0.63 4.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.022 -1.049 . . . . 0.0 110.894 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.743 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -159.65 -166.58 1.79 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 109.917 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.599 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.0 t 176.21 160.62 0.32 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 110.001 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.019 ' CG2' HG21 ' A' ' 70' ' ' VAL . 5.7 p -42.49 -37.86 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.363 -0.836 . . . . 0.0 110.151 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.478 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 2.4 tt0 -56.96 -49.1 76.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.883 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' HG3' ' CG2' ' A' ' 28' ' ' VAL . 2.0 tptt -70.06 -23.71 63.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 0.0 110.76 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.009 HD22 HG11 ' A' ' 45' ' ' VAL . 66.8 mt -69.32 -56.62 6.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.795 -1.19 . . . . 0.0 108.812 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.664 ' N ' HD21 ' A' ' 7' ' ' LEU . 12.3 m -60.2 -30.44 69.37 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 33.3 tttt -77.06 -23.17 52.02 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.542 -0.724 . . . . 0.0 109.61 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.719 ' HB3' ' HG ' ' A' ' 25' ' ' LEU . . . -72.79 -46.06 55.27 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.334 -0.854 . . . . 0.0 109.255 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.827 ' OG1' HG22 ' A' ' 21' ' ' VAL . 7.6 t -72.71 -34.14 66.93 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -63.96 -32.6 74.19 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.824 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -91.0 -9.53 45.6 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.457 -0.777 . . . . 0.0 109.395 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.032 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.08 -24.73 43.3 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.44 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.04 15.57 0.91 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.249 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.645 ' CB ' HG23 ' A' ' 9' ' ' VAL . 26.5 m-85 -139.72 110.21 7.34 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.562 -1.552 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.51 99.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 N-CA-C 107.509 -1.766 . . . . 0.0 107.509 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.529 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 9.2 p -108.43 -170.65 1.71 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.233 1.016 . . . . 0.0 112.767 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 t -150.64 -162.19 1.5 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.02 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.7 p -141.92 162.46 20.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.19 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.501 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -124.92 23.83 7.75 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.363 1.078 . . . . 0.0 108.944 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.592 ' HB2' HG21 ' A' ' 54' ' ' VAL . 1.7 tt0 . . . . . 0 C--N 1.286 -2.18 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.755 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -108.81 162.79 13.86 Favored 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 119.476 -0.889 . . . . 0.0 112.445 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 t -137.66 119.28 14.98 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.264 0.554 . . . . 0.0 109.599 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.617 HG21 HG22 ' A' ' 54' ' ' VAL . 3.0 m -126.55 170.36 16.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.279 -0.888 . . . . 0.0 109.803 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.95 161.32 14.82 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.001 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.94 156.45 48.98 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 118.541 -1.264 . . . . 0.0 110.036 -178.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.66 109.63 20.43 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.182 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -117.71 102.94 51.22 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.244 -0.91 . . . . 0.0 109.617 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.529 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 7.7 Cg_endo -75.71 32.48 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.428 1.418 . . . . 0.0 112.329 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.593 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -74.62 -69.72 1.35 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.546 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 48.63 30.68 2.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -1.078 . . . . 0.0 109.365 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 1.106 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -61.23 -10.4 6.69 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.735 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.8 t 89.93 98.4 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.615 0.722 . . . . 0.0 111.019 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 71.7 27.59 2.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.61 -0.681 . . . . 0.0 111.256 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.106 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -150.61 -44.67 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.796 -1.19 . . . . 0.0 110.531 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -45.73 -50.03 34.84 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.862 -1.149 . . . . 0.0 111.39 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 17' ' ' CYS . 6.8 Cg_endo -69.94 -20.89 33.39 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.234 1.289 . . . . 0.0 113.484 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.5 mt -91.35 -30.04 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.381 -1.45 . . . . 0.0 110.028 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.665 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.254 1.5 m -78.21 -40.59 37.05 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.471 0.653 . . . . 0.0 109.524 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.995 ' O ' HD12 ' A' ' 25' ' ' LEU . 55.8 t -70.54 -52.05 32.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.182 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.556 ' HA ' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -50.93 -43.26 60.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.82 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 12.8 mtpt -71.96 -26.69 62.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 110.795 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.587 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -70.24 -62.17 1.49 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.487 -0.758 . . . . 0.0 110.714 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.027 HD22 ' CG2' ' A' ' 45' ' ' VAL . 2.8 mp -59.55 -34.72 73.02 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.309 -0.869 . . . . 0.0 110.562 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.71 ' HA ' HG21 ' A' ' 31' ' ' VAL . 2.1 t -72.11 -22.89 61.27 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.406 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.22 -10.47 41.5 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.276 -0.89 . . . . 0.0 109.716 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.814 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.4 t -42.61 -80.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.444 -0.785 . . . . 0.0 109.851 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.814 ' N ' HG12 ' A' ' 28' ' ' VAL . 1.1 mt-10 177.11 -69.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 110.051 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.419 ' O ' ' OD2' ' A' ' 48' ' ' ASP . . . -77.52 -13.39 83.58 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 26' ' ' SER . 12.2 p -48.2 139.4 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -1.125 . . . . 0.0 110.539 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.412 ' OG ' ' OD2' ' A' ' 48' ' ' ASP . 5.9 m -128.26 -6.46 5.38 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -173.62 103.9 0.12 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.421 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.061 HG22 HG13 ' A' ' 45' ' ' VAL . 70.9 t -111.77 171.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 110.304 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.724 ' HB3' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -169.28 178.55 4.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.188 -0.945 . . . . 0.0 110.269 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 3.2 m -113.63 167.66 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.37 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.44 69.05 0.29 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -56.7 -15.84 5.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.302 -1.116 . . . . 0.0 110.472 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 38' ' ' PHE . 10.3 tp10 -44.41 -29.81 0.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 0.0 109.319 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -160.91 52.52 0.28 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.457 -0.777 . . . . 0.0 110.288 179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.546 ' NH1' ' HB2' ' A' ' 12' ' ' MET . 2.4 mtt180 41.31 63.61 1.2 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.526 -0.734 . . . . 0.0 110.496 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 1.1 pt-20 -149.02 150.17 32.36 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.599 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.698 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -115.81 143.88 44.78 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.724 HG12 ' HB3' ' A' ' 35' ' ' ASP . 8.5 p -105.15 129.18 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.509 -1.369 . . . . 0.0 108.895 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.061 HG13 HG22 ' A' ' 34' ' ' VAL . 21.5 t -124.97 156.35 33.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 122.524 1.154 . . . . 0.0 112.051 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 1.4 m -137.85 146.65 43.7 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.817 ' CE2' HD11 ' A' ' 57' ' ' LEU . 30.6 p90 -170.65 -174.57 1.64 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 117.154 -1.818 . . . . 0.0 112.569 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 30' ' ' GLY . 8.9 m-20 -106.27 116.56 32.15 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 35.7 t0 -63.21 -8.19 7.62 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.878 -177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.2 t -77.31 -17.98 57.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.925 . . . . 0.0 110.484 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -132.36 0.9 3.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.969 . . . . 0.0 110.894 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -166.28 -170.54 1.71 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.068 -1.02 . . . . 0.0 110.447 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.627 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER 171.52 173.04 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 110.008 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.068 HG13 HG21 ' A' ' 70' ' ' VAL . 17.8 t -41.59 -41.96 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.125 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -50.86 -48.53 60.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 110.228 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -79.26 -21.88 45.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 111.861 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.972 HD22 HG11 ' A' ' 45' ' ' VAL . 63.1 mt -71.5 -59.15 2.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.27 -1.519 . . . . 0.0 108.649 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.694 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 8.0 m -58.88 -28.4 66.1 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -79.18 -25.79 42.73 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.345 -0.847 . . . . 0.0 110.005 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.594 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -73.6 -47.41 40.57 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.022 -1.049 . . . . 0.0 109.201 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.969 ' OG1' HG22 ' A' ' 21' ' ' VAL . 9.0 t -71.38 -32.82 68.92 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -63.43 -34.53 77.94 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.964 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -89.43 -8.86 52.12 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.352 -0.842 . . . . 0.0 109.042 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.665 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.61 -25.05 41.58 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.89 15.37 0.72 Allowed Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.426 -1.368 . . . . 0.0 111.66 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.593 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 53.7 m-85 -141.71 111.43 6.29 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.443 -1.622 . . . . 0.0 111.41 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.02 99.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 85.6 p -108.22 -165.35 1.03 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 122.147 0.975 . . . . 0.0 112.793 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.62 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -157.68 -165.93 1.88 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.068 HG21 HG13 ' A' ' 54' ' ' VAL . 3.6 p -139.55 158.1 27.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 120.816 -1.178 . . . . 0.0 111.524 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 4.1 mtmt -124.41 25.85 7.52 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.478 1.132 . . . . 0.0 108.91 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.493 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.284 -2.274 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.992 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -117.26 165.39 13.51 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.71 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 4.2 t -132.5 124.29 28.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.794 -0.566 . . . . 0.0 110.031 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.7 HG21 HG22 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -124.79 172.41 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.797 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.6 162.01 14.34 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.227 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.029 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -133.35 153.54 51.5 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.859 -1.136 . . . . 0.0 109.651 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.537 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -108.9 98.55 8.02 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.137 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.126 HG21 HG21 ' A' ' 21' ' ' VAL . 2.2 p -113.17 90.69 16.91 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.7 Cg_endo -74.8 31.33 0.35 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.394 1.396 . . . . 0.0 112.323 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.3 -43.11 95.69 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 13.0 ptm 35.83 45.93 0.31 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.748 0.785 . . . . 0.0 109.894 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 1.165 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.2 t -72.1 0.54 9.34 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.69 -0.631 . . . . 0.0 110.142 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.719 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 82.19 88.58 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.508 0.671 . . . . 0.0 111.127 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 71.17 31.51 2.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.527 -0.733 . . . . 0.0 112.078 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.165 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -155.72 -35.4 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.532 -1.355 . . . . 0.0 110.658 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.749 ' H ' HG22 ' A' ' 13' ' ' THR . 0.0 OUTLIER -49.87 -48.57 77.57 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.727 -1.233 . . . . 0.0 110.825 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.595 ' HG3' ' CD1' ' A' ' 38' ' ' PHE . 18.7 Cg_endo -77.94 -9.87 16.77 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.312 1.341 . . . . 0.0 112.599 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 19' ' ' ILE . 18.7 mm -90.31 -42.38 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.719 -1.238 . . . . 0.0 109.735 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.965 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.251 0.9 OUTLIER -71.92 -39.11 69.7 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.921 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.126 HG21 HG21 ' A' ' 9' ' ' VAL . 21.1 t -67.7 -48.44 76.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.4 -47.32 26.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.31 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.564 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 1.2 mmmm -74.46 -20.37 60.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 111.693 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.7 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -73.24 -48.78 32.09 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 110.062 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 21' ' ' VAL . 4.9 mp -68.86 -33.28 73.54 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 109.676 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.726 ' HA ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -78.58 -20.88 49.55 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.964 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.564 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -98.3 -7.26 29.36 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.894 -1.129 . . . . 0.0 109.588 179.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.733 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.9 t -40.36 -80.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.668 -0.645 . . . . 0.0 109.776 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.733 ' N ' HG12 ' A' ' 28' ' ' VAL . 5.1 tt0 179.3 -57.85 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.183 -0.948 . . . . 0.0 109.825 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -92.15 -15.12 54.84 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' A' ' 26' ' ' SER . 10.6 p -43.16 141.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.101 -1.235 . . . . 0.0 110.49 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 t -120.89 -12.95 8.71 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.555 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.498 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 4.1 ttmt -166.25 168.71 14.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.028 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.461 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 4.7 p -164.68 172.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.405 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.575 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -167.21 169.4 12.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.835 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.584 HG13 ' HB3' ' A' ' 18' ' ' PRO . 24.8 t -109.92 147.47 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 110.509 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 42' ' ' GLU . . . -139.41 60.47 0.58 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.595 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -58.79 -20.82 53.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -1.116 . . . . 0.0 110.236 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.4 mp0 -45.93 -26.37 0.69 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.06 -1.025 . . . . 0.0 109.294 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.38 37.95 0.94 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.747 . . . . 0.0 110.104 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.451 ' CG ' ' HA ' ' A' ' 10' ' ' PRO . 1.7 mpp_? 43.43 56.25 4.43 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.348 -0.845 . . . . 0.0 110.482 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -143.46 150.11 38.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.835 . . . . 0.0 110.152 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -117.69 138.83 51.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.018 . . . . 0.0 108.791 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.575 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 10.1 p -105.61 144.57 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.532 -1.355 . . . . 0.0 109.939 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.893 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.2 p -145.86 144.94 20.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 118.928 -1.109 . . . . 0.0 113.174 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -111.77 153.17 26.92 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.676 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.9 p90 -171.48 -177.09 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.58 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.409 ' CG ' HG22 ' A' ' 50' ' ' THR . 6.3 t0 -106.38 110.76 23.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 23.6 t0 -64.65 -8.19 13.47 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.978 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.409 HG22 ' CG ' ' A' ' 48' ' ' ASP . 10.0 t -68.64 -11.36 60.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.957 -1.089 . . . . 0.0 110.134 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.3 -35.57 0.46 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.18 -0.95 . . . . 0.0 111.243 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -122.61 -174.67 2.97 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.273 -0.892 . . . . 0.0 110.366 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.568 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 7.3 t 173.14 175.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.024 HG23 HG21 ' A' ' 70' ' ' VAL . 1.6 p -40.34 -32.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.87 . . . . 0.0 110.672 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -49.98 75.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.098 . . . . 0.0 109.813 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 37.0 mmtt -77.43 -18.92 56.79 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.386 -0.821 . . . . 0.0 110.961 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.893 HD13 ' CG1' ' A' ' 45' ' ' VAL . 79.0 mt -74.51 -61.08 1.99 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.656 -1.277 . . . . 0.0 108.364 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.692 HG21 ' HB ' ' A' ' 70' ' ' VAL . 42.9 p -60.27 -25.38 65.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.469 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 5.5 tttm -78.11 -29.8 49.11 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 121.469 -0.77 . . . . 0.0 109.822 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.7 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -72.14 -46.63 55.72 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.101 -0.999 . . . . 0.0 109.224 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.882 ' OG1' HG22 ' A' ' 21' ' ' VAL . 7.3 t -70.5 -32.22 69.64 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -67.68 -31.67 71.81 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.261 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -90.47 -9.36 47.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.43 -0.794 . . . . 0.0 109.262 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.965 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -80.98 -29.02 35.38 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 140.89 22.47 0.27 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.424 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.8 ' CB ' HG23 ' A' ' 9' ' ' VAL . 42.5 m-85 -148.28 108.94 3.65 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.46 -1.612 . . . . 0.0 111.278 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.0 Cg_exo -57.17 100.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 3.7 t -107.3 -177.43 3.35 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.562 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.41 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -140.77 -164.75 1.8 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.029 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.5 p -142.73 155.25 17.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 O-C-N 120.813 -1.18 . . . . 0.0 111.384 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -124.81 25.72 7.32 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.583 1.182 . . . . 0.0 109.086 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.459 ' OXT' HG23 ' A' ' 5' ' ' VAL . 1.2 mm-40 . . . . . 0 C--N 1.286 -2.193 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.11 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER . . . . . 0 C--O 1.215 -0.74 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -111.79 160.65 17.13 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.861 0.839 . . . . 0.0 112.376 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.8 m -122.9 128.33 50.17 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.697 HG21 HG22 ' A' ' 70' ' ' VAL . 1.3 p -141.64 168.88 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 122.477 1.132 . . . . 0.0 111.101 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.697 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -108.84 159.36 16.85 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.015 HD11 HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -131.39 154.24 48.84 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.768 -1.207 . . . . 0.0 110.072 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.29 99.21 8.51 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.956 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.083 HG21 HG21 ' A' ' 21' ' ' VAL . 2.2 p -117.13 86.3 20.32 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 0.0 109.6 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.5 Cg_endo -76.62 37.51 0.57 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.575 1.517 . . . . 0.0 112.095 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' CG ' ' A' ' 12' ' ' MET . . . -79.68 -26.25 56.85 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.512 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 17.4 ptm 36.45 65.26 0.47 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.781 -0.835 . . . . 0.0 110.386 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.857 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -88.83 15.54 8.23 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.521 -0.737 . . . . 0.0 109.465 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER 68.12 88.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.548 -0.72 . . . . 0.0 110.128 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 58.01 31.95 21.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 0.0 110.174 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.857 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -134.4 -41.64 0.79 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.0 109.919 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.702 ' SG ' HG22 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -52.96 -50.0 84.14 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.748 179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.678 ' O ' HG11 ' A' ' 36' ' ' VAL . 9.7 Cg_endo -75.0 -8.87 20.46 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.168 1.246 . . . . 0.0 112.302 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 15' ' ' ALA . 12.3 mm -90.59 -43.48 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.808 -1.182 . . . . 0.0 109.699 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.956 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -78.86 -43.93 23.98 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.083 HG21 HG21 ' A' ' 9' ' ' VAL . 21.3 t -59.85 -43.57 92.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.987 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.756 ' O ' HG11 ' A' ' 34' ' ' VAL . 14.0 tttt -56.34 -58.67 7.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.073 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.7 pttt -73.58 3.41 6.28 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 110.547 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.672 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -87.71 -72.14 0.54 Allowed 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.887 -1.133 . . . . 0.0 108.775 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.839 ' CD2' HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -60.65 -16.23 36.73 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.154 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.739 ' O ' HG11 ' A' ' 31' ' ' VAL . 13.1 t -81.38 -35.03 31.28 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -75.9 -10.2 59.23 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.674 HG12 ' N ' ' A' ' 29' ' ' GLU . 6.5 t -37.47 -80.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.68 -0.637 . . . . 0.0 110.888 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.674 ' N ' HG12 ' A' ' 28' ' ' VAL . 2.4 mt-10 -172.85 -51.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.837 -1.165 . . . . 0.0 111.741 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -108.33 14.3 36.33 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.857 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.739 HG11 ' O ' ' A' ' 26' ' ' SER . 8.5 p -41.3 143.88 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.275 . . . . 0.0 111.11 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.614 ' HB3' HG22 ' A' ' 46' ' ' THR . 2.8 t -120.89 -16.22 8.16 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.461 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -173.06 162.64 4.61 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.768 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.777 HG13 HG22 ' A' ' 45' ' ' VAL . 1.3 t -153.04 148.12 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.058 -1.026 . . . . 0.0 110.684 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.595 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -154.64 164.41 38.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.315 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 18' ' ' PRO . 18.8 m -128.34 161.66 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.047 . . . . 0.0 110.74 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.18 90.7 0.13 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.611 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -65.51 -21.07 66.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 110.23 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 0.7 OUTLIER -53.24 -23.01 7.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.973 . . . . 0.0 109.122 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 41' ' ' ARG . 2.3 mmpp? -138.73 19.43 2.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.636 -0.665 . . . . 0.0 109.839 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 40' ' ' LYS . 1.7 tpp180 42.69 55.51 4.23 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -145.2 151.54 38.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.49 -0.756 . . . . 0.0 110.071 -179.251 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.23 136.96 52.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.979 . . . . 0.0 109.77 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.698 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.5 p -107.07 110.51 32.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.68 -1.263 . . . . 0.0 108.911 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.839 HG21 ' CD2' ' A' ' 25' ' ' LEU . 65.4 t -123.4 143.97 34.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.932 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.614 HG22 ' HB3' ' A' ' 32' ' ' SER . 1.3 m -110.07 163.01 14.0 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.873 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.1 p90 -171.35 -178.15 2.29 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.328 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -106.99 116.67 32.32 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -61.18 -11.33 8.75 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.735 -177.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.573 HG23 ' HG3' ' A' ' 51' ' ' LYS . 15.2 t -68.94 -13.76 62.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 110.551 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HG3' HG23 ' A' ' 50' ' ' THR . 21.7 mttt -143.62 10.2 1.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 110.512 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.572 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -169.83 -167.01 0.62 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.104 -0.997 . . . . 0.0 110.298 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.635 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 t 172.3 164.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.033 HG13 HG21 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -42.18 -50.95 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 109.613 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.504 ' N ' HG12 ' A' ' 54' ' ' VAL . 40.0 tp60 -47.9 -46.08 31.29 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.326 -0.858 . . . . 0.0 109.657 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -72.45 -27.33 62.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 111.246 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.873 HD11 ' CE2' ' A' ' 47' ' ' PHE . 55.3 mt -68.78 -59.83 2.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.63 -1.294 . . . . 0.0 108.682 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.668 HG22 ' O ' ' A' ' 54' ' ' VAL . 1.7 t -56.27 -28.84 60.01 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 29.9 tttp -72.1 -33.74 68.08 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.348 -0.845 . . . . 0.0 109.441 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.672 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -67.85 -40.43 83.69 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.169 -0.957 . . . . 0.0 110.022 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.801 ' OG1' HG22 ' A' ' 21' ' ' VAL . 3.7 t -72.21 -32.0 66.37 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.54 84.4 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.47 -7.49 52.9 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.463 -0.773 . . . . 0.0 109.572 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.956 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -82.2 -24.4 34.94 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 133.3 20.11 0.93 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.789 -1.196 . . . . 0.0 110.946 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.767 ' CB ' HG23 ' A' ' 9' ' ' VAL . 44.4 m-85 -147.94 112.59 3.89 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.585 -1.538 . . . . 0.0 111.404 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.07 93.57 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 N-CA-C 107.671 -1.704 . . . . 0.0 107.671 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.71 -171.21 1.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 111.827 -177.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.521 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -142.62 -164.02 1.74 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.033 HG21 HG13 ' A' ' 54' ' ' VAL . 2.4 p -141.39 154.1 20.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.886 -1.133 . . . . 0.0 111.448 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.464 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -118.8 23.69 11.3 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.394 1.093 . . . . 0.0 109.617 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.484 ' OXT' ' CB ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.283 -2.311 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.248 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.709 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -109.09 148.28 31.08 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.893 0.854 . . . . 0.0 111.947 -177.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 m -123.48 108.14 12.34 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.597 HG12 ' CB ' ' A' ' 72' ' ' GLN . 5.6 m -125.36 165.0 23.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.184 -0.947 . . . . 0.0 110.688 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.727 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -107.01 159.95 15.91 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.035 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -131.48 159.31 38.47 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.511 -178.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.803 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -114.03 119.13 36.13 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.923 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.568 HG13 ' CB ' ' A' ' 66' ' ' TYR . 2.9 t -108.87 103.3 51.49 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.289 -0.882 . . . . 0.0 109.315 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 7.3 Cg_endo -74.79 29.41 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.314 1.165 . . . . 0.0 111.867 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.523 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -91.93 -58.82 1.37 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.561 ' CG ' ' HD2' ' A' ' 41' ' ' ARG . 4.0 tmm? 52.25 51.17 16.83 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.406 -1.055 . . . . 0.0 109.195 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 1.134 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -76.72 2.74 13.4 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.755 -0.59 . . . . 0.0 109.54 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.67 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 4.1 t 80.48 94.51 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.604 0.716 . . . . 0.0 111.13 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.843 ' O ' HD12 ' A' ' 19' ' ' ILE . . . 68.08 37.4 2.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.606 -0.684 . . . . 0.0 111.825 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.134 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -163.19 -37.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.782 -1.199 . . . . 0.0 110.602 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.61 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -44.2 -51.54 18.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.861 -1.15 . . . . 0.0 110.132 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.83 ' O ' HG12 ' A' ' 36' ' ' VAL . 17.9 Cg_endo -83.4 -14.15 8.25 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.423 1.416 . . . . 0.0 112.572 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 15' ' ' ALA . 84.6 mt -80.77 -54.19 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.864 -1.148 . . . . 0.0 110.306 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.795 HG23 ' HB1' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -62.29 -37.54 85.92 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.925 ' O ' HD12 ' A' ' 25' ' ' LEU . 15.1 t -63.65 -41.61 93.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.914 ' HE2' HG13 ' A' ' 34' ' ' VAL . 16.0 tttm -52.82 -39.31 62.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 109.743 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 11.6 mtmt -73.08 -26.2 61.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 110.845 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.758 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -69.07 -55.64 10.15 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 110.646 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.925 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.7 mp -65.45 -37.44 86.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 111.478 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.526 ' HB3' HG11 ' A' ' 34' ' ' VAL . 36.1 p -70.98 -26.1 63.0 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.099 -1.0 . . . . 0.0 110.21 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' CE ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -99.64 -3.82 32.28 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.222 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.81 ' CG2' ' HB2' ' A' ' 60' ' ' ALA . 2.2 t -42.9 -73.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 109.855 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.712 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 175.08 -71.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.354 -0.841 . . . . 0.0 109.75 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -78.94 -20.51 70.31 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 25' ' ' LEU . 46.1 t -52.0 134.29 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -1.13 . . . . 0.0 110.449 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.1 m -122.63 -12.2 8.14 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.836 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.916 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -146.56 154.57 41.67 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.873 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.914 HG13 ' HE2' ' A' ' 22' ' ' LYS . 7.1 p -155.23 165.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 110.026 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.631 ' HB3' HG12 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -162.96 155.04 18.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.062 -1.024 . . . . 0.0 110.835 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 18' ' ' PRO . 8.7 m -109.68 113.76 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.766 . . . . 0.0 110.18 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.4 73.76 0.21 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.649 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -65.56 -14.94 62.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -1.193 . . . . 0.0 110.056 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -57.29 -17.31 11.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.89 . . . . 0.0 109.265 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.3 mttm -147.35 32.51 0.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.517 -0.74 . . . . 0.0 110.134 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.573 ' HD3' ' CD1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER 42.89 57.47 3.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 4.6 pt-20 -149.77 148.68 29.51 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.216 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -115.63 130.26 56.8 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' A' ' 35' ' ' ASP . 8.4 p -105.66 143.49 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.478 -1.389 . . . . 0.0 110.003 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.916 HG13 ' O ' ' A' ' 33' ' ' LYS . 57.4 t -152.48 148.12 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.447 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.548 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.1 m -109.42 159.03 17.36 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.854 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.4 p90 -170.33 179.74 3.32 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 117.962 -1.495 . . . . 0.0 111.726 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -106.49 112.9 26.11 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -53.33 -17.3 1.74 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.9 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -65.88 -40.84 91.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.948 . . . . 0.0 110.702 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.6 -0.65 13.59 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.096 -1.002 . . . . 0.0 110.747 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.473 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -150.55 -165.09 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.06 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.607 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 170.84 154.44 0.06 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.582 -0.699 . . . . 0.0 109.464 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.122 ' CG2' HG21 ' A' ' 70' ' ' VAL . 9.5 p -42.39 -39.84 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.902 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.538 ' N ' HG13 ' A' ' 54' ' ' VAL . 5.7 tp-100 -59.69 -47.5 85.39 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.169 -0.957 . . . . 0.0 109.313 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -66.29 -24.16 66.51 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.469 -0.769 . . . . 0.0 110.698 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.888 HD12 ' HA ' ' A' ' 54' ' ' VAL . 43.0 mt -72.65 -54.59 8.62 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.706 -1.246 . . . . 0.0 108.12 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 52.5 m -56.29 -32.84 64.96 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.538 -0.726 . . . . 0.0 109.223 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -77.55 -28.78 51.94 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.291 -0.88 . . . . 0.0 110.053 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.81 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -68.54 -49.39 59.88 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.214 -0.929 . . . . 0.0 109.12 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.734 ' CB ' HG13 ' A' ' 21' ' ' VAL . 7.4 t -67.02 -32.26 73.35 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -68.29 -26.86 65.86 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.053 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 4.1 t0 -88.65 -13.31 40.12 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.795 ' HB1' HG23 ' A' ' 20' ' ' THR . . . -79.3 -32.64 43.59 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 143.35 31.11 0.1 Allowed Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.593 -1.289 . . . . 0.0 111.168 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.61 ' CZ ' ' HA ' ' A' ' 17' ' ' CYS . 63.8 m-85 -155.9 105.89 2.12 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.664 -1.492 . . . . 0.0 111.621 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.529 ' O ' ' CG ' ' A' ' 10' ' ' PRO . 5.0 Cg_exo -56.31 98.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 N-CA-C 106.768 -2.051 . . . . 0.0 106.768 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 8' ' ' ALA . 1.1 t -107.27 -177.91 3.49 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.077 -1.014 . . . . 0.0 111.939 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.803 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 12.9 p -136.99 -162.01 1.23 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.122 HG21 ' CG2' ' A' ' 54' ' ' VAL . 4.6 p -144.27 157.43 15.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 118.522 -1.271 . . . . 0.0 112.058 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.431 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -128.62 33.3 4.68 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.317 1.056 . . . . 0.0 108.195 179.149 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.597 ' CB ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.338 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.724 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.86 173.5 6.33 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.164 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.699 HG23 ' OG1' ' A' ' 46' ' ' THR . 0.7 OUTLIER -143.39 128.48 18.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.776 -0.578 . . . . 0.0 110.064 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.584 ' CG1' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -132.79 161.4 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.391 -0.818 . . . . 0.0 109.371 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.712 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.61 157.31 17.78 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.023 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -130.38 157.65 42.0 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.753 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.04 106.48 16.0 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.906 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.699 HG23 ' CB ' ' A' ' 66' ' ' TYR . 1.4 p -115.62 94.33 39.99 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.3 Cg_endo -78.64 43.33 1.42 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.56 1.507 . . . . 0.0 111.56 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.597 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -90.44 -49.71 3.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.592 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 4.2 ptm 36.4 61.94 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.77 -0.841 . . . . 0.0 110.981 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.968 HG21 ' HB3' ' A' ' 16' ' ' ALA . 6.6 t -70.94 -2.38 15.02 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 109.269 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.5 OUTLIER 78.12 3.03 2.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.708 -0.62 . . . . 0.0 111.458 178.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.598 ' H ' HG23 ' A' ' 13' ' ' THR . . . -174.74 33.59 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.229 -0.92 . . . . 0.0 109.924 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.968 ' HB3' HG21 ' A' ' 13' ' ' THR . . . 179.74 -21.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.108 -0.995 . . . . 0.0 112.155 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.889 ' H ' HG22 ' A' ' 13' ' ' THR . 0.0 OUTLIER -46.27 -48.97 44.3 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.201 -1.562 . . . . 0.0 110.969 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.596 ' O ' HG11 ' A' ' 36' ' ' VAL . 19.5 Cg_endo -81.66 -11.75 11.42 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.437 1.425 . . . . 0.0 113.558 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.1 mt -92.57 -37.99 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.495 -1.378 . . . . 0.0 110.862 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.953 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -73.26 -36.57 66.4 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.882 ' O ' HD12 ' A' ' 25' ' ' LEU . 42.1 t -67.67 -44.04 86.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.227 -0.989 . . . . 0.0 108.56 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.558 ' HA ' ' CG1' ' A' ' 34' ' ' VAL . 4.5 tptm -52.74 -47.59 67.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.542 -0.724 . . . . 0.0 110.311 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 5.0 mmtm -77.08 -16.19 59.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.974 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.681 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -73.93 -58.73 3.11 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.966 -1.084 . . . . 0.0 110.315 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.902 ' O ' HG12 ' A' ' 28' ' ' VAL . 3.7 mp -71.7 -29.15 64.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.597 -0.689 . . . . 0.0 110.487 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.761 ' C ' HG11 ' A' ' 31' ' ' VAL . 54.7 p -73.36 -26.11 60.88 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.432 -0.792 . . . . 0.0 109.426 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -110.48 3.54 19.68 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.001 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.902 HG12 ' O ' ' A' ' 25' ' ' LEU . 3.3 p -49.24 -55.33 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.024 -1.048 . . . . 0.0 110.448 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.655 ' H ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 176.31 -69.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.781 -1.2 . . . . 0.0 111.541 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -98.57 -9.52 52.7 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.776 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.761 HG11 ' C ' ' A' ' 26' ' ' SER . 11.0 p -42.56 143.4 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.307 . . . . 0.0 110.928 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.39 -15.56 10.32 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.73 0.776 . . . . 0.0 109.14 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.653 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -161.33 161.44 30.51 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 45' ' ' VAL . 25.6 t -157.61 161.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.097 -1.002 . . . . 0.0 110.43 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.532 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 1.1 m-20 -163.63 166.57 22.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.915 . . . . 0.0 110.29 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.596 HG11 ' O ' ' A' ' 18' ' ' PRO . 15.7 m -140.92 157.22 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.419 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -147.61 105.31 0.31 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.58 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -64.0 -23.69 67.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.288 -1.124 . . . . 0.0 110.269 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -47.18 -37.3 9.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.925 . . . . 0.0 109.987 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -135.32 29.65 3.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.414 -0.804 . . . . 0.0 110.481 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.592 ' CD ' ' HB3' ' A' ' 12' ' ' MET . 0.0 OUTLIER 38.55 60.52 1.33 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.571 -0.706 . . . . 0.0 110.319 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 20.7 pt-20 -143.18 145.97 33.27 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.663 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.628 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -114.82 130.14 56.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 108.982 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 44' ' ' VAL . 10.0 p -105.54 126.91 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.904 -1.122 . . . . 0.0 109.1 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 34' ' ' VAL . 40.7 t -131.88 144.55 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.691 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.699 ' OG1' HG23 ' A' ' 4' ' ' THR . 1.3 m -108.86 157.62 18.43 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.615 ' CE2' HD11 ' A' ' 57' ' ' LEU . 46.7 p90 -171.6 -173.77 1.26 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.098 -1.441 . . . . 0.0 111.326 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 48' ' ' ASP . 5.7 m-20 -107.04 129.42 54.81 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.401 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 25.4 t70 -80.36 35.77 0.35 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.958 -1.089 . . . . 0.0 111.391 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.5 p -118.23 -16.97 9.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.37 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 7.5 mtpt -133.05 1.93 3.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.457 -0.777 . . . . 0.0 110.092 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . -179.65 -178.57 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 110.368 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.609 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 8.1 p 174.24 -176.01 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 0.0 109.659 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.023 HG23 HG21 ' A' ' 70' ' ' VAL . 2.1 p -38.34 -40.07 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.304 -0.873 . . . . 0.0 110.632 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 6.0 tt0 -56.52 -50.56 71.46 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.028 -1.045 . . . . 0.0 109.812 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 31.7 mmtt -79.69 -13.68 59.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 111.52 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.777 ' HB3' HD23 ' A' ' 25' ' ' LEU . 89.3 mt -78.35 -56.51 4.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.515 -1.366 . . . . 0.0 108.062 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 26.8 m -58.27 -29.68 65.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -78.05 -26.27 48.23 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.359 -0.838 . . . . 0.0 109.714 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.619 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -71.81 -46.33 58.54 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.264 -0.897 . . . . 0.0 109.237 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.56 ' HB ' HD11 ' A' ' 25' ' ' LEU . 10.0 t -71.57 -33.81 69.39 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -62.09 -34.64 76.68 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.849 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -91.13 -8.33 49.06 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.467 -0.771 . . . . 0.0 109.21 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.953 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.65 -25.18 41.41 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.55 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 137.11 17.29 0.71 Allowed Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.391 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.699 ' CB ' HG23 ' A' ' 9' ' ' VAL . 33.7 m-85 -143.94 114.78 5.49 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.444 -1.621 . . . . 0.0 111.601 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.99 95.32 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 N-CA-C 107.6 -1.731 . . . . 0.0 107.6 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.02 -170.56 1.68 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 112.332 -176.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 68' ' ' SER . 10.4 m -148.93 -161.86 1.44 Allowed 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 54' ' ' VAL . 5.1 p -140.09 163.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 120.657 -1.277 . . . . 0.0 111.937 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -125.88 26.12 6.68 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.381 1.086 . . . . 0.0 109.504 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.584 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 1.5 mt-30 . . . . . 0 C--N 1.285 -2.205 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.22 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -112.43 162.42 15.6 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.361 -177.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.5 m -135.31 132.87 38.22 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.705 HG21 ' CG2' ' A' ' 54' ' ' VAL . 3.9 t -139.18 169.34 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.015 . . . . 0.0 109.966 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.975 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.48 156.53 18.87 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.89 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -130.59 157.46 42.65 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 117.855 -1.538 . . . . 0.0 110.861 -178.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 68' ' ' SER . . . -109.84 111.35 22.72 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.808 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.751 HG21 HG21 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -117.94 98.13 51.31 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.186 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.518 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 10.7 Cg_endo -80.17 49.91 3.36 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.514 1.476 . . . . 0.0 110.965 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.655 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -90.97 -39.59 5.74 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 8.2 ptm 38.43 42.83 0.58 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.661 -0.905 . . . . 0.0 110.6 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.759 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -71.61 2.9 4.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.675 -0.64 . . . . 0.0 110.044 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 13' ' ' THR . 3.9 t 78.99 95.86 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.453 0.644 . . . . 0.0 110.152 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 54.44 23.61 4.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.45 -0.781 . . . . 0.0 110.028 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -123.61 -48.6 1.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -0.866 . . . . 0.0 109.71 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.577 ' SG ' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -39.7 -61.53 1.04 Allowed Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 121.474 -0.766 . . . . 0.0 111.445 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.617 ' HG3' ' CG ' ' A' ' 38' ' ' PHE . 5.6 Cg_endo -61.16 -20.65 68.81 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.96 1.773 . . . . 0.0 114.62 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.4 mt -90.42 -36.57 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.332 -1.48 . . . . 0.0 110.755 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.976 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -77.2 -40.71 44.21 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.937 ' O ' HD12 ' A' ' 25' ' ' LEU . 41.8 t -66.21 -48.08 82.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.616 ' HA ' HG21 ' A' ' 34' ' ' VAL . 23.3 tttm -52.42 -43.99 65.15 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.795 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 13.9 mmtt -72.82 -20.93 61.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 111.277 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -75.86 -60.95 2.1 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.165 -0.959 . . . . 0.0 110.269 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.937 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.7 mp -56.89 -36.32 69.98 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.431 -0.793 . . . . 0.0 109.96 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.562 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -71.07 -27.18 63.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.567 -0.708 . . . . 0.0 109.224 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -92.51 -4.54 53.41 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 121.225 -0.922 . . . . 0.0 109.753 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.777 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.7 t -44.01 -81.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.737 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.777 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 174.07 -73.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.45 -19.18 74.27 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.821 HG21 ' O ' ' A' ' 25' ' ' LEU . 4.2 p -49.97 137.56 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.559 -0.965 . . . . 0.0 110.454 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -121.5 -13.17 8.44 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.395 0.617 . . . . 0.0 109.606 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HG3' ' N ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -162.01 160.49 27.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.175 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.616 HG21 ' HA ' ' A' ' 22' ' ' LYS . 8.1 p -142.33 177.44 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.414 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.559 ' H ' HG22 ' A' ' 34' ' ' VAL . 12.0 t70 -156.6 155.64 32.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 110.186 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.549 ' CG1' ' HB2' ' A' ' 18' ' ' PRO . 3.3 t -108.87 111.27 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 110.443 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -117.47 52.48 0.68 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.617 ' CG ' ' HG3' ' A' ' 18' ' ' PRO . 2.2 t80 -62.49 -19.39 63.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -1.115 . . . . 0.0 110.128 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -48.81 -27.17 2.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -139.96 43.09 1.95 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.504 -0.748 . . . . 0.0 109.923 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HD2' ' HA ' ' A' ' 10' ' ' PRO . 1.6 mtt180 41.35 60.04 2.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.445 -0.784 . . . . 0.0 110.182 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -149.32 150.83 33.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.848 . . . . 0.0 110.777 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.645 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -122.23 134.03 54.7 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.975 ' CG2' HG22 ' A' ' 6' ' ' THR . 1.0 OUTLIER -106.38 142.55 19.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.327 -1.483 . . . . 0.0 109.396 -178.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.011 ' CG1' HD13 ' A' ' 57' ' ' LEU . 2.4 p -147.51 145.06 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.238 -1.385 . . . . 0.0 113.558 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -109.96 153.74 24.11 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.869 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.5 p90 -168.93 -178.43 3.31 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.675 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.96 113.86 27.59 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 9.3 t70 -57.67 -13.15 3.56 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 110.767 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.4 p -61.96 -31.24 71.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.664 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -133.15 -3.46 3.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.947 -1.095 . . . . 0.0 111.33 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -143.37 -175.93 4.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.973 -1.079 . . . . 0.0 110.642 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 172.3 169.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 0.0 109.681 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.06 HG13 HG21 ' A' ' 70' ' ' VAL . 19.1 t -39.1 -55.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.436 -0.79 . . . . 0.0 110.773 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 3.7 tp60 -44.51 -46.72 9.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 0.0 110.377 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -73.51 -28.5 61.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.185 -0.947 . . . . 0.0 111.333 -179.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.011 HD13 ' CG1' ' A' ' 45' ' ' VAL . 65.4 mt -68.95 -61.27 1.87 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.774 -1.204 . . . . 0.0 108.575 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.633 ' N ' HD21 ' A' ' 7' ' ' LEU . 10.1 t -60.34 -22.9 63.77 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.395 -0.816 . . . . 0.0 108.803 178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 2.7 tttt -78.34 -28.92 47.35 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.374 -0.829 . . . . 0.0 109.35 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.573 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -72.09 -45.55 60.22 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 108.995 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.854 ' OG1' HG22 ' A' ' 21' ' ' VAL . 9.9 t -70.8 -32.44 69.53 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -65.24 -31.71 73.02 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.579 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -88.72 -12.16 43.09 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.976 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -77.54 -26.48 51.05 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.06 19.84 0.69 Allowed Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.781 -1.2 . . . . 0.0 111.362 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.655 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 32.5 m-85 -142.51 113.7 6.09 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.511 -1.581 . . . . 0.0 111.758 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 2.7 Cg_endo -60.17 97.16 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 N-CA-C 107.418 -1.801 . . . . 0.0 107.418 177.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -108.3 -172.57 2.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.09 -1.006 . . . . 0.0 112.347 -176.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.503 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -148.52 -159.05 0.98 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.06 HG21 HG13 ' A' ' 54' ' ' VAL . 2.9 p -139.63 158.52 27.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 121.012 -1.055 . . . . 0.0 111.435 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 4.8 mtmt -121.41 23.09 10.54 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.223 1.011 . . . . 0.0 109.843 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.465 ' HA ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.283 -2.319 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.2 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.6 mt-30 -109.05 149.48 29.21 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.842 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.493 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 24.5 m -120.04 130.05 54.52 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.818 HG13 ' HA ' ' A' ' 72' ' ' GLN . 1.7 t -151.77 165.56 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.062 -1.024 . . . . 0.0 109.528 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.794 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -106.83 171.12 7.54 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.97 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.24 154.18 51.42 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.605 -178.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 68' ' ' SER . . . -108.57 94.24 4.95 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.463 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 21' ' ' VAL . 2.5 p -110.27 101.7 48.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.686 -0.634 . . . . 0.0 109.615 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.5 Cg_endo -78.28 44.37 1.59 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.728 1.383 . . . . 0.0 111.114 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.678 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -86.49 -41.35 6.93 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.513 ' HG3' ' HG2' ' A' ' 41' ' ' ARG . 12.2 mtp 59.18 -87.19 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.61 -0.935 . . . . 0.0 109.813 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.838 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 1.1 p 48.27 15.69 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' THR . 0.3 OUTLIER 45.43 104.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.823 . . . . 0.0 112.058 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 19' ' ' ILE . . . 56.01 32.19 19.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.263 -0.898 . . . . 0.0 111.044 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.838 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -137.61 -47.39 0.56 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 109.359 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -53.81 -45.94 98.63 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.538 -0.727 . . . . 0.0 111.183 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 10.3 Cg_endo -74.0 -11.37 23.45 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.005 1.136 . . . . 0.0 112.599 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 1.7 mt -92.39 -40.02 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.669 -1.269 . . . . 0.0 109.349 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 1.026 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.3 m -74.68 -40.5 61.36 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 9' ' ' VAL . 37.5 t -66.45 -48.89 79.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.544 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.612 ' O ' HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -47.93 -45.97 31.53 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 14.3 mttt -74.63 -23.43 58.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.251 -0.906 . . . . 0.0 111.6 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.699 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -68.92 -50.09 52.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.283 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.006 ' HB3' HG21 ' A' ' 45' ' ' VAL . 4.6 mp -70.53 -34.52 72.37 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 110.272 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.87 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -68.22 -21.33 64.86 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -113.39 5.04 16.61 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.04 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 25' ' ' LEU . 12.7 p -53.43 -49.19 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.128 -0.982 . . . . 0.0 110.421 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.608 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 170.17 -80.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.075 -1.016 . . . . 0.0 110.853 179.462 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.496 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -92.14 5.63 78.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.87 HG11 ' C ' ' A' ' 26' ' ' SER . 12.2 p -50.26 142.52 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.865 -1.373 . . . . 0.0 110.457 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.8 m -124.74 -9.79 7.29 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.758 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 1.3 tttt -168.31 138.55 2.56 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.578 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.793 HG21 ' CB ' ' A' ' 26' ' ' SER . 5.0 t -130.22 166.43 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.137 -0.977 . . . . 0.0 110.689 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.637 ' CB ' HG12 ' A' ' 44' ' ' VAL . 8.8 t0 -156.58 162.76 39.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.162 -0.961 . . . . 0.0 110.213 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.565 HG13 ' HB3' ' A' ' 18' ' ' PRO . 4.5 t -113.83 125.97 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -124.89 69.37 0.49 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -63.51 -11.75 26.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -1.116 . . . . 0.0 110.527 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -43.97 -31.36 0.88 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 108.979 179.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 41' ' ' ARG . 1.4 tttp -148.07 47.05 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.44 0.638 . . . . 0.0 109.308 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.513 ' HG2' ' HG3' ' A' ' 12' ' ' MET . 2.0 tpp180 42.03 58.96 2.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.436 -0.79 . . . . 0.0 110.363 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 13.9 pt-20 -138.38 169.42 17.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.294 -0.879 . . . . 0.0 110.286 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -134.74 134.96 41.55 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.648 HG23 ' HB ' ' A' ' 6' ' ' THR . 1.1 t -106.65 122.56 60.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.674 -1.266 . . . . 0.0 109.646 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.006 HG21 ' HB3' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -123.09 -178.28 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.669 1.223 . . . . 0.0 111.902 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -152.18 149.06 28.34 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.99 ' CE2' HD11 ' A' ' 57' ' ' LEU . 28.7 p90 -166.36 -175.3 3.19 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 117.601 -1.64 . . . . 0.0 112.011 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.542 ' OD1' HG22 ' A' ' 50' ' ' THR . 0.5 OUTLIER -106.23 110.52 22.79 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 5.9 t70 -57.81 -14.28 5.69 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.763 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.542 HG22 ' OD1' ' A' ' 48' ' ' ASP . 8.9 t -65.41 -34.97 79.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 110.294 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' N ' HG23 ' A' ' 50' ' ' THR . 1.6 mmpp? -125.39 3.82 7.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.146 -0.971 . . . . 0.0 110.431 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -150.77 -169.75 3.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.919 . . . . 0.0 110.339 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.4 p 170.05 165.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 0.0 109.618 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.925 HG13 HG21 ' A' ' 70' ' ' VAL . 2.9 t -43.44 -37.74 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.005 -1.059 . . . . 0.0 109.714 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -58.73 -46.72 86.74 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.019 -1.051 . . . . 0.0 109.544 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.509 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 10.5 mmmt -71.02 -25.61 62.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 110.861 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.99 HD11 ' CE2' ' A' ' 47' ' ' PHE . 55.2 mt -70.8 -58.7 3.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.786 -1.196 . . . . 0.0 108.21 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.649 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 99.7 m -56.47 -30.3 62.75 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -75.63 -28.73 58.93 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.403 -0.811 . . . . 0.0 109.555 179.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.699 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -70.01 -51.47 32.08 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.468 -0.77 . . . . 0.0 109.221 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.92 ' OG1' HG22 ' A' ' 21' ' ' VAL . 13.1 t -67.77 -30.06 69.41 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -67.54 -31.14 71.02 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.948 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -86.38 -12.88 48.03 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 1.026 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -32.4 57.42 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 137.94 31.9 0.22 Allowed Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.781 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.818 ' CB ' HG23 ' A' ' 9' ' ' VAL . 47.1 m-85 -151.88 113.81 2.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.786 -1.42 . . . . 0.0 111.596 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.38 94.71 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 N-CA-C 107.663 -1.706 . . . . 0.0 107.663 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -108.91 -165.0 0.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.032 . . . . 0.0 112.531 -177.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.499 ' N ' ' OG ' ' A' ' 68' ' ' SER . 49.1 m -152.49 -159.2 0.98 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.97 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.7 p -139.07 152.94 24.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.887 -1.133 . . . . 0.0 110.683 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.79 ' HB3' HG23 ' A' ' 6' ' ' THR . 1.3 tttp -125.51 49.51 1.91 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.923 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.818 ' HA ' HG13 ' A' ' 5' ' ' VAL . 3.5 pp0? . . . . . 0 C--N 1.28 -2.446 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.021 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -124.31 171.67 9.71 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.956 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.491 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 37.0 m -110.73 155.72 22.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.574 -0.704 . . . . 0.0 110.42 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.787 HG13 ' C ' ' A' ' 72' ' ' GLN . 1.8 t -152.79 161.8 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 108.687 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.763 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -108.02 161.08 15.27 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.999 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -132.58 155.13 49.23 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.82 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.84 101.74 10.32 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.412 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 21' ' ' VAL . 2.0 p -118.09 101.84 51.28 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.495 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.25 36.67 0.55 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.379 1.386 . . . . 0.0 111.579 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.643 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -76.58 -46.69 11.26 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 10.6 ptp 38.47 54.91 1.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.737 -0.861 . . . . 0.0 110.181 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.841 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -86.69 17.05 4.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.579 -0.7 . . . . 0.0 109.764 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.648 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 7.8 t 66.45 89.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 110.604 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 65.32 18.04 11.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 110.48 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.841 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -123.14 -48.12 2.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 109.522 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.626 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -55.7 -44.15 99.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.47 -0.769 . . . . 0.0 111.303 179.426 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 12.7 Cg_endo -76.55 -16.77 16.7 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 120.925 1.083 . . . . 0.0 112.681 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.67 -31.52 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.587 -1.321 . . . . 0.0 109.561 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.965 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.1 m -83.64 -47.98 10.67 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 9' ' ' VAL . 74.9 t -57.52 -48.8 82.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.889 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.677 ' O ' HG11 ' A' ' 34' ' ' VAL . 14.4 tttt -57.46 -45.84 84.3 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.27 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -76.21 -2.76 32.83 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.199 -0.938 . . . . 0.0 110.616 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.579 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -85.18 -54.03 4.87 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.128 -0.983 . . . . 0.0 109.438 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.944 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -80.55 -13.22 59.26 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.244 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.915 ' HA ' HG21 ' A' ' 31' ' ' VAL . 20.1 t -78.72 -35.93 44.15 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.499 -0.751 . . . . 0.0 108.981 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HD2' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -104.15 2.95 32.45 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.825 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 25' ' ' LEU . 4.6 p -54.11 -53.35 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.79 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.608 ' H ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 169.28 -86.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.881 -1.137 . . . . 0.0 111.557 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.662 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -67.69 -21.72 73.09 Favored Glycine 0 N--CA 1.494 2.514 0 O-C-N 121.221 -0.924 . . . . 0.0 111.331 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.915 HG21 ' HA ' ' A' ' 26' ' ' SER . 10.8 p -40.15 144.74 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.933 -1.334 . . . . 0.0 111.702 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 m -127.99 -8.63 5.44 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.258 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.555 ' C ' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -162.36 165.05 26.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.157 -0.965 . . . . 0.0 109.842 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -160.28 155.6 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.989 -1.069 . . . . 0.0 111.165 -178.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.61 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -155.75 161.15 40.75 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 18' ' ' PRO . 3.2 m -109.59 131.86 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.734 -1.229 . . . . 0.0 111.29 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.4 58.67 0.56 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -58.78 -17.52 24.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -1.05 . . . . 0.0 110.769 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.14 -22.54 1.72 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.031 . . . . 0.0 109.634 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -148.7 43.11 0.99 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.427 -0.795 . . . . 0.0 109.828 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 40' ' ' LYS . 5.4 mmt180 41.75 58.59 2.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.401 -0.812 . . . . 0.0 109.921 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 4.5 pt-20 -149.17 151.92 35.18 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.992 -1.067 . . . . 0.0 110.669 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.423 ' CB ' HG12 ' A' ' 21' ' ' VAL . . . -117.58 142.43 47.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.802 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 44' ' ' VAL . 5.4 p -108.72 110.5 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.649 -1.282 . . . . 0.0 108.604 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 34' ' ' VAL . 2.9 p -116.52 144.0 25.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.965 0.888 . . . . 0.0 112.36 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.549 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.2 m -109.79 150.78 27.86 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.656 ' CE2' HD11 ' A' ' 57' ' ' LEU . 23.4 p90 -171.25 173.03 5.06 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 117.736 -1.586 . . . . 0.0 112.303 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.752 ' HB2' HG22 ' A' ' 50' ' ' THR . 0.7 OUTLIER -107.26 118.86 37.83 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.176 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 6.1 p-10 -59.27 -10.99 3.41 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.279 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.752 HG22 ' HB2' ' A' ' 48' ' ' ASP . 7.7 t -68.77 -27.02 65.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.958 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HB2' ' OD1' ' A' ' 48' ' ' ASP . 5.6 mttt -120.94 0.55 10.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.92 -1.112 . . . . 0.0 110.579 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.662 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -171.76 -160.79 0.17 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 110.206 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.626 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 169.18 167.74 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.502 -0.749 . . . . 0.0 110.098 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.029 HG13 HG21 ' A' ' 70' ' ' VAL . 3.0 t -41.08 -42.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.875 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 6.9 tp-100 -52.02 -49.79 62.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.022 . . . . 0.0 109.504 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.546 ' CG ' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -74.17 -22.7 59.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.458 -0.776 . . . . 0.0 111.645 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.864 HD13 ' CG1' ' A' ' 45' ' ' VAL . 57.0 mt -72.66 -61.42 1.81 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.39 -1.444 . . . . 0.0 108.237 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.493 ' O ' HG22 ' A' ' 61' ' ' THR . 79.1 m -57.11 -26.08 59.87 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.503 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 3.1 ttmt -72.47 -36.05 68.37 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.558 -0.713 . . . . 0.0 109.104 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.579 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -66.13 -41.08 90.97 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.439 -0.788 . . . . 0.0 109.938 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.557 ' OG1' HG22 ' A' ' 21' ' ' VAL . 8.9 t -73.65 -29.92 62.62 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.15 -32.66 74.24 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 8.8 t0 -90.64 -12.45 36.83 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.672 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.965 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -78.22 -27.47 47.76 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 132.76 26.61 0.63 Allowed Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.672 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.762 ' CB ' HG23 ' A' ' 9' ' ' VAL . 37.7 m-85 -147.82 109.11 3.78 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.689 -1.477 . . . . 0.0 111.659 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -59.85 95.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 N-CA-C 107.312 -1.842 . . . . 0.0 107.312 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.03 -168.74 1.38 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 112.415 -176.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.543 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -151.63 -160.81 1.21 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.029 HG21 HG13 ' A' ' 54' ' ' VAL . 2.2 p -140.24 159.24 25.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.991 -1.068 . . . . 0.0 110.968 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.486 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 2.6 mttt -124.96 25.13 7.41 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.448 1.118 . . . . 0.0 109.155 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.787 ' C ' HG13 ' A' ' 5' ' ' VAL . 13.4 mm100 . . . . . 0 C--N 1.285 -2.211 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.136 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -108.72 163.49 13.21 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.501 -0.88 . . . . 0.0 112.493 -177.048 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.448 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 1.3 t -135.14 111.4 9.68 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.281 0.562 . . . . 0.0 109.775 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.447 HG21 HD12 ' A' ' 57' ' ' LEU 0.256 14.5 m -122.75 166.39 17.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.216 -0.928 . . . . 0.0 109.925 -179.155 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.731 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.45 166.47 10.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.008 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.15 161.42 33.38 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.1 -178.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.512 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -109.56 105.88 15.37 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.434 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.747 HG23 ' CB ' ' A' ' 66' ' ' TYR . 2.3 p -116.43 85.9 17.05 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -76.39 36.06 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.67 1.353 . . . . 0.0 112.318 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -78.72 -31.07 45.94 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.76 -2.136 . . . . 0.0 107.76 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 36.84 42.0 0.2 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.923 -0.751 . . . . 0.0 110.386 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.991 HG21 ' HB3' ' A' ' 16' ' ' ALA . 4.0 t -45.78 -27.88 0.93 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 13' ' ' THR . 7.6 t 144.33 -41.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 121.91 0.862 . . . . 0.0 109.241 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.601 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . . . -176.23 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.577 0.703 . . . . 0.0 109.366 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.991 ' HB3' HG21 ' A' ' 13' ' ' THR . . . -129.07 -26.27 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.607 -0.683 . . . . 0.0 109.981 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.642 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -44.62 -47.27 27.51 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.917 -1.114 . . . . 0.0 111.689 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.856 ' O ' HG21 ' A' ' 36' ' ' VAL . 6.9 Cg_endo -76.23 -18.21 16.35 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.334 1.356 . . . . 0.0 113.325 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 mm -87.59 -42.67 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.415 -1.428 . . . . 0.0 109.557 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.871 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.251 0.9 OUTLIER -69.55 -37.21 76.94 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.889 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.908 ' O ' HD12 ' A' ' 25' ' ' LEU . 25.6 t -64.6 -45.61 94.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 1.078 ' O ' HG21 ' A' ' 34' ' ' VAL . 68.7 tttt -50.67 -45.99 58.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.574 -0.704 . . . . 0.0 110.307 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 8.7 mtmt -75.67 -20.82 58.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 111.101 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.594 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -69.97 -52.65 22.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.439 -0.788 . . . . 0.0 110.557 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.932 HD21 ' CD2' ' A' ' 7' ' ' LEU . 4.0 mp -71.91 -31.09 66.05 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.144 -0.973 . . . . 0.0 110.028 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.803 ' C ' HG11 ' A' ' 31' ' ' VAL . 12.7 t -68.22 -22.99 64.76 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -111.6 2.8 17.52 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.274 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.922 HG12 ' O ' ' A' ' 25' ' ' LEU . 7.7 p -49.94 -52.13 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.073 -1.017 . . . . 0.0 110.339 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.602 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 172.34 -77.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 110.897 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.499 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -93.34 -1.88 66.26 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.803 HG11 ' C ' ' A' ' 26' ' ' SER . 6.9 p -44.0 141.05 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.238 . . . . 0.0 110.711 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.6 t -118.02 -13.86 9.99 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.606 0.717 . . . . 0.0 109.071 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.702 ' O ' HG13 ' A' ' 45' ' ' VAL . 7.5 tttt -159.46 166.28 31.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.546 -0.721 . . . . 0.0 109.649 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.078 HG21 ' O ' ' A' ' 22' ' ' LYS . 7.2 p -162.51 154.47 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.99 . . . . 0.0 111.366 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.565 ' HB2' HG13 ' A' ' 44' ' ' VAL . 1.3 m-20 -164.86 171.19 14.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 109.238 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.856 HG21 ' O ' ' A' ' 18' ' ' PRO . 3.1 m -152.06 164.6 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.935 -1.103 . . . . 0.0 111.173 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.26 112.31 0.52 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.602 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -66.27 -19.35 65.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -1.142 . . . . 0.0 109.934 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -53.8 -64.67 0.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.354 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -95.6 22.63 6.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.33 -0.856 . . . . 0.0 109.33 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.656 ' NH1' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 36.89 59.64 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.33 0.586 . . . . 0.0 110.772 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 18.3 pt-20 -146.11 166.96 24.59 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.536 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.786 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -125.56 132.57 52.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.161 -0.962 . . . . 0.0 109.163 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.668 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.8 p -106.51 116.18 49.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 120.791 -1.193 . . . . 0.0 109.119 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.876 HG22 HG23 ' A' ' 34' ' ' VAL . 39.3 t -129.84 144.78 37.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.122 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 1.2 m -108.6 161.29 15.21 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.4 p90 -170.22 -177.69 2.57 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 117.898 -1.521 . . . . 0.0 112.091 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -105.98 113.94 27.79 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 10.7 t70 -59.62 -10.2 3.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.784 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.0 p -70.55 -29.22 65.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 0.0 110.61 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -134.6 18.32 3.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.028 -1.045 . . . . 0.0 110.846 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -170.66 178.72 3.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.0 110.053 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.585 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.9 OUTLIER 176.2 171.01 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.387 -0.821 . . . . 0.0 109.511 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.963 HG13 HG21 ' A' ' 70' ' ' VAL . 2.7 t -41.8 -34.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -58.88 -50.27 74.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.896 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.575 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 16.3 mmtm -76.5 -20.52 56.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 111.246 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.859 HD11 ' CE2' ' A' ' 47' ' ' PHE . 76.1 mt -70.77 -59.71 2.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.572 -1.33 . . . . 0.0 108.482 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 94.5 m -58.63 -26.88 64.19 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.518 -0.739 . . . . 0.0 109.049 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 60.4 tttt -76.35 -29.59 57.29 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.51 -0.744 . . . . 0.0 109.307 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.594 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -69.94 -51.12 35.48 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.626 ' HB ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.64 -32.8 74.35 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -64.87 -31.27 72.42 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.903 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -88.54 -11.11 46.63 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.498 -0.751 . . . . 0.0 109.028 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.871 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -78.35 -27.3 47.0 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 135.86 23.8 0.55 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.093 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.747 ' CB ' HG23 ' A' ' 9' ' ' VAL . 43.7 m-85 -148.15 109.12 3.69 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.493 -1.592 . . . . 0.0 111.64 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.1 Cg_exo -57.19 98.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 107.014 -1.956 . . . . 0.0 107.014 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 71.6 p -108.41 -166.31 1.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.083 0.944 . . . . 0.0 112.68 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.497 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.8 m -151.8 -160.74 1.19 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.008 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.2 p -141.1 160.07 22.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.779 -1.2 . . . . 0.0 111.844 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.728 ' HG3' HG23 ' A' ' 6' ' ' THR . 9.2 mttt -127.85 25.35 5.97 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.367 1.079 . . . . 0.0 108.93 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.122 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.401 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -113.68 -174.93 2.56 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.312 -0.955 . . . . 0.0 112.462 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.552 ' C ' HG23 ' A' ' 5' ' ' VAL . 92.3 m -142.5 146.81 35.11 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.468 0.652 . . . . 0.0 110.34 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.918 HG13 ' HA ' ' A' ' 72' ' ' GLN . 15.9 t -156.03 167.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.461 -0.774 . . . . 0.0 109.764 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -109.66 169.47 8.69 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.997 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -133.29 157.99 44.08 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.934 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 68' ' ' SER . . . -110.24 103.33 12.0 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.735 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.828 HG21 HG21 ' A' ' 21' ' ' VAL . 1.9 p -114.56 92.65 29.53 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.397 -0.814 . . . . 0.0 109.995 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 10.7 Cg_endo -79.54 51.42 3.87 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.669 1.579 . . . . 0.0 111.581 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.606 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -95.44 -21.09 25.42 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.524 ' CG ' ' C ' ' A' ' 11' ' ' GLY . 1.2 ptt? 35.77 59.4 0.86 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.768 -0.842 . . . . 0.0 110.559 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.821 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -90.51 19.68 5.12 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.521 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 13' ' ' THR . 2.4 t 68.5 92.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.471 -0.768 . . . . 0.0 110.309 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.585 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . . . 50.25 30.96 4.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 110.085 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.821 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -127.17 -45.45 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.586 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -40.05 -69.37 0.21 Allowed Pre-proline 0 N--CA 1.505 2.281 0 O-C-N 121.109 -0.994 . . . . 0.0 111.673 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.857 ' O ' HG12 ' A' ' 36' ' ' VAL . 10.0 Cg_endo -65.8 -12.75 36.63 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.173 1.249 . . . . 0.0 112.752 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 20' ' ' THR . 1.5 mp -78.88 -56.0 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.864 -1.147 . . . . 0.0 109.583 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.533 HG23 ' HB1' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -69.37 -42.01 75.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.888 HG22 ' OG1' ' A' ' 61' ' ' THR . 5.6 t -57.71 -43.53 83.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.847 ' O ' HG21 ' A' ' 34' ' ' VAL . 12.8 tttt -53.08 -50.11 65.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.511 -0.743 . . . . 0.0 109.861 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 7.9 mtpm? -72.47 -11.59 60.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 111.501 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.476 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -77.8 -67.22 0.75 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.124 -0.985 . . . . 0.0 109.466 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.767 HD22 ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -68.28 -12.3 60.81 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 1.052 ' HA ' HG21 ' A' ' 31' ' ' VAL . 6.8 t -79.32 -30.24 42.73 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.99 9.41 18.72 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.238 -0.914 . . . . 0.0 109.813 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.613 HG13 ' H ' ' A' ' 29' ' ' GLU . 4.0 p -51.89 -53.73 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.349 -0.844 . . . . 0.0 111.08 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.613 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.6 tt0 -179.9 -86.28 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.598 -1.314 . . . . 0.0 110.85 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.547 ' N ' ' CG ' ' A' ' 29' ' ' GLU . . . -74.67 -15.14 80.78 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.052 HG21 ' HA ' ' A' ' 26' ' ' SER . 3.5 p -40.54 142.08 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -1.069 . . . . 0.0 110.961 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 m -127.02 -11.92 5.88 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.396 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.641 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -158.07 165.2 35.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.18 -0.95 . . . . 0.0 110.044 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 1.081 HG23 HG22 ' A' ' 45' ' ' VAL . 6.4 p -169.01 154.48 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.023 -1.048 . . . . 0.0 111.59 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.563 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -157.09 172.14 19.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.491 -0.756 . . . . 0.0 109.634 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.857 HG12 ' O ' ' A' ' 18' ' ' PRO . 2.9 m -109.91 151.09 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.057 -1.027 . . . . 0.0 110.926 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -142.85 64.35 0.49 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -57.33 -15.86 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 110.245 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -45.31 -33.62 2.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.124 -0.985 . . . . 0.0 109.21 179.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -141.57 40.04 1.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.509 -0.744 . . . . 0.0 109.459 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.6 OUTLIER 42.47 57.55 3.38 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.451 -0.781 . . . . 0.0 110.081 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 13.7 pt-20 -142.93 168.76 18.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 110.422 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -129.27 137.79 51.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.419 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.6 p -107.85 109.02 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.706 -1.246 . . . . 0.0 110.288 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.081 HG22 HG23 ' A' ' 34' ' ' VAL . 11.6 t -122.71 150.89 26.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 122.138 0.971 . . . . 0.0 112.068 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -114.12 159.53 19.94 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.637 ' CD2' HD11 ' A' ' 57' ' ' LEU . 38.5 p90 -170.91 -175.04 1.67 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.606 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.18 124.75 50.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -80.94 37.87 0.44 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.45 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.6 p -115.53 -24.53 8.29 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.171 -0.956 . . . . 0.0 109.23 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.7 mttt -127.7 -2.11 6.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.419 -0.8 . . . . 0.0 110.073 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 179.17 176.21 0.61 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.93 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.594 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 6.8 p 172.83 -166.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.671 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.046 HG13 HG21 ' A' ' 70' ' ' VAL . 6.5 t -36.68 -40.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.559 -0.713 . . . . 0.0 111.149 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -57.53 -49.49 76.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.106 -0.997 . . . . 0.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.585 ' HB3' HG21 ' A' ' 28' ' ' VAL . 58.1 mmtt -82.01 -16.95 48.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.263 -0.898 . . . . 0.0 111.736 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.751 HD22 ' HB2' ' A' ' 25' ' ' LEU . 48.0 mt -75.27 -58.47 3.26 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.514 -1.366 . . . . 0.0 108.065 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.534 ' O ' HG22 ' A' ' 61' ' ' THR . 12.9 m -54.46 -30.61 53.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.29 -34.6 65.85 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.513 -0.742 . . . . 0.0 109.858 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.446 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -67.93 -36.96 81.05 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.173 -0.955 . . . . 0.0 109.704 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.888 ' OG1' HG22 ' A' ' 21' ' ' VAL . 5.3 t -74.3 -35.57 63.7 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.418 ' N ' HG23 ' A' ' 61' ' ' THR . . . -64.65 -32.14 73.68 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -90.68 -8.08 50.91 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.533 ' HB1' HG23 ' A' ' 20' ' ' THR . . . -85.16 -21.11 29.33 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.452 -0.78 . . . . 0.0 108.942 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 133.08 17.01 1.18 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.004 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.812 ' CB ' HG23 ' A' ' 9' ' ' VAL . 35.2 m-85 -151.51 111.46 2.98 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.706 -1.467 . . . . 0.0 111.307 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.14 96.83 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 N-CA-C 107.87 -1.627 . . . . 0.0 107.87 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.9 -171.24 1.81 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.01 . . . . 0.0 112.187 -177.27 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.542 ' N ' ' OG ' ' A' ' 68' ' ' SER . 6.0 p -145.18 -157.45 0.79 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.046 HG21 HG13 ' A' ' 54' ' ' VAL . 3.1 p -142.47 158.81 19.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.209 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.536 ' CG ' HG23 ' A' ' 6' ' ' THR . 3.9 mttm -124.69 27.12 6.96 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.304 1.05 . . . . 0.0 109.659 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.918 ' HA ' HG13 ' A' ' 5' ' ' VAL . 17.2 pt20 . . . . . 0 C--N 1.287 -2.148 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.543 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.777 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--O 1.215 -0.711 0 CA-C-O 121.975 0.893 . . . . 0.0 109.181 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.06 176.1 9.75 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.071 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.4 HG23 ' OG1' ' A' ' 46' ' ' THR . 21.6 m -113.4 131.86 55.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 110.138 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.599 HG21 HG22 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -128.98 169.36 20.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.038 0.923 . . . . 0.0 109.296 179.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.683 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -108.51 159.88 16.34 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.963 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -133.04 152.97 51.91 Favored 'General case' 0 C--N 1.292 -1.921 0 O-C-N 120.868 -1.145 . . . . 0.0 109.688 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -108.95 111.48 23.18 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.616 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 21' ' ' VAL . 2.1 p -133.23 93.55 22.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 109.167 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 5.5 Cg_endo -73.26 19.13 0.37 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.388 1.392 . . . . 0.0 112.291 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.637 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -52.19 -36.18 43.99 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.516 ' C ' ' O ' ' A' ' 11' ' ' GLY . 2.1 ptt? 26.61 50.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.67 0.748 . . . . 0.0 110.765 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 1.155 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.9 t -81.38 9.86 6.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.676 -0.64 . . . . 0.0 110.035 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.3 OUTLIER 78.74 94.18 0.06 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.601 0.715 . . . . 0.0 111.104 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.518 ' O ' HD12 ' A' ' 19' ' ' ILE . . . 58.44 42.67 20.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.612 -0.68 . . . . 0.0 112.052 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.155 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -160.81 -44.0 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.709 -1.244 . . . . 0.0 111.005 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.858 ' H ' HG22 ' A' ' 13' ' ' THR . 0.0 OUTLIER -46.62 -53.17 26.49 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.627 -1.295 . . . . 0.0 110.167 179.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.641 ' CG ' ' CD2' ' A' ' 38' ' ' PHE . 10.6 Cg_endo -74.04 -16.59 22.75 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.29 1.327 . . . . 0.0 112.219 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 15' ' ' ALA . 29.6 mt -79.01 -38.49 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.828 -1.17 . . . . 0.0 109.632 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.923 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -77.06 -45.81 25.81 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 9' ' ' VAL . 16.9 t -56.37 -40.69 68.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.538 ' O ' HG21 ' A' ' 34' ' ' VAL . 7.2 tttt -55.67 -56.96 14.23 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 108.823 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -71.39 0.69 7.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.41 -0.806 . . . . 0.0 110.868 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.642 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -88.79 -72.14 0.56 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.669 -1.269 . . . . 0.0 108.929 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.808 HD12 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -64.78 -9.93 24.05 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.49 178.587 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.886 ' HA ' HG11 ' A' ' 31' ' ' VAL . 34.8 t -90.65 -45.5 8.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.5 -0.75 . . . . 0.0 110.397 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -79.28 -4.15 49.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.864 -1.147 . . . . 0.0 110.309 -179.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.682 HG12 ' CG ' ' A' ' 29' ' ' GLU . 5.4 t -29.85 -79.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.852 -0.53 . . . . 0.0 110.927 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.682 ' CG ' HG12 ' A' ' 28' ' ' VAL . 1.2 pt-20 178.0 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.948 -1.095 . . . . 0.0 110.935 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 48' ' ' ASP . . . -117.66 2.27 17.87 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.886 HG11 ' HA ' ' A' ' 26' ' ' SER . 71.6 t -49.69 147.87 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 122.459 1.123 . . . . 0.0 111.399 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 m -122.2 -10.18 8.56 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.459 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.508 ' CG ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -175.72 170.37 2.88 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.001 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.806 HG21 ' HB2' ' A' ' 26' ' ' SER . 9.7 p -170.09 156.49 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.862 . . . . 0.0 110.517 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.56 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -156.2 164.88 37.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.427 -0.795 . . . . 0.0 109.633 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 18' ' ' PRO . 7.2 m -112.18 140.49 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 110.704 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.17 69.82 0.53 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.641 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -61.92 -14.72 37.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -1.154 . . . . 0.0 110.435 -179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -54.89 -27.15 40.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 109.8 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 42' ' ' GLU . 2.8 ptmt -142.7 35.51 1.43 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 110.03 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 10' ' ' PRO . 1.9 mpp_? 42.9 55.75 4.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.214 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -145.61 149.42 34.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.233 -0.917 . . . . 0.0 110.11 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.501 ' N ' ' HG2' ' A' ' 42' ' ' GLU . . . -115.87 139.25 50.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 110.031 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.705 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.1 p -106.47 111.78 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.763 -1.211 . . . . 0.0 109.47 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.102 ' CG1' HD13 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -117.51 137.83 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.776 0.798 . . . . 0.0 112.289 -178.056 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.508 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.6 m -109.0 155.77 20.51 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.777 ' O ' ' HA ' ' A' ' 2' ' ' THR . 35.5 p90 -171.92 -176.81 1.79 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.449 -1.407 . . . . 0.0 110.798 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.498 ' HA ' ' HB ' ' A' ' 2' ' ' THR . 2.1 p30 -109.59 110.52 21.62 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 29.0 t70 -54.64 -14.69 1.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.959 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.418 ' OG1' ' HB2' ' A' ' 48' ' ' ASP . 2.2 p -61.63 -35.73 78.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 110.807 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.08 -5.23 9.52 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.043 -1.035 . . . . 0.0 111.361 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -153.02 -164.47 1.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.969 -1.082 . . . . 0.0 110.874 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.605 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 6.4 t 167.72 172.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.96 ' HB ' HG21 ' A' ' 70' ' ' VAL . 6.6 m -51.54 -32.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.753 -1.217 . . . . 0.0 109.451 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -47.66 -44.86 27.54 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.014 -1.054 . . . . 0.0 108.404 179.003 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -89.06 -20.58 24.18 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.763 -0.586 . . . . 0.0 111.244 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.102 HD13 ' CG1' ' A' ' 45' ' ' VAL . 42.3 mt -73.77 -64.04 1.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.229 -1.544 . . . . 0.0 107.98 178.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.532 ' O ' HG22 ' A' ' 61' ' ' THR . 1.4 m -56.59 -27.61 58.42 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -74.81 -32.0 61.85 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.168 -0.957 . . . . 0.0 109.327 179.362 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.642 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -70.48 -35.94 73.56 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.316 -0.865 . . . . 0.0 109.459 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.833 ' OG1' HG22 ' A' ' 21' ' ' VAL . 4.8 t -74.68 -34.7 62.73 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.415 ' N ' HG23 ' A' ' 61' ' ' THR . . . -66.36 -32.29 73.59 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.39 -10.09 45.19 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.576 -0.703 . . . . 0.0 109.378 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.923 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.48 -29.66 41.75 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.56 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.98 27.93 0.34 Allowed Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.699 -1.238 . . . . 0.0 110.996 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.701 ' CB ' HG23 ' A' ' 9' ' ' VAL . 53.0 m-85 -150.9 116.72 3.28 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.622 -1.517 . . . . 0.0 111.449 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.54 95.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 N-CA-C 106.875 -2.01 . . . . 0.0 106.875 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.605 ' HB2' HG23 ' A' ' 61' ' ' THR . 2.9 m -108.79 -165.1 0.99 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 112.51 -176.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.428 ' O ' ' OG1' ' A' ' 58' ' ' THR . 4.9 t -159.42 -167.11 1.95 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.963 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.1 p -139.06 155.92 27.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 120.804 -1.185 . . . . 0.0 111.379 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.502 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 1.1 mttt -124.49 26.72 7.19 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.432 1.111 . . . . 0.0 108.864 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 5' ' ' VAL . 1.8 mp0 . . . . . 0 C--N 1.29 -2.013 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.289 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 11.5 mt-30 -112.48 151.08 30.34 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.655 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 52.3 m -124.9 122.42 37.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.708 HG21 HG22 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -130.32 171.68 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.03 . . . . 0.0 110.419 -178.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.724 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.28 158.91 16.76 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.925 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -130.07 155.89 45.41 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.662 -1.273 . . . . 0.0 109.847 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.748 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -110.98 100.76 9.4 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.946 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.725 HG21 HG21 ' A' ' 21' ' ' VAL . 1.8 p -114.45 89.97 19.67 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.476 -0.765 . . . . 0.0 109.337 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 11.0 Cg_endo -78.06 46.53 2.1 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.361 1.374 . . . . 0.0 112.008 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.616 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -92.42 -34.31 7.12 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.486 ' C ' ' O ' ' A' ' 11' ' ' GLY . 0.9 OUTLIER 35.59 44.33 0.2 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.758 0.789 . . . . 0.0 110.087 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 1.14 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.4 t -61.22 -11.03 7.84 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.679 -0.638 . . . . 0.0 109.639 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.733 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 86.66 93.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.614 0.721 . . . . 0.0 111.029 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 73.55 24.4 2.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 111.831 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.14 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -150.84 -38.69 0.13 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.457 -1.402 . . . . 0.0 110.718 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.819 ' H ' HG22 ' A' ' 13' ' ' THR . 0.5 OUTLIER -45.15 -47.74 32.36 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.606 -1.309 . . . . 0.0 110.459 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.6 Cg_endo -70.75 -28.17 20.83 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 O-C-N 123.229 1.12 . . . . 0.0 111.655 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.5 mm -73.39 -32.18 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.955 . . . . 0.0 110.839 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.851 HG23 ' HB1' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -81.64 -53.27 6.37 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 108.965 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.037 HG22 ' OG1' ' A' ' 61' ' ' THR . 66.5 t -54.39 -43.46 62.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.678 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.9 tttm -55.55 -61.75 2.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.937 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.59 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -75.42 5.74 5.43 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.186 -0.946 . . . . 0.0 110.678 179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.547 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -85.36 -67.89 0.77 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.373 -1.454 . . . . 0.0 108.482 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.76 ' HB2' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -74.26 -11.62 60.33 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.859 ' HA ' HG21 ' A' ' 31' ' ' VAL . 46.5 t -85.51 -33.25 21.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.59 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.45 -10.1 42.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.6 -1.312 . . . . 0.0 110.433 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.061 HG11 ' CE ' ' A' ' 56' ' ' LYS . 3.2 t -40.39 -82.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.276 -0.89 . . . . 0.0 110.015 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.799 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 174.97 -57.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.418 -0.801 . . . . 0.0 109.906 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.444 ' O ' ' OD2' ' A' ' 48' ' ' ASP . . . -70.3 -26.76 73.73 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.859 HG21 ' HA ' ' A' ' 26' ' ' SER . 14.8 p -56.56 142.3 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -1.145 . . . . 0.0 110.699 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.84 -10.9 8.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.757 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.4 tttt -162.47 168.96 21.17 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.068 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.552 HG21 ' O ' ' A' ' 22' ' ' LYS . 13.7 p -169.07 159.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.093 -1.004 . . . . 0.0 111.384 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.476 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -158.85 162.95 37.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.513 ' CG1' ' HB2' ' A' ' 22' ' ' LYS . 22.4 m -116.23 152.33 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 110.603 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -144.41 79.13 0.25 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.565 ' CE2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -58.03 -18.92 27.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -1.121 . . . . 0.0 110.119 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -50.3 -47.99 55.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 0.0 109.092 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 41' ' ' ARG . 10.1 mttm -116.18 25.49 10.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.493 -0.754 . . . . 0.0 109.381 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.614 ' NH1' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 40.97 57.48 2.74 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.422 0.63 . . . . 0.0 110.191 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -148.06 155.86 41.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.412 -0.805 . . . . 0.0 109.742 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -112.13 138.66 48.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.944 -1.097 . . . . 0.0 110.276 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.744 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.6 p -106.09 105.65 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.821 -1.174 . . . . 0.0 109.064 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.004 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.8 p -109.72 148.84 13.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 122.089 0.947 . . . . 0.0 112.292 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -115.94 154.13 30.35 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.6 p90 -170.83 -177.24 2.22 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 117.669 -1.612 . . . . 0.0 112.051 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.765 ' HB2' HG22 ' A' ' 50' ' ' THR . 1.2 p30 -107.01 115.05 29.51 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 7.8 t70 -68.24 -3.79 11.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.777 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.765 HG22 ' HB2' ' A' ' 48' ' ' ASP . 4.1 t -66.63 -6.98 17.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 110.018 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -137.35 -51.09 0.64 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.136 -0.978 . . . . 0.0 110.937 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB1' ' CG ' ' A' ' 56' ' ' LYS . . . -130.49 -160.99 1.08 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.452 -0.78 . . . . 0.0 110.466 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.591 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.3 p 168.4 -169.02 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.379 -0.825 . . . . 0.0 109.338 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.036 HG13 HG21 ' A' ' 70' ' ' VAL . 3.1 t -35.5 -59.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.747 -0.595 . . . . 0.0 111.134 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 34.4 tt0 -43.13 -47.54 6.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 0.0 110.791 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 1.061 ' CE ' HG11 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -79.14 -24.06 43.58 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.964 . . . . 0.0 111.849 -178.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.004 HD13 ' CG1' ' A' ' 45' ' ' VAL . 79.9 mt -72.08 -56.73 5.1 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.503 -1.373 . . . . 0.0 108.384 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.491 ' O ' HG22 ' A' ' 61' ' ' THR . 7.4 m -56.48 -31.46 64.05 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.528 -0.732 . . . . 0.0 109.385 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -75.47 -31.57 60.29 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.287 -0.883 . . . . 0.0 110.005 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -69.07 -42.31 76.39 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.037 ' OG1' HG22 ' A' ' 21' ' ' VAL . 12.9 t -73.64 -32.89 64.26 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 66' ' ' TYR . . . -64.67 -31.25 72.4 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.59 -9.51 46.78 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.851 ' HB1' HG23 ' A' ' 20' ' ' THR . . . -81.93 -23.7 36.03 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.35 14.4 0.62 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.463 -1.351 . . . . 0.0 111.743 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.682 ' CB ' HG23 ' A' ' 9' ' ' VAL . 68.7 m-85 -145.69 114.11 4.71 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.313 -1.698 . . . . 0.0 111.79 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.77 97.58 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 N-CA-C 107.255 -1.863 . . . . 0.0 107.255 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 1.5 p -108.31 -166.14 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.0 112.751 -176.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.748 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 24.6 p -150.73 -164.92 2.13 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.036 HG21 HG13 ' A' ' 54' ' ' VAL . 2.4 p -141.07 158.32 22.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.906 -1.118 . . . . 0.0 111.516 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.482 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -125.95 24.72 6.95 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.294 1.045 . . . . 0.0 109.088 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.489 ' OXT' HG23 ' A' ' 5' ' ' VAL . 39.4 mt-30 . . . . . 0 C--N 1.289 -2.026 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.345 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.698 HG23 ' N ' ' A' ' 3' ' ' GLN 0.258 14.6 t . . . . . 0 C--O 1.214 -0.805 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.698 ' N ' HG23 ' A' ' 2' ' ' THR . 0.6 OUTLIER -173.37 153.88 2.5 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.455 179.048 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.6 m -143.16 107.73 4.83 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.594 HG13 ' HA ' ' A' ' 72' ' ' GLN . 2.5 t -140.17 165.15 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -0.854 . . . . 0.0 109.9 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 1.047 HG22 ' CG2' ' A' ' 44' ' ' VAL . 2.4 p -108.9 164.0 12.79 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.989 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.95 157.74 46.12 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.704 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.46 107.25 16.85 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.568 -0.707 . . . . 0.0 110.068 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.021 HG21 HG21 ' A' ' 21' ' ' VAL . 2.0 p -117.15 100.44 53.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.751 . . . . 0.0 109.524 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -76.27 34.96 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.381 1.388 . . . . 0.0 112.156 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.642 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.56 -46.11 86.34 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.562 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 16.9 ptt? 36.78 47.54 0.57 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.88 -0.776 . . . . 0.0 110.36 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 1.123 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -85.19 14.9 4.63 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.508 -0.745 . . . . 0.0 109.795 179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 13' ' ' THR . 4.0 t 77.68 87.97 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.489 0.661 . . . . 0.0 111.363 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 56.12 38.83 30.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.489 -0.757 . . . . 0.0 111.788 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.123 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -154.43 -31.27 0.11 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.883 -1.136 . . . . 0.0 111.122 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.761 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -50.82 -55.23 28.87 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.647 -1.283 . . . . 0.0 110.676 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 1.008 ' HB2' HG13 ' A' ' 36' ' ' VAL . 9.5 Cg_endo -69.05 -3.79 12.25 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.249 1.299 . . . . 0.0 112.543 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 15.5 mt -90.54 -48.49 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.857 -1.152 . . . . 0.0 109.229 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.941 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -62.56 -36.81 83.84 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.021 HG21 HG21 ' A' ' 9' ' ' VAL . 60.4 t -65.54 -48.13 83.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.653 ' O ' HG21 ' A' ' 34' ' ' VAL . 44.6 tttm -42.71 -54.19 4.16 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.634 -0.666 . . . . 0.0 110.669 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -71.44 -26.02 62.56 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.163 -0.961 . . . . 0.0 111.473 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -65.11 -55.37 19.13 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.302 -0.874 . . . . 0.0 110.818 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.99 ' HB3' HG11 ' A' ' 45' ' ' VAL . 3.2 mp -69.71 -31.65 69.78 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.099 -1.001 . . . . 0.0 110.534 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.569 ' HA ' HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -68.23 -22.08 64.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.239 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.46 1.09 15.78 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.025 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.579 HG13 ' N ' ' A' ' 29' ' ' GLU . 7.6 p -45.7 -46.94 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.883 -1.136 . . . . 0.0 110.627 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.579 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.4 OUTLIER 173.17 -80.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.897 -1.127 . . . . 0.0 110.891 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.534 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -92.41 -14.77 55.19 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.006 -1.093 . . . . 0.0 110.528 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.589 HG11 ' O ' ' A' ' 25' ' ' LEU . 9.6 t -42.43 139.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.027 -1.278 . . . . 0.0 110.428 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.1 t -118.32 -10.66 10.17 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.474 0.654 . . . . 0.0 109.245 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -154.0 164.59 38.19 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.264 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.888 HG23 HG13 ' A' ' 45' ' ' VAL . 6.4 p -152.94 174.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 109.242 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . 1.2 t0 -162.3 160.01 26.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.832 -1.168 . . . . 0.0 111.378 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.008 HG13 ' HB2' ' A' ' 18' ' ' PRO . 25.1 t -110.07 136.08 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.487 -0.758 . . . . 0.0 109.963 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -138.63 61.75 0.57 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -58.87 -23.48 60.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -1.135 . . . . 0.0 110.326 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -42.99 -40.77 3.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.864 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.539 ' CG ' ' HG2' ' A' ' 42' ' ' GLU . 12.9 ptpt -139.21 49.2 1.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.421 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.562 ' CD ' ' HB3' ' A' ' 12' ' ' MET . 0.0 OUTLIER 39.47 62.31 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.505 -0.747 . . . . 0.0 110.299 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HG2' ' CG ' ' A' ' 40' ' ' LYS . 2.0 pp20? -146.42 141.55 27.27 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.435 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -115.1 136.29 53.27 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.047 ' CG2' HG22 ' A' ' 6' ' ' THR . 1.6 t -106.24 143.68 16.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 120.233 -1.542 . . . . 0.0 109.355 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.99 HG11 ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -142.51 153.49 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.797 -178.059 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -123.75 151.3 43.4 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.932 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.9 p90 -167.52 -173.42 2.2 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 117.747 -1.581 . . . . 0.0 112.639 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 39.4 m-20 -105.59 118.49 36.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -66.15 -1.66 3.45 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.214 -177.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 48' ' ' ASP . 13.0 t -86.27 -20.49 28.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.043 -1.036 . . . . 0.0 110.525 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -128.47 -14.94 4.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.887 -1.133 . . . . 0.0 111.707 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -143.25 -170.39 3.26 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.023 -1.048 . . . . 0.0 110.137 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.632 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 174.15 167.92 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.873 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.931 HG23 HG21 ' A' ' 70' ' ' VAL . 2.5 p -42.73 -49.81 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 110.215 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.562 ' H ' HG13 ' A' ' 54' ' ' VAL . 7.3 tt0 -45.09 -47.04 12.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.041 . . . . 0.0 109.867 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.515 ' O ' HG21 ' A' ' 28' ' ' VAL . 11.2 mmtm -75.6 -27.09 58.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.43 -0.794 . . . . 0.0 111.437 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.932 HD11 ' CE2' ' A' ' 47' ' ' PHE . 68.5 mt -68.63 -57.69 5.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.602 -1.311 . . . . 0.0 108.761 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 4.0 m -56.22 -29.61 61.2 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.381 -0.824 . . . . 0.0 109.45 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 3.9 tttm -76.98 -29.52 55.55 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.297 -0.877 . . . . 0.0 109.699 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.765 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -69.97 -47.2 63.22 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.412 -0.805 . . . . 0.0 109.253 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.835 ' OG1' HG13 ' A' ' 21' ' ' VAL . 10.2 t -70.15 -32.95 71.18 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -68.14 -26.05 65.59 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.658 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 20.1 t0 -89.83 -13.34 36.77 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.941 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -80.27 -28.25 38.43 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.589 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 138.88 26.2 0.29 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.11 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.824 ' CB ' HG23 ' A' ' 9' ' ' VAL . 36.0 m-85 -151.38 105.2 2.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.655 -1.497 . . . . 0.0 110.993 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 3.0 Cg_exo -55.38 101.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 N-CA-C 107.184 -1.891 . . . . 0.0 107.184 177.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.53 ' HB3' HG23 ' A' ' 61' ' ' THR . 0.1 OUTLIER -107.94 -169.68 1.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.19 -1.004 . . . . 0.0 112.642 -176.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.529 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -152.38 -165.23 2.15 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.989 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.8 p -137.95 157.81 32.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.513 -1.367 . . . . 0.0 111.733 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.52 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -122.87 27.26 7.8 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.058 0.932 . . . . 0.0 109.639 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.594 ' HA ' HG13 ' A' ' 5' ' ' VAL . 34.3 mt-30 . . . . . 0 C--N 1.29 -2.019 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.531 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -109.13 153.26 23.97 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.874 0.845 . . . . 0.0 112.103 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 5.4 t -123.45 143.27 50.25 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.769 HG13 ' HA ' ' A' ' 72' ' ' GLN . 1.5 t -149.49 160.95 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -0.93 . . . . 0.0 109.152 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.687 ' O ' HD12 ' A' ' 7' ' ' LEU . 1.8 t -106.97 158.71 16.82 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.968 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -128.85 161.47 29.73 Favored 'General case' 0 C--N 1.276 -2.619 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.525 -177.601 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.43 101.15 10.14 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.816 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.84 HG22 ' SG ' ' A' ' 17' ' ' CYS . 3.5 p -115.21 90.3 23.66 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -77.41 45.35 1.71 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.545 1.496 . . . . 0.0 112.822 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.609 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -95.11 -34.04 6.33 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 1.2 mmt 54.3 -88.86 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.52 -0.988 . . . . 0.0 108.923 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 1.142 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.4 OUTLIER 58.31 9.76 1.11 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.592 179.768 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER 68.2 110.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.441 -0.787 . . . . 0.0 112.319 178.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . 33.19 48.81 0.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.841 -0.537 . . . . 0.0 112.375 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.142 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -151.26 -40.91 0.12 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.038 -1.039 . . . . 0.0 109.513 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.84 ' SG ' HG22 ' A' ' 9' ' ' VAL . 13.7 t -56.08 -41.35 90.55 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 110.834 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 1.021 ' O ' HG11 ' A' ' 36' ' ' VAL . 7.6 Cg_endo -78.35 -5.52 15.02 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.068 1.179 . . . . 0.0 111.661 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.9 mt -91.21 -35.52 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.831 -1.168 . . . . 0.0 108.672 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.933 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.2 m -75.94 -35.75 59.61 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.927 ' O ' HD12 ' A' ' 25' ' ' LEU . 81.9 t -66.08 -46.06 88.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.815 ' HG3' HG13 ' A' ' 34' ' ' VAL . 7.8 tttm -51.39 -54.61 24.8 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.101 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -72.87 -12.88 61.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 111.299 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.652 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -76.15 -63.61 1.28 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.956 -1.09 . . . . 0.0 109.649 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.928 HD21 ' CD2' ' A' ' 7' ' ' LEU . 3.5 mp -58.54 -33.8 70.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.495 -0.753 . . . . 0.0 110.081 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.517 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -70.46 -27.81 64.52 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.151 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -87.76 -9.57 53.58 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.322 -0.862 . . . . 0.0 109.942 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.762 HG12 ' N ' ' A' ' 29' ' ' GLU . 3.0 t -43.3 -80.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.133 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.762 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 172.35 -57.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.0 109.242 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.89 -26.21 38.53 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 25' ' ' LEU . 51.4 t -50.83 133.87 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -1.091 . . . . 0.0 110.324 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 m -115.0 -14.75 11.83 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.646 0.736 . . . . 0.0 109.218 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.754 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -153.63 159.64 42.16 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.27 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.815 HG13 ' HG3' ' A' ' 22' ' ' LYS . 7.1 p -156.84 157.13 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 110.203 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.584 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -158.1 171.52 20.07 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.227 -0.921 . . . . 0.0 110.113 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.021 HG11 ' O ' ' A' ' 18' ' ' PRO . 19.2 m -144.55 156.32 14.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 110.333 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.28 106.98 0.41 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.606 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -67.91 -25.54 65.54 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -1.091 . . . . 0.0 109.238 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -56.83 -23.55 44.69 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.354 -0.841 . . . . 0.0 108.984 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.524 ' O ' ' C ' ' A' ' 41' ' ' ARG . 6.7 tptm -138.93 33.18 2.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.546 -0.721 . . . . 0.0 109.807 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.575 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 8.7 tpm_? 22.35 60.2 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.225 0.535 . . . . 0.0 112.391 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 24.6 pt-20 -148.91 170.36 18.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.298 -0.876 . . . . 0.0 110.335 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.765 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -128.22 130.18 47.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.667 -1.27 . . . . 0.0 109.702 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 44' ' ' VAL . 15.0 p -105.27 117.87 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.796 -1.19 . . . . 0.0 109.415 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.798 ' CG1' HD13 ' A' ' 57' ' ' LEU . 7.2 p -126.3 150.77 32.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 122.257 1.027 . . . . 0.0 112.926 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -110.3 153.93 24.19 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.822 ' CD2' HD11 ' A' ' 57' ' ' LEU . 37.7 p90 -168.81 178.58 4.54 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 117.872 -1.531 . . . . 0.0 111.987 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -105.55 124.88 50.28 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 8.4 t0 -79.46 26.94 0.28 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.494 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.47 -29.07 11.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.941 -1.1 . . . . 0.0 109.145 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -123.77 -7.8 7.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.517 -0.739 . . . . 0.0 110.097 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -146.98 -164.77 2.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.454 -0.779 . . . . 0.0 109.498 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.597 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 174.06 164.28 0.2 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.08 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.08 HG22 HG21 ' A' ' 70' ' ' VAL . 7.9 p -44.86 -42.96 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.571 ' N ' HG13 ' A' ' 54' ' ' VAL . 23.0 tt0 -55.88 -43.84 77.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.973 . . . . 0.0 109.358 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -73.75 -22.33 59.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.501 -0.749 . . . . 0.0 110.572 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.87 HD12 ' HA ' ' A' ' 54' ' ' VAL . 90.8 mt -69.93 -55.76 8.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.776 -1.203 . . . . 0.0 108.391 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.52 ' N ' HD21 ' A' ' 7' ' ' LEU . 59.5 m -56.87 -35.62 69.12 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 16.9 tttt -73.24 -26.86 61.29 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.333 -0.854 . . . . 0.0 109.585 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.708 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -68.31 -50.68 51.81 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.414 -0.804 . . . . 0.0 109.379 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.792 ' OG1' HG22 ' A' ' 21' ' ' VAL . 6.6 t -67.12 -32.14 73.08 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -63.1 -32.27 73.61 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.058 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -88.54 -11.09 46.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.461 -0.774 . . . . 0.0 109.129 178.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.933 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.85 -31.8 57.1 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 142.9 32.18 0.11 Allowed Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.902 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.821 ' CB ' HG23 ' A' ' 9' ' ' VAL . 72.8 m-85 -159.17 107.84 1.54 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.698 -1.472 . . . . 0.0 111.291 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -56.27 99.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 N-CA-C 106.687 -2.082 . . . . 0.0 106.687 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.525 ' OG ' HG23 ' A' ' 61' ' ' THR . 60.3 p -108.42 -165.43 1.03 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.166 -0.959 . . . . 0.0 112.514 -176.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.86 -161.36 1.32 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.08 HG21 HG22 ' A' ' 54' ' ' VAL . 3.3 p -141.62 157.93 21.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 O-C-N 120.832 -1.167 . . . . 0.0 111.33 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.547 ' CG ' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -129.42 27.53 5.29 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.427 1.108 . . . . 0.0 109.002 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.769 ' HA ' HG13 ' A' ' 5' ' ' VAL . 10.9 pt20 . . . . . 0 C--N 1.289 -2.065 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.292 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -107.86 164.14 12.51 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.821 0.82 . . . . 0.0 112.236 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 t -131.59 128.12 38.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.445 0.64 . . . . 0.0 110.144 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.904 HG13 ' HA ' ' A' ' 72' ' ' GLN . 5.4 t -139.35 168.08 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 109.148 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.756 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -108.77 171.57 7.35 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.604 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.985 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -134.33 159.36 41.25 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.917 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -113.02 99.25 7.71 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.175 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.898 HG21 ' CG2' ' A' ' 21' ' ' VAL . 2.1 p -112.68 101.74 53.31 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 109.277 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.7 Cg_endo -77.63 39.83 0.79 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.494 1.463 . . . . 0.0 111.748 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.648 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -82.76 -51.24 4.34 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.482 ' HB2' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 42.97 57.23 3.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.538 -0.977 . . . . 0.0 109.916 -179.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.834 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -87.94 15.07 7.68 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.273 179.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 4.0 t 65.51 87.36 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.542 -0.724 . . . . 0.0 110.265 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.747 ' O ' HD12 ' A' ' 19' ' ' ILE . . . 68.26 29.72 5.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 0.0 110.089 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.834 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -138.56 -48.16 0.52 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.609 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -55.31 -47.4 98.67 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.411 -0.806 . . . . 0.0 111.206 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 9.2 Cg_endo -71.89 -9.44 24.73 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 120.895 1.063 . . . . 0.0 112.219 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.747 HD12 ' O ' ' A' ' 15' ' ' ALA . 20.6 mt -93.13 -37.86 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.787 -1.195 . . . . 0.0 109.842 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.905 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.2 m -77.02 -40.8 45.16 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.898 ' CG2' HG21 ' A' ' 9' ' ' VAL . 97.6 t -62.88 -45.45 98.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.827 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.871 ' HG3' HG12 ' A' ' 34' ' ' VAL . 39.7 tttt -54.04 -55.58 26.08 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.174 -0.954 . . . . 0.0 109.853 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -75.9 -0.94 23.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 111.223 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -80.95 -64.41 1.19 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.722 -1.236 . . . . 0.0 108.843 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.898 HD13 ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.06 -24.63 65.99 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.795 ' C ' HG11 ' A' ' 31' ' ' VAL . 3.3 t -72.66 -26.66 61.72 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -97.43 -5.23 36.64 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.329 -0.857 . . . . 0.0 110.378 179.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 25' ' ' LEU . 2.7 t -46.09 -59.99 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.52 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.568 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER 158.1 -72.22 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.433 0.635 . . . . 0.0 110.225 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -69.24 -27.23 73.91 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.795 HG11 ' C ' ' A' ' 26' ' ' SER . 8.0 p -39.68 139.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.427 -1.043 . . . . 0.0 110.484 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.34 -14.67 9.19 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.536 0.684 . . . . 0.0 109.63 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.686 ' O ' HG23 ' A' ' 34' ' ' VAL . 9.7 ttmm -162.96 164.7 25.65 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.114 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.894 HG22 HG22 ' A' ' 45' ' ' VAL . 52.7 t -159.51 150.64 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.076 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.682 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -142.36 169.25 17.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 0.0 109.503 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 18' ' ' PRO . 62.9 t -108.99 151.5 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.118 -0.989 . . . . 0.0 110.981 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.67 60.04 0.49 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.594 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -60.93 -23.74 65.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.515 -0.991 . . . . 0.0 110.544 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -21.9 2.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.999 -1.063 . . . . 0.0 109.35 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 41' ' ' ARG . 21.5 mttt -143.05 39.45 1.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -0.758 . . . . 0.0 110.077 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.482 ' HD2' ' HB2' ' A' ' 12' ' ' MET . 1.5 ttp180 36.22 60.21 0.88 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.633 -0.667 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -152.22 168.43 25.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.476 -0.889 . . . . 0.0 111.338 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -131.17 139.09 49.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 109.327 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.733 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.0 p -107.78 109.41 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.841 -1.162 . . . . 0.0 110.145 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.894 HG22 HG22 ' A' ' 34' ' ' VAL . 53.8 t -111.21 159.1 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 122.414 1.102 . . . . 0.0 112.915 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -123.59 150.72 43.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 177.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 2' ' ' THR . 32.7 p90 -171.62 -176.29 1.76 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.004 -1.878 . . . . 0.0 112.979 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.38 114.14 28.15 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 14.6 t70 -62.67 -6.76 3.85 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.143 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.5 p -83.73 -25.51 30.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.052 -1.03 . . . . 0.0 110.945 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.1 mmmt -116.55 -7.15 11.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.924 -1.11 . . . . 0.0 110.726 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . 179.43 -179.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.59 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.0 p 172.17 -172.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 110.323 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.942 HG22 HG21 ' A' ' 70' ' ' VAL . 9.3 t -36.53 -38.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.539 -0.725 . . . . 0.0 111.003 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -55.97 -51.88 66.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.151 -0.968 . . . . 0.0 110.497 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.49 ' HB3' HG13 ' A' ' 28' ' ' VAL . 11.3 mmtp -82.93 -17.64 42.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 112.085 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 ' HB2' ' A' ' 25' ' ' LEU . 37.2 mt -74.41 -53.82 8.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.353 -1.467 . . . . 0.0 108.455 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.488 ' CG2' ' HA ' ' A' ' 69' ' ' SER . 3.2 m -59.89 -35.62 75.23 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.032 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -73.21 -29.02 62.5 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.311 -0.868 . . . . 0.0 110.206 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.526 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -70.48 -43.68 69.25 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.067 -1.021 . . . . 0.0 109.704 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.592 HG23 ' HB2' ' A' ' 68' ' ' SER . 2.8 t -73.06 -29.1 62.71 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.74 68.61 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -10.8 42.15 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.516 -0.74 . . . . 0.0 109.22 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.905 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -81.61 -29.46 33.29 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.455 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 141.21 23.67 0.24 Allowed Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.618 -1.277 . . . . 0.0 111.471 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.703 ' CB ' HG23 ' A' ' 9' ' ' VAL . 56.1 m-85 -146.62 113.68 4.35 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.34 -1.682 . . . . 0.0 111.366 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.76 91.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 106.874 -2.01 . . . . 0.0 106.874 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.592 ' HB2' HG23 ' A' ' 61' ' ' THR . 55.0 m -108.79 -170.22 1.63 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.178 -0.951 . . . . 0.0 112.995 -176.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.488 ' HA ' ' CG2' ' A' ' 58' ' ' THR . 2.3 m -160.13 -159.95 0.75 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.985 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.2 p -139.37 161.53 27.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.921 -1.112 . . . . 0.0 111.172 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.721 ' HG3' HG23 ' A' ' 6' ' ' THR . 4.3 mttt -122.31 24.0 9.54 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 122.264 1.031 . . . . 0.0 110.133 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.904 ' HA ' HG13 ' A' ' 5' ' ' VAL . 10.2 tt0 . . . . . 0 C--N 1.284 -2.252 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.369 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 1.015 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.068 0.461 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -152.62 88.76 1.36 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -126.88 165.95 18.4 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.254 -0.904 . . . . 0.0 111.666 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 14.6 t -130.42 134.3 47.01 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.58 -0.7 . . . . 0.0 110.324 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.967 HG21 HG23 ' A' ' 54' ' ' VAL . 10.8 t -122.6 171.42 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.477 -0.765 . . . . 0.0 109.266 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.787 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -106.96 158.56 16.94 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.003 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.03 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -132.13 156.32 46.57 Favored 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 118.476 -1.289 . . . . 0.0 110.538 -178.471 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.542 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -109.19 101.67 10.68 Favored 'General case' 0 C--N 1.293 -1.88 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.412 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.968 HG21 HG21 ' A' ' 21' ' ' VAL . 1.5 p -113.89 87.85 13.29 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.609 -0.682 . . . . 0.0 109.614 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 11.5 Cg_endo -78.1 39.94 0.83 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.351 1.367 . . . . 0.0 111.764 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.601 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -81.4 -28.57 43.51 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.506 ' CG ' ' C ' ' A' ' 11' ' ' GLY . 7.7 ptt? 33.12 62.11 0.38 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.92 -0.753 . . . . 0.0 110.541 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.868 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -85.25 11.59 9.74 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.466 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER 70.31 90.06 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.434 -0.791 . . . . 0.0 110.088 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 59.4 26.98 15.98 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.573 -0.704 . . . . 0.0 110.103 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.868 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -131.44 -40.69 1.11 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.801 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.636 ' SG ' HG22 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -53.59 -48.93 91.41 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.0 110.992 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.614 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 7.5 Cg_endo -72.45 -10.36 25.33 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.434 1.229 . . . . 0.0 112.33 -178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.06 -45.75 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.682 -1.262 . . . . 0.0 109.875 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 1.061 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.257 1.2 m -73.44 -36.75 65.97 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.679 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.968 HG21 HG21 ' A' ' 9' ' ' VAL . 13.5 t -70.26 -47.85 64.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.878 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.619 ' O ' HG21 ' A' ' 34' ' ' VAL . 6.3 tmtt? -49.9 -51.57 39.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.491 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.556 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -70.52 -21.9 62.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.922 -1.111 . . . . 0.0 111.252 -179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.72 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -66.87 -54.36 23.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.243 -0.911 . . . . 0.0 110.471 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.907 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.6 mp -70.7 -31.09 67.83 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.084 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.854 ' C ' HG11 ' A' ' 31' ' ' VAL . 3.6 p -68.8 -20.47 64.33 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -116.31 4.92 13.5 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.449 -0.901 . . . . 0.0 109.816 179.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.819 HG12 ' O ' ' A' ' 25' ' ' LEU . 8.0 p -51.01 -50.03 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.0 110.867 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.611 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER 175.44 -77.37 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.883 -1.135 . . . . 0.0 110.888 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.94 2.36 56.82 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.854 HG11 ' C ' ' A' ' 26' ' ' SER . 14.9 p -44.77 144.48 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.042 -1.27 . . . . 0.0 110.592 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.513 ' HB2' HG22 ' A' ' 46' ' ' THR . 19.4 m -113.28 -16.3 12.54 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.4 OUTLIER -170.19 167.82 8.49 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.698 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.848 HG11 ' HB3' ' A' ' 26' ' ' SER . 13.6 p -157.88 167.36 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.124 -0.985 . . . . 0.0 110.55 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.519 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 1.6 m-20 -167.68 178.53 5.27 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.977 . . . . 0.0 110.086 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 3.8 m -150.13 165.4 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.136 -0.977 . . . . 0.0 111.127 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.3 106.85 0.32 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.614 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -70.05 -8.24 47.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -1.176 . . . . 0.0 110.53 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -60.34 -23.98 64.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.058 -1.026 . . . . 0.0 109.17 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -150.29 30.65 0.69 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.462 -0.774 . . . . 0.0 110.144 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 40' ' ' LYS . 2.0 mpp_? 40.56 58.94 2.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.522 -0.736 . . . . 0.0 110.408 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 42' ' ' GLU . 2.4 pt-20 -136.88 149.53 47.71 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.277 -0.889 . . . . 0.0 110.211 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.776 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -117.86 132.18 56.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.972 -1.08 . . . . 0.0 109.449 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 35' ' ' ASP . 8.1 p -106.83 130.61 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.738 -1.226 . . . . 0.0 109.531 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.037 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.2 p -133.33 147.47 31.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.178 -1.009 . . . . 0.0 113.049 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.513 HG22 ' HB2' ' A' ' 32' ' ' SER . 1.3 m -109.71 154.2 23.22 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.763 ' CE2' HD11 ' A' ' 57' ' ' LEU . 36.2 p90 -172.11 -177.2 1.82 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 117.883 -1.527 . . . . 0.0 111.811 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.628 ' HB3' HG22 ' A' ' 50' ' ' THR . 10.5 m-20 -107.22 114.44 28.49 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 1.015 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 11.0 t70 -62.96 -9.36 9.62 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.304 -0.872 . . . . 0.0 110.715 -178.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.628 HG22 ' HB3' ' A' ' 48' ' ' ASP . 4.8 t -72.88 -22.49 60.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -128.15 -7.16 5.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.213 -0.929 . . . . 0.0 110.902 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -154.43 -167.61 2.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.158 -0.964 . . . . 0.0 110.482 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.585 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 170.76 171.87 0.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.48 -0.763 . . . . 0.0 109.606 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.056 HG13 HG21 ' A' ' 70' ' ' VAL . 2.7 t -40.65 -47.51 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.38 -0.825 . . . . 0.0 110.317 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.96 -48.35 43.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.007 -1.058 . . . . 0.0 110.198 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 28.1 mmtm -73.74 -26.55 60.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -0.864 . . . . 0.0 111.318 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.037 HD13 ' CG1' ' A' ' 45' ' ' VAL . 63.3 mt -68.37 -58.18 4.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.668 -1.27 . . . . 0.0 108.809 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.682 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 16.4 m -57.79 -29.22 64.7 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 68.1 tttt -73.68 -29.37 62.26 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 121.379 -0.826 . . . . 0.0 109.54 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.72 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -70.74 -50.32 37.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.291 -0.881 . . . . 0.0 109.504 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.94 ' OG1' HG22 ' A' ' 21' ' ' VAL . 1.5 t -69.74 -26.63 64.41 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -66.73 -36.62 82.89 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.57 -9.92 55.08 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.061 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -29.27 55.68 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.564 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 135.04 25.18 0.55 Allowed Glycine 0 N--CA 1.486 2.002 0 C-N-CA 119.843 -1.17 . . . . 0.0 111.067 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.601 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 42.0 m-85 -146.03 120.86 5.48 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.62 -1.518 . . . . 0.0 111.856 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.72 95.54 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 N-CA-C 107.014 -1.956 . . . . 0.0 107.014 177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -108.47 -173.73 2.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 0.0 112.543 -176.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.518 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.5 OUTLIER -148.8 -162.57 1.59 Allowed 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.056 HG21 HG13 ' A' ' 54' ' ' VAL . 3.0 p -141.0 158.95 23.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.07 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.504 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 6.1 mtmt -116.27 17.52 15.6 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 122.198 0.999 . . . . 0.0 110.307 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.685 ' C ' HG13 ' A' ' 5' ' ' VAL . 13.2 mt-30 . . . . . 0 C--N 1.282 -2.368 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.57 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.585 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.299 0.571 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER -151.8 88.28 1.4 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -118.68 160.84 21.1 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.223 -0.991 . . . . 0.0 112.086 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.418 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 2.0 t -134.49 132.87 39.76 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.7 -0.625 . . . . 0.0 109.648 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.643 HG21 ' CG2' ' A' ' 70' ' ' VAL . 0.7 OUTLIER -133.24 169.03 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.884 0.849 . . . . 0.0 109.508 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.715 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.19 157.03 18.2 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.971 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.07 157.07 45.13 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 118.882 -1.127 . . . . 0.0 110.465 -178.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.23 112.44 24.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.55 -0.719 . . . . 0.0 110.279 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.036 HG21 HG21 ' A' ' 21' ' ' VAL . 1.4 p -123.42 88.0 51.7 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.272 -0.892 . . . . 0.0 110.011 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -78.53 59.77 7.31 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.427 1.418 . . . . 0.0 111.806 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.601 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -104.03 -26.83 6.5 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.509 ' O ' ' HG3' ' A' ' 12' ' ' MET . 19.0 ptm 29.64 61.47 0.16 Allowed 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.717 0.77 . . . . 0.0 111.356 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.847 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -85.97 13.72 7.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.465 -0.772 . . . . 0.0 109.36 179.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.7 t 69.76 91.82 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.556 -0.715 . . . . 0.0 110.24 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 59.53 16.83 5.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 110.31 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.847 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -118.64 -44.05 2.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.234 -0.916 . . . . 0.0 109.528 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.607 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -51.59 -48.37 87.05 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.421 -0.799 . . . . 0.0 111.231 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 5.6 Cg_endo -73.24 -11.87 25.16 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 121.274 1.316 . . . . 0.0 112.634 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 19' ' ' ILE . 10.0 mm -92.28 -41.43 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.692 -1.255 . . . . 0.0 109.567 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.993 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.25 1.2 m -73.83 -39.87 63.73 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.036 HG21 HG21 ' A' ' 9' ' ' VAL . 98.9 t -69.49 -49.86 55.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.108 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.555 ' HG3' HG13 ' A' ' 34' ' ' VAL . 13.8 tttt -47.23 -51.76 17.81 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 110.471 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.567 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -72.88 -21.38 60.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.034 -1.041 . . . . 0.0 111.393 -179.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 60' ' ' ALA . . . -68.12 -53.95 21.64 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 110.719 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.908 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.9 mp -71.18 -29.08 64.74 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.357 -0.839 . . . . 0.0 110.08 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.872 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -74.79 -17.82 60.57 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.422 -0.799 . . . . 0.0 109.224 179.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.567 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -115.35 2.07 13.88 Favored 'General case' 0 N--CA 1.483 1.193 0 O-C-N 121.111 -0.993 . . . . 0.0 110.062 179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 56' ' ' LYS . 9.3 p -53.56 -47.71 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.317 -0.864 . . . . 0.0 110.853 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.577 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.5 OUTLIER 179.25 -86.91 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.72 -1.237 . . . . 0.0 111.517 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -95.34 3.25 66.08 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 120.045 -1.074 . . . . 0.0 110.504 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.872 HG11 ' C ' ' A' ' 26' ' ' SER . 8.8 p -42.33 142.16 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.142 -1.211 . . . . 0.0 110.366 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 t -114.58 -17.34 11.71 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.688 0.756 . . . . 0.0 108.999 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 3.0 tttm -162.43 163.83 27.48 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.961 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 26' ' ' SER . 9.9 p -162.59 159.22 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.868 . . . . 0.0 110.489 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.507 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 2.7 t70 -166.26 171.84 11.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 0.0 109.853 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.497 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 4.3 m -140.69 163.17 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.033 -1.042 . . . . 0.0 110.865 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.77 113.23 0.57 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.615 ' CE1' ' HD3' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -70.19 -21.57 63.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -1.228 . . . . 0.0 110.281 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -45.82 -45.51 14.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.131 -0.981 . . . . 0.0 109.458 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.0 mttm -126.4 25.85 6.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.439 -0.788 . . . . 0.0 109.687 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.687 HH21 HG13 ' A' ' 9' ' ' VAL . 7.1 mmm180 38.75 60.19 1.43 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.837 -0.539 . . . . 0.0 110.175 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 6.9 pt-20 -141.68 150.27 41.66 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.957 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -116.14 131.95 56.8 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.004 -1.06 . . . . 0.0 108.969 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 35' ' ' ASP . 13.4 p -105.22 130.89 55.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.786 -1.196 . . . . 0.0 109.676 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.014 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.2 p -131.92 143.06 41.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.946 0.879 . . . . 0.0 112.454 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -109.38 157.89 18.47 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.773 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.9 p90 -171.88 -176.33 1.7 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 117.399 -1.72 . . . . 0.0 112.122 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.585 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 65.2 m-20 -106.85 113.51 27.05 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 15.8 t70 -59.61 -10.96 4.03 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 111.147 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.8 t -69.02 -24.75 64.24 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.204 -0.935 . . . . 0.0 110.929 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt -128.84 -12.0 4.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.903 -1.123 . . . . 0.0 111.509 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -148.24 -169.41 3.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.017 -1.052 . . . . 0.0 110.712 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.593 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER 171.2 172.58 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.442 -0.786 . . . . 0.0 109.914 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.03 HG23 HG21 ' A' ' 70' ' ' VAL . 2.1 p -40.73 -35.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.255 -0.903 . . . . 0.0 110.406 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -56.59 -49.63 74.35 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.232 -0.917 . . . . 0.0 110.293 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.641 ' O ' HG21 ' A' ' 28' ' ' VAL . 15.9 mmtt -78.82 -18.38 54.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.27 -0.894 . . . . 0.0 111.526 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.014 HD13 ' CG1' ' A' ' 45' ' ' VAL . 52.3 mt -75.01 -58.87 3.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.415 -1.428 . . . . 0.0 108.268 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.554 ' N ' HD21 ' A' ' 7' ' ' LEU . 19.5 m -58.76 -30.04 67.23 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.741 -0.783 . . . . 0.0 109.111 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.503 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -80.79 -23.43 39.29 Favored 'General case' 0 C--N 1.31 -1.127 0 O-C-N 121.308 -0.87 . . . . 0.0 109.536 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.597 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -72.81 -47.06 49.68 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.394 -0.816 . . . . 0.0 109.086 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.594 ' CB ' HG13 ' A' ' 21' ' ' VAL . 9.2 t -71.39 -35.78 71.17 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -64.04 -29.68 70.81 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.176 -0.92 . . . . 0.0 108.626 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 2.1 t70 -89.67 -11.35 42.71 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.993 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -28.26 55.28 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.72 23.44 0.51 Allowed Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.697 -1.239 . . . . 0.0 111.228 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.699 ' CB ' HG23 ' A' ' 9' ' ' VAL . 46.8 m-85 -146.13 110.94 4.37 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.649 -1.501 . . . . 0.0 111.103 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 4.3 Cg_exo -55.49 99.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 N-CA-C 107.297 -1.847 . . . . 0.0 107.297 177.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -109.06 -172.02 1.96 Allowed 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.362 -176.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.512 ' N ' ' OG ' ' A' ' 68' ' ' SER . 19.9 m -147.32 -162.75 1.61 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.03 HG21 HG23 ' A' ' 54' ' ' VAL . 3.5 p -139.92 160.37 26.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 C-N-CA 118.647 -1.221 . . . . 0.0 111.763 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.506 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 1.7 mttt -123.24 19.1 9.87 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.963 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.511 ' CG ' ' O ' ' A' ' 72' ' ' GLN . 1.8 tt0 . . . . . 0 C--N 1.283 -2.306 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.126 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.647 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.116 0.484 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.638 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -144.99 92.17 2.24 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.6 151.8 25.13 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.898 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.43 117.23 23.97 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.288 0.566 . . . . 0.0 109.616 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.527 HG11 ' CG2' ' A' ' 70' ' ' VAL . 4.6 t -126.76 168.19 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.392 -0.818 . . . . 0.0 109.931 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.811 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -108.88 160.47 15.97 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.937 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -133.66 155.36 49.85 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 118.572 -1.251 . . . . 0.0 110.623 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 68' ' ' SER . . . -109.6 110.75 21.91 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.879 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.845 HG21 HG21 ' A' ' 21' ' ' VAL . 1.6 p -124.38 85.99 55.25 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.505 -0.747 . . . . 0.0 109.67 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.446 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 11.2 Cg_endo -79.51 52.36 4.26 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.965 1.508 . . . . 0.0 111.294 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.624 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -97.6 -34.11 5.64 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.562 ' HG2' ' CZ ' ' A' ' 41' ' ' ARG . 1.8 mtp 69.04 -79.57 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.982 -0.716 . . . . 0.0 110.456 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.87 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.6 OUTLIER 50.86 14.39 0.18 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.92 -1.112 . . . . 0.0 109.638 -178.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 13' ' ' THR . 0.7 OUTLIER 51.25 108.41 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.333 -0.855 . . . . 0.0 111.519 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 43.81 36.76 1.41 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.464 -0.772 . . . . 0.0 111.034 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.87 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -139.01 -37.68 0.51 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 110.021 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.58 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -51.76 -50.34 78.16 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.197 -0.939 . . . . 0.0 110.772 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.77 ' O ' HG11 ' A' ' 36' ' ' VAL . 9.4 Cg_endo -73.38 -11.26 24.61 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 121.189 1.26 . . . . 0.0 112.633 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.8 mm -92.1 -45.47 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.64 -1.288 . . . . 0.0 109.872 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 1.117 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -70.13 -37.23 75.25 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.845 HG21 HG21 ' A' ' 9' ' ' VAL . 13.0 t -64.75 -44.64 96.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.581 ' HA ' HG11 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -52.78 -41.42 64.08 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.476 -0.765 . . . . 0.0 109.805 179.231 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -79.57 -22.37 43.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 111.173 -179.54 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.821 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -67.99 -51.15 50.51 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.174 -0.954 . . . . 0.0 110.089 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.944 ' O ' HG12 ' A' ' 28' ' ' VAL . 4.1 mp -78.93 -31.36 45.18 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.516 -0.74 . . . . 0.0 110.874 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.817 ' HA ' HG21 ' A' ' 31' ' ' VAL . 42.5 p -69.31 -21.36 63.86 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.04 -1.037 . . . . 0.0 108.844 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -116.12 0.55 12.99 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.843 179.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.944 HG12 ' O ' ' A' ' 25' ' ' LEU . 3.7 p -45.46 -52.64 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.032 -1.043 . . . . 0.0 110.681 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.592 ' H ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER 176.41 -77.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.84 -1.163 . . . . 0.0 111.08 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.5 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -96.46 0.43 61.55 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.817 HG21 ' HA ' ' A' ' 26' ' ' SER . 6.8 p -42.57 143.21 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.24 . . . . 0.0 110.834 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 m -117.26 -16.21 10.36 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.105 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.648 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -166.62 164.26 16.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.617 -0.677 . . . . 0.0 109.509 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 45' ' ' VAL . 37.9 t -156.14 163.22 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.061 -1.025 . . . . 0.0 110.687 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' HB3' HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -162.95 161.78 25.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.292 -0.88 . . . . 0.0 109.758 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.77 HG11 ' O ' ' A' ' 18' ' ' PRO . 4.1 m -142.82 151.85 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.516 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.49 104.54 0.35 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.607 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -64.44 -29.55 70.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.227 -1.161 . . . . 0.0 110.276 -179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.9 mm-40 -44.68 -28.52 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.147 -0.971 . . . . 0.0 109.721 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -132.99 1.55 3.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.306 -0.871 . . . . 0.0 110.396 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.569 ' NH1' ' HG3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 59.06 51.27 7.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.448 -0.783 . . . . 0.0 110.135 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 51.7 mt-10 -138.12 146.46 42.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.472 -0.767 . . . . 0.0 109.813 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.828 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -115.36 130.38 56.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.998 -1.064 . . . . 0.0 109.32 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 35' ' ' ASP . 14.7 p -105.68 127.45 60.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.907 -1.12 . . . . 0.0 109.079 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.832 HG22 HG22 ' A' ' 34' ' ' VAL . 37.3 t -134.06 148.06 30.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 119.049 -1.06 . . . . 0.0 112.484 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -108.89 158.62 17.51 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.799 ' CE2' HD11 ' A' ' 57' ' ' LEU . 33.1 p90 -171.54 -174.84 1.47 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 117.637 -1.625 . . . . 0.0 111.933 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.647 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 13.5 t0 -105.65 110.6 22.98 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.574 ' HB3' ' CB ' ' A' ' 1' ' ' ALA . 5.0 t70 -61.47 -11.48 10.83 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.709 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 82.4 p -75.01 -27.7 60.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.26 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.5 mtpp -122.08 -1.63 9.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.187 -0.946 . . . . 0.0 110.345 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -158.77 -169.07 2.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.282 -0.886 . . . . 0.0 110.33 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.598 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.4 p 170.32 170.53 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.437 -0.79 . . . . 0.0 109.528 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.998 HG23 HG21 ' A' ' 70' ' ' VAL . 2.5 p -42.24 -44.44 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 110.03 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.514 ' N ' HG13 ' A' ' 54' ' ' VAL . 6.7 tp-100 -51.44 -47.89 62.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -0.989 . . . . 0.0 109.694 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 18.2 mmtp -75.12 -20.67 59.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 0.0 110.966 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.799 HD11 ' CE2' ' A' ' 47' ' ' PHE . 82.0 mt -72.77 -60.27 2.31 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.688 -1.258 . . . . 0.0 108.19 178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.741 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 1.2 p -57.42 -29.66 64.33 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.483 -0.761 . . . . 0.0 109.012 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 55.2 tttt -74.57 -31.41 62.07 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.339 -0.85 . . . . 0.0 109.726 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.821 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -69.87 -51.34 34.13 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.283 -0.886 . . . . 0.0 109.325 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.75 ' OG1' HG22 ' A' ' 21' ' ' VAL . 1.6 t -68.64 -27.18 65.78 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -65.4 -35.22 80.28 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.79 -15.71 50.66 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.634 -0.827 . . . . 0.0 108.953 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.117 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -71.4 -29.55 65.05 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 131.93 23.71 0.84 Allowed Glycine 0 N--CA 1.486 1.978 0 C-N-CA 119.774 -1.203 . . . . 0.0 110.952 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.716 ' HB3' HG23 ' A' ' 9' ' ' VAL . 50.7 m-85 -139.36 111.84 7.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.686 -1.479 . . . . 0.0 111.72 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.85 96.65 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 107.046 -1.944 . . . . 0.0 107.046 176.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 10.0 p -108.1 -167.1 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 112.581 -176.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.493 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 19.2 m -157.81 -165.94 1.87 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.998 HG21 HG23 ' A' ' 54' ' ' VAL . 4.0 p -135.75 161.12 38.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 O-C-N 120.631 -1.293 . . . . 0.0 111.433 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.49 ' HE2' ' HB2' ' A' ' 8' ' ' ALA . 0.6 OUTLIER -123.97 25.7 7.85 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 122.303 1.049 . . . . 0.0 110.134 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.468 ' HA ' HG13 ' A' ' 5' ' ' VAL . 2.0 tm0? . . . . . 0 C--N 1.284 -2.261 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.113 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.181 0.515 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -146.36 89.92 1.9 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 179.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.33 162.03 14.71 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.328 -0.949 . . . . 0.0 112.713 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.482 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 1.2 t -125.0 147.33 48.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.568 HG13 ' CB ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -153.49 159.29 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.223 -0.923 . . . . 0.0 109.476 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.965 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -106.69 155.74 19.35 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 178.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.974 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.1 mp -129.9 158.54 39.22 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.41 -178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -112.39 105.32 13.56 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.212 0.529 . . . . 0.0 110.302 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.924 HG21 HG21 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -120.21 85.42 36.07 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.606 -0.684 . . . . 0.0 109.42 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 41' ' ' ARG . 10.2 Cg_endo -78.56 58.31 6.7 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.807 1.424 . . . . 0.0 111.216 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.608 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -102.08 -25.05 8.12 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 14.2 mtm 59.15 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.739 -0.859 . . . . 0.0 110.064 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.804 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.8 OUTLIER 50.32 14.05 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.363 -0.836 . . . . 0.0 109.958 -178.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER 54.48 109.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 111.626 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.687 ' O ' HD13 ' A' ' 19' ' ' ILE . . . 39.99 26.27 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.563 -0.711 . . . . 0.0 111.706 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.804 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -118.63 -42.53 2.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.939 -1.101 . . . . 0.0 109.139 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.741 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -52.5 -46.96 95.01 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.621 -0.675 . . . . 0.0 111.903 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 5.6 Cg_endo -70.29 -20.27 32.56 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.201 1.268 . . . . 0.0 113.49 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 15' ' ' ALA . 2.6 mp -92.4 -36.64 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.447 -1.408 . . . . 0.0 110.038 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.974 HG22 ' HB1' ' A' ' 64' ' ' ALA 0.252 1.2 m -73.45 -42.48 61.9 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.955 ' O ' HD12 ' A' ' 25' ' ' LEU . 96.9 t -62.75 -50.37 79.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.457 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.739 ' HA ' HG11 ' A' ' 34' ' ' VAL . 15.9 tttm -51.39 -44.07 62.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 110.268 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 5.0 mttm -69.89 -23.21 63.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.111 -0.993 . . . . 0.0 111.102 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.769 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -76.26 -62.5 1.59 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.281 -0.887 . . . . 0.0 110.533 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.955 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.6 mp -56.85 -30.73 64.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 0.0 110.486 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 1.024 ' HB3' HG21 ' A' ' 34' ' ' VAL . 4.5 p -76.05 -30.34 58.35 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.478 -0.764 . . . . 0.0 109.416 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -88.36 -3.92 58.76 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.268 -0.895 . . . . 0.0 109.625 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.792 HG12 ' N ' ' A' ' 29' ' ' GLU . 3.8 t -41.76 -83.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.429 -0.794 . . . . 0.0 110.066 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.792 ' N ' HG12 ' A' ' 28' ' ' VAL . 3.3 tt0 179.36 -52.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.46 -0.775 . . . . 0.0 109.062 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.492 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -96.74 -23.33 15.96 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.628 HG11 ' O ' ' A' ' 25' ' ' LEU . 39.6 t -51.63 134.52 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -1.108 . . . . 0.0 110.103 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.7 t -127.84 -5.09 5.73 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.083 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 13.9 tttp -155.71 116.33 3.8 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.524 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.024 HG21 ' HB3' ' A' ' 26' ' ' SER . 3.9 t -109.25 -178.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.686 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.647 ' H ' HG12 ' A' ' 34' ' ' VAL . 26.4 t0 -161.26 159.28 28.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.984 -1.073 . . . . 0.0 110.249 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.542 HG13 ' CB ' ' A' ' 18' ' ' PRO . 17.6 t -112.62 135.85 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.403 -0.811 . . . . 0.0 110.699 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.09 60.02 0.53 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.647 ' CZ ' ' NH1' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -62.49 -16.49 55.89 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -1.175 . . . . 0.0 110.358 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -44.84 -26.52 0.41 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 0.0 109.148 179.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.459 ' O ' ' C ' ' A' ' 41' ' ' ARG . 5.0 ttpt -152.43 47.21 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.611 -0.68 . . . . 0.0 109.833 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.647 ' NH1' ' CZ ' ' A' ' 38' ' ' PHE . 0.7 OUTLIER 39.91 63.16 1.09 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.661 -0.649 . . . . 0.0 109.684 -179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 7' ' ' LEU . 2.0 tm-20 -140.18 148.16 41.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.497 -0.752 . . . . 0.0 110.363 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.716 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -124.09 132.16 53.63 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.965 ' CG2' HG22 ' A' ' 6' ' ' THR . 0.9 OUTLIER -105.95 145.01 14.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 120.358 -1.464 . . . . 0.0 109.561 -178.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.791 HG11 ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -139.52 177.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 122.703 1.24 . . . . 0.0 112.362 -177.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.507 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -152.68 143.65 23.01 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 105.682 -1.969 . . . . 0.0 105.682 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.84 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.3 p90 -166.06 -176.0 3.58 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 117.242 -1.783 . . . . 0.0 112.934 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.733 ' HB3' HG22 ' A' ' 50' ' ' THR . 0.8 OUTLIER -106.8 115.83 30.87 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 17.5 t70 -62.12 -8.6 5.73 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 111.028 -177.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.733 HG22 ' HB3' ' A' ' 48' ' ' ASP . 15.1 t -76.26 -21.55 56.19 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.161 -0.962 . . . . 0.0 110.74 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -128.59 -6.45 5.19 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.101 -0.999 . . . . 0.0 110.922 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.492 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -156.52 -169.7 3.1 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.199 -0.938 . . . . 0.0 110.216 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.591 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 14.8 t 175.81 168.62 0.39 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.11 HG23 HG21 ' A' ' 70' ' ' VAL . 2.8 p -42.91 -40.42 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 110.039 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.496 ' N ' HG13 ' A' ' 54' ' ' VAL . 1.1 tt0 -54.34 -47.65 72.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.114 -0.991 . . . . 0.0 109.826 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 17.8 mmtt -75.73 -18.09 59.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 111.249 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.84 HD11 ' CE2' ' A' ' 47' ' ' PHE . 68.4 mt -75.49 -58.68 3.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.501 -1.375 . . . . 0.0 107.949 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.46 ' N ' HD21 ' A' ' 7' ' ' LEU . 1.9 m -57.67 -32.21 67.1 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -73.57 -33.18 64.54 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.406 -0.809 . . . . 0.0 109.727 179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.751 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -66.3 -46.34 77.31 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.272 -0.893 . . . . 0.0 109.371 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.638 ' HB ' HD11 ' A' ' 25' ' ' LEU . 5.7 t -68.7 -32.92 73.06 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.409 ' N ' HG23 ' A' ' 61' ' ' THR . . . -62.53 -31.83 72.68 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -86.95 -13.87 43.42 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.974 ' HB1' HG22 ' A' ' 20' ' ' THR . . . -75.64 -24.79 56.46 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 131.58 19.09 1.21 Allowed Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.848 -1.167 . . . . 0.0 110.937 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.707 ' CB ' HG23 ' A' ' 9' ' ' VAL . 35.4 m-85 -144.03 111.72 5.2 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.695 -1.474 . . . . 0.0 111.594 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.0 96.37 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 N-CA-C 107.844 -1.637 . . . . 0.0 107.844 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -108.85 -168.42 1.34 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.211 -0.931 . . . . 0.0 111.748 -177.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.539 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.0 OUTLIER -156.5 -163.49 1.46 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.11 HG21 HG23 ' A' ' 54' ' ' VAL . 5.7 p -137.18 159.44 36.13 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 O-C-N 120.583 -1.323 . . . . 0.0 111.022 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.57 ' CG ' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -130.56 39.12 3.66 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.019 -1.073 . . . . 0.0 109.46 179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.568 ' CB ' HG13 ' A' ' 5' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.687 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.274 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.982 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.21 0.528 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -152.63 89.89 1.44 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -110.09 169.92 8.42 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 119.369 -0.932 . . . . 0.0 112.799 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 4' ' ' THR . 3.1 t -143.99 113.41 6.98 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.36 0.6 . . . . 0.0 109.792 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.899 HG21 HG23 ' A' ' 54' ' ' VAL . 2.7 m -120.17 168.69 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 109.747 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.74 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.81 159.49 16.2 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 178.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.02 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.4 153.89 50.36 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 120.737 -1.227 . . . . 0.0 110.344 -178.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.536 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -108.84 104.74 14.05 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.411 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.881 HG21 HG21 ' A' ' 21' ' ' VAL . 1.2 p -112.4 93.36 22.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.608 -0.683 . . . . 0.0 109.999 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -76.82 35.24 0.47 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 O-C-N 123.737 1.388 . . . . 0.0 111.647 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.613 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.14 -62.85 4.57 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.939 -1.664 . . . . 0.0 108.939 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.497 ' HG2' ' CZ ' ' A' ' 41' ' ' ARG . 21.5 mtp 56.03 49.08 16.4 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.414 -1.051 . . . . 0.0 109.412 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 1.116 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -84.08 10.33 10.36 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.27 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.1 OUTLIER 77.32 97.06 0.06 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.651 0.739 . . . . 0.0 111.273 179.324 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 54.62 42.55 31.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.525 -0.735 . . . . 0.0 111.396 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.116 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -162.45 -29.61 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.976 -1.077 . . . . 0.0 111.315 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.645 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -50.33 -52.01 58.35 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.689 -1.257 . . . . 0.0 110.184 179.201 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.899 ' O ' HG11 ' A' ' 36' ' ' VAL . 9.5 Cg_endo -74.66 -6.9 18.83 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.353 1.369 . . . . 0.0 112.306 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 19' ' ' ILE . 13.4 mm -90.87 -42.25 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.69 -1.257 . . . . 0.0 109.759 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 1.032 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -69.79 -32.03 70.27 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.969 ' O ' HD12 ' A' ' 25' ' ' LEU . 40.4 t -73.42 -40.91 56.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.548 ' O ' HG11 ' A' ' 34' ' ' VAL . 7.8 tmtt? -50.06 -50.15 48.89 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.456 -0.778 . . . . 0.0 109.768 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 1.6 mmmm -77.6 -25.37 49.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.879 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 60' ' ' ALA . . . -62.5 -57.82 9.82 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.315 -0.865 . . . . 0.0 110.813 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.118 ' HB2' HG21 ' A' ' 34' ' ' VAL . 2.8 mp -75.91 -30.97 58.96 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.391 -0.818 . . . . 0.0 111.295 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.803 ' C ' HG11 ' A' ' 31' ' ' VAL . 1.8 t -69.39 -19.28 63.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.896 -1.127 . . . . 0.0 108.655 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.573 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 1.3 mptp? -115.54 -1.12 12.85 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.904 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.578 HG13 ' N ' ' A' ' 29' ' ' GLU . 11.5 p -44.24 -45.25 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.292 -0.88 . . . . 0.0 110.221 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.578 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 163.31 -85.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.458 -0.776 . . . . 0.0 111.193 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.743 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -80.79 -6.07 89.63 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 120.316 -0.945 . . . . 0.0 110.81 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.803 HG11 ' C ' ' A' ' 26' ' ' SER . 7.6 p -50.06 141.89 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.892 -1.358 . . . . 0.0 110.36 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -121.18 -12.55 8.66 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.576 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.479 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -176.02 107.53 0.08 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 119.191 -1.003 . . . . 0.0 110.788 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.118 HG21 ' HB2' ' A' ' 25' ' ' LEU . 1.5 p -114.01 179.06 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.154 -0.966 . . . . 0.0 111.399 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.556 ' H ' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -166.04 160.82 16.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.5 -0.75 . . . . 0.0 110.045 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.899 HG11 ' O ' ' A' ' 18' ' ' PRO . 15.8 m -130.39 158.75 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 0.0 110.476 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.3 112.47 0.62 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.625 ' CG ' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -75.22 -28.44 59.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -1.146 . . . . 0.0 110.604 -179.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -55.17 -23.35 21.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.146 -0.971 . . . . 0.0 110.346 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.474 ' HB3' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -134.59 16.5 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 0.0 110.43 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.497 ' CZ ' ' HG2' ' A' ' 12' ' ' MET . 1.5 mpp_? 42.53 55.58 4.1 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -0.914 . . . . 0.0 110.043 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 2.2 pp20? -148.49 149.77 32.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.397 -0.814 . . . . 0.0 109.898 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.515 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -123.03 136.73 54.96 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.956 -1.09 . . . . 0.0 108.932 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.2 p -105.44 132.19 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.493 -1.379 . . . . 0.0 109.325 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.009 HG11 HD22 ' A' ' 57' ' ' LEU . 3.2 t -123.11 152.3 27.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.442 1.115 . . . . 0.0 112.401 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 1.3 m -125.51 145.94 49.87 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 176.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.853 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.4 p90 -170.59 -178.43 2.64 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 117.235 -1.786 . . . . 0.0 112.523 -178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.577 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -107.0 120.22 41.47 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.982 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 1.6 t70 -64.6 -3.24 2.95 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.399 -0.813 . . . . 0.0 111.327 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.4 p -77.0 -23.25 52.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.027 . . . . 0.0 110.651 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.5 mttt -130.32 0.63 4.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.022 -1.049 . . . . 0.0 110.894 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.743 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -159.65 -166.58 1.79 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 109.917 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.599 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 10.0 t 176.21 160.62 0.32 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 110.001 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.019 ' CG2' HG21 ' A' ' 70' ' ' VAL . 5.7 p -42.49 -37.86 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.363 -0.836 . . . . 0.0 110.151 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.478 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 2.4 tt0 -56.96 -49.1 76.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.883 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' HG3' ' CG2' ' A' ' 28' ' ' VAL . 2.0 tptt -70.06 -23.71 63.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 0.0 110.76 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.009 HD22 HG11 ' A' ' 45' ' ' VAL . 66.8 mt -69.32 -56.62 6.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.795 -1.19 . . . . 0.0 108.812 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.664 ' N ' HD21 ' A' ' 7' ' ' LEU . 12.3 m -60.2 -30.44 69.37 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 33.3 tttt -77.06 -23.17 52.02 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.542 -0.724 . . . . 0.0 109.61 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.719 ' HB3' ' HG ' ' A' ' 25' ' ' LEU . . . -72.79 -46.06 55.27 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.334 -0.854 . . . . 0.0 109.255 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.827 ' OG1' HG22 ' A' ' 21' ' ' VAL . 7.6 t -72.71 -34.14 66.93 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -63.96 -32.6 74.19 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.824 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -91.0 -9.53 45.6 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.457 -0.777 . . . . 0.0 109.395 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.032 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.08 -24.73 43.3 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.44 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.04 15.57 0.91 Allowed Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.249 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.645 ' CB ' HG23 ' A' ' 9' ' ' VAL . 26.5 m-85 -139.72 110.21 7.34 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.562 -1.552 . . . . 0.0 111.004 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -55.51 99.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 N-CA-C 107.509 -1.766 . . . . 0.0 107.509 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.529 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 9.2 p -108.43 -170.65 1.71 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.233 1.016 . . . . 0.0 112.767 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.9 t -150.64 -162.19 1.5 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.02 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.7 p -141.92 162.46 20.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 118.735 -1.186 . . . . 0.0 112.19 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.501 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -124.92 23.83 7.75 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 122.363 1.078 . . . . 0.0 108.944 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.592 ' HB2' HG21 ' A' ' 54' ' ' VAL . 1.7 tt0 . . . . . 0 C--N 1.286 -2.18 0 CA-C-O 117.955 -1.022 . . . . 0.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.933 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.095 0.474 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -148.38 90.49 1.81 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -108.81 162.79 13.86 Favored 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 119.476 -0.889 . . . . 0.0 112.445 -177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.1 t -137.66 119.28 14.98 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.264 0.554 . . . . 0.0 109.599 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.617 HG21 HG22 ' A' ' 54' ' ' VAL . 3.0 m -126.55 170.36 16.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.279 -0.888 . . . . 0.0 109.803 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.95 161.32 14.82 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.001 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.94 156.45 48.98 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 118.541 -1.264 . . . . 0.0 110.036 -178.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.66 109.63 20.43 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.182 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.902 HG21 HG21 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -117.71 102.94 51.22 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.244 -0.91 . . . . 0.0 109.617 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.529 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 7.7 Cg_endo -75.71 32.48 0.39 Allowed 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.428 1.418 . . . . 0.0 112.329 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.593 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -74.62 -69.72 1.35 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.546 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 48.63 30.68 2.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -1.078 . . . . 0.0 109.365 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 1.106 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -61.23 -10.4 6.69 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.735 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.8 t 89.93 98.4 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.615 0.722 . . . . 0.0 111.019 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 71.7 27.59 2.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.61 -0.681 . . . . 0.0 111.256 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.106 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -150.61 -44.67 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.796 -1.19 . . . . 0.0 110.531 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -45.73 -50.03 34.84 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.862 -1.149 . . . . 0.0 111.39 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 17' ' ' CYS . 6.8 Cg_endo -69.94 -20.89 33.39 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.234 1.289 . . . . 0.0 113.484 -177.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 51.5 mt -91.35 -30.04 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.381 -1.45 . . . . 0.0 110.028 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.665 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.254 1.5 m -78.21 -40.59 37.05 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.471 0.653 . . . . 0.0 109.524 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.995 ' O ' HD12 ' A' ' 25' ' ' LEU . 55.8 t -70.54 -52.05 32.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.182 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.556 ' HA ' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -50.93 -43.26 60.07 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.82 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 12.8 mtpt -71.96 -26.69 62.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 110.795 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.587 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -70.24 -62.17 1.49 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.487 -0.758 . . . . 0.0 110.714 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.027 HD22 ' CG2' ' A' ' 45' ' ' VAL . 2.8 mp -59.55 -34.72 73.02 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.309 -0.869 . . . . 0.0 110.562 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.71 ' HA ' HG21 ' A' ' 31' ' ' VAL . 2.1 t -72.11 -22.89 61.27 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.406 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.22 -10.47 41.5 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.276 -0.89 . . . . 0.0 109.716 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.814 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.4 t -42.61 -80.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.444 -0.785 . . . . 0.0 109.851 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.814 ' N ' HG12 ' A' ' 28' ' ' VAL . 1.1 mt-10 177.11 -69.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.46 -0.775 . . . . 0.0 110.051 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.419 ' O ' ' OD2' ' A' ' 48' ' ' ASP . . . -77.52 -13.39 83.58 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' A' ' 26' ' ' SER . 12.2 p -48.2 139.4 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -1.125 . . . . 0.0 110.539 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.412 ' OG ' ' OD2' ' A' ' 48' ' ' ASP . 5.9 m -128.26 -6.46 5.38 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.152 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.5 OUTLIER -173.62 103.9 0.12 Allowed 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 118.772 -1.171 . . . . 0.0 111.421 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.061 HG22 HG13 ' A' ' 45' ' ' VAL . 70.9 t -111.77 171.46 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.403 -0.811 . . . . 0.0 110.304 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.724 ' HB3' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -169.28 178.55 4.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.188 -0.945 . . . . 0.0 110.269 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 18' ' ' PRO . 3.2 m -113.63 167.66 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 0.0 110.37 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.44 69.05 0.29 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -56.7 -15.84 5.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.302 -1.116 . . . . 0.0 110.472 -179.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 38' ' ' PHE . 10.3 tp10 -44.41 -29.81 0.75 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 0.0 109.319 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -160.91 52.52 0.28 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.457 -0.777 . . . . 0.0 110.288 179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.546 ' NH1' ' HB2' ' A' ' 12' ' ' MET . 2.4 mtt180 41.31 63.61 1.2 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.526 -0.734 . . . . 0.0 110.496 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 1.1 pt-20 -149.02 150.17 32.36 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.212 -0.93 . . . . 0.0 110.599 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.698 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -115.81 143.88 44.78 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.724 HG12 ' HB3' ' A' ' 35' ' ' ASP . 8.5 p -105.15 129.18 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.509 -1.369 . . . . 0.0 108.895 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.061 HG13 HG22 ' A' ' 34' ' ' VAL . 21.5 t -124.97 156.35 33.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 122.524 1.154 . . . . 0.0 112.051 -177.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 33' ' ' LYS . 1.4 m -137.85 146.65 43.7 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.817 ' CE2' HD11 ' A' ' 57' ' ' LEU . 30.6 p90 -170.65 -174.57 1.64 Allowed 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 117.154 -1.818 . . . . 0.0 112.569 -178.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.607 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 8.9 m-20 -106.27 116.56 32.15 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.933 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 35.7 t0 -63.21 -8.19 7.62 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.878 -177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.2 t -77.31 -17.98 57.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.925 . . . . 0.0 110.484 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.7 mmtm -132.36 0.9 3.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.969 . . . . 0.0 110.894 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.461 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -166.28 -170.54 1.71 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.068 -1.02 . . . . 0.0 110.447 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.627 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.2 OUTLIER 171.52 173.04 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 110.008 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.068 HG13 HG21 ' A' ' 70' ' ' VAL . 17.8 t -41.59 -41.96 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.125 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -50.86 -48.53 60.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 110.228 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.3 mmtt -79.26 -21.88 45.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 111.861 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.972 HD22 HG11 ' A' ' 45' ' ' VAL . 63.1 mt -71.5 -59.15 2.92 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.27 -1.519 . . . . 0.0 108.649 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.694 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 8.0 m -58.88 -28.4 66.1 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -79.18 -25.79 42.73 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 121.345 -0.847 . . . . 0.0 110.005 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.594 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -73.6 -47.41 40.57 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.022 -1.049 . . . . 0.0 109.201 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.969 ' OG1' HG22 ' A' ' 21' ' ' VAL . 9.0 t -71.38 -32.82 68.92 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -63.43 -34.53 77.94 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.964 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -89.43 -8.86 52.12 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.352 -0.842 . . . . 0.0 109.042 178.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.665 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.61 -25.05 41.58 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.89 15.37 0.72 Allowed Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.426 -1.368 . . . . 0.0 111.66 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.593 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 53.7 m-85 -141.71 111.43 6.29 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.443 -1.622 . . . . 0.0 111.41 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.02 99.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 N-CA-C 106.999 -1.962 . . . . 0.0 106.999 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.527 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 85.6 p -108.22 -165.35 1.03 Allowed 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 122.147 0.975 . . . . 0.0 112.793 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.62 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -157.68 -165.93 1.88 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.068 HG21 HG13 ' A' ' 54' ' ' VAL . 3.6 p -139.55 158.1 27.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 120.816 -1.178 . . . . 0.0 111.524 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 4.1 mtmt -124.41 25.85 7.52 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.478 1.132 . . . . 0.0 108.91 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.493 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.284 -2.274 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.992 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.617 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.094 0.473 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -146.18 87.47 1.74 Allowed 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -117.26 165.39 13.51 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.71 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 4.2 t -132.5 124.29 28.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.794 -0.566 . . . . 0.0 110.031 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.7 HG21 HG22 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -124.79 172.41 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.275 -0.891 . . . . 0.0 109.004 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.797 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.6 162.01 14.34 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.227 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.029 ' CD1' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -133.35 153.54 51.5 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.859 -1.136 . . . . 0.0 109.651 -179.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.537 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -108.9 98.55 8.02 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.137 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.126 HG21 HG21 ' A' ' 21' ' ' VAL . 2.2 p -113.17 90.69 16.91 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.7 Cg_endo -74.8 31.33 0.35 Allowed 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.394 1.396 . . . . 0.0 112.323 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.3 -43.11 95.69 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 13.0 ptm 35.83 45.93 0.31 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.748 0.785 . . . . 0.0 109.894 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 1.165 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.2 t -72.1 0.54 9.34 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.69 -0.631 . . . . 0.0 110.142 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.719 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 82.19 88.58 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.508 0.671 . . . . 0.0 111.127 179.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 71.17 31.51 2.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.527 -0.733 . . . . 0.0 112.078 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.165 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -155.72 -35.4 0.09 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.532 -1.355 . . . . 0.0 110.658 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.749 ' H ' HG22 ' A' ' 13' ' ' THR . 0.0 OUTLIER -49.87 -48.57 77.57 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.727 -1.233 . . . . 0.0 110.825 179.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.595 ' HG3' ' CD1' ' A' ' 38' ' ' PHE . 18.7 Cg_endo -77.94 -9.87 16.77 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.312 1.341 . . . . 0.0 112.599 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.441 HD13 ' HA ' ' A' ' 19' ' ' ILE . 18.7 mm -90.31 -42.38 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.719 -1.238 . . . . 0.0 109.735 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.965 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.251 0.9 OUTLIER -71.92 -39.11 69.7 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.921 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.126 HG21 HG21 ' A' ' 9' ' ' VAL . 21.1 t -67.7 -48.44 76.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -47.4 -47.32 26.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.31 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.564 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 1.2 mmmm -74.46 -20.37 60.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 111.693 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.7 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -73.24 -48.78 32.09 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.258 -0.901 . . . . 0.0 110.062 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 21' ' ' VAL . 4.9 mp -68.86 -33.28 73.54 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.119 -0.988 . . . . 0.0 109.676 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.726 ' HA ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -78.58 -20.88 49.55 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.964 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.564 ' CG ' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -98.3 -7.26 29.36 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.894 -1.129 . . . . 0.0 109.588 179.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.733 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.9 t -40.36 -80.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.668 -0.645 . . . . 0.0 109.776 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.733 ' N ' HG12 ' A' ' 28' ' ' VAL . 5.1 tt0 179.3 -57.85 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.183 -0.948 . . . . 0.0 109.825 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -92.15 -15.12 54.84 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' A' ' 26' ' ' SER . 10.6 p -43.16 141.99 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.101 -1.235 . . . . 0.0 110.49 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 t -120.89 -12.95 8.71 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.555 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.498 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 4.1 ttmt -166.25 168.71 14.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.028 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.461 ' N ' ' CG ' ' A' ' 33' ' ' LYS . 4.7 p -164.68 172.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.242 -0.911 . . . . 0.0 110.405 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.575 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -167.21 169.4 12.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.835 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.584 HG13 ' HB3' ' A' ' 18' ' ' PRO . 24.8 t -109.92 147.47 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.052 -1.03 . . . . 0.0 110.509 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 42' ' ' GLU . . . -139.41 60.47 0.58 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.595 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -58.79 -20.82 53.44 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.302 -1.116 . . . . 0.0 110.236 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 38' ' ' PHE . 3.4 mp0 -45.93 -26.37 0.69 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.06 -1.025 . . . . 0.0 109.294 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.38 37.95 0.94 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.504 -0.747 . . . . 0.0 110.104 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.451 ' CG ' ' HA ' ' A' ' 10' ' ' PRO . 1.7 mpp_? 43.43 56.25 4.43 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.348 -0.845 . . . . 0.0 110.482 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -143.46 150.11 38.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -0.835 . . . . 0.0 110.152 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -117.69 138.83 51.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.018 . . . . 0.0 108.791 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.575 ' CG1' ' CB ' ' A' ' 35' ' ' ASP . 10.1 p -105.61 144.57 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.532 -1.355 . . . . 0.0 109.939 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.893 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.2 p -145.86 144.94 20.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 118.928 -1.109 . . . . 0.0 113.174 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -111.77 153.17 26.92 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.676 ' CE2' HD11 ' A' ' 57' ' ' LEU . 35.9 p90 -171.48 -177.09 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 117.832 -1.547 . . . . 0.0 112.58 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.617 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 6.3 t0 -106.38 110.76 23.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.502 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 23.6 t0 -64.65 -8.19 13.47 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.978 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.409 HG22 ' CG ' ' A' ' 48' ' ' ASP . 10.0 t -68.64 -11.36 60.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.957 -1.089 . . . . 0.0 110.134 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.3 -35.57 0.46 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.18 -0.95 . . . . 0.0 111.243 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -122.61 -174.67 2.97 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.273 -0.892 . . . . 0.0 110.366 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.568 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 7.3 t 173.14 175.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.891 . . . . 0.0 110.103 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.024 HG23 HG21 ' A' ' 70' ' ' VAL . 1.6 p -40.34 -32.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.87 . . . . 0.0 110.672 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.83 -49.98 75.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.098 . . . . 0.0 109.813 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 37.0 mmtt -77.43 -18.92 56.79 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.386 -0.821 . . . . 0.0 110.961 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.893 HD13 ' CG1' ' A' ' 45' ' ' VAL . 79.0 mt -74.51 -61.08 1.99 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.656 -1.277 . . . . 0.0 108.364 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.692 HG21 ' HB ' ' A' ' 70' ' ' VAL . 42.9 p -60.27 -25.38 65.66 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.469 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 5.5 tttm -78.11 -29.8 49.11 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 121.469 -0.77 . . . . 0.0 109.822 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.7 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -72.14 -46.63 55.72 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.101 -0.999 . . . . 0.0 109.224 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.882 ' OG1' HG22 ' A' ' 21' ' ' VAL . 7.3 t -70.5 -32.22 69.64 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -67.68 -31.67 71.81 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.261 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -90.47 -9.36 47.68 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.43 -0.794 . . . . 0.0 109.262 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.965 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -80.98 -29.02 35.38 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.577 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 140.89 22.47 0.27 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.424 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.8 ' CB ' HG23 ' A' ' 9' ' ' VAL . 42.5 m-85 -148.28 108.94 3.65 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.46 -1.612 . . . . 0.0 111.278 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.0 Cg_exo -57.17 100.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 N-CA-C 107.009 -1.958 . . . . 0.0 107.009 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 3.7 t -107.3 -177.43 3.35 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.562 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.41 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -140.77 -164.75 1.8 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.029 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.5 p -142.73 155.25 17.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 O-C-N 120.813 -1.18 . . . . 0.0 111.384 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -124.81 25.72 7.32 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.583 1.182 . . . . 0.0 109.086 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.459 ' OXT' HG23 ' A' ' 5' ' ' VAL . 1.2 mm-40 . . . . . 0 C--N 1.286 -2.193 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.11 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.327 0.584 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.817 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -167.29 99.69 0.51 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -111.79 160.65 17.13 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-O 121.861 0.839 . . . . 0.0 112.376 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.8 m -122.9 128.33 50.17 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.697 HG21 HG22 ' A' ' 70' ' ' VAL . 1.3 p -141.64 168.88 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-O 122.477 1.132 . . . . 0.0 111.101 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.697 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -108.84 159.36 16.85 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.015 HD11 HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -131.39 154.24 48.84 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.768 -1.207 . . . . 0.0 110.072 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.29 99.21 8.51 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.956 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.083 HG21 HG21 ' A' ' 21' ' ' VAL . 2.2 p -117.13 86.3 20.32 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 0.0 109.6 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.5 Cg_endo -76.62 37.51 0.57 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.575 1.517 . . . . 0.0 112.095 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' CG ' ' A' ' 12' ' ' MET . . . -79.68 -26.25 56.85 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.679 -1.769 . . . . 0.0 108.679 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.512 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 17.4 ptm 36.45 65.26 0.47 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.781 -0.835 . . . . 0.0 110.386 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.857 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -88.83 15.54 8.23 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.521 -0.737 . . . . 0.0 109.465 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.1 OUTLIER 68.12 88.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.548 -0.72 . . . . 0.0 110.128 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 58.01 31.95 21.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 0.0 110.174 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.857 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -134.4 -41.64 0.79 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.0 109.919 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.702 ' SG ' HG22 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -52.96 -50.0 84.14 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 0.0 110.748 179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.678 ' O ' HG11 ' A' ' 36' ' ' VAL . 9.7 Cg_endo -75.0 -8.87 20.46 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.168 1.246 . . . . 0.0 112.302 -178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 15' ' ' ALA . 12.3 mm -90.59 -43.48 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.808 -1.182 . . . . 0.0 109.699 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.956 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -78.86 -43.93 23.98 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.083 HG21 HG21 ' A' ' 9' ' ' VAL . 21.3 t -59.85 -43.57 92.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.636 -0.826 . . . . 0.0 108.987 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.756 ' O ' HG11 ' A' ' 34' ' ' VAL . 14.0 tttt -56.34 -58.67 7.0 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.073 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.7 pttt -73.58 3.41 6.28 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.279 -0.888 . . . . 0.0 110.547 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.672 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -87.71 -72.14 0.54 Allowed 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.887 -1.133 . . . . 0.0 108.775 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.839 ' CD2' HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -60.65 -16.23 36.73 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.154 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.739 ' O ' HG11 ' A' ' 31' ' ' VAL . 13.1 t -81.38 -35.03 31.28 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -75.9 -10.2 59.23 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.674 HG12 ' N ' ' A' ' 29' ' ' GLU . 6.5 t -37.47 -80.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.68 -0.637 . . . . 0.0 110.888 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.674 ' N ' HG12 ' A' ' 28' ' ' VAL . 2.4 mt-10 -172.85 -51.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.837 -1.165 . . . . 0.0 111.741 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -108.33 14.3 36.33 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.857 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.739 HG11 ' O ' ' A' ' 26' ' ' SER . 8.5 p -41.3 143.88 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.033 -1.275 . . . . 0.0 111.11 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.614 ' HB3' HG22 ' A' ' 46' ' ' THR . 2.8 t -120.89 -16.22 8.16 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.461 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -173.06 162.64 4.61 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.768 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.777 HG13 HG22 ' A' ' 45' ' ' VAL . 1.3 t -153.04 148.12 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.058 -1.026 . . . . 0.0 110.684 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.595 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -154.64 164.41 38.77 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.315 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 18' ' ' PRO . 18.8 m -128.34 161.66 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.026 -1.047 . . . . 0.0 110.74 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.18 90.7 0.13 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.611 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -65.51 -21.07 66.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -1.182 . . . . 0.0 110.23 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 0.7 OUTLIER -53.24 -23.01 7.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.973 . . . . 0.0 109.122 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 41' ' ' ARG . 2.3 mmpp? -138.73 19.43 2.68 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.636 -0.665 . . . . 0.0 109.839 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 40' ' ' LYS . 1.7 tpp180 42.69 55.51 4.23 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.552 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER -145.2 151.54 38.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.49 -0.756 . . . . 0.0 110.071 -179.251 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.23 136.96 52.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.133 -0.979 . . . . 0.0 109.77 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.698 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.5 p -107.07 110.51 32.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.68 -1.263 . . . . 0.0 108.911 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.839 HG21 ' CD2' ' A' ' 25' ' ' LEU . 65.4 t -123.4 143.97 34.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.191 -1.003 . . . . 0.0 111.932 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.614 HG22 ' HB3' ' A' ' 32' ' ' SER . 1.3 m -110.07 163.01 14.0 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.873 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.1 p90 -171.35 -178.15 2.29 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.44 -1.304 . . . . 0.0 110.328 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.559 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 11.1 m-20 -106.99 116.67 32.32 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 0.7 OUTLIER -61.18 -11.33 8.75 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.735 -177.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.573 HG23 ' HG3' ' A' ' 51' ' ' LYS . 15.2 t -68.94 -13.76 62.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 110.551 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HG3' HG23 ' A' ' 50' ' ' THR . 21.7 mttt -143.62 10.2 1.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 110.512 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.572 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -169.83 -167.01 0.62 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.104 -0.997 . . . . 0.0 110.298 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.635 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.7 t 172.3 164.22 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.033 HG13 HG21 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -42.18 -50.95 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 109.613 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.504 ' N ' HG12 ' A' ' 54' ' ' VAL . 40.0 tp60 -47.9 -46.08 31.29 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.326 -0.858 . . . . 0.0 109.657 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -72.45 -27.33 62.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 0.0 111.246 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.873 HD11 ' CE2' ' A' ' 47' ' ' PHE . 55.3 mt -68.78 -59.83 2.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.63 -1.294 . . . . 0.0 108.682 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.668 HG22 ' O ' ' A' ' 54' ' ' VAL . 1.7 t -56.27 -28.84 60.01 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 29.9 tttp -72.1 -33.74 68.08 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.348 -0.845 . . . . 0.0 109.441 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.672 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -67.85 -40.43 83.69 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 121.169 -0.957 . . . . 0.0 110.022 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.801 ' OG1' HG22 ' A' ' 21' ' ' VAL . 3.7 t -72.21 -32.0 66.37 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.54 84.4 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.47 -7.49 52.9 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.463 -0.773 . . . . 0.0 109.572 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.956 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -82.2 -24.4 34.94 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 133.3 20.11 0.93 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.789 -1.196 . . . . 0.0 110.946 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.767 ' CB ' HG23 ' A' ' 9' ' ' VAL . 44.4 m-85 -147.94 112.59 3.89 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 120.585 -1.538 . . . . 0.0 111.404 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.07 93.57 0.15 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 N-CA-C 107.671 -1.704 . . . . 0.0 107.671 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.71 -171.21 1.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 111.827 -177.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.521 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -142.62 -164.02 1.74 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.033 HG21 HG13 ' A' ' 54' ' ' VAL . 2.4 p -141.39 154.1 20.15 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.886 -1.133 . . . . 0.0 111.448 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.464 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.4 OUTLIER -118.8 23.69 11.3 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 122.394 1.093 . . . . 0.0 109.617 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.484 ' OXT' ' CB ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.283 -2.311 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.248 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.721 ' HB1' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.142 0.496 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.709 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -156.98 94.38 1.42 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -109.09 148.28 31.08 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.893 0.854 . . . . 0.0 111.947 -177.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 m -123.48 108.14 12.34 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG12 ' CB ' ' A' ' 72' ' ' GLN . 5.6 m -125.36 165.0 23.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.184 -0.947 . . . . 0.0 110.688 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.727 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.8 OUTLIER -107.01 159.95 15.91 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.035 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -131.48 159.31 38.47 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.511 -178.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.803 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -114.03 119.13 36.13 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.923 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.568 HG13 ' CB ' ' A' ' 66' ' ' TYR . 2.9 t -108.87 103.3 51.49 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.289 -0.882 . . . . 0.0 109.315 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.529 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 7.3 Cg_endo -74.79 29.41 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.314 1.165 . . . . 0.0 111.867 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.523 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -91.93 -58.82 1.37 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.561 ' CG ' ' HD2' ' A' ' 41' ' ' ARG . 4.0 tmm? 52.25 51.17 16.83 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.406 -1.055 . . . . 0.0 109.195 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 1.134 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -76.72 2.74 13.4 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.755 -0.59 . . . . 0.0 109.54 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.67 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 4.1 t 80.48 94.51 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.604 0.716 . . . . 0.0 111.13 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.843 ' O ' HD12 ' A' ' 19' ' ' ILE . . . 68.08 37.4 2.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.606 -0.684 . . . . 0.0 111.825 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.134 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -163.19 -37.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.782 -1.199 . . . . 0.0 110.602 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.61 ' HA ' ' CZ ' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -44.2 -51.54 18.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.861 -1.15 . . . . 0.0 110.132 179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.83 ' O ' HG12 ' A' ' 36' ' ' VAL . 17.9 Cg_endo -83.4 -14.15 8.25 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.423 1.416 . . . . 0.0 112.572 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 15' ' ' ALA . 84.6 mt -80.77 -54.19 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.864 -1.148 . . . . 0.0 110.306 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.795 HG23 ' HB1' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -62.29 -37.54 85.92 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.925 ' O ' HD12 ' A' ' 25' ' ' LEU . 15.1 t -63.65 -41.61 93.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.914 ' HE2' HG13 ' A' ' 34' ' ' VAL . 16.0 tttm -52.82 -39.31 62.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 109.743 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.508 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 11.6 mtmt -73.08 -26.2 61.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.198 -0.939 . . . . 0.0 110.845 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.758 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -69.07 -55.64 10.15 Favored 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.183 -0.948 . . . . 0.0 110.646 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.925 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.7 mp -65.45 -37.44 86.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 111.478 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.526 ' HB3' HG11 ' A' ' 34' ' ' VAL . 36.1 p -70.98 -26.1 63.0 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.099 -1.0 . . . . 0.0 110.21 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' CE ' ' HA ' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -99.64 -3.82 32.28 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 118.847 -1.141 . . . . 0.0 110.222 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.81 ' CG2' ' HB2' ' A' ' 60' ' ' ALA . 2.2 t -42.9 -73.09 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 109.855 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.712 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 175.08 -71.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.354 -0.841 . . . . 0.0 109.75 -179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.46 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -78.94 -20.51 70.31 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.724 HG11 ' O ' ' A' ' 25' ' ' LEU . 46.1 t -52.0 134.29 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -1.13 . . . . 0.0 110.449 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.1 m -122.63 -12.2 8.14 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.836 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.916 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -146.56 154.57 41.67 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.873 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.914 HG13 ' HE2' ' A' ' 22' ' ' LYS . 7.1 p -155.23 165.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.322 -0.861 . . . . 0.0 110.026 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.631 ' HB3' HG12 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -162.96 155.04 18.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.062 -1.024 . . . . 0.0 110.835 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 18' ' ' PRO . 8.7 m -109.68 113.76 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.475 -0.766 . . . . 0.0 110.18 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.4 73.76 0.21 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.649 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -65.56 -14.94 62.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -1.193 . . . . 0.0 110.056 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -57.29 -17.31 11.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.275 -0.89 . . . . 0.0 109.265 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 41' ' ' ARG . 13.3 mttm -147.35 32.51 0.89 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.517 -0.74 . . . . 0.0 110.134 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.573 ' HD3' ' CD1' ' A' ' 38' ' ' PHE . 0.6 OUTLIER 42.89 57.47 3.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 4.6 pt-20 -149.77 148.68 29.51 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.216 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -115.63 130.26 56.8 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' A' ' 35' ' ' ASP . 8.4 p -105.66 143.49 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.478 -1.389 . . . . 0.0 110.003 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.916 HG13 ' O ' ' A' ' 33' ' ' LYS . 57.4 t -152.48 148.12 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.447 -178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.548 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.1 m -109.42 159.03 17.36 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.854 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.4 p90 -170.33 179.74 3.32 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 117.962 -1.495 . . . . 0.0 111.726 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 41.0 m-20 -106.49 112.9 26.11 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.721 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . 4.7 t70 -53.33 -17.3 1.74 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.9 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 p -65.88 -40.84 91.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.184 -0.948 . . . . 0.0 110.702 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.6 -0.65 13.59 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.096 -1.002 . . . . 0.0 110.747 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.473 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -150.55 -165.09 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 110.06 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.607 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 170.84 154.44 0.06 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.582 -0.699 . . . . 0.0 109.464 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.122 ' CG2' HG21 ' A' ' 70' ' ' VAL . 9.5 p -42.39 -39.84 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.267 -0.896 . . . . 0.0 109.902 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.538 ' N ' HG13 ' A' ' 54' ' ' VAL . 5.7 tp-100 -59.69 -47.5 85.39 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.169 -0.957 . . . . 0.0 109.313 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -66.29 -24.16 66.51 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.469 -0.769 . . . . 0.0 110.698 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.888 HD12 ' HA ' ' A' ' 54' ' ' VAL . 43.0 mt -72.65 -54.59 8.62 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.706 -1.246 . . . . 0.0 108.12 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 52.5 m -56.29 -32.84 64.96 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.538 -0.726 . . . . 0.0 109.223 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -77.55 -28.78 51.94 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 121.291 -0.88 . . . . 0.0 110.053 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.81 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -68.54 -49.39 59.88 Favored 'General case' 0 C--N 1.308 -1.235 0 O-C-N 121.214 -0.929 . . . . 0.0 109.12 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.734 ' CB ' HG13 ' A' ' 21' ' ' VAL . 7.4 t -67.02 -32.26 73.35 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -68.29 -26.86 65.86 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.053 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 4.1 t0 -88.65 -13.31 40.12 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.795 ' HB1' HG23 ' A' ' 20' ' ' THR . . . -79.3 -32.64 43.59 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.583 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 143.35 31.11 0.1 Allowed Glycine 0 N--CA 1.488 2.118 0 C-N-CA 119.593 -1.289 . . . . 0.0 111.168 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.61 ' CZ ' ' HA ' ' A' ' 17' ' ' CYS . 63.8 m-85 -155.9 105.89 2.12 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.664 -1.492 . . . . 0.0 111.621 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.529 ' O ' ' CG ' ' A' ' 10' ' ' PRO . 5.0 Cg_exo -56.31 98.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 N-CA-C 106.768 -2.051 . . . . 0.0 106.768 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 8' ' ' ALA . 1.1 t -107.27 -177.91 3.49 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.077 -1.014 . . . . 0.0 111.939 -176.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.803 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 12.9 p -136.99 -162.01 1.23 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.122 HG21 ' CG2' ' A' ' 54' ' ' VAL . 4.6 p -144.27 157.43 15.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 C-N-CA 118.522 -1.271 . . . . 0.0 112.058 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.431 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -128.62 33.3 4.68 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 122.317 1.056 . . . . 0.0 108.195 179.149 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.597 ' CB ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.338 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 1.017 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.367 0.604 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.61 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.15 91.27 1.51 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.86 173.5 6.33 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.164 -177.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.699 HG23 ' OG1' ' A' ' 46' ' ' THR . 0.7 OUTLIER -143.39 128.48 18.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.776 -0.578 . . . . 0.0 110.064 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.584 ' CG1' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -132.79 161.4 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.391 -0.818 . . . . 0.0 109.371 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.712 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -106.61 157.31 17.78 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.023 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -130.38 157.65 42.0 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.753 -177.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.04 106.48 16.0 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.906 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.699 HG23 ' CB ' ' A' ' 66' ' ' TYR . 1.4 p -115.62 94.33 39.99 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.3 Cg_endo -78.64 43.33 1.42 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.56 1.507 . . . . 0.0 111.56 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.597 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -90.44 -49.71 3.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.592 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 4.2 ptm 36.4 61.94 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.77 -0.841 . . . . 0.0 110.981 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.968 HG21 ' HB3' ' A' ' 16' ' ' ALA . 6.6 t -70.94 -2.38 15.02 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.316 -0.865 . . . . 0.0 109.269 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.5 OUTLIER 78.12 3.03 2.82 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.708 -0.62 . . . . 0.0 111.458 178.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.598 ' H ' HG23 ' A' ' 13' ' ' THR . . . -174.74 33.59 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.229 -0.92 . . . . 0.0 109.924 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.968 ' HB3' HG21 ' A' ' 13' ' ' THR . . . 179.74 -21.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.108 -0.995 . . . . 0.0 112.155 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.889 ' H ' HG22 ' A' ' 13' ' ' THR . 0.0 OUTLIER -46.27 -48.97 44.3 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.201 -1.562 . . . . 0.0 110.969 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.596 ' O ' HG11 ' A' ' 36' ' ' VAL . 19.5 Cg_endo -81.66 -11.75 11.42 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.437 1.425 . . . . 0.0 113.558 -178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.1 mt -92.57 -37.99 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.495 -1.378 . . . . 0.0 110.862 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.953 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.0 OUTLIER -73.26 -36.57 66.4 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.882 ' O ' HD12 ' A' ' 25' ' ' LEU . 42.1 t -67.67 -44.04 86.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.227 -0.989 . . . . 0.0 108.56 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.558 ' HA ' ' CG1' ' A' ' 34' ' ' VAL . 4.5 tptm -52.74 -47.59 67.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.542 -0.724 . . . . 0.0 110.311 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 5.0 mmtm -77.08 -16.19 59.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.974 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.681 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -73.93 -58.73 3.11 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.966 -1.084 . . . . 0.0 110.315 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.902 ' O ' HG12 ' A' ' 28' ' ' VAL . 3.7 mp -71.7 -29.15 64.25 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.597 -0.689 . . . . 0.0 110.487 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.761 ' C ' HG11 ' A' ' 31' ' ' VAL . 54.7 p -73.36 -26.11 60.88 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.432 -0.792 . . . . 0.0 109.426 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -110.48 3.54 19.68 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.001 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.902 HG12 ' O ' ' A' ' 25' ' ' LEU . 3.3 p -49.24 -55.33 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.024 -1.048 . . . . 0.0 110.448 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.655 ' H ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 176.31 -69.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.781 -1.2 . . . . 0.0 111.541 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -98.57 -9.52 52.7 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.788 -1.196 . . . . 0.0 110.776 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.761 HG11 ' C ' ' A' ' 26' ' ' SER . 11.0 p -42.56 143.4 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.978 -1.307 . . . . 0.0 110.928 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.39 -15.56 10.32 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.73 0.776 . . . . 0.0 109.14 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.653 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -161.33 161.44 30.51 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 45' ' ' VAL . 25.6 t -157.61 161.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.097 -1.002 . . . . 0.0 110.43 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.532 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 1.1 m-20 -163.63 166.57 22.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.915 . . . . 0.0 110.29 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.596 HG11 ' O ' ' A' ' 18' ' ' PRO . 15.7 m -140.92 157.22 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.419 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -147.61 105.31 0.31 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.58 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -64.0 -23.69 67.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.288 -1.124 . . . . 0.0 110.269 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -47.18 -37.3 9.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.925 . . . . 0.0 109.987 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -135.32 29.65 3.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.414 -0.804 . . . . 0.0 110.481 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.592 ' CD ' ' HB3' ' A' ' 12' ' ' MET . 0.0 OUTLIER 38.55 60.52 1.33 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.571 -0.706 . . . . 0.0 110.319 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 20.7 pt-20 -143.18 145.97 33.27 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.663 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.628 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -114.82 130.14 56.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.206 -0.934 . . . . 0.0 108.982 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 44' ' ' VAL . 10.0 p -105.54 126.91 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.904 -1.122 . . . . 0.0 109.1 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.841 HG22 HG22 ' A' ' 34' ' ' VAL . 40.7 t -131.88 144.55 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.827 -1.149 . . . . 0.0 112.691 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.699 ' OG1' HG23 ' A' ' 4' ' ' THR . 1.3 m -108.86 157.62 18.43 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.615 ' CE2' HD11 ' A' ' 57' ' ' LEU . 46.7 p90 -171.6 -173.77 1.26 Allowed 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 118.098 -1.441 . . . . 0.0 111.326 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 5.7 m-20 -107.04 129.42 54.81 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 1.017 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 25.4 t70 -80.36 35.77 0.35 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.958 -1.089 . . . . 0.0 111.391 -177.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.5 p -118.23 -16.97 9.64 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.37 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 7.5 mtpt -133.05 1.93 3.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.457 -0.777 . . . . 0.0 110.092 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . -179.65 -178.57 0.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -0.99 . . . . 0.0 110.368 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.609 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 8.1 p 174.24 -176.01 0.08 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.321 -0.862 . . . . 0.0 109.659 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.023 HG23 HG21 ' A' ' 70' ' ' VAL . 2.1 p -38.34 -40.07 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.304 -0.873 . . . . 0.0 110.632 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 6.0 tt0 -56.52 -50.56 71.46 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.028 -1.045 . . . . 0.0 109.812 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.467 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 31.7 mmtt -79.69 -13.68 59.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 111.52 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.777 ' HB3' HD23 ' A' ' 25' ' ' LEU . 89.3 mt -78.35 -56.51 4.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.515 -1.366 . . . . 0.0 108.062 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 26.8 m -58.27 -29.68 65.99 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -78.05 -26.27 48.23 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 121.359 -0.838 . . . . 0.0 109.714 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.619 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -71.81 -46.33 58.54 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.264 -0.897 . . . . 0.0 109.237 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.56 ' HB ' HD11 ' A' ' 25' ' ' LEU . 10.0 t -71.57 -33.81 69.39 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -62.09 -34.64 76.68 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.849 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -91.13 -8.33 49.06 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.467 -0.771 . . . . 0.0 109.21 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.953 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.65 -25.18 41.41 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.55 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 137.11 17.29 0.71 Allowed Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.701 -1.238 . . . . 0.0 111.391 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.699 ' CB ' HG23 ' A' ' 9' ' ' VAL . 33.7 m-85 -143.94 114.78 5.49 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.444 -1.621 . . . . 0.0 111.601 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.99 95.32 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 N-CA-C 107.6 -1.731 . . . . 0.0 107.6 177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.02 -170.56 1.68 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 112.332 -176.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 68' ' ' SER . 10.4 m -148.93 -161.86 1.44 Allowed 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 54' ' ' VAL . 5.1 p -140.09 163.18 24.35 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 120.657 -1.277 . . . . 0.0 111.937 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -125.88 26.12 6.68 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.381 1.086 . . . . 0.0 109.504 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.584 ' HA ' ' CG1' ' A' ' 5' ' ' VAL . 1.5 mt-30 . . . . . 0 C--N 1.285 -2.205 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.22 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.902 ' HB1' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.318 0.58 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -152.41 89.85 1.45 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 179.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -112.43 162.42 15.6 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.36 -0.936 . . . . 0.0 112.361 -177.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.5 m -135.31 132.87 38.22 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.705 HG21 ' CG2' ' A' ' 54' ' ' VAL . 3.9 t -139.18 169.34 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.077 -1.015 . . . . 0.0 109.966 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.975 HG22 ' CG2' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -107.48 156.53 18.87 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.89 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -130.59 157.46 42.65 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 117.855 -1.538 . . . . 0.0 110.861 -178.671 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 68' ' ' SER . . . -109.84 111.35 22.72 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.808 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.751 HG21 HG21 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -117.94 98.13 51.31 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.274 -0.891 . . . . 0.0 110.186 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.518 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 10.7 Cg_endo -80.17 49.91 3.36 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.514 1.476 . . . . 0.0 110.965 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.655 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -90.97 -39.59 5.74 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 8.2 ptm 38.43 42.83 0.58 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.661 -0.905 . . . . 0.0 110.6 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.759 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -71.61 2.9 4.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.675 -0.64 . . . . 0.0 110.044 178.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 13' ' ' THR . 3.9 t 78.99 95.86 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.453 0.644 . . . . 0.0 110.152 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 54.44 23.61 4.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.45 -0.781 . . . . 0.0 110.028 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.759 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -123.61 -48.6 1.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.314 -0.866 . . . . 0.0 109.71 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.577 ' SG ' ' HD3' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -39.7 -61.53 1.04 Allowed Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 121.474 -0.766 . . . . 0.0 111.445 -179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.617 ' HG3' ' CG ' ' A' ' 38' ' ' PHE . 5.6 Cg_endo -61.16 -20.65 68.81 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.96 1.773 . . . . 0.0 114.62 -178.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.4 mt -90.42 -36.57 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.332 -1.48 . . . . 0.0 110.755 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.976 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -77.2 -40.71 44.21 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.937 ' O ' HD12 ' A' ' 25' ' ' LEU . 41.8 t -66.21 -48.08 82.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.616 ' HA ' HG21 ' A' ' 34' ' ' VAL . 23.3 tttm -52.42 -43.99 65.15 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.795 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 13.9 mmtt -72.82 -20.93 61.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.197 -0.94 . . . . 0.0 111.277 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -75.86 -60.95 2.1 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.165 -0.959 . . . . 0.0 110.269 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.937 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.7 mp -56.89 -36.32 69.98 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.431 -0.793 . . . . 0.0 109.96 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.562 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -71.07 -27.18 63.45 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.567 -0.708 . . . . 0.0 109.224 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -92.51 -4.54 53.41 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 121.225 -0.922 . . . . 0.0 109.753 179.686 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.777 HG12 ' N ' ' A' ' 29' ' ' GLU . 2.7 t -44.01 -81.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.182 -0.949 . . . . 0.0 109.737 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.777 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 174.07 -73.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.45 -19.18 74.27 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 108.306 -1.917 . . . . 0.0 108.306 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.821 HG21 ' O ' ' A' ' 25' ' ' LEU . 4.2 p -49.97 137.56 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.559 -0.965 . . . . 0.0 110.454 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -121.5 -13.17 8.44 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.395 0.617 . . . . 0.0 109.606 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.541 ' HG3' ' N ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -162.01 160.49 27.68 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.175 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.616 HG21 ' HA ' ' A' ' 22' ' ' LYS . 8.1 p -142.33 177.44 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.414 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' H ' HG22 ' A' ' 34' ' ' VAL . 12.0 t70 -156.6 155.64 32.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.047 -1.033 . . . . 0.0 110.186 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.549 ' CG1' ' HB2' ' A' ' 18' ' ' PRO . 3.3 t -108.87 111.27 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 110.443 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -117.47 52.48 0.68 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.617 ' CG ' ' HG3' ' A' ' 18' ' ' PRO . 2.2 t80 -62.49 -19.39 63.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.305 -1.115 . . . . 0.0 110.128 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -48.81 -27.17 2.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -0.892 . . . . 0.0 109.398 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -139.96 43.09 1.95 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.504 -0.748 . . . . 0.0 109.923 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.518 ' HD2' ' HA ' ' A' ' 10' ' ' PRO . 1.6 mtt180 41.35 60.04 2.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.445 -0.784 . . . . 0.0 110.182 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -149.32 150.83 33.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.344 -0.848 . . . . 0.0 110.777 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.645 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -122.23 134.03 54.7 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.975 ' CG2' HG22 ' A' ' 6' ' ' THR . 1.0 OUTLIER -106.38 142.55 19.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 120.327 -1.483 . . . . 0.0 109.396 -178.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.011 ' CG1' HD13 ' A' ' 57' ' ' LEU . 2.4 p -147.51 145.06 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.238 -1.385 . . . . 0.0 113.558 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -109.96 153.74 24.11 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.869 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.5 p90 -168.93 -178.43 3.31 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 118.159 -1.416 . . . . 0.0 111.675 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.617 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -106.96 113.86 27.59 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.512 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 9.3 t70 -57.67 -13.15 3.56 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 110.767 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.902 HG23 ' HB1' ' A' ' 1' ' ' ALA . 8.4 p -61.96 -31.24 71.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.254 -0.904 . . . . 0.0 110.664 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -133.15 -3.46 3.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.947 -1.095 . . . . 0.0 111.33 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -143.37 -175.93 4.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.973 -1.079 . . . . 0.0 110.642 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 172.3 169.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 0.0 109.681 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.06 HG13 HG21 ' A' ' 70' ' ' VAL . 19.1 t -39.1 -55.91 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.436 -0.79 . . . . 0.0 110.773 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.478 ' O ' ' CB ' ' A' ' 59' ' ' LYS . 3.7 tp60 -44.51 -46.72 9.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 0.0 110.377 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -73.51 -28.5 61.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.185 -0.947 . . . . 0.0 111.333 -179.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.011 HD13 ' CG1' ' A' ' 45' ' ' VAL . 65.4 mt -68.95 -61.27 1.87 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.774 -1.204 . . . . 0.0 108.575 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.633 ' N ' HD21 ' A' ' 7' ' ' LEU . 10.1 t -60.34 -22.9 63.77 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.395 -0.816 . . . . 0.0 108.803 178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 2.7 tttt -78.34 -28.92 47.35 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.374 -0.829 . . . . 0.0 109.35 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.573 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -72.09 -45.55 60.22 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 108.995 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.854 ' OG1' HG22 ' A' ' 21' ' ' VAL . 9.9 t -70.8 -32.44 69.53 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -65.24 -31.71 73.02 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.579 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -88.72 -12.16 43.09 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.976 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -77.54 -26.48 51.05 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.06 19.84 0.69 Allowed Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.781 -1.2 . . . . 0.0 111.362 178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.655 ' CD1' ' HA3' ' A' ' 11' ' ' GLY . 32.5 m-85 -142.51 113.7 6.09 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 120.511 -1.581 . . . . 0.0 111.758 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 2.7 Cg_endo -60.17 97.16 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 N-CA-C 107.418 -1.801 . . . . 0.0 107.418 177.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -108.3 -172.57 2.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.09 -1.006 . . . . 0.0 112.347 -176.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.503 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.4 OUTLIER -148.52 -159.05 0.98 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.06 HG21 HG13 ' A' ' 54' ' ' VAL . 2.9 p -139.63 158.52 27.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 121.012 -1.055 . . . . 0.0 111.435 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 4.8 mtmt -121.41 23.09 10.54 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 122.223 1.011 . . . . 0.0 109.843 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.465 ' HA ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.283 -2.319 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.2 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.237 0.541 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -154.23 91.44 1.43 Allowed 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 1.6 mt-30 -109.05 149.48 29.21 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.842 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.493 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 24.5 m -120.04 130.05 54.52 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.818 HG13 ' HA ' ' A' ' 72' ' ' GLN . 1.7 t -151.77 165.56 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.062 -1.024 . . . . 0.0 109.528 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.794 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -106.83 171.12 7.54 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.97 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.24 154.18 51.42 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.605 -178.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 68' ' ' SER . . . -108.57 94.24 4.95 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.463 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 21' ' ' VAL . 2.5 p -110.27 101.7 48.91 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.686 -0.634 . . . . 0.0 109.615 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.5 Cg_endo -78.28 44.37 1.59 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.728 1.383 . . . . 0.0 111.114 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.678 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -86.49 -41.35 6.93 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.513 ' HG3' ' HG2' ' A' ' 41' ' ' ARG . 12.2 mtp 59.18 -87.19 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.61 -0.935 . . . . 0.0 109.813 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.838 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 1.1 p 48.27 15.69 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 110.074 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' THR . 0.3 OUTLIER 45.43 104.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.823 . . . . 0.0 112.058 178.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 19' ' ' ILE . . . 56.01 32.19 19.44 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.263 -0.898 . . . . 0.0 111.044 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.838 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -137.61 -47.39 0.56 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 109.359 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.618 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -53.81 -45.94 98.63 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.538 -0.727 . . . . 0.0 111.183 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 10.3 Cg_endo -74.0 -11.37 23.45 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 121.005 1.136 . . . . 0.0 112.599 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 15' ' ' ALA . 1.7 mt -92.39 -40.02 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.669 -1.269 . . . . 0.0 109.349 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 1.026 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.3 m -74.68 -40.5 61.36 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.948 HG21 HG21 ' A' ' 9' ' ' VAL . 37.5 t -66.45 -48.89 79.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.544 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.612 ' O ' HG11 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -47.93 -45.97 31.53 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.325 -0.859 . . . . 0.0 110.184 179.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 14.3 mttt -74.63 -23.43 58.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.251 -0.906 . . . . 0.0 111.6 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.699 ' HB1' ' C ' ' A' ' 60' ' ' ALA . . . -68.92 -50.09 52.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.283 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.006 ' HB3' HG21 ' A' ' 45' ' ' VAL . 4.6 mp -70.53 -34.52 72.37 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.302 -0.874 . . . . 0.0 110.272 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.87 ' C ' HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -68.22 -21.33 64.86 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -113.39 5.04 16.61 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.04 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 25' ' ' LEU . 12.7 p -53.43 -49.19 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.128 -0.982 . . . . 0.0 110.421 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.608 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER 170.17 -80.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.075 -1.016 . . . . 0.0 110.853 179.462 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.496 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -92.14 5.63 78.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.87 HG11 ' C ' ' A' ' 26' ' ' SER . 12.2 p -50.26 142.52 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.865 -1.373 . . . . 0.0 110.457 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.8 m -124.74 -9.79 7.29 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.758 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 1.3 tttt -168.31 138.55 2.56 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.578 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.793 HG21 ' CB ' ' A' ' 26' ' ' SER . 5.0 t -130.22 166.43 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.137 -0.977 . . . . 0.0 110.689 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.637 ' CB ' HG12 ' A' ' 44' ' ' VAL . 8.8 t0 -156.58 162.76 39.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.162 -0.961 . . . . 0.0 110.213 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.565 HG13 ' HB3' ' A' ' 18' ' ' PRO . 4.5 t -113.83 125.97 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' HG2' ' A' ' 42' ' ' GLU . . . -124.89 69.37 0.49 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -63.51 -11.75 26.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -1.116 . . . . 0.0 110.527 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.2 OUTLIER -43.97 -31.36 0.88 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 108.979 179.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 41' ' ' ARG . 1.4 tttp -148.07 47.05 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.44 0.638 . . . . 0.0 109.308 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.513 ' HG2' ' HG3' ' A' ' 12' ' ' MET . 2.0 tpp180 42.03 58.96 2.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.436 -0.79 . . . . 0.0 110.363 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 13.9 pt-20 -138.38 169.42 17.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.294 -0.879 . . . . 0.0 110.286 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -134.74 134.96 41.55 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.648 HG23 ' HB ' ' A' ' 6' ' ' THR . 1.1 t -106.65 122.56 60.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.674 -1.266 . . . . 0.0 109.646 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.006 HG21 ' HB3' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -123.09 -178.28 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.669 1.223 . . . . 0.0 111.902 -177.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -152.18 149.06 28.34 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.99 ' CE2' HD11 ' A' ' 57' ' ' LEU . 28.7 p90 -166.36 -175.3 3.19 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 117.601 -1.64 . . . . 0.0 112.011 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.601 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -106.23 110.52 22.79 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.074 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.488 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 5.9 t70 -57.81 -14.28 5.69 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.763 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.542 HG22 ' OD1' ' A' ' 48' ' ' ASP . 8.9 t -65.41 -34.97 79.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -0.975 . . . . 0.0 110.294 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' N ' HG23 ' A' ' 50' ' ' THR . 1.6 mmpp? -125.39 3.82 7.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.146 -0.971 . . . . 0.0 110.431 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -150.77 -169.75 3.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.919 . . . . 0.0 110.339 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.611 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.4 p 170.05 165.54 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.281 -0.887 . . . . 0.0 109.618 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.925 HG13 HG21 ' A' ' 70' ' ' VAL . 2.9 t -43.44 -37.74 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.005 -1.059 . . . . 0.0 109.714 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -58.73 -46.72 86.74 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.019 -1.051 . . . . 0.0 109.544 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.509 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 10.5 mmmt -71.02 -25.61 62.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.439 -0.788 . . . . 0.0 110.861 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.99 HD11 ' CE2' ' A' ' 47' ' ' PHE . 55.2 mt -70.8 -58.7 3.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.786 -1.196 . . . . 0.0 108.21 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.649 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 99.7 m -56.47 -30.3 62.75 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -75.63 -28.73 58.93 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.403 -0.811 . . . . 0.0 109.555 179.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.699 ' C ' ' HB1' ' A' ' 24' ' ' ALA . . . -70.01 -51.47 32.08 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.468 -0.77 . . . . 0.0 109.221 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.92 ' OG1' HG22 ' A' ' 21' ' ' VAL . 13.1 t -67.77 -30.06 69.41 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -67.54 -31.14 71.02 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.277 -0.874 . . . . 0.0 108.948 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -86.38 -12.88 48.03 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 1.026 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.89 -32.4 57.42 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 137.94 31.9 0.22 Allowed Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.781 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.818 ' CB ' HG23 ' A' ' 9' ' ' VAL . 47.1 m-85 -151.88 113.81 2.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.786 -1.42 . . . . 0.0 111.596 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.38 94.71 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 N-CA-C 107.663 -1.706 . . . . 0.0 107.663 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -108.91 -165.0 0.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.032 . . . . 0.0 112.531 -177.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.499 ' N ' ' OG ' ' A' ' 68' ' ' SER . 49.1 m -152.49 -159.2 0.98 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.97 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.7 p -139.07 152.94 24.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.887 -1.133 . . . . 0.0 110.683 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.79 ' HB3' HG23 ' A' ' 6' ' ' THR . 1.3 tttp -125.51 49.51 1.91 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.031 -1.068 . . . . 0.0 110.923 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.818 ' HA ' HG13 ' A' ' 5' ' ' VAL . 3.5 pp0? . . . . . 0 C--N 1.28 -2.446 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.021 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.657 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.53 90.39 1.56 Allowed 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -124.31 171.67 9.71 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.956 -177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.491 ' C ' ' CG2' ' A' ' 5' ' ' VAL . 37.0 m -110.73 155.72 22.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.574 -0.704 . . . . 0.0 110.42 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.787 HG13 ' C ' ' A' ' 72' ' ' GLN . 1.8 t -152.79 161.8 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 108.687 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.763 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -108.02 161.08 15.27 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.999 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -132.58 155.13 49.23 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 118.913 -1.115 . . . . 0.0 109.82 -179.006 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.84 101.74 10.32 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.412 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 21' ' ' VAL . 2.0 p -118.09 101.84 51.28 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.495 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.25 36.67 0.55 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 121.379 1.386 . . . . 0.0 111.579 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.643 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -76.58 -46.69 11.26 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 11' ' ' GLY . 10.6 ptp 38.47 54.91 1.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.737 -0.861 . . . . 0.0 110.181 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.841 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -86.69 17.05 4.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.579 -0.7 . . . . 0.0 109.764 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.648 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 7.8 t 66.45 89.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.47 -0.769 . . . . 0.0 110.604 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 65.32 18.04 11.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 110.48 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.841 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -123.14 -48.12 2.0 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.12 -0.987 . . . . 0.0 109.522 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.626 ' N ' ' CD ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -55.7 -44.15 99.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.47 -0.769 . . . . 0.0 111.303 179.426 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 12.7 Cg_endo -76.55 -16.77 16.7 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 120.925 1.083 . . . . 0.0 112.681 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 5.4 mt -91.67 -31.52 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.587 -1.321 . . . . 0.0 109.561 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.965 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.1 m -83.64 -47.98 10.67 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 9' ' ' VAL . 74.9 t -57.52 -48.8 82.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.889 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.677 ' O ' HG11 ' A' ' 34' ' ' VAL . 14.4 tttt -57.46 -45.84 84.3 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.27 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -76.21 -2.76 32.83 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.199 -0.938 . . . . 0.0 110.616 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.579 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -85.18 -54.03 4.87 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.128 -0.983 . . . . 0.0 109.438 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.944 ' HB2' HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -80.55 -13.22 59.26 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.244 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.915 ' HA ' HG21 ' A' ' 31' ' ' VAL . 20.1 t -78.72 -35.93 44.15 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.499 -0.751 . . . . 0.0 108.981 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HD2' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -104.15 2.95 32.45 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.275 -0.97 . . . . 0.0 109.825 179.63 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 25' ' ' LEU . 4.6 p -54.11 -53.35 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 110.79 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.608 ' H ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 169.28 -86.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.881 -1.137 . . . . 0.0 111.557 179.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.662 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -67.69 -21.72 73.09 Favored Glycine 0 N--CA 1.494 2.514 0 O-C-N 121.221 -0.924 . . . . 0.0 111.331 -178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.915 HG21 ' HA ' ' A' ' 26' ' ' SER . 10.8 p -40.15 144.74 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.933 -1.334 . . . . 0.0 111.702 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 m -127.99 -8.63 5.44 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.258 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.555 ' C ' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -162.36 165.05 26.99 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.157 -0.965 . . . . 0.0 109.842 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.997 HG13 HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -160.28 155.6 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.989 -1.069 . . . . 0.0 111.165 -178.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.61 ' CB ' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -155.75 161.15 40.75 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 18' ' ' PRO . 3.2 m -109.59 131.86 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.734 -1.229 . . . . 0.0 111.29 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -120.4 58.67 0.56 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.587 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.2 OUTLIER -58.78 -17.52 24.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -1.05 . . . . 0.0 110.769 -179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.14 -22.54 1.72 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.031 . . . . 0.0 109.634 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -148.7 43.11 0.99 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.427 -0.795 . . . . 0.0 109.828 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 40' ' ' LYS . 5.4 mmt180 41.75 58.59 2.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.401 -0.812 . . . . 0.0 109.921 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.533 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 4.5 pt-20 -149.17 151.92 35.18 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.992 -1.067 . . . . 0.0 110.669 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.423 ' CB ' HG12 ' A' ' 21' ' ' VAL . . . -117.58 142.43 47.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.802 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.667 ' O ' HG13 ' A' ' 44' ' ' VAL . 5.4 p -108.72 110.5 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.649 -1.282 . . . . 0.0 108.604 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.997 HG23 HG13 ' A' ' 34' ' ' VAL . 2.9 p -116.52 144.0 25.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.965 0.888 . . . . 0.0 112.36 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.549 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.2 m -109.79 150.78 27.86 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.656 ' CE2' HD11 ' A' ' 57' ' ' LEU . 23.4 p90 -171.25 173.03 5.06 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 117.736 -1.586 . . . . 0.0 112.303 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.752 ' HB2' HG22 ' A' ' 50' ' ' THR . 0.7 OUTLIER -107.26 118.86 37.83 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.176 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.653 ' CG ' ' HB3' ' A' ' 1' ' ' ALA . 6.1 p-10 -59.27 -10.99 3.41 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.279 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.752 HG22 ' HB2' ' A' ' 48' ' ' ASP . 7.7 t -68.77 -27.02 65.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 110.958 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HB2' ' OD1' ' A' ' 48' ' ' ASP . 5.6 mttt -120.94 0.55 10.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.92 -1.112 . . . . 0.0 110.579 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.662 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -171.76 -160.79 0.17 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.236 -0.915 . . . . 0.0 110.206 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.626 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.0 OUTLIER 169.18 167.74 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.502 -0.749 . . . . 0.0 110.098 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.029 HG13 HG21 ' A' ' 70' ' ' VAL . 3.0 t -41.08 -42.35 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.875 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 6.9 tp-100 -52.02 -49.79 62.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.022 . . . . 0.0 109.504 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.546 ' CG ' ' CG2' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -74.17 -22.7 59.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.458 -0.776 . . . . 0.0 111.645 -179.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.864 HD13 ' CG1' ' A' ' 45' ' ' VAL . 57.0 mt -72.66 -61.42 1.81 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.39 -1.444 . . . . 0.0 108.237 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.493 ' O ' HG22 ' A' ' 61' ' ' THR . 79.1 m -57.11 -26.08 59.87 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.503 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 3.1 ttmt -72.47 -36.05 68.37 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.558 -0.713 . . . . 0.0 109.104 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.579 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -66.13 -41.08 90.97 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.439 -0.788 . . . . 0.0 109.938 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.557 ' OG1' HG22 ' A' ' 21' ' ' VAL . 8.9 t -73.65 -29.92 62.62 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.15 -32.66 74.24 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 8.8 t0 -90.64 -12.45 36.83 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.672 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.965 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -78.22 -27.47 47.76 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 132.76 26.61 0.63 Allowed Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.672 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.762 ' CB ' HG23 ' A' ' 9' ' ' VAL . 37.7 m-85 -147.82 109.11 3.78 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.689 -1.477 . . . . 0.0 111.659 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -59.85 95.33 0.1 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 N-CA-C 107.312 -1.842 . . . . 0.0 107.312 177.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.543 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -109.03 -168.74 1.38 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.065 -1.022 . . . . 0.0 112.415 -176.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.543 ' N ' ' OG ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -151.63 -160.81 1.21 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.029 HG21 HG13 ' A' ' 54' ' ' VAL . 2.2 p -140.24 159.24 25.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 O-C-N 120.991 -1.068 . . . . 0.0 110.968 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.486 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 2.6 mttt -124.96 25.13 7.41 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.448 1.118 . . . . 0.0 109.155 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.787 ' C ' HG13 ' A' ' 5' ' ' VAL . 13.4 mm100 . . . . . 0 C--N 1.285 -2.211 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.136 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.191 0.519 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -146.17 88.75 1.82 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.538 ' O ' ' HA ' ' A' ' 46' ' ' THR . 0.0 OUTLIER -108.72 163.49 13.21 Favored 'General case' 0 C--N 1.291 -1.94 0 C-N-CA 119.501 -0.88 . . . . 0.0 112.493 -177.048 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.448 ' HB ' ' OG1' ' A' ' 46' ' ' THR . 1.3 t -135.14 111.4 9.68 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.281 0.562 . . . . 0.0 109.775 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.447 HG21 HD12 ' A' ' 57' ' ' LEU 0.256 14.5 m -122.75 166.39 17.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.216 -0.928 . . . . 0.0 109.925 -179.155 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.731 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.45 166.47 10.64 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.008 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -132.15 161.42 33.38 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 119.134 -1.026 . . . . 0.0 110.1 -178.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.512 ' O ' ' HD3' ' A' ' 10' ' ' PRO . . . -109.56 105.88 15.37 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.434 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.747 HG23 ' CB ' ' A' ' 66' ' ' TYR . 2.3 p -116.43 85.9 17.05 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.169 -0.957 . . . . 0.0 109.808 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -76.39 36.06 0.49 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.67 1.353 . . . . 0.0 112.318 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.514 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -78.72 -31.07 45.94 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.76 -2.136 . . . . 0.0 107.76 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.509 ' N ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER 36.84 42.0 0.2 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.923 -0.751 . . . . 0.0 110.386 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.991 HG21 ' HB3' ' A' ' 16' ' ' ALA . 4.0 t -45.78 -27.88 0.93 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.625 ' CB ' ' O ' ' A' ' 13' ' ' THR . 7.6 t 144.33 -41.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 121.91 0.862 . . . . 0.0 109.241 179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.601 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . . . -176.23 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.577 0.703 . . . . 0.0 109.366 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.991 ' HB3' HG21 ' A' ' 13' ' ' THR . . . -129.07 -26.27 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.607 -0.683 . . . . 0.0 109.981 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.642 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -44.62 -47.27 27.51 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.917 -1.114 . . . . 0.0 111.689 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.856 ' O ' HG21 ' A' ' 36' ' ' VAL . 6.9 Cg_endo -76.23 -18.21 16.35 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 121.334 1.356 . . . . 0.0 113.325 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.8 mm -87.59 -42.67 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.415 -1.428 . . . . 0.0 109.557 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.871 ' CG2' ' HB1' ' A' ' 64' ' ' ALA 0.251 0.9 OUTLIER -69.55 -37.21 76.94 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.889 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.908 ' O ' HD12 ' A' ' 25' ' ' LEU . 25.6 t -64.6 -45.61 94.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 1.078 ' O ' HG21 ' A' ' 34' ' ' VAL . 68.7 tttt -50.67 -45.99 58.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.574 -0.704 . . . . 0.0 110.307 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 8.7 mtmt -75.67 -20.82 58.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.954 -1.091 . . . . 0.0 111.101 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.594 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -69.97 -52.65 22.59 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.439 -0.788 . . . . 0.0 110.557 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.932 HD21 ' CD2' ' A' ' 7' ' ' LEU . 4.0 mp -71.91 -31.09 66.05 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.144 -0.973 . . . . 0.0 110.028 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.803 ' C ' HG11 ' A' ' 31' ' ' VAL . 12.7 t -68.22 -22.99 64.76 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -111.6 2.8 17.52 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.274 179.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.922 HG12 ' O ' ' A' ' 25' ' ' LEU . 7.7 p -49.94 -52.13 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.073 -1.017 . . . . 0.0 110.339 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.602 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.1 OUTLIER 172.34 -77.29 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 110.897 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.499 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -93.34 -1.88 66.26 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.803 HG11 ' C ' ' A' ' 26' ' ' SER . 6.9 p -44.0 141.05 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.096 -1.238 . . . . 0.0 110.711 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.6 t -118.02 -13.86 9.99 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.606 0.717 . . . . 0.0 109.071 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.702 ' O ' HG13 ' A' ' 45' ' ' VAL . 7.5 tttt -159.46 166.28 31.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.546 -0.721 . . . . 0.0 109.649 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.078 HG21 ' O ' ' A' ' 22' ' ' LYS . 7.2 p -162.51 154.47 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.99 . . . . 0.0 111.366 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.565 ' HB2' HG13 ' A' ' 44' ' ' VAL . 1.3 m-20 -164.86 171.19 14.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.31 -0.869 . . . . 0.0 109.238 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.856 HG21 ' O ' ' A' ' 18' ' ' PRO . 3.1 m -152.06 164.6 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.935 -1.103 . . . . 0.0 111.173 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.26 112.31 0.52 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.602 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -66.27 -19.35 65.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.258 -1.142 . . . . 0.0 109.934 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -53.8 -64.67 0.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 0.0 109.354 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.7 OUTLIER -95.6 22.63 6.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.33 -0.856 . . . . 0.0 109.33 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.656 ' NH1' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 36.89 59.64 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.33 0.586 . . . . 0.0 110.772 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 18.3 pt-20 -146.11 166.96 24.59 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.536 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.786 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -125.56 132.57 52.54 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.161 -0.962 . . . . 0.0 109.163 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.668 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.8 p -106.51 116.18 49.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 120.791 -1.193 . . . . 0.0 109.119 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.876 HG22 HG23 ' A' ' 34' ' ' VAL . 39.3 t -129.84 144.78 37.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.122 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 1.2 m -108.6 161.29 15.21 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.4 p90 -170.22 -177.69 2.57 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 117.898 -1.521 . . . . 0.0 112.091 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.613 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.7 m-20 -105.98 113.94 27.79 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 10.7 t70 -59.62 -10.2 3.34 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.784 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.0 p -70.55 -29.22 65.62 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.181 -0.949 . . . . 0.0 110.61 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -134.6 18.32 3.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.028 -1.045 . . . . 0.0 110.846 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -170.66 178.72 3.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.0 110.053 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.585 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.9 OUTLIER 176.2 171.01 0.41 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.387 -0.821 . . . . 0.0 109.511 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.963 HG13 HG21 ' A' ' 70' ' ' VAL . 2.7 t -41.8 -34.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 109.698 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -58.88 -50.27 74.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.896 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.575 ' HB3' ' CG2' ' A' ' 28' ' ' VAL . 16.3 mmtm -76.5 -20.52 56.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 111.246 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.859 HD11 ' CE2' ' A' ' 47' ' ' PHE . 76.1 mt -70.77 -59.71 2.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.572 -1.33 . . . . 0.0 108.482 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 94.5 m -58.63 -26.88 64.19 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.518 -0.739 . . . . 0.0 109.049 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 60.4 tttt -76.35 -29.59 57.29 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.51 -0.744 . . . . 0.0 109.307 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.594 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -69.94 -51.12 35.48 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.626 ' HB ' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -66.64 -32.8 74.35 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -64.87 -31.27 72.42 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.903 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -88.54 -11.11 46.63 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.498 -0.751 . . . . 0.0 109.028 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.871 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -78.35 -27.3 47.0 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 135.86 23.8 0.55 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.703 -1.237 . . . . 0.0 111.093 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.747 ' CB ' HG23 ' A' ' 9' ' ' VAL . 43.7 m-85 -148.15 109.12 3.69 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.493 -1.592 . . . . 0.0 111.64 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 6.1 Cg_exo -57.19 98.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 107.014 -1.956 . . . . 0.0 107.014 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 71.6 p -108.41 -166.31 1.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.083 0.944 . . . . 0.0 112.68 -176.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.497 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.8 m -151.8 -160.74 1.19 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.008 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.2 p -141.1 160.07 22.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 O-C-N 120.779 -1.2 . . . . 0.0 111.844 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.728 ' HG3' HG23 ' A' ' 6' ' ' THR . 9.2 mttt -127.85 25.35 5.97 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.367 1.079 . . . . 0.0 108.93 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.287 -2.122 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.401 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.606 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.105 0.478 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -153.58 91.58 1.5 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -113.68 -174.93 2.56 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.312 -0.955 . . . . 0.0 112.462 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.552 ' C ' HG23 ' A' ' 5' ' ' VAL . 92.3 m -142.5 146.81 35.11 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.468 0.652 . . . . 0.0 110.34 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.918 HG13 ' HA ' ' A' ' 72' ' ' GLN . 15.9 t -156.03 167.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.461 -0.774 . . . . 0.0 109.764 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.78 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -109.66 169.47 8.69 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.997 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -133.29 157.99 44.08 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.934 -179.395 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.515 ' O ' ' CB ' ' A' ' 68' ' ' SER . . . -110.24 103.33 12.0 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.735 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.828 HG21 HG21 ' A' ' 21' ' ' VAL . 1.9 p -114.56 92.65 29.53 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.397 -0.814 . . . . 0.0 109.995 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 10.7 Cg_endo -79.54 51.42 3.87 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.669 1.579 . . . . 0.0 111.581 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.606 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -95.44 -21.09 25.42 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.524 ' CG ' ' C ' ' A' ' 11' ' ' GLY . 1.2 ptt? 35.77 59.4 0.86 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.768 -0.842 . . . . 0.0 110.559 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.821 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -90.51 19.68 5.12 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.677 -0.639 . . . . 0.0 109.521 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 13' ' ' THR . 2.4 t 68.5 92.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.471 -0.768 . . . . 0.0 110.309 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.585 ' HA ' ' CE2' ' A' ' 38' ' ' PHE . . . 50.25 30.96 4.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 110.085 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.821 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -127.17 -45.45 1.55 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 110.498 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.586 ' CB ' ' CD ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -40.05 -69.37 0.21 Allowed Pre-proline 0 N--CA 1.505 2.281 0 O-C-N 121.109 -0.994 . . . . 0.0 111.673 -178.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.857 ' O ' HG12 ' A' ' 36' ' ' VAL . 10.0 Cg_endo -65.8 -12.75 36.63 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.173 1.249 . . . . 0.0 112.752 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 20' ' ' THR . 1.5 mp -78.88 -56.0 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.864 -1.147 . . . . 0.0 109.583 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.533 HG23 ' HB1' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -69.37 -42.01 75.76 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.888 HG22 ' OG1' ' A' ' 61' ' ' THR . 5.6 t -57.71 -43.53 83.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.847 ' O ' HG21 ' A' ' 34' ' ' VAL . 12.8 tttt -53.08 -50.11 65.04 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.511 -0.743 . . . . 0.0 109.861 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.567 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 7.9 mtpm? -72.47 -11.59 60.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 111.501 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.476 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -77.8 -67.22 0.75 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.124 -0.985 . . . . 0.0 109.466 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.767 HD22 ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -68.28 -12.3 60.81 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 1.052 ' HA ' HG21 ' A' ' 31' ' ' VAL . 6.8 t -79.32 -30.24 42.73 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.99 9.41 18.72 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.238 -0.914 . . . . 0.0 109.813 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.613 HG13 ' H ' ' A' ' 29' ' ' GLU . 4.0 p -51.89 -53.73 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.349 -0.844 . . . . 0.0 111.08 -179.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.613 ' H ' HG13 ' A' ' 28' ' ' VAL . 1.6 tt0 -179.9 -86.28 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.598 -1.314 . . . . 0.0 110.85 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.547 ' N ' ' CG ' ' A' ' 29' ' ' GLU . . . -74.67 -15.14 80.78 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -178.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.052 HG21 ' HA ' ' A' ' 26' ' ' SER . 3.5 p -40.54 142.08 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -1.069 . . . . 0.0 110.961 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 m -127.02 -11.92 5.88 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.396 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.641 ' O ' HG13 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -158.07 165.2 35.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.18 -0.95 . . . . 0.0 110.044 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 1.081 HG23 HG22 ' A' ' 45' ' ' VAL . 6.4 p -169.01 154.48 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.023 -1.048 . . . . 0.0 111.59 -179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.563 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -157.09 172.14 19.2 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.491 -0.756 . . . . 0.0 109.634 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.857 HG12 ' O ' ' A' ' 18' ' ' PRO . 2.9 m -109.91 151.09 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.057 -1.027 . . . . 0.0 110.926 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -142.85 64.35 0.49 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.585 ' CE2' ' HA ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -57.33 -15.86 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -1.154 . . . . 0.0 110.245 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 38' ' ' PHE . 0.8 OUTLIER -45.31 -33.62 2.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.124 -0.985 . . . . 0.0 109.21 179.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -141.57 40.04 1.71 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.509 -0.744 . . . . 0.0 109.459 179.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 40' ' ' LYS . 0.6 OUTLIER 42.47 57.55 3.38 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.451 -0.781 . . . . 0.0 110.081 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 13.7 pt-20 -142.93 168.76 18.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 110.422 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -129.27 137.79 51.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 109.419 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.6 p -107.85 109.02 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.706 -1.246 . . . . 0.0 110.288 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.081 HG22 HG23 ' A' ' 34' ' ' VAL . 11.6 t -122.71 150.89 26.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 122.138 0.971 . . . . 0.0 112.068 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -114.12 159.53 19.94 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.637 ' CD2' HD11 ' A' ' 57' ' ' LEU . 38.5 p90 -170.91 -175.04 1.67 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.219 -1.392 . . . . 0.0 111.606 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.606 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 1.1 m-20 -106.18 124.75 50.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HB3' ' CB ' ' A' ' 1' ' ' ALA . 10.2 t70 -80.94 37.87 0.44 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.45 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.6 p -115.53 -24.53 8.29 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.171 -0.956 . . . . 0.0 109.23 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 5.7 mttt -127.7 -2.11 6.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.419 -0.8 . . . . 0.0 110.073 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 51' ' ' LYS . . . 179.17 176.21 0.61 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.19 -0.944 . . . . 0.0 109.93 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.594 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 6.8 p 172.83 -166.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.671 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.046 HG13 HG21 ' A' ' 70' ' ' VAL . 6.5 t -36.68 -40.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.559 -0.713 . . . . 0.0 111.149 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -57.53 -49.49 76.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.106 -0.997 . . . . 0.0 110.385 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.585 ' HB3' HG21 ' A' ' 28' ' ' VAL . 58.1 mmtt -82.01 -16.95 48.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.263 -0.898 . . . . 0.0 111.736 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.751 HD22 ' HB2' ' A' ' 25' ' ' LEU . 48.0 mt -75.27 -58.47 3.26 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.514 -1.366 . . . . 0.0 108.065 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.534 ' O ' HG22 ' A' ' 61' ' ' THR . 12.9 m -54.46 -30.61 53.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.29 -34.6 65.85 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.513 -0.742 . . . . 0.0 109.858 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.446 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -67.93 -36.96 81.05 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 121.173 -0.955 . . . . 0.0 109.704 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.888 ' OG1' HG22 ' A' ' 21' ' ' VAL . 5.3 t -74.3 -35.57 63.7 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' N ' HG23 ' A' ' 61' ' ' THR . . . -64.65 -32.14 73.68 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -90.68 -8.08 50.91 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.533 ' HB1' HG23 ' A' ' 20' ' ' THR . . . -85.16 -21.11 29.33 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.452 -0.78 . . . . 0.0 108.942 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.579 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 133.08 17.01 1.18 Allowed Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.004 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.812 ' CB ' HG23 ' A' ' 9' ' ' VAL . 35.2 m-85 -151.51 111.46 2.98 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.706 -1.467 . . . . 0.0 111.307 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.14 96.83 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 N-CA-C 107.87 -1.627 . . . . 0.0 107.87 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 69' ' ' SER . 0.1 OUTLIER -108.9 -171.24 1.81 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.083 -1.01 . . . . 0.0 112.187 -177.27 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.542 ' N ' ' OG ' ' A' ' 68' ' ' SER . 6.0 p -145.18 -157.45 0.79 Allowed 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.046 HG21 HG13 ' A' ' 54' ' ' VAL . 3.1 p -142.47 158.81 19.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.209 -179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.536 ' CG ' HG23 ' A' ' 6' ' ' THR . 3.9 mttm -124.69 27.12 6.96 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.304 1.05 . . . . 0.0 109.659 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.918 ' HA ' HG13 ' A' ' 5' ' ' VAL . 17.2 pt20 . . . . . 0 C--N 1.287 -2.148 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.543 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.903 ' CB ' HG23 ' A' ' 50' ' ' THR . . . . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.256 0.55 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.777 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER 171.16 108.97 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.975 0.893 . . . . 0.0 109.181 179.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.06 176.1 9.75 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.071 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.4 HG23 ' OG1' ' A' ' 46' ' ' THR . 21.6 m -113.4 131.86 55.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 110.138 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.599 HG21 HG22 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -128.98 169.36 20.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-O 122.038 0.923 . . . . 0.0 109.296 179.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.683 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -108.51 159.88 16.34 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.963 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -133.04 152.97 51.91 Favored 'General case' 0 C--N 1.292 -1.921 0 O-C-N 120.868 -1.145 . . . . 0.0 109.688 -178.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -108.95 111.48 23.18 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.616 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 21' ' ' VAL . 2.1 p -133.23 93.55 22.13 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 109.167 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 5.5 Cg_endo -73.26 19.13 0.37 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.388 1.392 . . . . 0.0 112.291 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.637 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -52.19 -36.18 43.99 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.516 ' C ' ' O ' ' A' ' 11' ' ' GLY . 2.1 ptt? 26.61 50.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.67 0.748 . . . . 0.0 110.765 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 1.155 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.9 t -81.38 9.86 6.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.676 -0.64 . . . . 0.0 110.035 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.3 OUTLIER 78.74 94.18 0.06 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.601 0.715 . . . . 0.0 111.104 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.518 ' O ' HD12 ' A' ' 19' ' ' ILE . . . 58.44 42.67 20.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.612 -0.68 . . . . 0.0 112.052 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.155 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -160.81 -44.0 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.709 -1.244 . . . . 0.0 111.005 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.858 ' H ' HG22 ' A' ' 13' ' ' THR . 0.0 OUTLIER -46.62 -53.17 26.49 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.627 -1.295 . . . . 0.0 110.167 179.519 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.641 ' CG ' ' CD2' ' A' ' 38' ' ' PHE . 10.6 Cg_endo -74.04 -16.59 22.75 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.29 1.327 . . . . 0.0 112.219 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 15' ' ' ALA . 29.6 mt -79.01 -38.49 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.828 -1.17 . . . . 0.0 109.632 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.923 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.7 OUTLIER -77.06 -45.81 25.81 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.056 HG21 HG21 ' A' ' 9' ' ' VAL . 16.9 t -56.37 -40.69 68.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.538 ' O ' HG21 ' A' ' 34' ' ' VAL . 7.2 tttt -55.67 -56.96 14.23 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 108.823 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -71.39 0.69 7.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.41 -0.806 . . . . 0.0 110.868 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.642 ' C ' ' HB1' ' A' ' 60' ' ' ALA . . . -88.79 -72.14 0.56 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.669 -1.269 . . . . 0.0 108.929 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.808 HD12 HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -64.78 -9.93 24.05 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.49 178.587 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.886 ' HA ' HG11 ' A' ' 31' ' ' VAL . 34.8 t -90.65 -45.5 8.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.5 -0.75 . . . . 0.0 110.397 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -79.28 -4.15 49.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.864 -1.147 . . . . 0.0 110.309 -179.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.682 HG12 ' CG ' ' A' ' 29' ' ' GLU . 5.4 t -29.85 -79.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.852 -0.53 . . . . 0.0 110.927 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.682 ' CG ' HG12 ' A' ' 28' ' ' VAL . 1.2 pt-20 178.0 -31.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.948 -1.095 . . . . 0.0 110.935 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 48' ' ' ASP . . . -117.66 2.27 17.87 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.886 HG11 ' HA ' ' A' ' 26' ' ' SER . 71.6 t -49.69 147.87 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 122.459 1.123 . . . . 0.0 111.399 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.5 m -122.2 -10.18 8.56 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.459 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.508 ' CG ' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -175.72 170.37 2.88 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.001 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.806 HG21 ' HB2' ' A' ' 26' ' ' SER . 9.7 p -170.09 156.49 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -0.862 . . . . 0.0 110.517 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.56 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -156.2 164.88 37.82 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.427 -0.795 . . . . 0.0 109.633 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 18' ' ' PRO . 7.2 m -112.18 140.49 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 110.704 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -131.17 69.82 0.53 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.641 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -61.92 -14.72 37.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -1.154 . . . . 0.0 110.435 -179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -54.89 -27.15 40.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 109.8 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 42' ' ' GLU . 2.8 ptmt -142.7 35.51 1.43 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 110.03 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 10' ' ' PRO . 1.9 mpp_? 42.9 55.75 4.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 110.214 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -145.61 149.42 34.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.233 -0.917 . . . . 0.0 110.11 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.501 ' N ' ' HG2' ' A' ' 42' ' ' GLU . . . -115.87 139.25 50.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 0.0 110.031 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.705 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.1 p -106.47 111.78 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.763 -1.211 . . . . 0.0 109.47 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.102 ' CG1' HD13 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -117.51 137.83 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 121.776 0.798 . . . . 0.0 112.289 -178.056 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.508 ' HB ' ' CG ' ' A' ' 33' ' ' LYS . 1.6 m -109.0 155.77 20.51 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.777 ' O ' ' HA ' ' A' ' 2' ' ' THR . 35.5 p90 -171.92 -176.81 1.79 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.449 -1.407 . . . . 0.0 110.798 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.498 ' HA ' ' HB ' ' A' ' 2' ' ' THR . 2.1 p30 -109.59 110.52 21.62 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.525 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 29.0 t70 -54.64 -14.69 1.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.959 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.903 HG23 ' CB ' ' A' ' 1' ' ' ALA . 2.2 p -61.63 -35.73 78.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 110.807 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.08 -5.23 9.52 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.043 -1.035 . . . . 0.0 111.361 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . -153.02 -164.47 1.94 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.969 -1.082 . . . . 0.0 110.874 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.605 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 6.4 t 167.72 172.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.96 ' HB ' HG21 ' A' ' 70' ' ' VAL . 6.6 m -51.54 -32.12 13.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 120.753 -1.217 . . . . 0.0 109.451 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -47.66 -44.86 27.54 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.014 -1.054 . . . . 0.0 108.404 179.003 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.534 ' HA ' ' HB3' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -89.06 -20.58 24.18 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.763 -0.586 . . . . 0.0 111.244 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.102 HD13 ' CG1' ' A' ' 45' ' ' VAL . 42.3 mt -73.77 -64.04 1.08 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.229 -1.544 . . . . 0.0 107.98 178.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.532 ' O ' HG22 ' A' ' 61' ' ' THR . 1.4 m -56.59 -27.61 58.42 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HB3' ' HA ' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -74.81 -32.0 61.85 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 121.168 -0.957 . . . . 0.0 109.327 179.362 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.642 ' HB1' ' C ' ' A' ' 24' ' ' ALA . . . -70.48 -35.94 73.56 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.316 -0.865 . . . . 0.0 109.459 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.833 ' OG1' HG22 ' A' ' 21' ' ' VAL . 4.8 t -74.68 -34.7 62.73 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.415 ' N ' HG23 ' A' ' 61' ' ' THR . . . -66.36 -32.29 73.59 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.39 -10.09 45.19 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.576 -0.703 . . . . 0.0 109.378 178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.923 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -79.48 -29.66 41.75 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.56 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 136.98 27.93 0.34 Allowed Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.699 -1.238 . . . . 0.0 110.996 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.701 ' CB ' HG23 ' A' ' 9' ' ' VAL . 53.0 m-85 -150.9 116.72 3.28 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.622 -1.517 . . . . 0.0 111.449 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.54 95.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 N-CA-C 106.875 -2.01 . . . . 0.0 106.875 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.605 ' HB2' HG23 ' A' ' 61' ' ' THR . 2.9 m -108.79 -165.1 0.99 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.228 -0.92 . . . . 0.0 112.51 -176.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.428 ' O ' ' OG1' ' A' ' 58' ' ' THR . 4.9 t -159.42 -167.11 1.95 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.963 HG23 ' CD1' ' A' ' 7' ' ' LEU . 2.1 p -139.06 155.92 27.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 O-C-N 120.804 -1.185 . . . . 0.0 111.379 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.502 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 1.1 mttt -124.49 26.72 7.19 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.432 1.111 . . . . 0.0 108.864 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 5' ' ' VAL . 1.8 mp0 . . . . . 0 C--N 1.29 -2.013 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.289 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.156 0.503 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -151.61 88.42 1.42 Allowed 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 47' ' ' PHE . 11.5 mt-30 -112.48 151.08 30.34 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.655 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 52.3 m -124.9 122.42 37.32 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.708 HG21 HG22 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -130.32 171.68 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.053 -1.03 . . . . 0.0 110.419 -178.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.724 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -107.28 158.91 16.76 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.925 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -130.07 155.89 45.41 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 120.662 -1.273 . . . . 0.0 109.847 -178.774 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.748 ' HB3' ' OG ' ' A' ' 69' ' ' SER . . . -110.98 100.76 9.4 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.946 -178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.725 HG21 HG21 ' A' ' 21' ' ' VAL . 1.8 p -114.45 89.97 19.67 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.476 -0.765 . . . . 0.0 109.337 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 11.0 Cg_endo -78.06 46.53 2.1 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 121.361 1.374 . . . . 0.0 112.008 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.616 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -92.42 -34.31 7.12 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.486 ' C ' ' O ' ' A' ' 11' ' ' GLY . 0.9 OUTLIER 35.59 44.33 0.2 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.758 0.789 . . . . 0.0 110.087 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 1.14 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.4 t -61.22 -11.03 7.84 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.679 -0.638 . . . . 0.0 109.639 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.733 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 0.5 OUTLIER 86.66 93.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.614 0.721 . . . . 0.0 111.029 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.733 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 73.55 24.4 2.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 111.831 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.14 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -150.84 -38.69 0.13 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.457 -1.402 . . . . 0.0 110.718 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.819 ' H ' HG22 ' A' ' 13' ' ' THR . 0.5 OUTLIER -45.15 -47.74 32.36 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.606 -1.309 . . . . 0.0 110.459 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 17' ' ' CYS . 1.6 Cg_endo -70.75 -28.17 20.83 Favored 'Trans proline' 0 N--CA 1.488 1.202 0 O-C-N 123.229 1.12 . . . . 0.0 111.655 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 48.5 mm -73.39 -32.18 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.955 . . . . 0.0 110.839 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.851 HG23 ' HB1' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -81.64 -53.27 6.37 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 108.965 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.037 HG22 ' OG1' ' A' ' 61' ' ' THR . 66.5 t -54.39 -43.46 62.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.225 -0.99 . . . . 0.0 108.678 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.565 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.9 tttm -55.55 -61.75 2.14 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.937 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.59 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -75.42 5.74 5.43 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.186 -0.946 . . . . 0.0 110.678 179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.547 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -85.36 -67.89 0.77 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.373 -1.454 . . . . 0.0 108.482 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.76 ' HB2' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -74.26 -11.62 60.33 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.859 ' HA ' HG21 ' A' ' 31' ' ' VAL . 46.5 t -85.51 -33.25 21.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.15 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.59 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.45 -10.1 42.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.6 -1.312 . . . . 0.0 110.433 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.061 HG11 ' CE ' ' A' ' 56' ' ' LYS . 3.2 t -40.39 -82.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.276 -0.89 . . . . 0.0 110.015 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.799 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 174.97 -57.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.418 -0.801 . . . . 0.0 109.906 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.444 ' O ' ' OD2' ' A' ' 48' ' ' ASP . . . -70.3 -26.76 73.73 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.859 HG21 ' HA ' ' A' ' 26' ' ' SER . 14.8 p -56.56 142.3 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -1.145 . . . . 0.0 110.699 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.84 -10.9 8.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.757 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.4 tttt -162.47 168.96 21.17 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.068 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.552 HG21 ' O ' ' A' ' 22' ' ' LYS . 13.7 p -169.07 159.91 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 121.093 -1.004 . . . . 0.0 111.384 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.476 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -158.85 162.95 37.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.512 -0.743 . . . . 0.0 109.524 179.442 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.513 ' CG1' ' HB2' ' A' ' 22' ' ' LYS . 22.4 m -116.23 152.33 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 110.603 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -144.41 79.13 0.25 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.565 ' CE2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -58.03 -18.92 27.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -1.121 . . . . 0.0 110.119 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -50.3 -47.99 55.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 0.0 109.092 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 41' ' ' ARG . 10.1 mttm -116.18 25.49 10.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.493 -0.754 . . . . 0.0 109.381 179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.614 ' NH1' HG13 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 40.97 57.48 2.74 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.422 0.63 . . . . 0.0 110.191 -179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 0.4 OUTLIER -148.06 155.86 41.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.412 -0.805 . . . . 0.0 109.742 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -112.13 138.66 48.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.944 -1.097 . . . . 0.0 110.276 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.744 ' O ' HG13 ' A' ' 44' ' ' VAL . 8.6 p -106.09 105.65 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.821 -1.174 . . . . 0.0 109.064 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.004 ' CG1' HD13 ' A' ' 57' ' ' LEU . 4.8 p -109.72 148.84 13.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 122.089 0.947 . . . . 0.0 112.292 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.3 m -115.94 154.13 30.35 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.654 ' CE2' HD11 ' A' ' 57' ' ' LEU . 34.6 p90 -170.83 -177.24 2.22 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 117.669 -1.612 . . . . 0.0 112.051 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.765 ' HB2' HG22 ' A' ' 50' ' ' THR . 1.2 p30 -107.01 115.05 29.51 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.517 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 7.8 t70 -68.24 -3.79 11.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.777 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.765 HG22 ' HB2' ' A' ' 48' ' ' ASP . 4.1 t -66.63 -6.98 17.42 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 110.018 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -137.35 -51.09 0.64 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.136 -0.978 . . . . 0.0 110.937 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB1' ' CG ' ' A' ' 56' ' ' LYS . . . -130.49 -160.99 1.08 Allowed 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.452 -0.78 . . . . 0.0 110.466 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.591 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.3 p 168.4 -169.02 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.379 -0.825 . . . . 0.0 109.338 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.036 HG13 HG21 ' A' ' 70' ' ' VAL . 3.1 t -35.5 -59.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.747 -0.595 . . . . 0.0 111.134 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.497 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 34.4 tt0 -43.13 -47.54 6.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.036 -1.04 . . . . 0.0 110.791 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 1.061 ' CE ' HG11 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -79.14 -24.06 43.58 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.964 . . . . 0.0 111.849 -178.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.004 HD13 ' CG1' ' A' ' 45' ' ' VAL . 79.9 mt -72.08 -56.73 5.1 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.503 -1.373 . . . . 0.0 108.384 179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.491 ' O ' HG22 ' A' ' 61' ' ' THR . 7.4 m -56.48 -31.46 64.05 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.528 -0.732 . . . . 0.0 109.385 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -75.47 -31.57 60.29 Favored 'General case' 0 C--N 1.308 -1.209 0 O-C-N 121.287 -0.883 . . . . 0.0 110.005 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -69.07 -42.31 76.39 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.037 ' OG1' HG22 ' A' ' 21' ' ' VAL . 12.9 t -73.64 -32.89 64.26 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 66' ' ' TYR . . . -64.67 -31.25 72.4 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.59 -9.51 46.78 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.851 ' HB1' HG23 ' A' ' 20' ' ' THR . . . -81.93 -23.7 36.03 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 139.35 14.4 0.62 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 119.463 -1.351 . . . . 0.0 111.743 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.682 ' CB ' HG23 ' A' ' 9' ' ' VAL . 68.7 m-85 -145.69 114.11 4.71 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 120.313 -1.698 . . . . 0.0 111.79 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.77 97.58 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 N-CA-C 107.255 -1.863 . . . . 0.0 107.255 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.517 ' OG ' ' CG2' ' A' ' 61' ' ' THR . 1.5 p -108.31 -166.14 1.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.0 112.751 -176.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.748 ' OG ' ' HB3' ' A' ' 8' ' ' ALA . 24.6 p -150.73 -164.92 2.13 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.036 HG21 HG13 ' A' ' 54' ' ' VAL . 2.4 p -141.07 158.32 22.9 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.906 -1.118 . . . . 0.0 111.516 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.482 ' HB2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -125.95 24.72 6.95 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.294 1.045 . . . . 0.0 109.088 179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.489 ' OXT' HG23 ' A' ' 5' ' ' VAL . 39.4 mt-30 . . . . . 0 C--N 1.289 -2.026 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.345 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.539 0.685 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.698 HG23 ' N ' ' A' ' 3' ' ' GLN 0.258 14.6 t -100.2 -135.3 0.29 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.698 ' N ' HG23 ' A' ' 2' ' ' THR . 0.6 OUTLIER -173.37 153.88 2.5 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.455 179.048 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.6 m -143.16 107.73 4.83 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.594 HG13 ' HA ' ' A' ' 72' ' ' GLN . 2.5 t -140.17 165.15 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -0.854 . . . . 0.0 109.9 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 1.047 HG22 ' CG2' ' A' ' 44' ' ' VAL . 2.4 p -108.9 164.0 12.79 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.989 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -134.95 157.74 46.12 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 118.67 -1.212 . . . . 0.0 109.704 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -110.46 107.25 16.85 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.568 -0.707 . . . . 0.0 110.068 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.021 HG21 HG21 ' A' ' 21' ' ' VAL . 2.0 p -117.15 100.44 53.18 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.498 -0.751 . . . . 0.0 109.524 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -76.27 34.96 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.381 1.388 . . . . 0.0 112.156 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.642 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -65.56 -46.11 86.34 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.562 ' HB3' ' CD ' ' A' ' 41' ' ' ARG . 16.9 ptt? 36.78 47.54 0.57 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.88 -0.776 . . . . 0.0 110.36 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 1.123 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 1.0 OUTLIER -85.19 14.9 4.63 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.508 -0.745 . . . . 0.0 109.795 179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 13' ' ' THR . 4.0 t 77.68 87.97 0.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.489 0.661 . . . . 0.0 111.363 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 14' ' ' CYS . . . 56.12 38.83 30.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.489 -0.757 . . . . 0.0 111.788 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.123 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -154.43 -31.27 0.11 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.883 -1.136 . . . . 0.0 111.122 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.761 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -50.82 -55.23 28.87 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.647 -1.283 . . . . 0.0 110.676 179.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 1.008 ' HB2' HG13 ' A' ' 36' ' ' VAL . 9.5 Cg_endo -69.05 -3.79 12.25 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 121.249 1.299 . . . . 0.0 112.543 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 22' ' ' LYS . 15.5 mt -90.54 -48.49 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.857 -1.152 . . . . 0.0 109.229 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.941 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 0.9 OUTLIER -62.56 -36.81 83.84 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.021 HG21 HG21 ' A' ' 9' ' ' VAL . 60.4 t -65.54 -48.13 83.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.653 ' O ' HG21 ' A' ' 34' ' ' VAL . 44.6 tttm -42.71 -54.19 4.16 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.634 -0.666 . . . . 0.0 110.669 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -71.44 -26.02 62.56 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.163 -0.961 . . . . 0.0 111.473 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.838 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -65.11 -55.37 19.13 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.302 -0.874 . . . . 0.0 110.818 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.99 ' HB3' HG11 ' A' ' 45' ' ' VAL . 3.2 mp -69.71 -31.65 69.78 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.099 -1.001 . . . . 0.0 110.534 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.569 ' HA ' HG11 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -68.23 -22.08 64.8 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.239 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -112.46 1.09 15.78 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.025 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.579 HG13 ' N ' ' A' ' 29' ' ' GLU . 7.6 p -45.7 -46.94 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.883 -1.136 . . . . 0.0 110.627 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.579 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.4 OUTLIER 173.17 -80.43 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.897 -1.127 . . . . 0.0 110.891 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.534 ' H ' ' HB2' ' A' ' 52' ' ' ALA . . . -92.41 -14.77 55.19 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 120.006 -1.093 . . . . 0.0 110.528 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.589 HG11 ' O ' ' A' ' 25' ' ' LEU . 9.6 t -42.43 139.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.027 -1.278 . . . . 0.0 110.428 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.1 t -118.32 -10.66 10.17 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.474 0.654 . . . . 0.0 109.245 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -154.0 164.59 38.19 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.264 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.888 HG23 HG13 ' A' ' 45' ' ' VAL . 6.4 p -152.94 174.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.581 -0.699 . . . . 0.0 109.242 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.519 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . 1.2 t0 -162.3 160.01 26.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.832 -1.168 . . . . 0.0 111.378 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.008 HG13 ' HB2' ' A' ' 18' ' ' PRO . 25.1 t -110.07 136.08 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.487 -0.758 . . . . 0.0 109.963 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -138.63 61.75 0.57 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.626 ' CD2' ' CG ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -58.87 -23.48 60.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -1.135 . . . . 0.0 110.326 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -42.99 -40.77 3.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.864 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.539 ' CG ' ' HG2' ' A' ' 42' ' ' GLU . 12.9 ptpt -139.21 49.2 1.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.29 -0.881 . . . . 0.0 110.421 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.562 ' CD ' ' HB3' ' A' ' 12' ' ' MET . 0.0 OUTLIER 39.47 62.31 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.505 -0.747 . . . . 0.0 110.299 179.801 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HG2' ' CG ' ' A' ' 40' ' ' LYS . 2.0 pp20? -146.42 141.55 27.27 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.435 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 7' ' ' LEU . . . -115.1 136.29 53.27 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.047 ' CG2' HG22 ' A' ' 6' ' ' THR . 1.6 t -106.24 143.68 16.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 O-C-N 120.233 -1.542 . . . . 0.0 109.355 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.99 HG11 ' HB3' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -142.51 153.49 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.797 -178.059 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -123.75 151.3 43.4 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.932 ' CE2' HD11 ' A' ' 57' ' ' LEU . 31.9 p90 -167.52 -173.42 2.2 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 117.747 -1.581 . . . . 0.0 112.639 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 39.4 m-20 -105.59 118.49 36.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -66.15 -1.66 3.45 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.214 -177.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.427 HG22 ' HB3' ' A' ' 48' ' ' ASP . 13.0 t -86.27 -20.49 28.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.043 -1.036 . . . . 0.0 110.525 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -128.47 -14.94 4.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.887 -1.133 . . . . 0.0 111.707 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB2' ' H ' ' A' ' 30' ' ' GLY . . . -143.25 -170.39 3.26 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.023 -1.048 . . . . 0.0 110.137 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.632 ' HA ' ' CZ ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 174.15 167.92 0.22 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.911 . . . . 0.0 109.873 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.931 HG23 HG21 ' A' ' 70' ' ' VAL . 2.5 p -42.73 -49.81 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 110.215 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.562 ' H ' HG13 ' A' ' 54' ' ' VAL . 7.3 tt0 -45.09 -47.04 12.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.035 -1.041 . . . . 0.0 109.867 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.515 ' O ' HG21 ' A' ' 28' ' ' VAL . 11.2 mmtm -75.6 -27.09 58.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.43 -0.794 . . . . 0.0 111.437 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.932 HD11 ' CE2' ' A' ' 47' ' ' PHE . 68.5 mt -68.63 -57.69 5.35 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.602 -1.311 . . . . 0.0 108.761 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 62' ' ' ALA . 4.0 m -56.22 -29.61 61.2 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.381 -0.824 . . . . 0.0 109.45 179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 3.9 tttm -76.98 -29.52 55.55 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.297 -0.877 . . . . 0.0 109.699 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.765 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -69.97 -47.2 63.22 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.412 -0.805 . . . . 0.0 109.253 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.835 ' OG1' HG13 ' A' ' 21' ' ' VAL . 10.2 t -70.15 -32.95 71.18 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . -68.14 -26.05 65.59 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.658 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 20.1 t0 -89.83 -13.34 36.77 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.941 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -80.27 -28.25 38.43 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.589 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 138.88 26.2 0.29 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.773 -1.203 . . . . 0.0 111.11 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.824 ' CB ' HG23 ' A' ' 9' ' ' VAL . 36.0 m-85 -151.38 105.2 2.93 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.655 -1.497 . . . . 0.0 110.993 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 66' ' ' TYR . 3.0 Cg_exo -55.38 101.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 N-CA-C 107.184 -1.891 . . . . 0.0 107.184 177.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.53 ' HB3' HG23 ' A' ' 61' ' ' THR . 0.1 OUTLIER -107.94 -169.68 1.56 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.19 -1.004 . . . . 0.0 112.642 -176.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.529 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -152.38 -165.23 2.15 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.989 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.8 p -137.95 157.81 32.68 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 120.513 -1.367 . . . . 0.0 111.733 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.52 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -122.87 27.26 7.8 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 122.058 0.932 . . . . 0.0 109.639 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.594 ' HA ' HG13 ' A' ' 5' ' ' VAL . 34.3 mt-30 . . . . . 0 C--N 1.29 -2.019 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.531 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.618 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.167 0.508 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -146.88 89.88 1.86 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.358 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -109.13 153.26 23.97 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 121.874 0.845 . . . . 0.0 112.103 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 45' ' ' VAL . 5.4 t -123.45 143.27 50.25 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.769 HG13 ' HA ' ' A' ' 72' ' ' GLN . 1.5 t -149.49 160.95 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.212 -0.93 . . . . 0.0 109.152 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.687 ' O ' HD12 ' A' ' 7' ' ' LEU . 1.8 t -106.97 158.71 16.82 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.968 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -128.85 161.47 29.73 Favored 'General case' 0 C--N 1.276 -2.619 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.525 -177.601 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -109.43 101.15 10.14 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.816 -179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.84 HG22 ' SG ' ' A' ' 17' ' ' CYS . 3.5 p -115.21 90.3 23.66 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.8 Cg_endo -77.41 45.35 1.71 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.545 1.496 . . . . 0.0 112.822 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.609 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -95.11 -34.04 6.33 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 1.2 mmt 54.3 -88.86 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 O-C-N 121.52 -0.988 . . . . 0.0 108.923 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 1.142 ' CG2' ' HB3' ' A' ' 16' ' ' ALA . 0.4 OUTLIER 58.31 9.76 1.11 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.592 179.768 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.467 ' CB ' ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER 68.2 110.84 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.441 -0.787 . . . . 0.0 112.319 178.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 14' ' ' CYS . . . 33.19 48.81 0.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.841 -0.537 . . . . 0.0 112.375 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.142 ' HB3' ' CG2' ' A' ' 13' ' ' THR . . . -151.26 -40.91 0.12 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.038 -1.039 . . . . 0.0 109.513 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.84 ' SG ' HG22 ' A' ' 9' ' ' VAL . 13.7 t -56.08 -41.35 90.55 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.002 -1.061 . . . . 0.0 110.834 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 1.021 ' O ' HG11 ' A' ' 36' ' ' VAL . 7.6 Cg_endo -78.35 -5.52 15.02 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 121.068 1.179 . . . . 0.0 111.661 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.9 mt -91.21 -35.52 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.831 -1.168 . . . . 0.0 108.672 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.933 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.2 m -75.94 -35.75 59.61 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.927 ' O ' HD12 ' A' ' 25' ' ' LEU . 81.9 t -66.08 -46.06 88.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.815 ' HG3' HG13 ' A' ' 34' ' ' VAL . 7.8 tttm -51.39 -54.61 24.8 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.101 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -72.87 -12.88 61.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.144 -0.972 . . . . 0.0 111.299 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.652 ' HB2' ' HB2' ' A' ' 64' ' ' ALA . . . -76.15 -63.61 1.28 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.956 -1.09 . . . . 0.0 109.649 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.928 HD21 ' CD2' ' A' ' 7' ' ' LEU . 3.5 mp -58.54 -33.8 70.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.495 -0.753 . . . . 0.0 110.081 179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.517 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -70.46 -27.81 64.52 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.151 179.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -87.76 -9.57 53.58 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.322 -0.862 . . . . 0.0 109.942 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.762 HG12 ' N ' ' A' ' 29' ' ' GLU . 3.0 t -43.3 -80.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.327 -0.858 . . . . 0.0 110.133 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.762 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER 172.35 -57.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.385 -0.822 . . . . 0.0 109.242 -179.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.89 -26.21 38.53 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 25' ' ' LEU . 51.4 t -50.83 133.87 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -1.091 . . . . 0.0 110.324 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.9 m -115.0 -14.75 11.83 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.646 0.736 . . . . 0.0 109.218 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.754 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -153.63 159.64 42.16 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.27 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.815 HG13 ' HG3' ' A' ' 22' ' ' LYS . 7.1 p -156.84 157.13 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 110.203 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.584 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -158.1 171.52 20.07 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.227 -0.921 . . . . 0.0 110.113 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.021 HG11 ' O ' ' A' ' 18' ' ' PRO . 19.2 m -144.55 156.32 14.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.364 -0.835 . . . . 0.0 110.333 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.28 106.98 0.41 Allowed Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.606 ' CD2' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -67.91 -25.54 65.54 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -1.091 . . . . 0.0 109.238 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -56.83 -23.55 44.69 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.354 -0.841 . . . . 0.0 108.984 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.524 ' O ' ' C ' ' A' ' 41' ' ' ARG . 6.7 tptm -138.93 33.18 2.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.546 -0.721 . . . . 0.0 109.807 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.575 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 8.7 tpm_? 22.35 60.2 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.225 0.535 . . . . 0.0 112.391 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.553 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 24.6 pt-20 -148.91 170.36 18.47 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.298 -0.876 . . . . 0.0 110.335 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.765 ' HB2' HG11 ' A' ' 21' ' ' VAL . . . -128.22 130.18 47.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.667 -1.27 . . . . 0.0 109.702 179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 44' ' ' VAL . 15.0 p -105.27 117.87 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.796 -1.19 . . . . 0.0 109.415 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.798 ' CG1' HD13 ' A' ' 57' ' ' LEU . 7.2 p -126.3 150.77 32.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 122.257 1.027 . . . . 0.0 112.926 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -110.3 153.93 24.19 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.822 ' CD2' HD11 ' A' ' 57' ' ' LEU . 37.7 p90 -168.81 178.58 4.54 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 117.872 -1.531 . . . . 0.0 111.987 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.618 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 9.3 m-20 -105.55 124.88 50.28 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 8.4 t0 -79.46 26.94 0.28 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.494 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.47 -29.07 11.82 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.941 -1.1 . . . . 0.0 109.145 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -123.77 -7.8 7.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.517 -0.739 . . . . 0.0 110.097 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 53' ' ' SER . . . -146.98 -164.77 2.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.454 -0.779 . . . . 0.0 109.498 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.597 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER 174.06 164.28 0.2 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.243 -0.91 . . . . 0.0 110.08 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.08 HG22 HG21 ' A' ' 70' ' ' VAL . 7.9 p -44.86 -42.96 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.571 ' N ' HG13 ' A' ' 54' ' ' VAL . 23.0 tt0 -55.88 -43.84 77.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.142 -0.973 . . . . 0.0 109.358 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -73.75 -22.33 59.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.501 -0.749 . . . . 0.0 110.572 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.87 HD12 ' HA ' ' A' ' 54' ' ' VAL . 90.8 mt -69.93 -55.76 8.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.776 -1.203 . . . . 0.0 108.391 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.52 ' N ' HD21 ' A' ' 7' ' ' LEU . 59.5 m -56.87 -35.62 69.12 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 62' ' ' ALA . 16.9 tttt -73.24 -26.86 61.29 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.333 -0.854 . . . . 0.0 109.585 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.708 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -68.31 -50.68 51.81 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.414 -0.804 . . . . 0.0 109.379 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.792 ' OG1' HG22 ' A' ' 21' ' ' VAL . 6.6 t -67.12 -32.14 73.08 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 59' ' ' LYS . . . -63.1 -32.27 73.61 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.058 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -88.54 -11.09 46.67 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.461 -0.774 . . . . 0.0 109.129 178.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.933 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -76.85 -31.8 57.1 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.572 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 142.9 32.18 0.11 Allowed Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.569 -1.301 . . . . 0.0 110.902 179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.821 ' CB ' HG23 ' A' ' 9' ' ' VAL . 72.8 m-85 -159.17 107.84 1.54 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.698 -1.472 . . . . 0.0 111.291 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -56.27 99.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 N-CA-C 106.687 -2.082 . . . . 0.0 106.687 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.525 ' OG ' HG23 ' A' ' 61' ' ' THR . 60.3 p -108.42 -165.43 1.03 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.166 -0.959 . . . . 0.0 112.514 -176.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.86 -161.36 1.32 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.08 HG21 HG22 ' A' ' 54' ' ' VAL . 3.3 p -141.62 157.93 21.34 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 O-C-N 120.832 -1.167 . . . . 0.0 111.33 -179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.547 ' CG ' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -129.42 27.53 5.29 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.427 1.108 . . . . 0.0 109.002 179.917 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.769 ' HA ' HG13 ' A' ' 5' ' ' VAL . 10.9 pt20 . . . . . 0 C--N 1.289 -2.065 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.292 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.658 ' O ' ' HA ' ' A' ' 48' ' ' ASP . . . . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.113 0.483 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -142.41 91.94 2.37 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -107.86 164.14 12.51 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.821 0.82 . . . . 0.0 112.236 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 t -131.59 128.12 38.54 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.445 0.64 . . . . 0.0 110.144 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.904 HG13 ' HA ' ' A' ' 72' ' ' GLN . 5.4 t -139.35 168.08 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.438 -0.789 . . . . 0.0 109.148 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.756 ' O ' HD12 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -108.77 171.57 7.35 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.604 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.985 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -134.33 159.36 41.25 Favored 'General case' 0 C--N 1.287 -2.121 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.917 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 68' ' ' SER . . . -113.02 99.25 7.71 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.175 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.898 HG21 ' CG2' ' A' ' 21' ' ' VAL . 2.1 p -112.68 101.74 53.31 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 109.277 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 8' ' ' ALA . 9.7 Cg_endo -77.63 39.83 0.79 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.494 1.463 . . . . 0.0 111.748 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.648 ' HA3' ' CD1' ' A' ' 66' ' ' TYR . . . -82.76 -51.24 4.34 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.482 ' HB2' ' HD2' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 42.97 57.23 3.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.538 -0.977 . . . . 0.0 109.916 -179.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.834 ' HB ' ' HB3' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -87.94 15.07 7.68 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.273 179.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.684 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 4.0 t 65.51 87.36 0.12 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.542 -0.724 . . . . 0.0 110.265 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.747 ' O ' HD12 ' A' ' 19' ' ' ILE . . . 68.26 29.72 5.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 0.0 110.089 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.834 ' HB3' ' HB ' ' A' ' 13' ' ' THR . . . -138.56 -48.16 0.52 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 109.764 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.609 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -55.31 -47.4 98.67 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.411 -0.806 . . . . 0.0 111.206 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 17' ' ' CYS . 9.2 Cg_endo -71.89 -9.44 24.73 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 120.895 1.063 . . . . 0.0 112.219 -178.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.747 HD12 ' O ' ' A' ' 15' ' ' ALA . 20.6 mt -93.13 -37.86 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.787 -1.195 . . . . 0.0 109.842 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.905 ' CG2' ' HB1' ' A' ' 64' ' ' ALA . 1.2 m -77.02 -40.8 45.16 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.898 ' CG2' HG21 ' A' ' 9' ' ' VAL . 97.6 t -62.88 -45.45 98.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.827 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.871 ' HG3' HG12 ' A' ' 34' ' ' VAL . 39.7 tttt -54.04 -55.58 26.08 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.174 -0.954 . . . . 0.0 109.853 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.551 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -75.9 -0.94 23.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 111.223 -179.484 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.557 ' HB3' HD13 ' A' ' 25' ' ' LEU . . . -80.95 -64.41 1.19 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.722 -1.236 . . . . 0.0 108.843 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.898 HD13 ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.06 -24.63 65.99 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.795 ' C ' HG11 ' A' ' 31' ' ' VAL . 3.3 t -72.66 -26.66 61.72 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -97.43 -5.23 36.64 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 121.329 -0.857 . . . . 0.0 110.378 179.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 25' ' ' LEU . 2.7 t -46.09 -59.99 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.52 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.568 ' CB ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER 158.1 -72.22 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 121.433 0.635 . . . . 0.0 110.225 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -69.24 -27.23 73.91 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.795 HG11 ' C ' ' A' ' 26' ' ' SER . 8.0 p -39.68 139.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.427 -1.043 . . . . 0.0 110.484 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.34 -14.67 9.19 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.536 0.684 . . . . 0.0 109.63 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.686 ' O ' HG23 ' A' ' 34' ' ' VAL . 9.7 ttmm -162.96 164.7 25.65 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.114 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.894 HG22 HG22 ' A' ' 45' ' ' VAL . 52.7 t -159.51 150.64 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.076 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.682 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -142.36 169.25 17.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 0.0 109.503 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 18' ' ' PRO . 62.9 t -108.99 151.5 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.118 -0.989 . . . . 0.0 110.981 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.67 60.04 0.49 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.594 ' CD1' ' HG3' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -60.93 -23.74 65.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.515 -0.991 . . . . 0.0 110.544 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.02 -21.9 2.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.999 -1.063 . . . . 0.0 109.35 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 41' ' ' ARG . 21.5 mttt -143.05 39.45 1.46 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -0.758 . . . . 0.0 110.077 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.482 ' HD2' ' HB2' ' A' ' 12' ' ' MET . 1.5 ttp180 36.22 60.21 0.88 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.633 -0.667 . . . . 0.0 111.134 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -152.22 168.43 25.39 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.476 -0.889 . . . . 0.0 111.338 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 6' ' ' THR . . . -131.17 139.09 49.7 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 109.327 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.733 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.0 p -107.78 109.41 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.841 -1.162 . . . . 0.0 110.145 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.894 HG22 HG22 ' A' ' 34' ' ' VAL . 53.8 t -111.21 159.1 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-O 122.414 1.102 . . . . 0.0 112.915 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 33' ' ' LYS . 1.2 m -123.59 150.72 43.76 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 177.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.642 ' O ' ' HA ' ' A' ' 2' ' ' THR . 32.7 p90 -171.62 -176.29 1.76 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 117.004 -1.878 . . . . 0.0 112.979 -179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.658 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -105.38 114.14 28.15 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 178.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 52' ' ' ALA . 14.6 t70 -62.67 -6.76 3.85 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.143 -177.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.5 p -83.73 -25.51 30.51 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.052 -1.03 . . . . 0.0 110.945 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 1.1 mmmt -116.55 -7.15 11.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.924 -1.11 . . . . 0.0 110.726 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 49' ' ' ASP . . . 179.43 -179.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 110.056 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.59 ' HA ' ' CE1' ' A' ' 47' ' ' PHE . 2.0 p 172.17 -172.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.134 -0.979 . . . . 0.0 110.323 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.942 HG22 HG21 ' A' ' 70' ' ' VAL . 9.3 t -36.53 -38.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.539 -0.725 . . . . 0.0 111.003 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -55.97 -51.88 66.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.151 -0.968 . . . . 0.0 110.497 -179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.49 ' HB3' HG13 ' A' ' 28' ' ' VAL . 11.3 mmtp -82.93 -17.64 42.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 112.085 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 ' HB2' ' A' ' 25' ' ' LEU . 37.2 mt -74.41 -53.82 8.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.353 -1.467 . . . . 0.0 108.455 179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.488 ' CG2' ' HA ' ' A' ' 69' ' ' SER . 3.2 m -59.89 -35.62 75.23 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.032 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER -73.21 -29.02 62.5 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.311 -0.868 . . . . 0.0 110.206 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.526 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -70.48 -43.68 69.25 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.067 -1.021 . . . . 0.0 109.704 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.592 HG23 ' HB2' ' A' ' 68' ' ' SER . 2.8 t -73.06 -29.1 62.71 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.74 68.61 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.55 -10.8 42.15 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.516 -0.74 . . . . 0.0 109.22 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.905 ' HB1' ' CG2' ' A' ' 20' ' ' THR . . . -81.61 -29.46 33.29 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.455 ' O ' ' CD1' ' A' ' 66' ' ' TYR . . . 141.21 23.67 0.24 Allowed Glycine 0 N--CA 1.487 2.071 0 C-N-CA 119.618 -1.277 . . . . 0.0 111.471 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.703 ' CB ' HG23 ' A' ' 9' ' ' VAL . 56.1 m-85 -146.62 113.68 4.35 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.34 -1.682 . . . . 0.0 111.366 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.76 91.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 106.874 -2.01 . . . . 0.0 106.874 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.592 ' HB2' HG23 ' A' ' 61' ' ' THR . 55.0 m -108.79 -170.22 1.63 Allowed 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.178 -0.951 . . . . 0.0 112.995 -176.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.488 ' HA ' ' CG2' ' A' ' 58' ' ' THR . 2.3 m -160.13 -159.95 0.75 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.985 HG23 ' CD1' ' A' ' 7' ' ' LEU . 3.2 p -139.37 161.53 27.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 120.921 -1.112 . . . . 0.0 111.172 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.721 ' HG3' HG23 ' A' ' 6' ' ' THR . 4.3 mttt -122.31 24.0 9.54 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 122.264 1.031 . . . . 0.0 110.133 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.904 ' HA ' HG13 ' A' ' 5' ' ' VAL . 10.2 tt0 . . . . . 0 C--N 1.284 -2.252 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.369 179.464 . . . . . . . . 1 1 . 1 stop_ save_